<SEC-DOCUMENT>0001213900-26-035558.txt : 20260327
<SEC-HEADER>0001213900-26-035558.hdr.sgml : 20260327
<ACCEPTANCE-DATETIME>20260327163143
ACCESSION NUMBER:		0001213900-26-035558
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		54
CONFORMED PERIOD OF REPORT:	20251231
FILED AS OF DATE:		20260327
DATE AS OF CHANGE:		20260327

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Talon Capital Corp.
		CENTRAL INDEX KEY:			0002073340
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42827
		FILM NUMBER:		26807921

	BUSINESS ADDRESS:	
		STREET 1:		440 LOUISIANA STREET, SUITE 1050
		STREET 2:		C/O TALON CAPITAL CORP.
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002
		BUSINESS PHONE:		713-882-2818

	MAIL ADDRESS:	
		STREET 1:		440 LOUISIANA STREET, SUITE 1050
		STREET 2:		C/O TALON CAPITAL CORP.
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77002
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ea0280278-10k_talon.htm
<DESCRIPTION>ANNUAL REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:tlnc="http://TCC.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title>tlnc-20251231</title>
    <meta http-equiv="Content-Type" content="text/html"/>
  </head>
  <body>
    <div style="display:none">
      <ix:header>
        <ix:hidden>
          <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="cref_1598680374" id="fc_1730245694" unitRef="uref_504548813" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="cref_1598680374" id="fc_314223251" unitRef="uref_504548813" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="cref_1598680374" id="fc_889220744" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="cref_1598680374" id="fc_1663220068" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:CashEquivalentsAtCarryingValue" contextRef="cref_1598680374" id="fc_329852981" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefits" contextRef="cref_1598680374" id="fc_551881478" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" contextRef="cref_1598680374" id="fc_1991878236" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="dei:EntityPublicFloat" contextRef="cref_1638414482" id="fc_1638414482" unitRef="uref_144417410" scale="0" decimals="0">0</ix:nonFraction>
          <ix:nonFraction name="tlnc:WorkingCapitalLoan" contextRef="cref_1598680374" id="fc_311650695" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="tlnc:WorkingCapitalLoan" contextRef="cref_319930502" id="fc_319930502" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="cref_1494614152" id="fc_1494614152" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="cref_1598680374" id="fc_1417777316" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="cref_1598680374" id="fc_1674121332" unitRef="uref_504548813" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="cref_1598680374" id="fc_2010543561" unitRef="uref_504548813" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="cref_901612146" id="fc_901612146" unitRef="uref_504548813" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_901612146" id="fc_2017060097" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="cref_1432657015" id="fc_1432657015" unitRef="uref_504548813" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_1432657015" id="fc_1059445731" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_1401430648" id="fc_1401430648" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_2094209686" id="fc_2094209686" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_1062287955" id="fc_1062287955" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="cref_619454683" id="fc_1492816628" unitRef="uref_504548813" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="cref_619454683" id="fc_1690999302" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="cref_773573791" id="fc_897486254" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_1009755242" id="fc_1009755242" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="cref_619454683" id="fc_563129179" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="cref_1134712074" id="fc_1964059568" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="cref_1598084499" id="fc_1865024795" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="tlnc:StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits" contextRef="cref_1134712074" id="fc_75135273" unitRef="uref_504548813" xsi:nil="true"></ix:nonFraction>
          <ix:nonNumeric name="us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" contextRef="cref_144417410" id="fc_444643047">http://fasb.org/srt/2025#ChiefFinancialOfficerMember</ix:nonNumeric>
          <ix:nonFraction name="tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" contextRef="cref_1134712074" id="fc_200090691" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" contextRef="cref_773573791" id="fc_1848862879" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="cref_619454683" id="fc_1017008916" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="cref_1134712074" id="fc_1590491764" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="cref_773573791" id="fc_1229468603" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="cref_619454683" id="fc_1965622921" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="cref_1134712074" id="fc_854596447" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="cref_773573791" id="fc_1007521328" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" contextRef="cref_619454683" id="fc_471349154" unitRef="uref_504548813" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="cref_619454683" id="fc_54547320" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="cref_773573791" id="fc_1992560591" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="cref_144417410" id="fc_1390649182" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" contextRef="cref_619454683" id="fc_2094758649" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" contextRef="cref_1134712074" id="fc_1230420796" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" contextRef="cref_773573791" id="fc_131382469" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="cref_619454683" id="fc_855132543" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="cref_1134712074" id="fc_424924864" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="cref_1062287955" id="fc_764535795" unitRef="uref_144417410" xsi:nil="true"></ix:nonFraction>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="cref_1363532388" id="ixv-7332">0002073340</ix:nonNumeric>
          <ix:nonNumeric name="dei:AmendmentFlag" contextRef="cref_1363532388" id="ixv-7333">false</ix:nonNumeric>
          <ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="cref_1363532388" id="ixv-7334">FY</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="cref_1363532388" id="fc_226643184">00-0000000</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:arcrole="http://www.xbrl.org/2003/linkbase" xlink:href="tlnc-20251231.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="cref_1363532388">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-01-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_144417410">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1598680374">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_504548813">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1997855338">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_15768048">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tlnc:InterestRateMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_4055154">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tlnc:UnderwritingAgreementMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1318230788">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_126252359">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tlnc:UnderwritingAgreementMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_900732289">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1878519263">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-09-10</xbrli:startDate>
              <xbrli:endDate>2025-09-10</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1979561439">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-09-10</xbrli:startDate>
              <xbrli:endDate>2025-09-10</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1598308813">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_2070764536">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-09-08</xbrli:startDate>
              <xbrli:endDate>2025-09-08</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_674618302">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_2100456949">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_625298015">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_443971720">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCommodityMarketPriceMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_15267773">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1837988368">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1476606103">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-19</xbrli:startDate>
              <xbrli:endDate>2025-08-19</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_2028565431">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tlnc:FounderShareMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-08-19</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_2086386178">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tlnc:FounderShareMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1752672645">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tlnc:FounderShareMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_612105669">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-19</xbrli:startDate>
              <xbrli:endDate>2025-05-19</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_579383359">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tlnc:FounderShareMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-08</xbrli:startDate>
              <xbrli:endDate>2025-08-08</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1043056355">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-05-19</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_211807459">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-19</xbrli:startDate>
              <xbrli:endDate>2025-05-19</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_2107376139">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-19</xbrli:startDate>
              <xbrli:endDate>2025-05-19</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_259879653">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_837988157">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_105847728">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">tlnc:CohenMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1460463040">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">tlnc:CohenMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1963271763">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_331339811">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1095302256">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">tlnc:BusinessCombinationMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1268440538">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1077089133">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1366525390">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PublicWarrantMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_8341221">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-09-10</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1599573526">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PublicWarrantMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-09-10</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_880262097">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-09-10</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_458958402">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-09-10</xbrli:startDate>
              <xbrli:endDate>2025-09-10</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1115681054">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_198494574">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_726559528">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:ClassAOrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_81526736">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:ClassAOrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1715140789">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1543401983">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-13</xbrli:startDate>
              <xbrli:endDate>2025-11-13</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_540106651">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-09-10</xbrli:startDate>
              <xbrli:endDate>2025-09-10</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1789825159">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-09-10</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_966747690">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-09-10</xbrli:startDate>
              <xbrli:endDate>2025-09-10</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1352034729">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-11-13</xbrli:startDate>
              <xbrli:endDate>2025-11-13</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1620148570">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-09-10</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1637193316">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:CantorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1640571159">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1853513846">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_254867204">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1760969002">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_224377445">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-09-10</xbrli:startDate>
              <xbrli:endDate>2025-09-10</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1797476635">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-09-10</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_553879265">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-09-10</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_551854395">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-08-08</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_748934610">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_826432462">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_630293842">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_773573791">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1598084499">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1134712074">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_619454683">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-05-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1174554270">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-09-10</xbrli:startDate>
              <xbrli:endDate>2025-09-10</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_837726882">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-09-10</xbrli:startDate>
              <xbrli:endDate>2025-09-10</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_194733324">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-12-31</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1408966713">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-08-08</xbrli:startDate>
              <xbrli:endDate>2025-08-08</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_360148395">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2026-03-25</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1108974510">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2026-03-25</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_98240749">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-01-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_428742915">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:ClassAOrdinarySharesParValue00001PerShareMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-01-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_2032037207">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-01-01</xbrli:startDate>
              <xbrli:endDate>2025-12-31</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1638414482">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-06-30</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_319930502">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1494614152">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_901612146">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-04-30</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1432657015">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-04-30</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1401430648">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-04-30</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_2094209686">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-04-30</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1062287955">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-04-30</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:context id="cref_1009755242">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0002073340</xbrli:identifier>
              <xbrli:segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
              </xbrli:segment>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:instant>2025-12-31</xbrli:instant>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="uref_144417410">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="uref_493518290">
            <xbrli:measure>tlnc:Segment</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="uref_714491979">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="uref_504548813">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="uref_533780696">
            <xbrli:divide>
              <xbrli:unitNumerator>
                <xbrli:measure>iso4217:USD</xbrli:measure>
              </xbrli:unitNumerator>
              <xbrli:unitDenominator>
                <xbrli:measure>xbrli:shares</xbrli:measure>
              </xbrli:unitDenominator>
            </xbrli:divide>
          </xbrli:unit>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="fref_373772643" fromRefs="fc_711145113 fc_2078487242 fc_727457337 fc_201246941 fc_683422140"/>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="fref_194607409" fromRefs="fc_683422140 fc_201246941 fc_727457337 fc_2078487242 fc_711145113"/>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="fref_1220979658" fromRefs="fc_388358174 fc_1591609912"/>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="fref_1829989901" fromRefs="fc_1432657015 fc_678866056 fc_2135791975 fc_75135273 fc_1780571263"/>
          <ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" toRefs="fref_1339534370" fromRefs="fc_1780571263 fc_75135273 fc_2135791975 fc_678866056 fc_1432657015"/>
        </ix:resources>
      </ix:header>
    </div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">UNITED STATES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">Washington, D.C. 20549</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <span style="font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="cref_1363532388" id="ixv-8025">10-K</ix:nonNumeric></span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric name="dei:DocumentAnnualReport" contextRef="cref_1363532388" format="ixt:fixed-true" id="ixv-8026">&#9746;</ix:nonNumeric></span>&#160;<span style="font-weight: bold;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <span style="font-weight: bold;">For the fiscal year ended <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="cref_1363532388" format="ixt:date-monthname-day-year-en" id="ixv-8027"><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="cref_1363532388" format="ixt:date-monthname-day-en" id="ixv-8028">December 31</ix:nonNumeric>, <ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="cref_1363532388" format="ixt:num-dot-decimal" id="ixv-8029">2025</ix:nonNumeric></ix:nonNumeric></span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">OR</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric name="dei:DocumentTransitionReport" contextRef="cref_1363532388" format="ixt:fixed-false" id="ixv-8030">&#9744;</ix:nonNumeric></span>&#160;<span style="font-weight: bold;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="cref_1363532388" id="ixv-8031">Talon Capital Corp.</ix:nonNumeric></span>&#160; </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">(Exact name of registrant as specified in its
charter)</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top"> <td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="cref_1363532388" format="ixt-sec:edgarprovcountryen" id="ixv-8032">Cayman Islands</ix:nonNumeric></span></span></td><td style="text-align: center; width: 2%">&#160;</td><td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="cref_1363532388" id="ixv-8033">001-42827</ix:nonNumeric></span></span></td><td style="text-align: center; width: 2%">&#160;</td><td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><span style="font-weight: bold;"><span style="-sec-ix-hidden:fc_226643184">N/A</span></span></span></td> </tr>
<tr style="vertical-align: top">
<td>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">(State or other jurisdiction of</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">incorporation or organization)</span></p></td>
<td style="text-align: center">&#160;</td>
<td style="text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;">(Commission File Number)</span></span></td>
<td>&#160;</td>
<td>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">(I.R.S. Employer</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">Identification Number) </span></p></td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr> <td style="vertical-align: top; border-bottom: black 1.5pt solid; width: 49%"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="cref_1363532388" id="ixv-8034">440 Louisiana Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" contextRef="cref_1363532388" id="ixv-8035">Suite 1050</ix:nonNumeric></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="cref_1363532388" id="ixv-8036">Houston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="cref_1363532388" format="ixt-sec:stateprovnameen" id="ixv-8037">Texas</ix:nonNumeric></span></p></td><td style="vertical-align: top; width: 2%">&#160;</td><td style="vertical-align: bottom; border-bottom: black 1.5pt solid; text-align: center; width: 49%"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="cref_1363532388" id="ixv-8038">77002</ix:nonNumeric></span></span></td> </tr>
<tr style="vertical-align: top">
<td style="text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;">(Address of principal executive offices)</span></span></td>
<td>&#160;</td>
<td style="text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;">(Zip Code)</span></span></td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <span style="font-weight: bold;"><ix:nonNumeric name="dei:CityAreaCode" contextRef="cref_1363532388" id="ixv-8039">(281)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="cref_1363532388" id="ixv-8040">407-0686</ix:nonNumeric></span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">(Registrant&#8217;s telephone number, including
area code)</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">Not Applicable</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">(Former name, former address and former fiscal
year, if changed since last report)</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">Securities registered pursuant to Section 12(b)
of the Act:</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: bottom">
<td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><span style="font-weight: bold;">Title of Each Class:</span></span></td>
<td style="text-align: center; width: 2%">&#160;</td>
<td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><span style="font-weight: bold;">Trading Symbol:</span></span></td>
<td style="text-align: center; width: 2%">&#160;</td>
<td style="border-bottom: black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><span style="font-weight: bold;">Name of Each Exchange on Which Registered:</span></span></td></tr>
<tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="cref_2032037207" id="ixv-8041">Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant</ix:nonNumeric></span></span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="cref_2032037207" id="ixv-8042">TLNCU</ix:nonNumeric></span></span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="cref_2032037207" format="ixt-sec:exchnameen" id="ixv-8043">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td> </tr>
<tr style="background-color: White"> <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="cref_428742915" id="ixv-8044">Class A ordinary shares, par value $0.0001 per share</ix:nonNumeric></span></span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="cref_428742915" id="ixv-8045">TLNC</ix:nonNumeric></span></span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="cref_428742915" format="ixt-sec:exchnameen" id="ixv-8046">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td> </tr>
<tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" contextRef="cref_98240749" id="ixv-8047">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50</ix:nonNumeric></span></span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" contextRef="cref_98240749" id="ixv-8048">TLNCW</ix:nonNumeric></span></span></td><td style="vertical-align: top; text-align: center">&#160;</td><td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="cref_98240749" format="ixt-sec:exchnameen" id="ixv-8049">The Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td> </tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">Securities registered pursuant to Section 12(g)
of the Exchange Act: None</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"> Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span> <ix:nonNumeric name="dei:EntityWellKnownSeasonedIssuer" contextRef="cref_1363532388" id="ixv-8050">No</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span> </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"> Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span> <ix:nonNumeric name="dei:EntityVoluntaryFilers" contextRef="cref_1363532388" id="ixv-8051">No</ix:nonNumeric> <span style="font-family: Times New Roman, Times, Serif">&#9746;</span> </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Indicate by check mark whether the Registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d)&#160;of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the Registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. <ix:nonNumeric name="dei:EntityCurrentReportingStatus" contextRef="cref_1363532388" id="ixv-8052">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;No&#160;&#9744; </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric name="dei:EntityInteractiveDataCurrent" contextRef="cref_1363532388" id="ixv-8053">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;No&#160;&#9744; </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of &#8220;large
accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221;
in Rule&#160;12b-2 of the Exchange Act.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top"> <td style="text-align: left; width: 25%"><span style="font-size: 10pt">Large accelerated filer &#9744;&#160;</span></td><td style="text-align: left; width: 25%"><span style="font-size: 10pt">Accelerated filer &#9744;</span></td><td style="text-align: left; width: 25%"><span style="font-size: 10pt">&#160;<ix:nonNumeric name="dei:EntityFilerCategory" contextRef="cref_1363532388" format="ixt-sec:entityfilercategoryen" id="ixv-8054">Non-accelerated filer</ix:nonNumeric> &#9746;&#160;</span></td><td style="text-align: left; width: 25%"><span style="font-size: 10pt">Smaller reporting company <ix:nonNumeric name="dei:EntitySmallBusiness" contextRef="cref_1363532388" format="ixt:fixed-true" id="ixv-8055">&#9746;</ix:nonNumeric>&#160;</span></td> </tr>
<tr style="vertical-align: top"> <td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: left"><span style="font-size: 10pt">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="cref_1363532388" format="ixt:fixed-true" id="ixv-8056">&#9746;</ix:nonNumeric>&#160;</span></td> </tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;<span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric name="dei:EntityExTransitionPeriod" contextRef="cref_1363532388" format="ixt:fixed-false" id="ixv-8057">&#9744;</ix:nonNumeric></span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. <span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric name="dei:IcfrAuditorAttestationFlag" contextRef="cref_1363532388" format="ixt:fixed-false" id="ixv-8058">&#9744;</ix:nonNumeric></span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. <span style="font-family: Times New Roman, Times, Serif"><ix:nonNumeric name="dei:DocumentFinStmtErrorCorrectionFlag" contextRef="cref_1363532388" format="ixt:fixed-false" id="ixv-8059">&#9744;</ix:nonNumeric></span> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether any of those error corrections are restatements
that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive o&#64259;cers during
the relevant recovery period pursuant to &#167;240.10D-1(b). <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Indicate by check mark whether the Registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). Yes&#160;<ix:nonNumeric name="dei:EntityShellCompany" contextRef="cref_1363532388" format="ixt:fixed-true" id="ixv-8060">&#9746;</ix:nonNumeric>&#160;&#160;No&#160;&#9744; </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The registrant was <span style="-sec-ix-hidden:fc_1638414482">no</span>t a public company as of June 30, 2025 and therefore it cannot calculate the aggregate market value of its voting and non-voting common equity held by non-affiliates as of such date. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> As of March 25, 2026, there were&#160;<ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="cref_1108974510" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8061">25,679,000</ix:nonFraction>&#160;Class A ordinary shares, $0.0001 par value and&#160;<ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="cref_360148395" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8062">8,300,000</ix:nonFraction>&#160;Class B ordinary shares, $0.0001 par value, issued and outstanding. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">TABLE OF CONTENTS </p><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top"><a href="#a_001"><span style="font-weight: bold;">PART&#160;I</span></a></td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top; width: 9%">Item&#160;1.</td>
<td style="vertical-align: top; width: 83%"><a href="#a_002">Business.</a></td>
<td style="text-align: center; vertical-align: top; width: 8%">2</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 1A.</td>
<td style="vertical-align: top"><a href="#a_003">Risk Factors.</a></td>
<td style="text-align: center; vertical-align: top">20</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 1B.</td>
<td style="vertical-align: top"><a href="#a_004">Unresolved Staff Comments.</a></td>
<td style="text-align: center; vertical-align: top">56</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 1C.</td>
<td style="vertical-align: top"><a href="#a_005">Cybersecurity.</a></td>
<td style="text-align: center; vertical-align: top">56</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 2.</td>
<td style="vertical-align: top"><a href="#a_006">Properties.</a></td>
<td style="text-align: center; vertical-align: top">56</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 3.</td>
<td style="vertical-align: top"><a href="#a_007">Legal Proceedings.</a></td>
<td style="text-align: center; vertical-align: top">56</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 4.</td>
<td style="vertical-align: top"><a href="#a_008">Mine Safety Disclosures.</a></td>
<td style="text-align: center; vertical-align: top">56</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top"><a href="#a_009"><span style="font-weight: bold;">PART II</span></a></td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 5.</td>
<td style="vertical-align: top"><a href="#a_010">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.</a></td>
<td style="text-align: center; vertical-align: top">57</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 6.</td>
<td style="vertical-align: top"><a href="#a_011">[Reserved]</a></td>
<td style="text-align: center; vertical-align: top">57</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;7.</td>
<td style="vertical-align: top"><a href="#a_012">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</a></td>
<td style="text-align: center; vertical-align: top">57</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;7A.</td>
<td style="vertical-align: top"><a href="#a_013">Quantitative and Qualitative Disclosures About Market Risk.</a></td>
<td style="text-align: center; vertical-align: top">60</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 8.</td>
<td style="vertical-align: top"><a href="#a_014">Financial Statements and Supplementary Data.</a></td>
<td style="text-align: center; vertical-align: top">60</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 9.</td>
<td style="vertical-align: top"><a href="#a_015">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure.</a></td>
<td style="text-align: center; vertical-align: top">60</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;9A.</td>
<td style="vertical-align: top"><a href="#a_033">Controls and Procedures.</a></td>
<td style="text-align: center; vertical-align: top">60</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 9B.</td>
<td style="vertical-align: top"><a href="#a_016">Other Information.</a></td>
<td style="text-align: center; vertical-align: top">60</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item 9C.</td>
<td style="vertical-align: top"><a href="#a_017">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</a></td>
<td style="text-align: center; vertical-align: top">60</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top"><a href="#a_034"><span style="font-weight: bold;">PART&#160;III</span></a></td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;10.</td>
<td style="vertical-align: top"><a href="#a_018">Directors, Executive Officers and Corporate Governance.</a></td>
<td style="text-align: center; vertical-align: top">61</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;11.</td>
<td style="vertical-align: top"><a href="#a_019">Executive Compensation.</a></td>
<td style="text-align: center; vertical-align: top">68</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;12.</td>
<td style="vertical-align: top"><a href="#a_020">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.</a></td>
<td style="text-align: center; vertical-align: top">68</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;13.</td>
<td style="vertical-align: top"><a href="#a_021">Certain Relationships and Related Transactions, and Director Independence.</a></td>
<td style="text-align: center; vertical-align: top">70</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;14.</td>
<td style="vertical-align: top"><a href="#a_022">Principal Accountant Fees and Services.</a></td>
<td style="text-align: center; vertical-align: top">73</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top"><a href="#a_023"><span style="font-weight: bold;">PART IV</span></a></td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;15.</td>
<td style="vertical-align: top"><a href="#a_024">Exhibits and Financial Statement Schedules.</a></td>
<td style="text-align: center; vertical-align: top">74</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td style="vertical-align: top">Item&#160;16.</td>
<td style="vertical-align: top"><a href="#a_025">Form 10-K Summary.</a></td>
<td style="text-align: center; vertical-align: top">75</td></tr>
<tr style="background-color: White">
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: top">&#160;</td>
<td style="text-align: center; vertical-align: top">&#160;</td></tr>
<tr style="background-color: rgb(204,238,255)">
<td colspan="2" style="vertical-align: top"><a href="#a_026">SIGNATURES</a></td>
<td style="text-align: center; vertical-align: top">76</td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline"><span id="a_001" style="display: inline-block;"></span>PART I</span></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">Certain
statements in this Annual Report on Form 10-K (the &#8220;Annual Report&#8221;) may constitute &#8220;forward-looking statements&#8221;
for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our
or our management team&#8217;s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements
that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions,
are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221;
&#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221;
&#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and similar expressions
may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking
statements in this Annual Report may include, for example, statements about:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">our ability to complete our
initial business combination;</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">our expectations around the
performance of the prospective target business or businesses;</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">our success in retaining or
recruiting, or changes required in, our officers, key employees or directors following our initial business combination;</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">our officers and directors
allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial
business combination, as a result of which they would then receive expense reimbursements;</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">our potential ability to obtain
additional financing to complete our initial business combination;</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">the ability of our officers
and directors to generate a number of potential acquisition opportunities;</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">our public securities&#8217;
potential liquidity and trading;</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">the lack of a market for our
securities;</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">the use of proceeds not held
in the trust account or available to us from interest income on the trust account balance;</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">the trust account not being
subject to claims of third parties; or</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left"><span style="font-size: 10pt">our financial performance following
our initial public offering.</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">The
forward-looking statements contained in this Annual Report are based on our current expectations and beliefs concerning future developments
and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated.
These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions
that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements.
These risks and uncertainties include, but are not limited to, those factors described in the section of this Annual Report entitled &#8220;Risk
Factors.&#8221; Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual
results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or
revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under
applicable securities laws.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><span id="a_002" style="display: inline-block;"></span>ITEM 1. BUSINESS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">Overview</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Talon Capital Corp. (the
&#8220;Company&#8221;) is a blank check company, or special purpose acquisition company (&#8220;SPAC&#8221;), incorporated on May&#160;1,
2025, as a Cayman Islands exempted company and formed for the purpose of effecting a merger, share exchange, asset acquisition, share
purchase, recapitalization, reorganization or other similar business combination with one or more businesses, which we refer to throughout
this report as our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The registration statement for the Company&#8217;s initial public offering
(the &#8220;Initial Public Offering&#8221;) was declared effective on September 8, 2025. On September 10, 2025, the Company consummated
the Initial Public Offering of&#160;24,900,000&#160;units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included
in the Units being offered, the &#8220;Public Shares&#8221;), which includes the partial exercise by the underwriters of their over-allotment
option in the amount of&#160;2,400,000&#160;Units, at $10.00&#160;per Unit, generating gross proceeds of $249,000,000. Each Unit consists
of one Class A ordinary share and one-third of one redeemable warrant (each, a &#8220;Public Warrant&#8221;). Simultaneously with the
closing of the Initial Public Offering, the Company consummated the sale of&#160;779,000&#160;units (the &#8220;Private Placement Units&#8221;)
at a price of $10.00&#160;per Private Placement Unit, in a private placement to the Company&#8217;s sponsor, Talon Capital Sponsor LLC
(the &#8220;Sponsor&#8221;) and Cohen and Company Capital Markets, a division of Cohen &amp; Company Securities, LLC (&#8220;Cohen&#8221;),
as representative of the underwriters, generating gross proceeds of $7,790,000. Each Private Placement Unit consists of one Class A ordinary
share and one-third of one redeemable warrant (the &#8220;Private Placement Warrants&#8221; and together with the Public Warrants, the
&#8220;Warrants&#8221;). Each whole Warrant entitles the holder to purchase&#160;one&#160;Class A ordinary share at a price of $11.50&#160;per
share, subject to adjustment. Of those&#160;779,000&#160;Private Placement Units, the Sponsor purchased&#160;530,000&#160;Private Placement
Units, and Cohen purchased&#160;249,000&#160;Private Placement Units.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A total of $249,000,000&#160;($10.00 per Unit)&#160;of the net proceeds
from the Initial Public Offering and the Private Placement was placed in a trust account established for the benefit of the Company&#8217;s
public shareholders (the &#8220;Trust Account&#8221;), with Odyssey acting as trustee. Except with respect to interest earned on the funds
held in the Trust Account that may be released to the Company to fund the Company&#8217;s working capital requirements, which amount shall
be the lesser of $500,000 or 5% of the interest earned on the Trust Account per annum, and/or to pay the Company&#8217;s taxes, other
than excise taxes, if any, provided that all such permitted withdrawals can only be made (x) from interest and not from the principal
held in the Trust Account and (y) only to the extent such interest is in amount sufficient to cover the permitted withdrawal amount, and
the funds held in the Trust Account will not be released from the Trust Account until the earliest of: (i) the completion of the Company&#8217;s
initial business combination, (ii) the redemption of the Class A Ordinary Shares underlying the Units (the &#8220;Public Shares&#8221;)
if the Company is unable to complete its initial business combination by September 10, 2027, or such earlier date as the Company&#8217;s
board of directors may approve, or such other time period in which the Company must complete an initial business combination pursuant
to an amendment to the Amended Articles approved by a special resolution of the Company&#8217;s shareholders (collectively, the &#8220;Completion
Window&#8221;), subject to applicable law, or (iii) the redemption of the Public Shares properly submitted in connection with a shareholder
vote to amend the Amended Articles (a) to modify the substance or timing of the Company&#8217;s obligation to allow redemption in connection
with its initial business combination or to redeem 100% of the Public Shares if the Company has not consummated an initial business combination
within the Completion Window or (b) with respect to any other material provisions relating to shareholders&#8217; rights or pre-initial
business combination activity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have not selected any specific business combination target. Our
efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although we intend
to focus on target businesses in the energy and power industries. Our Sponsor and its principals may from time to time become aware of
potential business opportunities, one or more of which we may desire to pursue, for a business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will seek to capitalize on the significant experience and contacts
of our management team to complete our initial business combination. Our management team is led by Charlie Leykum, our Chairman and Chief
Executive Officer, who has more than 20&#160;years of experience in the traditional and renewable energy sectors, and Gerald Cimador,
our Chief Financial Officer, who has over 30&#160;years of public and private accounting experience. Charles Leykum served as a director,
and Gerald Cimador served as the Chief Financial Officer and Chief Accounting Officer of Sentinel, a former blank check company that raised
$345&#160;million in its initial public offering in November&#160;2017. In October&#160;2018, Sentinel announced a business combination
with Strike Capital LLC, backed by $150&#160;million in PIPE commitments. However, the deal was terminated in February&#160;2019. In November&#160;2019,
Sentinel announced the liquidation of the trust account and redeemed all 34,500,000 of its outstanding public Class&#160;A ordinary shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"></span></p><!-- Field: Page; Sequence: 4; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Recent Developments</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="background-color: white">On September 8, 2025, the Company
entered into an administrative services agreement with the Sponsor, in connection with the Company&#8217;s Initial Public Offering. On
September 16, 2025, the Company and the Sponsor entered into the amended and restated administrative services agreement (the &#8220;Amended
Agreement&#8221;), to add that the Sponsor or its affiliates may make available to the Company certain office space, utilities and secretarial
support as may be required by the Company from time to time. </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Business Strategy</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our acquisition and value creation strategy is to identify, acquire
and, after our initial business combination, build a company in the energy services and equipment industry that complements the experience
of our management team and that can benefit from our team&#8217;s operational expertise. We expect our acquisition strategy to leverage
our team&#8217;s network of potential proprietary and public transaction sources where we believe a combination of our relationships,
knowledge and experience in the energy services and equipment industry could effect a positive transformation or augmentation of existing
businesses or properties to improve their overall value proposition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We plan to utilize the network and industry experience of our board
of directors, including Mr.&#160;Leykum, and CSL in seeking an initial business combination and employing our acquisition strategy. Over
the course of their careers, the members of our management team and their affiliates have developed a broad network of contacts and corporate
relationships that we believe will serve as a useful source of acquisition opportunities. This network has been developed through our
management team&#8217;s extensive experience in both investing in and operating in the energy industry and we will leverage CSL&#8217;s
considerable experience. We expect these networks will provide our management team with a robust flow of acquisition opportunities. In
addition, we anticipate that target business candidates will be brought to our attention from various unaffiliated sources, which may
include investment market participants, private equity groups, investment banking firms, consultants, accounting firms and large business
enterprises. Upon completion of the Initial Public Offering, we expect that members of our management team will communicate with their
networks of relationships to articulate the parameters for our search for a target business and a potential business combination and begin
the process of pursuing and reviewing potentially interesting leads.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Initial Business Combination</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not presently engaged in, and we will not engage in, any substantive
commercial business for an indefinite period of time following the Initial Public Offering. We intend to utilize cash derived from the
proceeds of the Initial Public Offering and the private placement units, as well as our equity, debt or a combination of these, in effecting
a business combination which has not yet been identified. A business combination may involve the acquisition of, or merger with, a company
which does not need substantial additional capital but which desires to establish a public trading market for its shares, while avoiding
what it may deem to be adverse consequences of undertaking a public offering itself. These include time delays, significant expense, loss
of voting control and compliance with various federal and state securities laws. In the alternative, we may seek to consummate a business
combination with a company that may be financially unstable or in its early stages of development or growth. While we may seek to effect
simultaneous business combinations with more than one target business, we will probably have the ability, as a result of our limited resources,
to effect only a single business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will either (1)&#160;seek shareholder approval of our initial business
combination at a meeting called for such purpose at which shareholders may seek to redeem all or a portion of their public shares, regardless
of whether they vote for or against the proposed business combination, or (2)&#160;provide our shareholders with the opportunity to sell
their shares to us by means of a tender offer for an amount equal to their pro rata share of the aggregate amount then on deposit in the
trust account, including interest (which interest shall be net of permitted withdrawals, if any), in each case subject to the limitations
described herein. The decision as to whether we will seek shareholder approval of our proposed business combination or allow shareholders
to sell their shares to us in a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such
as the timing of the transaction and whether the terms of the transaction would otherwise require us to seek shareholder approval. Unlike
other blank check companies which require shareholder votes and conduct proxy solicitations in conjunction with their initial business
combinations and related redemptions of public shares for cash upon consummation of such initial business combinations even when a vote
is not required by law, we will have the flexibility to avoid such shareholder vote and allow our shareholders to sell their shares pursuant
to the tender offer rules of the SEC.&#160;In that case, we will file tender offer documents with the SEC, which will contain substantially
the same financial and other information about the initial business combination as is required under the SEC&#8217;s proxy rules. If we
seek shareholder approval, we will complete our initial business combination only if we obtain the approval of an ordinary resolution
under Cayman Islands law, being the affirmative vote of the holders of a simple majority of the shareholders who, being present and entitled
to vote at a general meeting of the company, attend and vote at a general meeting of the company, voting together as a single class.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will have until 24&#160;months from the closing of the Initial Public
Offering to consummate an initial business combination. If we are unable to consummate an initial business combination within such time
period, we will, as promptly as reasonably possible but not more than 10&#160;business days thereafter, redeem 100% of the outstanding
public shares, at a&#160;per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including
any interest earned on the funds held in the trust account and net of permitted withdrawals, and up to $100,000 of interest to pay dissolution
expenses, divided by the number of then issued and outstanding public shares, which redemption will completely extinguish the public shareholders&#8217;
rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law and as further
described herein, and then seek to liquidate and dissolve. We expect the pro rata redemption price to be approximately $10.00 per Class&#160;A
ordinary share (regardless of whether or not the underwriters exercise their over-allotment&#160;option), without taking into account
any interest earned on such funds. However, we cannot assure you that we will in fact be able to distribute such amounts as a result of
claims of creditors, which may take priority over the claims of our public shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 5; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our initial business combination must occur with one or more target
businesses that together have a fair market value of at least 80% of the assets held in the trust account (excluding any deferred underwriting
commissions and taxes payable on interest earned) at the time of the agreement to enter into the initial business combination. The fair
market value of the target or targets will be determined by our Board of Directors based upon one or more standards generally accepted
by the financial community (such as actual and potential sales, earnings, cash flow and/or book value). Even though our Board of Directors
will rely on generally accepted standards, our Board of Directors will have discretion to select the standards employed. In addition,
the application of the standards generally involves a substantial degree of judgment. Accordingly, investors will be relying on the business
judgment of the Board of Directors in evaluating the fair market value of the target or targets. The proxy solicitation materials or tender
offer documents used by us in connection with any proposed transaction will provide public shareholders with our analysis of the fair
market value of the target business, as well as the basis for our determinations. If our Board of Directors is not able independently
to determine the fair market value of the target business or businesses, we may, in our sole discretion, obtain an opinion from an independent
investment banking firm, or another independent entity that commonly renders valuation opinions on the type of target business we are
seeking to acquire, with respect to the satisfaction of such criteria. However, unless we consummate our initial business combination
with an affiliated entity, our Board of Directors is not required to obtain an opinion from an independent investment banking firm or
another independent entity that the price we are paying is fair to our shareholders from a financial point of view.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently anticipate structuring a business combination to acquire
100% of the equity interests or assets of the target business or businesses. We may, however, structure our initial business combination
where we merge directly with the target business or where we acquire less than 100% of such interests or assets of the target business
in order to meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such
business combination if the post-transaction&#160;company owns or acquires 50% or more of the outstanding voting securities of the target
or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under
the Investment Company Act&#160;of&#160;1940, as amended (the &#8220;Investment Company Act&#8221;). Even if the post-transaction&#160;company
owns or acquires 50% or more of the voting securities of the target, our shareholders prior to the business combination may collectively
own a minority interest in the post-transaction&#160;company, depending on valuations ascribed to the target and us in the business combination
transaction. For example, we could pursue a transaction in which we issue a substantial number of new shares in exchange for all of the
outstanding capital stock of a target. In this case, we could acquire a 100% controlling interest in the target; however, as a result
of the issuance of a substantial number of new shares, our shareholders immediately prior to our initial business combination could own
less than a majority of our outstanding shares subsequent to our initial business combination. If less than 100% of the equity interests
or assets of a target business or businesses are owned or acquired by the post-transaction&#160;company, the portion of such business
or businesses that is owned or acquired is what will be valued for purposes of the 80% fair market value test, as described above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If any of our officers or directors becomes aware of a business combination
opportunity that falls within the line of business of any entity to which he or she has fiduciary or contractual obligations, he or she
may be required to present such business combination opportunity to such entity prior to presenting such business combination opportunity
to us. Certain of our directors currently have, and any of our officers or directors may in the future have, certain relevant fiduciary
duties or contractual obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, our Sponsor, officers and directors may participate in
the formation of, or become an officer or director of, any other blank check company prior to completion of our initial business combination.
As a result, our Sponsor, officers or directors could have conflicts of interest in determining whether to present business combination
opportunities to us or to any other blank check company with which they may become involved. In such event, such companies may present
additional conflicts of interest in pursuing an acquisition target. However, we do not believe that any potential conflicts would materially
affect our ability to complete our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Other Acquisition Considerations</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not prohibited from pursuing an initial business combination
with a company that is affiliated with our Sponsor, officers or directors. In the event we seek to complete our initial business combination
with a company that is affiliated with our Sponsor, officers or directors,&#160;we, or a committee of independent directors, will obtain
an opinion from an independent entity that commonly renders valuation opinions that our initial business combination is fair to our company
from a financial point of view.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unless we complete our initial business combination with an affiliated
entity, or our Board of Directors cannot independently determine the fair market value of the target business or businesses, we are not
required to obtain an opinion from an independent entity that commonly renders valuation opinions that the price we are paying for a target
is fair to our company from a financial point of view. If no opinion is obtained, our shareholders will be relying on the business judgment
of our Board of Directors, which will have significant discretion in choosing the standard used to establish the fair market value of
the target or targets, and different methods of valuation may vary greatly in outcome from one another. Such standards used will be disclosed
in our tender offer documents or proxy solicitation materials, as applicable, related to our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 6; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Members of our management team may directly or indirectly own our ordinary
shares and/or private placement units following the Initial Public Offering, and, accordingly, may have a conflict of interest in determining
whether a particular target business is an appropriate business with which to effectuate our initial business combination. The price that
our Sponsor, executive officers and directors (directly or indirectly) paid for the founder shares creates an incentive whereby our officers
and directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value
and is unprofitable for public shareholders. If we are unable to complete our initial business combination within the completion window,
or by such earlier liquidation date as our board of directors may approve, the founder shares and private placement units may become worthless,
except to the extent they receive liquidating distributions from assets outside the trust account, which could create an incentive for
our Sponsor, executive officers and directors to complete a transaction even if we select an acquisition target that subsequently declines
in value and is unprofitable for public shareholders. Further, each of our officers and directors may have a conflict of interest with
respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included
by a target business as a condition to any agreement with respect to our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each of our directors and officers presently has, and in the future
any of our directors and our officers may have additional, fiduciary or contractual obligations or duties to one or more other entities
pursuant to which such officer or director is or will be required to present acquisition opportunities to such entity. Accordingly, subject
to his or her fiduciary duties under Cayman Islands law, if any of our officers or directors becomes aware of an acquisition opportunity
which is suitable for an entity to which he or she has then current fiduciary or contractual obligations, he or she will need to honor
his or her fiduciary or contractual obligations to present such acquisition opportunity to such other entity, and only present it to us
if such entity rejects the opportunity, subject to their fiduciary duties under Cayman Islands law. Our amended and restated memorandum
and articles of association provide that, to the fullest extent permitted by applicable law: (i)&#160;no individual serving as a director
or an officer shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly
in the same or similar business activities or lines of business as us; and (ii)&#160;we renounce any interest or expectancy in, or in
being offered an opportunity to participate in, any potential transaction or matter which may be a corporate opportunity for any director
or officer, on the one hand, and us, on the other or the presentation of which would breach an existing legal obligation of a director
or officer to any other entity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, our Sponsor, officers and directors may participate in
the formation of, or become an officer or director of, any other blank check company prior to completion of our initial business combination.
As a result, our Sponsor, officers or directors could have conflicts of interest in determining whether to present business combination
opportunities to us or to any other blank check company with which they may become involved. Although we have no formal policy in place
for vetting potential conflicts of interest, our Board of Directors will review any potential conflicts of interest on a&#160;case-by-case&#160;basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Acquisition Criteria</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Consistent with our business strategy, we have identified the following
general criteria and guidelines that we believe are important in evaluating prospective targets for our initial business combination.
We will use these criteria and guidelines in evaluating acquisition opportunities, but we may decide to enter into our initial business
combination with a target that does not meet these criteria and guidelines. We intend to acquire target businesses that we believe:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">are fundamentally sound but that we believe can achieve better
results by leveraging the operating and financial experience of our sponsor team;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">have substantial positive EBITDA, with a goal of building
a consolidated platform and growing EBITDA through strategic aggregation and scaling;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">can utilize the extensive networks and insights that our
sponsor has built in the energy services and equipment industry;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">are at an inflection point, including ownership transitions,
shifting industry dynamics, and operational or structural repositioning;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">have defensible market positions, hard asset backing, and
paths to scale through consolidation or organic growth;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">have a clear catalyst for re-rating, operational improvement,
or strategic repositioning;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">exhibit unrecognized value or other characteristics, desirable
returns on capital, and a need for capital to achieve the company&#8217;s growth strategy, that we believe have been misevaluated by
the marketplace based on our analysis and due diligence review;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">can enlarge their base of services and expand their geographical
footprint; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">will offer an attractive risk-adjusted&#160;return for our
shareholders.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 7; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will seek to acquire the target on terms and in a manner that leverages
our management team&#8217;s experience investing within the energy industry. Potential upside from growth in the target business and an
improved capital structure will be weighed against any identified downside risks.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These criteria are not intended to be exhaustive. Any evaluation relating
to the merits of a particular initial business combination may be based, to the extent relevant, on these general guidelines as well as
other considerations, factors and criteria that our management may deem relevant. In the event that we decide to enter into our initial
business combination with a target business that does not meet the above criteria and guidelines, we will disclose that the target business
does not meet the above criteria in our shareholder communications related to our initial business combination, which, as discussed in
this Report, would be in the form of proxy solicitation or tender offer materials that we would file with the SEC.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Sponsor Information</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Sponsor is a Delaware limited liability company, which was formed
to invest in our company. Although our Sponsor is permitted to undertake any activities permitted under the Delaware Limited Liability
Company Act and other applicable law, our Sponsor&#8217;s business is focused on investing in our company. Charles Leykum, our Chairman
and Chief Executive Officer, is the sole managing member of Talon Capital Holdings LLC, which is the sole managing member of our Sponsor,
and holds voting and investment discretion with respect to the securities held of record by the Sponsor. Mr.&#160;Leykum indirectly owns
approximately 75.9% of the membership interests in our Sponsor, which includes an indirect interest in approximately 74.3% of the founder
shares and 100% private placement units. Other than Mr.&#160;Leykum, no other person has a direct or indirect material interest in our
Sponsor. On August&#160;19, 2025, our Sponsor transferred 20,000 founder shares to each of our independent directors at a purchase price
of approximately $0.003 per share. In addition, Mr.&#160;Reynolds holds membership interests in our sponsor representing 20,000 founder
shares. Certain passive, non-managing&#160;entities hold membership interests in our Sponsor, including an affiliate of Mr.&#160;Reynolds,
which holds membership interests representing 100,000 founder shares. None of the non-managing&#160;members of our Sponsor have any rights
to control our Sponsor or to vote or dispose of any securities held by our Sponsor. Other than our management team, none of the other
members of our Sponsor will participate in our company&#8217;s activities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Sources of Target Businesses</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While we have not yet selected a target business with which to consummate
our initial business combination, we believe based on our management&#8217;s business knowledge and past experience that there are numerous
potential candidates. We expect that our principal means of identifying potential target businesses will be through the extensive contacts
and relationships of our Sponsor, initial shareholders, officers and directors. While our officers and directors are not required to commit
any specific amount of time in identifying or performing due diligence on potential target businesses, our officers and directors believe
that the relationships they have developed over their careers and their access to our Sponsor&#8217;s contacts and resources will generate
a number of potential business combination opportunities that will warrant further investigation. We also anticipate that target business
candidates will be brought to our attention from various unaffiliated sources, including investment bankers, venture capital funds, private
equity funds, leveraged buyout funds, management buyout funds and other members of the financial community as well as large business enterprises
seeking to divest&#160;non-core&#160;assets&#160;or divisions. Target businesses may be brought to our attention by such unaffiliated
sources as a result of being solicited by us through calls or mailings. These sources may also introduce us to target businesses they
think we may be interested in on an unsolicited basis, since many of these sources will have read this Report and know what types of businesses
we are targeting.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our officers and directors have agreed, until the earliest of our execution
of a definitive agreement for a business combination, our liquidation or such time as he or she ceases to be an officer or director, to
present to us all suitable target business opportunities that have a fair market value of at least 80% of the assets held in the trust
account (excluding deferred underwriting commissions and taxes payable on interest earned) at the time of the agreement to enter into
the initial business combination, prior to presentation to any other entity, any suitable business opportunity which may reasonably be
required to be presented to us, subject to any&#160;pre-existing&#160;fiduciary or contractual obligations. We may engage the services
of professional firms or other individuals that specialize in business acquisitions, in which event we may pay a finder&#8217;s fee, consulting
fee or other compensation to be determined in an arm&#8217;s length negotiation based on the terms of the transaction. In no event, however,
will our Sponsor, officers, directors or their respective affiliates be paid any compensation prior to, or for any services they render
in order to effectuate, the consummation of an initial business combination (regardless of the type of transaction that it is) other than
the $40,000 per month administrative fee, the payment of consulting, success or finder fees in connection with the consummation of our
initial business combination, the repayment of the $250,000 loan, the repayment of any working capital loans, and reimbursement of any&#160;out-of-pocket&#160;expenses.
Our audit committee will review and approve all reimbursements and payments made to our Sponsor, officers, directors or our or their respective
affiliates, with any interested director abstaining from such review and approval.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 8; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have no present intention to enter into a business combination with
a target business that is affiliated with any of our officers, directors or Sponsor. However, we are not restricted from entering into
any such transactions and may do so if (i)&#160;such transaction is approved by a majority of our disinterested independent directors
and (ii)&#160;we obtain an opinion from an independent investment banking firm, or another independent entity that commonly renders valuation
opinions, that the business combination is fair to our unaffiliated shareholders from a financial point of view.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Status as a Public Company</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We believe our structure will make us an attractive business combination
partner to target businesses. As an existing public company, we offer a target business an alternative to the traditional initial public
offering through a merger or other business combination. In this situation, the owners of the target business would exchange their shares
or other equity interests in the target business for our shares or for a combination of our shares and cash, allowing us to tailor the
consideration to the specific needs of the sellers. Although there are various costs and obligations associated with being a public company,
we believe target businesses will find this method a more certain and cost effective method to becoming a public company than the typical
initial public offering. In a typical initial public offering, there are additional expenses incurred in marketing, road show and public
reporting efforts that may not be present to the same extent in connection with a business combination with us.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Furthermore, once a proposed business combination is completed, the
target business will have effectively become public, whereas an initial public offering is always subject to the underwriters&#8217; ability
to complete the offering, as well as general market conditions, which could delay or prevent the offering from occurring. Once public,
we believe the target business would then have greater access to capital and an additional means of providing management incentives consistent
with shareholders&#8217; interests. It can offer further benefits by augmenting a company&#8217;s profile among potential new customers
and vendors and aid in attracting talented employees.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While we believe that our structure and our management team&#8217;s
backgrounds will make us an attractive business partner, some potential target businesses may have a negative view of us since we are
a blank check company, without an operating history, and there is uncertainty relating to our ability to obtain shareholder approval of
our proposed initial business combination and retain sufficient funds in our trust account in connection therewith.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are an &#8220;emerging growth company,&#8221; as defined in the
JOBS Act. We will remain an emerging growth company until the earlier of (1)&#160;the last&#160;day of the fiscal year (a)&#160;following
the fifth anniversary of the completion of the Initial Public Offering, (b)&#160;in which we have total annual gross revenue of at least
$1.235&#160;billion, or (c)&#160;in which we are deemed to be a large accelerated filer, which means the market value of our ordinary
shares that is held by&#160;non-affiliates&#160;equals&#160;or exceeds $700&#160;million as of the end of that year&#8217;s second fiscal
quarter, and (2)&#160;the date on which we have issued more than $1.0&#160;billion in&#160;non-convertible&#160;debt&#160;securities during
the prior three-year&#160;period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, we are a &#8220;smaller reporting company&#8221; as defined
in Rule&#160;10(f)(1)&#160;of&#160;Regulation&#160;S-K.&#160;Smaller&#160;reporting companies may take advantage of certain reduced disclosure
obligations, including, among other things, providing only two&#160;years of audited financial statements. We will remain a smaller reporting
company until the last&#160;day of the fiscal year in which (1)&#160;the market value of our ordinary shares held by&#160;non-affiliates&#160;equals&#160;or
exceeds $250&#160;million as of the end of that year&#8217;s second fiscal quarter, or (2)&#160;our annual revenues equals or exceeds
$100&#160;million during such completed fiscal year and the market value of our ordinary shares held by&#160;non-affiliates&#160;equals&#160;or
exceeds $700&#160;million as of the end of that year&#8217;s second fiscal quarter.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Financial Position</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With funds available for a business combination in the amount of approximately
$252,095,639, as of December 31, 2025, we can offer a target business a variety of options to facilitate a business combination and fund
future expansion and growth of its business. Because we are able to consummate a business combination using the cash proceeds in our trust
account, debt or a combination of the foregoing, we have the flexibility to use an efficient structure allowing us to tailor the consideration
to be paid to the target business to address the needs of the parties. However, if a business combination requires us to use substantially
all of our cash to pay for the purchase price, we may need to arrange third party financing to help fund our business combination. Since
we have no specific business combination under consideration, we have not taken any steps to secure third-party&#160;financing. Accordingly,
our flexibility in structuring a business combination may be subject to constraints resulting from a need to finance such business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Selection of a Target Business and Structuring of a Business Combination</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subject to our executive officers&#8217; and directors&#8217;&#160;pre-existing&#160;fiduciary
duties and the limitations that a target business have a fair market value of at least 80% of the balance in the trust account (excluding
any deferred underwriting commissions and taxes payable on interest earned) at the time of the execution of a definitive agreement for
our initial business combination, as described below in more detail, and that we must acquire a controlling interest in the target business,
our management will have virtually unrestricted flexibility in identifying and selecting a prospective target business. Except for the
general criteria and guidelines set forth above under the caption &#8220;<i>Business Strategy</i>,&#8221; we have not established any
specific attributes or criteria (financial or otherwise) for prospective target businesses. In evaluating a prospective target business,
our management may consider a variety of factors, including one or more of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">financial condition and results of operation;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"></p><!-- Field: Page; Sequence: 9; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">growth potential;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">brand recognition and potential;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">experience and skill of management and availability of additional
personnel;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">capital requirements;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">competitive position;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">barriers to entry;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">stage of development of the products, processes or services;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">existing distribution and potential for expansion;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">degree of current or potential market acceptance of the products,
processes or services;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">proprietary aspects of products and the extent of intellectual
property or other protection for products or formulas;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">impact of regulation on the business;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">regulatory environment of the industry;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">costs associated with effecting the business combination;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">industry leadership, sustainability of market share and attractiveness
of market industries in which a target business participates;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">macro competitive dynamics in the industry within which the
company competes; and</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">fit, cooperation and coachability of management team.</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">These criteria are not intended to be exhaustive. Any evaluation relating
to the merits of a particular business combination will be based, to the extent relevant, on the above factors as well as other considerations
deemed relevant by our management in effecting a business combination consistent with our business objective. In evaluating a prospective
target business, we will conduct an extensive due diligence review which will encompass, among other things, meetings with incumbent management
and inspection of facilities, as well as review of financial and other information which is made available to us. This due diligence review
will be conducted either by our management or by unaffiliated third parties we may engage, although we have no current intention to engage
any such third parties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The time and costs required to select and evaluate a target business
and to structure and complete the business combination cannot presently be ascertained with any degree of certainty. Any costs incurred
with respect to the identification and evaluation of a prospective target business with which a business combination is not ultimately
completed will result in a loss to us and reduce the amount of capital available to otherwise complete a business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Lack of business diversification</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For an indefinite period of time after consummation of our initial
business combination, the prospects for our success may depend entirely on the future performance of a single business. Unlike other entities
that have the resources to complete business combinations with multiple entities in one or several industries, it is probable that we
will not have the resources to diversify our operations and mitigate the risks of being in a single line of business. By consummating
our initial business combination with only a single entity, our lack of diversification may:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">subject us to negative economic, competitive and regulatory
developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial
business combination, and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">cause us to depend on the marketing and sale of a single product
or limited number of products or services.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"></span></p><!-- Field: Page; Sequence: 10; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Limited ability to evaluate the target&#8217;s management team</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although we intend to closely scrutinize the management of a prospective
target business when evaluating the desirability of effecting our initial business combination with that business, our assessment of a
target business&#8217; management may not prove to be correct. Moreover, members of our management team may not have significant experience
or knowledge relating to the operations of the particular target business. The future role of members of our management team, if any,
in a post-transaction&#160;company cannot presently be stated with any certainty. Consequently, members of our management team may not
become a part of the post-transaction&#160;company&#8217;s management team or serve it in advisory positions, and the future management
may not have the necessary skills, qualifications or abilities to manage a public company. Further, it is also not certain whether one
or more of our directors will remain associated with the post-transaction&#160;company in some capacity following our initial business
combination. The determination as to whether any of our key personnel will remain with the post-transaction&#160;company will be made
at the time of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following our initial business combination, we may seek to recruit
additional managers to supplement the incumbent management of the target business. However, we may not have the ability to recruit additional
managers, or to locate additional managers who will have the requisite skills, knowledge or experience necessary to enhance the incumbent
management.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Fair Market Value of Target Business</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The target business or businesses that we acquire must collectively
have a fair market value equal to at least 80% of the balance of the funds in the trust account (excluding any deferred underwriting commissions
and taxes payable on interest earned) at the time of the execution of a definitive agreement for our initial business combination, although
we may acquire a target business whose fair market value significantly exceeds 80% of the trust account balance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently anticipate structuring a business combination involving
100% of the equity interests or assets of the target business or businesses. We may, however, structure our initial business combination
where we merge directly with the target business or involving less than 100% of such interests or assets of the target business in order
to meet certain objectives of the target management team or shareholders or for other reasons, but we will only complete such business
combination if the post-transaction&#160;company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise
acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment
Company Act. Even if the post-transaction&#160;company owns or acquires 50% or more of the voting securities of the target, our shareholders
prior to the business combination may collectively own a minority interest in the post-transaction&#160;company, depending on valuations
ascribed to the target and us in the business combination transaction. For example, we could pursue a transaction in which we issue a
substantial number of new shares in exchange for all of the outstanding capital stock of a target. In this case, we could acquire a 100%
controlling interest in the target; however, as a result of the issuance of a substantial number of new shares, our shareholders immediately
prior to our initial business combination could own less than a majority of our outstanding shares subsequent to our initial business
combination. If less than 100% of the equity interests or assets of a target business or businesses are owned or acquired by the post-transaction&#160;company,
the portion of such business or businesses that is owned or acquired is what will be valued for purposes of the 80% fair market value
test. In order to consummate such an acquisition, we may issue a significant amount of our debt or equity securities to the sellers of
such businesses and/or seek to raise additional funds through a private offering of debt or equity securities. Since we have no specific
business combination under consideration, we have not entered into any such fundraising arrangement and have no current intention of doing
so. The fair market value of the target will be determined by our Board of Directors based upon one or more standards generally accepted
by the financial community (such as actual and potential sales, earnings, cash flow and/or book value). The proxy solicitation materials
or tender offer documents used by us in connection with any proposed transaction will provide public shareholders with our analysis of
the fair market value of the target business, as well as the basis for our determinations. If our Board of Directors is not able to independently
determine that the target business has a sufficient fair market value, we will obtain an opinion from an unaffiliated, independent investment
banking firm, or another independent entity that commonly renders valuation opinions on the type of target business we are seeking to
acquire, with respect to the satisfaction of such criteria. We will not be required to obtain an opinion from an investment banking firm
as to the fair market value if our Board of Directors independently determines that the target business complies with the 80% threshold.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Shareholders May Not Have the Ability to Approve an Initial Business
Combination</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with any proposed business combination, we will either
(1)&#160;seek shareholder approval of our initial business combination at a meeting called for such purpose at which shareholders may
seek to redeem their shares, regardless of whether they abstain, vote for or against or vote at all with respect to the proposed business
combination, or (2)&#160;provide our shareholders with the opportunity to sell their shares to us by means of a tender offer for an amount
equal to their pro rata share of the aggregate amount then on deposit in the trust account, including interest (which interest shall be
net of permitted withdrawals), in each case subject to the limitations described herein. We will seek shareholder approval if it is required
by applicable law or stock exchange listing requirement, provided, that we may also decide to seek shareholder approval for business or
other reasons.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the Nasdaq listing rules, shareholder approval would be required
for our initial business combination if, for example:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">we issue (other than in a public offering for cash) ordinary
shares that will either (a)&#160;be equal to or in excess of 20% of the number of ordinary shares then outstanding or (b)&#160;have voting
power equal to or in excess of 20% of the voting power then outstanding;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"></p><!-- Field: Page; Sequence: 11; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">any of our directors, officers or substantial security holders
(as defined by the Nasdaq rules) has a 5% or greater interest, directly or indirectly, in the target business or assets to be acquired
and if the number of ordinary shares to be issued, or if the number of ordinary shares into which the securities may be convertible or
exercisable, exceeds either (a)&#160;1% of the number of ordinary shares or 1% of the voting power outstanding before the issuance in
the case of any of our directors and officers or (b)&#160;5% of the number of ordinary shares or 5% of the voting power outstanding before
the issuance in the case of any substantial security holders; or</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the issuance or potential issuance of ordinary shares will
result in our undergoing a change of control.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Companies Act and Cayman Islands law do not currently require,
and we are not aware of any other applicable law that will require, shareholder approval of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The decision as to whether we will seek shareholder approval of a proposed
business combination in those instances in which shareholder approval is not required by law will be made by us, solely in our discretion,
and will be based on business and reasons, which include a variety of factors, including, but not limited to:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the timing of the proposed transaction, including in the event
we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing
so would place us at a disadvantage in the transaction or result in other additional burdens on us;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the expected cost of holding a shareholder vote;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the risk that our shareholders would fail to approve the initial
business combination;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">other time and budget constraints; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">potential additional legal complexities of an initial business
combination that would be time-consuming&#160;and burdensome to present to shareholders.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Permitted purchases and other transactions with respect to our securities</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we seek shareholder approval of our initial business combination
and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our Sponsor,
initial shareholders, directors, officers, advisors or their affiliates may purchase public shares or public warrants in privately-negotiated&#160;transactions
or in the open market either prior to or following the completion of our initial business combination. There is no limit on the number
of shares or warrants our initial shareholders, directors, officers, advisors or their affiliates may purchase in such transactions, subject
to compliance with applicable law and Nasdaq rules. Additionally, at any time at or prior to our initial business combination, subject
to applicable securities laws (including with respect to material nonpublic information), our Sponsor, directors, officers, advisors or
any of their affiliates may enter into transactions with investors and others to provide them with incentives to acquire public shares,
vote their public shares in favor of our initial business combination or not redeem their public shares. However, they have no current
commitments, plans or intentions to engage in such transactions and have not formulated any terms or conditions for any such transactions.
In the event our Sponsor, directors, officers, advisors or any of their affiliates determine to undertake any such transactions, such
transactions could have the effect of influencing the vote necessary to approve such transaction. None of the funds held in the trust
account will be used to purchase public shares or public warrants in such transactions. They will be restricted from making any such purchases
when they are in possession of any material&#160;non-public&#160;information&#160;not disclosed to the seller or if such purchases are
prohibited by Regulation&#160;M under the Exchange&#160;Act. Such a purchase may include a contractual acknowledgement that such shareholder,
although still the record holder of our shares, is no longer the beneficial owner thereof and therefore agrees not to exercise its redemption
rights. Subsequent to the consummation of the Initial Public Offering, we will <ix:nonNumeric name="ecd:InsiderTrdPoliciesProcAdoptedFlag" contextRef="cref_1363532388" format="ixt:fixed-true" id="ixv-8063">adopt</ix:nonNumeric> an insider trading policy which will require insiders
to (1)&#160;refrain from purchasing securities during certain blackout periods and when they are in possession of any material&#160;non-public&#160;information&#160;and
(2)&#160;clear certain trades prior to execution. We cannot currently determine whether our insiders will make such purchases pursuant
to a&#160;Rule&#160;10b5-1&#160;plan,&#160;as it will be dependent upon several factors, including but not limited to, the timing and
size of such purchases. Depending on such circumstances, our insiders may either make such purchases pursuant to a&#160;Rule&#160;10b5-1&#160;plan&#160;or
determine that such a plan is not necessary.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event that our Sponsor, directors, officers, advisors or any
of their affiliates purchase public shares in privately negotiated transactions from public shareholders who have already elected to exercise
their redemption rights or submitted a proxy to vote against our initial business combination, such selling shareholders would be required
to revoke their prior elections to redeem their shares and any proxy to vote against our initial business combination. We do not currently
anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the Exchange&#160;Act
or a going-private&#160;transaction subject to the going-private&#160;rules under the Exchange&#160;Act; however, if the purchasers determine
at the time of any such purchases that the purchases are subject to such rules, the purchasers will be required to comply with such rules.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 12; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The purpose of any such transaction could be to reduce the number of
public warrants outstanding or vote such public warrants on any matters submitted to the public warrant holders for approval in connection
with our initial business combination or to satisfy a closing condition in an agreement with a target that requires us to have a minimum
net worth or a certain amount of cash at the closing of our initial business combination, where it appears that such requirement would
otherwise not be met. This may result in the completion of our initial business combination that may not otherwise have been possible.
Any such purchases will be reported pursuant to Section&#160;13 and Section&#160;16 of the Exchange&#160;Act to the extent such purchasers
are subject to such reporting requirements. To the extent such securities are purchased, such public securities will not be voted as required
by Tender Offers and Schedules Compliance and Disclosure Interpretations Question 166.01 promulgated by the SEC.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, if such purchases are made, the public &#8220;float&#8221;
of our securities and the number of beneficial holders of our securities may be reduced, possibly making it difficult to maintain or obtain
the quotation, listing or trading of our securities on a national securities exchange.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Sponsor, officers, directors and/or any of their affiliates anticipate
that they may identify the shareholders with whom our Sponsor, officers, directors or their affiliates may pursue privately-negotiated&#160;purchases
by either the shareholders contacting us directly or by our receipt of redemption requests tendered by shareholders following our mailing
of proxy materials in connection with our initial business combination. To the extent that our Sponsor, officers, directors, advisors
or their affiliates enter into a private purchase, they would identify and contact only potential selling shareholders who have expressed
their election to redeem their shares for a pro rata share of the trust account or vote against our initial business combination, whether
or not such shareholder has already submitted a proxy with respect to our initial business combination. Such persons would select the
shareholders from whom to acquire shares based on the number of shares available, the negotiated price per share and such other factors
as any such person may deem relevant at the time of purchase. The price per share paid in any such transaction may be different than the
amount per share a public shareholder would receive if it elected to redeem its shares in connection with our initial business combination.
Our Sponsor, officers, directors, advisors or their affiliates will only purchase shares if such purchases comply with Regulation&#160;M
under the Exchange&#160;Act and the other federal securities laws.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any purchases by our Sponsor, officers, directors and/or their respective
affiliates who are affiliated purchasers under&#160;Rule&#160;10b-18&#160;under&#160;the Exchange&#160;Act will only be made to the extent
such purchases are able to be made in compliance with&#160;Rule&#160;10b-18,&#160;which is a safe harbor from liability for manipulation
under Section&#160;9(a)(2) and&#160;Rule&#160;10b-5&#160;of&#160;the Exchange&#160;Act.&#160;Rule&#160;10b-18&#160;has&#160;certain technical
requirements that must be complied with in order for the safe harbor to be available to the purchaser. Our Sponsor, officers, directors
and/or their respective affiliates will not make purchases of shares if the purchases would violate Section&#160;9(a)(2)&#160;or&#160;Rule&#160;10b-5&#160;of&#160;the
Exchange&#160;Act.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Additionally, in the event our Sponsor, initial shareholders, directors,
officers, advisors and their affiliates were to purchase public shares or warrants from public shareholders, such purchases would be structured
in compliance with the requirements of Rule&#160;14e-5&#160;under&#160;the Exchange&#160;Act including, in pertinent part, through adherence
to the following:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our registration statement/proxy statement filed for our
business combination transaction would disclose the possibility that our Sponsor, initial shareholders, directors, officers, advisors
and their affiliates may purchase public shares or warrants from public shareholders outside the redemption process, along with the purpose
of such purchases;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">if our Sponsor, initial shareholders, directors, officers,
advisors and their affiliates were to purchase public shares or warrants from public shareholders, they would do so at a price no higher
than the price offered through our redemption process;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our registration statement/proxy statement filed for our
business combination transaction would include a representation that any of our securities purchased by our Sponsor, initial shareholders,
directors, officers, advisors and their affiliates would not be voted in favor of approving the business combination transaction;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our Sponsor, initial shareholders, directors, officers, advisors
and their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess redemption
rights, they would waive such rights; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">we would disclose in a Form&#160;8-K,&#160;before our security
holder meeting to approve the business combination transaction, the following material items:</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the amount of our securities purchased outside of the redemption
offer by our Sponsor, initial shareholders, directors, officers, advisors and their affiliates, along with the purchase price;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the purpose of the purchases by our Sponsor, initial shareholders,
directors, officers, advisors and their affiliates;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the impact, if any, of the purchases by our Sponsor, initial
shareholders, directors, officers, advisors and their affiliates on the likelihood that the business combination transaction will be
approved;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 1in; text-indent: -24pt"></p><!-- Field: Page; Sequence: 13; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the identities of our security holders who sold to our Sponsor,
initial shareholders, directors, officers, advisors and their affiliates (if not purchased on the open market) or the nature of our security
holders (e.g., 5% security holders) who sold to our Sponsor, initial shareholders, directors, officers, advisors and their affiliates;
and</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the number of our securities for which we have received redemption
requests pursuant to our redemption offer.</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please see &#8220;<i>Risk Factors&#160;&#8212;&#160;If we seek shareholder
approval of our initial business combination, our Sponsor, initial shareholders, directors, officers, advisors and their affiliates may
elect to purchase shares or warrants from public shareholders, which may influence a vote on a proposed business combination and reduce
the public &#8220;float&#8221; of our Class&#160;A ordinary shares or public warrants</i>.&#8221;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Redemption rights for public shareholders upon completion of our
initial business combination</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will provide our public shareholders with the opportunity to redeem,
regardless of whether they abstain, vote for, or against, our initial business combination, all or a portion of their public shares upon
the completion of our initial business combination at a&#160;per-share&#160;price,&#160;payable in cash, equal to the aggregate amount
then on deposit in the trust account as of two&#160;business&#160;days prior to the consummation of the initial business combination,
including interest (which interest shall be net of permitted withdrawals) divided by the number of then issued and outstanding public
shares, subject to the limitations described herein. The amount in the trust account is initially anticipated to be approximately $10.00
per public share. The&#160;per-share&#160;amount&#160;we will distribute to investors who properly redeem their shares will not be reduced
by the deferred underwriting commissions we will pay to the underwriters. Our Sponsor, officers and directors have entered into a letter
agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, placement
shares and any public shares they may hold in connection with the completion of our initial business combination. However, our Sponsor,
officers and directors will be entitled to redemption rights with respect to any public shares held by them if we fail to consummate a
business combination or liquidate within the completion window.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Manner of Conducting Redemptions</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will provide our public shareholders with the opportunity to redeem,
regardless of whether they abstain, vote for, or against, our initial business combination, all or a portion of their Class&#160;A ordinary
shares upon the completion of our initial business combination either (i)&#160;in connection with a general meeting called to approve
the business combination or (ii)&#160;by means of a tender offer. The decision as to whether we will seek shareholder approval of a proposed
business combination or conduct a tender offer will be made by us, solely in our discretion, and will be based on a variety of factors
such as the timing of the transaction and whether the terms of the transaction would require us to seek shareholder approval under the
law or stock exchange listing requirement. Under Nasdaq rules, asset acquisitions and share purchases would not typically require shareholder
approval while direct mergers with our company where we do not survive and any transactions where we issue more than 20% of our issued
and outstanding ordinary shares or seek to amend our amended and restated memorandum and articles of association would require shareholder
approval. We currently intend to conduct redemptions in connection with a shareholder vote unless shareholder approval is not required
by applicable law or stock exchange listing requirements and we choose to conduct redemptions pursuant to the tender offer rules of the
SEC for business or other legal reasons.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a shareholder vote is not required and we do not decide to hold
a shareholder vote for business or other legal reasons, we will, pursuant to our amended and restated memorandum and articles of association:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">conduct the redemptions pursuant to&#160;Rule&#160;13e-4&#160;and&#160;Regulation&#160;14E
of the Exchange&#160;Act, which regulate issuer tender offers; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">file tender offer documents with the SEC prior to completing
our initial business combination which contain substantially the same financial and other information about the initial business combination
and the redemption rights as is required under Regulation&#160;14A of the Exchange&#160;Act, which regulates the solicitation of proxies.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon the public announcement of our initial business combination, we
or our Sponsor will terminate any plan established in accordance with&#160;Rule&#160;10b5-1&#160;to&#160;purchase our Class&#160;A ordinary
shares in the open market if we elect to redeem our public shares through a tender offer, to comply with&#160;Rule&#160;14e-5&#160;under&#160;the
Exchange&#160;Act.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event we conduct redemptions pursuant to the tender offer rules,
our offer to redeem will remain open for at least 20&#160;business&#160;days, in accordance with&#160;Rule&#160;14e-1(a)&#160;under&#160;the
Exchange&#160;Act, and we will not be permitted to complete our initial business combination until the expiration of the tender offer
period. In addition, the tender offer will be conditioned on public shareholders not tendering more than the number of public shares we
are permitted to redeem. If public shareholders tender more shares than we have offered to purchase, we will withdraw the tender offer
and not complete the initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If, however, shareholder approval of the transaction is required by
law or stock exchange listing requirement, or we decide to obtain shareholder approval for business or other legal reasons, we will, pursuant
to our amended and restated memorandum and articles of association:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">conduct the redemptions in conjunction with a proxy solicitation
pursuant to Regulation&#160;14A of the Exchange&#160;Act, which regulates the solicitation of proxies, and not pursuant to the tender
offer rules; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">file proxy materials with the SEC.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 14; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We expect that a final proxy statement would be mailed to public shareholders
at least 20&#160;days prior to the shareholder vote. However, we expect that a draft proxy statement would be made available to such shareholders
well in advance of such time, providing additional notice of redemption if we conduct redemptions in conjunction with a proxy solicitation.
Although we are not required to do so, we currently intend to comply with the substantive and procedural requirements of Regulation&#160;14A
in connection with any shareholder vote even if we are not able to maintain our Nasdaq listing or Exchange&#160;Act registration.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event that we seek shareholder approval of our initial business
combination, we will distribute proxy materials and, in connection therewith, provide our public shareholders with the redemption rights
described above upon completion of the initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we seek shareholder approval, we will complete our initial business
combination only if we obtain the approval of an ordinary resolution under Cayman Islands law, being the affirmative vote of at least
a majority of the votes cast by such shareholders who, being present and entitled to vote at a general meeting of the company, attend
and vote at a general meeting of the company. A quorum for such meeting will be present if the holders of at least one third of the issued
and outstanding shares entitled to vote at the meeting are represented in person or by proxy. In such case, pursuant to the terms of a
letter agreement entered into with us, our Sponsor, officers and directors have agreed (and&#160;their permitted transferees will agree)
to vote any founder shares and/or private placement shares held by them, and any public shares purchased during or after the Initial Public
Offering (including in open market and privately-negotiated&#160;transactions, aside from shares they may purchase in compliance with
the requirements of Rule&#160;14e-5&#160;under&#160;the Exchange&#160;Act, which would not be voted in favor of approving the business
combination transaction), in favor of our initial business combination. We expect that at the time of any shareholder vote relating to
our initial business combination, our Sponsor and its permitted transferees will own at least 25% of our issued and outstanding ordinary
shares entitled to vote thereon. Each public shareholder may elect to redeem their public shares without voting and, if they do vote,
irrespective of whether they vote for or against the proposed transaction. In addition, our initial shareholders, directors and officers
have entered into a letter agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to any
founder shares and public shares held by them in connection with the completion of a business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Redemptions of our public shares may be subject to a net tangible asset
test or cash requirement pursuant to an agreement relating to our initial business combination. For example, the proposed business combination
may require: (1)&#160;cash consideration to be paid to the target or its owners; (2)&#160;cash to be transferred to the target for working
capital or other general corporate purposes; or (3)&#160;the retention of cash to satisfy other conditions in accordance with the terms
of the proposed business combination. In the event the aggregate cash consideration we would be required to pay for all public shares
that are validly submitted for redemption plus any amount required to satisfy cash conditions pursuant to the terms of the proposed business
combination exceed the aggregate amount of cash available to us, we will not complete the business combination or redeem any shares, and
all ordinary shares submitted for redemption will be returned to the holders thereof. We may, however, raise funds through the issuance
of equity-linked&#160;securities or through loans, advances or other indebtedness in connection with our initial business combination,
including pursuant to forward purchase agreements or backstop arrangements we may enter into following consummation of the Initial Public
Offering, in order to, among other reasons, satisfy such net tangible assets or minimum cash requirements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Limitation on redemption upon completion of our initial business
combination if we seek shareholder approval</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding the foregoing, if we seek shareholder approval of our
initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender
offer rules, our amended and restated memorandum and articles of association provides that a public shareholder, together with any affiliate
of such shareholder or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined under
Section&#160;13 of the Exchange&#160;Act), will be restricted from redeeming its shares with respect to Excess Shares, without prior consent.
We believe this restriction will discourage shareholders from accumulating large blocks of shares, and subsequent attempts by such holders
to use their ability to exercise their redemption rights against a proposed business combination as a means to force us or our Sponsor
or its affiliates to purchase their shares at a significant premium to the then-current&#160;market price or on other undesirable terms.
Absent this provision, a public shareholder holding more than an aggregate of 20% of the shares sold in the Initial Public Offering could
threaten to exercise its redemption rights if such holder&#8217;s shares are not purchased by us or our Sponsor or its affiliates at a
premium to the then-current&#160;market price or on other undesirable terms. By limiting our shareholders&#8217; ability to redeem no
more than 20% of the shares sold in the Initial Public Offering, we believe we will limit the ability of a small group of shareholders
to unreasonably attempt to block our ability to complete our initial business combination, particularly in connection with a business
combination with a target that requires as a closing condition that we have a minimum net worth or a certain amount of cash. However,
we would not be restricting our shareholders&#8217; ability to vote all of their shares (including Excess Shares) for or against our initial
business combination. Our Sponsor, officers and directors have, pursuant to a letter agreement entered into with us, waived their right
to have any founder shares, private placement shares or public shares held by them redeemed in connection with our initial business combination.
Unless any of our other affiliates acquires founder shares through a permitted transfer from an initial shareholder, and thereby becomes
subject to the letter agreement, no such affiliate is subject to this waiver. However, to the extent any such affiliate acquires public
shares in the Initial Public Offering or thereafter through open market purchases, it would be a public shareholder and restricted from
seeking redemption rights with respect to any Excess Shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"></span></p><!-- Field: Page; Sequence: 15; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Tendering share certificates in connection with a tender offer or
redemption rights</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may require our public shareholders seeking to exercise their redemption
rights, whether they are record holders or hold their shares in &#8220;street name,&#8221; to either tender their certificates (if any)
to our transfer agent prior to the date set forth in the tender offer documents, or up to two&#160;business&#160;days prior to the vote
on the proposal to approve the business combination in the event we distribute proxy materials, or to deliver their shares to the transfer
agent electronically using The Depository Trust Company&#8217;s DWAC (Deposit/Withdrawal At Custodian) System, rather than simply voting
against the initial business combination. The tender offer or proxy materials, as applicable, that we will furnish to holders of our public
shares in connection with our initial business combination will indicate whether we are requiring public shareholders to satisfy such
delivery requirements. Accordingly, a public shareholder would have from the time we send out our tender offer materials until the close
of the tender offer period, or up to two&#160;days prior to the vote on the business combination if we distribute proxy materials, as
applicable, to tender its shares if it wishes to seek to exercise its redemption rights. Pursuant to the tender offer rules, the tender
offer period will be not less than 20&#160;business&#160;days and, in the case of a shareholder vote, a final proxy statement would be
mailed to public shareholders at least 20&#160;days prior to the shareholder vote. However, we expect that a draft proxy statement would
be made available to such shareholders well in advance of such time, providing additional notice of redemption if we conduct redemptions
in conjunction with a proxy solicitation. Given the relatively short exercise period, it is advisable for shareholders to use electronic
delivery of their public shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There is a nominal cost associated with the above-referenced&#160;tendering
process and the act of certificating the shares or delivering them through the DWAC System. The transfer agent will typically charge the
tendering broker $100.00 and it would be up to the broker whether or not to pass this cost on to the redeeming holder. However, this fee
would be incurred regardless of whether or not we require holders seeking to exercise redemption rights to tender their shares. The need
to deliver shares is a requirement of exercising redemption rights regardless of the timing of when such delivery must be effectuated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to perfect redemption rights in connection with their business
combinations, many blank check companies would distribute proxy materials for the shareholders&#8217; vote on an initial business combination,
and a holder could simply vote against a proposed business combination and check a box on the proxy card indicating such holder was seeking
to exercise his or her redemption rights. After the business combination was approved, the company would contact such shareholder to arrange
for him or her to deliver his or her certificate to verify ownership. As a result, the shareholder then had an &#8220;option window&#8221;
after the completion of the business combination during which he or she could monitor the price of the company&#8217;s shares in the market.
If the price rose above the redemption price, he or she could sell his or her shares in the open market before actually delivering his
or her shares to the company for cancellation. As a result, the redemption rights, to which shareholders were aware they needed to commit
before the general meeting, would become &#8220;option&#8221; rights surviving past the completion of the business combination until the
redeeming holder delivered its certificate. The requirement for physical or electronic delivery prior to the general meeting ensures that
a redeeming holder&#8217;s election to redeem is irrevocable once the business combination is approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any request to redeem such shares, once made, may be withdrawn at any
time up to the date set forth in the tender offer materials or the date of the general meeting set forth in our proxy materials, as applicable.
Furthermore, if a holder of a public share delivered its certificate in connection with an election of redemption rights and subsequently
decides prior to the applicable date not to elect to exercise such rights, such holder may simply request that the transfer agent return
the certificate (physically or electronically). It is anticipated that the funds to be distributed to holders of our public shares electing
to redeem their shares will be distributed promptly after the completion of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our initial business combination is not approved or completed for
any reason, then our public shareholders who elected to exercise their redemption rights would not be entitled to redeem their shares
for the applicable pro rata share of the trust account. In such case, we will promptly return any certificates delivered by public holders
who elected to redeem their shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our initial proposed business combination is not completed, we may
continue to try to complete a business combination with a different target until up to 24&#160;months from the closing of the Initial
Public Offering.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Liquidation if No Business Combination</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our amended and restated articles and memorandum of association provides
that we will have only up to 24&#160;months from the closing of the Initial Public Offering to complete an initial business combination.
If we have not completed an initial business combination by such date, we will (i)&#160;cease all operations except for the purpose of
winding up, (ii)&#160;as promptly as reasonably possible but not more than ten (10)&#160;business&#160;days thereafter, redeem 100% of
the outstanding public shares, at a&#160;per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the trust
account, including interest earned on the funds held in the trust account (which interest shall be net permitted withdrawals, and up to
$100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, which redemption
will completely extinguish public shareholders&#8217; rights as shareholders (including the right to receive further liquidation distributions,
if any), subject to applicable law, and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval
of our remaining shareholders and our Board of Directors, liquidate and dissolve, subject (in the case of (ii)&#160;and (iii)&#160;above)
to our obligations under the Cayman Islands laws to provide for claims of creditors and the requirements of other applicable law.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 16; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Sponsor, executive officers and directors have agreed that they
will not propose any amendment to our amended and restated memorandum and articles of association that would stop our public shareholders
from converting, redeeming or selling their public shares to us in connection with a business combination in a manner that would affect
the substance or timing of our obligation to allow redemption in connection with our initial business combination or to redeem 100% of
our public shares if we do not complete a business combination within 24&#160;months from the closing of the Initial Public Offering or
with respect to any other provision relating to shareholders&#8217; rights or pre-initial&#160;business combination activity, in each
case unless we provide our public shareholders with the opportunity to redeem their public shares upon approval of any such amendment
at a&#160;per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the trust account, net of permitted
withdrawals, divided by the number of then issued and outstanding public shares. This redemption right shall apply in the event of the
approval of any such amendment, whether proposed by our Sponsor, any executive officer, director or director nominee, or any other person.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are required to use our reasonable best efforts to have all third
parties (including any vendors or other entities we engage after the Initial Public Offering) and any prospective target businesses enter
into agreements with us waiving any right, title, interest or claim of any kind they may have in or to any monies held in the trust account.
As a result, the claims that could be made against us will be limited, thereby lessening the likelihood that any claim would result in
any liability extending to the trust. We therefore believe that any necessary provision for creditors will be reduced and should not have
a significant impact on our ability to distribute the funds in the trust account (net of permitted withdrawals) to our public shareholders.
Nevertheless, we cannot assure you of this fact as there is no guarantee that vendors, service providers and prospective target businesses
will execute such agreements. If any third party refuses to execute an agreement waiving such claims to the monies held in the trust account,
our management will perform an analysis of the alternatives available to it and will only enter into an agreement with a third party that
has not executed a waiver if management believes that such third party&#8217;s engagement would be significantly more beneficial to us
than any alternative. Examples of possible instances where we may engage a third party that refuses to execute a waiver include the engagement
of a third-party&#160;consultant whose particular expertise or skills are believed by management to be significantly superior to those
of other consultants that would agree to execute a waiver or in cases where management is unable to find a service provider willing to
execute a waiver. Our underwriters and auditor are the only third parties we are currently aware of that may not execute a waiver. Nor
is there any guarantee that, even if they execute such agreements with us, they will not seek recourse against the trust account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We anticipate notifying the trustee of the trust account to begin liquidating
such assets promptly after such date and anticipate it will take no more than ten (10)&#160;business&#160;days to effectuate such distribution.
Our initial shareholders have waived their rights to participate in any liquidation distribution with respect to the founder shares and
private placement shares. There will be no distribution from the trust account with respect to our warrants, which will expire worthless.
We will pay the costs of any subsequent liquidation from our remaining assets outside of the trust account and the interest earned on
the funds held in the trust account that we are permitted to withdraw to pay such expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we are unable to complete an initial business combination and expend
all of the net proceeds of the Initial Public Offering, other than the proceeds deposited in the trust account, and without taking into
account interest, if any, earned on the trust account, the initial&#160;per-share&#160;redemption price would be $10.00. The proceeds
deposited in the trust account could, however, become subject to claims of our creditors that are in preference to the claims of public
shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our public shareholders shall be entitled to receive funds from the
trust account only in the event of our failure to complete a business combination within the required time period or if the shareholders
seek to have us redeem or purchase their respective shares upon a business combination which is actually completed by us or upon certain
amendments to our charter documents as described elsewhere herein. In no other circumstances shall a shareholder have any right or interest
of any kind to or in the trust account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our initial shareholders will not participate in any redemption distribution
from our trust account with respect to their founder shares and private placement shares. Additionally, any loans made by our officers,
directors, Sponsors or their affiliates for working capital needs will be forgiven and not repaid if we are unable to complete an initial
business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we are forced to file a bankruptcy case or an involuntary bankruptcy
case is filed against us which is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy law,
and may be included in our bankruptcy estate and subject to the claims of third parties with priority over the claims of our shareholders.
To the extent any bankruptcy claims deplete the trust account, we cannot make any assurance of the amount we will be able to return to
our public shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 17; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we are forced to file a bankruptcy case or an involuntary bankruptcy
case is filed against us which is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor
and/or bankruptcy laws as either a &#8220;preferential transfer&#8221; or a &#8220;fraudulent conveyance.&#8221; As a result, a bankruptcy
court could seek to recover all amounts received by our shareholders. Furthermore, because we intend to distribute the proceeds held in
the trust account to our public shareholders promptly after 24&#160;months from the closing of the Initial Public Offering, this may be
viewed or interpreted as giving preference to our public shareholders over any potential creditors with respect to access to or distributions
from our assets. Furthermore, our Board of Directors may be viewed as having breached their fiduciary duties to our creditors and/or may
have acted in bad faith, and thereby exposing itself and our company to claims of punitive damages, by paying public shareholders from
the trust account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought against us for these
reasons.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Competition</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">In identifying, evaluating and selecting a target business, we may
encounter intense competition from other entities having a business objective similar to ours. Many of these entities are well established
and have extensive experience identifying and effecting business combinations directly or through affiliates. Many of these competitors
possess greater technical, human and other resources than us and our financial resources will be relatively limited when contrasted with
those of many of these competitors. Although we believe there may be numerous potential target businesses that we could acquire with the
net proceeds of the Initial Public Offering, our ability to compete in acquiring certain sizable target businesses may be limited by our
available financial resources.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">The following also may not be viewed favorably by certain target businesses:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our obligation to seek shareholder approval of a business
combination or engage in a tender offer may delay the completion of a transaction;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our obligation to convert or repurchase Class&#160;A ordinary
shares held by our public shareholders may reduce the resources available to us for a business combination; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our outstanding warrants and unit purchase options, and the
potential future dilution they represent.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Any of these factors may place us at a competitive disadvantage in
successfully negotiating a business combination. Our management believes, however, that our status as a public entity and potential access
to the United&#160;States public equity markets may give us a competitive advantage over privately held entities having a similar business
objective as ours in acquiring a target business with significant growth potential on favorable terms.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we succeed in effecting a business combination, there will be, in
all likelihood, intense competition from competitors of the target business. We cannot assure you that, subsequent to a business combination,
we will have the resources or ability to compete effectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Conflicts of Interest</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our management team, in their capacities as directors, officers or
employees of our Sponsor or its affiliates or in their other endeavors, may choose to present potential business combinations to the
related entities described above, current or future entities affiliated with or managed by our Sponsor, or third parties, before they
present such opportunities to us, subject to his or her fiduciary duties under Cayman Islands law and any other applicable fiduciary
duties. Our amended and restated memorandum and articles of association provide that, to the fullest extent permitted by applicable law:
(i)&#160;no individual serving as a director or an officer shall have any duty, except and to the extent expressly assumed by contract,
to refrain from engaging directly or indirectly in the same or similar business activities or lines of business as us; and (ii)&#160;we
renounce any interest or expectancy in, or in being offered an opportunity to participate in, any potential transaction or matter which
may be a corporate opportunity for any director or officer, on the one hand, and us, on the other or the presentation of which would
breach an existing legal obligation of a director or officer to any other entity. For more information, see the section entitled &#8220;<i>Directors,
Executive Officers and Corporate Governance&#160;&#8212;&#160;Conflicts of Interest</i>.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, members of our management team and our board of directors
will directly or indirectly own founder shares and/or private placement units following the Initial Public Offering, as set forth in
&#8220;Principal Shareholders,&#8221; and, accordingly, may have a conflict of interest in determining whether a particular target business
is an appropriate business with which to effectuate our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"></span></p><!-- Field: Page; Sequence: 18; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our directors and officers presently have, and any of them in the future
may have, additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be
required to present a business combination opportunity to such entity. Accordingly, if any of our directors or officers becomes aware
of a business combination opportunity that is suitable for an entity to which he or she has then-current&#160;fiduciary or contractual
obligations, he or she may need to honor these fiduciary or contractual obligations to present such business combination opportunity to
such entity, or in the case of a&#160;non-compete&#160;restriction,&#160;may not present such opportunity to us at all, subject to his
or her fiduciary duties under Cayman Islands law. See &#8220;<i>Risk Factors&#160;&#8212;&#160;Certain of our directors and officers are
now, and all of them may in the future become, affiliated with entities engaged in business activities similar to those intended to be
conducted by us and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should
be presented</i>.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Indemnity</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Sponsor has agreed that it will be liable to us if and to the extent
any claims by a third-party&#160;(other than our independent auditors) for services rendered or products sold to us, or a prospective
target business with which we have discussed entering into a transaction agreement, reduce the amount of funds in the trust account to
below (i)&#160;$10.00 per public share or (ii)&#160;such lesser amount per public share held in the trust account as of the date of the
liquidation of the trust account due to reductions in the value of the trust assets, in each case net of permitted withdrawals, except
as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any
claims under our indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, our Sponsor will
not be responsible to the extent of any liability for such third party claims. We have not independently verified whether the Sponsor
has sufficient funds to satisfy their indemnity obligations and believe that the Sponsor&#8217;s only assets are securities of our company.
We have not asked the Sponsor to reserve for such obligations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Facilities</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We currently maintain our principal executive offices at 440 Louisiana
Street, Suite 1050, Houston, TX&#160;77002. The cost for this space is included in the $40,000&#160;monthly fee Talon Capital Sponsor
LLC and/or its affiliates will charge us for general and administrative services pursuant to an Administrative Services Agreement between
us and Talon Capital Sponsor LLC until the consummation of an initial business combination. We consider our current office space, combined
with the other office space otherwise available to our executive officers, adequate for our current operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Employees</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have two executive officers. The amount of time they will devote
in any time period will vary based on whether a target business has been selected for the business combination and the stage of the business
combination process the Company is in. Accordingly, once a suitable target business to acquire has been located, management will spend
more time investigating such target business and negotiating and processing the business combination (and consequently spend more time
on our affairs) than had been spent prior to locating a suitable target business. We presently expect our executive officers to devote
such amount of time as they reasonably believe is necessary to our business. We do not intend to have any full-time&#160;employees prior
to the consummation of a business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Periodic Reporting and Audited Financial Statements</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have registered our units, Class&#160;A ordinary shares and warrants
under the Exchange&#160;Act and have reporting obligations, including the requirement that we file annual, quarterly and current reports
with the SEC.&#160;In accordance with the requirements of the Exchange&#160;Act, our annual reports will contain financial statements
audited and reported on by our independent registered public auditors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will provide shareholders with audited financial statements of the
prospective target business as part of the tender offer materials or proxy solicitation materials sent to shareholders to assist them
in assessing the target business. These financial statements may be required to be prepared in accordance with, or be reconciled to, U.S.&#160;GAAP,
or IFRS, depending on the circumstances and the historical financial statements may be required to be audited in accordance with the PCAOB.&#160;These
financial statement requirements may limit the pool of potential target businesses we may acquire because some targets may be unable to
provide such statements in time for us to disclose such statements in accordance with federal proxy rules and complete our initial business
combination within the prescribed time frame. While this may limit the pool of potential acquisition candidates, we do not believe that
this limitation will be material.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 19; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will be required to evaluate our internal control procedures for
the fiscal year ending December&#160;31, 2026, as required by the Sarbanes-Oxley&#160;Act. Only in the event we are deemed to be a large
accelerated filer or an accelerated filer will we be required to have our internal control procedures audited. A target company may not
be in compliance with the provisions of the Sarbanes-Oxley&#160;Act regarding adequacy of their internal controls. The development of
the internal controls of any such entity to achieve compliance with the Sarbanes-Oxley&#160;Act may increase the time and costs necessary
to complete any such acquisition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have filed a Registration Statement on&#160;Form&#160;8-A&#160;with&#160;the
SEC to register our securities under Section&#160;12 of the Exchange&#160;Act. As a result, we are subject to the rules and regulations
promulgated under the Exchange&#160;Act. We have no current intention of filing a Form&#160;15 to suspend our reporting or other obligations
under the Exchange&#160;Act prior or subsequent to the consummation of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a)&#160;of
the Securities Act, as modified by the JOBS Act. As such, we are eligible to take advantage of certain exemptions from various reporting
requirements that are applicable to other public companies that are not &#8220;emerging growth companies&#8221; including, but not limited
to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley&#160;Act, reduced
disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements
of holding a&#160;non-binding&#160;advisory&#160;vote on executive compensation and shareholder approval of any golden parachute payments
not previously approved. If some investors find our securities less attractive as a result, there may be a less active trading market
for our securities and the prices of our securities may be more volatile.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, Section&#160;107 of the JOBS Act also provides that an
&#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section&#160;7(a)(2)(B)&#160;of
the Securities Act for complying with new or revised accounting standards. In other words, an &#8220;emerging growth company&#8221; can
delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We intend to take
advantage of the benefits of this extended transition period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will remain an emerging growth company until the earlier of (1)&#160;the
last&#160;day of the fiscal year (a)&#160;following the fifth anniversary of the completion of the Initial Public Offering, (b)&#160;in
which we have total annual gross revenue of at least $1.235&#160;billion, or (c)&#160;in which we are deemed to be a large accelerated
filer, which means the market value of our ordinary shares that is held by&#160;non-affiliates&#160;equals&#160;or exceeds $700&#160;million
as of the end of that year&#8217;s second fiscal quarter, and (2)&#160;the date on which we have issued more than $1.0&#160;billion in&#160;non-convertible&#160;debt&#160;securities
during the prior three-year&#160;period. References herein to &#8220;emerging growth company&#8221; shall have the meaning associated
with it in the JOBS Act.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Legal Proceedings</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There is no material litigation, arbitration or governmental proceeding
currently pending against us or any members of our management team.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><!-- Field: Page; Sequence: 20; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">RISK FACTORS SUMMARY</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.75pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">An investment in our securities
involves a high degree of risk. The occurrence of one or more of the events or circumstances described in the section entitled &#8220;Risk
Factors,&#8221; alone or in combination with other events or circumstances, may materially adversely affect our business, financial condition
and operating results. In that event, the trading price of our securities could decline, and you could lose all or part of your investment.
Such risks include, but are not limited to, the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 23.75pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Our public shareholders may not be afforded an opportunity
to vote on our proposed business combination, which means we may complete our initial business combination even though a majority of
our public shareholders do not support such a combination.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">If we seek shareholder approval of our initial business combination,
our Sponsor, officers and directors have agreed to vote in favor of such initial business combination, regardless of how our public shareholders
vote.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">The ability of our public shareholders to redeem their shares
for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us
to enter into a business combination with a target.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">The requirement that we complete our initial business combination
within the 24&#160;months, as the case may be, from the closing of the Initial Public Offering may give potential target businesses leverage
over us in negotiating a business combination and may decrease our ability to conduct due diligence on potential business combination
targets as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms
that would produce value for our shareholders.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">If the net proceeds of the Initial Public Offering and the
sale of the private placement units not being held in the trust account are insufficient, it could limit the amount available to fund
our search for a target business or businesses and complete our initial business combination and we will depend on loans from our Sponsor
or management team to fund our search, to pay our taxes and to complete our initial business combination.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">If we seek shareholder approval of our initial business combination,
our Sponsor, directors, executive officers, advisors and their affiliates may elect to purchase shares or warrants from public shareholders,
which may influence a vote on a proposed business combination and reduce the public &#8220;float&#8221; of our ordinary shares or public
warrants.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">If a shareholder fails to receive notice of our offer to
redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its
shares, such shares may not be redeemed.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">You will not have any rights or interests in funds from the
trust account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced to sell your public
shares or warrants, potentially at a loss.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Nasdaq may delist our securities from trading on its exchange,
which could limit investors&#8217; ability to make transactions in our securities and subject us to additional trading restrictions.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">You will not be entitled to protections normally afforded
to investors of many other blank check companies.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Because of our limited resources and the significant competition
for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we are unable
to complete our initial business combination, our public shareholders may receive only approximately $10.00 per share, or less in certain
circumstances, on our redemption, and our warrants will expire worthless.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">If the net proceeds of the Initial Public Offering not being
held in the trust account are insufficient to allow us to operate for at least 24&#160;months following the closing of the Initial Public
Offering, we may be unable to complete our initial business combination.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">The grant of registration rights to our initial holders and
holders of placement units may make it more difficult to complete our initial business combination, and the future exercise of such rights
may adversely affect the market price of our Class&#160;A ordinary shares.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Past performance by our management team and their affiliates
may not be indicative of future performance of an investment in us.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">We may seek acquisition opportunities in industries or sectors
that may be outside of our management&#8217;s areas of expertise.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"></p><!-- Field: Page; Sequence: 21; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">We are not required to obtain an opinion from an independent
entity that commonly renders valuation opinions, and consequently, you may have no assurance from an independent source that the price
we are paying for the business is fair to our company from a financial point of view.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">We may reincorporate in another jurisdiction in connection
with our initial business combination and such reincorporation may result in taxes imposed on shareholders.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">We may have a limited ability to assess the management of
a prospective target business and, as a result, may affect our initial business combination with a target business whose management may
not have the skills, qualifications or abilities to manage a public company.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">We have no operating history and no revenues, and you have
no basis on which to evaluate our ability to achieve our business objective.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">We do not have a specified maximum redemption threshold.
The absence of such a redemption threshold may make it possible for us to complete a business combination with which a substantial majority
of our shareholders do not agree.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">If we are deemed to be an investment company under the Investment
Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make
it difficult for us to complete our initial business combination.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_003" style="display: inline-block;"></span>ITEM 1A. RISK FACTORS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif"><i>This
Annual Report contains forward-looking information based on our current expectations. You should carefully consider the risks and uncertainties
described below together with all of the other information contained in this Annual Report, including our consolidated financial statements
and the related notes appearing at the end of this Annual Report, before deciding whether to invest in our securities. If any of the
following events occur, our business, financial condition and operating results may be materially adversely affected. In that event,
the trading price of our securities could decline, and you could lose all or part of your investment</i></span><i>.</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">Risks Relating to our Search for, Consummation
of, or Inability to Consummate, a Business Combination and&#160;Post-Business&#160;Combination Risks</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our public shareholders may not be afforded an opportunity to
vote on our proposed business combination, which means we may complete our initial business combination even though a majority of our
public shareholders do not support such a combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may not hold a shareholder vote to approve our initial business
combination unless the business combination would require shareholder approval under applicable Cayman Islands law or the rules of Nasdaq
or if we decide to hold a shareholder vote for business or other reasons. Examples of transactions that would not ordinarily require shareholder
approval include asset acquisitions and share purchases, while transactions such as a statutory merger or consolidation with our company
or transactions where we issue more than 20% of our outstanding shares would require shareholder approval. For instance, the Nasdaq rules
currently allow us to engage in a tender offer in lieu of a general meeting but would still require us to obtain shareholder approval
if we were seeking to issue more than 20% of our outstanding shares to a target business as consideration in any business combination.
Therefore, if we were structuring a business combination that required us to issue more than 20% of our outstanding shares, we would seek
shareholder approval of such business combination. Except as required by law or Nasdaq rules, the decision as to whether we will seek
shareholder approval of a proposed business combination or will allow shareholders to sell their shares to us in a tender offer will be
made by us, solely in our discretion, and will be based on a variety of factors, such as the timing of the transaction and whether the
terms of the transaction would otherwise require us to seek shareholder approval. Accordingly, we may consummate our initial business
combination even if holders of a majority of the issued and outstanding ordinary shares do not approve of the business combination we
consummate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If we seek shareholder approval of our initial business combination,
our Sponsor, officers and directors have agreed to vote in favor of such initial business combination, regardless of how our public shareholders
vote.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Sponsor, officers and directors have agreed (and their permitted
transferees will agree), pursuant to the terms of a letter agreement entered into with us, to vote any founder shares and/or private placement
shares held by them, as well as any public shares purchased during or after the Initial Public Offering (aside from shares they may purchase
in compliance with the requirements of Rule 14e-5&#160;under the Exchange Act, which would not be voted in favor of approving the business
combination transaction), in favor of our initial business combination. We expect that our Sponsor and its permitted transferees will
own approximately 26% of our issued and outstanding ordinary shares at the time of any such shareholder vote. As a result, in addition
to the founder shares and private placement shares held by our Sponsor, we would need only 8,159,501 or approximately 32.8%, of the 24,900,000
public shares sold in the Initial Public Offering to be voted in favor of a transaction (assuming all outstanding shares are voted and
the parties to the letter agreement do not acquire any Class&#160;A ordinary shares). Assuming that only the holders of&#160;one-third&#160;of
our issued and outstanding ordinary shares, representing a quorum under our amended and restated memorandum and articles of association,
vote their shares at a general meeting of the company, we will not need any public shares in addition to our founder shares and placement
shares to be voted in favor of an initial business combination in order to approve an initial business combination. Accordingly, if we
seek shareholder approval of our initial business combination, it is more likely that the necessary shareholder approval will be received
than would be the case if such persons agreed to vote their founder shares in accordance with the majority of the votes cast by our public
shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 22; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Your only opportunity to affect the investment decision regarding
a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash, unless we seek
shareholder approval of the business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the time of your investment in us, you will not be provided with
an opportunity to evaluate the specific merits or risks of one or more target businesses. Since our Board of Directors may complete a
business combination without seeking shareholder approval, public shareholders may not have the right or opportunity to vote on the business
combination, unless we seek such shareholder approval. Accordingly, if we do not seek shareholder approval, your only opportunity to affect
the investment decision regarding a potential business combination may be limited to exercising your redemption rights within the period
of time (which will be at least 20&#160;business&#160;days) set forth in our tender offer documents mailed to our public shareholders
in which we describe our initial business combination. The amount of the deferred underwriting commissions payable to the underwriters
will not be adjusted for any shares that are redeemed in connection with an initial business combination. The&#160;per-share&#160;amount
we will distribute to shareholders who properly exercise their redemption rights will not be reduced by the deferred underwriting commission
and after such redemptions, the&#160;per-share&#160;value of shares held by&#160;non-redeeming&#160;shareholders will reflect our obligation
to pay the deferred underwriting commissions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We do not have a minimum net tangible asset requirement.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our amended and restated memorandum and articles of association does
not contain a minimum net tangible asset requirement. Such a requirement can serve to ensure that our securities are not determined to
be &#8220;penny stock&#8221; under Rule&#160;3a-51&#160;of&#160;the Exchange&#160;Act. Whether or not our amended and restated memorandum
and articles of association contains a net tangible assets requirement, if our securities are deemed to be &#8220;penny stock,&#8221;
we will become subject to Rule&#160;419 of the Securities Act. In the event that our securities are delisted from Nasdaq, our securities
could be determined to be &#8220;penny stock&#8221; under Rule&#160;3a-51&#160;of&#160;the Exchange&#160;Act and we would be required
to comply with the requirements of Rule&#160;419 of the Securities Act. Being subject to the requirements of Rule&#160;419 would make
us less attractive to potential business combination targets and thereby adversely affect our ability to complete an initial business
combination. See&#160;&#8212;&#160;&#8220;<i>You will not be entitled to protections normally afforded to investors of many other blank
check companies</i>&#8221;, &#8220;<i>Nasdaq may delist our securities from trading on its exchange, which could limit investors&#8217;
ability to make transactions in our securities and subject us to additional trading restrictions</i>&#8221;, &#8220;<i>The ability of
our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination
targets, which may make it difficult for us to enter into a business combination with a target</i>&#8221;, and &#8220;<i>The ability of
our public shareholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most
desirable business combination or optimize our capital structure</i>.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The ability of our public shareholders to redeem their shares
for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to
enter into a business combination with a target.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may seek to enter into a business combination transaction agreement
with a prospective target that requires as a closing condition that we have a minimum net worth or a certain amount of cash. If too many
public shareholders exercise their redemption rights, we would not be able to meet such closing condition and, as a result, would not
be able to proceed with the business combination. Consequently, if accepting all properly submitted redemption requests would cause our
net worth or minimum cash to be less than required by the prospective target either immediately prior to or upon completion of our initial
business combination, we may determine not to proceed with such redemption and the related business combination and may instead search
for an alternate business combination, or we may raise funds through the issuance of equity-linked&#160;securities or through loans, advances
or other indebtedness in connection with our initial business combination, including pursuant to forward purchase agreements or backstop
arrangements we may enter into following consummation of the Initial Public Offering, in order to, among other reasons, satisfy such net
worth or minimum cash requirements. Prospective targets will be aware of these risks and, thus, may be reluctant to enter into a business
combination transaction with us.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The ability of our public shareholders to exercise redemption
rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our
capital structure.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the time we enter into an agreement for our initial business combination,
we will not know how many shareholders may exercise their redemption rights, and therefore we will need to structure the transaction based
on our expectations as to the number of shares that will be submitted for redemption. If our initial business combination agreement requires
us to use a portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing,
we will need to reserve a portion of the cash in the trust account to meet such requirements, or arrange for third party financing. In
addition, if a larger number of shares are submitted for redemption than we initially expected, we may need to restructure the transaction
to reserve a greater portion of the cash in the trust account or arrange for third party financing. Raising additional third party financing
may involve dilutive equity issuances or the incurrence of indebtedness at higher than desirable levels. Furthermore, this dilution would
increase to the extent that the anti-dilution&#160;provisions of the Class&#160;B ordinary shares result in the issuance of Class&#160;A
ordinary shares on a greater than&#160;one-to-one&#160;basis&#160;upon conversion of the Class&#160;B ordinary shares at the time of the
initial business combination. The above considerations may limit our ability to complete the most desirable business combination available
to us or optimize our capital structure.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 23; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The ability of our public shareholders to exercise redemption
rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful
and that you would have to wait for liquidation in order to redeem your shares.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our initial business combination agreement requires us to use a
portion of the cash in the trust account to pay the purchase price, or requires us to have a minimum amount of cash at closing, the probability
that our initial business combination would be unsuccessful is increased. If our initial business combination is unsuccessful, you would
not receive your pro rata portion of the trust account until we liquidate the trust account. If you are in need of immediate liquidity,
you could attempt to sell your shares in the open market; however, at such time our shares may trade at a discount to the pro rata amount
per share in the trust account. In either situation, you may suffer a material loss on your investment or lose the benefit of funds expected
in connection with our redemption until we liquidate or you are able to sell your shares in the open market.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The requirement that we complete our initial business combination
within the prescribed time frame may give potential target businesses leverage over us in negotiating a business combination and may decrease
our ability to conduct due diligence on potential business combination targets as we approach our dissolution deadline, which could undermine
our ability to complete our initial business combination on terms that would produce value for our shareholders.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any potential target business with which we enter into negotiations
concerning a business combination will be aware that we must complete our initial business combination within 24&#160;months from the
closing of the Initial Public Offering. Consequently, such target business may obtain leverage over us in negotiating a business combination,
knowing that if we do not complete our initial business combination with that particular target business, we may be unable to complete
our initial business combination with any target business. This risk will increase as we get closer to the end of the prescribed timeframe.
In addition, we may have limited time to conduct due diligence and may enter into our initial business combination on terms that we would
have rejected upon a more comprehensive investigation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If the net proceeds of the Initial Public Offering and the sale
of the private placement units not being held in the trust account are insufficient, it could limit the amount available to fund our search
for a target business or businesses and complete our initial business combination and we will depend on loans from our Sponsor or management
team to fund our search, to pay our taxes and to complete our initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Of the net proceeds of the Initial Public Offering and the sale of
the private placement units, only approximately $2,980,000 was available to us initially outside the trust account to fund our working
capital requirements. If we are required to seek additional capital, we would need to borrow funds from our Sponsor, members of our management
team or any of their affiliates to operate or may be forced to liquidate. Neither our Sponsor, members of our management team nor any
of their affiliates is under any obligation to advance funds to us in such circumstances. Any such advances would be repaid only from
funds held outside the trust account or from funds released to us upon completion of our initial business combination. If we are unable
to complete our initial business combination because we do not have sufficient funds available to us, we will be forced to cease operations
and liquidate the trust account. In such case, our public shareholders may only receive $10.00&#160;per share, and our warrants will expire
worthless. In certain circumstances, our public shareholders may receive less than $10.00 per share on the redemption of their shares.
See&#160;&#8220;<i>&#8212;&#160;If third parties bring claims against us, the proceeds held in the trust account could be reduced and
the&#160;per-share&#160;redemption&#160;amount received by shareholders may be less than $10.00 per share</i>&#8221; and other risk factors
herein.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may not be able to complete our initial business combination
within the&#160;prescribed timeframe, in which case we would cease all operations except for the purpose of winding up and we would redeem
our public shares and liquidate, in which case our public shareholders may only receive $10.00 per share, or less than such amount in
certain circumstances, and our warrants will expire worthless.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our amended and restated memorandum and articles of association provides
that we must complete our initial business combination within 24&#160;months from the closing of the Initial Public Offering. We may not
be able to find a suitable target business and complete our initial business combination within such time period. Our ability to complete
our initial business combination may be negatively impacted by general market conditions, volatility in the capital and debt markets and
the other risks described herein. For example, geopolitical instability emanating from the ongoing conflict between Russia and the Ukraine
as well as tensions in the Middle East could limit our ability to complete our initial business combination, including as a result of
increased market volatility, decreased market liquidity and third-party&#160;financing being unavailable on terms acceptable to us or
at all. Additionally, geopolitical stability may negatively impact businesses we may seek to acquire.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 24; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we have not completed our initial business combination within such
time period, we will: (1)&#160;cease all operations except for the purpose of winding up; (2)&#160;as promptly as reasonably possible
but not more than 10&#160;business&#160;days thereafter (and subject to lawfully available funds therefor), redeem the public shares,
at a&#160;per-share&#160;price,&#160;payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
(which interest shall be net of permitted withdrawals, and up to $100,000 of interest to pay dissolution expenses), divided by the number
of then issued and outstanding public shares, which redemption will completely extinguish public shareholders&#8217; rights as shareholders
(including the right to receive further liquidating distributions, if any); and (3)&#160;as promptly as reasonably possible following
such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in
each case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
In such case, our public shareholders may receive only $10.00 per share, or less than $10.00 per share, on the redemption of their shares,
and our warrants will expire worthless. See&#160;&#8220;<i>&#8212;&#160;If third parties bring claims against us, the proceeds held in
the trust account could be reduced and the&#160;per-share&#160;redemption&#160;amount received by shareholders may be less than $10.00
per share</i>&#8221; and other risk factors herein.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we are unable to complete an initial business combination within
the 24&#160;month&#160;period, we may seek an amendment to our amended and restated memorandum and articles of association to extend the
period of time we have to complete an initial business combination beyond 24&#160;months. Amending our memorandum and articles of association
will require a special resolution of our shareholders as a matter of Cayman Islands law, meaning that such an amendment be approved by
the affirmative vote of at least&#160;two-thirds&#160;(2/3)&#160;of the votes cast by such shareholders who, being present and entitled
to vote, attend and vote at a general meeting of the company. If we seek shareholder approval to extend the initial 24&#160;month&#160;period,
in which to complete an initial business combination to a later date, we will offer our public shareholders the right to have their public
ordinary shares redeemed for a pro rata share of the aggregate amount then on deposit in the trust account, as described in greater detail
in this Report.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Changes in international trade policies, tariffs and treaties
affecting imports and exports may have a material adverse effect on our search for an initial business combination target or the performance
or business prospects of a post-business combination company.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There have recently been significant changes to international trade
policies and tariffs affecting imports and exports. Any significant increases in tariffs on goods or materials or other changes in trade
policy could negatively affect our search for a target and/or our ability to complete our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recently, the U.S. has implemented a range of new tariffs and increases
to existing tariffs. In response to the tariffs announced by the U.S., other countries have imposed, are considering imposing, and may
in the future impose new or increased tariffs on certain exports from the United States. There is currently significant uncertainty about
the future relationship between the United States and other countries with respect to trade policies, taxes, government regulations and
tariffs. and we cannot predict whether, and to what extent, current tariffs will continue or trade policies will change in the future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tariffs, or the threat of tariffs or increased tariffs, could have
a significant negative impact on certain businesses (either due to domestic businesses&#8217; reliance on imported goods or dependence
on access to foreign markets, or foreign businesses&#8217; reliance on sales into the United States). In addition, retaliatory tariffs
could have a significant negative impact on foreign businesses that rely on imports from the United States, and domestic businesses that
rely on exporting goods internationally. These tariffs and threats of tariffs and other potential trade policy changes could negatively
affect the attractiveness of certain initial business combination targets, or lead to material adverse effects on a post-business&#160;combination
company. Among other things, historical financial performance of companies affected by trade policies and/or tariffs may not provide useful
guidance as to the future performance of such companies, because future financial performance of those companies may be materially affected
by new U.S. tariffs or foreign retaliatory tariffs, or other changes to trade policies. The business prospects of a particular target
for a business combination could change even after we enter into a business combination agreement, as a result of tariffs or the threat
of tariffs that may have a material impact on that target&#8217;s business, and it may be costly or impractical for us to terminate that
business combination agreement. These factors could affect our selection of a business combination target.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may not be able to adequately address the risks presented by these
tariffs or other potential trade policy changes. As a result, we may deem it costly, impractical or risky to complete an initial business
combination with a particular target or with a target in a particular industry or from a particular country. Consequently, the pool of
potential target companies may be reduced, which could impair our ability to identify a suitable target and to complete an initial business
combination. If we complete an initial business combination with such a target, the post-business&#160;combination company&#8217;s operations
and financial results could be adversely affected as a result of tariffs or changes to trade policies, which may cause the market value
of the securities of the post-business&#160;combination company to decline.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 25; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If we seek shareholder approval of our initial business combination,
our Sponsor, directors, executive officers, advisors and their affiliates may elect to purchase shares or warrants from public shareholders,
which may influence a vote on a proposed business combination and reduce the public &#8220;float&#8221; of our ordinary shares or public
warrants.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At any time prior to the general meeting to approve our initial business
combination, during a period when they are not then aware of any material nonpublic information regarding the company or its securities,
the Sponsor, directors, executive officers, advisors or any of their affiliates, may, in privately negotiated transactions or in the open
market, (i)&#160;purchase shares from institutional and other investors who vote, or indicate an intention to vote, against the business
combination, (ii)&#160;execute agreements to purchase such shares from institutional and other investors in the future, and/or (iii)&#160;enter
into transactions with institutional and other investors to provide such persons with incentives to acquire Class&#160;A ordinary shares.
Such an agreement may include a contractual acknowledgement that such shareholder, although still the record holder of such shares, is
no longer the beneficial owner thereof and therefore agrees not to exercise its redemption rights. In the event that the Sponsor, directors,
executive officers, advisors or any of their affiliates purchase shares in privately negotiated transactions from public shareholders
who have already elected to exercise their redemption rights, such selling public shareholders would be required to revoke their prior
elections to redeem their shares. While the exact nature of any such incentives has not been determined as of the date of this Report,
they might include, without limitation, arrangements to protect such investors or holders against potential loss in value of their shares,
including the granting of put options and the transfer of shares or the company&#8217;s warrants owned by the Sponsor for nominal value
to such investors or holders. Any Class&#160;A ordinary shares acquired by the persons described above would not be voted in connection
with the business combination.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">The purpose of any such transaction could be to reduce the number of
public shares or warrants outstanding or vote such shares or warrants on any matters submitted to the share or warrant holders for approval
in connection with our initial business combination or to satisfy a closing condition in an agreement with a target that requires us to
have a certain amount of cash at the closing of our initial business combination. Any such purchases of our securities may result in the
completion of our initial business combination that may not otherwise have been possible. Any such purchases will be reported pursuant
to Section&#160;13 and Section&#160;16 of the Exchange&#160;Act to the extent such purchasers are subject to such reporting requirements.
To the extent such securities are purchased, such public securities will not be voted as required by Tender Offers and Schedules Compliance
and Disclosure Interpretations Question 166.01 promulgated by the SEC.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">In addition, if such purchases are made, the public &#8220;float&#8221;
of our Class&#160;A ordinary shares or warrants may be reduced and the number of beneficial holders of our securities may be reduced,
which may make it difficult to maintain or obtain the quotation, listing or trading of our securities on a national securities exchange.
Any such purchases will</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">be reported pursuant to Section&#160;13 and Section&#160;16 of the
Exchange&#160;Act to the extent such purchasers are subject to such reporting requirements. Additionally, in the event our Sponsor, initial
shareholders, directors, officers, advisors and their affiliates were to purchase public shares or warrants from public shareholders,
such purchases would be structured in compliance with the requirements of Rule&#160;14e-5&#160;under&#160;the Exchange&#160;Act including,
in pertinent part, through adherence to the following:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our registration statement/proxy statement filed for our
business combination transaction would disclose the possibility that our Sponsor, initial shareholders, directors, officers, advisors
and their affiliates may purchase public shares or warrants from public shareholders outside the redemption process, along with the purpose
of such purchases;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">if our Sponsor, initial shareholders, directors, officers,
advisors and their affiliates were to purchase public shares or warrants from public shareholders, they would do so at a price no higher
than the price offered through our redemption process;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our registration statement/proxy statement filed for our
business combination transaction would include a representation that any of our securities purchased by our Sponsor, initial shareholders,
directors, officers, advisors and their affiliates would not be voted in favor of approving the business combination transaction;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our Sponsor, initial shareholders, directors, officers, advisors
and their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess redemption
rights, they would waive such rights; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">we would disclose in a Form&#160;8-K,&#160;before our security
holder meeting to approve the business combination transaction, the following material items:</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the amount of our securities purchased outside of the redemption
offer by our Sponsor, initial shareholders, directors, officers, advisors and their affiliates, along with the purchase price;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the purpose of the purchases by our Sponsor, initial shareholders,
directors, officers, advisors and their affiliates;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the impact, if any, of the purchases by our Sponsor, initial
shareholders, directors, officers, advisors and their affiliates on the likelihood that the business combination transaction will be
approved;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the identities of our security holders who sold to our Sponsor,
initial shareholders, directors, officers, advisors and their affiliates (if not purchased on the open market) or the nature of our security
holders (e.g., 5% security holders) who sold to our Sponsor, initial shareholders, directors, officers, advisors and their affiliates;
and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 1in; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the number of our securities for which we have received redemption
requests pursuant to our redemption offer.</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 26; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>You will not be entitled to protections normally afforded to
investors of many other blank check companies.</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since the net proceeds of the Initial Public Offering and the sale
of the private placement units are intended to be used to complete an initial business combination with a target business that has not
been identified, we may be deemed to be a &#8220;blank check&#8221; company under the United&#160;States securities laws. However, we
are exempt from rules promulgated by the SEC to protect investors in blank check companies, such as Rule&#160;419. Accordingly, investors
will not be afforded the benefits or protections of those rules. Among other things, this means our units will be immediately tradable
and we will have a longer period of time to complete our initial business combination than do companies subject to Rule&#160;419. Moreover,
if the Initial Public Offering were subject to Rule&#160;419, that rule would prohibit the release of any interest earned on funds held
in the trust account to us unless and until the funds in the trust account were released to us in connection with our completion of an
initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Because of our limited resources and the significant competition
for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we are unable
to complete our initial business combination, our public shareholders may receive only approximately $10.00 per share, or less in certain
circumstances, on our redemption, and our warrants will expire worthless.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We expect to encounter intense competition from other entities having
a business objective similar to ours, including private investors (which may be individuals or investment partnerships), other blank check
companies and other entities, domestic and international, competing for the types of businesses we intend to acquire. Many of these individuals
and entities are well-established&#160;and have extensive experience in identifying and effecting, directly or indirectly, acquisitions
of companies operating in or providing services to various industries. Many of these competitors possess greater technical, human and
other resources or more local industry knowledge than we do and our financial resources will be relatively limited when contrasted with
those of many of these competitors. While we believe there are numerous target businesses we could potentially acquire with the net proceeds
of the Initial Public Offering and the sale of the private placement units, our ability to compete with respect to the acquisition of
certain target businesses that are sizable will be limited by our available financial resources. This inherent competitive limitation
gives others an advantage in pursuing the acquisition of certain target businesses. Furthermore, if we are obligated to pay cash for the
Class&#160;A ordinary shares redeemed and, in the event we seek shareholder approval of our initial business combination, we make purchases
of our Class&#160;A ordinary shares, potentially reducing the resources available to us for our initial business combination. Any of these
obligations may place us at a competitive disadvantage in successfully negotiating a business combination. If we are unable to complete
our initial business combination, our public shareholders may receive only approximately $10.00 per share (or less in certain circumstances)
on the liquidation of our trust account and our warrants will expire worthless. In certain circumstances, our public shareholders may
receive less than $10.00 per share on the redemption of their shares. See &#8220;<i>&#8212;&#160;If third parties bring claims against
us, the proceeds held in the trust account could be reduced and the&#160;per-share&#160;redemption&#160;amount received by shareholders
may be less than $10.00 per share</i>&#8221; and other risk factors herein.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If the net proceeds of the Initial Public Offering not being
held in the trust account are insufficient to allow us to operate for at least 24&#160;months following the closing of the Initial Public
Offering, we may be unable to complete our initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The funds available to us outside of the trust account may not be
sufficient to allow us to operate for at least the 24&#160;months following the closing of the Initial Public Offering, assuming that
our initial business combination is not completed during that time. We expect to incur significant costs in pursuit of our acquisition
plans. Management&#8217;s plans to address this need for capital through the Initial Public Offering and potential loans from our affiliates
as discussed in the section of this Report titled &#8220;<i>Management&#8217;s Discussion and Analysis of Financial Condition and Results
of Operations</i>.&#8221; Our Sponsor may loan funds to us in such circumstances. However, our affiliates, including our Sponsor, are
not obligated to make additional loans to us in the future, and we may not be able to raise additional financing from unaffiliated parties
necessary to fund our expenses. Any such event in the future may negatively impact the analysis regarding our ability to continue as
a going concern at such time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We believe that, upon the closing of the Initial Public Offering, the
funds available to us outside of the trust account, will be sufficient to allow us to operate for at least the 24&#160;months following
the closing of the Initial Public Offering; however, we cannot assure you that our estimate is accurate. Of the funds available to us,
we could use a portion of the funds available to us to pay fees to consultants to assist us with our search for a target business. We
could also use a portion of the funds as a down payment or to fund a&#160;&#8220;no-shop&#8221;&#160;provision (a provision in letters
of intent designed to keep target businesses from &#8220;shopping&#8221; around for transactions with other companies on terms more favorable
to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to
do so. If we entered into a letter of intent where we paid for the right to receive exclusivity from a target business and were subsequently
required to forfeit such funds (whether as a result of our breach or otherwise), we might not have sufficient funds to continue searching
for, or conduct due diligence with respect to, a target business. If we are unable to complete our initial business combination, our public
shareholders may receive only approximately $10.00 per share (or less in certain circumstances) on the liquidation of our trust account
and our warrants will expire worthless. In such case, our public shareholders may only receive $10.00 per share, and our warrants will
expire worthless. In certain circumstances, our public shareholders may receive less than $10.00 per share on the redemption of their
shares. See&#160;&#8220;<i>&#8212;</i>&#160;<i>If third parties bring claims against us, the proceeds held in the trust account could
be reduced and the&#160;per-share&#160;redemption&#160;amount received by shareholders may be less than $10.00 per share</i>&#8221; and
other risk factors herein.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 27; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Subsequent to the completion of our initial business combination,
we may be required to take&#160;write-downs&#160;or&#160;write-offs, restructuring and impairment or other charges that could have a significant
negative effect on our financial condition, results of operations and our share price, which could cause you to lose some or all of your
investment.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Even if we conduct extensive due diligence on a target business with
which we combine, we cannot assure you that this diligence will surface all material issues that may be present inside a particular target
business, that it would be possible to uncover all material issues through a customary amount of due diligence, or that factors outside
of the target business and outside of our control will not later arise. As a result of these factors, we may be forced to later write-down&#160;or&#160;write-off&#160;assets,&#160;restructure
our operations, or incur impairment or other charges that could result in our reporting losses. Even if our due diligence successfully
identifies certain risks, unexpected risks may arise and previously known risks may materialize in a manner not consistent with our preliminary
risk analysis. Even though these charges may be&#160;non-cash&#160;items&#160;and not have an immediate impact on our liquidity, the fact
that we report charges of this nature could contribute to negative market perceptions about us or our securities. In addition, charges
of this nature may cause us to violate net worth or other covenants to which we may be subject as a result of assuming&#160;pre-existing&#160;debt&#160;held
by a target business or by virtue of our obtaining post-combination&#160;debt financing. Accordingly, any shareholders who choose to remain
shareholders following the business combination could suffer a reduction in the value of their shares. Such shareholders are unlikely
to have a remedy for such reduction in value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If third parties bring claims against us, the proceeds held in
the trust account could be reduced and the&#160;per-share&#160;redemption&#160;amount received by shareholders may be less than $10.00
per share.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our placing of funds in the trust account may not protect those funds
from third-party&#160;claims against us. Although we will seek to have all third parties (other than our independent auditors), prospective
target businesses</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or other entities with which we do business execute agreements with
us waiving any right, title, interest or claim of any kind in or to any monies held in the trust account for the benefit of our public
shareholders, such parties may not execute such agreements, or even if they execute such agreements they may not be prevented from bringing
claims against the trust account, including, but not limited to, fraudulent inducement, breach of fiduciary responsibility or other similar
claims, as well as claims challenging the enforceability of the waiver, in each case in order to gain advantage with respect to a claim
against our assets, including the funds held in the trust account. If any third party refuses to execute an agreement waiving such claims
to the monies held in the trust account, our management will perform an analysis of the alternatives available to it and will only enter
into an agreement with a third party that has not executed a waiver if management believes that such third party&#8217;s engagement would
be significantly more beneficial to us than any alternative.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Examples of possible instances where we may engage a third party that
refuses to execute a waiver include the engagement of a third party consultant whose particular expertise or skills are believed by management
to be significantly superior to those of other consultants that would agree to execute a waiver or in cases where management is unable
to find a service provider willing to execute a waiver. In addition, there is no guarantee that such entities will agree to waive any
claims they may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with us and will not seek
recourse against the trust account for any reason. Upon redemption of our public shares, if we are unable to complete our initial business
combination within the prescribed timeframe, or upon the exercise of a redemption right in connection with our initial business combination,
we will be required to provide for payment of claims of creditors that were not waived that may be brought against us within the 10&#160;years
following redemption. Accordingly, the&#160;per-share&#160;redemption&#160;amount received by public shareholders could be less than the
$10.00 per share initially held in the trust account, due to claims of such creditors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Sponsor has agreed that it will be liable to us if and to the extent
any claims by a third-party&#160;(other than our independent auditors) for services rendered or products sold to us, or a prospective
target business with which we have discussed entering into a transaction agreement, reduce the amount of funds in the trust account to
below (i)&#160;$10.00 per public share or (ii)&#160;such lesser amount per public share held in the trust account as of the date of the
liquidation of the trust account due to reductions in the value of the trust assets, in each case net of permitted withdrawals, except
as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account and except as to any
claims under our indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under
the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will
not be responsible to the extent of any liability for such third party claims. We have not independently verified whether the Sponsor
has sufficient funds to satisfy their indemnity obligations and believe that the Sponsor&#8217;s only assets are securities of our company.
The Sponsor may not have sufficient funds available to satisfy those obligations. We have not asked the Sponsor to reserve for such obligations,
and therefore, no funds are currently set aside to cover any such obligations. As a result, if any such claims were successfully made
against the trust account, the funds available for our initial business combination and redemptions could be reduced to less than $10.00
per public share. In such event, we may not be able to complete our initial business combination, and you would receive such lesser amount
per share in connection with any redemption of your public shares. None of our officers or directors will indemnify us for claims by third
parties including, without limitation, claims by third parties and prospective target businesses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 28; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our directors may decide not to enforce the indemnification obligations
of the Sponsor, resulting in a reduction in the amount of funds in the trust account available for distribution to our public shareholders.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event that the proceeds in the trust account are reduced below
the lesser of (i)&#160;$10.00 per public share or (ii)&#160;such lesser amount per share held in the trust account as of the date of the
liquidation of the trust account due to reductions in the value of the trust assets, in each case net of permitted withdrawals, and the
Sponsor asserts that it is unable to satisfy its obligations or that it has no indemnification obligations related to a particular claim,
our independent directors would determine whether to take legal action against the Sponsor to enforce its indemnification obligations.
While we currently expect that our independent directors would take legal action on our behalf against the Sponsor to enforce its indemnification
obligations to us, it is possible that our independent directors in exercising their business judgment may choose not to do so in any
particular instance. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the
trust account available for distribution to our public shareholders may be reduced below $10.00 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If, after we distribute the proceeds in the trust account to
our public shareholders, we file a bankruptcy or&#160;winding-up&#160;petition&#160;or an involuntary bankruptcy&#160;or&#160;winding-up&#160;petition&#160;is
filed against us that is not dismissed, a bankruptcy or insolvency court may seek to recover such proceeds, and the members of our Board
of Directors may be viewed as having breached their fiduciary duties to our creditors, thereby exposing the members of our Board of Directors
and us to claims of punitive damages.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If, after we distribute the proceeds in the trust account to our public
shareholders, we file a bankruptcy or&#160;winding-up&#160;petition&#160;or an involuntary bankruptcy or&#160;winding-up&#160;petition&#160;is
filed against us that is not dismissed, any distributions received by shareholders could be viewed under applicable debtor/creditor and/or
bankruptcy or insolvency laws as either a &#8220;preferential transfer&#8221; or a &#8220;fraudulent conveyance.&#8221; As a result, a
bankruptcy or insolvency court could seek to recover all amounts received by our shareholders. In addition, our Board of Directors may
be viewed as having breached its fiduciary duty to our creditors and/or having acted in bad faith, thereby exposing itself and us to claims
of punitive damages, by paying public shareholders from the trust account prior to addressing the claims of creditors, thereby exposing
itself and us to claims of punitive damages.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If, before distributing the proceeds in the trust account to
our public shareholders, we file a bankruptcy or&#160;winding-up&#160;petition&#160;or an involuntary bankruptcy&#160;or&#160;winding-up&#160;petition&#160;is
filed against us that is not dismissed, the claims of creditors in such proceeding may have priority over the claims of our shareholders
and&#160;the&#160;per-share&#160;amount&#160;that would otherwise be received by our shareholders in connection with our liquidation may
be reduced.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If, before distributing the proceeds in the trust account to our public
shareholders, we file a bankruptcy or&#160;winding-up&#160;petition&#160;or an involuntary bankruptcy or&#160;winding-up&#160;petition&#160;is
filed against us that is not dismissed, the proceeds held in the trust account could be subject to applicable bankruptcy or insolvency
law, and may be included in our bankruptcy or insolvency estate and subject to the claims of third parties with priority over the claims
of our shareholders. To the extent any bankruptcy claims deplete the trust account, the&#160;per-share&#160;amount&#160;that would otherwise
be received by our shareholders in connection with our liquidation may be reduced.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Adverse developments affecting the financial services industry,
including events or concerns involving liquidity, defaults or&#160;non-performance&#160;by financial institutions, could adversely affect
our business, financial condition or results of operations, or our prospects.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The funds in our operating account and our trust account will be held
in banks or other financial institutions and will be invested or held only in either (i)&#160;U.S.&#160;government treasury obligations
with a maturity of 185&#160;days or less or in money market funds meeting certain conditions under Rule&#160;2a-7&#160;under&#160;the
Investment Company Act which invest only in direct U.S.&#160;government treasury obligations, (ii)&#160;as uninvested cash, or (iii)&#160;an
interest bearing bank demand deposit account or other accounts at a bank. To mitigate the risk that we might be deemed to be an investment
company for purposes of the Investment Company Act, which risk increases the longer we hold investments in the trust account, we may,
at any time (and will no later than 24&#160;months from the closing of the Initial Public Offering) instruct the trustee to liquidate
the investments held in the trust account and instead to hold the funds in the trust account in cash or in an interest bearing demand
deposit account. For more information about the risk of the company being considered to be operating as an unregistered investment company,
see &#8220;<i>&#8212;&#160;If we are deemed to be an investment company under the Investment Company Act, we may be required to institute
burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial business
combination.</i>&#8221; Our cash held in&#160;non-interest&#160;bearing&#160;and interest-bearing&#160;accounts may exceed any applicable
Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) insurance limits. Should events, including limited liquidity, defaults,&#160;non-performance&#160;or&#160;other
adverse developments occur with respect to the banks or other financial institutions that hold our funds, or that affect financial institutions
or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, the value
of the assets in our trust account could be impaired, which could have a material impact on our operating results, liquidity, financial
condition and prospects. For example, on March&#160;10, 2023, the FDIC announced that Silicon Valley Bank had been closed by the California
Department of Financial Protection and Innovation. We cannot guarantee that the banks or other financial institutions that will hold our
funds will not experience similar issues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 29; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Although we have identified general criteria and guidelines that
we believe are important in evaluating prospective target businesses, we may enter into our initial business combination with a target
that does not meet such criteria and guidelines, and as a result, the target business with which we enter into our initial business combination
may not have attributes entirely consistent with our general criteria and guidelines.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although we have identified general criteria and guidelines for evaluating
prospective target businesses, it is possible that a target business with which we enter into our initial business combination will not
have all of these positive attributes. If we complete our initial business combination with a target that does not meet some or all of
these guidelines, such combination may not be as successful as a combination with a business that does meet all of our general criteria
and guidelines. In addition, if we announce a prospective business combination with a target that does not meet our general criteria and
guidelines, a greater number of shareholders may exercise their redemption rights, which may make it difficult for us to meet any closing
condition with a target business that requires us to have a minimum net worth or a certain amount of cash. In addition, if shareholder
approval of the transaction is required by law, or we decide to obtain shareholder approval for business or other legal reasons, it may
be more difficult for us to attain shareholder approval of our initial business combination if the target business does not meet our general
criteria and guidelines. If we are unable to complete our initial business combination, our public shareholders may receive only approximately
$10.00 per share on the liquidation of our trust account and our warrants will expire worthless.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may seek acquisition opportunities in industries or sectors
that may be outside of our management&#8217;s areas of expertise.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will consider a business combination outside of our management&#8217;s
areas of expertise if a business combination candidate is presented to us and we determine that such candidate offers an attractive acquisition
opportunity for our company. In the event we elect to pursue an acquisition outside of the areas of our management&#8217;s expertise,
our management&#8217;s expertise may not be directly applicable to its evaluation or operation, and the information contained in this
Report regarding the areas of our management&#8217;s expertise would not be relevant to an understanding of the business that we elect
to acquire. As a result, our management may not be able to adequately ascertain or assess all of the significant risk factors. Accordingly,
any shareholders who choose to remain shareholders following our initial business combination could suffer a reduction in the value of
their shares. Such shareholders are unlikely to have a remedy for such reduction in value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We are not required to obtain an opinion from an independent
entity that commonly renders valuation opinions, and consequently, you may have no assurance from an independent source that the price
we are paying for the business is fair to our company from a financial point of view.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unless we complete our business combination with an affiliated entity,
or our Board of Directors cannot independently determine the fair market value of the target business or businesses, we are not required
to obtain an opinion from an independent entity that commonly renders valuation opinions that the price we are paying for a target is
fair to our company from a financial point of view. If no opinion is obtained, our shareholders will be relying on the judgment of our
Board of Directors, who will determine fair market value based on standards generally accepted by the financial community. Such standards
used will be disclosed in our tender offer documents or proxy solicitation materials, as applicable, related to our initial business combination.
However, if our Board of Directors is unable to determine the fair value of an entity with which we seek to complete an initial business
combination based on such standards, we will be required to obtain an opinion as described above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Because we must furnish our shareholders with target business
financial statements, we may lose the ability to complete an otherwise advantageous initial business combination with some prospective
target businesses.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The federal proxy rules require that a proxy statement with respect
to a vote on a business combination meeting certain financial significance tests include historical and/or pro forma financial statement
disclosure in periodic reports. We will include the same financial statement disclosure in connection with our tender offer documents,
whether or not they are required under the tender offer rules. These financial statements may be required to be prepared in accordance
with, or be reconciled to, accounting principles generally accepted in the United&#160;States of America, or U.S.&#160;GAAP, or international
financing reporting standards as issued by the International Accounting Standards Board, or IFRS, depending on the circumstances and the
historical financial statements may be required to be audited in accordance with the standards of the Public Company Accounting Oversight
Board (United&#160;States), or PCAOB.&#160;These financial statement requirements may limit the pool of potential target businesses we
may acquire because some targets may be unable to provide such statements in time for us to disclose such statements in accordance with
federal proxy rules and complete our initial business combination within the prescribed time frame.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 30; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Compliance obligations under the&#160;Sarbanes-Oxley&#160;Act
may make it more difficult for us to effectuate our initial business combination, require substantial financial and management resources,
and increase the time and costs of completing an acquisition.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section&#160;404 of the Sarbanes-Oxley&#160;Act requires that we evaluate
and report on our system of internal controls beginning with our Annual Report on&#160;Form&#160;10-K&#160;for&#160;the year ending December&#160;31,
2026. Only in the event we are deemed to be a large accelerated filer or an accelerated filer will we be required to comply with the independent
registered public accounting firm attestation requirement on our internal control over financial reporting. Further, for as long as we
remain an emerging growth company, we will not be required to comply with the independent registered public accounting firm attestation
requirement on our internal control over financial reporting. The fact that we are a blank check company makes compliance with the requirements
of the Sarbanes-Oxley&#160;Act particularly burdensome on us as compared to other public companies because a target company with which
we seek to complete our initial business combination may not be in compliance with the provisions of the Sarbanes-Oxley&#160;Act regarding
adequacy of its internal controls. The development of the internal control of any such entity to achieve compliance with the Sarbanes-Oxley&#160;Act
may increase the time and costs necessary to complete any such acquisition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may engage one or more of our underwriters or one of their
respective affiliates to provide additional services to us after the Initial Public Offering, which may include acting as M&amp;A advisor
in connection with an initial business combination or as placement agent in connection with a related financing transaction. Our underwriters
are entitled to receive deferred underwriting commissions that will be released from the trust account only upon a completion of an initial
business combination. These financial incentives may cause them to have potential conflicts of interest in rendering any such additional
services to us after the Initial Public Offering, including, for example, in connection with the sourcing and consummation of an initial
business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may engage one or more of our underwriters or one of their respective
affiliates to provide additional services to us after the Initial Public Offering, including, for example, identifying potential targets,
providing M&amp;A advisory services, acting as a placement agent in a private offering or arranging debt financing transactions. We may
pay such underwriters or their affiliate fair and reasonable fees or other compensation that would be determined at that time in an arm&#8217;s
length negotiation; provided that no agreement will be entered into with any of the underwriters or their respective affiliates and no
fees or other compensation for such services will be paid to any of the underwriters or their respective affiliates prior to the date
that is 60&#160;days from the date of the final prospectus, unless such payment would not be deemed underwriters&#8217; compensation in
connection with the Initial Public Offering.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The underwriters are also entitled to receive deferred underwriting
commissions that are conditioned on the completion of an initial business combination. The underwriters&#8217; or their respective affiliates&#8217;
financial interests tied to the consummation of a business combination transaction may give rise to potential conflicts of interest in
providing any such additional services to us, including potential conflicts of interest in connection with the sourcing and consummation
of an initial business combination. The underwriters are under no obligation to provide any further services to us in order to receive
all or any part of the deferred underwriting commissions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We do not have a specified maximum redemption threshold. The
absence of such a redemption threshold may make it possible for us to complete a business combination with which a substantial majority
of our shareholders do not agree.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our amended and restated memorandum and articles of association will
not provide a specified maximum redemption threshold. As a result, we may be able to complete our initial business combination even though
a substantial majority of our public shareholders do not agree with the transaction and have redeemed their shares. In the event the aggregate
cash consideration we would be required to pay for all Class&#160;A ordinary shares that are validly submitted for redemption plus any
amount required to satisfy cash conditions pursuant to the terms of the proposed business combination exceed the aggregate amount of cash
available to us, we will not complete the business combination or redeem any shares, all Class&#160;A ordinary shares submitted for redemption
will be returned to the holders thereof, and we instead may search for an alternate business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Investors may not have sufficient time to comply with the delivery
requirements for redemption.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to our amended and restated memorandum and articles of association,
we are required to give a minimum of only five clear&#160;days&#8217; notice for each general meeting. As a result, if we require public
shareholders who wish to redeem their public shares into the right to receive a<i>&#160;pro&#160;rata</i>&#160;portion of the funds in
the trust account to comply with specific delivery requirements for redemption, holders may not have sufficient time to receive the notice
and deliver their shares for redemption. Accordingly, investors may not be able to exercise their redemption rights and may be forced
to retain our securities when they otherwise would not want to.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>In order to effectuate an initial business combination, blank
check companies have, in the recent past, amended various provisions of their charters and modified governing instruments. We cannot assure
you that we will not seek to amend our amended and restated memorandum and articles of association or governing instruments in a manner
that will make it easier for us to complete our initial business combination that some of our shareholders may not support.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to effectuate a business combination, blank check companies
have, in the past, amended various provisions of their charters and modified governing instruments. For example, blank check companies
have amended the definition of business combination, increased redemption thresholds and extended the period of time in which it had to
consummate a business combination. Amending our amended and restated memorandum and articles of association requires a special resolution
of our shareholders as a matter of Cayman Islands law. We cannot assure you that we will not seek to amend our amended and restated memorandum
and articles of association or other governing instruments or extend the time in which we have to consummate a business combination in
order to effectuate our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 31; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may have a limited ability to assess the management of a prospective
target business and, as a result, may affect our initial business combination with a target business whose management may not have the
skills, qualifications or abilities to manage a public company.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">When evaluating the desirability of effecting our initial business
combination with a prospective target business, our ability to assess the target business&#8217;s management may be limited due to a lack
of time, resources or information. Our assessment of the capabilities of the target&#8217;s management, therefore, may prove to be incorrect
and such management may lack the skills, qualifications or abilities we suspected. Should the target&#8217;s management not possess the
skills, qualifications or abilities necessary to manage a public company, the operations and profitability of the post-combination&#160;business
may be negatively impacted. Accordingly, any shareholders who choose to remain shareholders following the business combination could suffer
a reduction in the value of their shares. Such shareholders are unlikely to have a remedy for such reduction in value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The officers and directors of an acquisition candidate may resign upon
completion of our initial business combination. The departure of a business combination target&#8217;s key personnel could negatively
impact the operations and profitability of our post-combination&#160;business. The role of an acquisition candidates&#8217; key personnel
upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that certain members
of an acquisition candidate&#8217;s management team will remain associated with the acquisition candidate following our initial business
combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Certain provisions of our amended and restated memorandum and
articles of association that relate to&#160;our&#160;pre-initial&#160;business&#160;combination activity (and corresponding provisions
of the agreement governing the release of funds from our trust account), including an amendment to permit us to withdraw funds from the
trust account such that the per share amount investors will receive upon any redemption or liquidation is substantially reduced or eliminated,
may be amended with the approval of a special resolution under Cayman Islands law, being the affirmative vote of at&#160;least&#160;two-thirds&#160;(2/3)&#160;of
the votes cast by such shareholders who, being present and entitled to vote, attend and vote at a general meeting (and corresponding provisions
of the trust agreement governing the release of funds from our trust account may be amended in accordance with the terms of the trust
agreement). It may be easier for us, therefore, to amend our amended and restated memorandum and articles of association and the trust
agreement to facilitate the completion of an initial business combination that some of our shareholders may not support.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our amended and restated memorandum and articles of association provides
that any of its provisions, (other than amendments relating to the appointment or removal of directors prior to our initial business combination,
which would require the approval of a majority of at least 90% of our ordinary shares voting at the applicable general meeting, and amendments
relating to the company&#8217;s continuation in a jurisdiction outside the Cayman Islands, which would require the approval of our board
of directors) related to&#160;pre-initial&#160;business&#160;combination activity (including the requirement to deposit proceeds of the
Initial Public Offering and the private placement into the trust account and not release such amounts except in specified circumstances,
and to provide redemption rights to public shareholders as described herein and in our amended and restated memorandum and articles of
association or an amendment to permit us to withdraw funds from the trust account such that the per share amount investors will receive
upon any redemption or liquidation is substantially reduced or eliminated), may be amended if approved by a special resolution under Cayman
Islands law, being the affirmative vote of at least&#160;two-thirds&#160;(2/3)&#160;of the issued ordinary shares who, being present and
entitled to vote at a general meeting, vote at a general meeting, and corresponding provisions of the trust agreement governing the release
of funds from our trust account may be amended in accordance with the terms of the trust agreement. Our initial holders and holders of
placement shares will participate in any vote to amend our amended and restated memorandum and articles of association and/or trust agreement
and will have the discretion to vote in any manner they choose. As a result, we may be able to amend the provisions of our amended and
restated memorandum and articles of association which govern our pre-initial&#160;business&#160;combination behavior more easily than
some other blank check companies, and this may increase our ability to complete a business combination with which you do not agree. Our
shareholders may pursue remedies against us for any breach of our amended and restated memorandum and articles of association.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 32; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may be unable to obtain additional financing to complete our
initial business combination or to fund the operations and growth of a target business, which could compel us to restructure or abandon
a particular business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although we believe that the net proceeds of the Initial Public Offering
and the sale of the private placement units will be sufficient to allow us to complete our initial business combination, because we have
not yet identified any prospective target business we cannot ascertain the capital requirements for any particular transaction. If the
net proceeds of the Initial Public Offering and the sale of the private placement units prove to be insufficient, either because of the
size of our initial business combination, the depletion of the available net proceeds in search of a target business, the obligation to
redeem for cash a significant number of shares from shareholders who elect redemption in connection with our initial business combination
or the terms of negotiated transactions to purchase shares in connection with our initial business combination, we may be required to
seek additional financing or to abandon the proposed business combination. We cannot assure you that such financing will be available
on acceptable terms, if at all. To the extent that additional financing proves to be unavailable when needed to complete our initial business
combination, we would be compelled to either restructure the transaction or abandon that particular business combination and seek an alternative
target business candidate. In addition, even if we do not need additional financing to complete our initial business combination, we may
require such financing to fund the operations or growth of the target business. The failure to secure additional financing could have
a material adverse effect on the continued development or growth of the target business. None of our officers, directors or shareholders
is required to provide any financing to us in connection with or after our initial business combination. If we are unable to complete
our initial business combination, our public shareholders may only receive approximately $10.00 per share on the liquidation of our trust
account, and our warrants will expire worthless.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Resources could be wasted in researching acquisitions that are
not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we
are unable to complete our initial business combination, our public shareholders may receive only approximately $10.00 per share, or less
than such amount in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We anticipate that the investigation of each specific target business
and the negotiation, drafting and execution of relevant agreements, disclosure documents and other instruments will require substantial
management time and attention and substantial costs for accountants, attorneys and others. If we decide not to complete a specific initial
business combination, the costs incurred up to that point for the proposed transaction likely would not be recoverable. Furthermore, if
we reach an agreement relating to a specific target business, we may fail to complete our initial business combination for any number
of reasons including those beyond our control. Any such event will result in a loss to us of the related costs incurred which could materially
adversely affect subsequent attempts to locate and acquire or merge with another business. If we are unable to complete our initial business
combination, our public shareholders may receive only approximately $10.00 per share on the liquidation of our trust account and our warrants
will expire worthless. See &#8220;<i>&#8212;&#160;If third parties bring claims against us, the proceeds held in the trust account could
be reduced and the&#160;per-share&#160;redemption&#160;amount received by shareholders may be less than $10.00 per share</i>&#8221; and
other risk factors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our management may not be able to maintain control of a target
business after our initial business combination. We cannot provide assurance that, upon loss of control of a target business, new management
will possess the skills, qualifications or abilities necessary to profitably operate such business.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may structure a business combination so that the post-transaction&#160;company
in which our public shareholders own shares will own less than 100% of the equity interests or assets of a target business, but we will
only complete such business combination if the post-transaction&#160;company owns or acquires 50% or more of the outstanding voting securities
of the target or otherwise acquires a controlling interest in the target sufficient for us not to be required to register as an investment
company under the Investment Company Act. We will not consider any transaction that does not meet such criteria. Even if the post-transaction&#160;company
owns 50% or more of the voting securities of the target, our shareholders prior to the business combination may collectively own a minority
interest in the post business combination company, depending on valuations ascribed to the target and us in the business combination transaction.
For example, we could pursue a transaction in which we issue a substantial number of new ordinary shares in exchange for all of the outstanding
shares or other equity interests of a target. In this case, we would acquire a 100% interest in the target. However, as a result of the
issuance of a substantial number of new ordinary shares, our shareholders immediately prior to such transaction could own less than a
majority of our issued and outstanding ordinary shares subsequent to such transaction. In addition, other minority shareholders may subsequently
combine their holdings resulting in a single person or group obtaining a larger share of the company&#8217;s shares than we initially
acquired. Accordingly, this may make it more likely that our management will not be able to maintain our control of the target business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may issue notes or other debt securities, or otherwise incur
substantial debt, to complete a business combination, which may adversely affect our leverage and financial condition and thus negatively
impact the value of our shareholders&#8217; investment in us.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Although we have no commitments as of the date of this Report to issue
any notes or other debt securities, or to otherwise incur outstanding debt following the Initial Public Offering, we may choose to incur
substantial debt to complete our initial business combination. We have agreed that we will not incur any indebtedness unless we have obtained
from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust account. As such, no
issuance of debt will affect the&#160;per-share&#160;amount&#160;available for redemption from the trust account. Nevertheless, the incurrence
of debt could have a variety of negative effects, including:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">default and foreclosure on our assets if our operating revenues
after an initial business combination are insufficient to repay our debt obligations;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt"></p><!-- Field: Page; Sequence: 33; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">acceleration of our obligations to repay the indebtedness
even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial
ratios or reserves without a waiver or renegotiation of that covenant;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our immediate payment of all principal and accrued interest,
if any, if the debt security is payable on demand;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our inability to obtain necessary additional financing if
the debt security contains covenants restricting our ability to obtain such financing while the debt security is outstanding;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our inability to pay dividends on our Class A ordinary shares;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">using a substantial portion of our cash flow to pay principal
and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital
expenditures, acquisitions and other general corporate purposes;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">limitations on our flexibility in planning for and reacting
to changes in our business and in the industry in which we operate;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">increased vulnerability to adverse changes in general economic,
industry and competitive conditions and adverse changes in government regulation or prevailing interest rates; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">limitations on our ability to borrow additional amounts for
expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages
compared to our competitors who have less debt.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Holders of Class&#160;A ordinary shares will not be entitled
to vote on any appointment or removal of directors we hold prior to our initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Prior to our initial business combination, only holders of our Class&#160;B
ordinary shares will have the right to vote on the appointment and removal of directors. Holders of our public shares will not be entitled
to vote on the appointment or removal of directors during such time. In addition, prior to our initial business combination, holders of
a majority of our Class&#160;B ordinary shares may remove a member of the board of directors for any reason. Accordingly, as holders of
our Class&#160;A ordinary shares, our public shareholders will not have any say in the management of our company prior to the consummation
of an initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Because we are not limited to a particular industry or any specific
target businesses with which to pursue our initial business combination, you will be unable to ascertain the merits or risks of any particular
target business&#8217;s operations.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may seek to complete a business combination with an operating company
in any industry or sector. However, we will not, under our amended and restated memorandum and articles of association, be permitted to
effectuate our initial business combination with another blank check company or similar company with nominal operations. Because we have
not yet identified or approached any specific target business with respect to a business combination, there is no basis to evaluate the
possible merits or risks of any particular target business&#8217;s operations, results of operations, cash flows, liquidity, financial
condition or prospects. To the extent we complete our initial business combination, we may be affected by numerous risks inherent in the
business operations with which we combine. For example, if we combine with a financially unstable business or an entity lacking an established
record of sales or earnings, we may be affected by the risks inherent in the business and operations of a financially unstable entity.
Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you
that we will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence.
Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those
risks will adversely impact a target business. We also cannot assure you that an investment in our units will ultimately prove to be more
favorable to investors than a direct investment, if such opportunity were available, in a business combination target. Accordingly, any
shareholders who choose to remain shareholders following the business combination could suffer a reduction in the value of their shares.
Such shareholders are unlikely to have a remedy for such reduction in value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may seek acquisition opportunities with an&#160;early-stage&#160;company,
a financially unstable business or an entity lacking an established record of revenue or earnings.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the extent we complete our initial business combination with an
early-stage&#160;company, a financially unstable business or an entity lacking an established record of sales or earnings, we may be affected
by numerous risks inherent in the operations of the business with which we combine. These risks include volatile revenues or earnings
and difficulties in obtaining and retaining key personnel. In recent&#160;years, a number of target businesses have underperformed financially
post-business&#160;combination. There are no assurances that the target business with which we consummate our initial business combination
will perform as anticipated. Although our officers and directors will endeavor to evaluate the risks inherent in a particular target business,
we may not be able to properly ascertain or assess all of the significant risk factors and we may not have adequate time to complete due
diligence. Furthermore, some of these risks may be outside of our control and leave us with no ability to control or reduce the chances
that those risks will adversely impact a target business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 34; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may only be able to complete one business combination with
the proceeds of the Initial Public Offering and the sale of the private placement units, which will cause us to be solely dependent on
a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations
and profitability.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Of the gross proceeds from the Initial Public Offering and the sale
of the private placement units, $249,000,000 was immediately available to complete our business combination and pay related fees and expenses
(which includes up to $10,200,000 for the payment of deferred underwriting commissions).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may effectuate our initial business combination with a single target
business or multiple target businesses simultaneously or within a short period of time. However, we may not be able to effectuate our
initial business combination with more than one target business because of various factors, including the existence of complex accounting
issues and the requirement that we prepare and file pro forma financial statements with the SEC that present operating results and the
financial condition of several target businesses as if they had been operated on a combined basis. By completing our initial business
combination with only a single entity our lack of diversification may subject us to numerous economic, competitive and regulatory risks.
Further, we would not be able to diversify our operations or benefit from the possible spreading of risks or offsetting of losses, unlike
other entities which may have the resources to complete several business combinations in different industries or different areas of a
single industry. Accordingly, the prospects for our success may be:</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">solely dependent upon the performance of a single business,
property or asset; or</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">dependent upon the development or market acceptance of a
single or limited number of products, processes or services.</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This lack of diversification may subject us to numerous economic, competitive
and regulatory risks, any or all of which may have a substantial adverse impact upon the particular industry in which we may operate subsequent
to our initial business combination.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may attempt to simultaneously complete business combinations
with multiple prospective targets, which may hinder our ability to complete our initial business combination and give rise to increased
costs and risks that could negatively impact our operations and profitability.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we determine to simultaneously acquire several businesses that are
owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent on the simultaneous
closings of the other business combinations, which may make it more difficult for us, and delay our ability, to complete our initial business
combination. With multiple business combinations, we could also face additional risks, including additional burdens and costs with respect
to possible multiple negotiations and due diligence investigations (if there are multiple sellers) and the additional risks associated
with the subsequent assimilation of the operations and services or products of the acquired companies in a single operating business.
If we are unable to adequately address these risks, it could negatively impact our profitability and results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may attempt to complete our initial business combination with
a private company about which little information is available, which may result in a business combination with a company that is not as
profitable as we suspected, if at all.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In pursuing our acquisition strategy, we may seek to effectuate our
initial business combination with a privately held company. Very little public information generally exists about private companies, and
we could be required to make our decision on whether to pursue a potential initial business combination on the basis of limited information,
which may result in a business combination with a company that is not as profitable as we suspected, if at all</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may partner, submit a joint bid or enter into a similar transaction
with holders of founder shares or an affiliate in connection with our pursuit of, or in connection with, a business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not prohibited from partnering, submitting a joint bid or entering
into any similar transaction with holders of founder shares or their affiliates in our pursuit of a business combination. Although we
currently have no plans to do so, we could pursue such a transaction if we determined that such affiliated entity met our criteria for
a business combination and the transaction was approved by a majority of our disinterested directors. Despite our agreement to obtain
an opinion from an independent entity that commonly renders valuation opinions regarding the fairness to our company from a financial
point of view of a business combination with any holder of founder shares or its affiliates, the terms of the business combination may
not be as advantageous to our public shareholders as they would be absent any conflicts of interest. Additionally, were we successful
in consummating such a transaction, conflicts could invariably arise from the interest of the holder of founder shares or its affiliate
in maximizing its returns, which may be at odds with the strategy of the post-business&#160;combination company or not in the best interests
of the public shareholders of the post-business&#160;combination company. Any or all of such conflicts could materially reduce the value
of your investment, whether before or after our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"></span></p><!-- Field: Page; Sequence: 35; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">Risks Relating to our Sponsor and Management
Team</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We are dependent upon our officers and directors and their departure
could adversely affect our ability to operate.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our operations are dependent upon a relatively small group of individuals.
We believe that our success depends on the continued service of our officers and directors, at least until we have completed our initial
business combination. In addition, our officers and directors are not required to commit any specified amount of time to our affairs and,
accordingly, will have conflicts of interest in allocating management time among various business activities, including identifying potential
business combinations and monitoring the related due diligence. We do not have an employment agreement with, or&#160;key-man&#160;insurance&#160;on
the life of, any of our directors or officers. The unexpected loss of the services of one or more of our directors or officers could have
a detrimental effect on us.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our ability to successfully effect our initial business combination
and to be successful thereafter will be totally dependent upon the efforts of our key personnel, some of whom may join us following our
initial business combination. The loss of key personnel could negatively impact the operations and profitability of our&#160;post-combination&#160;business.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our ability to successfully effect our initial business combination
is dependent upon the efforts of our key personnel. The role of our key personnel in the target business, however, cannot presently be
ascertained. Although some of our key personnel may remain with the target business in senior management or advisory positions following
our initial business combination, it is likely that some or all of the management of the target business will remain in place. While we
intend to closely scrutinize any individuals we engage after our initial business combination, we cannot assure you that our assessment
of these individuals will prove to be correct. These individuals may be unfamiliar with the requirements of operating a company regulated
by the SEC, which could cause us to have to expend time and resources helping them become familiar with such requirements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, the directors and officers of an acquisition candidate
may resign upon completion of our initial business combination. The departure of a business combination target&#8217;s key personnel could
negatively impact the operations and profitability of our post-combination&#160;business. The role of an acquisition candidate&#8217;s
key personnel upon the completion of our initial business combination cannot be ascertained at this time. Although we contemplate that
certain members of an acquisition candidate&#8217;s management team will remain associated with the acquisition candidate following our
initial business combination, it is possible that members of the management of an acquisition candidate will not wish to remain in place.
The loss of key personnel could negatively impact the operations and profitability of our post-combination&#160;business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our key personnel may negotiate employment or consulting agreements
with a target business in connection with a particular business combination. These agreements may provide for them to receive compensation
following our initial business combination and as a result, may cause them to have conflicts of interest in determining whether a particular
business combination is the most advantageous.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our key personnel may be able to remain with the company after the
completion of our initial business combination only if they are able to negotiate employment or consulting agreements in connection with
the business combination. Such negotiations would take place simultaneously with the negotiation of the business combination and could
provide for such individuals to receive compensation in the form of cash payments and/or our securities for services they would render
to us after the completion of the business combination. The personal and financial interests of such individuals may influence their motivation
in identifying and selecting a target business, subject to his or her fiduciary duties under Cayman Islands law. Accordingly, if any of
our officers or directors becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then
current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such business
combination opportunity to such other entity, subject to their fiduciary duties under Cayman Islands law. However, we believe the ability
of such individuals to remain with us after the completion of our initial business combination will not be the determining factor in our
decision as to whether or not we will proceed with any potential business combination. There is no certainty, however, that any of our
key personnel will remain with us after the completion of our initial business combination. We cannot assure you that any of our key personnel
will remain in senior management or advisory positions with us. The determination as to whether any of our key personnel will remain with
us will be made at the time of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 36; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our officers and directors will allocate their time to other
businesses thereby causing conflicts of interest in their determination as to how much time to devote to our affairs. This conflict of
interest could have a negative impact on our ability to complete our initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our officers and directors are not required to, and will not, commit
their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our search
for a business combination and their other businesses. We do not intend to have any full-time&#160;employees prior to the completion of
our initial business combination. Each of our officers is engaged in several other business endeavors for which he or she may be entitled
to substantial compensation and our officers are not obligated to contribute any specific number of&#160;hours per week to our affairs.
Our independent directors also serve as officers and board members for other entities. If our officers&#8217; and directors&#8217; other
business affairs require them to devote substantial amounts of time to such affairs in excess of their current commitment levels, it could
limit their ability to devote time to our affairs which may have a negative impact on our ability to complete our initial business combination.
For a complete discussion of our officers&#8217; and directors&#8217; other business affairs, please see &#8220;<i>Directors, Executive
Officers and Corporate Governance</i>.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our officers and directors&#160;have&#160;pre-existing&#160;fiduciary&#160;and
contractual obligations and accordingly, may have conflicts of interest in determining to which entity a particular business opportunity
should be presented.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following the completion of the Initial Public Offering and until we
consummate our initial business combination, we intend to engage in the business of identifying and combining with one or more businesses.
Our officers and directors have&#160;pre-existing&#160;fiduciary&#160;and contractual obligations to other companies, including other
companies that are engaged in business activities similar to those intended to be conducted by us. As a result, our Sponsor, officers
or directors could have conflicts of interest in determining whether to present business combination opportunities to us or to any other
company with which they may become involved. Although we have no formal policy in place for vetting potential conflicts of interest, our
Board of Directors will review any potential conflicts of interest on a&#160;case-by-case&#160;basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our officers and directors also may become aware of business opportunities
which may be appropriate for presentation to us and the other entities to which they owe certain fiduciary or contractual duties. Accordingly,
they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts
may not be resolved in our favor and a potential target business may be presented to other entities prior to its presentation to us, subject
to his or her fiduciary duties under Cayman Islands law. Accordingly, if any of our officers or directors becomes aware of a business
combination opportunity which is suitable for an entity to which he or she has then current fiduciary or contractual obligations, he or
she will honor his or her fiduciary or contractual obligations to present such business combination opportunity to such other entity,
subject to their fiduciary duties under Cayman Islands law. Our amended and restated memorandum and articles of association provide that,
to the fullest extent permitted by law: (i)&#160;no individual serving as a director or an officer, among other persons, shall have any
duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar business
activities or lines of business as us, and (ii)&#160;we renounce any interest or expectancy in, or in being offered an opportunity to
participate in, any potential transaction or matter which (a)&#160;may be a corporate opportunity for any director or officer, on the
one hand, and us, on the other or (b)&#160;the presentation of which would breach an existing legal obligation of a director or officer
to any other entity.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For a complete discussion of our officers&#8217; and directors&#8217;
business affiliations and the potential conflicts of interest that you should be aware of, please see &#8220;<i>Directors, Executive Officers
and Corporate Governance.</i>&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may engage one or more affiliates of our Sponsor, officers
or directors or their respective affiliates to provide additional services to us after the Initial Public Offering, which may include
acting as financial advisor in connection with an initial business combination. These financial incentives may cause them to have potential
conflicts of interest in rendering any such additional services to us after the Initial Public Offering, including, for example, in connection
with the sourcing and consummation of an initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may engage one or more affiliates of our Sponsor, officers or directors
or their respective affiliates to provide additional services to us after the Initial Public Offering, including, for example, identifying
potential targets or providing financial advisory services. We may pay such affiliates fair and reasonable fees or other compensation
that would be determined at that time in an arm&#8217;s length negotiation. Any such affiliates&#8217; financial interests tied to the
consummation of a business combination transaction may give rise to potential conflicts of interest in providing any such additional services
to us, including potential conflicts of interest in connection with advising on, sourcing and consummating of an initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our officers, directors, security holders and their respective
affiliates may have competitive pecuniary interests that conflict with our interests.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have not adopted a policy that expressly prohibits our directors,
officers, security holders or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired
or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a business combination
with a target business that is affiliated with our Sponsor, our directors or officers, although we do not intend to do so. Nor do we have
a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by
us. Accordingly, such persons or entities may have a conflict between their interests and ours.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 37; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In particular, affiliates of our Sponsor have invested in a diverse
set of industries. As a result, there may be substantial overlap between companies that would be a suitable business combination for us
and companies that would make an attractive target for such other affiliates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, members of our management team and our Board of Directors
will directly or indirectly own founder shares and/or private placement units following the Initial Public Offering, as set forth in &#8220;Principal
Shareholders,&#8221; and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate
business with which to effectuate our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may engage in a business combination with one or more target
businesses that have relationships with entities that may be affiliated with our Sponsor, officers, directors or existing holders which
may raise potential conflicts of interest.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In light of the involvement of our Sponsor, officers and directors
with other entities, we may decide to acquire one or more businesses affiliated with our Sponsor, officers and directors. Our officers
and directors also serve as officers and board members for other entities, including, without limitation, those described under &#8220;<i>Directors,
Executive Officers and Corporate Governance&#160;&#8212;&#160;Conflicts of Interest</i>.&#8221; Such entities may compete with us for
business combination opportunities. Our Sponsor, officers and directors are not currently aware of any specific opportunities for us
to complete our initial business combination with any entities with which they are affiliated, and there have been no preliminary discussions
concerning a business combination with any such entity or entities. Although we will not be specifically focusing on, or targeting, any
transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria
for a business combination and such transaction was approved by a majority of our disinterested directors. Despite our agreement that
we, or a committee of independent and disinterested directors, will obtain an opinion from an independent investment banking firm that
is a member of FINRA or from an independent accounting firm, regarding the fairness to our company from a financial point of view of
a business combination with one or more domestic or international businesses affiliated with our Sponsor, directors or officers, potential
conflicts of interest still may exist and, as a result, the terms of the business combination may not be as advantageous to our public
shareholders as they would be absent any conflicts of interest.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Members of our management team and board of directors have significant
experience as founders, board members, officers or executives of other companies. As a result, certain of those persons have been, or
may become, involved in proceedings, investigations and litigation relating to the business affairs of the companies with which they were,
are, or may be in the future be, affiliated. These activities may have an adverse effect on us, which may impede our ability to consummate
an initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the course of their careers, members of our management team
and board of directors have had significant experience as founders, board members, officers, executives or employees of other companies.
As a result of their involvement and positions in these companies, certain of those persons have been, may be or may in the future become
involved in litigation, investigations or other proceedings, including relating to the business affairs of such companies, transactions
entered into by such companies, or otherwise. Individual members of our management team and board of directors also may become involved
in litigation, investigations or other proceedings involving claims or allegations related to or as a result of their personal conduct,
either in their capacity as a corporate officer or director or otherwise, and may be personally named in such actions and potentially
subject to personal liability. Any such liability may or may not be covered by insurance and/or indemnification, depending on the facts
and circumstances. The defense or prosecution of these matters could be time-consuming. Any litigation, investigations or other proceedings
and the potential outcomes of such actions may divert the attention and resources of our management team and board of directors away from
identifying and selecting a target business or businesses for our initial business combination and may negatively affect our reputation,
which may impede our ability to complete an initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Since our Sponsor, officers and directors and any other holder
of our founder shares will lose their entire investment in us if our initial business combination is not completed (other than with respect
to any public shares they may acquire during or after the Initial Public Offering), and because our Sponsor, officers and directors and
any other holder of our founder shares, directly or indirectly may profit substantially from a business combination as a result of their
ownership of founder shares even under circumstances where our public shareholders would experience losses in connection with their investment,
a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business
combination, including in connection with the shareholder vote in respect thereto.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May&#160;19, 2025, our Sponsor paid $25,000, or approximately $0.004
per share, to cover certain of our offering and formation costs in exchange for 5,750,000 founder shares. On August&#160;8, 2025, the
Company effected a 1 for 1.5&#160;share split of the founder shares resulting in our Sponsor holding an aggregate of 8,625,000 founder
shares. On August&#160;19, 2025, our Sponsor transferred 20,000 founder shares to each of our independent directors at a purchase price
of approximately $0.003 per share. As a result, our Sponsor currently holds 8,585,000 founder shares and each of our independent directors
holds 20,000 founder shares. Prior to this initial investment in us by the Sponsor, we had no assets, tangible or intangible. 325,000
of the founder shares were forfeited by our Sponsor. Our initial shareholders collectively beneficially own approximately 26% of our issued
and outstanding ordinary shares after the Initial Public Offering and the private placements (assuming they do not purchase any units
in the Initial Public Offering). The founder shares may be worthless if we do not complete an initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 38; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, our Sponsor has purchased 530,000 private placement units
for a purchase price of $5.3&#160;million in a private placement that occurred simultaneously with the closing of the Initial Public Offering.
There will be no redemption rights or liquidating distributions from the trust account with respect to the founder shares, private placement
shares or private placement warrants, which may become worthless if we do not consummate a business combination within 24&#160;months
from the closing of the Initial Public Offering.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Given the differential in the purchase price paid for the founder shares
as compared to the initial public offering price of the public shares and the substantial number of Class&#160;A ordinary shares that
holders of our founder shares would receive upon conversion of the founder shares upon a business combination, the founder shares may
have significant value after the business combination even if our Class&#160;A ordinary shares trade below the initial public offering
price and holders of our public shares have a substantial loss on their investment. Our initial shareholders have agreed (A)&#160;to vote
any shares owned by them in favor of any proposed business combination and (B)&#160;not to redeem any founder shares in connection with
a shareholder vote to approve a proposed initial business combination. In addition, we may obtain loans from our Sponsor, any of their
respective affiliates or certain of our directors and officers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The personal and financial interests of our Sponsor, directors and
officers and any holders of our founder shares may influence their motivation in identifying and selecting a target business combination,
completing an initial business combination and influencing the operation of the business following the initial business combination and
may result in a misalignment of interests between the holders of our founder shares, including our officers and directors, on the one
hand, and our public shareholders, on the other. These risks may become more acute as the deadline to complete our initial business combination
nears. In particular, because the founder shares were purchased at a nominal purchase price, the holders of our founder shares (including
certain of our directors and officers that directly or indirectly own founder shares) could make a substantial profit after our initial
business combination even if our public shareholders lose money on their investment as a result of a decrease in the post-combination&#160;value
of their Class&#160;A ordinary shares (after accounting for any adjustments in connection with an exchange or other transaction contemplated
by the business combination). For example, a holder of 1,000 founder shares would have paid approximately $4.35 to purchase such shares.
At the time of an initial business combination, such holder would be able to convert such founder shares into 1,000 Class&#160;A ordinary
shares, and would receive the same consideration in connection with our initial business combination as a public shareholder for the same
number of Class&#160;A ordinary shares. If the trading price of our Class&#160;A ordinary shares on a post-combination&#160;basis (after
accounting for any adjustments in connection with an exchange or other transaction contemplated by the business combination) were to decrease
to $5.00 per Class&#160;A ordinary share, such holder of our founder shares would obtain a profit of approximately $4,996 on account of
the 1,000 founder shares that the holder had converted into Class&#160;A ordinary shares in connection with the initial business combination.
By contrast, a public shareholder holding 1,000 Class&#160;A ordinary shares acquired in the Initial Public Offering would lose approximately
$5,000 in connection with the same transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Further, each of our officers and directors may have a conflict of
interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors
were to be included by a target business as a condition to any agreement with respect to our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The nominal purchase price paid by our Sponsor for the founder
shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination,
and our Sponsor is likely to make a substantial profit on its investment in us in the event we consummate an initial business combination,
even if the business combination causes the trading price of our ordinary shares to materially decline.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We offered our units at an offering price of $10.00 per unit and the
amount in our trust account is initially anticipated to be $10.00 per public share, implying an initial value of $10.00 per public share.
However, prior to the Initial Public Offering, our Sponsor paid a nominal aggregate purchase price of $25,000 for the founder shares.
As a result, the value of your public shares may be significantly diluted upon the consummation of our initial business combination, when
the founder shares are converted into public shares. For example, the following table shows the dilutive effect of the founder shares
on the implied value of the public shares upon the consummation of our initial business combination, assuming that our equity value at
that time is $238,800,000 which is the amount we would have for our initial business combination in the trust account after payment of
$10,200,000 of deferred underwriting commissions, assuming no interest is earned on the funds held in the trust account, and no public
shares are redeemed in connection with our initial business combination, and without taking into account any other potential impacts on
our valuation at such time, such as the trading price of our public shares, the business combination transaction costs, any equity issued
or cash paid to the target&#8217;s sellers or other third parties, or the target&#8217;s business itself, including its assets, liabilities,
management and prospects, as well as the value of our public and placement warrants. At such valuation, each of our ordinary shares would
have an implied value of approximately $7.33 per share upon consummation of our initial business combination, which would be an approximate
26.7% decrease as compared to the initial implied value per public share of $10.00.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tbody><tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 88%; text-indent: -10pt; padding-left: 10pt">Public shares</td><td style="width: 1%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">24,900,000</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -10pt; padding-left: 10pt">Founder shares</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">8,300,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"><span style="font-size: 10pt">Placement shares<sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt">&#160;</td>
<td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">779.000</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -10pt; padding-left: 10pt">Total shares</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">33,979,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Total funds in trust available for initial business combination (less deferred underwriting commissions)</td><td>&#160;</td>
<td style="text-align: left">$</td><td style="text-align: right">249,000,000</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -10pt; padding-left: 10pt">Initial implied value per public share</td><td>&#160;</td>
<td style="text-align: left">$</td><td style="text-align: right">10.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Implied value per share upon consummation of initial business combination</td><td>&#160;</td>
<td style="text-align: left">$</td><td style="text-align: right">7.33</td><td style="text-align: left">&#160;</td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 39; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The value of the founder shares held by our Sponsor following
completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the
trading price of our ordinary shares at such time is substantially less than $10.00 per share.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon the closing of the Initial Public Offering, our Sponsor have invested
in us an aggregate of $5,325,000, comprised of the $25,000 purchase price for the founder shares and the $5,300,000 purchase price for
the private placement units purchased by the Sponsor. Assuming a trading price of $10.00 per share upon consummation of our initial business
combination, the 8,260,000 founder shares and the 530,000 private placement shares held by our Sponsor would have an aggregate value of
$87,900,000. Even if the trading price of our ordinary shares was as low as approximately $0.66 per share, and the private placement warrants
were worthless, the value of the founder shares and the private placement shares held by our Sponsor would be equal to the Sponsor&#8217;s
initial investment in us. As a result, our Sponsor is likely to be able to recoup its investment in us and make a substantial profit on
that investment, even if our public shares have lost significant value. Accordingly, our management team, which owns interests in our
Sponsor, may have an economic incentive that differs from that of the public shareholders to pursue and consummate an initial business
combination rather than to liquidate and to return all of the cash in the trust to the public shareholders, even if that business combination
were with a riskier or less-established&#160;target business. For the foregoing reasons, you should consider our management team&#8217;s
financial incentive to complete an initial business combination when evaluating whether to redeem your shares prior to or in connection
with the initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The personal and financial interests of our officers and directors
may influence their motivation in identifying and selecting a target business combination, completing an initial business combination
and influencing the operation of the business following the initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may not be able to complete an initial business combination
with a U.S.&#160;target company if such initial business combination is subject to U.S.&#160;foreign investment regulations and review
by a U.S.&#160;government entity such as the Committee on Foreign Investment in the United&#160;States (&#8220;CFIUS&#8221;), or is ultimately
prohibited.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our initial business combination may be subject to regulatory review
and approval requirements by governmental entities, or ultimately prohibited. For example, CFIUS has authority to review direct or indirect
foreign investments in U.S.&#160;companies. Among other things, CFIUS is empowered to require certain foreign investors to make mandatory
filings, to charge filing fees related to such filings, and to self-initiate&#160;national security reviews of foreign direct and indirect
investments in U.S.&#160;companies if the parties to that investment choose not to file voluntarily. In the case that CFIUS determines
an investment to be a threat to national security, CFIUS has the power to unwind or place restrictions on the investment. Whether CFIUS
has jurisdiction to review an acquisition or investment transaction depends on&#160;&#8212;&#160;among other factors&#160;&#8212;&#160;the
nature and structure of the transaction, including the level of beneficial ownership interest and the nature of any information or governance
rights involved. For example, investments that result in &#8220;control&#8221; of a U.S.&#160;business by a foreign person always are
subject to CFIUS jurisdiction. CFIUS&#8217;s expanded jurisdiction under the Foreign Investment Risk Review Modernization Act&#160;of&#160;2018
and implementing regulations that became effective on February&#160;13, 2020 further includes investments that do not result in control
of a U.S.&#160;business by a foreign person but afford certain foreign investors certain information or governance rights in a U.S.&#160;business
that has a nexus to &#8220;critical technologies,&#8221; &#8220;critical infrastructure&#8221; and/or &#8220;sensitive personal data.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">While our Sponsor is exclusively &#8220;controlled&#8221; for CFIUS
purposes by U.S.&#160;citizens, has no substantial ties with a&#160;non-U.S.&#160;person, and thus we do not believe that our Sponsor
is a &#8220;foreign person&#8221; as defined in the CFIUS regulations, it is possible that&#160;non-U.S.&#160;persons could be involved
in our initial business combination (e.g., as existing shareholders of a target company or as PIPE investors), which may increase the
risk that our initial business combination becomes subject to regulatory review, including review by CFIUS.&#160;If a particular proposed
initial business combination with a U.S.&#160;business falls within CFIUS&#8217;s jurisdiction, we may determine that we are required
to make a mandatory filing or that we will submit to CFIUS review on a voluntary basis, or to proceed with the transaction without submitting
to CFIUS and risk CFIUS intervention, before or after closing the transaction. CFIUS may decide to block or delay our proposed initial
business combination, impose conditions with respect to such initial business combination or request the President of the United&#160;States
to order us to divest all or a portion of the U.S.&#160;target business of our initial business combination that we acquired without first
obtaining CFIUS approval, which may limit the attractiveness of, delay or prevent us from pursuing certain target companies that we believe
would otherwise be beneficial to us and our shareholders. As a result, the pool of potential targets with which we could complete an initial
business combination may be limited and we may be adversely affected in terms of competing with other special purpose acquisition companies
which do not have similar foreign ownership issues. In addition, certain federally licensed businesses may be subject to rules or regulations
that limit foreign ownership.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 40; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Moreover, the process of government review, whether by CFIUS or otherwise,
could be lengthy and we have limited time to complete our initial business combination. If we cannot complete our initial business combination
within 24&#160;months from the closing of this because the review process drags on beyond such timeframe or because our initial business
combination is ultimately prohibited by CFIUS or another U.S.&#160;government entity, we may be required to liquidate and our warrants
will expire worthless. This will also cause you to lose the investment opportunity in a target company, and the chance of realizing future
gains on your investment through any price appreciation in the combined company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">Risks Relating to our Securities</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may issue our shares to investors in connection with our initial
business combination at a price that is less than the prevailing market price of our shares at that time.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with our initial business combination, we may issue shares
to investors in private placement transactions&#160;(so-called&#160;PIPE transactions) at a price of $10.00 per share or at a price which
approximates the&#160;per-share&#160;amounts in our trust account at such time. The purpose of such issuances will be to enable us to
provide sufficient liquidity to the post-business&#160;combination entity and such issuances may be made upon beneficial terms to such
investors, which could cause dilution to our existing shareholders. The price of the shares we issue may therefore be less, and potentially
significantly less, than the market price for our shares at such time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If a shareholder fails to receive notice of our offer to redeem
our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares,
such shares may not be redeemed.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We will comply with the tender offer rules or proxy rules, as applicable,
when conducting redemptions in connection with our initial business combination. Despite our compliance with these rules, if a shareholder
fails to receive our tender offer or proxy materials, as applicable, such shareholder may not become aware of the opportunity to redeem
its shares. In addition, the tender offer documents or proxy materials, as applicable, that we will furnish to holders of our public shares
in connection with our initial business combination will describe the various procedures that must be complied with in order to validly
tender or redeem public shares. In the event that a shareholder fails to comply with these procedures, its shares may not be redeemed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>You will not have any rights or interests in funds from the trust
account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced to sell your public shares
or warrants, potentially at a loss.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our public shareholders will be entitled to receive funds from the
trust account only upon the earlier to occur of: (i)&#160;the completion of our initial business combination, (ii)&#160;the redemption
of any public shares properly tendered in connection with a shareholder vote to amend our amended and restated memorandum and articles
of association to (A)&#160;modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete
our initial business combination within 24&#160;months from the closing of the Initial Public Offering or (B)&#160;with respect to any
other provision relating to shareholders&#8217; rights or&#160;pre-business&#160;combination activity and (iii)&#160;the redemption of
all of our public shares if we are unable to complete our initial business combination within 24&#160;months from the closing of the Initial
Public Offering, subject to applicable law and as further described herein. In no other circumstances will a public shareholder have any
right or interest of any kind in the trust account. Accordingly, to liquidate your investment, you may be forced to sell your public shares
or warrants, potentially at a loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If we have not completed our initial business combination within
the completion window, our public shareholders may be forced to wait beyond such completion window before redemption from our trust account.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we have not completed our initial business combination within 24&#160;months
from the closing of the Initial Public Offering, we will distribute the aggregate amount then on deposit in the trust account, including
interest (which interest shall be net permitted withdrawals, and up to $100,000 of interest to pay dissolution expenses), pro rata to
our public shareholders by way of redemption and cease all operations except for the purposes of winding up our affairs, as further described
herein. Any redemption of public shareholders from the trust account shall be effected automatically by function of our amended and restated
memorandum and articles of association prior to any voluntary winding up. If we are required to wind-up, liquidate the trust account and
distribute such amount therein, pro rata, to our public shareholders, as part of any liquidation process, such winding up, liquidation
and distribution must comply with the applicable provisions of the Companies Act. In that case, investors may be forced to wait beyond
the completion window before the redemption proceeds of our trust account become available to them and they receive the return of their
pro rata portion of the proceeds from our trust account. We have no obligation to return funds to investors prior to the date of our redemption
or liquidation unless, prior thereto, we consummate our initial business combination or amend certain provisions of our amended and restated
memorandum and articles of association and then only in cases where investors have properly sought to redeem their Class&#160;A ordinary
shares. Only upon our redemption or any liquidation will public shareholders be entitled to distributions if we have not completed our
initial business combination within the required time period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 41; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we are unable to complete an initial business combination within
the 24&#160;month period, we may seek an amendment to our amended and restated memorandum and articles of association to extend the period
of time we have to complete an initial business combination beyond the completion window. Amending our amended and restated memorandum
and articles of association will require at least a special resolution of our shareholders as a matter of Cayman Islands law, meaning
that such an amendment be approved by the affirmative vote at least&#160;two-thirds&#160;(2/3) of the votes cast by such shareholders
who, being present and entitled to vote at a general meeting, attend and vote at a general meeting of the company. If we seek shareholder
approval to extend the initial completion window in which to complete an initial business combination to a later date, we will offer our
public shareholders the right to have their public ordinary shares redeemed for a pro rata share of the aggregate amount then on deposit
in the trust account, as described in greater detail in this Report.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our shareholders may be held liable for claims by third parties
against us to the extent of distributions received by them upon redemption of their shares.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we are forced to enter into an insolvent liquidation, any distributions
received by shareholders could be viewed as an unlawful payment if it was proved that immediately following the date on which the distribution
was made, we were unable to pay our debts as they fall due in the ordinary course of business. As a result, a liquidator could seek to
recover some or all amounts received by our shareholders. Furthermore, our directors may be viewed as having breached their fiduciary
duties to us or our creditors and/or may have acted in bad faith, and thereby exposing themselves and our company to claims, by paying
public shareholders from the trust account prior to addressing the claims of creditors. We cannot assure you that claims will not be brought
against us for these reasons. We and our directors and officers who knowingly and willfully authorized or permitted any distribution to
be paid out of our share premium account while we were unable to pay our debts as they fall due in the ordinary course of business would
be guilty of an offence and may be liable for a fine of up to approximately $18,300 and to imprisonment for five&#160;years in the Cayman
Islands, or both.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We are not registering the Class&#160;A ordinary shares issuable
upon exercise of the warrants under the Securities Act or any state securities laws at this time, and such registration may not be in
place when an investor desires to exercise warrants, thus precluding such investor from being able to exercise its warrants except on
a cashless basis and potentially causing such warrants to expire worthless.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are not registering the Class&#160;A ordinary shares issuable upon
exercise of the warrants under the Securities Act or any state securities laws at this time. In no event will we be required to net cash
settle any public warrant, or issue securities or other compensation in exchange for the public warrants in the event that we are unable
to register or qualify the shares underlying the public warrants under applicable state securities laws and no exemption is available.
If the issuance of the shares upon exercise of the public warrants is not so registered or qualified or exempt from registration or qualification,
the holder of such public warrant shall not be entitled to exercise such public warrant and such public warrant may have no value and
expire worthless. In such event, holders who acquired their public warrants as part of a purchase of units will have paid the full unit
purchase price solely for the Class&#160;A ordinary shares included in the units.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">However, we have agreed that, as soon as practicable, but in no event
later than 15&#160;business days after the closing of our initial business combination, we will use our commercially reasonable efforts
to file with the SEC a registration statement covering the issuance, under the Securities Act, of the Class&#160;A ordinary shares issuable
upon exercise of the warrants, and we will use our commercially reasonable efforts to cause the same to become effective within 60&#160;business
days after the closing of our initial business combination and to maintain the effectiveness of such registration statement and a current
prospectus relating thereto until the expiration of the warrants in accordance with the provisions of the warrant agreement. We cannot
assure you that we will be able to do so if, for example, any facts or events arise which represent a fundamental change in the information
set forth in the registration statement or prospectus, the financial statements contained or incorporated by reference therein are not
current, complete or correct or the SEC issues a stop order. If the shares issuable upon exercise of the public warrants are not registered
under the Securities Act in accordance with the above requirements, we will be required to permit holders to exercise their public warrants
on a cashless basis. However, no public warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue
any shares to holders seeking to exercise their public warrants, unless the issuance of the shares upon such exercise is registered or
qualified under the securities laws of the state of the exercising holder, or an exemption from registration is available. Additionally,
if, at the time that a public warrant is exercised, our Class&#160;A ordinary shares are not listed on a national securities exchange
such that they satisfy the definition of a &#8220;covered security&#8221; under Section&#160;18(b)(1)&#160;of the Securities Act, we may,
at our option, require holders of public warrants who exercise their warrants to do so on a cashless basis in accordance with Section&#160;3(a)(9)&#160;of
the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, but
will use our commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption
is not available. In the event of a cashless exercise pursuant to the preceding paragraph, the number of Class&#160;A ordinary shares
that you will receive upon cashless exercise of a public warrant will be based on the formula described under &#8220;<i>Description of
Securities&#160;&#8212;&#160;Redeemable Warrants&#160;&#8212;&#160;Public Shareholders&#8217; Warrants</i>.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 42; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There may be a circumstance where an exemption from registration exists
for holders of our private placement warrants to exercise their warrants while a corresponding exemption does not exist for holders of
the public warrants included as part of units sold in the Initial Public Offering. In such an instance, the Sponsor and its permitted
transferees (which may include our directors and executive officers) would be able to exercise their warrants and sell the ordinary shares
underlying their warrants while holders of our public warrants would not be able to exercise their warrants and sell the underlying ordinary
shares. If and when the public warrants become redeemable by us, we may exercise our redemption right even if we are unable to register
or qualify the underlying Class&#160;A ordinary shares for sale under all applicable state securities laws. As a result, we may redeem
the public warrants as set forth above even if the holders are otherwise unable to exercise their warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our Sponsor will control the appointment of our Board of Directors
until consummation of our initial business combination and will hold a substantial interest in us. As a result, it will appoint all of
our directors and may exert a substantial influence on actions requiring shareholder vote, potentially in a manner that you do not support.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon the closing of the Initial Public Offering, our Sponsor owned
approximately 26% of our issued and outstanding ordinary shares (including the placement shares underlying the private placement units
and assuming our initial holders do not purchase any units in the Initial Public Offering). In addition, holders of the Class&#160;B ordinary
shares will be entitled to appoint and remove directors prior to our initial business combination. Holders of our public shares will have
no right to vote on the appointment or removal of directors during such time. These provisions of our amended and restated memorandum
and articles of association may only be amended by a special resolution passed by at least 90% of our ordinary shares voting in a general
meeting. As a result, you will not have any influence over the appointment of directors prior to our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Neither our Sponsor nor, to our knowledge, any of our officers or directors,
have any current intention to purchase additional securities, other than as disclosed in this Report. Factors that would be considered
in making such additional purchases would include consideration of the current trading price of our Class&#160;A ordinary shares. In addition,
as a result of its substantial ownership in our company, our Sponsor may exert a substantial influence on other actions requiring a shareholder
vote, potentially in a manner that you do not support, including amendments to our amended and restated memorandum and articles of association
and approval of major corporate transactions. If our Sponsor purchases any additional ordinary shares in the aftermarket or in privately
negotiated transactions, this would increase its influence over these actions. Accordingly, our Sponsor will exert significant influence
over actions requiring a shareholder vote at least until the completion of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, our board of directors, whose members were appointed by
our&#160;Sponsor,&#160;is comprised of directors who will generally serve a three-year&#160;term. We may not hold an annual general meeting
to appoint new directors prior to the completion of our initial business combination, in which case all of the current directors will
continue in office until at least the completion of the business combination. If there is an annual general meeting, our Sponsor will
control the outcome, as only holders of our Class&#160;B ordinary shares will have the right to vote on the appointment of directors and
to remove directors prior to our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accordingly, holders of our founder shares will exert significant influence
over actions requiring a shareholder vote at least until the completion of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Changes in laws or regulations, or a failure to comply with any
laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination,
and results of operations.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are subject to laws and regulations enacted by national, regional
and local governments. In particular, we will be required to comply with certain SEC and other legal requirements. Compliance with, and
monitoring of, applicable laws and regulations may be difficult, time consuming and costly. Those laws and regulations and their interpretation
and application may also change from time to time and those changes could have a material adverse effect on our business, investments
and results of operations. In addition, a failure to comply with applicable laws or regulations, as interpreted and applied, could have
a material adverse effect on our business, including our ability to negotiate and complete our initial business combination, and results
of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January&#160;24, 2024, the SEC issued final rules (the &#8220;2024
SPAC Rules&#8221;), which went effective on July&#160;1, 2024, that formally adopted some of the SEC&#8217;s proposed rules for special
purpose acquisition companies that were released on March&#160;30, 2022. The 2024 SPAC Rules, among other items, impose additional disclosure
requirements in initial public offerings by SPACs and business combination transactions involving SPACs and private operating companies;
amend the financial statement requirements applicable to business combination transactions involving such companies; update and expand
guidance regarding the general use of projections in SEC filings, as well as when projections are disclosed in connection with proposed
business combination transactions; increase the potential liability of certain participants in proposed business combination transactions;
and could impact the extent to which SPACs could become subject to regulation under the Investment Company Act. The 2024 SPAC Rules may
materially adversely affect our business, including our ability to negotiate and complete, and the costs associated with, our initial
business combination, and results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 43; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Changes in international trade policies, tariffs and treaties
affecting imports and exports may have a material adverse effect on our search for an initial business combination target or the performance
or business prospects of a post-business combination company.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There have recently been significant changes to international trade
policies and tariffs affecting imports and exports. Any significant increases in tariffs on goods or materials or other changes in trade
policy could negatively affect our search for a target and/or our ability to complete our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recently, the U.S. has implemented a range of new tariffs and increases
to existing tariffs. In response to the tariffs announced by the U.S., other countries have imposed, are considering imposing, and may
in the future impose new or increased tariffs on certain exports from the United States. There is currently significant uncertainty about
the future relationship between the United States and other countries with respect to trade policies, taxes, government regulations and
tariffs. and we cannot predict whether, and to what extent, current tariffs will continue or trade policies will change in the future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tariffs, or the threat of tariffs or increased tariffs, could have
a significant negative impact on certain businesses (either due to domestic businesses&#8217; reliance on imported goods or dependence
on access to foreign markets, or foreign businesses&#8217; reliance on sales into the United States). In addition, retaliatory tariffs
could have a significant negative impact on foreign businesses that rely on imports from the United States, and domestic businesses that
rely on exporting goods internationally. These tariffs and threats of tariffs and other potential trade policy changes could negatively
affect the attractiveness of certain initial business combination targets, or lead to material adverse effects on a post-business&#160;combination
company. Among other things, historical financial performance of companies affected by trade policies and/or tariffs may not provide useful
guidance as to the future performance of such companies, because future financial performance of those companies may be materially affected
by new U.S. tariffs or foreign retaliatory tariffs, or other changes to trade policies. The business prospects of a particular target
for a business combination could change even after we enter into a business combination agreement, as a result of tariffs or the threat
of tariffs that may have a material impact on that target&#8217;s business, and it may be costly or impractical for us to terminate that
business combination agreement. These factors could affect our selection of a business combination target.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may not be able to adequately address the risks presented by these
tariffs or other potential trade policy changes. As a result, we may deem it costly, impractical or risky to complete an initial business
combination with a particular target or with a target in a particular industry or from a particular country. Consequently, the pool of
potential target companies may be reduced, which could impair our ability to identify a suitable target and to complete an initial business
combination. If we complete an initial business combination with such a target, the post-business&#160;combination company&#8217;s operations
and financial results could be adversely affected as a result of tariffs or changes to trade policies, which may cause the market value
of the securities of the post-business&#160;combination company to decline.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If we are deemed to be an investment company under the Investment
Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it
difficult for us to complete our initial business combination.</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we are deemed to be an investment company under the Investment Company
Act, our activities may be restricted, including:</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">restrictions on the nature of our investments; and</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">restrictions on the issuance of securities;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">each of which may make it difficult for us to complete our initial
business combination.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, we may have imposed upon us burdensome requirements, including:</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">registration as an investment company;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">adoption of a specific form of corporate structure; and</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reporting, record keeping, voting, proxy and disclosure requirements
and other rules and regulations.</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The 2024 SPAC Rules do not provide a safe harbor for SPACs from the
definition of &#8220;investment company&#8221; under the Investment Company Act. Instead, the SEC&#8217;s adopting release provided guidance
describing circumstances in which a SPAC could become subject to regulation under the Investment Company Act, including as a result of
its duration, asset composition, business purpose, and the activities of the SPAC and its management team in furtherance of such goals.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 44; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order not to be regulated as an investment company under the Investment
Company Act, unless we can qualify for an exclusion, we must ensure that we are engaged primarily in a business other than investing,
reinvesting or trading in securities and that our activities do not include investing, reinvesting, owning, holding or trading &#8220;investment
securities&#8221; constituting more than 40% of our total assets (exclusive of U.S.&#160;government securities and cash items) on an unconsolidated
basis. Our business will be to identify and complete an initial business combination and thereafter to operate the post-transaction&#160;business
or assets for the long term. We do not plan to buy businesses or assets with a view to resale or profit from their resale. We do not plan
to buy unrelated businesses or assets or to be a passive investor.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not believe that our anticipated principal activities will subject
us to the Investment Company Act. To this end, the proceeds held in the trust account will be invested or held only in either (i)&#160;U.S.&#160;government
treasury obligations with a maturity of 185&#160;days or less or in money market funds meeting certain conditions under&#160;Rule&#160;2a-7&#160;under
the Investment Company Act which invest only in direct U.S.&#160;government treasury obligations, (ii)&#160;as uninvested cash, or (iii)&#160;an
interest bearing bank demand deposit account or other accounts at a bank. To mitigate the risk that we might be deemed to be an investment
company for purposes of the Investment Company Act, which risk increases the longer we hold investments in the trust account, we may,
at any time (and will no later than 24&#160;months from the closing of the Initial Public Offering) instruct the trustee to liquidate
the investments held in the trust account and instead to hold the funds in the trust account in cash or in an interest bearing demand
deposit account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the trust agreement, the trustee is not permitted to invest
in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted
at acquiring and growing businesses for the long term (rather than on buying and selling businesses in the manner of a merchant bank or
private equity fund), we intend to avoid being deemed an &#8220;investment company&#8221; within the meaning of the Investment Company
Act. The initial public offering is not intended for persons who are seeking a return on investments in government securities or investment
securities. The trust account is intended as a holding place for funds pending the earliest to occur of: (i)&#160;the completion of our
initial business combination; (ii)&#160;the redemption of any public shares properly submitted in connection with a shareholder vote to
amend our amended and restated memorandum and articles of association (A)&#160;in a manner that would affect the substance or timing of
our obligation to offer redemption rights in connection with any proposed initial business combination or certain amendments to our amended
and restated memorandum and articles of association prior thereto or to redeem 100% of our public shares if we do not complete our initial
business combination within the completion window; or (B)&#160;with respect to any other material provision relating to shareholders&#8217;
rights or&#160;pre-initial&#160;business combination activity; or (iii)&#160;absent an initial business combination within the completion
window, from the closing of the Initial Public Offering, our return of the funds held in the trust account to our public shareholders
as part of our redemption of the public shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are aware of litigation against certain special purpose acquisition
companies asserting that notwithstanding the foregoing, those special purpose acquisition companies should be considered investment companies.
Although we believe that these claims are without merit, we cannot guarantee that we will not be deemed to be an investment company and
thus subject to the Investment Company Act. If we were deemed to be subject to the Investment Company Act, compliance with these additional
regulatory burdens would require additional expenses for which we have not allotted funds, may require us to otherwise change our operations
and may hinder our ability to complete an initial business combination or may result in our liquidation and the winding up of our operations.
If we are unable to complete our initial business combination and are required to liquidate, our public shareholders would lose their
opportunity to invest in a target business or businesses through our initial business combination, including any price appreciation of
the combined company&#8217;s securities following such initial business combination, and may receive only approximately $10.00 per share
on the liquidation of our trust account as well as our warrants will expire worthless. If our facts and circumstances change over time,
we will update our disclosure in future filings with the SEC to reflect how those changes impact the risk that we may be considered to
be operating as an unregistered investment company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>To mitigate the risk that we might be deemed to be an investment
company for purposes of the Investment Company Act, we may, at any time, instruct the trustee to liquidate the securities held in the
trust account and instead to hold the funds in the trust account in cash until the earlier of the consummation of our initial business
combination or our liquidation. As a result, following the liquidation of securities in the trust account, we would likely receive minimal
interest, if any, on the funds held in the trust account, which would reduce the dollar amount our public shareholders would receive upon
any redemption or liquidation of the Company.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The funds in the trust account will be held only in U.S.&#160;government
treasury obligations with a maturity of 185&#160;days or less or in money market funds investing solely in U.S.&#160;government treasury
obligations and meeting certain conditions under&#160;Rule&#160;2a-7&#160;under the Investment Company Act or in an interest-bearing&#160;demand
deposit account. However, to mitigate the risk of us being deemed to be an unregistered investment company (including under the subjective
test of Section&#160;3(a)(1)(A)&#160;of the Investment Company Act) and thus subject to regulation under the Investment Company Act, we
may, at any time, and we expect that we will, on or prior to the end of the prescribed timeframe, instruct Odyssey Transfer and Trust
Company, the trustee with respect to the trust account, to liquidate the U.S.&#160;government treasury obligations or money market funds
held in the trust account and thereafter to hold all funds in the trust account in cash until the earlier of consummation of our initial
business combination or liquidation of the Company. Following such liquidation, we would likely receive minimal interest, if any, on the
funds held in the trust account. However, interest previously earned on the funds held in the trust account still may be released to us
for permitted withdrawals, and certain other expenses as permitted. As a result, any decision to liquidate the securities held in the
trust account and thereafter to hold all funds in the trust account in cash would reduce the dollar amount our public shareholders would
receive upon any redemption or liquidation of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 45; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, even prior to the&#160;24-month&#160;anniversary of the
effective date of the registration statement, we may be deemed to be an investment company. The longer that the funds in the trust account
are held in short-term&#160;U.S.&#160;government treasury obligations or in money&#160;market funds invested exclusively in such securities,
even prior to the end of the prescribed timeframe, the greater the risk that we may be considered an unregistered investment company,
in which case we may be required to liquidate the Company. If our facts and circumstances change over time, we will update our disclosure
to reflect how those changes impact the risk that we may be considered to be operating as an unregistered investment company. As disclosed
above, we may determine, in our discretion, to liquidate the securities held in the trust account at any time, and instead hold all funds
in the trust account in cash, which would further reduce the dollar amount our public shareholders would receive upon any redemption or
liquidation of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If we seek shareholder approval of our initial business combination
and we do not conduct redemptions pursuant to the tender offer rules, and if you or a &#8220;group&#8221; of shareholders are deemed to
hold in excess of 20% of our Class&#160;A ordinary shares, you will lose the ability to redeem all such shares in excess of 20% of our
Class&#160;A ordinary shares.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we seek shareholder approval of our initial business combination
and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended
and restated memorandum and articles of association provides that a public shareholder, together with any affiliate of such shareholder
or any other person with whom such shareholder is acting in concert or as a &#8220;group&#8221; (as defined under Section&#160;13 of the
Exchange&#160;Act), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the shares sold in the
Initial Public Offering, without prior written consent, which we refer to as the &#8220;Excess Shares.&#8221; However, we would not be
restricting our shareholders&#8217; ability to vote all of their shares (including Excess Shares) for or against our initial business
combination. Your inability to redeem the Excess Shares will reduce your influence over our ability to complete our initial business combination
and you could suffer a material loss on your investment in us if you sell Excess Shares in open market transactions. Additionally, you
will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And as a
result, you will continue to hold that number of shares exceeding 20% and, in order to dispose of such shares, would be required to sell
your shares in open market transactions, potentially at a loss.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The determination of the offering price of our units and the
size of the Initial Public Offering is more arbitrary than the pricing of securities and size of an offering of an operating company in
a particular industry. You may have less assurance, therefore, that the offering price of our units properly reflects the value of such
units than you would have in a typical offering of an operating company.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Prior to the Initial Public Offering there was no public market for
any of our securities. The public offering price of the units and the terms of the warrants were negotiated between us and the representative.
In determining the size of the Initial Public Offering, management held customary organizational meetings with the representative, both
prior to our inception and thereafter, with respect to the state of capital markets, generally, and the amount the representative believed
it reasonably could raise on our behalf. Factors considered in determining the size of the Initial Public Offering, prices and terms of
the units, including the Class&#160;A ordinary shares and warrants underlying the units, include:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">the history and prospects of companies whose principal business
is the acquisition of other companies;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">prior offerings of those companies;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our prospects for acquiring an operating business at attractive
values;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">a review of debt to equity ratios in leveraged transactions;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">our capital structure;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">an assessment of our management and their experience in identifying
operating companies;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">general conditions of the securities markets at the time
of the Initial Public Offering; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">other factors as were deemed relevant.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Although these factors were considered, the determination of our offering
price is more arbitrary than the pricing of securities of an operating company in a particular industry since we have no historical operations
or financial results.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Nasdaq may delist our securities from trading on its exchange,
which could limit investors&#8217; ability to make transactions in our securities and subject us to additional trading restrictions.</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our units have been approved for listing and currently trade on Nasdaq.
Following the date that the Class&#160;A ordinary shares and public warrants are eligible to trade separately, the Class A ordinary shares
and public warrants became separately listed on Nasdaq. We cannot assure you that our securities will continue to be listed on Nasdaq
in the future or prior to our initial business combination. In order to continue listing our securities on Nasdaq prior to our initial
business combination, we must maintain certain financial, distribution and share price levels. In general, we must maintain an average
global market capitalization and a minimum of 400 public holders. Additionally, in connection with our initial business combination, we
will be required to demonstrate compliance with Nasdaq&#8217;s initial listing requirements, which are more rigorous than Nasdaq&#8217;s
continued listing requirements, in order to continue to maintain the listing of our securities on Nasdaq. For instance, our share price
would generally be required to be at least $4.00 per share and we would be required to have a minimum of 400 round lot holders of our
unrestricted securities. We cannot assure you that we will be able to meet those initial listing requirements at that time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 46; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">If Nasdaq delists our securities from trading on its exchange and we
are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an&#160;over-the-counter&#160;market.
If this were to occur, we could face significant material adverse consequences, including:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">a limited availability of market quotations for our securities;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reduced liquidity for our securities;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">a determination that our Class&#160;A ordinary shares are
a &#8220;penny stock&#8221; which will require brokers trading in our Class&#160;A ordinary shares to adhere to more stringent rules
and possibly result in a reduced level of trading activity in the secondary trading market for our securities;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">a limited amount of news and analyst coverage; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">a decreased ability to issue additional securities or obtain
additional financing in the future.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">The National Securities Markets Improvement Act&#160;of&#160;1996,
which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as &#8220;covered
securities.&#8221; Because we expect our units and eventually our Class&#160;A ordinary shares and warrants will be listed on Nasdaq,
our units, Class&#160;A ordinary shares and warrants will be covered securities. Although the states are preempted from regulating the
sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there
is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. While we
are not aware of a state having used these powers to prohibit or restrict the sale of securities issued by blank check companies, other
than the State of Idaho, certain state securities regulators view blank check companies unfavorably and might use these powers, or threaten
to use these powers, to hinder the sale of securities of blank check companies in their states. Further, if we were no longer listed on
Nasdaq, our securities would not be covered securities and we would be subject to regulation in each state in which we offer our securities,
including in connection with our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may issue additional Class&#160;A ordinary or preference shares
to complete our initial business combination or under an employee incentive plan after completion of our initial business combination.
We may also issue Class&#160;A ordinary shares upon the conversion of the Class&#160;B ordinary shares at a ratio greater than&#160;one-to-one&#160;at
the time of our initial business combination, or earlier at the option of the holder, as a result of the&#160;anti-dilution&#160;provisions
contained in our amended and restated memorandum and articles of association. Any such issuances would dilute the interest of our shareholders
and likely present other risks.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our amended and restated memorandum and articles of association authorizes
the issuance of up to 200,000,000 Class&#160;A ordinary shares, par value $0.0001 per share, 20,000,000 Class&#160;B ordinary shares,
par value $0.0001 per share and 1,000,000 preference shares, par value $0.0001 per share. Immediately after the Initial Public Offering,
there were 174,321,000 and 11,700,000 authorized but unissued Class&#160;A and Class&#160;B ordinary shares available, respectively, for
issuance, which amount takes into account shares reserved for issuance upon exercise of outstanding warrants but not upon conversion of
the Class&#160;B ordinary shares. Class&#160;B ordinary shares are convertible into Class&#160;A ordinary shares, initially at a&#160;one-for-one&#160;ratio
but subject to adjustment as set forth herein and in our amended and restated memorandum and articles of association. Immediately after
the Initial Public Offering, there will be no preference shares issued and outstanding.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">We may issue a substantial number of additional ordinary shares, and
may issue preference shares, in order to complete our initial business combination or under an employee incentive plan after completion
of our initial business combination. We may also issue Class&#160;A ordinary shares upon conversion of the Class&#160;B ordinary shares
at a ratio greater than&#160;one-to-one&#160;at the time of our initial business combination, or earlier at the option of the holder,
as a result of the anti-dilution&#160;provisions contained in our amended and restated memorandum and articles of association. However,
our amended and restated memorandum and articles of association provides, among other things, that prior to our initial business combination,
we may not, except in connection with the conversion of Class&#160;B ordinary shares into Class&#160;A ordinary shares where the holders
of such shares have waived any rights to receive funds from the trust account issue additional ordinary shares that would entitle the
holders thereof to (i)&#160;receive funds from the trust account or (ii)&#160;vote on any initial business combination or any other proposal
presented to our shareholders prior to or in connection with the completion of an initial business combination. These provisions of our
amended and restated memorandum and articles of association, like all provisions of our amended and restated memorandum and articles of
association, may be amended with a shareholder vote. The issuance of additional ordinary shares or preference shares:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">may significantly dilute the equity interest of investors
in the Initial Public Offering;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt"></p><!-- Field: Page; Sequence: 47; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">may subordinate the rights of holders of ordinary shares
if preference shares are issued with rights senior to those afforded our ordinary shares;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">could cause a change in control if a substantial number of
ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and
could result in the resignation or removal of our present officers and directors; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">may adversely affect prevailing market prices for our units,
Class&#160;A ordinary shares and/or warrants.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The grant of registration rights to our initial holders and holders
of placement units may make it more difficult to complete our initial business combination, and the future exercise of such rights may
adversely affect the market price of our Class&#160;A ordinary shares.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to an agreement entered into prior to the closing of the Initial
Public Offering, our initial holders and their permitted transferees can demand that we register their founder shares, after those shares
convert to our Class&#160;A ordinary shares at the time of our initial business combination. In addition, holders of our private placement
units (and underlying securities) and their permitted transferees can demand that we register the private placement shares as well as
the private placement warrants and Class&#160;A ordinary shares issuable upon exercise of the private placement warrants, and holders
of private placement shares and private placement warrants underlying private placement units that may be issued upon conversion of working
capital loans, may demand that we register such Class&#160;A ordinary shares, warrants or the Class&#160;A ordinary shares issuable upon
exercise of such warrants. We will bear the cost of registering these securities. The registration and availability of such a significant
number of securities for trading in the public market may have an adverse effect on the market price of our Class&#160;A ordinary shares.
In addition, the existence of the registration rights may make our initial business combination more costly or difficult to conclude.
This is because the shareholders of the target business may increase the equity stake they seek in the combined entity or ask for more
cash consideration to offset the negative impact on the market price of our Class&#160;A ordinary shares that is expected when the ordinary
shares owned by our Sponsor, holders of our private placement units or holders of our working capital loans or their respective permitted
transferees are registered.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may amend the terms of the warrants in a manner that may be
adverse to holders of warrants with the approval by the holders of at least a majority of the then outstanding warrants.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our warrants are issued in registered form under a warrant agreement
between Odyssey Transfer and Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may
be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the
holders of at least a majority of the then outstanding warrants to make any change that adversely affects the interests of the registered
holders of warrants. Accordingly, we may amend the terms of the warrants in a manner adverse to a holder if holders of at least a majority
of the then outstanding warrants approve of such amendment. Although our ability to amend the terms of the warrants with the consent of
at least a majority of the then outstanding warrants is unlimited, examples of such amendments could be amendments to, among other things,
increase the exercise price of the warrants, shorten the exercise period or decrease the number of ordinary shares purchasable upon exercise
of a warrant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our warrant agreement will designate the courts of the State
of New&#160;York or the United&#160;States District Court for the Southern District of New&#160;York as the sole and exclusive forum for
certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders
to obtain a favorable judicial forum for disputes with our company.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our warrant agreement provides that, subject to applicable law, (i)&#160;any
action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including under the Securities
Act, will be brought and enforced in the courts of the State of New&#160;York or the United&#160;States District Court for the Southern
District of New&#160;York, and (ii)&#160;that we irrevocably submit to such jurisdiction, which jurisdiction shall be the exclusive forum
for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent an
inconvenient forum.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notwithstanding the foregoing, these provisions of the warrant agreement
will not apply to suits brought to enforce any liability or duty created by the Exchange&#160;Act or any other claim for which the federal
district courts of the United&#160;States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring
any interest in any of our warrants shall be deemed to have notice of and to have consented to the forum provisions in our warrant agreement.
If any action, the subject matter of which is within the scope the forum provisions of the warrant agreement, is filed in a court other
than a court of the State of New&#160;York or the United&#160;States District Court for the Southern District of New&#160;York (a&#160;&#8220;foreign
action&#8221;) in the name of any holder of our warrants, such holder shall be deemed to have consented to: (x)&#160;the personal jurisdiction
of the state and federal courts located in the State of New&#160;York in connection with any action brought in any such court to enforce
the forum provisions (an &#8220;enforcement action&#8221;), and (y)&#160;having service of process made upon such warrant holder in any
such enforcement action by service upon such warrant holder&#8217;s counsel in the foreign action as agent for such warrant holder.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This&#160;choice-of-forum&#160;provision may limit a warrant holder&#8217;s
ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits.
Alternatively, if a court were to find this provision of our warrant agreement inapplicable or unenforceable with respect to one or more
of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions,
which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the
time and resources of our management and board of directors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 48; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may redeem your unexpired warrants prior to their exercise
at a time that is disadvantageous to you, thereby making your warrants worthless.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have the ability to redeem outstanding warrants at any time after
they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of
our Class&#160;A ordinary shares equals or exceeds $18.00 per share (as adjusted for share sub divisions, share capitalizations, rights
issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20&#160;trading&#160;days within a 30&#160;trading-day&#160;period
ending on the third&#160;trading&#160;day prior to the date we send the notice of redemption to the warrant holders. Redemption of the
outstanding&#160;warrants could force you (i)&#160;to exercise your warrants and pay the exercise price therefor at a time when it may
be disadvantageous for you to do so, (ii)&#160;to sell your warrants at the then-current&#160;market price when you might otherwise wish
to hold your warrants or (iii)&#160;to accept the nominal redemption price which, at the time the outstanding warrants are called for
redemption, is likely to be substantially less than the market value of your warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our management&#8217;s ability to require holders of our warrants
to exercise such warrants on a cashless basis will cause holders to receive fewer Class&#160;A ordinary shares upon their exercise of
the warrants than they would have received had they been able to exercise their warrants for cash.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we call our public warrants for redemption after the redemption
criteria described elsewhere in this Report have been satisfied, our management will have the option to require any holder that wishes
to exercise their warrant (including any warrants held by our Sponsor, officers or directors, other purchasers of our private placement
units, or their permitted transferees) to do so on a &#8220;cashless basis.&#8221; If our management chooses to require holders to exercise
their warrants on a cashless basis, the number of Class&#160;A ordinary shares received by a holder upon exercise will be fewer than it
would have been had such holder exercised his warrant for cash. This will have the effect of reducing the potential &#8220;upside&#8221;
of the holder&#8217;s investment in our company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our warrants and founder shares may have an adverse effect on
the market price of our Class&#160;A ordinary shares and make it more difficult to effectuate our initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have issued warrants to purchase 8,300,000 of our Class&#160;A ordinary
shares, at a price of $11.50 per share (subject to adjustment as provided herein), as part of the units offered simultaneously with the
closing of the Initial Public Offering, we have issued in private placements an aggregate of 779,000 private placement units. The private
placement units will include warrants to purchase an aggregate of 259,667 Class&#160;A ordinary shares at $11.50 per share, subject to
adjustment as provided herein. In addition, our Sponsor or its affiliates may from time to time make working capital loans to us, which
will be repaid upon the closing of a business combination. Up to $1,500,000 of such loans may be convertible into units at a price of
$10.00 per unit at the option of the lender at the time of the business combination. The units would be identical to the private placement
units sold in the private placement. To the extent we issue ordinary shares to effectuate a business combination, the potential for the
issuance of a substantial number of additional Class&#160;A ordinary shares upon exercise of these warrants could make us a less attractive
acquisition vehicle to a target business. Such warrants, when exercised, will increase the number of issued and outstanding Class&#160;A
ordinary shares and reduce the value of the Class&#160;A ordinary shares issued to complete the business combination. Therefore, our warrants
may make it more difficult to effectuate a business combination or increase the cost of acquiring the target business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Because each unit contains&#160;one-third&#160;of one warrant
and only a whole warrant may be exercised, the units may be worth less than units of other blank check companies.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each unit contains&#160;one-third&#160;of one warrant. Because, pursuant
to the warrant agreement, the warrants may only be exercised for a whole number of Class&#160;A ordinary shares, only a whole warrant
may be exercised at any given time. This is different from other offerings similar to ours whose units include one ordinary share and
one warrant to purchase one share. We have established the components of the units in this way in order to reduce the dilutive effect
of the warrants upon completion of a business combination since the warrants will be exercisable in the aggregate for one third of the
number of shares compared to units that each contain a warrant to purchase one whole share, thus making us, we believe, a more attractive
merger partner for target businesses. Nevertheless, this unit structure may cause our units to be worth less than if they included a warrant
to purchase one whole share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>A provision of our warrant agreement may make it more difficult
for us to consummate an initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Unlike most blank check companies, if (x)&#160;we issue additional
Class&#160;A ordinary shares or equity-linked&#160;securities for capital raising purposes in connection with the closing of our initial
business combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective
issue price to be determined in good faith by us and in the case of any such issuance to our Sponsor or its affiliates, without taking
into account any founder shares held by our initial shareholders or such affiliates, as applicable, prior to such issuance) (the &#8220;Newly
Issued Price&#8221;), (y)&#160;the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds,
and interest thereon, available for the funding of our initial business combination on the date of the completion of our initial business
combination (net of redemptions), and (z)&#160;the volume-weighted&#160;average trading price of our Class&#160;A ordinary shares during
the 20&#160;trading&#160;day period starting on the&#160;trading&#160;day prior to the&#160;day on which we complete our initial business
combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted
(to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption
trigger price. This may make it more difficult for us to consummate an initial business combination with a target business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 49; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Provisions in our amended and restated memorandum and articles
of association may inhibit a takeover of us, which could limit the price investors might be willing to pay in the future for our Class&#160;A
ordinary shares and could entrench management.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our amended and restated memorandum and articles of association contains
provisions that may discourage unsolicited takeover proposals that shareholders may consider to be in their best interests. These provisions
include three-year&#160;director terms and the ability of the Board of Directors to designate the terms of and issue new series of preference
shares, which may make the removal of management more difficult and may discourage transactions that otherwise could involve payment of
a premium over prevailing market prices for our securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Together these provisions may make the removal of management more difficult
and may discourage transactions that otherwise could involve payment of a premium over prevailing market prices for our securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">However, under Cayman Islands law, our directors may only exercise
the rights and powers granted to them under our amended and restated memorandum and articles of association for a proper purpose and for
what they believe in good faith to be in the best interests of our company. Furthermore, directors also owe a duty of care, which is not
fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge,
skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in
relation to the company and the general knowledge, skill and experience which that director has.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">Risks Associated with Acquiring and Operating
a Business in Foreign Countries</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-weight: bold;"><i>If we effect our initial business combination with a company
with operations or opportunities outside of the United&#160;States, we would be subject to a variety of additional risks that may negatively
impact our operations.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">If we effect our initial business combination with a company with operations
or opportunities outside of the United&#160;States, we would be subject to any special considerations or risks associated with companies
operating in an international setting, including any of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">costs and difficulties inherent in managing cross-border&#160;business
operations;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">rules and regulations regarding currency redemption;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">complex withholding taxes on holders of our Class A ordinary
shares;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">laws governing the manner in which future business combinations
may be effected;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">tariffs and trade barriers;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">regulations related to customs and import/export matters;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">longer payment cycles;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">tax issues, such as tax law changes and variations in tax
laws as compared to the United&#160;States;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">currency fluctuations and exchange controls;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">rates of inflation;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">challenges in collecting accounts receivable;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">cultural and language differences;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">employment regulations;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">crime, strikes, riots, civil disturbances, terrorist attacks
and wars; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">deterioration of political relations with the United&#160;States.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 50; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may not be able to adequately address these additional risks. If
we were unable to do so, our operations might suffer, which may adversely impact our results of operations and financial condition.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>After our initial business combination, it is possible that a
majority of our directors and officers will live outside the United&#160;States and all of our assets will be located outside the United&#160;States;
therefore investors may not be able to enforce federal securities laws or their other legal rights.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">It is possible that after our initial business combination, a majority
of our directors and officers will reside outside of the United&#160;States and all of our assets will be located outside of the United&#160;States.
As a result, it may be difficult, or in some cases not possible, for investors in the United&#160;States to enforce their legal rights,
to effect service of process upon all of our directors or officers or to enforce judgments of United&#160;States courts predicated upon
civil liabilities and criminal penalties on our directors and officers under United&#160;States laws.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If our management following our initial business combination
is unfamiliar with U.S.&#160;securities laws, they may have to expend time and resources becoming familiar with such laws, which could
lead to various regulatory issues.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following our initial business combination, any or all of our management
could resign from their positions as officers of the company, and the management of the target business at the time of the business combination
could remain in place. Management of the target business may not be familiar with U.S.&#160;securities laws. If new management is unfamiliar
with U.S.&#160;securities laws, they may have to expend time and resources becoming familiar with such laws. This could be expensive and
time-consuming&#160;and could lead to various regulatory issues which may adversely affect our operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Exchange rate fluctuations and currency policies may cause a
target business&#8217; ability to succeed in the international markets to be diminished.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event we acquire a&#160;non-U.S.&#160;target,&#160;all revenues
and income would likely be received in a foreign currency, and the dollar equivalent of our net assets and distributions, if any, could
be adversely affected by reductions in the value of the local currency. The value of the currencies in our target regions fluctuate and
are affected by, among other things, changes in political and economic conditions. Any change in the relative value of such currency against
our reporting currency may affect the attractiveness of any target business or, following consummation of our initial business combination,
our financial condition and results of operations. Additionally, if a currency appreciates in value against the dollar prior to the consummation
of our initial business combination, the cost of a target business as measured in dollars will increase, which may make it less likely
that we are able to consummate such transaction.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">General Risk Factors</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We have no operating history and no revenues, and you have no
basis on which to evaluate our ability to achieve our business objective.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have no operating results and no revenues. Because we lack an operating
history, you have no basis upon which to evaluate our ability to achieve our business objective of completing our initial business combination
with one or more target businesses. We have no plans, arrangements or understandings with any prospective target business concerning a
business combination and may be unable to complete our initial business combination. If we fail to complete our initial business combination,
we will never generate any operating revenues.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Past performance by our management team and their affiliates
may not be indicative of future performance of an investment in us.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Information regarding performance by, or businesses associated with,
our management team and their affiliates is presented for informational purposes only. Past performance by our management, including their
affiliates&#8217; past performance, is not a guarantee either (i)&#160;of success with respect to any business combination we may consummate
or (ii)&#160;that we will be able to locate a suitable candidate for our initial business combination. You should not rely on the historical
record of our management team or their affiliates as indicative of our future performance. Additionally, in the course of their respective
careers, members of our management team have been involved in businesses and deals that were unsuccessful.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our Sponsor has the ability to remove itself as the Company&#8217;s
Sponsor or to substantially reduce its interests in the Company before identifying a business combination, which may result in change
in the strategy and focus of our Company in pursuing a business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Sponsor may surrender&#160;or forfeit, transfer or exchange our
founder shares, private units or any of our other securities, including for no consideration, as well as subject any such securities to
earn-outs&#160;or other restrictions, or otherwise amend the terms of any such securities or enter into any other arrangements with respect
to any such securities. In addition, the members of our Sponsor could, with the permission of the Sponsor&#8217;s managing member, transfer
their membership interests in the Sponsor, thereby transferring control of our Sponsor to a third party. Through the forgoing means, our
Sponsor may remove itself as the Company&#8217;s Sponsor, substantially reduce its interests in the Company, or have its control transferred
to a third party before we identify a business combination. Any such reduction of the interests of our Sponsor in the securities of the
Company or transfer of Sponsor interests may lead to the Sponsor&#8217;s managing member no longer having voting power and control over
the affairs of the Company in pursuing a business combination. This could also result in a change to our management team, acquisition
strategy and criteria and our industry focus without shareholders having the ability to consider the merits of a change in the management
team.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 51; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Attractive targets may become scarcer and there may be more competition
for attractive targets. This could increase the cost of our initial business combination and could even result in our inability to find
a target or to consummate an initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Many potential targets for special purpose acquisition companies have
already entered into an initial business combination, and there are still many special purpose acquisition companies seeking targets for
their initial business combination. As a result, at times, fewer attractive targets may be available, and it may require more time, more
effort and more resources to identify a suitable target and to consummate an initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, because there are many special purpose acquisition companies
seeking to enter into an initial business combination with available targets, the competition for available targets with attractive fundamentals
or business models may increase, which could cause target companies to demand improved financial terms. Attractive deals could also become
scarcer for other reasons, such as economic or industry sector downturns (including a negative public perception of mergers involving
SPACs), geopolitical tensions, or increases in the cost of additional capital needed to close business combinations or operate targets
post-business&#160;combination. This could increase the cost of, delay or otherwise complicate or frustrate our ability to find and consummate
an initial business combination, and may result in our inability to consummate an initial business combination on terms favorable to our
investors altogether.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Changes in the market for directors and officers liability insurance
could make it more difficult and more expensive for us to negotiate and complete an initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In recent&#160;years, the market for directors and officers liability
insurance for special purpose acquisition companies has changed in ways adverse to us and our management team. Fewer insurance companies
are offering quotes for directors and officers liability coverage, the premiums charged for such policies have generally increased and
the terms of such policies have generally become less favorable. These trends may continue into the future.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The increased cost and decreased availability of directors and officers
liability insurance could make it more difficult and more expensive for us to negotiate an initial business combination. In order to obtain
directors and officers liability insurance or modify its coverage as a result of becoming a public company, the post-business&#160;combination
entity might need to incur greater expense or accept less favorable terms, or both. However, any failure to obtain adequate directors
and officers liability insurance could have an adverse impact on the post-business&#160;combination&#8217;s ability to attract and retain
qualified officers and directors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, even if we were to complete an initial business combination,
our directors and officers could still be subject to potential liability from claims arising from conduct alleged to have occurred prior
to the initial business combination. As a result, in order to protect our directors and officers, the post-business&#160;combination entity
may need to purchase additional insurance with respect to any such claims&#160;(&#8220;run-off&#160;insurance&#8221;). The need for&#160;run-off&#160;insurance
would be an added expense for the post-business&#160;combination entity and could interfere with or frustrate our ability to consummate
an initial business combination on terms favorable to our investors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Changes to laws or regulations or in how such laws or regulations
are interpreted or applied, or a failure to comply with any laws, regulations, interpretations or applications, may adversely affect our
business, including our ability to negotiate and complete our initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are subject to the laws and regulations, and interpretations and
applications of such laws and regulations, of national, regional, state and local governments and applicable&#160;non-U.S.&#160;jurisdictions.&#160;In
particular, we are required to comply with certain SEC and potentially other legal and regulatory requirements, and our consummation of
an initial business combination may be contingent upon our ability to comply with certain laws, regulations, interpretations and applications
and any post-business&#160;combination company may be subject to additional laws, regulations, interpretations and applications. Compliance
with, and monitoring of, the foregoing may be difficult, time consuming and costly. Those laws and regulations and their interpretation
and application may also change from time to time, and those changes could have a material adverse effect on our business, including our
ability to negotiate and complete an initial business combination. A failure to comply with applicable laws or regulations, as interpreted
and applied, could have a material adverse effect on our business, including our ability to negotiate and complete an initial business
combination, and results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January&#160;24, 2024, the SEC adopted a series of new rules relating
to SPACs requiring, among other items, (i)&#160;additional disclosures relating to SPAC business combination transactions; (ii)&#160;additional
disclosures relating to dilution and to conflicts of interest involving sponsors and their affiliates in both SPAC initial public offerings
and SPAC initial business combinations; (iii)&#160;the use of projections by SPACs in SEC filings in connection with proposed business
combination transactions; and (iv)&#160;both the SPAC and the target company&#8217;s status as&#160;co-registrants&#160;on&#160;de-SPAC&#160;transaction
registration statements. In addition, the SEC&#8217;s adopting release provided guidance describing circumstances in which a SPAC could
become subject to regulation under the Investment Company Act, including as a result of its duration, asset composition, business purpose,
and the activities of the SPAC and its management team in furtherance of such goals. Compliance with such rules and related guidance may
increase the costs and the time needed to negotiate and complete an initial business combination, may constrain the circumstances under
which we could complete an initial business combination or otherwise impair our ability to complete a business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 52; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Recent increases in inflation and interest rates in the United&#160;States
and elsewhere could make it more difficult for us to consummate an initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Recent increases in inflation and interest rates in the United&#160;States
and elsewhere may lead to (i)&#160;increased price volatility for publicly traded securities, including ours, (ii)&#160;other national,
regional and international economic disruptions, and (iii)&#160;uncertainty regarding the valuation of target businesses, any of which
could make it more difficult for us to consummate an initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Our search for a business combination, and any target business
with which we ultimately consummate a business combination, may be materially adversely affected by current global geopolitical conditions
resulting from the ongoing&#160;Russia-Ukraine&#160;conflict and conflicts in the Middle East and Southwest Asia.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United&#160;States and global markets are experiencing volatility and
disruption following the geopolitical instability resulting from the ongoing Russia-Ukraine&#160;conflict and the recent escalation of
the Israel-Hamas&#160;conflict. In response to the ongoing Russia-Ukraine&#160;conflict, the North Atlantic Treaty Organization (&#8220;NATO&#8221;)
deployed additional military forces to eastern Europe, and the United&#160;States, the United Kingdom, the European Union and other countries
have announced various sanctions and restrictive actions against Russia, Belarus and related individuals and entities, including the removal
of certain financial institutions from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Certain
countries, including the United&#160;States, have also provided and may continue to provide military aid or other assistance to Ukraine
and to Israel, increasing geopolitical tensions among a number of nations. The invasion of Ukraine by Russia and the conflicts in the
Middle East and Southwest Asia, particularly the recent escalation of the Israel-Hamas&#160;and Israel-Iran&#160;conflicts, and the resulting
measures that have been taken, and could be taken in the future, by NATO, the United&#160;States, the United Kingdom, the European Union,
Israel and its neighboring states and other countries have created global security concerns that could have a lasting impact on regional
and global economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions,
including significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased
cyber-attacks&#160;against U.S.&#160;companies. Additionally, any resulting sanctions could adversely affect the global economy and financial
markets and lead to instability and lack of liquidity in capital markets.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any of the abovementioned factors, or any other negative impact on
the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the conflicts in
the Middle East and Southwest Asia, particularly the recent escalation of the Israel-Hamas&#160;and Israel-Iran&#160;conflicts, and subsequent
sanctions or related actions, could adversely affect our search for an initial business combination and any target business with which
we may ultimately consummate an initial business combination. The extent and duration of the ongoing conflicts, resulting sanctions and
any related market disruptions are impossible to predict, but could be substantial, particularly if current or new sanctions continue
for an extended period of time or if geopolitical tensions result in expanded military operations on a global scale. Any such disruptions
may also have the effect of heightening many of the other risks described in this section. If these disruptions or other matters of global
concern continue for an extensive period of time, our ability to consummate an initial business combination, or the operations of a target
business with which we may ultimately consummate an initial business combination, may be materially adversely affected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may not hold an annual general meeting until after the consummation
of our initial business combination. Our public shareholders will not have the right to appoint directors prior to the consummation of
our initial business combination.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In accordance with Nasdaq corporate governance requirements, we are
not required to hold an annual general meeting until no later than one year after our first fiscal year end following our listing on Nasdaq.&#160;There
is no requirement under the Companies Act for us to hold annual or extraordinary general meetings. Until we hold an annual general meeting,
public shareholders may not be afforded the opportunity to discuss company affairs with management. In addition, unless there are no longer
any Class&#160;B ordinary shares outstanding, our public shareholders, as holders of our Class&#160;A ordinary shares, will not have the
right to vote on the appointment or removal of directors prior to consummation of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 53; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We are an emerging growth company and a smaller reporting company
within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to emerging
growth companies or smaller reporting companies, this could make our securities less attractive to investors and may make it more difficult
to compare our performance with other public companies.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are an &#8220;emerging growth company&#8221; within the meaning
of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the auditor internal controls attestation requirements of Section&#160;404 of the Sarbanes-Oxley&#160;Act, reduced disclosure
obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding
a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
As a result, our shareholders may not have access to certain information they may deem important. We could be an emerging growth company
for up to five&#160;years, although circumstances could cause us to lose that status earlier, including if the market value of our ordinary
shares held by&#160;non-affiliates&#160;equals or exceeds $700&#160;million as of any June&#160;30 before that time, in which case we
would no longer be an emerging growth company as of the following December&#160;31. We cannot predict whether investors will find our
securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result
of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less
active trading market for our securities and the trading prices of our securities may be more volatile.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging
growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those
that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the
Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company
can elect to opt out of the extended transition period and comply with the requirements that apply to&#160;non-emerging&#160;growth companies
but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that
when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth
company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison
of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which
has opted out of using the extended transition period difficult or impossible because of the potential differences in accountant standards
used.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additionally, we are a &#8220;smaller reporting company&#8221; as defined
in Rule&#160;10(f)(1)&#160;of&#160;Regulation&#160;S-K.&#160;Smaller&#160;reporting companies may take advantage of certain reduced disclosure
obligations, including, among other things, providing only two&#160;years of audited financial statements. We will remain a smaller reporting
company until the last&#160;day of the fiscal year in which (1)&#160;the market value of our ordinary shares held by&#160;non-affiliates&#160;equals
or exceeds $250&#160;million as of the end of that year&#8217;s second fiscal quarter, or (2)&#160;our annual revenues equals or exceeds
$100&#160;million during such completed fiscal year and the market value of our ordinary shares held by&#160;non-affiliates&#160;equals
or exceeds $700&#160;million as of the end of that year&#8217;s second fiscal quarter. To the extent we take advantage of such reduced
disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The requirements of being a public company may strain our resources
and divert management&#8217;s attention.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a public company, we will be subject to the reporting requirements
of the Exchange&#160;Act, the Sarbanes-Oxley&#160;Act&#160;of&#160;2002 (which we refer to as the Sarbanes-Oxley&#160;Act), the Dodd-Frank&#160;Act
Wall Street Reform and Consumer Protection Act (which we refer to as the Dodd-Frank&#160;Act), the listing requirements of Nasdaq and
other applicable securities rules and regulations. Compliance with these rules and regulations will increase our legal and financial compliance
costs, make some activities more difficult, time-consuming&#160;or costly and increase demand on our systems and resources, particularly
after we are no longer an &#8220;emerging growth company.&#8221; The&#160;Sarbanes-Oxley&#160;Act requires, among other things, that we
maintain effective disclosure controls and procedures and internal control over financial reporting. In order to maintain and, if required,
improve our disclosure controls and procedures and internal control over financial reporting to meet this standard, significant resources
and management oversight may be required. As a result, management&#8217;s attention may be diverted from other business concerns, which
could adversely affect our business and operating results. We may need to hire more employees in the future or engage outside consultants
to comply with these requirements, which will increase our costs and expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, changing laws, regulations and standards relating to corporate
governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs and making
some activities more time consuming. These laws, regulations and standards are subject to varying interpretations, in many cases due to
their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory
and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing
revisions to disclosure and governance practices. We intend to invest resources to comply with evolving laws, regulations and standards,
and this investment may result in increased general and administrative expenses and a diversion of management&#8217;s time and attention.
If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies
due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our
business may be adversely affected.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">However, for as long as we remain an &#8220;emerging growth company&#8221;
as defined in the JOBS Act, we may take advantage of certain exemptions from various reporting requirements that are applicable to &#8220;emerging
growth companies&#8221; including, but not limited to, not being required to comply with the auditor attestation requirements of the Sarbanes-Oxley&#160;Act,
reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the
requirement of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments
not previously approved. We may take advantage of these reporting exemptions until we are no longer an &#8220;emerging growth company.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 54; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may be a passive foreign investment company, or &#8220;PFIC,&#8221;
which could result in adverse U.S.&#160;federal income tax consequences to U.S.&#160;investors.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we are a PFIC for any taxable year (or portion thereof) that is
included in the holding period of a U.S.&#160;holder of our Class&#160;A ordinary shares or warrants, the U.S.&#160;holder may be subject
to adverse U.S.&#160;federal income tax consequences and may be subject to additional reporting requirements. Our PFIC status for our
current and subsequent taxable&#160;years may depend on whether we qualify for the PFIC&#160;start-up&#160;exception.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Depending on the particular circumstances the application of the&#160;start-up&#160;exception
may be subject to uncertainty, and there cannot be any assurance that we will qualify for such&#160;start-up&#160;exception. Accordingly,
there can be no assurances with respect to our status as a PFIC for our current taxable year or any subsequent taxable year. Our actual
PFIC status for any taxable year will not be determinable until after the end of such taxable year. Moreover, if we determine we are a
PFIC for any taxable year, we will endeavor to provide to a U.S.&#160;holder such information as the Internal Revenue Service (&#8220;IRS&#8221;)
may require, including a PFIC annual information statement, in order to enable the U.S.&#160;holder to make and maintain a &#8220;qualified
electing fund&#8221; election, but there can be no assurance that we will timely provide such required information, and such election
would be unavailable with respect to our warrants in any event. We urge U.S.&#160;holders to consult their own tax advisors regarding
the possible application of the PFIC rules to holders of our Class&#160;A ordinary shares and warrants.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The excise tax on stock repurchases may decrease the value of
our securities following our initial business combination, hinder our ability to consummate an initial business combination, and decrease
the amount of funds available for distribution in connection with a liquidation.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Code imposes a 1% excise tax on the fair market value of shares
repurchased by a domestic corporation, with certain exceptions (the &#8220;Excise Tax&#8221;). Because there is a possibility that we
may acquire a U.S.&#160;domestic corporation or engage in a transaction in which a domestic corporation becomes our parent or our affiliate,
and our securities trade on Nasdaq, we may become a &#8220;covered corporation&#8221; within the meaning of the Code following the consummation
of our initial business combination, and while not free from doubt, it is possible that the Excise Tax will apply to any redemptions of
our ordinary shares, including redemptions in connection with an initial business combination and any amendment to our amended and restated
memorandum and articles of association to extend the time to consummate an initial business combination, unless an exemption is available.
If we were to become a covered corporation, we generally would become subject to the Excise Tax, subject to considerations including whether
there are applicable share issuances during the taxable year, including in connection with an initial business combination or share private
placement which would exceed and net against redemption during such period (such netting, the &#8220;Netting Rule&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, because the Excise Tax would be payable by us and not
by the redeeming holder, the mechanics of any required payment of the Excise Tax have not been determined. For these reasons, the value
of your investment in our securities may decrease as a result of the Excise Tax in some circumstances. In addition, the Excise Tax may
make a transaction with us less appealing to potential business combination targets, and thus, potentially hinder our ability to enter
into and consummate an initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Whether the Excise Tax will apply to redemptions in connection with
a&#160;de-SPAC&#160;transaction may depend on the structure of the&#160;de-SPAC&#160;transaction, subject to application of the Netting
Rule. For example, where the target business entity is the issuer of shares and/or other equity and in certain other business combination
structures where the equity is not issued by the SPAC, the Excise Tax may apply.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accordingly, there is a risk that if the Excise Tax is applicable,
we could have reduced funds in our trust account to pay redemptions or that are available to a combined company following a&#160;de-SPAC,&#160;which
could cause investors in our securities who do not redeem or the other shareholders of the combined company to economically bear the impact
of such Excise Tax.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>We may transfer by way of continuation into another jurisdiction
in connection with our initial business combination and such continuation may result in taxes imposed on shareholders.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We may, in connection with our initial business combination and subject
to requisite shareholder approval under the Companies Act, transfer by way of continuation into the jurisdiction in which the target company
or business is located. The transaction may require a shareholder to recognize taxable income in the jurisdiction in which the shareholder
is a tax resident or in which its members are resident if it is a tax transparent entity. We do not intend to make any cash distributions
to shareholders to pay such taxes. Shareholders may be subject to withholding taxes or other taxes with respect to their ownership of
us after the continuation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 55; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>If a U.S.&#160;investor is treated as owning at least 10% of
the stock of the Company, such person may be subject to adverse U.S.&#160;federal income tax consequences.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If a U.S.&#160;Holder is treated as owning (directly, indirectly or
constructively) at least 10% of the value or voting power of the stock of the Company (such a holder, a &#8220;10% United&#160;States
shareholder&#8221;), such holder may be treated as a &#8220;United&#160;States shareholder&#8221; with respect to each of the Company
and its direct and indirect subsidiaries (the &#8220;Company Group&#8221;) that is a &#8220;controlled foreign corporation,&#8221; (a
&#8220;CFC&#8221;), for U.S.&#160;federal income tax purposes. A non-U.S.&#160;corporation is considered a CFC if more than 50% of (1)&#160;the
total combined voting power of all classes of stock of such corporation entitled to vote, or (2)&#160;the total value of the stock of
such corporation is owned, or is considered as owned by applying certain constructive ownership rules, by 10% United&#160;States shareholders
on any&#160;day during the taxable year of such non-U.S.&#160;corporation.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the Company or any of its non-U.S.&#160;subsidiaries is a CFC, 10%
United&#160;States shareholders will be subject to potentially adverse income inclusion and reporting requirements with respect to such
CFC.&#160;No assurance can be provided that the Company will assist holders in determining whether it or any of its non-U.S.&#160;subsidiaries
is treated as a CFC or whether any holder is treated as a 10% United&#160;States shareholder with respect to any of such CFCs or furnish
to any holder information that may be necessary to comply with reporting and tax payment obligations with respect to such CFCs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>The Company&#8217;s business, investments and operations and
shareholders&#8217; post-tax&#160;returns may be negatively affected due to taxes.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We intend to&#160;structure our business combination to maximize returns
for shareholders in as efficient a manner as is practicable. Accordingly, the Company will need to make certain assumptions regarding
taxation. However, if these assumptions are not correct, taxes may be imposed with respect to the Company&#8217;s assets, or the Company
may be subject to tax on its income, profits, gains or distributions (whether on a liquidation, redemption or otherwise) in a particular
jurisdiction or jurisdictions in excess of taxes that were anticipated. The Company also may become subject to tariffs in excess of rates
that were anticipated. In addition, the taxation consequences of subscribing for, purchasing, holding or disposing of Class&#160;A ordinary
shares or warrants, including of the receipt of any distributions that may be paid by the Company (whether on a liquidation, redemption
or otherwise) will depend on the laws and tax authority practices to which a shareholder is subject. Any of these factors could adversely
affect the post-tax&#160;returns for shareholders (or shareholders in certain jurisdictions). Any change in laws or tax authority practices
could also adversely affect any post-tax&#160;returns to shareholders. In addition, the Company may incur costs in taking steps to mitigate
any such adverse effect on the post-tax&#160;returns for shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Certain agreements related to the Initial Public Offering may
be amended without shareholder approval.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain agreements, including the underwriting agreement relating to
the Initial Public Offering, the investment management trust agreement between us and Odyssey Transfer and Trust Company, the letter agreement
among us and our Sponsor, officers and directors, and the registration rights agreement among us, the initial holders and holders of placement
units and the administrative services agreement between us and our sponsor, may be amended without shareholder approval. These agreements
contain various provisions that our public shareholders might deem to be material. For example, the underwriting agreement related to
the Initial Public Offering contains a covenant that the target company that we acquire must have a fair market value equal to at least
80% of the balance in the trust account at the time of signing the definitive agreement for the transaction with such target business
(excluding the deferred underwriting commissions and taxes payable on interest earned) so long as we obtain and maintain a listing for
our securities on Nasdaq.&#160;While we do not expect our board to approve any amendment to any of these agreements prior to our initial
business combination, it may be possible that our board, in exercising its business judgment and subject to its fiduciary duties, chooses
to approve one or more amendments to any such agreement in connection with the consummation of our initial business combination. Any such
amendment may have an adverse effect on the value of an investment in our securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Because we are incorporated under the laws of the Cayman Islands,
you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S.&#160;Federal courts may
be limited.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are an exempted company incorporated under the laws of the Cayman
Islands. As a result, it may be difficult for investors to effect service of process within the United&#160;States upon our directors
or officers, or enforce judgments obtained in the United&#160;States courts against our directors or officers.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our corporate affairs will be governed by our amended and restated
memorandum and articles of association, the Companies Act (as revised) and the common law of the Cayman Islands. The rights of shareholders
to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under
Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived
in part from comparatively limited judicial precedent in the Cayman Islands as well as from English common law, the decisions of whose
courts are of persuasive authority, but are not binding on a court in the Cayman Islands. The rights of our shareholders and the fiduciary
responsibilities of our directors under Cayman Islands law are different from what they would be under statutes or judicial precedent
in some jurisdictions in the United&#160;States. In particular, the Cayman Islands has a different body of securities laws as compared
to the United&#160;States, and certain states, such as Delaware, may have more fully developed and judicially interpreted bodies of corporate
law. In addition, Cayman Islands companies may not have standing to initiate a shareholders&#8217; derivative action in a Federal court
of the United&#160;States.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 56; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have been advised by our Cayman Islands legal counsel, that the
courts of the Cayman Islands are unlikely (i)&#160;to recognize or enforce against us judgments of courts of the United&#160;States obtained
against us or our directors or officers predicated upon the civil liability provisions of the federal securities laws of the United&#160;States
or any state in the United&#160;States; and (ii)&#160;in original actions brought in the Cayman Islands, to impose liabilities against
us or our directors or officers predicated upon the civil liability provisions of the federal securities laws of the United&#160;States
or any state in the United&#160;States, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances,
although there is currently no statutory enforcement or treaty between the United&#160;States and the Cayman Islands providing for enforcement
of judgments obtained in the United&#160;States. The courts of the Cayman Islands will recognize and enforce a foreign money judgment
of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign
court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are
met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive, given by a court of competent
jurisdiction (the courts of the Cayman Islands will apply the rules of the Cayman Islands private international law to determine whether
the foreign court is a court of competent jurisdiction), and must not be in respect of taxes or a fine or penalty, inconsistent with a
Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the
enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands. Furthermore, it is uncertain that Cayman
Islands courts would enforce: (1)&#160;judgments of U.S.&#160;courts obtained in actions against us or other persons that are predicated
upon the civil liability provisions of the U.S.&#160;federal securities laws; or (2)&#160;original actions brought against us or other
persons predicated upon the Securities Act. Appleby (Cayman) Ltd has informed us that there is uncertainty with regard to Cayman Islands
law relating to whether a judgment obtained from the U.S.&#160;courts under civil liability provisions of the securities laws will be
determined by the courts of the Cayman Islands as penal, punitive in nature. A Cayman Islands Court may stay enforcement proceedings if
concurrent proceedings are being brought elsewhere.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As a result of all of the above, public shareholders may have more
difficulty in protecting their interests in the face of actions taken by management, members of the Board of Directors or controlling
shareholders than they would as public shareholders of a United&#160;States company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>After our initial business combination, our results of operations
and prospects will be subject, to a significant extent, to the economic, political and legal policies, developments and conditions in
the country in which we operate.</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The economic, political and social conditions, as well as government
policies, of the country in which our operations are located could affect our business. Economic growth could be uneven, both geographically
and among various sectors of the economy and such growth may not be sustained in the future. If in the future such country&#8217;s economy
experiences a downturn or grows at a slower rate than expected, there may be less demand for spending in certain industries. A decrease
in demand for spending in certain industries could materially and adversely affect our ability to find an attractive target business with
which to consummate our initial business combination and if we effect our initial business combination, the ability of that target business
to become profitable.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Since only holders of our founder shares will have the right
to vote on the appointment of directors, upon the listing of our shares on the Nasdaq, the Nasdaq may consider us to be a &#8220;controlled
company&#8221; within the meaning of the Nasdaq rules&#160;and, as a result, we may qualify for exemptions from certain corporate governance
requirements.</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">After completion of the Initial Public Offering, only holders of our
founder shares have the right to vote on the appointment of directors. As a result, the Nasdaq may consider us to be a &#8220;controlled
company&#8221; within the meaning of the Nasdaq corporate governance standards. Under the Nasdaq corporate governance standards, a company
of which more than 50% of the voting power is held by an individual, group or another company is a &#8220;controlled company&#8221; and
may elect not to comply with certain corporate governance requirements, including the requirements that:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">we have a board that includes a majority of &#8220;independent
directors,&#8221; as defined under the rules&#160;of the Nasdaq;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">we have a compensation committee of our board that is comprised
entirely of independent directors with a written charter addressing the committee&#8217;s purpose and responsibilities; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">a majority of the independent directors recommend director
nominees for selection by the board of directors.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">We do not intend to utilize these exemptions and intend to comply with
the corporate governance requirements of the Nasdaq, subject to applicable&#160;phase-in&#160;rules. However, if we determine in the future
to utilize some or all of these exemptions, you will not have the same protections afforded to shareholders of companies that are subject
to all of the Nasdaq corporate governance requirements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 57; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>Cybersecurity risks and cyber incidents could adversely affect
our business by causing a disruption to our operations, a compromise or corruption of our confidential information and confidential information
in our possession and/or damage to our business relationships, any of which could negatively impact our business, financial condition
and operating results.</i></span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We and our Sponsor and its affiliates face increasingly frequent and
sophisticated cyber and security threats, with attacks ranging from those common to businesses generally to those that are more advanced
and persistent, which may target us because we are affiliated with an alternative asset management firm and may hold confidential and
other price sensitive information about existing and potential investments. We depend on digital technologies, including information systems,
infrastructure and cloud applications and services, including those of our Sponsor and its third party vendors, and other third parties.
Cyber attacks and other security threats could originate from a wide variety of sources, including cyber criminals, nation state hackers,
hacktivists and other outside parties. As a result, we may face a heightened risk of a security breach or disruption with respect to sensitive
information resulting from an attack by computer hackers, foreign governments or cyber terrorists.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The efficient operation of our business is dependent on computer hardware
and software systems, as well as data processing systems and the secure processing, storage and transmission of information, which are
vulnerable to security breaches and cyber incidents. A cyber incident is considered to be any adverse event that threatens the confidentiality,
integrity or availability of our information resources. These incidents may be an intentional attack or an unintentional event and could
involve gaining unauthorized access to our information systems for purposes of misappropriating assets, stealing confidential information,
corrupting data or causing operational disruption. In addition, we and our employees may be the target of fraudulent emails or other targeted
attempts to gain unauthorized access to proprietary or sensitive information. The result of these incidents may include disrupted operations,
misstated or unreliable financial data, increased cybersecurity protection and insurance costs, litigation and damage to our business
relationships. Any processes, procedures and internal controls we may implement to mitigate cybersecurity risks and cyber intrusions,
as well as our increased awareness of the nature and extent of a risk of a cyber-incident, will not guarantee that a cyber-incident&#160;will
not occur or that our financial results, operations or confidential information will not be negatively impacted by such an incident, especially
because the cyber-incident&#160;techniques change frequently or are not recognized until launched and because cyber-incidents&#160;can
originate from a wide variety of sources. We may not have sufficient funding and resources to comply with evolving cybersecurity regulations
and to continually monitor and enhance our cybersecurity procedures and controls.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_004" style="display: inline-block;"></span>ITEM 1B. UNRESOLVED STAFF COMMENTS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">None.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_005" style="display: inline-block;"></span>ITEM 1C. CYBERSECURITY</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"> <ix:nonNumeric name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-8064">We are a special purpose acquisition company with no business operations. Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. <ix:nonNumeric name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-8065"><ix:nonNumeric name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-8066">Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if any.</ix:nonNumeric> <ix:nonNumeric name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-8067">We have <ix:nonNumeric name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" contextRef="cref_1363532388" format="ixt:fixed-false" id="ixv-8068">not encountered</ix:nonNumeric> any cybersecurity incidents since our Initial Public Offering.</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_006" style="display: inline-block;"></span>ITEM 2. PROPERTIES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">We currently maintain our
executive offices at 440 Louisiana Street, Suite 1050, Houston, Texas 77002. The cost for this space is included in the $40,000 per
month fee. Pursuant to an administrative services agreement, dated September 8, 2025, as amended on September 16, 2025, between the
Company and the Sponsor (the &#8220;Administrative Services Agreement&#8221;), until the completion of our initial business
combination or liquidation, we will pay a monthly fee of $40,000 to our Sponsor or its affiliates for secretarial and administrative
services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_007" style="display: inline-block;"></span>ITEM 3. LEGAL PROCEEDINGS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">There is no material litigation,
arbitration or governmental proceeding currently pending against us or any members of our management team.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_008" style="display: inline-block;"></span>ITEM 4. MINE SAFETY DISCLOSURES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Not applicable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><!-- Field: Page; Sequence: 58; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"><span style="text-decoration:underline"><span id="a_009" style="display: inline-block;"></span>PART II</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_010" style="display: inline-block;"></span>ITEM 5. MARKET FOR REGISTRANT&#8217;S COMMON
EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Our equity securities trade
on the Nasdaq Global Market. Each of our units consists of one Class&#160;A ordinary share, and&#160;one-third&#160;of one redeemable
warrant and, commencing on September 9, 2025, trades on the Nasdaq Global Market under the symbol &#8220;TLNCU.&#8221; The Class A ordinary
shares and warrants underlying our units are trading separately on the Nasdaq Global Market under the symbols &#8220;TLNC&#8221; and &#8220;TLNCW,&#8221;
respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Holders of Record</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">On March 3, 2026, there were
3 holders of record of our units, 1 holder of record of our Class A ordinary shares, and 1 holder of record of our warrants. Such numbers
do not include beneficial owners holding our securities through nominee names.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Dividends</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">We have not paid any cash
dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The payment of any dividends
subsequent to a business combination will be within the discretion of our board of directors at such time and we will only pay such dividend
out of our profits or share premium (subject to solvency requirements) as permitted under Cayman Islands Law. It is the present intention
of our board of directors to retain all earnings, if any, for use in our business operations and, accordingly, our board of directors
does not anticipate declaring any dividends in the foreseeable future. In addition, our board of directors is not currently contemplating
and does not anticipate declaring any share dividends in the foreseeable future. Further, the ability to pay such dividends in kind at
the combined company&#8217;s option may result in dilution to existing shareholders. If we incur any indebtedness in connection with our
initial business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Use of Proceeds from our Initial Public Offering</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 19.4pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">On September 10, 2025, we
consummated our Initial Public Offering of 24,900,000 units at $10.00 per unit, each unit consisting of one Class A ordinary share and
one-third of one redeemable warrant, generating gross proceeds of $249,000,000. Simultaneously with the closing of the Initial Public
Offering, we consummated the sale of an aggregate of 779,000 private placement units at a price of $10.00 per unit in a private placement
to the Sponsor and CCM, generating gross proceeds of $7,790,000. Following the closings of the Initial Public Offering and the private
placement on September 10, 2025, an aggregate amount of $249,000,000 ($10.00 per unit) from the net proceeds of the sale of the public
units, and a portion of the net proceeds from the sale of the private placement units, was placed in the Trust Account and held in demand
deposit or cash accounts or invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment
Company Act, with a maturity of 185 days or less, or in any open-ended investment company that holds itself out as a money market fund
investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 of the Investment Company Act, as determined by the
Company, until the earlier of (i) the completion of a business combination and (ii) the distribution of the funds in the Trust Account
to the Company&#8217;s shareholders. Transaction costs amounted to $14,742,001, consisting of $4,040,000 of cash underwriting fee (net
of $700,000 underwriters&#8217; reimbursement), $10,200,000 of deferred underwriting fee, and $502,001 of other offering costs.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 19.4pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">For a description of the
use of the proceeds generated in our Initial Public Offering, see Part&#160;II,&#160;Item 7 of this Annual Report.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-weight: bold;"><span id="a_011" style="display: inline-block;"></span>ITEM 6. [RESERVED]</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-weight: bold;"><span id="a_012" style="display: inline-block;"></span>ITEM 7. MANAGEMENT&#8217;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The following discussion and analysis of the Company&#8217;s financial
condition and results of operations should be read in conjunction with our audited financial statements and the notes related thereto
which are included in &#8220;Item 8. Financial Statements and Supplementary Data&#8221; of this Annual Report on Form 10-K. Certain information
contained in the discussion and analysis set forth below includes forward-looking statements. Our actual results may differ materially
from those anticipated in these forward-looking statements as a result of many factors, including those set forth under &#8220;Special
Note Regarding Forward-Looking Statements,&#8221; &#8220;Item 1A. Risk Factors&#8221; and elsewhere in this Annual Report on Form 10-K.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 59; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Overview</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a blank check company incorporated in the Cayman Islands on
May 1, 2025, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization
or other similar business combination with one or more businesses. We intend to effectuate our business combination using cash derived
from the proceeds of the initial public offering and the sale of the private placement units, our shares, debt or a combination of cash,
shares and debt.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We expect to continue to incur significant costs in the pursuit of
our acquisition plans. We cannot assure you that our plans to complete a business combination will be successful.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Results of Operations</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have neither engaged in any operations nor generated any revenues
to date. Our only activities from May 1, 2025 (inception) through December 31, 2025 were organizational activities and those necessary
to prepare for the initial public offering, described below, and, after our initial public offering, identifying a target company for
a business combination. We do not expect to generate any operating revenues until after the completion of our business combination. Subsequent
to the initial public offering, we generate non-operating income in the form of interest income on cash held in the trust account. We
incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as
for due diligence expenses.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the period from May 1, 2025 (inception) through December 31, 2025,
we had a net income of $2,625,175, which consists of interest income on cash held in the trust account of $3,171,560, offset by</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">general and administrative expenses of $547,385.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Liquidity and Capital Resources</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 10, 2025, we consummated the initial public offering of
24,900,000 units, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 2,400,000 units,
at $10.00 per unit, generating gross proceeds of $249,000,000. Simultaneously with the closing of the initial public offering, we consummated
the sale of 779,000 private placement units at a price of $10.00 per private placement unit, in a private placement to the Sponsor and
Cohen and Company Capital Markets, a division of Cohen &amp; Company Securities, LLC (&#8220;Cohen&#8221;), generating gross proceeds
of $7,790,000. Of those 779,000 private placement units, the Sponsor purchased 530,000 private placement units and Cohen purchased 249,000
private placement units.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following the closing of the initial public offering and the private
placement, a total of $249,000,000 was placed in the trust account. The proceeds held in the trust account will be invested or held only
in either (i) U.S. government securities with a maturity of 185 days or less or in money market funds meeting certain conditions under
Rule 2a-7 under the Investment Company Act of 1940, as amended (the &#8220;Investment Company Act&#8221;) which invest only in direct
U.S. government treasury obligations, (ii) as uninvested cash, or (iii) an interest or non-interest bearing bank demand deposit account
or other accounts at a bank. We are permitted to withdraw amounts from the trust account (i) to fund our working capital requirements,
which amount will be the lesser of $500,000 or 5% of the interest earned on the trust account per annum, and/or (ii) to pay our taxes
(other than excise taxes, if any), provided that all permitted withdrawals can only be made (x) from interest and not from the principal
held in the trust account and (y) only to the extent such interest is in amount sufficient to cover the permitted withdrawal amount (&#8220;permitted
withdrawals&#8221;). We incurred $14,742,001, consisting of $4,040,000 of cash underwriting fee (net of $700,000 underwriters&#8217; reimbursement),
$10,200,000 of deferred underwriting fee, and $502,001 of other offering costs.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The remaining proceeds from the initial public offering and the private
placement are held outside the trust account, in the cash operating account amounting to $2,872,627 as of December 31, 2025. Such funds
are being used primarily to enable us to identify a target and to negotiate and consummate our initial business combination.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For the period from May 1, 2025 (inception) through December 31, 2025,
cash used in operating activities was $464,952. Net income of $2,625,175 was affected by interest earned on cash held in the trust account
of $3,171,560, cash withdrawn from Trust Account for working capital purposes of $75,921, payment of general and administrative costs
through advances from related party of $10,420 and compensation expense of $74,000. Changes in operating assets and liabilities used $78,908
of cash for operating activities.&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2025, we had cash held in the trust account of $252,095,639
(including approximately $3,171,560 of interest income) consisting of U.S. Treasury Bills with a maturity of 185 days or less. We may
withdraw interest from the trust account as described above. We intend to use substantially all of the funds held in the trust account,
including any amounts representing interest earned on the trust account (which interest shall be net of any permitted withdrawals and
excluding deferred underwriting commissions), to complete our business combination. To the extent that our share capital or debt is used,
in whole or in part, as consideration to complete our business combination, the remaining proceeds held in the trust account will be used
as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
<span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 60; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December 31, 2025, we had cash of $2,872,627. We intend to use
the funds held outside the trust account primarily to identify and evaluate target businesses, perform business due diligence on prospective
target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives
or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete
a business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to fund working capital deficiencies or finance transaction
costs in connection with a business combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are
not obligated to, loan us funds as may be required. If we complete a business combination, we would repay such loaned amounts. In the
event that a business combination does not close, we may use a portion of the working capital held outside the trust account to repay
such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such working capital
loans may be convertible into units of the post-business combination entity at a price of $10.00 per unit. The private placement units
issued upon conversion of any such loans would be identical to the private placement units sold in a private placement concurrently with
the initial public offering.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not believe we will need to raise additional funds in order to
meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking
in-depth due diligence and negotiating a business combination are less than the actual amount necessary to do so, we may have insufficient
funds available to operate our business prior to our business combination. Moreover, we may need to obtain additional financing either
to complete our business combination or because we become obligated to redeem a significant number of our public shares upon consummation
of our business combination, in which case we may issue additional securities or incur debt in connection with such business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Off-Balance Sheet Arrangements</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have no obligations, assets or liabilities, which would be considered
off-balance sheet arrangements as of December 31, 2025.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Contractual Obligations</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not have any long-term debt, capital lease obligations, operating
lease obligations or long-term liabilities, other than an agreement to pay the Sponsor and/or its affiliates $40,000 per month for office
space, secretarial and administrative services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The underwriters were entitled to a cash underwriting discount amounting
to $240,000 which is payable to the underwriters upon the completion of an initial business combination. In addition, the underwriters
were entitled to $0.40 per unit sold in the offering, or up to $9,960,000 in the aggregate, payable to the underwriters based on the percentage
of funds remaining in the trust account after redemptions of public shares, for deferred underwriting commissions, and to be released
to the underwriters only upon the completion of an initial business combination. Furthermore, 50% of such deferred underwriting commissions
will be contingent upon permitted withdrawals of interest, at the lesser of $500,000 or 5% of the interest earned per annum, on the trust
account per annum, for working capital from the trust account.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Critical Accounting Estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preparation of the financial statements and related disclosures
in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported.
Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect
of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in
formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could
materially differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Warrant Instruments</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company accounted for the Public Warrants
and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the
guidance contained in FASB ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Accordingly, the Company evaluated and classified
the warrant instruments under equity treatment at their assigned values.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Stock Compensation Expense</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company accounts for stock-based compensation expense in accordance
with ASC 718, &#8220;Compensation &#8211; Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated
with equity-classified awards is measured at fair value upon the grant date and recognized over the requisite service period. To the extent
a stock-based award is subject to a performance condition, the amount of expense recorded in a given period, if any, reflects an assessment
of the probability of achieving such performance condition, with compensation recognized once the event is deemed probable to occur. Forfeitures
are recognized as incurred (see Note 5 for more discussion about the details). For the period from May 1, 2025 (Inception) through December
31,2025, share-based compensation expenses recognized by the Company were $74,000.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 61; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Recent Accounting Standards</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Management does not believe that any recently issued, but not yet effective,
accounting standards, if currently adopted, would have a material effect on our condensed financial statements.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><span id="a_013" style="display: inline-block;"></span>ITEM 7A. Quantitative and Qualitative Disclosures about Market Risk</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 15.4pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Not required for smaller
reporting companies.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><span id="a_014" style="display: inline-block;"></span>ITEM 8. Financial Statements and Supplementary Data</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This information appears following Item 15 of
this Report and is included herein by reference.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><span id="a_015" style="display: inline-block;"></span>ITEM 9. Changes in and Disagreements with Accountants on Accounting
and Financial Disclosure</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">None.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><span id="a_033" style="display: inline-block;"></span>ITEM 9A. Controls and Procedures.</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: -45.1pt">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Evaluation of Disclosure Controls and Procedures</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Disclosure controls are procedures that are designed
with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed,
summarized, and reported within the time period specified in the SEC&#8217;s rules and forms. Disclosure controls are also designed with
the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer
and chief financial officer, as appropriate to al ow timely decisions regarding required disclosure.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As required by Rules 13a-15 and 15d-15 under the
Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and
operation of our disclosure controls and procedures as of December 31, 2025. Based upon their evaluation, our Chief Executive Officer
and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the
Exchange Act) were effective, Accordingly, management believes that the financial statements included&#8239;in this Annual Report present
fairly in all material respects our financial position, results of operations and cash flows for the period presented.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Management&#8217;s Report on Internal Controls
Over Financial Reporting</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">This Annual Report on Form 10-K does not include
a report of management&#8217;s assessment regarding internal control over financial reporting or an attestation report of our independent
registered public accounting firm due to a transition period established by rules of the SEC for newly public companies.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Changes in Internal Control over Financial Reporting</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">There were no changes in our internal control
over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal
quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 17.85pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_016" style="display: inline-block;"></span>ITEM 9B. OTHER INFORMATION</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Trading Arrangements</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> No director or officer of the Company <ix:nonNumeric name="ecd:Rule10b51ArrAdoptedFlag" contextRef="cref_1363532388" format="ixt:fixed-false" id="ixv-8069"><ix:nonNumeric name="ecd:NonRule10b51ArrAdoptedFlag" contextRef="cref_1363532388" format="ixt:fixed-false" id="ixv-8070">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric name="ecd:Rule10b51ArrTrmntdFlag" contextRef="cref_1363532388" format="ixt:fixed-false" id="ixv-8071"><ix:nonNumeric name="ecd:NonRule10b51ArrTrmntdFlag" contextRef="cref_1363532388" format="ixt:fixed-false" id="ixv-8072">terminated</ix:nonNumeric></ix:nonNumeric> any contract, instruction or written plan for the purchase or sale of securities of the registrant intended to satisfy the affirmative defense conditions of Rule 10b5-1(c); or any &#8220;non-Rule 10b5-1 trading arrangement&#8221; as defined in paragraph (c) of Item 408 of Regulation S-K. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_017" style="display: inline-block;"></span>ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS
THAT PREVENT INSPECTIONS.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Not applicable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><!-- Field: Page; Sequence: 62; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"><span id="a_034" style="display: inline-block;"></span>PART III</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><span id="a_018" style="display: inline-block;"></span>ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND
CORPORATE GOVERNANCE</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">Executive Officers and Directors</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our current directors and executive officers are listed below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: bottom">
<td style="border-bottom: Black 1.5pt solid; width: 31%"><span style="font-size: 10pt"><span style="font-weight: bold;">Name</span></span></td>
<td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt">&#160;</td>
<td style="border-bottom: Black 1.5pt solid; width: 6%; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;">Age</span></span></td>
<td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt">&#160;</td>
<td style="border-bottom: Black 1.5pt solid; width: 61%; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;">Position</span></span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Charles Leykum</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt; text-align: center"><span style="font-size: 10pt">48</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Chairman and Chief Executive Officer</span></td></tr>
<tr style="vertical-align: top">
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Gerald Cimador</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt; text-align: center"><span style="font-size: 10pt">53</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
<tr style="vertical-align: top; background-color: #CCEEFF">
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Shawn Reynolds</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt; text-align: center"><span style="font-size: 10pt">63</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Thomas Simons</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt; text-align: center"><span style="font-size: 10pt">56</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Director</span></td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Charles S.&#160;Leykum</span>&#160;has served as Chairman of our board
of directors and as our Chief Executive Officer since May&#160;1, 2025. Mr.&#160;Leykum founded CSL, an energy services-focused&#160;private
equity firm in 2008, specializing in energy services, power, and infrastructure companies. Prior to founding CSL, Mr.&#160;Leykum was
a Portfolio Manager at Soros Fund Management LLC, where he oversaw investments in the energy sector. Before his time at Soros, he worked
in the Principal Investment Area and the Investment Banking Division of Goldman Sachs&#160;&amp; Co. LLC. From January 2021 to the present,&#160;Mr.&#160;Leykum
also serves as Founder and Chairman of RNWBL, LLC, a leading independent provider of renewable services focusing on wind and solar power,
and has served on the board of directors of Ranger Energy Services, Inc. (NYSE: &#8220;RNGR&#8221;) from August 2017 to November 2024.
Mr.&#160;Leykum was also a co-founder&#160;and sponsor, and served as a director, of Sentinel from June 2017 to December 2023. Mr.&#160;Leykum
graduated with a Bachelor of Arts in Economics from Columbia University and a Master of Business Administration from Harvard Business
School.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Gerald Cimador</span>&#160;has served as our Chief Financial Officer
since May&#160;1, 2025. He currently serves as the Chief Financial Officer and Chief Compliance Officer of CSL.&#160;Since joining CSL
in May&#160;2008, he has overseen all administrative and operational functions, including accounting, reporting, tax, and compliance,
and sits on the firm&#8217;s investment committee. From 1999 to 2008 Mr.&#160;Cimador was Controller of Moore Capital Management LP, a
private investment management firm, where he managed accounting and reporting for the investment manager and its subsidiaries. Prior to
that, from 1997 to 1999, Mr.&#160;Cimador served as Audit Manager of Ernst&#160;&amp; Young LLP.&#160;Mr.&#160;Cimador started his career
as Audit Senior for Goldstein Golub Kessler&#160;&amp; Co. from 1994 to 1997. Mr.&#160;Cimador served on the board of directors of Ranger
Energy Services, Inc. (NYSE: &#8220;RNGR&#8221;) from January 2018 to May 2023. In addition to his role at CSL, Mr.&#160;Cimador served
as Chief Financial Officer and Chief Accounting Officer of Sentinel from June 2017 to December 2023. He has a BBA in Accounting from Hofstra
University.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Shawn Reynolds</span>&#160;serves on our board of directors. Since
2010, Mr.&#160;Reynolds has been the head of public and private resource-related&#160;investment strategies for VanEck, a $200&#160;billion
AUM global asset manager, and currently serves as Portfolio Manager for VanEck&#8217;s Global Resources Fund. Prior to joining VanEck
in 2005, Mr.&#160;Reynolds was an investment banker and equity research analyst for Credit Suisse First Boston, Lehman Brothers, Goldman
Sachs and Petrie Parkman in New York, Melbourne and London. He was an exploration geologist for Sohio in 1985 and Tenneco Oil from 1987
to 1989. Mr.&#160;Reynolds currently serves as a member of the Board of Directors of TAG Oil Ltd. and from 2017 to 2019 was the Vice Chairman
of the Board of Kuwait Energy Company. Currently, Mr.&#160;Reynolds serves as chair of HMH Hospitals Corp., part of the largest health
care network in New Jersey. From 2011 to 2015, Mr.&#160;Reynolds served as the President of the Board of Trustees at the Rumson Country
Day School. Mr.&#160;Reynolds received a Master of Business Administration in Finance from Columbia Business School, a Master of Arts
in Petroleum Geology from the University of Texas, Austin, and a Bachelor of Science in Engineering from Cornell University.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Thomas Simons</span>&#160;serves on our board of directors. Since November
2025, Mr.&#160;Simons has been a senior advisor to Uniquem Chemicals, a private Canadian supplier of oilfield upstream chemicals. From
February 2024 to June 2024, Mr.&#160;Simons served as the CEO and President of Convrg Innovations Inc., an Arc Financial portfolio company.
Since November 2018, Mr.&#160;Simons has been a director at Accelerate Financial Technologies, a provider of Alternative ETF products
on TMX. Mr.&#160;Simons was the founder of CES Energy Solutions, which completed its initial public offering on TMX in March 2006, and
since then has played an instrumental role in the company&#8217;s organic growth and vertical expansion from 2001 to 2021. Mr.&#160;Simons
graduated from Advanced Management Program at Harvard Business School.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"></span></p><!-- Field: Page; Sequence: 63; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Number, Terms of Office and Election of Executive Officers and Directors</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board of Directors will be elected each year at our annual meeting
of shareholders. We may not hold an annual meeting of shareholders until after we consummate our initial business combination (unless
required by Nasdaq).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our executive officers are elected by the Board of Directors and serve
at the discretion of the Board of Directors, rather than for specific terms of office. Our Board of Directors and the holders of our Class&#160;B
ordinary shares are authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association
as it deems appropriate.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Director Independence</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Nasdaq requires that a majority of our board must be composed of &#8220;independent
directors,&#8221; which is defined generally as a person other than an executive officer or employee of the Company or its subsidiaries
or any other individual having a relationship, which, in the opinion of the Company&#8217;s Board of Directors would interfere with the
director&#8217;s exercise of independent judgment in carrying out the responsibilities of a director.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr.&#160;Reynolds and Mr.&#160;Simons are our independent directors.
Our independent directors may have regularly scheduled meetings at which only independent directors are present in certain circumstances.
Any affiliated transactions will be on terms no less favorable to us than could be obtained from independent parties. Any affiliated transactions
must be approved by a majority of our independent and disinterested directors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Executive Officer and Director Compensation</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Commencing on the date that our securities are first listed on Nasdaq
through the earlier of consummation of our initial business combination and our liquidation, we will pay our Sponsor and/or its affiliates,
a monthly fee of $40,000 per month for office space and general and administrative services until the consummation of an initial business
combination. Our Sponsor and the officers and directors shall be entitled to reimbursement from the Company for their out-of-pocket&#160;expenses
incurred and advisory fees shall be paid to the directors and advisors in connection with certain activities on the Company&#8217;s behalf.
This arrangement is being agreed to by an affiliate of our Chairman of our Board of Directors for our benefit and is not intended to provide
such affiliate of our Chairman of our Board of Directors and Chief Executive Officer compensation in lieu of a salary. We believe that
such fees are at least as favorable as we could have obtained from an unaffiliated third party for such services.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Except as set forth above and in this paragraph, no compensation will
be paid to our Sponsor, executive officers and directors, or any of their respective affiliates, prior to or in connection with the consummation
of our initial business combination. Additionally, these individuals will be reimbursed for any&#160;out-of-pocket&#160;expenses incurred
in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business
combinations. Our Board of Directors may also approve the payment of advisory fees to directors in connection with such activities, including
board committee service, and extraordinary administrative and analytical services. Our independent directors will review on a quarterly
basis all payments that were made to our Sponsor, executive officers, directors or our or their affiliates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">After the completion of our initial business combination, members of
our management team who remain with us, may be paid consulting, management or other fees from the combined company with any and all amounts
being fully disclosed to shareholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished
to our shareholders in connection with a proposed business combination. It is unlikely the amount of such compensation will be known at
the time, as it will be up to the directors of the post-combination&#160;business to determine executive and director compensation. Any
compensation to be paid to our officers will be determined, or recommenced, to the Board of Directors for determination, either by a committee
constituted solely of independent directors or by a majority of the independent directors on our Board of Directors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not intend to take any action to ensure that members of our management
team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or
all of our officers and directors may negotiate employment or consulting arrangements to remain with us after the initial business combination.
The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management&#8217;s
motivation in identifying or selecting a target business but we do not believe that the ability of our management to remain with us after
the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business
combination. We are not party to any agreements with our officers and directors that provide for benefits upon termination of employment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Committees of the Board of Directors</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board of Directors has two standing committees: an audit committee
and a compensation committee. Each of our audit committee and our compensation committee is composed solely of independent directors.
Each committee operates under a charter that has been approved by our Board of Directors and has the composition and responsibilities
described below. The charter of each committee will be available on our website following the closing of the initial public offering.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p><!-- Field: Page; Sequence: 64; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Audit Committee</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">We have established an audit committee of the Board of Directors. Mr.&#160;Reynolds
and Mr.&#160;Simons serve as members of our audit committee. Under the Nasdaq listing standards and applicable SEC rules, we are required
to have three members of the audit committee, all of whom must be independent. As allowed under the applicable rules and regulations of
the SEC and Nasdaq, we intend to phase in compliance with the audit committee composition requirements prior to the end of the one-year&#160;transition
period.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">Mr.&#160;Reynolds serves as the chairperson of the audit committee.
Each of Mr.&#160;Reynolds and Mr.&#160;Simons are independent. Each member of the audit committee is financially literate and our Board
of Directors has determined that Mr.&#160;Reynolds qualifies as an &#8220;audit committee financial expert&#8221; as defined in applicable
SEC rules.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">We have adopted an audit committee charter, which details the purpose
and principal functions of the audit committee, including:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">assisting the Board of Directors in the oversight of (1)&#160;the
accounting and financial reporting processes of the Company and the audits of the financial statements of the Company, (2)&#160;the preparation
and integrity of the financial statements of the Company, (3)&#160;the compliance by the Company with financial statement and regulatory
requirements, (4)&#160;the performance of the Company&#8217;s internal finance and accounting personnel and its independent registered
public accounting firms, and (5)&#160;the qualifications and independence of the Company&#8217;s independent registered public accounting
firms;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing with each of the internal and independent registered
public accounting firms the overall scope and plans for audits, including authority and organizational reporting lines and adequacy of
staffing and compensation;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and discussing with management and internal auditors
the Company&#8217;s system of internal control and discussing with the independent registered public accounting firm any significant
matters regarding internal controls over financial reporting that have come to its attention during the conduct of its audit;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and discussing with management, internal auditors
and the independent registered public accounting firm the Company&#8217;s financial and critical accounting practices, and policies relating
to risk assessment and management;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">receiving and reviewing reports of the independent registered
public accounting firm and discussing (1) all critical accounting policies and practices to be used in the firm&#8217;s audit of the
Company&#8217;s financial statements, (2) all alternative treatments of financial information within GAAP that have been discussed with
management, ramifications of the use of such alternative disclosures and treatments, and the treatment preferred by the independent registered
public accounting firm, and (3) other material written communications between the independent registered public accounting firm and management,
such as any management letter or schedule of unadjusted differences;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and discussing with management and the independent
registered public accounting firm the annual and quarterly financial statements and section entitled &#8220;<i>Management&#8217;s Discussion
and Analysis of Financial Condition and Results of Operations</i>&#8221; of the Company prior to the filing of the Company&#8217;s Annual
Report on Form&#160;10-K&#160;and Quarterly Reports on Form&#160;10-Q;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing, or establishing, standards for the type of information
and the type of presentation of such information to be included in, earnings press releases and earnings guidance provided to analysts
and rating agencies;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">discussing with management and the independent registered
public accounting firm any changes in the Company&#8217;s critical accounting principles and the effects of alternative GAAP methods,&#160;off-balance&#160;sheet
structures and regulatory and accounting initiatives;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing material pending legal proceedings involving the
Company and other contingent liabilities;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">meeting periodically with the Chief Executive Officer, Chief
Financial Officer, the senior internal auditing executive and the independent registered public accounting firm in separate executive
sessions to discuss results of examinations;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and approving all transactions between the Company
and related parties or affiliates of the officers of the Company requiring disclosure under Item&#160;404 of Regulation&#160;S-K&#160;prior
to the Company entering into such transactions;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">establishing procedures for the receipt, retention and treatment
of complaints received by the Company regarding accounting, internal accounting controls or auditing matters, and the confidential, anonymous
submissions by employees or contractors of concerns regarding questionable accounting or accounting matters;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing periodically with the Company&#8217;s management,
independent registered public accounting firm and outside legal counsel (i)&#160;legal and regulatory matters which may have a material
effect on the financial statements, and (ii)&#160;corporate compliance policies or codes of conduct, including any correspondence with
regulators or government agencies and any employee complaints or published reports that raise material issues regarding the Company&#8217;s
financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial
Accounting Standards Board, the SEC or other regulatory authorities; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">establishing policies for the hiring of employees and former
employees of the independent registered public accounting firm.</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><i></i></p><!-- Field: Page; Sequence: 65; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>&#160;</i></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Compensation Committee</i></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">We have established a compensation committee of the Board of Directors.
The members of our compensation committee are Mr.&#160;Reynolds and Mr.&#160;Simons. Mr.&#160;Simons serves as the chairman of the compensation
committee. We have adopted a compensation committee charter, which will detail the purpose and responsibility of the compensation committee,
including:</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing the performance of the Chief Executive Officer and
executive management;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">assisting the Board of Directors in developing and evaluating
potential candidates for executive positions (including Chief Executive Officer);</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and approving goals and objectives relevant to the
Chief Executive Officer and other executive officer compensation, evaluating the Chief Executive Officer&#8217;s and other executive
officers&#8217; performance in light of these corporate goals and objectives, and setting the Chief Executive Officer and other executive
officer compensation levels consistent with its evaluation and the company philosophy;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">approving the salaries, bonus and other compensation for all
executive officers;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and approving compensation packages for new corporate
officers and termination packages for corporate officers as requested by management;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and discussing with the Board of Directors and senior
officers plans for officer development and corporate succession plans for the Chief Executive Officer and other senior officers;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and making recommendations concerning executive
compensation policies and plans;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and recommending to the Board of Directors the adoption
of or changes to the compensation of the Company&#8217;s directors;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and approving the awards made under any executive
officer bonus plan, and providing an appropriate report to the Board of Directors;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing and making recommendations concerning long-term&#160;incentive
compensation plans, including the use of stock options and other equity-based&#160;plans, and, except as otherwise delegated by the Board
of Directors, acting as the &#8220;Plan Administrator&#8221; for equity-based&#160;and employee benefit plans;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">approving all special perquisites, special cash payments and
other special compensation and benefit arrangements for the Company&#8217;s executive officers and employees;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">reviewing periodic reports from management on matters relating
to the Company&#8217;s personnel appointments and practices;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">assisting management in complying with the Company&#8217;s
proxy statement and annual report disclosure requirements;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">issuing an annual Report of the Compensation Committee on
Executive Compensation for the Company&#8217;s annual proxy statement in compliance with applicable SEC rules and regulations;</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">annually evaluating the committee&#8217;s performance and
the committee&#8217;s charter and recommending to the Board of Directors any proposed changes to the charter or the committee; and</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">undertaking all further actions and discharge all further
responsibilities imposed upon the compensation committee from time to time by the Board of Directors, the federal securities laws or
the rules and regulations of the SEC.</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The charter also provides that the compensation committee may, in its
sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other adviser and will be directly
responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice
from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence
of each such adviser, including the factors required by Nasdaq and the SEC.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"></span></p><!-- Field: Page; Sequence: 66; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Director Nominations</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not have a standing nominating committee though we intend to
form a corporate governance and nominating committee as and when required to do so by law or Nasdaq rules. In accordance with Rule&#160;5605
of the Nasdaq rules, a majority of the independent directors may recommend a director nominee for selection by the Board of Directors.
The Board of Directors believes that the independent directors can satisfactorily carry out the responsibility of properly selecting or
approving director nominees without the formation of a standing nominating committee. The directors who will participate in the consideration
and recommendation of director nominees are Mr.&#160;Reynolds, Mr.&#160;Simons and an additional independent director to be appointed
following our initial public offering. In accordance with Rule&#160;5605 of the Nasdaq rules, all such directors are independent. As there
is no standing nominating committee, we do not have a nominating committee charter in place.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to our initial business combination, the Board of Directors will
also consider director candidates recommended for nomination by holders of our founder shares during such times as they are seeking proposed
nominees to stand for appointment at an annual general meeting (or, if applicable, an extraordinary general meeting). Prior to our initial
business combination, holders of our public shares will not have the right to recommend director candidates for nomination to our board.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have not formally established any specific, minimum qualifications
that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director,
the Board of Directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional
reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Code of Conduct and Ethics</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We have adopted a code of conduct and ethics applicable
to our directors, officers and employees in accordance with applicable federal securities laws. We will file a copy of our form of Code
of Business Conduct and our board committee charters as exhibits to the registration statement. You will be able to review these documents
by accessing our public filings at the SEC&#8217;s web site at<i>&#160;www.sec.gov</i>. In addition, a copy of the Code of Business Conduct
will be provided without charge upon request from us. We intend to disclose any amendments to or waivers of certain provisions of our
Code of Business Conduct in a Current Report on Form&#160;8-K.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Conflicts of Interest</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Under Cayman Islands law, directors and officers owe the following
fiduciary duties:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">duty to act in good faith in what the director or officer
believes to be in the best interests of the company as a whole;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">duty to exercise powers for the purposes for which those
powers were conferred and not for a collateral purpose;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">directors should not improperly fetter the exercise of future
discretion;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">duty to exercise powers fairly as between different sections
of shareholders;</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">duty not to put themselves in a position in which there is
a conflict between their duty to the company and their personal interests; and</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">duty to exercise independent judgment.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In addition to the above, directors also owe a duty of care which is
not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge,
skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in
relation to the company and the general knowledge skill and experience which that director has.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">As set out above, directors have a duty not to put themselves in a
position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position. However,
in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders provided
that there is full disclosure by the directors. This can be done by way of permission granted in the amended and restated memorandum and
articles of association or alternatively by shareholder approval at general meetings.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 67; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, each of our officers and directors presently has, and
any of them in the future may have additional, fiduciary, contractual or other obligations or duties to one or more other entities pursuant
to which such officer or director is or will be required to present a business combination opportunity to such entities. Accordingly,
if any of our officers or directors becomes aware of a business combination opportunity which is suitable for one or more entities to
which he or she has fiduciary, contractual or other obligations or duties, he or she will honor these obligations and duties to present
such business combination opportunity to such entities first, and only present it to us if such entities reject the opportunity and he
or she determines to present the opportunity to us (including as described in &#8220;<i>Business&#160;&#8212;&#160;Initial Business Combination</i>&#8221;).
These conflicts may not be resolved in our favor and a potential target business may be presented to another entity prior to its presentation
to us.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our amended and restated memorandum and articles of association provides
that, to the fullest extent permitted by law: (i)&#160;no individual serving as a director or an officer, among other persons, shall have
any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same or similar
business activities or lines of business as us, and (ii)&#160;we renounce any interest or expectancy in, or in being offered an opportunity
to participate in, any potential transaction or matter which (a)&#160;may be a corporate opportunity for any director or officer, on the
one hand, and us, on the other or (b)&#160;the presentation of which would breach an existing legal obligation of a director or officer
to any other entity. As a result, the fiduciary duties or contractual obligations of our officers or directors could materially affect
our ability to complete our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Sponsor, officers and directors may participate in the formation
of, or become an officer or director of, any other blank check company prior to completion of our initial business combination. As a result,
our Sponsor, officers or directors could have conflicts of interest in determining whether to present business combination opportunities
to us or to any other blank check company with which they may become involved. Investors should be aware of the following potential conflicts
of interest:</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">None of our officers and directors is required to commit
their full time to our affairs and, accordingly, they may have conflicts of interest in allocating their time among various business
activities.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">In the course of their other business activities, our Sponsor,
officers and directors may become aware of investment and business opportunities which may be appropriate for presentation to our company
as well as the other entities with which they are affiliated. However, our officers and directors have agreed to present to us all suitable
target business opportunities, subject to any fiduciary or contractual obligations.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Each of the holders of the founder shares and private placement
units has agreed that his, her or its founder shares and private placement shares, as applicable, will be subject to transfer restrictions
and that he, she or it will not sell or transfer such shares until the applicable forfeiture provisions no longer apply. Holders of founder
shares and private placement shares have agreed to waive their redemption rights with respect to their founder shares and private placement
shares, as applicable, (i)&#160;in connection with the consummation of a business combination, (ii)&#160;in connection with a shareholder
vote to amend our amended and restated memorandum and articles of association to modify the substance or timing of our obligation to
redeem 100% of our public shares if we do not complete our initial business combination within the completion window (excluding any exercise
of the underwriters&#8217; over-allotment&#160;option) and (iii)&#160;if we fail to consummate a business combination within the completion
window or if we liquidate prior to the expiration of the completion window. Our Sponsor, officers and directors have also agreed to waive
their redemption rights with respect to public shares in connection with the consummation of a business combination and in connection
with a shareholder vote to amend our amended and restated memorandum and articles of association to modify the substance or timing of
our obligation to redeem 100% of our public shares if we do not complete our initial business combination within the completion window.
However, our Sponsor, officers and directors will be entitled to redemption rights with respect to any public shares held by them if
we fail to consummate a business combination or liquidate within the completion window. To the extent our holders of founder shares or
private placement shares transfer any of these securities to certain permitted transferees, such permitted transferees will agree, as
a condition to such transfer, to waive these same redemption rights. If we do not complete our initial business combination within the
completion window, the portion of the proceeds of the sale of the private placement units placed into the trust account will be used
to fund the redemption of our public shares. There will be no redemption rights or liquidating distributions with respect to our founder
shares, private placement shares or private placement warrants, which may become worthless if we do not consummate an initial business
combination within the completion window (excluding any exercise of the underwriter&#8217;s over-allotment&#160;option). Except as described
under &#8220;Principal Shareholders&#160;&#8212;&#160;Transfers of Founder Shares and Placement Units&#8221;, the founder shares, private
placement units and their underlying securities will not be transferable, assignable or salable.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Our officers and directors may have a conflict of interest
with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included
by a target business as a condition to any agreement with respect to our initial business combination.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Members of our management team and our independent directors
may directly or indirectly own founder shares, private placement shares and/or private placement warrants following the initial public
offering and, accordingly, may have a conflict of interest in determining whether a particular target business is an appropriate business
with which to effectuate our initial business combination.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">In the event our Sponsor or members of our management team
provide loans to us to finance transaction costs and/or incur expenses on our behalf in connection with an initial business combination,
such persons may have a conflict of interest in determining whether a particular target business is an appropriate business with which
to effectuate our initial business combination as such loans may not be repaid and/or such expenses may not be reimbursed unless we consummate
such business combination.</td>
</tr></tbody></table><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt"></p><!-- Field: Page; Sequence: 68; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: left; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">We are not prohibited from pursuing an initial business combination
with a company that is affiliated with our Sponsor, officers or directors, or completing the business combination through a joint venture
or other form of shared ownership with our Sponsor, officers or directors; accordingly, such affiliated person(s)&#160;may have a conflict
of interest in determining whether a particular target business is an appropriate business with which to effectuate our initial business
combination as such affiliated person(s)&#160;would have interests different from our public shareholders and would likely not receive
any financial benefit unless we consummated such business combination.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Our Sponsor, officers and directors may participate in the
formation of, or become an officer or director of, any other blank check company prior to completion of our initial business combination.
As a result, our Sponsor, officers or directors could have conflicts of interest in determining whether to present business combination
opportunities to us or to any other blank check company with which they may become involved. Although we have no formal policy in place
for vetting potential conflicts of interest, our Board of Directors will review any potential conflicts of interest on a case-by-case&#160;basis.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">Unless we consummate our initial business combination, our
executive officers, directors and Sponsor will not receive reimbursement for any&#160;out-of-pocket&#160;expenses incurred by them to
the extent that such expenses exceed the amount of available proceeds not deposited in the trust account.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0 0pt 48pt; text-indent: -24pt">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: left">The founder shares, private placement shares and private
placement warrants (and underlying securities) will be released from their respective&#160;lock-up&#160;restrictions only if a business
combination is successfully completed, and the private placement warrants will expire worthless if a business combination is not consummated.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">For the foregoing reasons, our Board of Directors may have a conflict
of interest in determining whether a particular target business is appropriate to effect a business combination with the Company.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accordingly, as a result of multiple business affiliations, our officers
and directors may have similar legal obligations relating to presenting business opportunities meeting the above-listed&#160;criteria
to multiple entities. In addition, conflicts of interest may arise when our Board of Directors evaluates a particular business opportunity
with respect to the above-listed&#160;criteria. We cannot assure you that any of the above-mentioned&#160;conflicts will be resolved in
our favor.</p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Below is a table summarizing the entities to which our officers and
directors currently have fiduciary duties or contractual obligations:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: bottom">
<td style="border-bottom: Black 1.5pt solid; width: 18%"><span style="font-size: 10pt"><span style="font-weight: bold;">Individual<sup>(1)</sup></span></span></td>
<td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt">&#160;</td>
<td style="border-bottom: Black 1.5pt solid; width: 47%; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;">Entity</span></span></td>
<td style="white-space: nowrap; width: 1%; padding-bottom: 1.5pt">&#160;</td>
<td style="border-bottom: Black 1.5pt solid; width: 33%; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;">Affiliation</span></span></td></tr>
<tr style="vertical-align: top">
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Charles Leykum</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">CSL Capital Management, LP</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Founder and CEO</span></td></tr>
<tr style="vertical-align: top">
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Gerald Cimador</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">CSL Capital Management, LP</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Chief Financial Officer and Chief Compliance Officer</span></td></tr>
<tr style="vertical-align: top">
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Shawn Reynolds</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">VanEck</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Portfolio Manager</span></td></tr>
<tr style="vertical-align: top">
<td style="padding-bottom: 2.25pt">&#160;</td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">TAG Oil Ltd.</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Director</span></td></tr>
<tr style="vertical-align: top">
<td style="padding-bottom: 2.25pt">&#160;</td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">HMH Hospitals Corp.</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Chairman</span></td></tr>
<tr style="vertical-align: top">
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Thomas Simons</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Uniquem Chemicals</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Senior Advisor</span></td></tr>
<tr style="vertical-align: top">
<td style="padding-bottom: 2.25pt">&#160;</td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Accelerate Financial Technologies</span></td>
<td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
<td style="padding-bottom: 2.25pt"><span style="font-size: 10pt">Director</span></td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we submit our initial business combination to our public shareholders
for a vote, our initial shareholders have agreed to vote any shares held by them in favor of our initial business combination. In addition,
they have agreed to waive their respective rights to participate in any liquidation distribution with respect to their founder shares
and private placement shares. If they purchase Class&#160;A ordinary shares as part of the initial public offering or in the open market,
however, they would be entitled to participate in any liquidation distribution in respect of such shares but have agreed not to convert
or sell such shares to us in connection with the consummation of an initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All ongoing and future transactions between us and any of our Sponsor,
executive officers and directors or their respective affiliates will be on terms believed by us to be no less favorable to us than are
available from unaffiliated third parties. Such transactions will require prior approval by a majority of our uninterested &#8220;independent&#8221;
directors or the members of our Board of Directors who do not have an interest in the transaction, in either case who had access, at our
expense, to our attorneys or independent legal counsel. We will not enter into any such transaction unless our disinterested &#8220;independent&#8221;
directors determine that the terms of such transaction are no less favorable to us than those that would be available to us with respect
to such a transaction from unaffiliated third parties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p><!-- Field: Page; Sequence: 69; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">Section 16(a) Beneficial Ownership Reporting
Compliance</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Section 16(a) of the Securities
Exchange Act of 1934, as amended, requires our officers, directors and persons who beneficially own more than ten percent of our common
stock to file reports of ownership and changes in ownership with the SEC. These reporting persons are also required to furnish us with
copies of all Section 16(a) forms they file. Based solely upon a review of such forms, we believe that for the year ended December 31,
2025, all Section 16(a) filing requirements applicable to our officers, directors and greater than 10% beneficial owners were complied
with.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><span id="a_019" style="display: inline-block;"></span>ITEM 11. EXECUTIVE COMPENSATION</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">Executive Officer and Director Compensation</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">None of our officers or directors
has received any cash compensation for services rendered to us. On August 19, 2025, our Sponsor transferred 20,000 founder shares to each
of our independent director nominees at a purchase price of approximately $0.003 per share. We may pay finder&#8217;s and consulting fees
to our initial shareholders or any of their respective affiliates for services rendered prior to or in connection with the completion
of our initial business combination. In addition, our officers, directors, or any of their respective affiliates will be reimbursed for
any out-of-pocket&#160;expenses incurred in connection with activities on our behalf such as identifying potential target businesses and
performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were
made to our initial shareholders or their affiliates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">After the completion of our
initial business combination, directors or members of our management team who remain with us may be paid consulting or management fees
from the combined company. All of these fees will be fully disclosed to shareholders, to the extent then known, in the tender offer materials
or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination. We have not established
any limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely
the amount of such compensation will be known at the time of the proposed business combination, because the directors of the post-combination&#160;business
will be responsible for determining officer and director compensation. Any compensation to be paid to our officers will be determined,
or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors
or by a majority of the independent directors on our board of directors.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Following a business combination,
to the extent we deem it necessary, we may seek to recruit additional managers to supplement the incumbent management team of the target
business. We cannot assure you that we will have the ability to recruit additional managers, or that additional managers will have the
requisite skills, knowledge or experience necessary to enhance the incumbent management.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">Clawback Policy</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On September 10, 2025, our
board of directors adopted a clawback policy (the &#8220;Clawback Policy&#8221;) permitting the Company to seek the recovery of incentive
compensation received by any of the Company&#8217;s current and former executive officers (as determined by the board in accordance with
Section 10D of the Exchange Act and Nasdaq rules) and such other senior executives/employees who may from time to time be deemed subject
to the Clawback Policy by the board (collectively, the &#8220;Covered Executives&#8221;). The amount to be recovered will be the excess
of the incentive compensation paid to the Covered Executive based on the erroneous data over the incentive compensation that would have
been paid to the Covered Executive had it been based on the restated results, as determined by the board. If the board cannot determine
the amount of excess incentive compensation received by the Covered Executive directly from the information in the accounting restatement,
then it will make its determination based on a reasonable estimate of the effect of the accounting restatement. Refer to Exhibit 97.1
of this Annual Report for the Company&#8217;s Clawback Policy.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_020" style="display: inline-block;"></span>ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The
following table sets forth information regarding the beneficial ownership of our ordinary shares as of the date of this Annual Report,
and as adjusted to reflect the sale of our ordinary shares included in the units offered by this Annual Report, and assuming no purchase
of units in the Initial Public Offering, by:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr>
<td style="text-align: left; width: 0.25in">
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p></td>
<td style="vertical-align: top; width: 0.25in; text-align: left">&#9679;</td>
<td style="vertical-align: top; text-align: left"><span style="font-size: 10pt">each person known by us to be the beneficial owner of more than 5% of our outstanding ordinary shares;</span></td></tr>
</tbody></table><p style="text-align: left; margin: 0 0 0 0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr>
<td style="text-align: left; width: 0.25in">&#160;</td>
<td style="vertical-align: top; text-align: left; width: 0.25in">&#9679;</td>
<td style="vertical-align: top; text-align: left"><span style="font-size: 10pt">each of our executive officers and directors; and</span></td></tr>
</tbody></table><p style="text-align: left; margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr>
<td style="text-align: left; width: 0.25in">&#160;</td>
<td style="vertical-align: top; text-align: left; width: 0.25in">&#9679;</td>
<td style="vertical-align: top; text-align: left"><span style="font-size: 10pt">all our executive officers and directors as a group.</span></td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"></p><!-- Field: Page; Sequence: 70; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left; background-color: white">Unless
otherwise indicated, we believe that all persons named in the table have sole voting and investment power with respect to all ordinary
shares beneficially owned by them.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tbody><tr style="vertical-align: bottom">
<td style="border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">Name and Address
of Beneficial Owner<sup>(1)</sup></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
<td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Class A<br/> Ordinary<br/> Shares<br/> Beneficially<br/> Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
<td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Approximate<br/> Percentage&#160;of<br/>
    Outstanding<br/> Class A<br/> Ordinary<br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
<td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<br/> Class B<br/> Ordinary<br/> Shares<br/> Beneficially<br/> Owned</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
<td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Approximate<br/> Percentage&#160;of<br/> Outstanding<br/> Class B<br/> Ordinary<br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
<td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Approximate<br/> Percentage&#160;of<br/> Outstanding<br/> Ordinary<br/> Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 38%; text-align: left">Talon Capital Sponsor LLC</td><td style="width: 1%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">530,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">2.1</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">8,260,000</td><td style="padding-bottom: 5.4pt; width: 3%; text-align: left"><sup>(2)&#160;(3)</sup></td><td style="width: 1%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">99.5</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%">&#160;</td>
<td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">24.3</td><td style="width: 1%; text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td><span style="font-size: 10pt">Charles Leykum<sup>(2)</sup></span></td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
<td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">-</td><td style="font-style: italic; text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td><span style="font-size: 10pt">Gerald Cimador<sup>(3)</sup></span></td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td style="font-style: italic">&#160;</td>
<td style="font-style: italic; text-align: left">&#160;</td><td style="font-style: italic; text-align: right">-</td><td style="font-style: italic; text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: justify">Shawn Reynolds</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Thomas Simons</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">*</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-style: italic; text-align: left; text-indent: -9pt; padding-left: 9pt">All officers and directors as a group (four individuals)</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">2.1</td><td style="text-align: left">%</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">8,300,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">100</td><td style="text-align: left">%</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">24.4</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold; text-align: left; text-indent: -9pt; padding-left: 9pt">Other 5% Shareholders</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font-size: 10pt">T. Rowe Price Associates, Inc.<sup>(4)</sup></span></td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">2,256,811</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">8.8</td><td style="text-align: left">%</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">6.6</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left"><span style="font-size: 10pt">LMR Partners LLP<sup>(5)</sup></span></td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">1,500,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">5.8</td><td style="text-align: left">%</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">4.4</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left"><span style="font-size: 10pt">Adage Capital Management, L.P.<sup>(6)</sup></span></td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">2,025,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">7.9</td><td style="text-align: left">%</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">6.0</td><td style="text-align: left">%</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left"><span style="font-size: 10pt">Linden Capital L.P.<sup>(7)</sup></span></td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">1,426,356</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">5.6</td><td style="text-align: left">%</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">4.2</td><td style="text-align: left">%</td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: left"><span style="font-size: 10pt">Indicates less than 1%.</span></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: left"><span style="font-size: 10pt">Unless otherwise noted, the
business address of each of the following entities or individuals is c/o Talon Capital Corp., 440 Louisiana Street, Suite 1050, Houston,
Texas 77002.</span></td>
</tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; width: 4%"><span style="font-size: 10pt">(2)</span></td>
<td style="text-align: left"><span style="font-size: 10pt">Represents securities held by Talon Capital Sponsor LLC, our Sponsor, of which Mr. Leykum is the sole managing member.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; width: 0.25in"><span style="font-size: 10pt">(3)</span></td>
<td style="text-align: left"><span style="font-size: 10pt">Does not include certain shares indirectly owned by Mr. Cimador as a result of his ownership interest in our Sponsor.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left"><span style="font-size: 10pt">(4)</span></td>
<td style="text-align: left"><span style="font-size: 10pt">Based on a Schedule 13G filed on November 14, 2025, by T. Rowe Price Associates, Inc., a Maryland corporation. The address of principal business office of the reporting persons is 1307 Point Street, Baltimore, MD 21231.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left"><span style="font-size: 10pt">(5)</span></td>
<td style="text-align: left"><span style="font-size: 10pt">Based on a Schedule 13G filed on November 14, 2025, by (i) LMR Partners LLP, LMR Partners Limited, LMR Partners LLC, LMR Partners AG, LMR Partners (DIFC) Limited and LMR Partners (Ireland) Limited (collectively, the &#8220;LMR Investment Managers&#8221;),; and (ii) Ben Levine and Stefan Renold, who are ultimately in control of the investment and voting decisions of the LMR Investment Managers with respect to the securities held by certain funds. The address of principal business office of the each of the reporting persons is c/o LMR Partners LLP, 9th Floor, Devonshire House, 1 Mayfair Place, London, W1J 8AJ, United Kingdom.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left"><span style="font-size: 10pt">(6)</span></td>
<td style="text-align: left"><span style="font-size: 10pt">Based on a Schedule 13G filed on November 13, 2025, by (i) Adage Capital Management, L.P., a Delaware limited partnership (&#8220;ACM&#8221;), as the investment manager of Adage Capital Partners, L.P., a Delaware limited partnership (&#8220;ACP&#8221;), with respect to the Class A ordinary shares, par value $0.0001 per share (&#8220;Class A Ordinary Shares&#8221;) of Talon Capital Corp., a Cayman Islands exempted company (the &#8220;Company&#8221;) directly held by ACP; (ii) Robert Atchinson (&#8220;Mr. Atchinson&#8221;), as (1) managing member of Adage Capital Advisors, L.L.C., a limited liability company organized under the laws of the State of Delaware (&#8220;ACA&#8221;), managing member of Adage Capital Partners GP, L.L.C., a limited liability company organized under the laws of the State of Delaware (&#8220;ACPGP&#8221;), general partner of ACP and (2) managing member of Adage Capital Partners LLC, a Delaware limited liability company (&#8220;ACPLLC&#8221;), general partner of ACM, with respect to the Class A Ordinary Shares directly held by ACP; and (iii) Phillip Gross (&#8220;Mr. Gross&#8221;), as (1) managing member of ACA, managing member of ACPGP and (2) managing member of ACPLLC, general partner of ACM, with respect to the Class A Ordinary Shares directly held by ACP. The address of principal business office of the each of the reporting persons is 200 Clarendon Street, 52nd Floor, Boston, Massachusetts 02116.</span></td></tr>
</tbody></table><p style="margin: 0">&#160;</p><p style="margin: 0"></p><!-- Field: Page; Sequence: 71; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="margin: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(7)</span></td><td style="text-align: left"><span style="font-size: 10pt">Based on a Schedule 13G filed
on November 13, 2025, by i) Linden Capital L.P., a Bermuda limited partnership (&#8220;Linden Capital&#8221;); ii) Linden GP LLC, a Delaware
limited liability company (&#8220;Linden GP&#8221;); iii) Linden Advisors LP, a Delaware limited partnership (&#8220;Linden Advisors&#8221;);
and iv) Siu Min (Joe) Wong (&#8220;Mr. Wong&#8221;). The principal business address for Linden Capital is Victoria Place, 31 Victoria Street,
Hamilton HM10, Bermuda. Linden Capital is a Bermuda limited partnership. Linden GP is a Delaware limited liability company. Linden Advisors
is a Delaware limited partnership. Mr. Wong is a citizen of China (Hong Kong) and the United States.The principal business address for
each of Linden Advisors, Linden GP and Mr. Wong is 590 Madison Avenue, 32nd Floor, New York, New York 10022.</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Because of our initial shareholders&#8217;
ownership block, our initial shareholders may be able to effectively influence the outcome of all matters requiring approval by our shareholders,
including the election of directors, amendments to our amended and restated memorandum and articles of association and approval of significant
corporate transactions, including approval of our initial business combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Our initial shareholders have
agreed (A)&#160;to vote any shares owned by them in favor of any proposed business combination (subject to applicable securities laws)
provided that in connection with any proposed business combination, our initial shareholders will not vote any ordinary shares that they
purchase after we publicly announce our intention to engage in such proposed business combination, (B)&#160;not to redeem any shares owned
by them in connection with a shareholder vote to approve a proposed initial business combination or amendment to our amended and restated
memorandum and articles of association prior thereto and (C)&#160;to waive liquidation rights with respect to their founder shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Our Sponsor and its controlling
individuals and our executive officers are deemed to be our &#8220;promoters&#8221; as such term is defined under the federal securities
laws.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_021" style="display: inline-block;"></span>ITEM 13. CERTAIN RELATIONSHIPS AND RELATED
TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Certain Relationships and Related Transactions</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">On May&#160;19, 2025, our Sponsor
purchased 5,750,000 Class&#160;B ordinary shares from us for an aggregate purchase price of $25,000, or approximately $0.004 per share.
On August&#160;8, 2025, the Company effected a 1 for 1.5&#160;share split of the founder shares resulting in our Sponsor holding an aggregate
of 8,625,000 founder shares. On August&#160;19, 2025, our Sponsor transferred 20,000 founder shares to each of our independent directors
at a purchase price of approximately $0.003 per share. In connection with the initial public offering, 325,000 founder shares were forfeited
by our Sponsor. As a result, our Sponsor currently holds 8,260,000 founder shares and each of our independent directors holds 20,000 founder
shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Our Sponsor, officers and directors,
or any of their respective affiliates, will be reimbursed for any&#160;out-of-pocket&#160;expenses incurred in connection with activities
on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our Board
of Directors may also approve the payment of advisory fees to directors in connection with such activities, including board committee
service and extraordinary administrative and analytical services. Our audit committee will review on a quarterly basis all payments that
were made to our Sponsor, officers, directors or our or any of their affiliates and will determine which expenses and the amount of expenses
that will be reimbursed. There is no cap or ceiling on the reimbursement of&#160;out-of-pocket&#160;expenses incurred by such persons
in connection with activities on our behalf.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Pursuant to a registration
rights agreement we entered into an agreement with each of our initial shareholders on or prior to the closing of the initial public offering,
we are required to register certain securities for sale under the Securities Act. These holders, and the holders of warrants issued upon
conversion of working capital loans, if any, are entitled under the registration rights agreement to make up to three demands that we
register certain of our securities held by them under the Securities Act and to have the securities covered thereby registered for resale
pursuant to Rule&#160;415 under the Securities Act. In addition, these holders have the right to include their securities in any other
registration statement filed by us. However, the registration rights agreement provides that we will not permit any registration statement
filed under the Securities Act to become effective until the securities covered thereby are released from their respective&#160;lock-up&#160;restrictions,
as described herein. We will bear the costs and expenses of filing any such registration statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Our Sponsor has purchased 530,000
private placement units at $10.00 per unit, and the representative has purchased an aggregate of 249,000 private placement units at a
price of $10.00 per unit. These purchases took place on a private placement basis simultaneously with the consummation of the initial
public offering and the over-allotment&#160;option, as applicable. The foregoing purchases were made by our Sponsor and the representative
in accordance with Regulation&#160;M and Sections 9(a)(2)&#160;and 10(b)&#160;and Rule&#160;10b-5&#160;of the Exchange&#160;Act. A portion
of the proceeds we received from the purchase of the private placement units were placed in the trust account described below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p><!-- Field: Page; Sequence: 72; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Except with respect to certain
permitted transferees, our initial shareholders have agreed not to transfer, assign or sell any of their respective founder shares, private
placement shares, private placement warrants or any securities underlying the private placement warrants that they may hold until the
date that is (i)&#160;in the case of the founder shares, the earlier of (A)&#160;180&#160;days after the date of the consummation of our
initial business combination or (B)&#160;subsequent to our initial business combination, (x)&#160;the date on which the last sale price
of our public shares equals or exceeds $11.50 per share (as adjusted for share splits, dividends, reorganizations, recapitalizations and
the like) for any 20&#160;trading days within any&#160;30-trading&#160;day period commencing after our initial business combination, or
(y)&#160;the date on which we consummate a liquidation, merger, share exchange or other similar transaction after our initial business
combination which results in all of our shareholders having the right to exchange their public shares for cash, securities or other property,
and (ii)&#160;in the case of the private placement shares, private placement warrants or any securities underlying the private placement
warrants, until 30&#160;days after the completion of our initial business combination. Permitted transferees would be subject to the same
restrictions and other agreements of our initial shareholders with respect to any such securities.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">In order to finance transaction
costs in connection with an intended initial business combination, our Sponsor, executive officers, directors, or their affiliates may,
but are not obligated to, loan us funds as may be required. If we consummate our initial business combination, we would repay such loaned
amounts. In the event that the initial business combination does not close, we may use a portion of the offering proceeds held outside
the trust account to repay such loaned amounts but no proceeds from our trust account would be used to repay such loaned amounts. Up to
$1,500,000 of such loans may be convertible into additional units of the post-business&#160;combination entity at a price of $10.00 per
unit at the option of the lender. The units would be identical to the private placement units. The terms of such loans by our officers
and directors, if any, have not been determined and no written agreements exist with respect to such loans.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">The holders of our founder
shares and private placement shares, as well as the holders of the private placement warrants, our Sponsor, officers, directors or their
affiliates may be issued in payment of working capital loans made to us (and all underlying securities), will be entitled to registration
rights pursuant to an agreement to be signed prior to or on the effective date of the initial public offering. The holders of a majority
of these securities are entitled to make up to three demands that we register such securities. The holders of a majority of these securities
or units issued in payment of working capital loans made to us (or underlying securities) can elect to exercise these registration rights
at any time after we consummate a business combination. In addition, the holders have certain &#8220;piggy-back&#8221; registration rights
with respect to registration statements filed subsequent to our consummation of a business combination. Notwithstanding anything to the
contrary, the representative may only make a demand on one occasion and only during the five-year&#160;period beginning on the effective
date of the registration statement. In addition, the representative may participate in a &#8220;piggy-back&#8221; registration only during
the seven-year&#160;period beginning on the effective date of the registration statement. We will bear the expenses incurred in connection
with the filing of any such registration statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">On September 8, 2025, the Company entered into an administrative services agreement with the Sponsor, in connection with the Company&#8217;s
Initial Public Offering. On September 16, 2025, the Company and the Sponsor entered into the Amended Agreement, to add that the Sponsor
or its affiliates may make available to the Company certain office space, utilities and secretarial support as may be required by the
Company from time to time.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Other than the foregoing and
as described in this paragraph, no compensation or fees of any kind, including finder&#8217;s, consulting fees and other similar fees,
will be paid to our Sponsor, members of our management team or their respective affiliates, for services rendered prior to or in connection
with the consummation of our initial business combination (regardless of the type of transaction that it is). However, such individuals
will receive the repayment of any loans from our Sponsor, officers and directors for working capital purposes and reimbursement for any&#160;out-of-pocket&#160;expenses
incurred by them in connection with activities on our behalf, such as identifying potential target businesses, performing business due
diligence on suitable target businesses and business combinations as well as traveling to and from the offices, plants or similar locations
of prospective target businesses to examine their operations. Our Board of Directors may also approve the payment of advisory fees for
such activities, including board committee service, and extraordinary administrative and analytical services. There is no limit on the
amount of&#160;out-of-pocket&#160;expenses reimbursable by us. Our independent directors will review on a quarterly basis all payments
that were made to our Sponsor, executive officers or our or their affiliates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">After our initial business
combination, members of our management team who remain with us may be paid consulting, management or other fees from the combined company
with any and all amounts being fully disclosed to shareholders, to the extent then known, in the proxy solicitation materials furnished
to our shareholders. It is unlikely the amount of such compensation will be known at the time of a shareholder meeting held to consider
an initial business combination, as it will be up to the directors of the post-combination&#160;business to determine executive and director
compensation. In this event, such compensation will be publicly disclosed at the time of its determination in a Current Report on Form&#160;8-K,&#160;as
required by the SEC.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p><!-- Field: Page; Sequence: 73; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">All ongoing and future transactions
between us and any of our officers and directors or their respective affiliates will be on terms believed by us to be no less favorable
to us than are available from unaffiliated third parties. Such transactions will require prior approval by a majority of our uninterested
&#8220;independent&#8221; directors or the members of our Board of Directors who do not have an interest in the transaction, in either
case who had access, at our expense, to our attorneys or independent legal counsel. We will not enter into any such transaction unless
our disinterested &#8220;independent&#8221; directors determine that the terms of such transaction are no less favorable to us than those
that would be available to us with respect to such a transaction from unaffiliated third parties.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-weight: bold;">Sponsor Ownership</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Our Sponsor is a U.S.-based&#160;limited
liability company formed for the purpose of acting as the sponsor in connection with the initial public offering and the Sponsor conducts
no other business. Charles Leykum, our Chairman and Chief Executive Officer, is the sole managing member of Talon Capital Holdings LLC,
which is the sole managing member of our Sponsor. Accordingly, all shares held by our Sponsor may be deemed to be beneficially owned by
Mr.&#160;Leykum. Mr.&#160;Leykum indirectly owns approximately 75.9% of the membership interests in our Sponsor, which includes an indirect
interest in approximately 74.3% of the founder shares and 100% of the private placement units. Other than Mr.&#160;Leykum, no other person
has a direct or indirect material interest in our Sponsor. On August&#160;19, 2025, our Sponsor transferred 20,000 founder shares to each
of our independent directors at a purchase price of approximately $0.003 per share. In addition, Mr.&#160;Reynolds holds membership interests
in our Sponsor representing 20,000 founder shares. Certain passive, non-managing&#160;entities hold membership interests in our Sponsor,
including an affiliate of Mr.&#160;Reynolds, which holds membership interests representing 100,000 founder shares. None of the non-managing&#160;members
of our Sponsor have any rights to control our Sponsor or to vote or dispose of any securities held by our Sponsor.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><span style="font-weight: bold;">Related Party Policy</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Our Code of Business Conduct
requires us to avoid, wherever possible, all related party transactions that could result in actual or potential conflicts of interests,
except under guidelines approved by the Board of Directors (or the audit committee). Related party transactions are defined as transactions
in which (1)&#160;the aggregate amount involved will or may be expected to exceed $120,000 in any calendar year, (2)&#160;we or any of
our subsidiaries is a participant, and (3)&#160;any (a)&#160;executive officer, director or nominee for election as a director, (b)&#160;greater
than 5% beneficial owner of our shares, or (c)&#160;immediate family member, of the persons referred to in clauses (a)&#160;and (b), has
or will have a direct or indirect material interest (other than solely as a result of being a director or a less than 10% beneficial owner
of another entity). A conflict of interest situation can arise when a person takes actions or has interests that may make it difficult
to perform his or her work objectively and effectively. Conflicts of interest may also arise if a person, or a member of his or her family,
receives improper personal benefits as a result of his or her position.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Our audit committee, pursuant
to its written charter, will be responsible for reviewing and approving related party transactions to the extent we enter into such transactions.
The audit committee will consider all relevant factors when determining whether to approve a related party transaction, including whether
the related party transaction is on terms no less favorable to us than terms generally available from an unaffiliated third party under
the same or similar circumstances and the extent of the related party&#8217;s interest in the transaction. No director may participate
in the approval of any transaction in which he is a related party, and that director is required to provide the audit committee with all
material information concerning the transaction. We also require each of our directors and executive officers to complete a directors&#8217;
and officers&#8217; questionnaire that elicits information about related party transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">These procedures are intended
to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the
part of a director, employee or officer.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 24pt">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">To further minimize conflicts
of interest, we have agreed not to consummate an initial business combination with an entity that is affiliated with any of our Sponsor,
officers or directors, including (i)&#160;an entity that is either a portfolio company of, or has otherwise received a material financial
investment from, any private equity fund or investment company (or an affiliate thereof) that is affiliated with any of the foregoing,
(ii)&#160;an entity in which any of the foregoing or their affiliates are currently passive investors, (iii)&#160;an entity in which any
of the foregoing or their affiliates are currently officers or directors, or (iv)&#160;an entity in which any of the foregoing or their
affiliates are currently invested through an investment vehicle controlled by them, unless we have obtained an opinion from an independent
investment banking firm, or another independent entity that commonly renders valuation opinions on the type of target business we are
seeking to acquire, and the approval of a majority of our disinterested independent directors that the business combination is fair to
our unaffiliated shareholders from a financial point of view.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"></span></p><!-- Field: Page; Sequence: 74; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">Director Independence</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">NASDAQ listing standards
require that a majority of our board of directors be independent, subject to certain phase-in&#160;provisions. An &#8220;independent director&#8221;
is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a
relationship which in the opinion of the company&#8217;s board of directors, would interfere with the director&#8217;s exercise of independent
judgment in carrying out the responsibilities of a director. Our board of directors has determined that each of Mr.&#160;Reynolds and Mr.&#160;Simons are &#8220;independent directors&#8221; as defined in the NASDAQ listing standards and applicable SEC rules.
Our independent directors will have regularly scheduled meetings at which only independent directors are present.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><span id="a_022" style="display: inline-block;"></span>ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The firm of WithumSmith+Brown, PC, or Withum,
acts as our independent registered public accounting firm. The following is a summary of fees paid to Withum for services rendered.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Audit Fees</i>. During the period from May
1, 2025 (inception) through December 31, 2025, fees for our independent registered public accounting firm were approximately $98,800 for
the services Withum performed in connection with our Initial Public Offering and the audit of our December 31, 2025 financial statements
included in this Annual Report on Form 10-K.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Audit-Related Fees.</i> During the period from
May 1, 2025 (inception) through December 31, 2025, our independent registered public accounting firm did not render assurance and related
services related to the performance of the audit or review of financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Tax Fees</i>. During the period from May 1,
2025 (inception) through December 31, 2025, our independent registered public accounting firm did not render services to us for tax compliance,
tax advice and tax planning.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>All Other Fees</i>. During the period from
May 1, 2025 (inception) through December 31, 2025, there were no fees billed for products and services provided by our independent registered
public accounting firm other than those set forth above.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Pre-Approval Policy</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Our audit committee was formed upon the consummation
of our Initial Public Offering. As a result, the audit committee did not pre-approve all of the foregoing services, although any services
rendered prior to the formation of our audit committee were approved by our board of directors. Since the formation of our audit committee,
and on a going-forward basis, the audit committee has and will pre-approve all auditing services and permitted non-audit services to be
performed for us by our auditors, including the fees and terms thereof (subject to the de minimis exceptions for non-audit services described
in the Exchange Act which are approved by the audit committee prior to the completion of the audit).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><!-- Field: Page; Sequence: 75; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><span style="font-weight: bold;"><span id="a_023" style="display: inline-block;"></span>PART IV</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><span id="a_024" style="display: inline-block;"></span>ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td style="width: 0.25in; text-align: justify"><span style="font-size: 10pt">(a)</span></td>
<td style="text-align: justify"><span style="font-size: 10pt">The following documents are filed as part of this Form 10-K:</span></td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Financial Statements:</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td style="text-indent: -0.125in; padding-left: 0.125in; width: 90%">&#160;</td>
<td style="width: 1%">&#160;</td>
<td style="width: 9%; border-bottom: black 1.5pt solid; text-align: center">Page</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_027">Report of Independent Registered Public Accounting Firm</a></td>
<td>&#160;</td>
<td style="text-align: center">F-2</td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_028">Balance Sheet as of December 31, 2025</a></td>
<td>&#160;</td>
<td style="text-align: center">F-3</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_029">Statement of Operations for the period from May 1, 2025 (Inception) through December 31, 2025</a></td>
<td>&#160;</td>
<td style="text-align: center">F-4</td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_030">Statement of Changes in Shareholders&#8217; Deficit for the period from May 1, 2025 (Inception) through December 31, 2025</a></td>
<td>&#160;</td>
<td style="text-align: center">F-5</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_031">Statement of Cash Flows for the period from May 1, 2025 (Inception) through December 31, 2025</a></td>
<td>&#160;</td>
<td style="text-align: center">F-6</td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_032">Notes to Financial Statements</a></td>
<td>&#160;</td>
<td style="text-align: center">F-7</td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Financial Statement Schedules:</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">None.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">(3)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Exhibits</span></td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We hereby file as part of this Report the exhibits
listed in the attached Exhibit Index. Exhibits which are incorporated herein by reference can be inspected and copied at the public reference
facilities maintained by the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549. Copies of such material can also be obtained
from the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549, at prescribed rates or on the SEC website at
www.sec.gov.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><!-- Field: Page; Sequence: 76; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">The following documents are
included as exhibits to this Annual Report:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: bottom">
<td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; text-align: justify; width: 9%"><span style="font-size: 10pt"><span style="font-weight: bold;">Exhibit&#160;No.</span></span></td>
<td style="padding-bottom: 1.5pt; text-align: justify; width: 1%">&#160;</td>
<td style="border-bottom: Black 1.5pt solid; text-align: left; width: 90%"><span style="font-size: 10pt"><span style="font-weight: bold;">Description</span></span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">3.1<sup>(1)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025087276/ea025690003ex3-1_talon.htm"><span style="font-size: 10pt">Amended and Restated Memorandum and Articles of Association of the Company</span></a></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">4.1<sup>(2)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025077602/ea024608902ex4-1_talon.htm">Specimen Unit Certificate.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">4.2<sup>(2)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025077602/ea024608902ex4-2_talon.htm">Specimen Class A Ordinary Share Certificate.</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">4.3<sup>(2)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025077602/ea024608902ex4-3_talon.htm">Specimen Warrant Certificate.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">4.5*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="ea028027801ex4-5.htm">Description of Securities of the Registrant</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">10.1<sup>(1)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2073340/000121390025087276/ea025690003ex10-2_talon.htm">Investment Management Trust Agreement, dated September 8, 2025, between the Company and Odyssey Transfer and Trust Company.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">10.2<sup>(1)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/2073340/000121390025087276/ea025690003ex10-4_talon.htm">Private Placement Units Purchase Agreement, dated September 8, 2025, between the Company and Talon Capital Sponsor LLC</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">10.3<sup>(1)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025087276/ea025690003ex10-5_talon.htm">Private Placement Unit Purchase Agreement, dated September 8, 2025, between the Company and Cohen and Company Capital Markets, a division of Cohen &amp; Company Securities, LLC.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">10.4<sup>(1)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025087276/ea025690003ex10-3_talon.htm">Registration Rights Agreement, dated September 8, 2025, among the Company and certain securityholders.</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">10.5<sup>(1)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025087276/ea025690003ex10-6_talon.htm">Administrative Services Agreement, dated September 8, 2025, between the Company and Talon Capital Sponsor LLC.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">10.6<sup>(3)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025088251/ea025733001ex10-1_talon.htm">Amended and Restated Administrative Services Agreement, dated September 16, 2025.</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">10.7<sup>(1)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025087276/ea025690003ex10-1_talon.htm">Insider Letter Agreement, dated September 8, 2025, among the Company, its directors and officers and Talon Capital Sponsor LLC.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">10.8<sup>(1)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025077602/ea024608902ex10-6_talon.htm">Form of Indemnity Agreement.</a></span><span style="font-size: 10pt">&#160;</span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">10.9<sup>(1)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/2073340/000121390025087276/ea025690003ex1-1_talon.htm">Underwriting Agreement, dated September 8, 2025, between the Company and Cohen and Company Capital Markets, a division of Cohen &amp; Company Securities, LLC.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">19.1*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="ea028027801ex19-1.htm">Insider Trading Policy</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">31.1*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="ea028027801ex31-1.htm">Certification of Chief Executive Officer (Principal Executive Officer) required by Rule&#160;13a-14(a)&#160;or Rule&#160;15d-14(a).</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">31.2*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="ea028027801ex31-2.htm">Certification of Chief Financial Officer (Principal Financial and Accounting Officer) required by Rule&#160;13a-14(a)&#160;or Rule&#160;15d-14(a).</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">32.1**</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="ea028027801ex32-1.htm">Certification of Chief Executive Officer required by Rule&#160;13a-14(b)&#160;or Rule&#160;15d-14(b)&#160;and 18 U.S.C. 1350.</a></span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">32.2**</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt"><a href="ea028027801ex32-2.htm">Certification of Chief Financial Officer required by Rule&#160;13a-14(b)&#160;or Rule&#160;15d-14(b)&#160;and 18 U.S.C. 1350.</a></span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">97.1<sup>(2)</sup></span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><a href="https://www.sec.gov/Archives/edgar/data/2073340/000121390025077602/ea024608902ex99-6_talon.htm"><span style="font-size: 10pt">Clawback Policy</span></a></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">101.INS*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt">XBRL Instance Document</span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">101.SCH*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt">XBRL Taxonomy Extension Schema</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">101.CAL*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt">XBRL Taxonomy Calculation Linkbase</span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">101.LAB*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt">XBRL Taxonomy Label Document</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">101.PRE*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt">XBRL Definition Linkbase Document</span></td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-align: justify"><span style="font-size: 10pt">101.DEF*</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt">XBRL Definition Linkbase Document</span></td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-align: justify"><span style="font-size: 10pt">104</span></td>
<td style="text-align: justify">&#160;</td>
<td style="text-align: left"><span style="font-size: 10pt">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></td></tr>
</tbody></table><p style="margin-top: 0; margin-bottom: 0">&#160;</p><!-- Field: Rule-Page --><div style="width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><p style="margin-top: 0; margin-bottom: 0"></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Filed herewith.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: justify">&#160;</td></tr>
</tbody></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">**</td><td style="text-align: left">Furnished herewith.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: left">Incorporated by reference to an exhibit to the Registrant&#8217;s
Current Report on Form 8-K, filed with the Securities and Exchange Commission on September 12, 2025.</td>
</tr></tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: -0.25in">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tbody><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: left">Incorporated by reference to an exhibit to the Registrant&#8217;s
Form&#160;S-1 (File No.&#160;333-289674), filed with the SEC on August 15, 2025, as amended.</td>
</tr><tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: top; text-align: justify">
<td style="text-align: left">(3)</td><td style="text-align: left"> Incorporated by reference to an exhibit to the Registrant&#8217;s Current Report on Form 8-K, filed with the Securities and Exchange
Commission on September 16, 2025.</td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;">&#160;&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-weight: bold;"><span id="a_025" style="display: inline-block;"></span>ITEM 16. FORM 10-K SUMMARY</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">None</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p><!-- Field: Page; Sequence: 77; Value: 1 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">TALON CAPITAL CORP.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">INDEX TO FINANCIAL STATEMENTS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td style="text-indent: -0.125in; padding-left: 0.125in; width: 90%">&#160;</td>
<td style="width: 1%">&#160;</td>
<td style="width: 9%; border-bottom: black 1.5pt solid; text-align: center">Page</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_027">Report of Independent Registered Public Accounting Firm (PCAOB ID: 100)</a></td>
<td>&#160;</td>
<td style="text-align: center">F-2</td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">Financial Statements:</td>
<td>&#160;</td>
<td style="text-align: center">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_028">Balance Sheet as of December 31, 2025</a></td>
<td>&#160;</td>
<td style="text-align: center">F-3</td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_029">Statement of Operations for the period from May 1, 2025 (Inception) through December 31, 2025</a></td>
<td>&#160;</td>
<td style="text-align: center">F-4</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_030">Statement of Changes in Shareholders&#8217; Deficit for the period from May 1, 2025 (Inception) through December 31, 2025</a></td>
<td>&#160;</td>
<td style="text-align: center">F-5</td></tr>
<tr style="vertical-align: top; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_031">Statement of Cash Flows for the period from May 1, 2025 (Inception) through December 31, 2025</a></td>
<td>&#160;</td>
<td style="text-align: center">F-6</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
<td style="text-indent: -0.125in; padding-left: 0.125in"><a href="#a_032">Notes to Financial Statements</a></td>
<td>&#160;</td>
<td style="text-align: center">F-7 to F-15</td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 78; Options: NewSection; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-transform: uppercase"><span style="font-weight: bold;"><span id="a_027" style="display: inline-block;"></span>Report of Independent Registered Public Accounting Firm</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="text-transform: uppercase"><span style="font-weight: bold;">&#160;</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">To the Shareholders and the Board of Directors of</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Talon Capital Corp.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><ix:nonNumeric name="dei:AuditorOpinionTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-5187"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Opinion on the Financial Statements</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We have audited the accompanying balance sheet of Talon Capital Corp. (the &#8220;Company&#8221;) as of December 31, 2025, the related statements of operations, changes in shareholders&#8217; deficit and cash flows for the period from May 1, 2025 (inception) through December 31, 2025, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the period from May 1, 2025 (inception) through December 31, 2025 in conformity with accounting principles generally accepted in the United States of America.</p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Basis for Opinion</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#8220;PCAOB&#8221;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> /s/ <ix:nonNumeric name="dei:AuditorName" contextRef="cref_1363532388" id="ixv-8073">WithumSmith+Brown, PC</ix:nonNumeric> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We have served as the Company&#8217;s auditor since 2025.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> <ix:nonNumeric name="dei:AuditorLocation" contextRef="cref_1363532388" id="ixv-8074">New York, New York</ix:nonNumeric> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">March 27, 2026</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> PCAOB ID Number <ix:nonNumeric name="dei:AuditorFirmId" contextRef="cref_1363532388" id="ixv-8075">100</ix:nonNumeric> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><!-- Field: Page; Sequence: 79; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"><span id="a_028" style="display: inline-block;"></span>TALON CAPITAL CORP.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">BALANCE SHEET</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">DECEMBER 31, 2025</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tbody><tr style="vertical-align: bottom">
<td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Assets:</td><td>&#160;</td>
<td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-indent: -0.125in; padding-left: 0.125in">Current assets</td><td>&#160;</td>
<td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 88%">Cash</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8076">2,872,627</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Prepaid expenses</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherPrepaidExpenseCurrent" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8077">3,443</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Prepaid insurance</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidInsurance" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8078">77,500</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total current assets</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8079">2,953,570</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Long-term prepaid insurance</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseOtherNoncurrent" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8080">51,667</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Cash held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8081">252,095,639</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Assets</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8082">255,100,876</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Current liabilities</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accounts payable and accrued expenses</td><td>&#160;</td><td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8083">53,702</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accrued offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="tlnc:AccruedOfferingCosts" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8084">75,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Total current liabilities</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8085">128,702</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Deferred underwriting fee</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="tlnc:DeferredUnderwritingFeeNoncurrent" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8086">10,200,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Liabilities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8087">10,328,702</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Commitments (Note 6)</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1417777316">&#160;</span></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in">Class A ordinary shares subject to possible redemption, $<ix:nonFraction name="us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital" contextRef="cref_1997855338" unitRef="uref_144417410" scale="0" decimals="4" format="ixt:num-dot-decimal" id="ixv-8088">0.0001</ix:nonFraction> par value; <ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="cref_1997855338" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8089">24,900,000</ix:nonFraction> shares at redemption value of $<ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="cref_1997855338" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8090">10.12</ix:nonFraction> per share</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="cref_1997855338" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8091">252,012,982</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Shareholders&#8217; Deficit</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in">Preference shares, $<ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="cref_1598680374" unitRef="uref_533780696" scale="0" decimals="4" format="ixt:num-dot-decimal" id="ixv-8092">0.0001</ix:nonFraction> par value; <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="cref_1598680374" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8093">1,000,000</ix:nonFraction> shares authorized; <span style="-sec-ix-hidden:fc_1674121332"><span style="-sec-ix-hidden:fc_2010543561">no</span></span> shares issued or outstanding</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_889220744">&#8212;</span></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Class A ordinary shares, $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="cref_1997855338" unitRef="uref_533780696" scale="0" decimals="4" format="ixt:num-dot-decimal" id="ixv-8094">0.0001</ix:nonFraction> par value; <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="cref_1997855338" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8095">200,000,000</ix:nonFraction> shares authorized; <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="cref_1997855338" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8096"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="cref_1997855338" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8097">779,000</ix:nonFraction></ix:nonFraction> shares issued and outstanding (excluding 24,900,000 shares subject to possible redemption)</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="cref_1997855338" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8098">78</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"><span style="font-size: 10pt">Class B ordinary shares, $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" id="fc_683422140" contextRef="cref_504548813" unitRef="uref_533780696" scale="0" decimals="4" format="ixt:num-dot-decimal">0.0001</ix:nonFraction> par value; <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" id="fc_2078487242" contextRef="cref_504548813" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">20,000,000</ix:nonFraction> shares authorized; <ix:nonFraction name="us-gaap:CommonStockSharesIssued" id="fc_727457337" contextRef="cref_504548813" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" id="fc_711145113" contextRef="cref_504548813" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">8,300,000</ix:nonFraction></ix:nonFraction> shares issued and outstanding<sup>(1)(2)</sup></span></td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" id="fc_201246941" contextRef="cref_504548813" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal">830</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Additional paid-in capital</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1663220068">&#8212;</span></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated deficit</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8104">7,241,716</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1.5pt">Total Shareholders&#8217; Deficit</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8105">7,240,808</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8106">255,100,876</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td> </tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tbody><tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">(1)</span></td> <td style="text-align: left"><span style="font-size: 10pt"><ix:footnote id="fref_373772643" xml:lang="en-US">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional <ix:nonFraction name="tlnc:NumberOfAdditionalFounderShareIssued" contextRef="cref_551854395" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8108">2,875,000</ix:nonFraction> founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate <ix:nonFraction name="tlnc:NumberOfFounderShareIssued" contextRef="cref_551854395" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8109"><ix:nonFraction name="tlnc:NumberOfFounderShareOutstanding" contextRef="cref_551854395" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8110">8,625,000</ix:nonFraction></ix:nonFraction> founder shares issued and outstanding (Note 5).</ix:footnote></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-size: 10pt">(2)</span></td> <td style="text-align: left"><span style="font-size: 10pt"><ix:footnote id="fref_194607409" xml:lang="en-US">Includes <ix:nonFraction name="tlnc:NumberOfSharesSubjectToForfeiture" contextRef="cref_504548813" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8112">1,125,000</ix:nonFraction> Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, <ix:nonFraction name="tlnc:NumberOfShareSubjectNotToForfeiture" contextRef="cref_880262097" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8113">800,000</ix:nonFraction> founder shares are no longer subject to forfeiture and <ix:nonFraction name="tlnc:NumberOfSharesSubjectToForfeiture" contextRef="cref_880262097" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8114">325,000</ix:nonFraction> founder shares were forfeited, resulting in the Sponsor holding <ix:nonFraction name="tlnc:NumberOfFounderSharesHolding" contextRef="cref_553879265" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8115">8,260,000</ix:nonFraction> founder shares (after taking into account the assignment of <ix:nonFraction name="tlnc:NumberOfFounderSharesHolding" contextRef="cref_1797476635" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8116">40,000</ix:nonFraction> founder shares to the directors) (Note 5).</ix:footnote></span></td></tr> </tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><!-- Field: Page; Sequence: 80; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"><span id="a_029" style="display: inline-block;"></span>TALON CAPITAL CORP.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">STATEMENT OF OPERATIONS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tbody><tr style="vertical-align: bottom">
<td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
<td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For&#160;the<br/>
    Period&#160;from<br/> May&#160;1, 2025<br/> (Inception)<br/> Through<br/> December&#160;31,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left; padding-bottom: 1.5pt">General and administrative costs</td><td style="width: 1%; padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 9%; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8117">546,385</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Loss from operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8118">546,385</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Other income:</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Interest earned on cash held in Trust Account</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8119">3,171,560</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other income, net</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8120">3,171,560</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Net income</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8121">2,625,175</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average shares outstanding, Class A ordinary shares</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="cref_198494574" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8122"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="cref_198494574" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8123">11,787,082</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted net income per share, Class A ordinary shares</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="cref_198494574" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8124"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="cref_198494574" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8125">0.13</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-size: 10pt">Basic and diluted weighted average shares outstanding, Class B ordinary shares <sup>(1)</sup></span></td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" id="fc_388358174" contextRef="cref_1115681054" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" id="fc_1591609912" contextRef="cref_1115681054" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">7,867,213</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Basic and diluted net income per share, Class B ordinary shares</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="cref_1115681054" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8128"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="cref_1115681054" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8129">0.13</ix:nonFraction></ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td> </tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tbody><tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">(1)</span></td> <td style="text-align: left"><span style="font-size: 10pt"><ix:footnote id="fref_1220979658" xml:lang="en-US">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional <ix:nonFraction name="tlnc:NumberOfAdditionalFounderSharesIssued" contextRef="cref_1408966713" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8131">2,875,000</ix:nonFraction> founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate <ix:nonFraction name="tlnc:NumberOfFounderSharesOutstanding" contextRef="cref_1408966713" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8132"><ix:nonFraction name="tlnc:NumberOfFounderSharesIssued" contextRef="cref_1408966713" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8133">8,625,000</ix:nonFraction></ix:nonFraction> founder shares issued and outstanding. All share and per share amounts have been retroactively presented (Note 5).</ix:footnote></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-size: 10pt">(2)</span></td> <td style="text-align: left"><span style="font-size: 10pt">Excluded <ix:nonFraction name="tlnc:NumberOfShareSubjectToForfeiture" contextRef="cref_194733324" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8134">1,125,000</ix:nonFraction> Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, <ix:nonFraction name="tlnc:NumberOfSharesSubjectNotToForfeiture" contextRef="cref_1878519263" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8135">800,000</ix:nonFraction> founder shares are no longer subject to forfeiture and <ix:nonFraction name="tlnc:NumberOfShareSubjectToForfeiture" contextRef="cref_1878519263" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8136">325,000</ix:nonFraction> founder shares were forfeited, resulting in the Sponsor holding <ix:nonFraction name="tlnc:NumberOfFounderShareHolding" contextRef="cref_837726882" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8137">8,260,000</ix:nonFraction> founder shares (after taking into account the assignment of <ix:nonFraction name="tlnc:NumberOfFounderShareHolding" contextRef="cref_1174554270" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8138">40,000</ix:nonFraction> founder shares to the directors) (Note 5).</span></td></tr> </tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><!-- Field: Page; Sequence: 81; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"><span id="a_030" style="display: inline-block;"></span>TALON CAPITAL CORP.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">STATEMENT OF CHANGES IN SHAREHOLDERS&#8217;
DEFICIT</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">FOR THE PERIOD FROM MAY 1, 2025 (INCEPTION)
THROUGH DECEMBER 31, 2025</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tbody><tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class A<br/> Ordinary Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class B<br/> Ordinary Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="font-weight: bold; text-align: center">Additional<br/> Paid-in</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="font-weight: bold; text-align: center">Accumulated</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="font-weight: bold; text-align: center">Total<br/> Shareholders&#8217;</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-size: 10pt"><span style="font-weight: bold;">Shares&#160;<sup>(1)&#160;(2)</sup></span></span></td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Amount</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Capital</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
<td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deficit</td><td style="font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold">Balance &#8212; May 1, 2025 (inception)</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_901612146">&#8212;</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden:fc_2017060097">&#8212;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1432657015">&#8212;</span></td><td style="text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden:fc_1059445731">&#8212;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden:fc_1401430648">&#8212;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden:fc_2094209686">&#8212;</span></td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold; text-align: left">$</td><td style="font-weight: bold; text-align: right"><span style="-sec-ix-hidden:fc_1062287955">&#8212;</span></td><td style="font-weight: bold; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 30%; text-align: left">Class B ordinary shares issued to Sponsor</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden:fc_1492816628">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden:fc_1690999302">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" id="fc_2135791975" contextRef="cref_1134712074" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">8,625,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="cref_1134712074" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8140">863</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="cref_1598084499" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8141">24,137</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><span style="-sec-ix-hidden:fc_897486254">&#8212;</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 7%; text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8142">25,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Sale of <ix:nonFraction name="tlnc:SaleOfStockNumberOfSharesIssued" id="fc_1814512358" contextRef="cref_144417410" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">779,000</ix:nonFraction> Private Placement Units</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="tlnc:StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits" contextRef="cref_619454683" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8144">779,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" contextRef="cref_619454683" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8145">78</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_75135273">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_200090691">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" contextRef="cref_1598084499" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8146">7,789,922</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1848862879">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8147">7,790,000</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fair value of Public Warrants at issuance</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1017008916">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1590491764">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="cref_1598084499" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8148">1,817,700</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1229468603">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8149">1,817,700</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Allocated value of transaction costs to Class A non-redeemable shares</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1965622921">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_854596447">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="cref_1598084499" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8150">122,734</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1007521328">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8151">122,734</ix:nonFraction></td><td style="text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in">Forfeiture of founder shares</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_471349154">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_54547320">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" id="fc_1780571263" contextRef="cref_1134712074" unitRef="uref_504548813" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal">325,000</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="cref_1134712074" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8153">33</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" contextRef="cref_1598084499" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8154">33</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1992560591">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1390649182">&#8212;</span></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Fair value of founder Shares assigned to directors</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_2094758649">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_1230420796">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" contextRef="cref_1598084499" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8155">74,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_131382469">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8156">74,000</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Accretion for Class A ordinary shares to redemption amount</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_855132543">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><span style="-sec-ix-hidden:fc_424924864">&#8212;</span></td><td style="text-align: left">&#160;</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="cref_1598084499" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8157">9,583,058</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="cref_773573791" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8158">9,866,891</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValue" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8159">19,449,949</ix:nonFraction></td><td style="text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left; padding-bottom: 1.5pt">Net income</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden:fc_563129179">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden:fc_1964059568">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden:fc_1865024795">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="cref_773573791" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8160">2,625,175</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8161">2,625,175</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-indent: -0.125in; padding-left: 0.125in">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; padding-bottom: 2.5pt">Balance &#8211; December 31, 2025</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="cref_630293842" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8162">779,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_630293842" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8163">78</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" id="fc_678866056" contextRef="cref_826432462" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">8,300,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_826432462" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8165">830</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><span style="-sec-ix-hidden:fc_1009755242">&#8212;</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_748934610" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8166">7,241,716</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8167">7,240,808</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</td> </tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"></span>&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tbody><tr style="vertical-align: top"> <td style="width: 0.25in"><span style="font-size: 10pt">(1)</span></td> <td style="text-align: left"><span style="font-size: 10pt"><ix:footnote id="fref_1829989901" xml:lang="en-US">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional <ix:nonFraction name="tlnc:NumberOfAdditionalFounderShareIssued" id="fc_422495093" contextRef="cref_551854395" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">2,875,000</ix:nonFraction> founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate <ix:nonFraction name="tlnc:NumberOfFounderShareIssued" id="fc_1406517433" contextRef="cref_551854395" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal"><ix:nonFraction name="tlnc:NumberOfFounderShareOutstanding" id="fc_551854395" contextRef="cref_551854395" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">8,625,000</ix:nonFraction></ix:nonFraction> founder shares issued and outstanding. All share and per share amounts have been retroactively presented (Note 5).</ix:footnote></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: left">&#160;</td> <td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: top"> <td style="text-align: left"><span style="font-size: 10pt">(2)</span></td> <td style="text-align: left"><span style="font-size: 10pt"><ix:footnote id="fref_1339534370" xml:lang="en-US">Includes <ix:nonFraction name="tlnc:NumberOfSharesSubjectToForfeiture" id="fc_88804847" contextRef="cref_504548813" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">1,125,000</ix:nonFraction> Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, <ix:nonFraction name="tlnc:NumberOfShareSubjectNotToForfeiture" id="fc_22075095" contextRef="cref_880262097" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">800,000</ix:nonFraction> founder shares are no longer subject to forfeiture and <ix:nonFraction name="tlnc:NumberOfSharesSubjectToForfeiture" id="fc_1235998977" contextRef="cref_880262097" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">325,000</ix:nonFraction> founder shares were forfeited, resulting in the Sponsor holding <ix:nonFraction name="tlnc:NumberOfFounderSharesHolding" id="fc_553879265" contextRef="cref_553879265" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal">8,260,000</ix:nonFraction> founder shares (after taking into account the assignment of <ix:nonFraction name="tlnc:NumberOfFounderSharesHolding" contextRef="cref_1797476635" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8177">40,000</ix:nonFraction> founder shares to the directors) (Note 5).</ix:footnote></span></td></tr> </tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><!-- Field: Page; Sequence: 82; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"><span id="a_031" style="display: inline-block;"></span>TALON CAPITAL CORP.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">STATEMENT OF CASH FLOWS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">FOR THE PERIOD FROM MAY 1, 2025 (INCEPTION)
THROUGH DECEMBER 31, 2025</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;">&#160;</span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tbody><tr style="vertical-align: bottom">
<td style="font-weight: bold">Cash Flows from Operating Activities:</td><td>&#160;</td>
<td colspan="2">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Net income</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8178">2,625,175</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Adjustments to reconcile net income to net cash used in operating activities:</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Payment of general and administrative costs through advances from related party</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="tlnc:PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8179">10,420</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest earned on cash held in Trust Account</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8180">3,171,560</ix:nonFraction></td><td style="text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash withdrawn from Trust Account for working capital purposes</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="tlnc:CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8181">75,921</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Compensation expense</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ShareBasedCompensation" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8182">74,000</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Changes in operating assets and liabilities:</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpensesOther" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8183">80,943</ix:nonFraction></td><td style="text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Long-term prepaid insurance</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidInsurance" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8184">51,667</ix:nonFraction></td><td style="text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Accounts payable and accrued expenses</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8185">53,702</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8186">464,952</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold; text-align: left">Cash Flows from Investing Activities:</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Investment of cash in Trust Account</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsToAcquireTrustPreferredInvestments" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8187">249,000,000</ix:nonFraction></td><td style="text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8188">249,000,000</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: White">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold; text-align: left">Cash Flows from Financing Activities:</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Proceeds from issuance of Class B ordinary shares to Sponsor</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8189">25,000</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Proceeds from sale of Units, net of underwriting discounts paid</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromOtherEquity" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8190">244,260,000</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Proceeds from sale of Private Placement Units</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8191">7,790,000</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Underwriters&#8217; reimbursement</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="tlnc:ProceedsFromSaleOfUnderwritersReimbursement" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8192">700,000</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Repayment of advances from related party</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8193">39,936</ix:nonFraction></td><td style="text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Proceeds from promissory note - related party</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8194">83,927</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Repayment of promissory note - related party</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8195">83,927</ix:nonFraction></td><td style="text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Payment of offering costs</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfStockIssuanceCosts" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8196">397,485</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">)</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt">Net cash provided by financing activities</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8197">252,337,579</ix:nonFraction></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Net Change in Cash</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8198">2,872,627</ix:nonFraction></td><td style="font-weight: bold; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Cash &#8211; Beginning of period</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden:fc_764535795">&#8212;</span></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt">Cash &#8211; End of period</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8199">2,872,627</ix:nonFraction></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>&#160;</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">Non-cash investing and financing activities:</td><td>&#160;</td>
<td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Offering costs included in accrued offering costs</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="tlnc:DeferredOfferingCostsIncludedInAccruedOfferingCosts" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8200">75,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred offering costs paid through advances from related party</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="tlnc:DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8201">29,516</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred underwriting fee payable</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="tlnc:DeferredUnderwritingFeePayable" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8202">10,200,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr>
<tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Forfeiture of founder shares</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="tlnc:ForfeitureOfFounderShares" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8203">33</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-weight: bold;"></span>&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The accompanying notes are an integral part of
these financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 83; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;">&#160;</span></p> <ix:nonNumeric name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6511"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><span id="a_032" style="display: inline-block;"></span>1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Talon Capital Corp. (the &#8220;Company&#8221;) was incorporated as a Cayman Islands exempted company on <ix:nonNumeric name="dei:EntityIncorporationDateOfIncorporation" contextRef="cref_144417410" format="ixt:date-monthname-day-year-en" id="ixv-8204">May&#160;1, 2025</ix:nonNumeric>. The Company is a newly organized blank check company or special purpose acquisition company (&#8220;SPAC&#8221;), formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses (the &#8220;Business Combination&#8221;). The Company has not selected any specific Business Combination target. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus on target businesses in the energy and power industries. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> As of December 31, 2025, the Company had not commenced any operations. All activity for the period from <ix:nonNumeric name="tlnc:YearOfInception" contextRef="cref_144417410" id="ixv-8205">May&#160;1, 2025 (inception) through December 31, 2025</ix:nonNumeric> relates to the Company&#8217;s formation, the initial public offering (the &#8220;Initial Public Offering&#8221;), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after completion of the Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on investments from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31 as its fiscal year end. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The registration statement for the Company&#8217;s Initial Public Offering was declared effective on September 8, 2025. On September 10, 2025, the Company consummated the Initial Public Offering of <ix:nonFraction name="tlnc:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="cref_224377445" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8206">24,900,000</ix:nonFraction> units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in the Units being offered, the &#8220;Public Shares&#8221;), which includes the partial exercise by the underwriters of their over-allotment option in the amount of <ix:nonFraction name="tlnc:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="cref_1878519263" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8207">2,400,000</ix:nonFraction> Units, at $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="cref_880262097" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8208">10.00</ix:nonFraction> per Unit, generating gross proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="cref_458958402" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8209">249,000,000</ix:nonFraction>. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (each, a &#8220;Public Warrant&#8221;). </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="cref_1760969002" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8210">779,000</ix:nonFraction> units (the &#8220;Private Placement Units&#8221;) at a price of $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="cref_1077089133" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8211">10.00</ix:nonFraction> per Private Placement Unit, in a private placement to the Company&#8217;s sponsor, Talon Capital Sponsor LLC (the &#8220;Sponsor&#8221;) and Cohen and Company Capital Markets, a division of Cohen &amp; Company Securities, LLC (&#8220;Cohen&#8221;), as representative of the underwriters, generating gross proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="cref_254867204" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8212">7,790,000</ix:nonFraction>. Each Private Placement Unit consists of one Class A ordinary share and one-third of one redeemable warrant (the &#8220;Private Placement Warrants&#8221; and together with the Public Warrants, the &#8220;Warrants&#8221;). Each whole Warrant entitles the holder to purchase <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" contextRef="cref_1853513846" unitRef="uref_504548813" scale="0" decimals="0" format="ixt-sec:numwordsen" id="ixv-8213">one</ix:nonFraction> Class A ordinary share at a price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="cref_1853513846" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8214">11.50</ix:nonFraction> per share, subject to adjustment. Of those <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="cref_1077089133" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8215">779,000</ix:nonFraction> Private Placement Units, the Sponsor purchased <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="cref_1640571159" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8216">530,000</ix:nonFraction> Private Placement Units, and Cohen purchased <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" contextRef="cref_1637193316" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8217">249,000</ix:nonFraction> Private Placement Units. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Transaction costs amounted to $<ix:nonFraction name="tlnc:TransactionCosts" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8218">14,742,001</ix:nonFraction>, consisting of $<ix:nonFraction name="tlnc:CashUnderwritingFee" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8219">4,040,000</ix:nonFraction> of cash underwriting fees (net of $<ix:nonFraction name="tlnc:ProceedsFromSaleOfUnderwritersReimbursement" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8220">700,000</ix:nonFraction> underwriters&#8217; reimbursement), $<ix:nonFraction name="tlnc:DeferredUnderwritingFee" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8221">10,200,000</ix:nonFraction> of deferred underwriting fees, and $<ix:nonFraction name="tlnc:OtherOfferingCosts" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8222">502,001</ix:nonFraction> of other offering costs. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Following the closing of the Initial Public Offering, on September 10, 2025, an amount of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="cref_458958402" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8223">249,000,000</ix:nonFraction> ($<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="cref_1620148570" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8224">10.00</ix:nonFraction> per Unit) from the net proceeds of the sale of the Units and the Private Placement Units was placed in the trust account (the &#8220;Trust Account&#8221;), located in the United States, and will be invested or held only in either (i)&#160;U.S.&#160;government treasury obligations with a maturity of <ix:nonNumeric name="tlnc:NoOfMaturityDays" contextRef="cref_1979561439" format="ixt-sec:durday" id="ixv-8225">185</ix:nonNumeric>&#160;days or less or in money market funds meeting certain conditions under&#160;Rule&#160;2a-7&#160;under&#160;the&#160;Investment Company Act&#160;of&#160;1940 which invest only in direct U.S.&#160;government treasury obligations, (ii)&#160;as uninvested cash, or (iii)&#160;an interest bearing bank demand deposit account or other accounts at a bank. Funds will remain in the Trust Account until the earlier of (i)&#160;the completion of the Business Combination or (ii)&#160;the distribution of the Trust Account as described below. The Company is permitted to withdraw amounts from the Trust Account (i) to fund its working capital requirements, which amount will be the lesser of $<ix:nonFraction name="tlnc:AdvanceReceivedForWorkingCapital" contextRef="cref_1979561439" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8226">500,000</ix:nonFraction> or <ix:nonFraction name="tlnc:InterestEarnedOnTheTrustAccountPerAnnum" contextRef="cref_1979561439" unitRef="uref_714491979" scale="-2" decimals="2" format="ixt:num-dot-decimal" id="ixv-8227">5</ix:nonFraction>% of the interest earned on the Trust Account per annum, and/or (ii) to pay its taxes (other than excise taxes, if any), provided that all permitted withdrawals can only be made (x) from interest and not from the principal held in the Trust Account and (y) only to the extent such interest is in amount sufficient to cover the permitted withdrawal amount (&#8220;permitted withdrawals&#8221;). On November 13, 2025 the Company withdrew $<ix:nonFraction name="tlnc:CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" contextRef="cref_1352034729" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8228">75,921</ix:nonFraction> from the Trust Account for working capital purposes. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company will provide the holders of the public units, or the &#8220;public shareholders,&#8221; with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination at a&#160;per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two&#160;business days prior to consummation of the initial Business Combination, including interest (which interest shall be net of permitted withdrawals), divided by the number of then issued and outstanding public shares, subject to limitations. The amount in the Trust Account is initially invested at $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="cref_1598680374" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8229">10.00</ix:nonFraction> per public share. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, &#8220;Target Business&#8221; must be with one or more target businesses that together have a fair market value equal to at least <ix:nonFraction name="tlnc:MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" contextRef="cref_900732289" unitRef="uref_714491979" scale="-2" decimals="2" format="ixt:num-dot-decimal" id="ixv-8230">80</ix:nonFraction>% of the balance in the Trust Account (less the deferred underwriting commissions and the taxes payable on interest earned) at the time the Company signs a definitive agreement in connection with the Business Combination. There is no assurance that the Company will be able to successfully effect a Business Combination. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company, after signing a definitive agreement for a Business Combination, will either (i)&#160;seek shareholder approval of the Business Combination at a meeting called for such purpose in connection with which shareholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes payable) or (ii)&#160;provide shareholders with the opportunity to have their shares redeemed by the Company by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, net of taxes payable, if any. The decision as to whether the Company will seek shareholder approval of the Business Combination or will allow shareholders to redeem their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval unless a vote is required by the Nasdaq rules. If the Company seeks shareholder approval, it will complete its Business Combination only if a majority of the outstanding shares are voted in favor of the Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><!-- Field: Page; Sequence: 84; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company will have 24&#160;months from the closing date of the Initial Public Offering to complete its initial Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i)&#160;cease all operations except for the purposes of winding up; (ii)&#160;as promptly as reasonably possible, but not more than ten (10)&#160;business&#160;days thereafter, redeem <ix:nonFraction name="tlnc:InitialBusinessCombinationOrToRedeemPercentage" contextRef="cref_144417410" unitRef="uref_714491979" scale="-2" decimals="2" format="ixt:num-dot-decimal" id="ixv-8231">100</ix:nonFraction>% of the outstanding public shares, at a&#160;per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of permitted withdrawals, and up to $<ix:nonFraction name="tlnc:MaximumNetInterestToPayDissolutionExpenses" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8232">100,000</ix:nonFraction> of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders&#8217; rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Board of Directors, liquidate and dissolve, subject (in the case of (ii)&#160;and (iii)&#160;above) to obligations under the Cayman Islands laws to provide for claims of creditors and the requirements of other applicable law. The initial shareholders will each enter into agreements with the Company, pursuant to which they will agree (1)&#160;to waive their redemption rights with respect to their founder shares, private placement units and any Class&#160;A ordinary shares issuable upon conversion thereof in connection with the consummation of the initial Business Combination or a tender offer conducted prior to a Business Combination or in connection with it; and (2)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and private placement units if the Company fails to complete the initial Business Combination within 24&#160;months from the closing of this offering, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Liquidity</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company&#8217;s liquidity needs up to December 31, 2025 had been satisfied through the loan under an unsecured promissory note from the Sponsor of up to $<ix:nonFraction name="us-gaap:UnsecuredDebt" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8233">250,000</ix:nonFraction>. On September 10, 2025, Simultaneously with the closing of the initial public offering, the Company consummated the sale of <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="cref_966747690" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8234">779,000</ix:nonFraction> private placement units at a price of $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="cref_1789825159" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8235">10.00</ix:nonFraction> per private placement unit, generating gross proceeds of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="cref_540106651" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8236">7,790,000</ix:nonFraction>. On November 13, the Company withdrew cash from the Trust Account for working capital purposes of $<ix:nonFraction name="tlnc:CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" contextRef="cref_1543401983" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8237">75,921</ix:nonFraction>. As of December 31, 2025, the Company had cash of $<ix:nonFraction name="us-gaap:Cash" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8238">2,872,627</ix:nonFraction> and working capital surplus of $<ix:nonFraction name="tlnc:WorkingCapitalDeficit" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8239">2,824,868</ix:nonFraction>. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but is not obligated to, loan the Company funds as may be required (the &#8220;Working Capital Loans&#8221;). If the Company completes a Business Combination, the Company would repay such loaned amounts at that time. Up to $<ix:nonFraction name="tlnc:WorkingCapitalLoan" contextRef="cref_1715140789" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8240">1,500,000</ix:nonFraction> of such Working Capital Loans may be converted into units upon consummation of the Business Combination at a price of $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="cref_1598680374" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8241">10.00</ix:nonFraction> per unit. The units would be identical to the Private Placement Units. As of December 31, 2025, the Company had <span style="-sec-ix-hidden:fc_311650695">no</span> borrowings under the Working Capital Loans. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In connection with the Company&#8217;s assessment of going concern considerations in accordance with ASC 205-40, &#8220;Presentation of Financial Statements - Going Concern,&#8221; the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. The Company will have 24 months from the closing of the Initial Public Offering to complete the initial Business Combination. Management has determined that the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the financial statements.</p></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p> <ix:nonNumeric name="us-gaap:SignificantAccountingPoliciesTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6556"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><i>&#160;</i></p><ix:nonNumeric name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6561"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Basis of Presentation</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><ix:nonNumeric name="tlnc:EmergingGrowthCompanyPolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6568"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Emerging Growth Company</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 85; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><ix:nonNumeric name="us-gaap:UseOfEstimates" contextRef="cref_1363532388" escape="true" id="ixv-6592"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The preparation of the financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><ix:nonNumeric name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6603"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Cash and Cash Equivalents</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company considers all short-term investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company has $<ix:nonFraction name="us-gaap:Cash" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8242">2,872,627</ix:nonFraction> in cash and <span style="-sec-ix-hidden:fc_329852981">no</span> cash equivalents as of December 31, 2025. </p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><ix:nonNumeric name="tlnc:CashHeldInTrustAccountPolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6613"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Cash Held in Trust Account</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> As of December 31, 2025, the assets held in the Trust Account, amounting to $<ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8243">252,095,639</ix:nonFraction>, were held in a demand deposit account. </p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><ix:nonNumeric name="us-gaap:ConcentrationRiskCreditRisk" contextRef="cref_1363532388" escape="true" id="ixv-6620"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Concentration of Credit Risk</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $<ix:nonFraction name="us-gaap:CashFDICInsuredAmount" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8244">250,000</ix:nonFraction>. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s financial condition, results of operations, and cash flows. </p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><ix:nonNumeric name="tlnc:OfferingCostsPolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6629"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Offering Costs</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, &#8220;Expenses of Offering.&#8221; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, &#8220;Debt with Conversion and Other Options,&#8221; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the warrants and to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Warrants and Private Placement Units were charged to shareholders&#8217; deficit as Public Warrants and Private Placement Warrants after management&#8217;s evaluation were accounted for under equity treatment.</p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><ix:nonNumeric name="us-gaap:IncomeTaxPolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6638"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Income Taxes</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company follows the asset and liability method of accounting for income taxes under ASC&#160;740, &#8220;Income Taxes&#8221; (&#8220;ASC&#160;740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> ASC&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span style="-sec-ix-hidden:fc_551881478">no</span> unrecognized tax benefits and <span style="-sec-ix-hidden:fc_1991878236">no</span> amounts accrued for interest and penalties as of December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands, and the Company believes it is presently not subject to income taxes or income tax filing requirements in the United&#160;States. As such, the Company&#8217;s tax provision was zero for the period presented.</p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><ix:nonNumeric name="us-gaap:FairValueOfFinancialInstrumentsPolicy" contextRef="cref_1363532388" escape="true" id="ixv-6651"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Fair Value of Financial Instruments</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><!-- Field: Page; Sequence: 86; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><ix:nonNumeric name="us-gaap:DerivativesPolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6665"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Warrant Instruments</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company accounted for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values.</p></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><ix:nonNumeric name="us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6672"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Class A Ordinary Shares Subject to Possible Redemption</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#8217;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#8217;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#8217; deficit section of the Company&#8217;s balance sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><ix:nonNumeric name="us-gaap:TemporaryEquityTableTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6679"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As of December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Gross proceeds</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="cref_81526736" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8245">249,000,000</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Proceeds allocated to Public Warrants</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfWarrants" contextRef="cref_81526736" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8246">1,817,700</ix:nonFraction></td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class A ordinary shares issuance costs</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(<ix:nonFraction name="tlnc:ClassAOrdinarySharesIssuanceCosts" contextRef="cref_81526736" unitRef="uref_144417410" scale="0" decimals="0" sign="-" format="ixt:num-dot-decimal" id="ixv-8247">14,619,267</ix:nonFraction></td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment" contextRef="cref_81526736" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8248">19,449,949</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Class A ordinary shares subject to possible redemption, December 31, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="cref_726559528" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8249">252,012,982</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="us-gaap:EarningsPerSharePolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6726"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<span style="font-weight: bold;"><i>Net Income per Ordinary Share</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; Net income per ordinary share is computed by dividing net income by the weighted average number of shares of ordinary shares outstanding for the period. The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary Shares and Class&#160;B ordinary shares. Accretion associated with the redeemable shares of Class&#160;A Ordinary Shares is excluded from income per ordinary share as the redemption value approximates fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><ix:nonNumeric name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" contextRef="cref_1363532388" continuedAt="continuation_1193060767" escape="true" id="ixv-6733"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period from<br/> May 1, 2025<br/> (Inception) Through<br/> December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Basic net income per ordinary share</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Basic net income per ordinary share</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Numerator:</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="cref_198494574" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8250">1,574,371</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" contextRef="cref_1115681054" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8251">1,050,804</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Basic weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="cref_198494574" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8252">11,787,082</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="cref_1115681054" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8253">7,867,213</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic net income per ordinary share</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="cref_198494574" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8254">0.13</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="cref_1115681054" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8255">0.13</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><ix:continuation id="continuation_1193060767"><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period from<br/> May 1, 2025<br/> (Inception) Through<br/> December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Diluted net income per ordinary share</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Diluted net income per ordinary share</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Numerator:</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="cref_198494574" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8256">1,574,371</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" contextRef="cref_1115681054" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8257">1,050,804</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Diluted weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="cref_198494574" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8258">11,787,082</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="cref_1115681054" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8259">7,867,213</ix:nonFraction></td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Diluted net income per ordinary share</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="cref_198494574" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8260">0.13</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="cref_1115681054" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8261">0.13</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table></ix:continuation></ix:nonNumeric><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><!-- Field: Page; Sequence: 87; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><ix:nonNumeric name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6894"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>Recent Accounting Standards</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In November&#160;2023, the FASB issued ASU&#160;2023-07,&#8221;<i>Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures</i>&#8221;. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (&#8220;CODM&#8221;), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic&#160;280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU&#160;2023-07 on May&#160;1, 2025, inception (see Note 8 for more information).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</p></ix:nonNumeric></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p> <ix:nonNumeric name="tlnc:InitialPublicOfferingTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6904"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">3. INITIAL PUBLIC OFFERING</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> In the Initial Public Offering on September 10, 2025, the Company sold <ix:nonFraction name="tlnc:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="cref_458958402" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8262">24,900,000</ix:nonFraction>&#160;Units, which includes the partial exercise by the underwriters of their over-allotment option in the amount of <ix:nonFraction name="tlnc:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="cref_1878519263" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8263">2,400,000</ix:nonFraction> Units, at a price of $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="cref_880262097" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8264">10.00</ix:nonFraction> per Unit. Each Unit consists of <ix:nonFraction name="tlnc:UnitsIssuedDuringPeriodSharesNewIssues" contextRef="cref_1979561439" unitRef="uref_504548813" scale="0" decimals="0" format="ixt-sec:numwordsen" id="ixv-8265">one</ix:nonFraction> Public Share, $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="cref_1599573526" unitRef="uref_533780696" scale="0" decimals="4" format="ixt:num-dot-decimal" id="ixv-8266">0.0001</ix:nonFraction> par value, and one-third of one redeemable Public Warrant. The Warrants will only be exercisable for whole shares at $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="cref_8341221" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8267">11.50</ix:nonFraction> per share. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> <span style="font-weight: bold;">Warrants&#160;&#8212;</span>&#160;As of December 31, 2025, there were <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="cref_1963271763" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8268">8,559,667</ix:nonFraction> Warrants outstanding, including <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="cref_1366525390" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8269">8,300,000</ix:nonFraction> Public Warrants and <ix:nonFraction name="us-gaap:ClassOfWarrantOrRightOutstanding" contextRef="cref_1077089133" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8270">259,667</ix:nonFraction> Private Placement Warrants. Each whole warrant entitles the registered holder to purchase one Class&#160;A ordinary share at a price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="cref_1268440538" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8271">11.50</ix:nonFraction> per share, at any time commencing on the later of 12&#160;months from the closing of the Initial Public Offering and after the completion of the initial Business Combination. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class&#160;A ordinary shares. This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants will be issued upon separation of the Units&#160;and only whole warrants will trade. The warrants will expire at 5:00&#160;p.m., New&#160;York City time, on the fifth anniversary of the completion of an initial Business Combination, or earlier upon redemption. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $<ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="cref_1095302256" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8272">9.20</ix:nonFraction> per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good faith by the Board of Directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by them prior to such issuance), (y)&#160;the aggregate gross proceeds from such issuances represent more than <ix:nonFraction name="tlnc:PercentageOfGrossProceedsOnTotalEquityProceeds" contextRef="cref_144417410" unitRef="uref_714491979" scale="-2" decimals="2" format="ixt:num-dot-decimal" id="ixv-8273">60</ix:nonFraction>% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of Class&#160;A ordinary shares during the <ix:nonNumeric name="tlnc:NumberOfTradingDays" contextRef="cref_144417410" format="ixt-sec:durday" id="ixv-8274">20</ix:nonNumeric> trading-day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $<ix:nonFraction name="tlnc:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" contextRef="cref_144417410" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8275">9.20</ix:nonFraction> per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to <ix:nonFraction name="tlnc:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" contextRef="cref_331339811" unitRef="uref_714491979" scale="-2" decimals="2" format="ixt:num-dot-decimal" id="ixv-8276">115</ix:nonFraction>% of the greater of (i)&#160;the Market Value or (ii)&#160;the price at which the Company issue the additional Class&#160;A ordinary shares or equity-linked securities. On the exercise of any warrant, the exercise price will be paid directly to the Company and not placed in the Trust Account. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company has agreed that as soon as practicable, but in no event later than 15&#160;business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration under the Securities Act&#160;of&#160;the warrant shares and thereafter use its best efforts to cause the registration statement to become effective and to maintain the effectiveness of such registration statement until the expiration of the warrants. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the issuance of the warrant shares and a current prospectus relating thereto.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If a registration statement covering the issuance of the warrant shares is not effective within 90&#160;days following the consummation of the initial Business Combination, warrant holders may nevertheless, until such time as there is such an effective registration statement and during any period when the Company shall have failed to maintain such an effective registration statement, exercise warrants on a cashless basis in accordance with Section&#160;3(a)(9)&#160;of the Securities Act. In this circumstance, each holder would pay the exercise price by surrendering warrants exercisable for the number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A ordinary shares underlying such warrants and the difference between the exercise price of such warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value. The &#8220;fair market value&#8221; means the average reported last sale price of the Class&#160;A ordinary shares for the five&#160;trading days ending on the&#160;trading day prior to the date of exercise.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p><!-- Field: Page; Sequence: 88; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>&#160;</i></p></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Redemption of Warrants:</i> The Company may redeem the outstanding warrants:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tbody><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-size: 10pt">at a price of $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="cref_1963271763" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8277">0.01</ix:nonFraction> per warrant;</span></td> </tr></tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tbody><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-size: 10pt">upon a minimum of 30&#160;days&#8217; prior written notice of redemption (the &#8220;<ix:nonNumeric name="tlnc:NoticePeriodForRedemptionOfWarrants" contextRef="cref_144417410" format="ixt-sec:durday" id="ixv-8278">30</ix:nonNumeric>-day redemption period&#8221;); and</span></td> </tr></tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tbody><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.25in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-size: 10pt">if, and only if, the last reported sale price of the Class&#160;A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, dividends, reorganizations, recapitalizations and the like) for any <ix:nonNumeric name="tlnc:NumberOfTradingDays" contextRef="cref_144417410" format="ixt-sec:durday" id="ixv-8279">20</ix:nonNumeric>&#160;trading days within a 30-trading&#160;day period ending on the third&#160;trading day prior to the date on which the Company will send the notice of redemption to the warrant holders.</span></td> </tr></tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company will not redeem the warrants unless a registration statement under the Securities Act covering the issuance of the warrant shares underlying the warrants to be so redeemed is then effective and a current prospectus relating to those warrant shares is available throughout the <ix:nonNumeric name="tlnc:EffectiveRedemptionPeriod" contextRef="cref_144417410" format="ixt-sec:durday" id="ixv-8280">30</ix:nonNumeric>-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by the Company, it may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> If the foregoing conditions are satisfied and the Company issues a notice of redemption, each warrant holder may exercise his, her or its warrants prior to the scheduled redemption date. However, the price of the Class&#160;A ordinary shares may fall below the $<ix:nonFraction name="tlnc:TriggerPrice" contextRef="cref_1997855338" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8281">18.00</ix:nonFraction> trigger price (as adjusted) as well as the $<ix:nonFraction name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" contextRef="cref_1997855338" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8282">11.50</ix:nonFraction> exercise price (as adjusted) after the redemption notice is issued. The redemption criteria for the warrants have been established at a price which is intended to provide warrant holders a reasonable premium to the initial exercise price and provide a sufficient differential between the then-prevailing share price and the exercise price so that if the share price declines as a result of the redemption call, the redemption will not cause the share price to drop below the exercise price of the warrants. If the Company calls the warrants for redemption as described above, the management will have the option to require all holders that wish to exercise warrants to do so on a &#8220;cashless basis.&#8221; In making such determination, management will consider, among other factors, the Company&#8217;s cash position, the number of warrants that are outstanding and the dilutive effect on shareholders of issuing the maximum number of warrant shares issuable upon exercise of outstanding warrants. In such event, the holder would pay the exercise price by surrendering the warrants for that number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the product of the number of warrant shares underlying the warrants to be so exercised, and the difference between the exercise price of the warrants and the fair market value by (y)&#160;the fair market value. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">No fractional Class&#160;A ordinary share will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class&#160;A ordinary shares to be issued to the holder.</p></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p> <ix:nonNumeric name="tlnc:PrivatePlacementTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6967"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">4. PRIVATE PLACEMENT UNITS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Simultaneously with the closing of the Initial Public Offering, the Sponsor and Cohen purchased an aggregate of <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="cref_1460463040" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8283">779,000</ix:nonFraction> Private Placement Units at $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="cref_105847728" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8284">10.00</ix:nonFraction> per Private Placement Unit, for an aggregate purchase price of $<ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="cref_837988157" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8285">7,790,000</ix:nonFraction>, of which <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="cref_259879653" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8286">530,000</ix:nonFraction> Private Placement Units were purchased by the Sponsor and <ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="cref_900732289" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8287">249,000</ix:nonFraction> Private Placement Units were purchased by Cohen, in a private placement. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Certain proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, such proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).</p></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p> <ix:nonNumeric name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-6975"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">5. RELATED PARTY TRANSACTIONS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Founder Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> On May&#160;19, 2025, the Sponsor purchased <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="cref_2107376139" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8288">5,750,000</ix:nonFraction> Class&#160;B ordinary shares from the Company for an aggregate purchase price of $<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="cref_211807459" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8289">25,000</ix:nonFraction>, or $<ix:nonFraction name="us-gaap:SharePrice" contextRef="cref_1043056355" unitRef="uref_533780696" scale="0" decimals="3" format="ixt:num-dot-decimal" id="ixv-8290">0.004</ix:nonFraction> per share. On August 8, 2025, the Company effected a <ix:nonNumeric name="us-gaap:StockholdersEquityReverseStockSplit" contextRef="cref_579383359" id="ixv-8291">1 for 1.5</ix:nonNumeric> share split of the founder shares. All share and per share amounts have been retroactively restated. Up to <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" contextRef="cref_612105669" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8292">1,125,000</ix:nonFraction> founder shares were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option is exercised during the Initial Public Offering. The forfeiture will be adjusted to the extent that the over-allotment option is not exercised in full by the underwriters so that the Sponsor will own <ix:nonFraction name="tlnc:PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders" contextRef="cref_2100456949" unitRef="uref_714491979" scale="-2" decimals="2" format="ixt:num-dot-decimal" id="ixv-8293">25</ix:nonFraction>% of the Company&#8217;s issued and outstanding Class&#160;A and Class&#160;B ordinary shares after the Initial Public Offering. On September 10, 2025, the underwriters partially exercised their over-allotment option and forfeited the unexercised balance. As a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" contextRef="cref_1752672645" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8294">800,000</ix:nonFraction> founder shares are no longer subject to forfeiture and <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" contextRef="cref_2086386178" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8295">325,000</ix:nonFraction> founder shares were forfeited, resulting in the Sponsor holding <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="cref_2086386178" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8296">8,260,000</ix:nonFraction> founder shares. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> On August 19, 2025, the Sponsor assigned a total of <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="cref_2028565431" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8297">40,000</ix:nonFraction> founder shares to the two directors of the Company (<ix:nonFraction name="tlnc:AggregateShares" contextRef="cref_1476606103" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8298">20,000</ix:nonFraction> each) for an aggregate consideration of $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="cref_2028565431" unitRef="uref_533780696" scale="0" decimals="3" format="ixt:num-dot-decimal" id="ixv-8299">0.003</ix:nonFraction> per share, or an aggregate total amount of $<ix:nonFraction name="tlnc:AggregateAmount" contextRef="cref_1476606103" unitRef="uref_144417410" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8300">115.94</ix:nonFraction>. The founder shares will automatically be forfeited and be returned to the Sponsor if the holder of such founder shares is not a member of the board of directors of the Company on or prior to the closing of the Company&#8217;s Initial Public Offering. The assignment of the founder shares to the directors of the Company are in the scope of FASB ASC Topic 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the assignment date. The total fair value of the <ix:nonFraction name="tlnc:FairValueOfShares" contextRef="cref_1476606103" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8301">40,000</ix:nonFraction> founder shares granted to the Company&#8217;s directors on August 19, 2025 was $<ix:nonFraction name="tlnc:AmountOfFairValue" contextRef="cref_1476606103" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8302">74,000</ix:nonFraction> or $<ix:nonFraction name="tlnc:FairValuePerSharePrice" contextRef="cref_1476606103" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8303">1.85</ix:nonFraction> per share. The founder shares were granted subject to a performance condition (i.e., to be a member of the board of directors of the Company on or prior to the closing of the Company&#8217;s Initial Public Offering). Thus, the fair value of $<ix:nonFraction name="tlnc:AmountOfFairValue" contextRef="cref_1979561439" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8304">74,000</ix:nonFraction> was recorded as compensation expense on September 10, 2025, the date of the Company&#8217;s Initial Public Offering. The fair value of the founder shares was derived through a third party valuation using the Monte Carlo simulation with the following market assumptions; (i) stock price of $<ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="cref_1837988368" unitRef="uref_714491979" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8305">9.92</ix:nonFraction>, (ii) risk-free rate of <ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="cref_15267773" unitRef="uref_714491979" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8306">4.36</ix:nonFraction>%, (iii) market adjustments of <ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="cref_443971720" unitRef="uref_714491979" scale="0" decimals="1" format="ixt:num-dot-decimal" id="ixv-8307">18.7</ix:nonFraction>%, and (iv) volatility of <ix:nonFraction name="us-gaap:DebtInstrumentMeasurementInput" contextRef="cref_625298015" unitRef="uref_714491979" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8308">5</ix:nonFraction>%. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i></i></span></p><!-- Field: Page; Sequence: 89; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Promissory Note&#160;&#8212;&#160;Related Party</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Sponsor has agreed to loan the Company an aggregate of up to $<ix:nonFraction name="tlnc:AggregateAmount" contextRef="cref_2100456949" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8309">250,000</ix:nonFraction> to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing and unsecured with maturity date at the earlier of December&#160;31, 2025 or the closing of the Initial Public Offering. On September 10, 2025, the Company repaid the total outstanding balance of the Promissory Note amounting to $<ix:nonFraction name="tlnc:OutstandingBalancePromissoryNote" contextRef="cref_1979561439" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8310">83,927</ix:nonFraction>. Borrowings under the Note are no longer available. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Advances from Related Party</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Advances from related party represents payment of expenses by an affiliate of the Sponsor that are not covered by the Promissory Note. As of December 31, 2025, <span style="-sec-ix-hidden:fc_1494614152">no</span> advances from related party have been made. </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Working Capital Loans</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $<ix:nonFraction name="tlnc:WorkingCapitalLoan" contextRef="cref_674618302" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8311">1,500,000</ix:nonFraction> of such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at the option of the lender. The units would be identical to the Private Placement Units. As of December 31, 2025, <span style="-sec-ix-hidden:fc_319930502">no</span> such Working Capital Loans were outstanding. </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Administrative Support Agreement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company entered into an agreement with the Sponsor, commencing on September 8, 2025 through the earlier of the Company&#8217;s consummation of initial Business Combination and its liquidation, to pay the Sponsor an aggregate of $<ix:nonFraction name="tlnc:AggregateSponsorAmount" contextRef="cref_2070764536" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8312">40,000</ix:nonFraction> per month for office space, secretarial and administrative services. On September 16, 2025, the Company and the Sponsor entered into the amended and restated administrative services agreement, to add that the Sponsor or its affiliates may make available to the Company certain office space, utilities and secretarial support as may be required by the Company from time to time. For the period from May 1, 2025 (inception) through December 31, 2025, the Company incurred and paid $<ix:nonFraction name="us-gaap:AdministrativeFeesExpense" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8313">150,667</ix:nonFraction> in fees for these services. </p></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p> <ix:nonNumeric name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-7034"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">6. COMMITMENTS<i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Risks and Uncertainties</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company&#8217;s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company&#8217;s control. The Company&#8217;s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company&#8217;s ability to complete an initial Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Registration Rights</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company&#8217;s initial shareholders and their permitted transferees can demand that the Company register the founder shares, the Private Placement Shares, the Private Placement Warrants and underlying securities and any securities issued upon conversion of Working Capital Loans, pursuant to an agreement signed on September 8, 2025. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities. The holders of a majority of these securities or units issued in payment of working capital loans made to the Company (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain piggyback registration rights on registration statements filed after the Company&#8217;s consummation of a Business Combination. Notwithstanding anything to the contrary, the representative of the underwriters may only make a demand on one occasion and only during the five-year period beginning on the effective date of Initial Public Offering. In addition, the representative of the underwriters may participate in a piggyback registration only during the seven-year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><!-- Field: Page; Sequence: 90; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p></ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>Underwriting Agreement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company granted the underwriters a <ix:nonNumeric name="tlnc:UnderwritingOptionPeriod" contextRef="cref_1598308813" format="ixt-sec:durday" id="ixv-8314">45</ix:nonNumeric>-day option to purchase up to <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesOther" contextRef="cref_144417410" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8315">3,375,000</ix:nonFraction> additional Units&#160;to cover any over-allotments, at the initial public offering price less the underwriting discounts. On September 10, 2025, the underwriters partially exercised their over-allotment option, purchasing <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="cref_1979561439" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8316">2,400,000</ix:nonFraction> Units and forfeiting the remaining unexercised balance of <ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" contextRef="cref_1878519263" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8317">975,000</ix:nonFraction> Units. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The underwriters were entitled to a cash underwriting discount of $<ix:nonFraction name="tlnc:UnderwritingDiscountAmountPerUnit" contextRef="cref_900732289" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8318">0.20</ix:nonFraction> per Unit sold in the Initial Public Offering, or $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="cref_900732289" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8319">4,980,000</ix:nonFraction> in the aggregate. The underwriter paid the Company an aggregate amount of $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="cref_126252359" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8320">940,000</ix:nonFraction> at the closing of the Initial Public Offering as reimbursement to the Company for certain of its expenses and fees incurred in connection with the Initial Public Offering, $<ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8321">240,000</ix:nonFraction> of which is payable to the underwriters upon the completion of an initial Business Combination. In addition, the underwriters were entitled to $<ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="cref_1318230788" unitRef="uref_533780696" scale="0" decimals="2" format="ixt:num-dot-decimal" id="ixv-8322">0.40</ix:nonFraction> per Unit sold in the offering, or up to $<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="cref_4055154" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8323">9,960,000</ix:nonFraction> in the aggregate, payable to the underwriters based on the percentage of funds remaining in the Trust Account after redemptions of public shares, for deferred underwriting commissions, and to be released to the underwriters only upon the completion of an initial Business Combination. Furthermore, <ix:nonFraction name="tlnc:PercentageOfDeferredUnderwritings" contextRef="cref_144417410" unitRef="uref_714491979" scale="-2" decimals="2" format="ixt:num-dot-decimal" id="ixv-8324">50</ix:nonFraction>% of such deferred underwriting commissions will be contingent upon permitted withdrawals of interest, at the lesser of $<ix:nonFraction name="us-gaap:InterestIncomeOther" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8325">500,000</ix:nonFraction> or <ix:nonFraction name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" contextRef="cref_15768048" unitRef="uref_714491979" scale="-2" decimals="2" format="ixt:num-dot-decimal" id="ixv-8326">5</ix:nonFraction>% of the interest earned per annum, on the Trust Account per annum, for working capital from the Trust Account. </p></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <ix:nonNumeric name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-7072"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">7. SHAREHOLDERS&#8217; DEFICIT</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Preference Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company is authorized to issue <ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="cref_1598680374" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8327">1,000,000</ix:nonFraction> shares of preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Board of Directors. As of December 31, 2025, there were <span style="-sec-ix-hidden:fc_1730245694"><span style="-sec-ix-hidden:fc_314223251">no</span></span> preference shares issued or outstanding. </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Class&#160;A Ordinary Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company is authorized to issue <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="cref_1997855338" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8328">200,000,000</ix:nonFraction> Class&#160;A ordinary shares with a par value of $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="cref_1997855338" unitRef="uref_533780696" scale="0" decimals="4" format="ixt:num-dot-decimal" id="ixv-8329">0.0001</ix:nonFraction> per share. As of December 31, 2025, there were <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="cref_1997855338" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8330"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="cref_1997855338" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8331">779,000</ix:nonFraction></ix:nonFraction> Class A ordinary shares issued and outstanding, excluding <ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="cref_1997855338" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8332">24,900,000</ix:nonFraction> shares subject to possible redemption. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Class&#160;B Ordinary Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company is authorized to issue <ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="cref_504548813" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8333">20,000,000</ix:nonFraction> Class&#160;B ordinary shares with a par value of $<ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="cref_504548813" unitRef="uref_533780696" scale="0" decimals="4" format="ixt:num-dot-decimal" id="ixv-8334">0.0001</ix:nonFraction> per share. As of December 31, 2025, there were <ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="cref_504548813" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8335"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="cref_504548813" unitRef="uref_504548813" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8336">8,300,000</ix:nonFraction></ix:nonFraction> Class B ordinary shares issued and outstanding. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The founder shares will automatically convert into Class A ordinary shares in connection with the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. The Class A ordinary shares issuable in connection with the conversion of the founder shares may result in material dilution to public shareholders due to the anti-dilution rights of founder shares that may result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion. In the case that additional Class A ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class B ordinary shares convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, <ix:nonFraction name="tlnc:ConversionOfOrdinarySharesPercentage" contextRef="cref_144417410" unitRef="uref_714491979" scale="-2" decimals="2" format="ixt:num-dot-decimal" id="ixv-8337">25</ix:nonFraction>% of the sum of (i) the aggregate of issued and outstanding founder shares, private placement shares and public shares after this offering and the private placement, plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent units issued to the Sponsor or any of its affiliates or to officers or directors upon conversion of working capital loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders in connection with an initial Business Combination; provided that such conversion of founder shares will never occur on a less than one-for-one basis.&#160;<span style="font-weight: bold;">&#160;</span> </p><ix:exclude><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p></ix:exclude></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><!-- Field: Page; Sequence: 91; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p> <ix:nonNumeric name="us-gaap:SegmentReportingDisclosureTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-7110"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">8. SEGMENT INFORMATION</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">ASC Topic 280, &#8220;Segment Reporting,&#8221; establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;), or group, in deciding how to allocate resources and assess performance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> <ix:nonNumeric name="us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription" contextRef="cref_144417410" id="ixv-7118">The Company&#8217;s CODM has been identified as the <span style="-sec-ix-hidden:fc_444643047">Chief Financial Officer</span>, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has <ix:nonFraction name="us-gaap:NumberOfReportableSegments" contextRef="cref_144417410" unitRef="uref_493518290" scale="0" decimals="0" format="ixt-sec:numwordsen" id="ixv-8338">one</ix:nonFraction> reportable segment.</ix:nonNumeric> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statements of operations as net income or loss. The measure of segment assets is reported on the balance sheet as total assets. <ix:nonNumeric name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" contextRef="cref_1363532388" continuedAt="continuation_373496380" escape="true" id="ixv-8339">When evaluating the Company&#8217;s performance and making key decisions regarding resource allocation the CODM reviews the key metrics below.</ix:nonNumeric> </p><ix:continuation id="continuation_373496380"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Cash</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8340">2,872,627</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash held in Trust Account</td><td>&#160;</td><td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="cref_1598680374" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8341">252,095,639</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr> </tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-weight: bold;">For the<br/> Period from</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-weight: bold;">May&#160;1,&#160;2025<br/> (Inception)<br/> through<br/> December 31,<br/> 2025</span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">General and administrative costs</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8342">546,385</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest earned on cash held in Trust Account</td><td>&#160;</td><td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeInterest" contextRef="cref_144417410" unitRef="uref_144417410" scale="0" decimals="0" format="ixt:num-dot-decimal" id="ixv-8343">3,171,560</ix:nonFraction></td><td style="text-align: left">&#160;</td> </tr> </tbody></table></ix:continuation><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The CODM reviews interest earned on the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">General and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also reviews General and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative costs, as reported on the statements of operations, are the significant segment expenses provided to the CODM on a regular basis.</p></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p> <ix:nonNumeric name="us-gaap:SubsequentEventsTextBlock" contextRef="cref_1363532388" escape="true" id="ixv-7178"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">NOTE 9. SUBSEQUENT EVENTS</span>&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company evaluated subsequent events and transactions that occurred after the balance sheet date, the date that the financial statements was issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</p></ix:nonNumeric> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><!-- Field: Page; Sequence: 92; Value: 1 --><div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt"></p></div><!-- Field: /Page --><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration:underline"><span id="a_026" style="display: inline-block;"></span>SIGNATURES</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td>&#160;</td>
<td colspan="2"><span style="font-weight: bold;">TALON CAPITAL CORP.</span></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td colspan="2">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 60%"><span style="font-size: 10pt">Dated: March 27, 2026</span></td>
<td style="width: 3%"><span style="font-size: 10pt">By:</span></td>
<td style="border-bottom: Black 1.5pt solid; width: 37%"><span style="font-size: 10pt">/s/ Charles Leykum</span></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td>
<td>Charles Leykum</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td>
<td>&#160;</td>
<td><span style="font-size: 10pt">Chief Executive Officer</span></td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to the requirements of the Securities
Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated
on March 26, 2026.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tbody><tr style="vertical-align: top">
<td style="border-bottom: Black 1.5pt solid; text-align: left; width: 49%; vertical-align: bottom"><span style="font-weight: bold;">Signatures</span></td>
<td style="width: 2%">&#160;</td>
<td style="border-bottom: Black 1.5pt solid; text-align: center; width: 49%"><span style="font-weight: bold;">Capacity in Which Signed</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; vertical-align: bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: bottom">/s/ Charles Leykum</td>
<td>&#160;</td>
<td>Chairman and Chief Executive Officer </td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; vertical-align: bottom">Charles Leykum</td>
<td>&#160;</td>
<td>(Principal Executive Officer)</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; vertical-align: bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: bottom">/s/ Gerald Cimador</td>
<td>&#160;</td>
<td>Chief Financial Officer</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; vertical-align: bottom">Gerald Cimador</td>
<td>&#160;</td>
<td>(Principal Financial and Accounting Officer)</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; vertical-align: bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: bottom">/s/ Shawn Reynolds</td>
<td>&#160;</td>
<td>Director</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; vertical-align: bottom">Shawn Reynolds</td>
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; vertical-align: bottom">&#160;</td>
<td>&#160;</td>
<td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="border-bottom: Black 1.5pt solid; text-align: left; vertical-align: bottom">/s/ Thomas Simons</td>
<td>&#160;</td>
<td>Director</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; vertical-align: bottom">Thomas Simons</td>
<td>&#160;</td>
<td>&#160;</td></tr>
</tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><!-- Field: Page; Sequence: 93; Options: NewSection Last; Value: 76 --><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></p></div><!-- Field: /Page -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>ea028027801ex4-5.htm
<DESCRIPTION>DESCRIPTION OF SECURITIES OF THE REGISTRANT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TALON CAPITAL CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>DESCRIPTION OF SECURITIES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As of the date of this Annual Report (the &ldquo;Annual
Report&rdquo;) of Talon Capital Corp., a Cayman Islands exempted company (&ldquo;we,&rdquo; &ldquo;us,&rdquo; &ldquo;our&rdquo; or &ldquo;the
company&rdquo;), of which this exhibit forms a part, the Company had the following three classes of securities registered under Section
12 of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange Act&rdquo;): (i) its units, each unit consisting of one Class
A ordinary share and one-third of one warrant to purchase one share of Class A ordinary shares for a price of $11.50 per share, subject
to adjustment, (the &ldquo;units&rdquo;), (ii) its Class A ordinary shares, $0.0001 par value per share (&ldquo;Class A ordinary shares&rdquo;),
and (iii) its warrants, each whole public warrant entitles the holder thereof to purchase one Class&nbsp;A ordinary share at a price of
$11.50 per share, subject to adjustment. Defined terms used herein but not otherwise defined shall have the meaning ascribed to such terms
in the Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the Company&rsquo;s amended and restated
memorandum and articles of association (the &ldquo;Amended Articles&rdquo;), our authorized capital stock consists of 200,000,000 Class
A ordinary shares, 20,000,000 Class B ordinary shares, par value $0.0001 per share, and 1,000,000 undesignated preference shares, par
value $0.0001 per share. The following description summarizes the material terms of our capital stock and does not purport to be complete.
It is subject to, and qualified in its entirety by reference to, the Amended Articles and our warrants agreement, each of which is incorporated
by reference as an exhibit to the Annual Report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Units</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each unit consists of one Class&nbsp;A ordinary
share and&nbsp;one-third&nbsp;of one warrant to purchase one share of our Class&nbsp;A ordinary shares for an exercise price of $11.50
per share, subject to adjustment. Only whole warrants are exercisable. The warrants will become exercisable on the later of (a)&nbsp;the
consummation of our initial business combination; and (b)&nbsp;12&nbsp;months after the initial public offering. The warrants will expire
at 5:00&nbsp;p.m., New&nbsp;York City time, on the fifth anniversary of our completion of an initial business combination, or earlier
upon redemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Ordinary Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Upon the closing of the initial public offering,
25,679,000 Class A ordinary shares par value $0.0001 per share, and 8,300,000 Class B ordinary shares, par value $0.0001 per share, were
issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Class&nbsp;A ordinary shareholders of record are
entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in our amended and restated memorandum
and articles of association, or as required by applicable provisions of Cayman Island laws or stock exchange rules, the affirmative vote
of at least a simple majority of our shares that are voted is required to approve any such matter voted on by our shareholders. Our shareholders
are entitled to receive ratable dividends when, as and if declared by the Board of Directors out of funds legally available therefor.
If we seek shareholder approval of our initial business combination, we will consummate our initial business combination only if we obtain
the approval of an ordinary resolution under Cayman Islands law, being the affirmative vote of the holders of at least a simple majority
of the issued ordinary shares held who, being present and entitled to vote, vote at a general meeting of the company held for the purposes
of approving the business combination, or as a special resolution under Cayman Islands law, being the affirmative vote of the holders
of at least&nbsp;two-thirds&nbsp;(2/3)&nbsp;of the issued ordinary shares held by shareholders who, being present and entitled to vote,
vote at a general meeting of the company held for the purposes of approving the business combination, vote at the general meeting of the
company to the extent that such business combination is structured as a statutory merger or consolidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Holders of our Class&nbsp;A ordinary shares and
Class&nbsp;B ordinary shares of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except
as described below, holders of Class&nbsp;A ordinary shares and holders of Class&nbsp;B ordinary shares will vote together as a single
class on all matters submitted to a vote of our shareholders except as required by law. Unless otherwise specified in our amended and
restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable stock exchange
rules, the affirmative vote of at least a simple majority of our ordinary shares that are represented in person or by proxy and are voted
is required to approve any such matter voted on by our shareholders, voting together as a single class. Approval of certain actions will
require a special resolution under Cayman Islands law, being the affirmative vote of at least&nbsp;two-thirds&nbsp;of the votes cast by
such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting
of the company, and pursuant to our amended and restated memorandum and articles of association; such actions include amending our amended
and restated memorandum and articles of association and approving a statutory merger or consolidation with another company. Our board
of directors is divided into three classes, each of which will generally serve for terms of three&nbsp;years with only one class of directors
being elected in each year. There is no cumulative voting with respect to the appointment of directors, with the result that the holders
of more than 50% of the shares entitled to vote and voted for the appointment of directors can appoint all of the directors. Our shareholders
are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.
Prior to our initial business combination, only holders of our Class&nbsp;B ordinary shares will have the right to vote on the appointment
and removal of directors. Holders of our public shares will not be entitled to vote on the appointment of directors during such time.
Further, prior to the closing of our initial business combination, only holders of our Class&nbsp;B ordinary shares will be entitled to
vote on transferring the Company by way of continuation in a jurisdiction outside the Cayman Islands (including any special resolution
required to amend the constitutional documents of the Company or to adopt new constitutional documents of the company, in each case, as
a result of the company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands) and, as a result, our
initial shareholders will be able to approve any such proposal without the vote of any other shareholder. The provisions of our amended
and restated memorandum and articles of association governing the appointment of directors prior to our initial business combination and
our continuation in a jurisdiction outside the Cayman Islands prior to our initial business combination may only be amended by a special
resolution passed by holders representing at least&nbsp;two-thirds&nbsp;of our outstanding Class&nbsp;B ordinary shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board of Directors is elected each year at
our annual meeting of shareholders; however, we do not currently intend to hold an annual meeting of shareholders until after we consummate
a business combination (unless required by Nasdaq). There is no cumulative voting with respect to the appointment of directors, with the
result that the holders of more than 50% of the shares eligible to vote for the election of directors can elect all of the directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We will provide our public shareholders with the
opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a&nbsp;per-share&nbsp;price
which is payable in cash and equal to the aggregate amount then on deposit in the trust account as of two&nbsp;business days prior to
the consummation of our initial business combination, including interest (which interest shall be net of permitted withdrawals) divided
by the number of then issued and outstanding public shares, subject to the limitations. The amount in the trust account is initially anticipated
to be approximately $10.00 per public share. Our initial shareholders will enter into agreements with us, pursuant to which they will
agree to waive their redemption rights with respect to their founder shares, private placement shares, private placement warrants and
shares underlying any private placement warrants in connection with the completion of our business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Unlike many blank check companies that hold shareholder
votes and conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of public
shares for cash upon completion of such initial business combinations even when a vote is not required by law, if a shareholder vote is
not required by law and we do not decide to hold a shareholder vote for business or other legal reasons, we will, pursuant to our amended
and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the SEC and file tender
offer documents with the SEC prior to completing our initial business combination. Our amended and restated memorandum and articles of
association will require these tender offer documents to contain substantially the same financial and other information about the initial
business combination and the redemption rights as is required under the SEC&rsquo;s proxy rules. If, however, a shareholder approval of
the transaction is required by law, or we decide to obtain shareholder approval for business or other legal reasons, we will, like many
blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to
the tender offer rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer
rules, our amended and restated memorandum and articles of association provides that a public shareholder, together with any affiliate
of such shareholder or any other person with whom such shareholder is acting in concert or as a &ldquo;group&rdquo; (as defined under
Section&nbsp;13 of the Exchange&nbsp;Act), will be restricted from redeeming its public shares with respect to Excess Shares, without
our prior consent. However, we would not be restricting our shareholders&rsquo; ability to vote all of their shares (including Excess
Shares) for or against our initial business combination. Our shareholders&rsquo; inability to redeem the Excess Shares will reduce their
influence over our ability to complete our initial business combination, and such shareholders could suffer a material loss in their investment
if they sell such Excess Shares on the open market. Additionally, such shareholders will not receive redemption distributions with respect
to the Excess Shares if we complete our initial business combination. And, as a result, such shareholders will continue to hold that number
of shares exceeding 20% and, in order to dispose such shares would be required to sell their shares in open market transactions, potentially
at a loss.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If we seek shareholder approval, we will complete
our initial business combination only if we receive approval of an ordinary resolution under Cayman Islands law and pursuant to our amended
and restated memorandum and articles of association, which requires the affirmative vote of at least a majority of the votes cast by such
shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of
the company. A quorum for such meeting will be present if the holders of at least one third of issued and outstanding shares entitled
to vote at the meeting are represented in person or by proxy. In such case, our Sponsor and each member of our management team have agreed
to vote their founder shares, private placement shares and public shares purchased during or after the initial public offering (aside
from shares they may purchase in compliance with the requirements of Rule 14e-5&nbsp;under the Exchange Act, which would not be voted
in favor of approving the business combination transaction) in favor of our initial business combination. For purposes of seeking approval
of an ordinary resolution, non-votes&nbsp;will have no effect on the approval of our initial business combination once a quorum is obtained.
As a result, in addition to our initial shareholders&rsquo; founder shares and private placement shares, we would need 7,139,376 public
shares, or approximately 31.7% of the 22,500,000 public shares sold in the initial public offering to be voted in favor of an initial
business combination in order to have our initial business combination approved (assuming all issued and outstanding shares are voted
and the over-allotment&nbsp;option is not exercised). Assuming that only the holders of&nbsp;one-third&nbsp;of our issued and outstanding
ordinary shares, representing a quorum under our amended and restated memorandum and articles of association, vote their shares, we will
not need any public shares in addition to our founder shares and the private placement shares held by our Sponsor to be voted in favor
of an initial business combination in order to approve an initial business combination. Additionally, each public shareholder may elect
to redeem their public shares irrespective of whether they vote for or against the proposed transaction or vote at all.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If we seek shareholder approval of our initial
business combination and we do not conduct redemptions in connection with our business combination pursuant to the tender offer rules,
our amended and restated memorandum and articles of association provides that a public shareholder, together with any affiliate of such
shareholder or any other person with whom such shareholder is acting in concert or as a &ldquo;group&rdquo; (as defined under Section&nbsp;13
of the Exchange&nbsp;Act), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the shares sold
in the initial public offering. However, we would not be restricting our shareholders&rsquo; ability to vote all of their shares for or
against our business combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to our amended and restated memorandum
and articles of association, if we are unable to complete our business combination within 24&nbsp;months from the closing of the initial
public offering, we will (i)&nbsp;cease all operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible
but no more than 10&nbsp;business days thereafter, subject to lawfully available funds therefor, redeem the public shares, at a&nbsp;per-share&nbsp;price
which is payable in cash and equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall
be net of permitted withdrawals and up to $100,000 of interest to pay dissolution expenses) divided by the number of then issued and outstanding
public shares, which redemption will completely extinguish public shareholders&rsquo; rights as shareholders (including the right to receive
further liquidation distributions, if any), subject to applicable law, and (iii)&nbsp;as promptly as reasonably possible following such
redemption, subject to the approval of our remaining shareholders and our Board of Directors, liquidate and dissolve, subject in each
case to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. Our
initial shareholders have entered into a letter agreement with us, pursuant to which they have agreed to waive their rights to liquidating
distributions from the trust account with respect to their founder shares and private placement shares if we fail to complete our business
combination within 24&nbsp;months from the closing of the initial public offering. However, if our Sponsor, representative, executive
officers or directors acquire public shares in or after the initial public offering, they will be entitled to liquidating distributions
from the trust account with respect to such public shares if we fail to complete our business combination within the prescribed time period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event of a liquidation, dissolution or winding
up of the Company after a business combination, our shareholders are entitled to share ratably in all assets remaining available for distribution
to them after payment of liabilities and after provision is made for each class of shares, if any, having preference over the ordinary
shares. Our shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the ordinary
shares, except that we will provide our public shareholders with the opportunity to redeem their public shares for cash equal to their
pro rata share of the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of permitted
withdrawals and up to $100,000 of interest to pay dissolution expenses) upon the completion of our initial business combination, subject
to the limitations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each whole warrant entitles the registered holder
to purchase one Class&nbsp;A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time commencing
on the later of 12&nbsp;months from the closing of the initial public offering and the completion of our initial business combination.
Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class&nbsp;A ordinary shares.
This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants will be issued upon
separation of the units and only whole warrants will trade. The warrants will expire at 5:00&nbsp;p.m., New&nbsp;York City time, on the
fifth anniversary of our completion of an initial business combination, or earlier upon redemption; provided, however, that the private
placement warrants issued to the representative will not be exercisable more than five&nbsp;years after the effective date of the registration
statement in accordance with FINRA Rule&nbsp;5110(g)(8).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No public warrants will be exercisable for cash
unless we have an effective and current registration statement covering the warrant shares issuable upon exercise of the warrants and
a current prospectus relating to such warrant shares. Notwithstanding the foregoing, if a registration statement covering the issuance
of the warrant shares issuable upon exercise of the public warrants is not effective within 90&nbsp;days from the closing of our initial
business combination, warrant holders may, until such time as there is an effective registration statement and during any period when
we shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption
from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their
warrants on a cashless basis. In the event of a cashless exercise, each holder would pay the exercise price by surrendering the warrants
for that number of warrant shares equal to the quotient obtained by dividing (x)&nbsp;the product of the number of warrant shares underlying
the warrants, multiplied by the difference between the exercise price of the warrants and the &ldquo;fair market value&rdquo; by (y)&nbsp;the
fair market value. The &ldquo;fair market value&rdquo; for this purpose will mean the average reported last sale price of the public shares
for the five&nbsp;trading days ending on the&nbsp;trading day prior to the date of exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The private placement warrants (including the Class&nbsp;A
ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30&nbsp;days
after the completion of our initial business combination (except pursuant to limited exceptions as described under &ldquo;Principal Shareholders&nbsp;&mdash;&nbsp;Transfers
of Founder Shares and Placement Units,&rdquo; to our officers and directors and other persons or entities affiliated with the initial
purchasers of the placement units). The placement warrants will not be redeemable by us. The private placement warrants held by the representative
will not be exercisable more than five&nbsp;years from the commencement of sales in the initial public offering in accordance with FINRA
Rule&nbsp;5110(g)(8).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Once the warrants become exercisable, we may redeem
the outstanding warrants (excluding the private placement warrants):</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left">at a price of $0.01 per warrant;</TD></TR><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
                                                                                                                   </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left">upon a minimum of 30&nbsp;days&rsquo; prior written notice of redemption, which we refer to as the 30- day&nbsp;redemption period;
and</TD></TR><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
             </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="text-align: left; width: 0.25in">&#9679;</TD><TD STYLE="text-align: left">if, and only if, the last reported sale price of our Class&nbsp;A ordinary shares equals or exceeds $18.00 per share (as adjusted
for share splits, dividends, reorganizations, recapitalizations and the like) for any 20&nbsp;trading days within a&nbsp;30-trading&nbsp;day
period ending on the third&nbsp;trading day prior to the date on which we send the notice of redemption to the warrant holders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We will not redeem the warrants unless a registration
statement under the Securities Act covering the issuance of the warrant shares underlying the warrants to be so redeemed is then effective
and a current prospectus relating to those warrant shares is available throughout the&nbsp;30-day&nbsp;redemption period, except if the
warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and
when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying
securities for sale under all applicable state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the foregoing conditions are satisfied and
we issue a notice of redemption, each warrant holder may exercise his, her or its warrants prior to the scheduled redemption date. However,
the price of the public shares may fall below the $18.00 trigger price (as adjusted) as well as the $11.50 exercise price (as adjusted)
after the redemption notice is issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The redemption criteria for our warrants have
been conditioned on a share price which is intended to provide warrant holders a reasonable premium to the initial exercise price and
provide a sufficient differential between the then-prevailing&nbsp;share price and the exercise price so that if the share price declines
as a result of our redemption call, the redemption will not cause the share price to drop below the exercise price of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If we call the warrants for redemption as described
above, our management will have the option to require all holders that wish to exercise warrants to do so on a &ldquo;cashless basis.&rdquo;
In making such determination, our management will consider, among other factors, our cash position, the number of warrants that are outstanding
and the dilutive effect on our shareholders of issuing the maximum number of warrant shares issuable upon exercise of outstanding warrants.
In such event, the holder would pay the exercise price by surrendering the warrants for that number of Class&nbsp;A ordinary shares equal
to the quotient obtained by dividing (x)&nbsp;the product of the number of warrant shares underlying the warrants to be so exercised,
and the difference between the exercise price of the warrants and the fair market value by (y)&nbsp;the fair market value. The &ldquo;fair
market value&rdquo; shall mean the average reported last sale price of the public shares for the five&nbsp;trading days ending on the
third&nbsp;trading day prior to the date on which the notice of redemption is sent to the holders of warrants. No fractional shares will
be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, we will round
down to the nearest whole number of the number of Class&nbsp;A ordinary shares to be issued to the holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A holder of a warrant may notify us in writing
in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent
that after giving effect to such exercise, such person (together with such person&rsquo;s affiliates), to the warrant agent&rsquo;s actual
knowledge, would beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the shares outstanding immediately
after giving effect to such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The warrants will be issued in registered form
under a warrant agreement between Odyssey Transfer and Trust Company, as warrant agent, and us. You should review a copy of the warrant
agreement for a complete description of the terms and conditions applicable to the warrants. The warrant agreement provides that the terms
of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires
the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely affects the interests
of the registered holders of public warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The exercise price and number of warrant shares
issuable on exercise of the warrants may be adjusted in certain circumstances including in the event of a dividend or our recapitalization,
reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuances of Class&nbsp;A
ordinary shares at a price below their respective exercise prices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If (x)&nbsp;we issue additional ordinary shares
or equity-linked&nbsp;securities for capital raising purposes in connection with the closing of our initial business combination at an
issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in
good faith by our Board of Directors, and in the case of any such issuance to our Sponsor or its affiliates, without taking into account
any founder shares held by them prior to such issuance), (y)&nbsp;the aggregate gross proceeds from such issuances represent more than
60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the
consummation of our initial business combination (net of redemptions), and (z)&nbsp;the Market Value is below $9.20 per share, the exercise
price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i)&nbsp;the Market Value or (ii)&nbsp;the
price at which we issue the additional ordinary shares or equity-linked&nbsp;securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The warrants may be exercised upon surrender of
the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse
side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless
basis, if applicable), by certified or official bank check payable to us, for the number of warrants being exercised. The warrant holders
do not have the rights or privileges of holders of Class&nbsp;A ordinary shares and any voting rights until they exercise their warrants
and receive Class&nbsp;A ordinary shares. After the issuance of Class&nbsp;A ordinary shares upon exercise of the warrants, each holder
will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Under the terms of the warrant agreement, we have
agreed that as soon as practicable, but in no event later than 15&nbsp;business days after the closing of our initial business combination,
we will use our best efforts to file with the SEC a registration statement for the registration under the Securities Act&nbsp;of&nbsp;the
warrant shares and thereafter use its best efforts to cause the registration statement to become effective and to maintain the effectiveness
of such registration statement until the expiration of the warrants. However, we cannot assure you that we will be able to do so and,
if we do not maintain a current prospectus relating to the warrant shares issuable upon exercise of the warrants, holders will be unable
to exercise their warrants for cash and we will not be required to net cash settle or cash settle the warrant exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">No fractional shares will be issued upon exercise
of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon
exercise, round down to the nearest whole number of shares to be issued to the warrant holder. As a result, warrant holders not purchasing
an even number of warrants must sell any odd number of warrants in order to obtain full value from the fractional interest that will not
be issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">We have agreed that, subject to applicable law,
any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement will be brought and enforced
in the courts of the State of New&nbsp;York or the United&nbsp;States District Court for the Southern District of New&nbsp;York, and we
irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. This
provision applies to claims under the Securities Act but does not apply to claims under the Exchange&nbsp;Act or any claim for which the
federal district courts of the United&nbsp;States of America are the sole and exclusive forum. However, there is uncertainty as to whether
a court would enforce such provision, and investors cannot waive compliance with the federal securities laws and the rules and regulations
thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Preference Shares</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no preference shares outstanding. Our
amended and restated memorandum and articles of association authorizes the issuance of 1,000,000 preference shares and provides that preference
shares may be issued from time to time in one or more series. Our board of directors will be authorized to fix the voting rights, if any,
designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and
restrictions thereof, applicable to the shares of each series. Our board of directors will be able to, without shareholder approval, issue
preference shares with voting or other rights which could adversely affect the voting power or other rights of the holders of ordinary
shares. However, the underwriting agreement prohibits us, prior to a business combination, from issuing preference shares which participates
in any manner in the proceeds of the trust account, or which votes as a class with the ordinary shares on a business combination. We may
issue some or all of the preference shares to effect a business combination. In addition, the preference shares could be utilized as a
method of discouraging, delaying or preventing a change in control of us. Although we do not currently intend to issue any preference
shares, we cannot assure you that we will not do so in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 6; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>3
<FILENAME>ea028027801ex19-1.htm
<DESCRIPTION>INSIDER TRADING POLICY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 19.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TALON CAPITAL CORP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="text-transform: uppercase"><B>Insider
Trading POLICY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Talon Capital Corp. (the &ldquo;<U>Company</U>&rdquo;)
has adopted the following policy and procedures for securities trading by the Company and the Company&rsquo;s directors, employees and
other individuals (our &ldquo;<U>Insider Trading Policy</U>&rdquo;). Our Insider Trading Policy is intended to prevent the misuse of material
nonpublic information, insider trading in securities, and the severe consequences associated with violations of insider trading laws.
It is your obligation to review, understand, and comply with this Insider Trading Policy and applicable laws. Our Board of Directors has
approved this Insider Trading Policy, and we have appointed the Company&rsquo;s Chief Financial Officer as the Compliance Officer (with
their designees, the &ldquo;<U>Compliance Officer</U>&rdquo;) to administer the policy and to be available to answer your questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>PART I. OVERVIEW</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>A.&nbsp;Who
Must Comply?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">This Insider Trading Policy
applies to all of our employees and members of our Board of Directors, including anyone employed by or acting as a director of any of
the Company&rsquo;s subsidiaries, as well as any other individuals whom the Compliance Officer may designate as Insiders (defined below)
because they have access to material nonpublic information about the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In addition, all of our directors,
executive officers (as defined by Section 16 of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;))
and other designated employees must comply with the Trading Procedures included in Part II of this Insider Trading Policy (the &ldquo;<U>Trading
Procedures</U>&rdquo;); we will refer to these individuals in this policy as &ldquo;<U>Insiders</U>.&rdquo; The Trading Procedures provide
rules for when Insiders can trade in our securities and explain the process for mandatory pre-clearance of proposed trades. You will be
notified if you are considered to be an Insider who is required to comply with the Trading Procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Insider Trading Policy
and, for Insiders, the Trading Procedures also apply to the following persons (&ldquo;<U>Affiliated Persons</U>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left">your &ldquo;<U>Family Members</U>&rdquo; (&ldquo;Family Members&rdquo; are (a) your spouse or domestic
partner, children, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws who reside in the same household
as you, (b) your children or your spouse&rsquo;s children who do not reside in the same household as you but are financially dependent
on you, (c) any of your other family members who do not reside in your household but whose transactions are directed by you, and (d) any
other individual over whose account you have control and to whose financial support you materially contribute. (Materially contributing
to financial support would include, for example, paying an individual&rsquo;s rent but not just a phone bill.));</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left">all trusts, family partnerships and other types of entities formed for your benefit or for the benefit
of a member of your family and over which you have the ability to influence or direct investment decisions concerning securities;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">all persons who execute trades on your behalf; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left">all investment funds, trusts, retirement plans, partnerships, corporations and other types of entities
over which you have the ability to influence or direct investment decisions concerning securities; <U>provided</U>, <U>however</U>, that
the Trading Procedures do not apply to any such entity that engages in the investment of securities in the ordinary course of its business
(e.g., an investment fund or partnership) if the entity has established its own insider trading controls and procedures in compliance
with applicable securities laws and it (or an affiliated entity) has represented to the Company that its affiliated entities: (a) engage
in the investment of securities in the ordinary course of their respective businesses; (b) have established insider trading controls and
procedures in compliance with securities laws, including the establishment of internal information barriers to ensure that any material
nonpublic information concerning the Company of which you may become in possession is not shared with the persons at such entity making
investment decisions with respect to securities issued by the Company; and (c) are aware the securities laws prohibit any person or entity
who has material nonpublic information concerning the Company from purchasing or selling securities of the Company or from communicating
such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase
or sell securities.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">You are responsible for ensuring
compliance with this Insider Trading Policy, including the Trading Procedures contained herein, by all of your Affiliated Persons.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Transactions in the Company&rsquo;s
securities by the Company are generally subject to approval by the Company&rsquo;s Board of Directors and compliance with applicable securities
laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>B.&nbsp;What
is Prohibited by this Insider Trading Policy?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">You and your Affiliated Persons
are prohibited from engaging in insider trading and from trading in securities in violation of this Insider Trading Policy. &ldquo;Insider
trading&rdquo; is (1) trading (buying or selling) the securities of a company whether for your account or for the account of another,
while in the possession of material nonpublic information (see definition below) about that company or (2) disclosing material nonpublic
information about a company to others who may trade on the basis of that information. Insider trading can result in criminal prosecution,
jail time, significant fines and public embarrassment for you and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Prohibition on Trading in
Company Securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">When you are in possession
of material nonpublic information about the Company, whether positive or negative, you are prohibited from trading (whether for your account
of for the account of another) in the Company&rsquo;s securities, which include ordinary shares, options to purchase ordinary shares,
any other type of securities that the Company may issue (such as preferred stock, convertible debentures, warrants and exchange-traded
options), and any derivative securities that provide the economic equivalent of ownership of any the Company&rsquo;s securities or an
opportunity, direct or indirect, to profit from any change in the value of the Company&rsquo;s securities, except for trades made pursuant
to plans approved by the Compliance Officer in accordance with this policy that comply with Rule 10b5-1 under the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The trading prohibitions in
this Insider Trading Policy do <U>not</U> apply to: (1) an exercise of an employee stock option when payment of the exercise price is
made in cash or (2) the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted
stock units to satisfy applicable tax withholding requirements if (a) such withholding is required by the applicable plan or award agreement
or (b) the election to exercise such tax withholding right was made by the Insider in compliance with the Trading Procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The trading prohibitions in
this Insider Trading Policy <U>do</U> apply, however, to the use of outstanding Company securities to pay part or all of the exercise
price of a stock option, any sale of stock as part of a broker-assisted cashless exercise of an option, and any other market sale for
the purpose of generating the cash needed to pay the exercise price of an option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Prohibition on Tipping</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Providing material nonpublic
information about the Company to another person who may trade or advise others to trade on the basis of that information is known as &ldquo;<U>tipping</U>&rdquo;
and is illegal. You are prohibited from providing material nonpublic information about the Company to a friend, relative, or anyone else
who might buy or sell a security or other financial instrument on the basis of that information, whether or not you intend to or actually
do realize a profit (or any other benefit) from such tipping. Additionally, you are prohibited from recommending to any person that such
person engage in or refrain from engaging in any transaction involving the Company&rsquo;s securities, or otherwise give trading advice
concerning the Company&rsquo;s securities, if you are in possession of material nonpublic information about the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Prohibition on Trading in Securities of Other
Companies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">This policy&rsquo;s prohibitions
against insider trading and tipping also apply to trading in securities of other companies, including the Company&rsquo;s customers, suppliers,
partners and other enterprises with which we are working (such as when negotiating an acquisition, investment or other transaction that
could be material to the other company). Whenever, during the course of your service to or employment by the Company, you become aware
of material nonpublic information about another company, including any confidential information that is reasonably likely to affect the
market price of that company&rsquo;s securities (for example, discussions of licensing a product or acquiring that other company), neither
you nor your Affiliated Persons may trade in any securities of that company, give trading advice about that company, tip or disclose that
information, pass it on to others, or engage in any other action to take advantage of that information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If your work regularly involves
handling or discussing confidential information of one of our partners, suppliers or customers, you should consult with the Compliance
Officer before trading in any of that company&rsquo;s securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Duration of Trading Prohibitions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">These trading prohibitions
continue whenever and for as long as you know or are in possession of material nonpublic information. Remember, anyone scrutinizing your
transactions will be doing so after the fact, with the benefit of hindsight. As a practical matter, before engaging in any transaction,
you should carefully consider even the appearance of improper insider trading and how enforcement authorities and others might view the
transaction in hindsight.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">This Insider Trading Policy
applies to you and your Affiliated Persons so long as you are associated with the Company. If you leave the Company for any reason, this
Insider Trading Policy, including, if applicable, the Trading Procedures contained herein, will continue to apply to you and your Affiliated
Persons until the later of: (1) the first trading day following the public release of earnings for the fiscal quarter in which you leave
the Company or (2) the first trading day after any material nonpublic information known to you has become public or is no longer material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Restricted Trading Periods</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">From time to time, in connection
with an announcement of material information about the Company or when significant developments or announcements are anticipated, we may
impose a temporary prohibition on trading in our securities that applies to specified groups of employees or, in rare instances, all persons
covered by this policy. In such event, you will be notified by e-mail and/or other means of the imposition and expected duration of the
trading prohibition. During that period, no person covered by such a notice may trade in our securities (subject to the limited exceptions
set forth in this policy).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>C.&nbsp;What
is Material nonpublic Information?</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">This Insider Trading Policy
prohibits you from trading in a company&rsquo;s securities if you are in possession of information about the company that is both &ldquo;<I>material</I>&rdquo;
and &ldquo;<I>nonpublic</I>.&rdquo; If you have a question whether certain information you are aware of is material or has been made public,
you are encouraged to consult with the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&ldquo;Material&rdquo; Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Information about us or any
other company is &ldquo;material&rdquo; if it could reasonably be expected to affect the investment decisions of a shareholder or potential
investor, or if the disclosure of the information could reasonably be expected to significantly alter the total mix of information in
the marketplace about us or any other company. We speak mostly in this Insider Trading Policy about determining whether information about
us is material and nonpublic, but the same analysis applies to information that would preclude you from trading in securities of other
companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In simple terms, material
information is any type of information that could reasonably be expected to affect the market price of our securities. Both positive and
negative information may be material. While it is not possible to identify all information that would be deemed &ldquo;material,&rdquo;
the following items are types of information that should be considered carefully to determine whether they are material:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">projections of future earnings or losses, or other earnings guidance;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">quarterly financial results that are known but have not been publicly disclosed;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left">potential restatements of the Company&rsquo;s financial statements, changes in auditors or auditor notification
that the Company may no longer rely on an auditor&rsquo;s audit report;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">pending or proposed corporate mergers, acquisitions, tender offers, joint ventures or dispositions of
significant assets;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">changes in senior management or our Board of Directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">significant actual or threatened litigation or governmental investigations or major developments in such
matters;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">cybersecurity risks and incidents, including the discovery of significant vulnerabilities or breaches;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left">significant developments regarding products, customers, suppliers, orders, contracts or financing sources
(e.g., the acquisition or loss of a contract);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">changes in dividend policy, declarations of stock splits, or securities offerings or other financings;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">potential defaults under our credit agreements or indentures, or the existence of material liquidity deficiencies;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">bankruptcies or receiverships.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">By including the list above,
we do not mean to imply that each of these items above is always material. Rather, the information and events on the list still require
determinations as to their materiality (although some determinations will be reached more easily than others). For example, some new products
or contracts may clearly be material to an issuer; yet that does not mean that all product developments or contracts will be material.
No &ldquo;bright-line&rdquo; standard or list of items can adequately address the range of situations that may arise. Furthermore, we
cannot create an exclusive list of events and information that have a higher likelihood of being considered material.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&ldquo;Nonpublic&rdquo; Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Material information is &ldquo;nonpublic&rdquo;
if it has not been disseminated in a manner making it available to investors generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">To show that information is
public, it is necessary to point to some fact that establishes that the information has become publicly available, such as the filing
of a report with the SEC, the distribution of a press release, publishing the information on our website or via social media if such posting
is a regular way we communicate with investors, or by other means that are reasonably designed to provide broad public access. Before
a person with material nonpublic information can trade, there also must be adequate time for the market as a whole to absorb the information
that has been disclosed. For the purposes of this Insider Trading Policy, information will be considered public after the completion of
one full day of trading following the Company&rsquo;s public release of the information. For such purposes, a full day of trading means
an entire calendar day in which a session of regular trading hours on the NYSE or Nasdaq between 9:30 a.m. and 4:00 p.m. Eastern Time
(or such earlier close time as has been set by exchange rules) has occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">For example, if the Company
announces material nonpublic information of which you are aware before trading begins on a Tuesday, the first time you can buy or sell
Company securities is the opening of the market on Wednesday. However, if the Company announces this material information after trading
begins on that Tuesday, the first time that you can buy or sell Company securities is the opening of the market on Thursday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">D. What are the Penalties for Insider Trading and Noncompliance with this Insider Trading Policy?</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Both the U.S. Securities and
Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;) and the national securities exchanges, through the Financial Industry Regulatory Authority
(&ldquo;<U>FINRA</U>&rdquo;), investigate and are very effective at detecting insider trading. The U.S. government pursues insider trading
violations vigorously. For instance, cases have been successfully prosecuted against trading by employees in foreign accounts, trading
by family members and friends, and trading involving only a small number of shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The penalties for violating
insider trading or tipping rules can be severe and include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">forfeiting any profit gained or loss avoided by the trading;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left">payment of the loss suffered by the persons who, contemporaneously with the purchase or sale of securities
that are subject of such violation, have purchased or sold, as applicable, securities of the same class;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">payment of criminal penalties of up to $5,000,000;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">payment of civil penalties of up to three times the profit made or loss avoided; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify">imprisonment for up to 20 years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Company and/or the supervisors
of the person engaged in insider trading may also be required to pay civil penalties of fines starting from more than $2 million up to
three times the profit made or loss avoided, as well as criminal penalties of up to $25,000,000, and could under certain circumstances
be subject to private lawsuits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Violation of this Insider
Trading Policy or any federal or state insider trading laws may subject you to disciplinary action by the Company, including termination
of your employment or other relationship with the Company. The Company reserves the right to determine, in our own discretion and on the
basis of the information available to us, whether this Insider Trading Policy has been violated. We may determine that specific conduct
violates this Insider Trading Policy, whether or not the conduct also violates the law. It is not necessary for the Company to await the
filing or conclusion of a civil or criminal action against the alleged violator before taking disciplinary action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">E.&nbsp;How
Do You Report a Violation of this Insider Trading Policy?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If you have a question about
this Insider Trading Policy, including whether certain information you are aware of is material or has been made public, you are encouraged
to consult with the Compliance Officer. In addition, if you violate this Insider Trading Policy or any federal or state laws governing
insider trading or know of any such violation by any director or employee of the Company, you should report the violation immediately
to the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>PART II. TRADING PROCEDURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B><I>A.&nbsp;Special
Trading Restrictions Applicable to Insiders</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">In addition to needing to
comply with the restrictions on trading in our securities set forth above, Insiders and their Affiliated Persons are subject to the following
special trading restrictions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>1.</B></TD><TD STYLE="text-align: justify"><B>[Reserved]</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>2.</B></TD><TD STYLE="text-align: justify"><B>Special Closed Trading Periods</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The Compliance Officer may
designate, from time to time, a &ldquo;Special Closed Window&rdquo; during what would temporally be a permitted trading window. During
a Special Closed Window, designated Insiders (which could be all Insiders or a subset of them) may not trade in the Company&rsquo;s securities.
The Compliance Officer may also apply a Special Closed Window to Insiders or a subset of them to the trading in the securities of certain
other companies, as deemed appropriate or advisable, including certain of the Company&rsquo;s peers or competitors. The existence of a
Special Closed Window will not be announced to the Company generally, should not be communicated to any other person, and may itself be
considered under this Insider Trading Policy to be material nonpublic information about the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>3.</B></TD><TD STYLE="text-align: justify"><B>Prohibited Transactions</B></TD>
</TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">The
following transactions are prohibited unless authorized by the Audit Committee of the Board of Directors:</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left"><B>No Short Sales</B><FONT STYLE="font-style: normal">. You many not at any time sell any securities of
the Company that are not owned by you at the time of the sale (a &ldquo;short sale&rdquo;). </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left"><B>No Purchases or Sales of Derivative Securities or Hedging Transactions</B>. <FONT STYLE="font-style: normal">You
may not buy or sell puts, calls, other derivative securities of the Company or any derivative securities that provide the economic equivalent
of ownership of any of the Company&rsquo;s securities or an opportunity, direct or indirect, to profit from any change in the value of
our securities or engage in any other hedging transaction with respect to our securities, at any time.</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left"><B>No Company Securities Subject to Margin Calls</B>. <FONT STYLE="font-style: normal">You may not use
the Company&rsquo;s securities as collateral in a margin account.</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><B>No Pledges</B><FONT STYLE="font-style: normal">. You may not pledge Company securities as collateral
for a loan (or modify an existing pledge).</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-style: normal"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Gifts and Other Distributions
in Kind</B>.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">No Insider may donate or make
any other transfer of Company securities in kind without consideration during a period when the Insider is not permitted to trade. In
addition to charitable donations or gifts to family members, friends, trusts or others, this obligation applies to distributions by limited
partnerships that are subject to this Insider Trading Policy to their limited partners.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="text-decoration: none"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left"><B>5.</B></TD><TD STYLE="text-align: justify"><B>No Trading During Retirement Plan Blackout Periods</B>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If we adopt a policy to allow
ownership of Company stock in our 401(k) or other retirement plan, then no Insider may trade in any Company securities, which were acquired
in connection with such Insider&rsquo;s service or employment with the Company, during a retirement plan &ldquo;blackout period&rdquo;
except as specifically permitted below. A blackout period includes any period of more than three (3) consecutive business days during
which at least fifty percent (50%) of all participants and beneficiaries under all of the individual account plans maintained by the Company
and members of our controlled group are prohibited from trading in Company securities through their plan accounts. Insiders will receive
advance notice of any such blackout period from the Compliance Officer.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">B. &nbsp;Pre-Clearance
Procedures</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-style: normal">No
Insider may trade in our securities (including any purchases, sales, gifts, donations or charitable contributions), even during an open
trading window, unless the trade has been approved by the Compliance Officer under the procedures described below. In reviewing trading
requests, the Compliance Officer may consult with our other officers and/or outside legal counsel and will receive approval for his own
trades from the Chief Operating Officer. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-style: normal"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Procedures. </B>No Insider may trade in our securities unless and
until:</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-style: normal">The Insider has notified the Compliance Officer of the amount and nature
of the proposed trade(s) using the Stock Transaction Request form attached to this Insider Trading Policy. In order to provide adequate
time for the preparation of any required reports under Section 16 of the Exchange Act, a Stock Transaction Request form should, if practicable,
be received by the Compliance Officer at least two (2) business days prior to the intended trade date;</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-style: normal">The Insider has certified to the Compliance Officer in writing prior
to the proposed trade(s) that the Insider is not in possession of material nonpublic information concerning the Company;</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-style: normal">If the Insider is an executive officer or director, the Insider has informed
the Compliance Officer, using the Stock Transaction Request form attached hereto, whether, to the Insider&rsquo;s best knowledge, (a)
the Insider has (or is deemed to have) engaged in any opposite way transactions within the previous six months that were not exempt from
Section 16(b) of the Exchange Act and (b) if the transaction involves a sale by an &ldquo;affiliate&rdquo; of the Company or of &ldquo;restricted
securities&rdquo; (as such terms are defined under Rule 144 under the Securities Act of 1933, as amended (&ldquo;Rule 144&rdquo;)), whether
the transaction meets all of the applicable conditions of Rule 144; and</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font: normal 10pt Times New Roman, Times, Serif">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal">The Compliance Officer has approved the trade(s) and has certified such
approval in writing (which may be by email). </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-style: normal">The
Compliance Officer does not assume the responsibility for, and approval from the Compliance Officer does not protect the Insider from,
the consequences of prohibited insider trading.</FONT></P>


<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-style: normal"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Additional Information. </B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-style: normal">Insiders
shall provide to the Compliance Officer any documentation reasonably requested by the officer in furtherance of the foregoing procedures.
Any failure to provide such requested information will be grounds for denial of approval by the Compliance Officer.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-style: normal"><B>3.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Notification of Brokers of Insider Status</B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-style: normal">Insiders
who are required to file reports under Section 16 of the Exchange Act shall inform all broker-dealers that may trade in our shares on
the Insider&rsquo;s or an Affiliated Person&rsquo;s behalf of their status as a Section 16 officer and affiliate of the Company, the requirement
that the broker confirm that any trade by the Insider has been approved by the Company pursuant to these pre-clearance procedures before
making any trade, and arrange for the broker to provide transaction information to the Insider and/or Compliance Officer on the day of
any executed transaction. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-style: normal"><B>4.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>No Obligation to Approve Trades.</B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-style: normal; font-weight: normal">The
existence of the foregoing approval procedures does not in any way obligate the Compliance Officer to approve any trade requested by an
Insider. The Compliance Officer may reject any trading request at their sole discretion. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">From
time to time, an event may occur that is material to the Company and is known by only by a limited number of directors and employees.
Insiders may not trade in our securities if they are notified by the Compliance Officer that a proposed trade has not been cleared because
of the existence of a material nonpublic development &ndash; even if that particular Insider is not aware of the material nonpublic development
involving the Company. If any Insider engages in a trade before a material nonpublic development is disclosed to the public or resolved,
the Insider and the Company might be exposed to a charge of insider trading that could be costly and difficult to refute even if the Insider
was unaware of the development. So long as the event remains material and nonpublic, the Compliance Officer may determine not to approve
any transactions in the Company&rsquo;s securities. The Compliance Officer will subsequently notify the Insider once the material nonpublic
development is disclosed to the public or resolved. If an Insider requests clearance to trade in our securities during the pendency of
such an event, the Compliance Officer may reject the trading request without disclosing the reason.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-style: normal"><B>5.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Completion of Trades. </B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">After
receiving written clearance to engage in a trade signed by the Compliance Officer, an Insider must complete the proposed trade within
three (3) business days or make a new trading request. Notwithstanding that an Insider has received such clearance, the Insider shall
not engage in a trade if (i) such clearance has been rescinded by the Compliance Officer, (ii) the Insider has otherwise received notice
that the trading window has been closed or (iii) the Insider believes that they may have material nonpublic information.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-style: normal"><B>6.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Post-Trade Reporting. </B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">The
details of any transactions in our securities (including transactions effected pursuant to a Rule 10b5-1 Plan or any other purchases,
sales, gifts, donations or charitable contributions) by an Insider (or one of their Affiliated Persons) who is required to file reports
under Section 16 of the Exchange Act must be reported to the Compliance Officer by the Insider or their brokerage firm on the same day
on which a trade order is placed or such a transaction otherwise is entered into. Such report shall include the date of the transaction,
quantity of shares, the price and the name of any broker-dealer through which the transaction was effected. This reporting requirement
may be satisfied by providing (or having such Insider&rsquo;s broker provide) a trade order confirmation to the Compliance Officer if
such information is received by the Compliance Officer by the required date. Compliance by directors and executive officers with this
provision is imperative given the requirement of Section 16 of the Exchange Act that these persons generally must report changes in ownership
of Company securities within two (2) business days. The sanctions for noncompliance with this reporting deadline include mandatory disclosure
in the Company&rsquo;s proxy statement for the next annual meeting of shareholders, as well as possible civil or criminal sanctions for
chronic or egregious violators.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">C.&nbsp;Exemptions</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-style: normal"><B>1.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Pre-Approved Rule 10b5-1 Plan. </B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Transactions
made pursuant to an approved Rule 10b5-1 Plan (as defined below) will not be subject to our trading windows, retirement plan blackout
periods or pre-clearance procedures, and Insiders are not required to complete a Stock Transaction Request form for such transactions.
Rule 10b5-1 of the Exchange Act provides an affirmative defense from insider trading liability under the federal securities laws for trading
plans, arrangements or instructions that meet certain requirements. A trading plan, arrangement or instruction that meets the requirements
of Rule 10b5-1 (a &ldquo;Rule 10b5-1 Plan&rdquo;) enables Insiders to trade in Company securities outside of our trading windows, even
when in possession of material nonpublic information. </FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">If
an Insider intends to trade pursuant to a Rule 10b5-1 Plan, such plan, arrangement or instruction must:</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">satisfy
the requirements of Rule 10b5-1 in effect at such time; </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be documented
in writing; </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be established
during a trading window; </FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be entered
into in good faith by the Insider, not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1, at a time when such Insider
does not possess material nonpublic information, and, if the Insider is a director or executive officer, such plan must include representations
by the Insider certifying the foregoing;</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">must
(a) specify the amount of securities to be sold, the price at which and the date on which the securities are to be sold, (b) include a
written formula or algorithm, or computer program, for determining the amount of securities to be sold and the price at which and the
date on which the securities are to be sold, or (c) not permit the Insider to exercise any subsequent influence over how, when, or whether
to effect transactions; provided, in addition, that any other person who, pursuant to such plan, arrangement or instruction, exercises
such influence must not have been aware of material nonpublic information when doing so;</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">provide
                                            that no transactions may occur thereunder until the expiration of the applicable cooling-off
                                            period specified in Rule 10b5-1(c)(ii)(B) (the &ldquo;<U>Cooling-Off Period</U>&rdquo;)</FONT><SUP>1</SUP>
                                            <FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">(and
                                            no transactions thereunder occur until after that time);</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be the
only outstanding plan, arrangement or instruction entered into by the Insider (subject to the limited exceptions in Rule 10b5-1(c)(ii)(D));
and</FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">&#9679;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">be pre-approved
by the Compliance Officer.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in">Prior to approving any 10b5-1
Plan, the Compliance Officer may require that the plan exclude or include certain additional provisions (e.g., longer cooling off periods,
minimum number of trades requirement, specified term) to ensure compliance with SEC regulations, best practices or otherwise as the Compliance
Officer deems to be in the best interests of the Company. Alternatively, the Compliance Officer may refuse to approve a 10b5-1 Plan that
does not meet applicable legal requirements or satisfy best practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Any proposed deviation from
the specifications of an approved Rule 10b5-1 Plan (including, without limitation, the amount, price or timing of a purchase or sale)
must be reported immediately to, and be approved by, the Compliance Officer. <B>Any transaction pursuant to a Rule 10b5-1 Plan must be
timely reported following the transaction in accordance with the procedures set forth above.</B> The Compliance Officer may refuse to
approve a Rule 10b5-1 Plan as they deem appropriate including, without limitation, if they determine that such plan does not satisfy the
requirements of Rule 10b5-1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Any modification or termination
of an Insider&rsquo;s existing Rule 10b5-1 Plan requires pre-approval by the Compliance Officer. The Compliance Officer shall require
as a condition to such approval that the modification or termination occur during a trading window and be entered into in good faith,
not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1, while such Insider is not aware of material nonpublic information.
In addition to the foregoing, any modifications of a Rule 10b5-1 Plan (including any changes to the pricing, amount of securities, or
timing of transactions, but not for purely ministerial changes such as changes in account information or adjustment for stock splits)
will be subject to the applicable Cooling-Off Period prior to any transaction occurring under the Rule 10b5-1 Plan as modified.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-style: normal"><B></B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal">The
appropriate Cooling-Off Period varies based on the status of the Insider. For directors and executive officers, the cooling-off period
ends on the later of (x) 90 days after adoption or modification of the plan or (y) two business days following disclosure of the Company&rsquo;s
financial results in a Form 10-K or Form 10-Q for the completed fiscal quarter in which the plan was adopted (not to exceed 120 days).
For all other Insiders, the Cooling-Off Period ends 30 days after adoption or modification of the plan. The Cooling-Off Period will apply
to the entry into a new plan and any revision or modification of a plan, including changes to the pricing, amount of securities, or timing
of transactions, but not for purely ministerial changes such as changes in account information or adjustment for stock splits.</FONT></TD>
</TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-style: normal"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: italic 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-style: normal"><B>2.</B></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-style: normal"><B>Employee Equity and Retirement Plans.</B></FONT></TD></TR></TABLE>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><B>Exercise of Stock
Options</B><FONT STYLE="font-style: normal">. The trading prohibitions and restrictions set forth in the Trading Procedures do not apply
to the exercise of an option to purchase securities of the Company when payment of the exercise price is made in cash. However, the exercise
of an option to purchase securities of the Company is subject to the current reporting requirements of Section 16 of the Exchange Act
and, therefore, Insiders must comply with the post-trade reporting requirement described in Section C above for any such transaction.
In addition, the securities acquired upon the exercise of an option to purchase Company securities are subject to all of the requirements
of this Insider Trading Policy, including the Trading Procedures contained herein. Moreover, the Trading Procedures apply to the use of
outstanding Company securities to pay part or all of the exercise price of an option, any net option exercise, any exercise of a stock
appreciation right, share withholding, any sale of stock as part of a broker-assisted cashless exercise of an option, or any other market
sale for the purpose of generating the cash needed to pay the exercise price of an option.</FONT></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><B>Tax Withholding
on Restricted Stock/Units</B><FONT STYLE="font-style: normal">. The trading prohibitions and restrictions set forth in the Trading Procedures
do not apply to the withholding by the Company of shares of stock upon vesting of restricted stock or upon settlement of restricted stock
units to satisfy applicable tax withholding requirements if (a) such withholding is required by the applicable plan or award agreement
or (b) the election to exercise such tax withholding right was made by the Insider in compliance with the Trading Procedures.</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">D.&nbsp;Waivers</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">A waiver of any provision
of this Insider Trading Policy, or the Trading Procedures contained herein, in a specific instance may be authorized in writing by the
Audit Committee of the Board of Directors, and any such waiver shall be reported to the Board of Directors.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-style: normal">&nbsp;</FONT></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-style: normal">PART
III. ACKNOWLEDGEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">We will deliver a copy of
this Insider Trading Policy to all current employees and directors and to future employees and directors at the start of their employment
or relationship with the Company. Upon first receiving a copy of this Insider Trading Policy, each individual must acknowledge that they
have received a copy and agree to comply with the terms of this Insider Trading Policy, and, if applicable, the Trading Procedures contained
herein. The acknowledgment attached hereto must be completed and submitted to the Company within ten (10) days of receipt.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Upon our request, directors
and employees and consultants will be required to re-acknowledge and agree to comply with the Insider Trading Policy (including any amendments
or modifications). For such purpose, an individual will be deemed to have acknowledged and agreed to comply with the Insider Trading Policy,
as amended from time to time, when copies of such items have been delivered by regular or electronic mail (or other delivery option used
by the Company) to the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">*&#9;*&#9;*</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Questions regarding this Insider
Trading Policy are encouraged and may be directed to the Compliance Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">ADOPTED: &nbsp;&nbsp;&nbsp;&nbsp;, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">EFFECTIVE: &nbsp;&nbsp;&nbsp;&nbsp;, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>EXHIBIT A</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>STOCK TRANSACTION REQUEST</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Pursuant to Talon Capital Corp.&rsquo;s Insider
Trading Policy, I hereby notify Talon Capital Corp. (the &ldquo;Company&rdquo;) of my intent to trade the securities of the Company as
indicated below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="4" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; border-top: Black 1pt solid; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; border-top: Black 1pt solid; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="4" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B><U>REQUESTER INFORMATION</U></B></TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Insider&rsquo;s Name:</TD><TD COLSPAN="3" STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">____________________________________________</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD><TD COLSPAN="3" STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="4" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B><U>INTENT TO PURCHASE</U></B></TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Number of shares:</TD><TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD>
                          <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">__________________________________</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Intended trade date:</TD>
              <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">__________________________________</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="text-align: left; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Means of acquiring shares:</FONT></TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&#9744;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">Acquisition through employee benefit plan (please specify):<BR>
________________________________________________________________</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; width: 20%; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; width: 6%; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; width: 4%; padding-left: 5.4pt">&#9744;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; width: 60%; padding-left: 5.4pt">Purchase through a broker on the open market</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; width: 10%; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&#9744;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">Other (please specify): ______________________________________________</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="4" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B><U>INTENT TO SELL OR TRANSFER</U></B></TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Number of shares:</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">__________________________________</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">Intended trade date:</TD>
              <TD COLSPAN="2" STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">__________________________________</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Means of selling shares:</FONT></TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&#9744;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">Sale through employee benefit plan (please specify):<BR>
________________________________________________________________</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&#9744;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">Sale through a broker on the open market</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&#9744;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-size: 10pt">Gift, Donation or Charitable Contribution</FONT></TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&#9744;</TD>
              <TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">Other (please specify): ______________________________________________</TD><TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; border-bottom: Black 1pt solid; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; border-bottom: Black 1pt solid; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
              <TD STYLE="padding-right: 5.4pt; border-bottom: Black 1pt solid; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>SECTION 16<BR>
<BR>
_____________________________________________</B></TD><TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD COLSPAN="2" STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: left; padding-left: 5.4pt"><B>RULE
                                            144 (Not applicable if transaction requested involves (i) a purchase, or (ii) a sale pursuant
                                            to an effective registration statement)<BR>
______________________________________________________________________</B></TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
<TD COLSPAN="2" STYLE="border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD COLSPAN="2" STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt; width: 5%">&#9744;</TD>
<TD STYLE="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt; width: 35%">I am not subject to Section 16.</TD><TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt; width: 2%">&nbsp;</TD><TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt; width: 5%">&#9744;</TD>
                                                                                                                                                                             <TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: left; padding-left: 5.4pt; width: 53%">I am not an &ldquo;affiliate&rdquo; of the Company and the transaction
requested above does not involve the sale of &ldquo;restricted securities&rdquo; (as such terms are defined under Rule 144 under the Securities
Act of 1933, as amended).</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
                                                                                                                                                                             <TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-left: Black 1pt solid; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt">&#9744;</TD>
<TD STYLE="text-align: left; padding-right: 5.4pt; padding-left: 5.4pt">To the best of my knowledge, I have not (and am not deemed to have) engaged in an opposite way transaction within the previous 6 months
that was not exempt from Section 16(b) of the Exchange Act.</TD><TD STYLE="padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&#9744;</TD>
                                                                                                                                                   <TD STYLE="border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">To the best of my knowledge, the transaction requested above will meet
all of the applicable conditions of Rule 144.</P></TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; text-align: left; padding-left: 5.4pt">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; text-align: center; padding-left: 5.4pt">&nbsp;</TD>
                                                                                                                                                   <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; text-align: justify; padding-left: 5.4pt">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
<TD STYLE="border-top: Black 1pt solid">&nbsp;</TD><TD STYLE="border-top: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-top: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</TD></TR>
                                                                                                                                          <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid; width: 2%">&nbsp;</TD>
<TD STYLE="width: 40%"><B><U>CERTIFICATION</U></B></TD><TD STYLE="width: 16%; text-align: left">&nbsp;</TD><TD STYLE="text-align: justify; width: 40%">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid; width: 2%">&nbsp;</TD>
</TR><TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
<TD COLSPAN="3" STYLE="text-align: left">I hereby certify that I: (1) am not in possession of any material nonpublic information concerning the Company, as defined in the Company&rsquo;s Insider Trading Policy, (2) am not purchasing any securities of the Company on margin in contravention of the Company&rsquo;s trading procedures, and (3) have executed the Acknowledgement of the Company&rsquo;s Insider Trading Policy. I understand that, if I trade while possessing such information or in violation of such trading restrictions, I may be subject to severe civil and/or criminal penalties and may be subject to discipline by the Company including termination.</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
<TD>Insider&rsquo;s Signature</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">Date</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
<TD></TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
<TD><B><U>AUTHORIZED APPROVAL</U></B></TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
<TD>&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-left: Black 1pt solid">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: justify">&nbsp;</TD>
    <TD STYLE="border-right: Black 1pt solid">&nbsp;</TD></TR>
     <TR STYLE="vertical-align: top; text-align: justify">
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid">&nbsp;</TD>
<TD STYLE="border-bottom: Black 1pt solid">Signature of Compliance Officer (or designee)</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: justify">Date</TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-right: Black 1pt solid">&nbsp;</TD></TR>
     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><I>*NOTE:</I></TD><TD STYLE="text-align: justify"><I>Multiple lots must be listed on separate forms or broken
out herein.</I></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt"></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><U>EXHIBIT B</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B>ACKNOWLEDGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.75in">I hereby acknowledge that
I have read, that I understand, and that I agree to comply with, the Insider Trading Policy of Talon Capital Corp. (the &ldquo;Company&rdquo;).
I further acknowledge and agree that I am responsible for ensuring compliance with the Insider Trading Policy and the Trading Procedures
included therein by all of my &ldquo;Affiliated Persons.&rdquo; I also understand and agree that I will be subject to sanctions, including
termination of employment, that may be imposed by the Company, in its sole discretion, for violation of the Insider Trading Policy, and
that the Company may give stop-transfer and other instructions to the Company&rsquo;s transfer agent or any brokerage firm managing the
Company&rsquo;s equity incentive plan(s) against the transfer of any Company securities in a transaction that the Company considers to
be in contravention of the Insider Trading Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This acknowledgement will
constitute consent for the Company to impose sanctions for violation of the Insider Trading Policy, including the Trading Procedures,
and to issue any necessary stop-transfer orders to the Company&rsquo;s transfer agent to ensure compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; text-align: justify; font-size: 10pt">Date:</TD>
    <TD STYLE="width: 25%; border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 17%; text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: justify; font-size: 10pt">Signature:</TD>
    <TD STYLE="width: 37%; border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Name:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="3" STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">Title:</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>ea028027801ex31-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-variant: normal"><B>Exhibit</B></FONT><B>
<FONT STYLE="font-variant: small-caps">31.1</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF CHIEF EXECUTIVE OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES
EXCHANGE ACT OF 1934,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">I, Charles Leykum, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">1.</TD>
    <TD><FONT STYLE="font-size: 10pt">I have reviewed this annual report on Form&nbsp;10-K&nbsp;of Talon Capital Corp.;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">3.</TD>
    <TD><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">4.</TD>
    <TD><FONT STYLE="font-size: 10pt">I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and&nbsp;15d-15(e))&nbsp;for the registrant and have:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">a)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant,&nbsp;is made known to us by others within those entities, particularly during the period in which this report is being prepared; and</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">b)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">(Paragraph omitted pursuant to Exchange Act Rules&nbsp;13a-14(a)&nbsp;and&nbsp;15d-15(a));</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp; &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">c)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp; &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">d)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">5.</TD>
    <TD><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp; &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">a)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp; &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">b)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Date: March 27, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-size: 10pt">/s/ Charles Leykum</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Charles Leykum</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Principal Executive Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>&nbsp;</B></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>ea028027801ex31-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit <FONT STYLE="font-variant: small-caps">31.2</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION OF CHIEF FINANCIAL OFFICER</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PURSUANT TO RULE 13A-14(A) UNDER THE SECURITIES
EXCHANGE ACT OF 1934,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY
ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">I, Gerald Cimador, certify that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">1.</TD>
    <TD><FONT STYLE="font-size: 10pt">I have reviewed this annual report on Form&nbsp;10-K&nbsp;of Talon Capital Corp.;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">2.</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">3.</TD>
    <TD><FONT STYLE="font-size: 10pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">4.</TD>
    <TD><FONT STYLE="font-size: 10pt">I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and&nbsp;15d-15(e))&nbsp;for the registrant and have:</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp; &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">a)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant,&nbsp;is made known to us by others within those entities, particularly during the period in which this report is being prepared; and</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">b)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">(Paragraph omitted pursuant to Exchange Act Rules&nbsp;13a-14(a)&nbsp;and&nbsp;15d-15(a));</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp; &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">c)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Evaluated the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp; &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">d)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Disclosed in this report any change in the registrant&rsquo;s internal control over financial reporting that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&rsquo;s internal control over financial reporting; and</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">5.</TD>
    <TD><FONT STYLE="font-size: 10pt">The registrant&rsquo;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board of directors (or persons performing the equivalent functions):</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp; &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">a)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s ability to record, process, summarize and report financial information; and</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.25in">&nbsp; &nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 0.25in"><FONT STYLE="font-size: 10pt">b)</FONT></TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Date: March 27, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-size: 10pt">/s/ Gerald Cimador</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Gerald Cimador</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Principal Financial and Accounting Officer)</P></TD></TR>
  </TABLE>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>ea028027801ex32-1.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Exhibit</B><B>
32.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">In connection with the Annual Report of Talon
Capital Corp. (the &ldquo;Company&rdquo;) on Form&nbsp;10-K&nbsp;for the year ended December 31, 2025, as filed with the Securities and
Exchange Commission (the &ldquo;Report&rdquo;), I, Charles Leykum, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
&sect;1350, as adopted pursuant to &sect;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The Report fully complies with
the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The information contained in
the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Dated: March 27, 2026</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Charles Leykum</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Charles Leykum</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Principal Executive Officer)</P></TD></TR>
  </TABLE>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>ea028027801ex32-2.htm
<DESCRIPTION>CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>Exhibit <FONT STYLE="font-variant: small-caps">32.2</FONT></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CERTIFICATION PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>18 U.S.C. SECTION 1350</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AS ADOPTED PURSUANT TO</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">In connection with the Annual Report of Talon
Capital Corp. (the &ldquo;Company&rdquo;) on Form&nbsp;10-K&nbsp;for the year ended December 31, 2025, as filed with the Securities and
Exchange Commission (the &ldquo;Report&rdquo;), I, Gerald Cimador, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
&sect;1350, as adopted pursuant to &sect;906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">1.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The Report fully complies with
the requirements of Section&nbsp;13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="text-align: left; width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">2.</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The information contained in
the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</FONT></TD>
</TR></TABLE>
<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Dated: March 27, 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%">
    <P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Gerald Cimador</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Gerald Cimador</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Financial Officer</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Principal Financial and Accounting Officer)</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>tlnc-20251231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><xs:schema targetNamespace="http://TCC.com/20251231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tlnc="http://TCC.com/20251231" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2025">
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/cyd/2025" schemaLocation="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd" />
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tlnc-20251231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tlnc-20251231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tlnc-20251231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tlnc-20251231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple" />
      <link:roleType roleURI="http://TCC.com/20251231/role/Cover" id="Cover">
        <link:definition>995300 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/AuditInformation" id="AuditInformation">
        <link:definition>995301 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/BalanceSheet" id="BalanceSheet">
        <link:definition>995302 - Statement - Balance Sheet</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/BalanceSheetParentheticals" id="BalanceSheetParentheticals">
        <link:definition>995303 - Statement - Balance Sheet (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/StatementofOperations" id="StatementofOperations">
        <link:definition>995304 - Statement - Statement of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/StatementofOperationsParentheticals" id="StatementofOperationsParentheticals">
        <link:definition>995305 - Statement - Statement of Operations (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit" id="StatementofChangesInShareholdersDeficit">
        <link:definition>995306 - Statement - Statement of Changes In Shareholders&#8217; Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals" id="StatementofChangesInShareholdersDeficitParentheticals">
        <link:definition>995307 - Statement - Statement of Changes In Shareholders&#8217; Deficit (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/StatementofCashFlows" id="StatementofCashFlows">
        <link:definition>995308 - Statement - Statement of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperations" id="DescriptionofOrganizationandBusinessOperations">
        <link:definition>995309 - Disclosure - Description of Organization and Business Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPolicies" id="SummaryofSignificantAccountingPolicies">
        <link:definition>995310 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/InitialPublicOffering" id="InitialPublicOffering">
        <link:definition>995311 - Disclosure - Initial Public Offering</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/PrivatePlacementUnits" id="PrivatePlacementUnits">
        <link:definition>995312 - Disclosure - Private Placement Units</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>995313 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/Commitments" id="Commitments">
        <link:definition>995314 - Disclosure - Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/ShareholdersDeficit" id="ShareholdersDeficit">
        <link:definition>995315 - Disclosure - Shareholders' Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SegmentInformation" id="SegmentInformation">
        <link:definition>995316 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>995317 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure" id="CybersecurityRiskManagementandStrategyDisclosure">
        <link:definition>995318 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies" id="SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>996319 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesTables" id="SummaryofSignificantAccountingPoliciesTables">
        <link:definition>996320 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SegmentInformationTables" id="SegmentInformationTables">
        <link:definition>996321 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails" id="DescriptionofOrganizationandBusinessOperationsDetails">
        <link:definition>996322 - Disclosure - Description of Organization and Business Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails" id="SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>996323 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails" id="SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails">
        <link:definition>996324 - Disclosure - Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails" id="SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails">
        <link:definition>996325 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Income Per Ordinary Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/InitialPublicOfferingDetails" id="InitialPublicOfferingDetails">
        <link:definition>996326 - Disclosure - Initial Public Offering (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/PrivatePlacementUnitsDetails" id="PrivatePlacementUnitsDetails">
        <link:definition>996327 - Disclosure - Private Placement Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/RelatedPartyTransactionsDetails" id="RelatedPartyTransactionsDetails">
        <link:definition>996328 - Disclosure - Related Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/CommitmentsDetails" id="CommitmentsDetails">
        <link:definition>996329 - Disclosure - Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/ShareholdersDeficitDetails" id="ShareholdersDeficitDetails">
        <link:definition>996330 - Disclosure - Shareholders' Deficit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SegmentInformationDetails" id="SegmentInformationDetails">
        <link:definition>996331 - Disclosure - Segment Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://TCC.com/20251231/role/SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails" id="SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails">
        <link:definition>996332 - Disclosure - Segment Information - Schedule of Performance and Making Key Decisions Regarding Resource Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="tlnc_AccruedOfferingCosts" name="AccruedOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_DeferredUnderwritingFeeNoncurrent" name="DeferredUnderwritingFeeNoncurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_NumberOfFounderShareIssued" name="NumberOfFounderShareIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfFounderShareOutstanding" name="NumberOfFounderShareOutstanding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfFounderSharesHolding" name="NumberOfFounderSharesHolding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfSharesSubjectToForfeiture" name="NumberOfSharesSubjectToForfeiture" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfShareSubjectNotToForfeiture" name="NumberOfShareSubjectNotToForfeiture" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="tlnc_SponsorMember" name="SponsorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" name="PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="tlnc_ProceedsFromSaleOfUnderwritersReimbursement" name="ProceedsFromSaleOfUnderwritersReimbursement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_CashHeldInTrustAccountPolicyTextBlock" name="CashHeldInTrustAccountPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_EmergingGrowthCompanyPolicyTextBlock" name="EmergingGrowthCompanyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_OfferingCostsPolicyTextBlock" name="OfferingCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_TransactionCosts" name="TransactionCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="tlnc_UnitsIssuedDuringPeriodSharesNewIssues" name="UnitsIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_WorkingCapitalDeficit" name="WorkingCapitalDeficit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_WorkingCapitalLoan" name="WorkingCapitalLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_YearOfInception" name="YearOfInception" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_CantorMember" name="CantorMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_CashUnderwritingFee" name="CashUnderwritingFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" name="CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="tlnc_DeferredUnderwritingFee" name="DeferredUnderwritingFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable" name="DescriptionOfOrganizationAndBusinessOperationsTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_InitialBusinessCombinationOrToRedeemPercentage" name="InitialBusinessCombinationOrToRedeemPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_InterestEarnedOnTheTrustAccountPerAnnum" name="InterestEarnedOnTheTrustAccountPerAnnum" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_MaximumNetInterestToPayDissolutionExpenses" name="MaximumNetInterestToPayDissolutionExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" name="MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_NoOfMaturityDays" name="NoOfMaturityDays" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_AdvanceReceivedForWorkingCapital" name="AdvanceReceivedForWorkingCapital" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_BusinessCombinationMember" name="BusinessCombinationMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" name="ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" name="ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_EffectiveRedemptionPeriod" name="EffectiveRedemptionPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_InitialPublicOfferingAbstract" name="InitialPublicOfferingAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_InitialPublicOfferingTable" name="InitialPublicOfferingTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_NoticePeriodForRedemptionOfWarrants" name="NoticePeriodForRedemptionOfWarrants" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfTradingDays" name="NumberOfTradingDays" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds" name="PercentageOfGrossProceedsOnTotalEquityProceeds" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_PrivatePlacementWarrantsMember" name="PrivatePlacementWarrantsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_PublicWarrantMember" name="PublicWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_TriggerPrice" name="TriggerPrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="tlnc_UnderwritingOptionPeriod" name="UnderwritingOptionPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_InitialPublicOfferingTextBlock" name="InitialPublicOfferingTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember" name="ClassAOrdinarySharesSubjectToPossibleRedemptionMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_UnderwritingDiscountAmountPerUnit" name="UnderwritingDiscountAmountPerUnit" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_ClassAOrdinarySharesIssuanceCosts" name="ClassAOrdinarySharesIssuanceCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable" name="ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_AggregateAmount" name="AggregateAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_AggregateShares" name="AggregateShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_AggregateSponsorAmount" name="AggregateSponsorAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_AmountOfFairValue" name="AmountOfFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_FairValueOfShares" name="FairValueOfShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_FairValuePerSharePrice" name="FairValuePerSharePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_FounderShareMember" name="FounderShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_OutstandingBalancePromissoryNote" name="OutstandingBalancePromissoryNote" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders" name="PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits" name="StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" name="StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member" name="WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember" name="UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_ClassAOrdinarySharesParValue00001PerShareMember" name="ClassAOrdinarySharesParValue00001PerShareMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_NumberOfAdditionalFounderShareIssued" name="NumberOfAdditionalFounderShareIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" />
  <xs:element id="tlnc_OtherOfferingCosts" name="OtherOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit" />
  <xs:element id="tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts" name="DeferredOfferingCostsIncludedInAccruedOfferingCosts" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty" name="DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_DeferredUnderwritingFeePayable" name="DeferredUnderwritingFeePayable" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_ForfeitureOfFounderShares" name="ForfeitureOfFounderShares" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit" />
  <xs:element id="tlnc_InterestRateMember" name="InterestRateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_UnderwritingAgreementMember" name="UnderwritingAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_SaleOfStockNumberOfSharesIssued" name="SaleOfStockNumberOfSharesIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_ShareholdersDeficitTable" name="ShareholdersDeficitTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_ConversionOfOrdinarySharesPercentage" name="ConversionOfOrdinarySharesPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_CohenMember" name="CohenMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_PrivatePlacementAbstract" name="PrivatePlacementAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xs:element id="tlnc_PercentageOfDeferredUnderwritings" name="PercentageOfDeferredUnderwritings" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_PrivatePlacementTextBlock" name="PrivatePlacementTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfAdditionalFounderSharesIssued" name="NumberOfAdditionalFounderSharesIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfFounderSharesIssued" name="NumberOfFounderSharesIssued" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfFounderSharesOutstanding" name="NumberOfFounderSharesOutstanding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfShareSubjectToForfeiture" name="NumberOfShareSubjectToForfeiture" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfSharesSubjectNotToForfeiture" name="NumberOfSharesSubjectNotToForfeiture" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
  <xs:element id="tlnc_NumberOfFounderShareHolding" name="NumberOfFounderShareHolding" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>tlnc-20251231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#BalanceSheet" roleURI="http://TCC.com/20251231/role/BalanceSheet" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#StatementofCashFlows" roleURI="http://TCC.com/20251231/role/StatementofCashFlows" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#StatementofOperations" roleURI="http://TCC.com/20251231/role/StatementofOperations" />
  <link:calculationLink xlink:role="http://TCC.com/20251231/role/BalanceSheet" xlink:type="extended" xlink:title="calculationLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AccruedOfferingCosts" xlink:label="tlnc_AccruedOfferingCosts" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredUnderwritingFeeNoncurrent" xlink:label="tlnc_DeferredUnderwritingFeeNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:calculationArc xlink:type="arc" order="1.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_Cash" />
    <link:calculationArc xlink:type="arc" order="2.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent" />
    <link:calculationArc xlink:type="arc" order="3.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" />
    <link:calculationArc xlink:type="arc" order="107.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" />
    <link:calculationArc xlink:type="arc" order="108.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" />
    <link:calculationArc xlink:type="arc" order="109.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapital" />
    <link:calculationArc xlink:type="arc" order="110.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:calculationArc xlink:type="arc" order="1.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" order="2.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="tlnc_AccruedOfferingCosts" />
    <link:calculationArc xlink:type="arc" order="4.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" />
    <link:calculationArc xlink:type="arc" order="5.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="tlnc_DeferredUnderwritingFeeNoncurrent" />
    <link:calculationArc xlink:type="arc" order="4.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" />
    <link:calculationArc xlink:type="arc" order="3.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent" />
    <link:calculationArc xlink:type="arc" order="4.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent" />
    <link:calculationArc xlink:type="arc" order="4.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:calculationArc xlink:type="arc" order="111.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" />
    <link:calculationArc xlink:type="arc" order="511.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" />
    <link:calculationArc xlink:type="arc" order="3.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_CommitmentsAndContingencies" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://TCC.com/20251231/role/StatementofCashFlows" xlink:type="extended" xlink:title="calculationLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" xlink:label="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" xlink:label="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidInsurance" xlink:label="us-gaap_IncreaseDecreaseInPrepaidInsurance" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:label="us-gaap_PaymentsToAcquireTrustPreferredInvestments" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ProceedsFromSaleOfUnderwritersReimbursement" xlink:label="tlnc_ProceedsFromSaleOfUnderwritersReimbursement" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:calculationArc xlink:type="arc" order="1.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" order="1.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" />
    <link:calculationArc xlink:type="arc" order="2.00" weight="-1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_InvestmentIncomeInterest" />
    <link:calculationArc xlink:type="arc" order="3.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" />
    <link:calculationArc xlink:type="arc" order="4.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" />
    <link:calculationArc xlink:type="arc" order="1.00" weight="-1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
    <link:calculationArc xlink:type="arc" order="2.00" weight="-1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidInsurance" />
    <link:calculationArc xlink:type="arc" order="3.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:calculationArc xlink:type="arc" order="523.00" weight="-1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireTrustPreferredInvestments" />
    <link:calculationArc xlink:type="arc" order="1.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:calculationArc xlink:type="arc" order="2.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromOtherEquity" />
    <link:calculationArc xlink:type="arc" order="3.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
    <link:calculationArc xlink:type="arc" order="4.00" weight="-1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="tlnc_ProceedsFromSaleOfUnderwritersReimbursement" />
    <link:calculationArc xlink:type="arc" order="5.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
    <link:calculationArc xlink:type="arc" order="6.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:calculationArc xlink:type="arc" order="7.00" weight="-1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt" />
    <link:calculationArc xlink:type="arc" order="8.00" weight="-1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:calculationArc xlink:type="arc" order="524.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:calculationArc xlink:type="arc" order="9.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:calculationArc xlink:type="arc" order="4.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
  </link:calculationLink>
  <link:calculationLink xlink:role="http://TCC.com/20251231/role/StatementofOperations" xlink:type="extended" xlink:title="calculationLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:calculationArc xlink:type="arc" order="3.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" />
    <link:calculationArc xlink:type="arc" order="1.00" weight="-1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_GeneralAndAdministrativeExpense" />
    <link:calculationArc xlink:type="arc" order="2.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" />
    <link:calculationArc xlink:type="arc" order="4.00" weight="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" />
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>tlnc-20251231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit" xlink:href="tlnc-20251231.xsd#StatementofChangesInShareholdersDeficit" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/StatementofOperations" xlink:href="tlnc-20251231.xsd#StatementofOperations" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/BalanceSheetParentheticals" xlink:href="tlnc-20251231.xsd#BalanceSheetParentheticals" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:href="tlnc-20251231.xsd#DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/InitialPublicOfferingDetails" xlink:href="tlnc-20251231.xsd#InitialPublicOfferingDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/ShareholdersDeficitDetails" xlink:href="tlnc-20251231.xsd#ShareholdersDeficitDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails" xlink:href="tlnc-20251231.xsd#SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/RelatedPartyTransactionsDetails" xlink:href="tlnc-20251231.xsd#RelatedPartyTransactionsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals" xlink:href="tlnc-20251231.xsd#StatementofChangesInShareholdersDeficitParentheticals" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/CommitmentsDetails" xlink:href="tlnc-20251231.xsd#CommitmentsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/Cover" xlink:href="tlnc-20251231.xsd#Cover" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/BalanceSheet" xlink:href="tlnc-20251231.xsd#BalanceSheet" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:href="tlnc-20251231.xsd#SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/PrivatePlacementUnitsDetails" xlink:href="tlnc-20251231.xsd#PrivatePlacementUnitsDetails" xlink:type="simple" />
  <link:roleRef roleURI="http://TCC.com/20251231/role/StatementofOperationsParentheticals" xlink:href="tlnc-20251231.xsd#StatementofOperationsParentheticals" xlink:type="simple" />
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_1008" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_1009" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_1006" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_1005" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_1016" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_1012" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_1018" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_1007" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_36856" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_36854" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_36350" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_36857" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_36349" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_1014" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_1003" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_1013" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_1004" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits" xlink:label="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits_36955" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" xlink:label="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits_36954" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_1011" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_36852" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_36853" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_36855" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1010_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_1005_default" />
    <link:definitionArc xlink:type="arc" order="17.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_1007" xlink:to="us-gaap_ClassOfStockDomain_1010" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_1010" xlink:to="us-gaap_CommonClassAMember_1008" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_1010" xlink:to="us-gaap_CommonClassBMember_1009" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain_1005" xlink:to="us-gaap_CommonStockMember_1006" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis_1004" xlink:to="us-gaap_EquityComponentDomain_1005" />
    <link:definitionArc xlink:type="arc" order="23.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_NetIncomeLoss_1016" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain_1005" xlink:to="us-gaap_RetainedEarningsMember_1012" />
    <link:definitionArc xlink:type="arc" order="25.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_SharesOutstanding_1018" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_1003" xlink:to="us-gaap_StatementClassOfStockAxis_1007" />
    <link:definitionArc xlink:type="arc" order="22.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_36856" />
    <link:definitionArc xlink:type="arc" order="19.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_36854" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_36350" />
    <link:definitionArc xlink:type="arc" order="20.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_36857" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_36349" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockholdersEquity_1014" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StatementTable_1003" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_1003" xlink:to="us-gaap_StatementEquityComponentsAxis_1004" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits_36955" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits_36954" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain_1005" xlink:to="us-gaap_AdditionalPaidInCapitalMember_1011" />
    <link:definitionArc xlink:type="arc" order="21.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_36852" />
    <link:definitionArc xlink:type="arc" order="18.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_36853" />
    <link:definitionArc xlink:type="arc" order="17.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_36855" />
    <link:definitionArc xlink:type="arc" order="17.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_1007" xlink:to="us-gaap_ClassOfStockDomain_1010_default" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis_1004" xlink:to="us-gaap_EquityComponentDomain_1005_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/Cover" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_33513" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_33507" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_33561" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_33499" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_33538" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_33540" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_33537" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_33536" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_33535" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType_33426" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_33438" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_33476" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable_33422" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems_33425" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_33477" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_33478" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_36963" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport_33437" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_33503" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_33543" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_33471" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36343" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36344" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36345" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36342" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member" xlink:label="tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member_36348" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember" xlink:label="tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember_36346" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassAOrdinarySharesParValue00001PerShareMember" xlink:label="tlnc_ClassAOrdinarySharesParValue00001PerShareMember_36347" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_33554" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_33565" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_33562" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_33544" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag_37038" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_36961" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_36962" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_33500" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness_33515" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_33512" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_33498" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat_37039" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_33443" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_33524" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_33508" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_33511" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod_33514" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36343_default" />
    <link:definitionArc xlink:type="arc" order="29.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityEmergingGrowthCompany_33513" />
    <link:definitionArc xlink:type="arc" order="25.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityCurrentReportingStatus_33507" />
    <link:definitionArc xlink:type="arc" order="41.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityCommonStockSharesOutstanding_33561" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityCentralIndexKey_33499" />
    <link:definitionArc xlink:type="arc" order="34.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressStateOrProvince_33538" />
    <link:definitionArc xlink:type="arc" order="35.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressPostalZipCode_33540" />
    <link:definitionArc xlink:type="arc" order="33.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressCityOrTown_33537" />
    <link:definitionArc xlink:type="arc" order="32.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressAddressLine2_33536" />
    <link:definitionArc xlink:type="arc" order="31.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressAddressLine1_33535" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentType_33426" />
    <link:definitionArc xlink:type="arc" order="21.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentTransitionReport_33438" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentPeriodEndDate_33476" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentInformationTable_33422" />
    <link:definitionArc xlink:type="arc" order="17.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentFiscalYearFocus_33477" />
    <link:definitionArc xlink:type="arc" order="18.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentFiscalPeriodFocus_33478" />
    <link:definitionArc xlink:type="arc" order="607.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_36963" />
    <link:definitionArc xlink:type="arc" order="20.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentAnnualReport_33437" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_CurrentFiscalYearEndDate_33503" />
    <link:definitionArc xlink:type="arc" order="36.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_CityAreaCode_33543" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_AmendmentFlag_33471" />
    <link:definitionArc xlink:type="arc" order="86.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36342" xlink:to="us-gaap_ClassOfStockDomain_36343" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="us-gaap_CommonClassAMember_36344" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="us-gaap_CommonClassBMember_36345" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable_33422" xlink:to="us-gaap_StatementClassOfStockAxis_36342" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member_36348" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember_36346" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="tlnc_ClassAOrdinarySharesParValue00001PerShareMember_36347" />
    <link:definitionArc xlink:type="arc" order="39.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_TradingSymbol_33554" />
    <link:definitionArc xlink:type="arc" order="40.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_SecurityExchangeName_33565" />
    <link:definitionArc xlink:type="arc" order="38.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_Security12bTitle_33562" />
    <link:definitionArc xlink:type="arc" order="37.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_LocalPhoneNumber_33544" />
    <link:definitionArc xlink:type="arc" order="630.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_IcfrAuditorAttestationFlag_37038" />
    <link:definitionArc xlink:type="arc" order="605.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityWellKnownSeasonedIssuer_36961" />
    <link:definitionArc xlink:type="arc" order="606.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityVoluntaryFilers_36962" />
    <link:definitionArc xlink:type="arc" order="23.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityTaxIdentificationNumber_33500" />
    <link:definitionArc xlink:type="arc" order="28.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntitySmallBusiness_33515" />
    <link:definitionArc xlink:type="arc" order="26.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityShellCompany_33512" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityRegistrantName_33498" />
    <link:definitionArc xlink:type="arc" order="631.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityPublicFloat_37039" />
    <link:definitionArc xlink:type="arc" order="22.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityInteractiveDataCurrent_33443" />
    <link:definitionArc xlink:type="arc" order="24.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityIncorporationStateCountryCode_33524" />
    <link:definitionArc xlink:type="arc" order="27.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityFilerCategory_33508" />
    <link:definitionArc xlink:type="arc" order="19.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityFileNumber_33511" />
    <link:definitionArc xlink:type="arc" order="30.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityExTransitionPeriod_33514" />
    <link:definitionArc xlink:type="arc" order="86.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36342" xlink:to="us-gaap_ClassOfStockDomain_36343_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/StatementofOperations" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36847" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36848" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_36338" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_36339" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_36335" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest_36842" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_36341" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_36843" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_36340" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_36840" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36845" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_36334" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_36330" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36337" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36336" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36846" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36846_default" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36846" xlink:to="us-gaap_CommonClassAMember_36847" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36846" xlink:to="us-gaap_CommonClassBMember_36848" />
    <link:definitionArc xlink:type="arc" order="17.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_EarningsPerShareBasic_36338" />
    <link:definitionArc xlink:type="arc" order="18.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_EarningsPerShareDiluted_36339" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_GeneralAndAdministrativeExpense_36335" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract_36840" xlink:to="us-gaap_InvestmentIncomeInterest_36842" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_NetIncomeLoss_36341" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract_36840" xlink:to="us-gaap_NonoperatingIncomeExpense_36843" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_OperatingIncomeLoss_36340" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_36840" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36330" xlink:to="us-gaap_StatementClassOfStockAxis_36845" />
    <link:definitionArc xlink:type="arc" order="80.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_StatementTable_36330" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36337" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36336" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36845" xlink:to="us-gaap_ClassOfStockDomain_36846" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36845" xlink:to="us-gaap_ClassOfStockDomain_36846_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/BalanceSheet" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AccruedOfferingCosts" xlink:label="tlnc_AccruedOfferingCosts_36363" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredUnderwritingFeeNoncurrent" xlink:label="tlnc_DeferredUnderwritingFeeNoncurrent_36832" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_36364" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent_36830" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance_36829" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_36380" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_36379" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_36360" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_36354" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_36357" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_36355" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_36831" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_36356" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36589" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_36375" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36367" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36368" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_36378" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_36833" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_36382" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_36361" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_36374" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_36362" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_36828" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_36377" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36366" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_36371" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_36365" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_36381" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_36376" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_36834" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36589_default" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract_36362" xlink:to="tlnc_AccruedOfferingCosts_36363" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract_36362" xlink:to="tlnc_DeferredUnderwritingFeeNoncurrent_36832" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract_36362" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_36364" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract_36354" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent_36830" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract_36355" xlink:to="us-gaap_PrepaidInsurance_36829" />
    <link:definitionArc xlink:type="arc" order="120.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_36380" />
    <link:definitionArc xlink:type="arc" order="119.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_AdditionalPaidInCapital_36379" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract_36354" xlink:to="us-gaap_Assets_36360" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_AssetsAbstract_36354" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract_36355" xlink:to="us-gaap_AssetsCurrent_36357" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract_36354" xlink:to="us-gaap_AssetsCurrentAbstract_36355" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract_36354" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_36831" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract_36355" xlink:to="us-gaap_Cash_36356" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36366" xlink:to="us-gaap_ClassOfStockDomain_36589" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_CommitmentsAndContingencies_36375" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36589" xlink:to="us-gaap_CommonClassAMember_36367" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36589" xlink:to="us-gaap_CommonClassBMember_36368" />
    <link:definitionArc xlink:type="arc" order="118.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_CommonStockValue_36378" />
    <link:definitionArc xlink:type="arc" order="521.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_36361" xlink:to="us-gaap_Liabilities_36833" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_36382" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_36361" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract_36362" xlink:to="us-gaap_LiabilitiesCurrent_36374" />
    <link:definitionArc xlink:type="arc" order="102.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_36361" xlink:to="us-gaap_LiabilitiesCurrentAbstract_36362" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract_36355" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_36828" />
    <link:definitionArc xlink:type="arc" order="117.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_PreferredStockValue_36377" />
    <link:definitionArc xlink:type="arc" order="106.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36365" xlink:to="us-gaap_StatementClassOfStockAxis_36366" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_StatementTable_36365" />
    <link:definitionArc xlink:type="arc" order="121.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_StockholdersEquity_36381" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_StockholdersEquityAbstract_36376" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_36834" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36366" xlink:to="us-gaap_ClassOfStockDomain_36589_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/BalanceSheetParentheticals" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareIssued" xlink:label="tlnc_NumberOfFounderShareIssued_37042" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareOutstanding" xlink:label="tlnc_NumberOfFounderShareOutstanding_37043" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesHolding" xlink:label="tlnc_NumberOfFounderSharesHolding_37046" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfSharesSubjectToForfeiture" xlink:label="tlnc_NumberOfSharesSubjectToForfeiture_37044" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfShareSubjectNotToForfeiture" xlink:label="tlnc_NumberOfShareSubjectNotToForfeiture_37045" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_36968" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36387" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36388" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36389" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_36395" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_36396" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_36397" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_36398" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36980" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_36391" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_36392" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_36393" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember_37049" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_37047" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_37048" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfAdditionalFounderShareIssued" xlink:label="tlnc_NumberOfAdditionalFounderShareIssued_37041" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_36394" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36966" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36965" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36978" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36386" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_36390" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_36385" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36977" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_36836" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued_36837" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_36835" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36387_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_37048_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36966_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36978_default" />
    <link:definitionArc xlink:type="arc" order="634.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfFounderShareIssued_37042" />
    <link:definitionArc xlink:type="arc" order="635.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfFounderShareOutstanding_37043" />
    <link:definitionArc xlink:type="arc" order="638.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfFounderSharesHolding_37046" />
    <link:definitionArc xlink:type="arc" order="636.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfSharesSubjectToForfeiture_37044" />
    <link:definitionArc xlink:type="arc" order="637.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfShareSubjectNotToForfeiture_37045" />
    <link:definitionArc xlink:type="arc" order="612.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain_36966" xlink:to="tlnc_SponsorMember_36968" />
    <link:definitionArc xlink:type="arc" order="126.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36386" xlink:to="us-gaap_ClassOfStockDomain_36387" />
    <link:definitionArc xlink:type="arc" order="127.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36387" xlink:to="us-gaap_CommonClassAMember_36388" />
    <link:definitionArc xlink:type="arc" order="128.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36387" xlink:to="us-gaap_CommonClassBMember_36389" />
    <link:definitionArc xlink:type="arc" order="18.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_36395" />
    <link:definitionArc xlink:type="arc" order="19.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_CommonStockSharesAuthorized_36396" />
    <link:definitionArc xlink:type="arc" order="20.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_CommonStockSharesIssued_36397" />
    <link:definitionArc xlink:type="arc" order="21.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_CommonStockSharesOutstanding_36398" />
    <link:definitionArc xlink:type="arc" order="624.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36978" xlink:to="us-gaap_OverAllotmentOptionMember_36980" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_36391" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_PreferredStockSharesAuthorized_36392" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_PreferredStockSharesIssued_36393" />
    <link:definitionArc xlink:type="arc" order="641.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_37048" xlink:to="srt_DirectorMember_37049" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36385" xlink:to="srt_TitleOfIndividualAxis_37047" />
    <link:definitionArc xlink:type="arc" order="640.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis_37047" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_37048" />
    <link:definitionArc xlink:type="arc" order="633.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfAdditionalFounderShareIssued_37041" />
    <link:definitionArc xlink:type="arc" order="17.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_PreferredStockSharesOutstanding_36394" />
    <link:definitionArc xlink:type="arc" order="610.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36965" xlink:to="us-gaap_RelatedPartyDomain_36966" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36385" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36965" />
    <link:definitionArc xlink:type="arc" order="622.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36977" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36978" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36385" xlink:to="us-gaap_StatementClassOfStockAxis_36386" />
    <link:definitionArc xlink:type="arc" order="124.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_StatementTable_36385" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36385" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36977" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_36836" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_TemporaryEquitySharesIssued_36837" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_36835" />
    <link:definitionArc xlink:type="arc" order="126.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36386" xlink:to="us-gaap_ClassOfStockDomain_36387_default" />
    <link:definitionArc xlink:type="arc" order="640.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis_37047" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_37048_default" />
    <link:definitionArc xlink:type="arc" order="610.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36965" xlink:to="us-gaap_RelatedPartyDomain_36966_default" />
    <link:definitionArc xlink:type="arc" order="622.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36977" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36978_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_36438" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36455" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36428" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebt" xlink:label="us-gaap_UnsecuredDebt_36884" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_36433" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_TransactionCosts" xlink:label="tlnc_TransactionCosts_36445" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_36437" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WorkingCapitalDeficit" xlink:label="tlnc_WorkingCapitalDeficit_36886" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WorkingCapitalLoan" xlink:label="tlnc_WorkingCapitalLoan_36887" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_YearOfInception" xlink:label="tlnc_YearOfInception_37037" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_37075" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_37074" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_36885" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36456" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_36424" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CantorMember" xlink:label="tlnc_CantorMember_36458" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashUnderwritingFee" xlink:label="tlnc_CashUnderwritingFee_36446" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" xlink:label="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_37034" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredUnderwritingFee" xlink:label="tlnc_DeferredUnderwritingFee_36447" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DescriptionOfOrganizationAndBusinessOperationsTable" xlink:label="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialBusinessCombinationOrToRedeemPercentage" xlink:label="tlnc_InitialBusinessCombinationOrToRedeemPercentage_36451" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InterestEarnedOnTheTrustAccountPerAnnum" xlink:label="tlnc_InterestEarnedOnTheTrustAccountPerAnnum_37059" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_MaximumNetInterestToPayDissolutionExpenses" xlink:label="tlnc_MaximumNetInterestToPayDissolutionExpenses_36450" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:label="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_36449" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NoOfMaturityDays" xlink:label="tlnc_NoOfMaturityDays_36459" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_36441" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36439" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36432" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36431" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36434" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36440" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_37076" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation_36436" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AdvanceReceivedForWorkingCapital" xlink:label="tlnc_AdvanceReceivedForWorkingCapital_36460" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_OtherOfferingCosts" xlink:label="tlnc_OtherOfferingCosts_36448" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PrivatePlacementWarrantsMember" xlink:label="tlnc_PrivatePlacementWarrantsMember_36426" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ProceedsFromSaleOfUnderwritersReimbursement" xlink:label="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_36807" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_36425" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_36443" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_36442" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_36444" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36457" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_36429" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36430" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_37075_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36456_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36432_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36434_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_36425_default" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_SharesIssuedPricePerShare_36438" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_StatementClassOfStockAxis_36455" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36428" />
    <link:definitionArc xlink:type="arc" order="546.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_UnsecuredDebt_36884" />
    <link:definitionArc xlink:type="arc" order="169.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain_36432" xlink:to="tlnc_SponsorMember_36433" />
    <link:definitionArc xlink:type="arc" order="20.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_TransactionCosts_36445" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_36437" />
    <link:definitionArc xlink:type="arc" order="548.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_WorkingCapitalDeficit_36886" />
    <link:definitionArc xlink:type="arc" order="549.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_WorkingCapitalLoan_36887" />
    <link:definitionArc xlink:type="arc" order="629.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_YearOfInception_37037" />
    <link:definitionArc xlink:type="arc" order="667.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis_37074" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_37075" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_BusinessAcquisitionAxis_37074" />
    <link:definitionArc xlink:type="arc" order="547.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_Cash_36885" />
    <link:definitionArc xlink:type="arc" order="192.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36455" xlink:to="us-gaap_ClassOfStockDomain_36456" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_36424" />
    <link:definitionArc xlink:type="arc" order="194.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain_36432" xlink:to="tlnc_CantorMember_36458" />
    <link:definitionArc xlink:type="arc" order="21.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_CashUnderwritingFee_36446" />
    <link:definitionArc xlink:type="arc" order="628.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_37034" />
    <link:definitionArc xlink:type="arc" order="22.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_DeferredUnderwritingFee_36447" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" />
    <link:definitionArc xlink:type="arc" order="30.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_InitialBusinessCombinationOrToRedeemPercentage_36451" />
    <link:definitionArc xlink:type="arc" order="651.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_InterestEarnedOnTheTrustAccountPerAnnum_37059" />
    <link:definitionArc xlink:type="arc" order="29.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_MaximumNetInterestToPayDissolutionExpenses_36450" />
    <link:definitionArc xlink:type="arc" order="28.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_36449" />
    <link:definitionArc xlink:type="arc" order="25.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_NoOfMaturityDays_36459" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_SaleOfStockPricePerShare_36441" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36439" />
    <link:definitionArc xlink:type="arc" order="168.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36431" xlink:to="us-gaap_RelatedPartyDomain_36432" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36431" />
    <link:definitionArc xlink:type="arc" order="170.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36428" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36434" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36440" />
    <link:definitionArc xlink:type="arc" order="668.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_37075" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_37076" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="dei_EntityIncorporationDateOfIncorporation_36436" />
    <link:definitionArc xlink:type="arc" order="26.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_AdvanceReceivedForWorkingCapital_36460" />
    <link:definitionArc xlink:type="arc" order="24.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_OtherOfferingCosts_36448" />
    <link:definitionArc xlink:type="arc" order="162.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_36425" xlink:to="tlnc_PrivatePlacementWarrantsMember_36426" />
    <link:definitionArc xlink:type="arc" order="23.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_36807" />
    <link:definitionArc xlink:type="arc" order="161.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_36424" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_36425" />
    <link:definitionArc xlink:type="arc" order="18.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_36443" />
    <link:definitionArc xlink:type="arc" order="17.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_36442" />
    <link:definitionArc xlink:type="arc" order="19.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_36444" />
    <link:definitionArc xlink:type="arc" order="193.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36456" xlink:to="us-gaap_CommonClassAMember_36457" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36434" xlink:to="us-gaap_IPOMember_36429" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36434" xlink:to="us-gaap_OverAllotmentOptionMember_36430" />
    <link:definitionArc xlink:type="arc" order="667.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis_37074" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_37075_default" />
    <link:definitionArc xlink:type="arc" order="192.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36455" xlink:to="us-gaap_ClassOfStockDomain_36456_default" />
    <link:definitionArc xlink:type="arc" order="168.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36431" xlink:to="us-gaap_RelatedPartyDomain_36432_default" />
    <link:definitionArc xlink:type="arc" order="170.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36428" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36434_default" />
    <link:definitionArc xlink:type="arc" order="161.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_36424" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_36425_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/InitialPublicOfferingDetails" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_BusinessCombinationMember" xlink:label="tlnc_BusinessCombinationMember_36958" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_36583" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_36586" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_EffectiveRedemptionPeriod" xlink:label="tlnc_EffectiveRedemptionPeriod_37069" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialPublicOfferingTable" xlink:label="tlnc_InitialPublicOfferingTable_36491" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NoticePeriodForRedemptionOfWarrants" xlink:label="tlnc_NoticePeriodForRedemptionOfWarrants_36527" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfTradingDays" xlink:label="tlnc_NumberOfTradingDays_36532" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds" xlink:label="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds_36584" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PrivatePlacementWarrantsMember" xlink:label="tlnc_PrivatePlacementWarrantsMember_36927" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PublicWarrantMember" xlink:label="tlnc_PublicWarrantMember_36926" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_TriggerPrice" xlink:label="tlnc_TriggerPrice_36960" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_36536" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_36506" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36497" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_36516" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_36509" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_36510" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_36507" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_36519" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_36925" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36498" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_36582" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_36494" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36495" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36493" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_36957" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36496" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36492" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_36512" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36497_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_36510_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_36507_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36493_default" />
    <link:definitionArc xlink:type="arc" order="603.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_36507" xlink:to="tlnc_BusinessCombinationMember_36958" />
    <link:definitionArc xlink:type="arc" order="20.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_36583" />
    <link:definitionArc xlink:type="arc" order="23.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_36586" />
    <link:definitionArc xlink:type="arc" order="661.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_EffectiveRedemptionPeriod_37069" />
    <link:definitionArc xlink:type="arc" order="219.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_InitialPublicOfferingTable_36491" />
    <link:definitionArc xlink:type="arc" order="19.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_NoticePeriodForRedemptionOfWarrants_36527" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_NumberOfTradingDays_36532" />
    <link:definitionArc xlink:type="arc" order="21.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds_36584" />
    <link:definitionArc xlink:type="arc" order="580.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_36510" xlink:to="tlnc_PrivatePlacementWarrantsMember_36927" />
    <link:definitionArc xlink:type="arc" order="579.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_36510" xlink:to="tlnc_PublicWarrantMember_36926" />
    <link:definitionArc xlink:type="arc" order="604.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_TriggerPrice_36960" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_36536" />
    <link:definitionArc xlink:type="arc" order="234.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_InitialPublicOfferingTable_36491" xlink:to="us-gaap_BusinessAcquisitionAxis_36506" />
    <link:definitionArc xlink:type="arc" order="225.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36496" xlink:to="us-gaap_ClassOfStockDomain_36497" />
    <link:definitionArc xlink:type="arc" order="237.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_InitialPublicOfferingTable_36491" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_36509" />
    <link:definitionArc xlink:type="arc" order="238.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_36509" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_36510" />
    <link:definitionArc xlink:type="arc" order="235.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BusinessAcquisitionAxis_36506" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_36507" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_36519" />
    <link:definitionArc xlink:type="arc" order="578.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_36925" />
    <link:definitionArc xlink:type="arc" order="226.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36497" xlink:to="us-gaap_CommonClassAMember_36498" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_36582" />
    <link:definitionArc xlink:type="arc" order="222.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36493" xlink:to="us-gaap_IPOMember_36494" />
    <link:definitionArc xlink:type="arc" order="223.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36493" xlink:to="us-gaap_OverAllotmentOptionMember_36495" />
    <link:definitionArc xlink:type="arc" order="221.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36492" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36493" />
    <link:definitionArc xlink:type="arc" order="602.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="us-gaap_SharesIssuedPricePerShare_36957" />
    <link:definitionArc xlink:type="arc" order="224.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_InitialPublicOfferingTable_36491" xlink:to="us-gaap_StatementClassOfStockAxis_36496" />
    <link:definitionArc xlink:type="arc" order="220.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_InitialPublicOfferingTable_36491" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36492" />
    <link:definitionArc xlink:type="arc" order="240.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_36510" xlink:to="us-gaap_WarrantMember_36512" />
    <link:definitionArc xlink:type="arc" order="225.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36496" xlink:to="us-gaap_ClassOfStockDomain_36497_default" />
    <link:definitionArc xlink:type="arc" order="238.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_36509" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_36510_default" />
    <link:definitionArc xlink:type="arc" order="235.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BusinessAcquisitionAxis_36506" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_36507_default" />
    <link:definitionArc xlink:type="arc" order="221.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36492" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36493_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/CommitmentsDetails" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnderwritingOptionPeriod" xlink:label="tlnc_UnderwritingOptionPeriod_37035" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_36821" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnderwritingDiscountAmountPerUnit" xlink:label="tlnc_UnderwritingDiscountAmountPerUnit_36653" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36654" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_36652" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_36662" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="us-gaap_PaymentsForUnderwritingExpense_36663" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable_36664" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36665" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36666" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36667" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_37071" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_36822" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InterestRateMember" xlink:label="tlnc_InterestRateMember_36824" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnderwritingAgreementMember" xlink:label="tlnc_UnderwritingAgreementMember_37072" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems_36668" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther_36670" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_36671" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_36672" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PercentageOfDeferredUnderwritings" xlink:label="tlnc_PercentageOfDeferredUnderwritings_36750" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_36650" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_37070" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_36651" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36666_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_37071_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_36822_default" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="tlnc_UnderwritingOptionPeriod_37035" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable_36664" xlink:to="us-gaap_DebtInstrumentAxis_36821" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="tlnc_UnderwritingDiscountAmountPerUnit_36653" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36654" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_36652" />
    <link:definitionArc xlink:type="arc" order="18.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_SaleOfStockPricePerShare_36662" />
    <link:definitionArc xlink:type="arc" order="19.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_PaymentsForUnderwritingExpense_36663" />
    <link:definitionArc xlink:type="arc" order="373.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_LossContingenciesTable_36664" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable_36664" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36665" />
    <link:definitionArc xlink:type="arc" order="375.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36665" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36666" />
    <link:definitionArc xlink:type="arc" order="376.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36666" xlink:to="us-gaap_OverAllotmentOptionMember_36667" />
    <link:definitionArc xlink:type="arc" order="663.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis_37070" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_37071" />
    <link:definitionArc xlink:type="arc" order="514.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis_36821" xlink:to="us-gaap_DebtInstrumentNameDomain_36822" />
    <link:definitionArc xlink:type="arc" order="516.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain_36822" xlink:to="tlnc_InterestRateMember_36824" />
    <link:definitionArc xlink:type="arc" order="664.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_37071" xlink:to="tlnc_UnderwritingAgreementMember_37072" />
    <link:definitionArc xlink:type="arc" order="21.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_InterestIncomeOther_36670" />
    <link:definitionArc xlink:type="arc" order="22.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_36671" />
    <link:definitionArc xlink:type="arc" order="381.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36666" xlink:to="us-gaap_IPOMember_36672" />
    <link:definitionArc xlink:type="arc" order="20.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="tlnc_PercentageOfDeferredUnderwritings_36750" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_36650" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LossContingenciesTable_36664" xlink:to="us-gaap_TypeOfArrangementAxis_37070" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_36651" />
    <link:definitionArc xlink:type="arc" order="375.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36665" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36666_default" />
    <link:definitionArc xlink:type="arc" order="663.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis_37070" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_37071_default" />
    <link:definitionArc xlink:type="arc" order="514.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis_36821" xlink:to="us-gaap_DebtInstrumentNameDomain_36822_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/ShareholdersDeficitDetails" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36721" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36722" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36723" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_36727" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_36732" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_36733" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_36728" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_36729" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_36731" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36724" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_36725" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued_36952" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ShareholdersDeficitTable" xlink:label="tlnc_ShareholdersDeficitTable_36720" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ConversionOfOrdinarySharesPercentage" xlink:label="tlnc_ConversionOfOrdinarySharesPercentage_36744" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_36734" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36722_default" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_ShareholdersDeficitTable_36720" xlink:to="us-gaap_StatementClassOfStockAxis_36721" />
    <link:definitionArc xlink:type="arc" order="421.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36721" xlink:to="us-gaap_ClassOfStockDomain_36722" />
    <link:definitionArc xlink:type="arc" order="422.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36722" xlink:to="us-gaap_CommonClassAMember_36723" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_PreferredStockSharesAuthorized_36727" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_CommonStockSharesAuthorized_36732" />
    <link:definitionArc xlink:type="arc" order="17.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_CommonStockSharesIssued_36733" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_PreferredStockSharesIssued_36728" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_PreferredStockSharesOutstanding_36729" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_36731" />
    <link:definitionArc xlink:type="arc" order="423.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36722" xlink:to="us-gaap_CommonClassBMember_36724" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_TemporaryEquitySharesIssued_36952" />
    <link:definitionArc xlink:type="arc" order="419.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="tlnc_ShareholdersDeficitTable_36720" />
    <link:definitionArc xlink:type="arc" order="20.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="tlnc_ConversionOfOrdinarySharesPercentage_36744" />
    <link:definitionArc xlink:type="arc" order="18.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_CommonStockSharesOutstanding_36734" />
    <link:definitionArc xlink:type="arc" order="421.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36721" xlink:to="us-gaap_ClassOfStockDomain_36722_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember" xlink:label="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember_36899" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems_36900" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_36902" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_36903" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassAOrdinarySharesIssuanceCosts" xlink:label="tlnc_ClassAOrdinarySharesIssuanceCosts_36904" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_36905" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_36906" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_36907" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable" xlink:label="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable_36896" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36949" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36897" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36898" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36898_default" />
    <link:definitionArc xlink:type="arc" order="556.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36898" xlink:to="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember_36899" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems_36900" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_36902" />
    <link:definitionArc xlink:type="arc" order="560.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_36902" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_36903" />
    <link:definitionArc xlink:type="arc" order="561.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_36902" xlink:to="tlnc_ClassAOrdinarySharesIssuanceCosts_36904" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems_36900" xlink:to="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_36905" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_36905" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_36906" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_36905" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_36907" />
    <link:definitionArc xlink:type="arc" order="553.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems_36900" xlink:to="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable_36896" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems_36900" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36949" />
    <link:definitionArc xlink:type="arc" order="554.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable_36896" xlink:to="us-gaap_StatementClassOfStockAxis_36897" />
    <link:definitionArc xlink:type="arc" order="555.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36897" xlink:to="us-gaap_ClassOfStockDomain_36898" />
    <link:definitionArc xlink:type="arc" order="555.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36897" xlink:to="us-gaap_ClassOfStockDomain_36898_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_36918" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_36911" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_36922" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36923" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_36924" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36913" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36914" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36915" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="us-gaap_EarningsPerShareBasicLineItems_36916" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_36919" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36921" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract_36917" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36912" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36913_default" />
    <link:definitionArc xlink:type="arc" order="571.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAbstract_36917" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_36918" />
    <link:definitionArc xlink:type="arc" order="564.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EarningsPerShareBasicLineItems_36916" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_36911" />
    <link:definitionArc xlink:type="arc" order="575.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" xlink:to="us-gaap_EarningsPerShareBasic_36922" />
    <link:definitionArc xlink:type="arc" order="576.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36923" />
    <link:definitionArc xlink:type="arc" order="577.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" xlink:to="us-gaap_EarningsPerShareDiluted_36924" />
    <link:definitionArc xlink:type="arc" order="566.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36912" xlink:to="us-gaap_ClassOfStockDomain_36913" />
    <link:definitionArc xlink:type="arc" order="567.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36913" xlink:to="us-gaap_CommonClassAMember_36914" />
    <link:definitionArc xlink:type="arc" order="568.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36913" xlink:to="us-gaap_CommonClassBMember_36915" />
    <link:definitionArc xlink:type="arc" order="572.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NetIncomeLossAbstract_36917" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_36919" />
    <link:definitionArc xlink:type="arc" order="573.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems_36916" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" />
    <link:definitionArc xlink:type="arc" order="574.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36921" />
    <link:definitionArc xlink:type="arc" order="570.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EarningsPerShareBasicLineItems_36916" xlink:to="us-gaap_NetIncomeLossAbstract_36917" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_36911" xlink:to="us-gaap_StatementClassOfStockAxis_36912" />
    <link:definitionArc xlink:type="arc" order="566.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36912" xlink:to="us-gaap_ClassOfStockDomain_36913_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/RelatedPartyTransactionsDetails" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36601" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36602" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_36625" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_36627" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems_36613" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_36615" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_36616" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36603" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36605" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36597" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_36631" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AggregateAmount" xlink:label="tlnc_AggregateAmount_36635" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AggregateShares" xlink:label="tlnc_AggregateShares_36632" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AggregateSponsorAmount" xlink:label="tlnc_AggregateSponsorAmount_36647" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AmountOfFairValue" xlink:label="tlnc_AmountOfFairValue_36637" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_FairValueOfShares" xlink:label="tlnc_FairValueOfShares_36745" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_FairValuePerSharePrice" xlink:label="tlnc_FairValuePerSharePrice_36746" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_FounderShareMember" xlink:label="tlnc_FounderShareMember_36612" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_OutstandingBalancePromissoryNote" xlink:label="tlnc_OutstandingBalancePromissoryNote_36648" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders_36618" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_36619" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember_36642" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_36641" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput_36639" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_36693" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36598" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputOptionVolatilityMember" xlink:label="us-gaap_MeasurementInputOptionVolatilityMember_37077" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_36610" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_36611" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_36643" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputCommodityMarketPriceMember" xlink:label="us-gaap_MeasurementInputCommodityMarketPriceMember_36644" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_36640" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36606" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36607" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember_36609" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember_36600" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_36617" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_36624" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WorkingCapitalLoan" xlink:label="tlnc_WorkingCapitalLoan_36646" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="us-gaap_AdministrativeFeesExpense_36951" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36603_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_36641_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36598_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_36611_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36607_default" />
    <link:definitionArc xlink:type="arc" order="316.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36598" xlink:to="us-gaap_OverAllotmentOptionMember_36601" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_StatementClassOfStockAxis_36602" />
    <link:definitionArc xlink:type="arc" order="17.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_36625" />
    <link:definitionArc xlink:type="arc" order="18.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_36627" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_36615" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_36616" />
    <link:definitionArc xlink:type="arc" order="318.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36602" xlink:to="us-gaap_ClassOfStockDomain_36603" />
    <link:definitionArc xlink:type="arc" order="320.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36603" xlink:to="us-gaap_CommonClassBMember_36605" />
    <link:definitionArc xlink:type="arc" order="311.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36597" />
    <link:definitionArc xlink:type="arc" order="19.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_CommonStockSharesIssued_36631" />
    <link:definitionArc xlink:type="arc" order="21.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_AggregateAmount_36635" />
    <link:definitionArc xlink:type="arc" order="20.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_AggregateShares_36632" />
    <link:definitionArc xlink:type="arc" order="29.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_AggregateSponsorAmount_36647" />
    <link:definitionArc xlink:type="arc" order="23.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_AmountOfFairValue_36637" />
    <link:definitionArc xlink:type="arc" order="22.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_FairValueOfShares_36745" />
    <link:definitionArc xlink:type="arc" order="25.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_FairValuePerSharePrice_36746" />
    <link:definitionArc xlink:type="arc" order="325.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionDomain_36611" xlink:to="tlnc_FounderShareMember_36612" />
    <link:definitionArc xlink:type="arc" order="30.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_OutstandingBalancePromissoryNote_36648" />
    <link:definitionArc xlink:type="arc" order="15.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders_36618" />
    <link:definitionArc xlink:type="arc" order="332.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain_36607" xlink:to="tlnc_SponsorMember_36619" />
    <link:definitionArc xlink:type="arc" order="351.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain_36641" xlink:to="us-gaap_MeasurementInputSharePriceMember_36642" />
    <link:definitionArc xlink:type="arc" order="350.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_MeasurementInputTypeAxis_36640" xlink:to="us-gaap_MeasurementInputTypeDomain_36641" />
    <link:definitionArc xlink:type="arc" order="26.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_DebtInstrumentMeasurementInput_36639" />
    <link:definitionArc xlink:type="arc" order="31.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_OtherLiabilitiesCurrent_36693" />
    <link:definitionArc xlink:type="arc" order="313.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36597" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36598" />
    <link:definitionArc xlink:type="arc" order="669.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain_36641" xlink:to="us-gaap_MeasurementInputOptionVolatilityMember_37077" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_RelatedPartyTransactionAxis_36610" />
    <link:definitionArc xlink:type="arc" order="324.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionAxis_36610" xlink:to="us-gaap_RelatedPartyTransactionDomain_36611" />
    <link:definitionArc xlink:type="arc" order="352.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain_36641" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_36643" />
    <link:definitionArc xlink:type="arc" order="353.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_MeasurementInputTypeDomain_36641" xlink:to="us-gaap_MeasurementInputCommodityMarketPriceMember_36644" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_MeasurementInputTypeAxis_36640" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36606" />
    <link:definitionArc xlink:type="arc" order="322.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36606" xlink:to="us-gaap_RelatedPartyDomain_36607" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain_36607" xlink:to="us-gaap_RelatedPartyMember_36609" />
    <link:definitionArc xlink:type="arc" order="315.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36598" xlink:to="us-gaap_PrivatePlacementMember_36600" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_36617" />
    <link:definitionArc xlink:type="arc" order="16.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_SharePrice_36624" />
    <link:definitionArc xlink:type="arc" order="28.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_WorkingCapitalLoan_36646" />
    <link:definitionArc xlink:type="arc" order="600.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_AdministrativeFeesExpense_36951" />
    <link:definitionArc xlink:type="arc" order="318.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36602" xlink:to="us-gaap_ClassOfStockDomain_36603_default" />
    <link:definitionArc xlink:type="arc" order="350.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_MeasurementInputTypeAxis_36640" xlink:to="us-gaap_MeasurementInputTypeDomain_36641_default" />
    <link:definitionArc xlink:type="arc" order="313.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36597" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36598_default" />
    <link:definitionArc xlink:type="arc" order="324.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionAxis_36610" xlink:to="us-gaap_RelatedPartyTransactionDomain_36611_default" />
    <link:definitionArc xlink:type="arc" order="322.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36606" xlink:to="us-gaap_RelatedPartyDomain_36607_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_37014" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_37015" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_37016" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_37022" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_37023" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_37008" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_37009" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37010" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfAdditionalFounderShareIssued" xlink:label="tlnc_NumberOfAdditionalFounderShareIssued_37060" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareIssued" xlink:label="tlnc_NumberOfFounderShareIssued_37061" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareOutstanding" xlink:label="tlnc_NumberOfFounderShareOutstanding_37062" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfSharesSubjectToForfeiture" xlink:label="tlnc_NumberOfSharesSubjectToForfeiture_37063" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfShareSubjectNotToForfeiture" xlink:label="tlnc_NumberOfShareSubjectNotToForfeiture_37064" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesHolding" xlink:label="tlnc_NumberOfFounderSharesHolding_37065" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_37025" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_37066" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_37067" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember_37068" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SaleOfStockNumberOfSharesIssued" xlink:label="tlnc_SaleOfStockNumberOfSharesIssued_37073" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_37011" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_37013" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_37015_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_37023_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_37067_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_37011_default" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_37008" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_37014" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_37014" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_37015" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_37015" xlink:to="us-gaap_OverAllotmentOptionMember_37016" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_37008" xlink:to="us-gaap_StatementClassOfStockAxis_37022" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_37022" xlink:to="us-gaap_ClassOfStockDomain_37023" />
    <link:definitionArc xlink:type="arc" order="597.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="us-gaap_StatementTable_37008" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_37008" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37010" />
    <link:definitionArc xlink:type="arc" order="652.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfAdditionalFounderShareIssued_37060" />
    <link:definitionArc xlink:type="arc" order="653.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfFounderShareIssued_37061" />
    <link:definitionArc xlink:type="arc" order="654.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfFounderShareOutstanding_37062" />
    <link:definitionArc xlink:type="arc" order="655.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfSharesSubjectToForfeiture_37063" />
    <link:definitionArc xlink:type="arc" order="656.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfShareSubjectNotToForfeiture_37064" />
    <link:definitionArc xlink:type="arc" order="657.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfFounderSharesHolding_37065" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_37023" xlink:to="us-gaap_CommonClassBMember_37025" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_37008" xlink:to="srt_TitleOfIndividualAxis_37066" />
    <link:definitionArc xlink:type="arc" order="659.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis_37066" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_37067" />
    <link:definitionArc xlink:type="arc" order="660.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_37067" xlink:to="srt_DirectorMember_37068" />
    <link:definitionArc xlink:type="arc" order="665.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_SaleOfStockNumberOfSharesIssued_37073" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37010" xlink:to="us-gaap_RelatedPartyDomain_37011" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain_37011" xlink:to="tlnc_SponsorMember_37013" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_37014" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_37015_default" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_37022" xlink:to="us-gaap_ClassOfStockDomain_37023_default" />
    <link:definitionArc xlink:type="arc" order="659.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis_37066" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_37067_default" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37010" xlink:to="us-gaap_RelatedPartyDomain_37011_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/PrivatePlacementUnitsDetails" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36576" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36568" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_36571" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36569" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36959" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_36574" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CohenMember" xlink:label="tlnc_CohenMember_36581" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_36577" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_36570" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember_36578" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_36580" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_36579" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36575" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36576_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36569_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_36580_default" />
    <link:definitionArc xlink:type="arc" order="302.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36575" xlink:to="us-gaap_RelatedPartyDomain_36576" />
    <link:definitionArc xlink:type="arc" order="293.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_36571" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36568" />
    <link:definitionArc xlink:type="arc" order="295.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36568" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36569" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_36571" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36959" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_36571" xlink:to="us-gaap_SaleOfStockPricePerShare_36574" />
    <link:definitionArc xlink:type="arc" order="307.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain_36580" xlink:to="tlnc_CohenMember_36581" />
    <link:definitionArc xlink:type="arc" order="303.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain_36576" xlink:to="tlnc_SponsorMember_36577" />
    <link:definitionArc xlink:type="arc" order="296.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36569" xlink:to="us-gaap_IPOMember_36570" />
    <link:definitionArc xlink:type="arc" order="304.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36569" xlink:to="us-gaap_PrivatePlacementMember_36578" />
    <link:definitionArc xlink:type="arc" order="306.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis_36579" xlink:to="dei_EntityDomain_36580" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" xlink:to="dei_LegalEntityAxis_36579" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36575" />
    <link:definitionArc xlink:type="arc" order="302.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36575" xlink:to="us-gaap_RelatedPartyDomain_36576_default" />
    <link:definitionArc xlink:type="arc" order="295.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36568" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36569_default" />
    <link:definitionArc xlink:type="arc" order="306.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis_36579" xlink:to="dei_EntityDomain_36580_default" />
  </link:definitionLink>
  <link:definitionLink xlink:role="http://TCC.com/20251231/role/StatementofOperationsParentheticals" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36987" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36989" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_36990" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36998" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36986" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_36985" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36999" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_37001" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_37002" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_37003" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_37004" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfAdditionalFounderSharesIssued" xlink:label="tlnc_NumberOfAdditionalFounderSharesIssued_37050" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesIssued" xlink:label="tlnc_NumberOfFounderSharesIssued_37051" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesOutstanding" xlink:label="tlnc_NumberOfFounderSharesOutstanding_37052" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfShareSubjectToForfeiture" xlink:label="tlnc_NumberOfShareSubjectToForfeiture_37053" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfSharesSubjectNotToForfeiture" xlink:label="tlnc_NumberOfSharesSubjectNotToForfeiture_37054" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareHolding" xlink:label="tlnc_NumberOfFounderShareHolding_37055" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_37056" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_37057" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember_37058" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36987_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36999_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_37003_default" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_37057_default" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis_36986" xlink:to="us-gaap_ClassOfStockDomain_36987" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain_36987" xlink:to="us-gaap_CommonClassBMember_36989" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36985" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36998" />
    <link:definitionArc xlink:type="arc" order="13.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36985" xlink:to="us-gaap_StatementClassOfStockAxis_36986" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="true" use="optional" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="us-gaap_StatementTable_36985" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36998" xlink:to="us-gaap_RelatedPartyDomain_36999" />
    <link:definitionArc xlink:type="arc" order="11.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyDomain_36999" xlink:to="tlnc_SponsorMember_37001" />
    <link:definitionArc xlink:type="arc" order="12.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36985" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_37002" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_37002" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_37003" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_37003" xlink:to="us-gaap_OverAllotmentOptionMember_37004" />
    <link:definitionArc xlink:type="arc" order="642.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfAdditionalFounderSharesIssued_37050" />
    <link:definitionArc xlink:type="arc" order="643.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfFounderSharesIssued_37051" />
    <link:definitionArc xlink:type="arc" order="644.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfFounderSharesOutstanding_37052" />
    <link:definitionArc xlink:type="arc" order="645.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfShareSubjectToForfeiture_37053" />
    <link:definitionArc xlink:type="arc" order="646.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfSharesSubjectNotToForfeiture_37054" />
    <link:definitionArc xlink:type="arc" order="647.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfFounderShareHolding_37055" />
    <link:definitionArc xlink:type="arc" order="14.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable_36985" xlink:to="srt_TitleOfIndividualAxis_37056" />
    <link:definitionArc xlink:type="arc" order="649.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis_37056" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_37057" />
    <link:definitionArc xlink:type="arc" order="650.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_37057" xlink:to="srt_DirectorMember_37058" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis_36986" xlink:to="us-gaap_ClassOfStockDomain_36987_default" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36998" xlink:to="us-gaap_RelatedPartyDomain_36999_default" />
    <link:definitionArc xlink:type="arc" order="10.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_37002" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_37003_default" />
    <link:definitionArc xlink:type="arc" order="649.00" priority="1" xbrldt:closed="false" use="optional" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis_37056" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_37057_default" />
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd#eedm" xlink:type="simple" />
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended" xlink:title="definitionLink">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefFinancialOfficerMember" xlink:label="us-gaap_ChiefFinancialOfficerMember" />
    <link:definitionArc xlink:type="arc" order="0" priority="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="us-gaap_ChiefFinancialOfficerMember" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>tlnc-20251231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AccruedOfferingCosts" xlink:label="tlnc_AccruedOfferingCosts" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredUnderwritingFeeNoncurrent" xlink:label="tlnc_DeferredUnderwritingFeeNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareIssued" xlink:label="tlnc_NumberOfFounderShareIssued" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareOutstanding" xlink:label="tlnc_NumberOfFounderShareOutstanding" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesHolding" xlink:label="tlnc_NumberOfFounderSharesHolding" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfSharesSubjectToForfeiture" xlink:label="tlnc_NumberOfSharesSubjectToForfeiture" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfShareSubjectNotToForfeiture" xlink:label="tlnc_NumberOfShareSubjectNotToForfeiture" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" xlink:label="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ProceedsFromSaleOfUnderwritersReimbursement" xlink:label="tlnc_ProceedsFromSaleOfUnderwritersReimbursement" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:label="us-gaap_PaymentsToAcquireTrustPreferredInvestments" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebt" xlink:label="us-gaap_UnsecuredDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashHeldInTrustAccountPolicyTextBlock" xlink:label="tlnc_CashHeldInTrustAccountPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_EmergingGrowthCompanyPolicyTextBlock" xlink:label="tlnc_EmergingGrowthCompanyPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_OfferingCostsPolicyTextBlock" xlink:label="tlnc_OfferingCostsPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_TransactionCosts" xlink:label="tlnc_TransactionCosts" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="tlnc_UnitsIssuedDuringPeriodSharesNewIssues" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WorkingCapitalDeficit" xlink:label="tlnc_WorkingCapitalDeficit" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WorkingCapitalLoan" xlink:label="tlnc_WorkingCapitalLoan" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_YearOfInception" xlink:label="tlnc_YearOfInception" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CantorMember" xlink:label="tlnc_CantorMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashUnderwritingFee" xlink:label="tlnc_CashUnderwritingFee" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" xlink:label="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredUnderwritingFee" xlink:label="tlnc_DeferredUnderwritingFee" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DescriptionOfOrganizationAndBusinessOperationsTable" xlink:label="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialBusinessCombinationOrToRedeemPercentage" xlink:label="tlnc_InitialBusinessCombinationOrToRedeemPercentage" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InterestEarnedOnTheTrustAccountPerAnnum" xlink:label="tlnc_InterestEarnedOnTheTrustAccountPerAnnum" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_MaximumNetInterestToPayDissolutionExpenses" xlink:label="tlnc_MaximumNetInterestToPayDissolutionExpenses" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:label="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NoOfMaturityDays" xlink:label="tlnc_NoOfMaturityDays" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AdvanceReceivedForWorkingCapital" xlink:label="tlnc_AdvanceReceivedForWorkingCapital" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_BusinessCombinationMember" xlink:label="tlnc_BusinessCombinationMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_EffectiveRedemptionPeriod" xlink:label="tlnc_EffectiveRedemptionPeriod" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialPublicOfferingAbstract" xlink:label="tlnc_InitialPublicOfferingAbstract" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialPublicOfferingTable" xlink:label="tlnc_InitialPublicOfferingTable" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NoticePeriodForRedemptionOfWarrants" xlink:label="tlnc_NoticePeriodForRedemptionOfWarrants" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfTradingDays" xlink:label="tlnc_NumberOfTradingDays" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds" xlink:label="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PrivatePlacementWarrantsMember" xlink:label="tlnc_PrivatePlacementWarrantsMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PublicWarrantMember" xlink:label="tlnc_PublicWarrantMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_TriggerPrice" xlink:label="tlnc_TriggerPrice" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnderwritingOptionPeriod" xlink:label="tlnc_UnderwritingOptionPeriod" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialPublicOfferingTextBlock" xlink:label="tlnc_InitialPublicOfferingTextBlock" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember" xlink:label="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnderwritingDiscountAmountPerUnit" xlink:label="tlnc_UnderwritingDiscountAmountPerUnit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLineItems" xlink:label="dei_AuditorLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassAOrdinarySharesIssuanceCosts" xlink:label="tlnc_ClassAOrdinarySharesIssuanceCosts" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:label="us-gaap_SegmentReportingInformationProfitLossAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable" xlink:label="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="us-gaap_PaymentsForUnderwritingExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AggregateAmount" xlink:label="tlnc_AggregateAmount" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AggregateShares" xlink:label="tlnc_AggregateShares" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AggregateSponsorAmount" xlink:label="tlnc_AggregateSponsorAmount" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AmountOfFairValue" xlink:label="tlnc_AmountOfFairValue" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_FairValueOfShares" xlink:label="tlnc_FairValueOfShares" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_FairValuePerSharePrice" xlink:label="tlnc_FairValuePerSharePrice" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_FounderShareMember" xlink:label="tlnc_FounderShareMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_OutstandingBalancePromissoryNote" xlink:label="tlnc_OutstandingBalancePromissoryNote" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits" xlink:label="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" xlink:label="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member" xlink:label="tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember" xlink:label="tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassAOrdinarySharesParValue00001PerShareMember" xlink:label="tlnc_ClassAOrdinarySharesParValue00001PerShareMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfAdditionalFounderShareIssued" xlink:label="tlnc_NumberOfAdditionalFounderShareIssued" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_OtherOfferingCosts" xlink:label="tlnc_OtherOfferingCosts" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts" xlink:label="tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty" xlink:label="tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredUnderwritingFeePayable" xlink:label="tlnc_DeferredUnderwritingFeePayable" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ForfeitureOfFounderShares" xlink:label="tlnc_ForfeitureOfFounderShares" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidInsurance" xlink:label="us-gaap_IncreaseDecreaseInPrepaidInsurance" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InterestRateMember" xlink:label="tlnc_InterestRateMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnderwritingAgreementMember" xlink:label="tlnc_UnderwritingAgreementMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputOptionVolatilityMember" xlink:label="us-gaap_MeasurementInputOptionVolatilityMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputCommodityMarketPriceMember" xlink:label="us-gaap_MeasurementInputCommodityMarketPriceMember" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SaleOfStockNumberOfSharesIssued" xlink:label="tlnc_SaleOfStockNumberOfSharesIssued" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ShareholdersDeficitTable" xlink:label="tlnc_ShareholdersDeficitTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="us-gaap_EarningsPerShareBasicLineItems" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ConversionOfOrdinarySharesPercentage" xlink:label="tlnc_ConversionOfOrdinarySharesPercentage" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CohenMember" xlink:label="tlnc_CohenMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PrivatePlacementAbstract" xlink:label="tlnc_PrivatePlacementAbstract" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PercentageOfDeferredUnderwritings" xlink:label="tlnc_PercentageOfDeferredUnderwritings" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PrivatePlacementTextBlock" xlink:label="tlnc_PrivatePlacementTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="us-gaap_AdministrativeFeesExpense" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfAdditionalFounderSharesIssued" xlink:label="tlnc_NumberOfAdditionalFounderSharesIssued" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesIssued" xlink:label="tlnc_NumberOfFounderSharesIssued" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesOutstanding" xlink:label="tlnc_NumberOfFounderSharesOutstanding" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfShareSubjectToForfeiture" xlink:label="tlnc_NumberOfShareSubjectToForfeiture" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfSharesSubjectNotToForfeiture" xlink:label="tlnc_NumberOfSharesSubjectNotToForfeiture" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareHolding" xlink:label="tlnc_NumberOfFounderShareHolding" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassAMember" xlink:to="us-gaap_CommonClassAMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_AccruedOfferingCosts" xlink:to="tlnc_AccruedOfferingCosts_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_DeferredUnderwritingFeeNoncurrent" xlink:to="tlnc_DeferredUnderwritingFeeNoncurrent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfFounderShareIssued" xlink:to="tlnc_NumberOfFounderShareIssued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfFounderShareOutstanding" xlink:to="tlnc_NumberOfFounderShareOutstanding_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfFounderSharesHolding" xlink:to="tlnc_NumberOfFounderSharesHolding_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfSharesSubjectToForfeiture" xlink:to="tlnc_NumberOfSharesSubjectToForfeiture_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfShareSubjectNotToForfeiture" xlink:to="tlnc_NumberOfShareSubjectNotToForfeiture_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_SponsorMember" xlink:to="tlnc_SponsorMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" xlink:to="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ProceedsFromSaleOfUnderwritersReimbursement" xlink:to="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:to="us-gaap_PaymentsToAcquireTrustPreferredInvestments_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnsecuredDebt" xlink:to="us-gaap_UnsecuredDebt_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_CashHeldInTrustAccountPolicyTextBlock" xlink:to="tlnc_CashHeldInTrustAccountPolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_EmergingGrowthCompanyPolicyTextBlock" xlink:to="tlnc_EmergingGrowthCompanyPolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_OfferingCostsPolicyTextBlock" xlink:to="tlnc_OfferingCostsPolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_TransactionCosts" xlink:to="tlnc_TransactionCosts_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_UnitsIssuedDuringPeriodSharesNewIssues" xlink:to="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_WorkingCapitalDeficit" xlink:to="tlnc_WorkingCapitalDeficit_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_WorkingCapitalLoan" xlink:to="tlnc_WorkingCapitalLoan_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_YearOfInception" xlink:to="tlnc_YearOfInception_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Cash" xlink:to="us-gaap_Cash_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightAxis" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_CantorMember" xlink:to="tlnc_CantorMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_CashUnderwritingFee" xlink:to="tlnc_CashUnderwritingFee_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" xlink:to="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_DeferredUnderwritingFee" xlink:to="tlnc_DeferredUnderwritingFee_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable" xlink:to="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_InitialBusinessCombinationOrToRedeemPercentage" xlink:to="tlnc_InitialBusinessCombinationOrToRedeemPercentage_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_InterestEarnedOnTheTrustAccountPerAnnum" xlink:to="tlnc_InterestEarnedOnTheTrustAccountPerAnnum_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_MaximumNetInterestToPayDissolutionExpenses" xlink:to="tlnc_MaximumNetInterestToPayDissolutionExpenses_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:to="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NoOfMaturityDays" xlink:to="tlnc_NoOfMaturityDays_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OverAllotmentOptionMember" xlink:to="us-gaap_OverAllotmentOptionMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyDomain" xlink:to="us-gaap_RelatedPartyDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromOtherEquity" xlink:to="us-gaap_ProceedsFromOtherEquity_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_AdvanceReceivedForWorkingCapital" xlink:to="tlnc_AdvanceReceivedForWorkingCapital_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract" xlink:to="us-gaap_ClassOfStockDisclosuresAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_BusinessCombinationMember" xlink:to="tlnc_BusinessCombinationMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xlink:to="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xlink:to="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_EffectiveRedemptionPeriod" xlink:to="tlnc_EffectiveRedemptionPeriod_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_InitialPublicOfferingAbstract" xlink:to="tlnc_InitialPublicOfferingAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_InitialPublicOfferingTable" xlink:to="tlnc_InitialPublicOfferingTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NoticePeriodForRedemptionOfWarrants" xlink:to="tlnc_NoticePeriodForRedemptionOfWarrants_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfTradingDays" xlink:to="tlnc_NumberOfTradingDays_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds" xlink:to="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_PrivatePlacementWarrantsMember" xlink:to="tlnc_PrivatePlacementWarrantsMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_PublicWarrantMember" xlink:to="tlnc_PublicWarrantMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_TriggerPrice" xlink:to="tlnc_TriggerPrice_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesPolicyTextBlock" xlink:to="us-gaap_DerivativesPolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_UnderwritingOptionPeriod" xlink:to="tlnc_UnderwritingOptionPeriod_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsHeldInTrustNoncurrent" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFDICInsuredAmount" xlink:to="us-gaap_CashFDICInsuredAmount_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_InitialPublicOfferingTextBlock" xlink:to="tlnc_InitialPublicOfferingTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember" xlink:to="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_UnderwritingDiscountAmountPerUnit" xlink:to="tlnc_UnderwritingDiscountAmountPerUnit_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLineItems" xlink:to="dei_AuditorLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorOpinionTextBlock" xlink:to="dei_AuditorOpinionTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfReportableSegments" xlink:to="us-gaap_NumberOfReportableSegments_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ClassAOrdinarySharesIssuanceCosts" xlink:to="tlnc_ClassAOrdinarySharesIssuanceCosts_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:to="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:to="us-gaap_SegmentReportingInformationProfitLossAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityTableTextBlock" xlink:to="us-gaap_TemporaryEquityTableTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable" xlink:to="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForUnderwritingExpense" xlink:to="us-gaap_PaymentsForUnderwritingExpense_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingenciesTable" xlink:to="us-gaap_LossContingenciesTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_AggregateAmount" xlink:to="tlnc_AggregateAmount_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_AggregateShares" xlink:to="tlnc_AggregateShares_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_AggregateSponsorAmount" xlink:to="tlnc_AggregateSponsorAmount_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_AmountOfFairValue" xlink:to="tlnc_AmountOfFairValue_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_FairValueOfShares" xlink:to="tlnc_FairValueOfShares_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_FairValuePerSharePrice" xlink:to="tlnc_FairValuePerSharePrice_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_FounderShareMember" xlink:to="tlnc_FounderShareMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_OutstandingBalancePromissoryNote" xlink:to="tlnc_OutstandingBalancePromissoryNote_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:to="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputSharePriceMember" xlink:to="us-gaap_MeasurementInputSharePriceMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeDomain" xlink:to="us-gaap_MeasurementInputTypeDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits" xlink:to="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" xlink:to="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseOtherNoncurrent" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member" xlink:to="tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember" xlink:to="tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ClassAOrdinarySharesParValue00001PerShareMember" xlink:to="tlnc_ClassAOrdinarySharesParValue00001PerShareMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherPrepaidExpenseCurrent" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfAdditionalFounderShareIssued" xlink:to="tlnc_NumberOfAdditionalFounderShareIssued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_OtherOfferingCosts" xlink:to="tlnc_OtherOfferingCosts_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts" xlink:to="tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty" xlink:to="tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_DeferredUnderwritingFeePayable" xlink:to="tlnc_DeferredUnderwritingFeePayable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ForfeitureOfFounderShares" xlink:to="tlnc_ForfeitureOfFounderShares_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidInsurance" xlink:to="us-gaap_IncreaseDecreaseInPrepaidInsurance_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightDomain" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_InterestRateMember" xlink:to="tlnc_InterestRateMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMeasurementInput" xlink:to="us-gaap_DebtInstrumentMeasurementInput_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_UnderwritingAgreementMember" xlink:to="tlnc_UnderwritingAgreementMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputOptionVolatilityMember" xlink:to="us-gaap_MeasurementInputOptionVolatilityMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCommitmentsLineItems" xlink:to="us-gaap_OtherCommitmentsLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestIncomeOther" xlink:to="us-gaap_InterestIncomeOther_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionAxis" xlink:to="us-gaap_RelatedPartyTransactionAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionDomain" xlink:to="us-gaap_RelatedPartyTransactionDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputCommodityMarketPriceMember" xlink:to="us-gaap_MeasurementInputCommodityMarketPriceMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyMember" xlink:to="us-gaap_RelatedPartyMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_SaleOfStockNumberOfSharesIssued" xlink:to="tlnc_SaleOfStockNumberOfSharesIssued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ShareholdersDeficitTable" xlink:to="tlnc_ShareholdersDeficitTable_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicLineItems" xlink:to="us-gaap_EarningsPerShareBasicLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_ConversionOfOrdinarySharesPercentage" xlink:to="tlnc_ConversionOfOrdinarySharesPercentage_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_CohenMember" xlink:to="tlnc_CohenMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_PrivatePlacementAbstract" xlink:to="tlnc_PrivatePlacementAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_PercentageOfDeferredUnderwritings" xlink:to="tlnc_PercentageOfDeferredUnderwritings_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_PrivatePlacementTextBlock" xlink:to="tlnc_PrivatePlacementTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesOther" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdministrativeFeesExpense" xlink:to="us-gaap_AdministrativeFeesExpense_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfAdditionalFounderSharesIssued" xlink:to="tlnc_NumberOfAdditionalFounderSharesIssued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfFounderSharesIssued" xlink:to="tlnc_NumberOfFounderSharesIssued_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfFounderSharesOutstanding" xlink:to="tlnc_NumberOfFounderSharesOutstanding_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfShareSubjectToForfeiture" xlink:to="tlnc_NumberOfShareSubjectToForfeiture_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfSharesSubjectNotToForfeiture" xlink:to="tlnc_NumberOfSharesSubjectNotToForfeiture_lbl" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="tlnc_NumberOfFounderShareHolding" xlink:to="tlnc_NumberOfFounderShareHolding_lbl" />
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Class A</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A Ordinary Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassAMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class A Ordinary Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Class B</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class B Ordinary Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class B Ordinary Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonClassBMember_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Class B Ordinary Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Ordinary Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance (in Shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance (in Shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares, Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentInformationLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Accretion for Class A ordinary shares to redemption amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeiture of founder shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Value, Share-Based Payment Arrangement, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class B ordinary shares issued to sponsor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Forfeiture of founder shares (in Shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class B ordinary shares issued to sponsor (in Shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total Shareholders&#8217; Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity, Attributable to Parent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic net income per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Basic net income per ordinary share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted net income per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Diluted net income per ordinary share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest earned on cash held in Trust Account</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest earned on cash held in Trust Account</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other income, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted weighted average shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic weighted average shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AccruedOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AccruedOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of accrued offering costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredUnderwritingFeeNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Deferred underwriting fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredUnderwritingFeeNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Underwriting Fee, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredUnderwritingFeeNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of deferred underwriting fee, noncurrent.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderShareIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Founder shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderShareIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Founder Share Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderShareIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of founder share issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderShareOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Founder shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderShareOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Founder Share Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderShareOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of founder share outstanding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderSharesHolding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of founder shares holding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderSharesHolding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Founder Shares Holding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderSharesHolding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the holding number of founder shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfSharesSubjectToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of share subject to forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfSharesSubjectToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Shares Subject to Forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfSharesSubjectToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of share subject to forfeiture.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfShareSubjectNotToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of share subject not to forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfShareSubjectNotToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Share Subject Not to Forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfShareSubjectNotToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of share subject not to forfeiture.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_SponsorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sponsor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_SponsorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sponsor [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Payment of general and administrative costs through advances from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment of general and administrative costs through advances from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of payment of operating expenses through advances from related party.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Underwriters&#8217; reimbursement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Proceeds from sale of Underwriters Reimbursement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from sale of Underwriters Reimbursement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of underwriters&#8217; reimbursement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Flows from Investing Activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Flows from Operating Activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Payment of offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireTrustPreferredInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Investment of cash in Trust Account</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireTrustPreferredInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Trust Preferred Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of Class B ordinary shares to Sponsor</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnsecuredDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unsecured promissory note</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnsecuredDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unsecured Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CashHeldInTrustAccountPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Held in Trust Account</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CashHeldInTrustAccountPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Held in Trust Account [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CashHeldInTrustAccountPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for cash held in trust account.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Emerging Growth Company [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_EmergingGrowthCompanyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for emerging growth company status.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_OfferingCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_OfferingCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Offering Costs [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_OfferingCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of accounting policy for offering costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_TransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Transaction costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_TransactionCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of expenses related to transaction costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of units issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of units issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_WorkingCapitalDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Working capital surplus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_WorkingCapitalDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Working capital deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_WorkingCapitalDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of working capital deficit.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_WorkingCapitalLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Working capital loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_WorkingCapitalLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Working capital loans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_WorkingCapitalLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of working capital loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_YearOfInception_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Year of Inception</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_YearOfInception_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The term of year of inception.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Cash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Cash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CantorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cantor [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CashUnderwritingFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash underwriting fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CashUnderwritingFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the amount of cash underwriting fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Cash withdrawn from trust Account for working capital purposes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash withdrawn from Trust Account for working capital purposes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of cash withdrawn from Trust Account for working capital purposes.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredUnderwritingFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred underwriting fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredUnderwritingFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the amount of deferred underwriting fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description of Organization and Business Operations [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InitialBusinessCombinationOrToRedeemPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial business combination or to redeem percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InitialBusinessCombinationOrToRedeemPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial business combination or to redeem percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InitialBusinessCombinationOrToRedeemPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Initial Business Combination or to redeem percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InterestEarnedOnTheTrustAccountPerAnnum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">InterestEarnedOnTheTrustAccountPerAnnum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InterestEarnedOnTheTrustAccountPerAnnum_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Interest earned on the trust account per annum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_MaximumNetInterestToPayDissolutionExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum net interest to pay dissolution expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_MaximumNetInterestToPayDissolutionExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the maximum net interest to pay dissolution expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of fair market value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The percentage of fair market value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NoOfMaturityDays_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maturity days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NoOfMaturityDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">No of maturity days.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrants price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Units price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ordinary shares, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ordinary shares, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ordinary shares, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ordinary shares, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Over-Allotment Option</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OverAllotmentOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Over-Allotment Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preference shares, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preference shares, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preference shares, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preference shares, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Aggregate amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gross proceeds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related and Nonrelated Parties [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Sale of private placement warrants shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2009/role/netLabel">Purchased aggregate shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business Combination [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination, Series of Individually Immaterial Business Combinations [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of Private Placement Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from sale of Units, net of underwriting discounts paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromOtherEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Other Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from promissory note - related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Related Party Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Repayment of advances from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from (Repayments of) Related Party Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Repayment of promissory note - related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Repayments of Related Party Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description of Organization and Business Operations [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, Date of Incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AdvanceReceivedForWorkingCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Advance received for working capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AdvanceReceivedForWorkingCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of advance received for working capital.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_BusinessCombinationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Business Combination [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Business combination issue price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Adjustment of Exercise Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of adjustment of exercise price of warrants based on market value and newly issued price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of exercise price of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Adjustment of Redemption Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Class of Warrant or Right, Adjustment of Redemption Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_EffectiveRedemptionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Redemption Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_EffectiveRedemptionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The effective redemption period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InitialPublicOfferingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Initial Public Offering [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InitialPublicOfferingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Public Offering [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InitialPublicOfferingTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Public Offering [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NoticePeriodForRedemptionOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Notice period for redemption of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NoticePeriodForRedemptionOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Notice period for redemption of warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NoticePeriodForRedemptionOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Minimum threshold written notice period for redemption of public warrants.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of trading days</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfTradingDays_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of trading days.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of equity proceeds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Gross Proceeds On Total Equity Proceeds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represents the percentage of gross proceeds on total equity proceeds.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PrivatePlacementWarrantsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement Warrants [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PublicWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Public Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_TriggerPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trigger price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_TriggerPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The price per share of trigger price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Warrant Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DerivativesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Derivatives, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Income per Ordinary Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_UnderwritingOptionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting option period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_UnderwritingOptionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The term of underwriting grant option period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A Ordinary Shares Subject to Possible Redemption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Assets held in trust account</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash held in Trust Account</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset, Held-in-Trust, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">COMMITMENTS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal deposit insurance corporation coverage limit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashFDICInsuredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, FDIC Insured Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized accrued for interest and penalties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InitialPublicOfferingTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">INITIAL PUBLIC OFFERING</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InitialPublicOfferingTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Public Offering [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InitialPublicOfferingTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The entire disclosure for initial public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A ordinary shares subject to possible redemption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class A Ordinary Shares Subject to Possible Redemption [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Class A Ordinary Shares Subject to Possible Redemption [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basic allocation of net income, as adjusted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_UnderwritingDiscountAmountPerUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Underwriting discount amount per unit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_UnderwritingDiscountAmountPerUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Discount Amount Per Unit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_UnderwritingDiscountAmountPerUnit_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of underwriting discount amount per unit.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Basic and Diluted Net Income Per Ordinary Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shareholders' Deficit [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shareholders' Deficit [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Basic and Diluted Net Income Per Ordinary Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Basic and Diluted Net Income Per Ordinary Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance or Sale of Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preference shares, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorOpinionTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Opinion [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of reportable segment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfReportableSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Reportable Segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds allocated to Public Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassAOrdinarySharesIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A ordinary shares issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassAOrdinarySharesIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class A ordinary shares issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassAOrdinarySharesIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of class A ordinary shares issuance costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plus:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Other Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Class A ordinary shares subject to possible redemption, December 31, 2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class A ordinary shares subject to possible redemption, $0.0001 par value; 24,900,000 shares at redemption value of $10.12 per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accretion of carrying value to redemption value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Accretion to Redemption Value, Adjustment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shareholders&#8217; Deficit [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Initial Public Offering [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Ordinary share possible redemption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subject to possible redemption, shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingInformationProfitLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Performance and Making Key Decisions Regarding Resource Allocation [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SUBSEQUENT EVENTS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsequent Events [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SHAREHOLDERS' DEFICIT</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of operating segment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Class A Ordinary Shares Subject To Possible Redemption</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Class A Ordinary Shares Subject to Possible Redemption [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Class A Ordinary Shares Subject to Possible Redemption [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Number of shares forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Forfeiting unexercised units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Reverse Stock Split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payable to underwriters</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForUnderwritingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Underwriting Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingenciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingencies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement Units [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement Units [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">RELATED PARTY TRANSACTIONS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AggregateAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AggregateAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of aggregate.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AggregateShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AggregateShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number of aggregate shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AggregateSponsorAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate sponsor amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AggregateSponsorAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate sponsor amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AggregateSponsorAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of aggregate sponsor amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AmountOfFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amount of fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_AmountOfFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of fair value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_FairValueOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair value of shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_FairValueOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of shares fair value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_FairValuePerSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value share price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_FairValuePerSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Share Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_FairValuePerSharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of fair value share price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_FounderShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Founder Shares [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_FounderShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Founder Share [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_OutstandingBalancePromissoryNote_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding balance promissory note</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_OutstandingBalancePromissoryNote_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Outstanding balance promissory note</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_OutstandingBalancePromissoryNote_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of outstanding balance promissory note.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sponsor owns issue and outstanding percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Price [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputSharePriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Share Price [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Segment Information Related to CODM</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Segment Reporting Information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of 779,000 Private Placement Units (in Shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares Sale of Private Placement Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The shares of sale private placement units.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of 779,000 Private Placement Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value Sale of Private Placement Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of sale private placement units.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of founder Shares assigned to directors</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Allocated value of transaction costs to Class A non-redeemable shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of Public Warrants at issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term prepaid insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense Other, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ClassAOrdinarySharesParValue00001PerShareMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class A ordinary shares, par value $0.0001 per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments (Note 6)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Ordinary shares value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Prepaid Expense, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shareholders&#8217; Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shareholder&#8217;s Deficit [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Director</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Director [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title and Position [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfAdditionalFounderShareIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of additional founder shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfAdditionalFounderShareIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Additional Founder Share Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfAdditionalFounderShareIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of additional founder share issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subject to possible redemption, per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Redemption Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subject to possible redemption, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_OtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_OtherOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the amount of other offering costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Offering costs included in accrued offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred offering costs included in accrued offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The amount of offering costs included in or accrued offering costs that were incurred during a noncash or partial noncash transaction.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred offering costs paid through advances from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of deferred offering costs paid through advances from related party.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredUnderwritingFeePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred underwriting fee payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_DeferredUnderwritingFeePayable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of deferred underwriting fee payable.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ForfeitureOfFounderShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forfeiture of founder shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ForfeitureOfFounderShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of forfeiture of founder shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net income to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash &#8211; End of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash &#8211; Beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Change in Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Prepaid expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expenses, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Long-term prepaid insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Flows from Financing Activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash investing and financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercise price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of each warrants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of warrants purchased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description of Organization and Business Operations [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value of Financial Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Standards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_InterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMeasurementInput_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Measurement Input</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Advances from related party</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_UnderwritingAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Underwriting Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputOptionVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Volatility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputOptionVolatilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Option Volatility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherCommitmentsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Commitments [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest earned per annum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestIncomeOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Income, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of interest earned</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk Free Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputCommodityMarketPriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Market Adjustments [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputCommodityMarketPriceMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input, Commodity Market Price [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Input Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_SaleOfStockNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of private placement warrants shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_SaleOfStockNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock Number of Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_SaleOfStockNumberOfSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The number of shares sale of stock number of shares issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ShareholdersDeficitTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shareholders' Deficit [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ShareholdersDeficitTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shareholder&#8217;s Deficit [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Basic and Diluted Net Income Per Ordinary Share [Line Item]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ConversionOfOrdinarySharesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of ordinary shares percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ConversionOfOrdinarySharesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion of Ordinary Shares Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_ConversionOfOrdinarySharesPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of ordinary shares percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_CohenMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cohen [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PrivatePlacementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement Units [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PercentageOfDeferredUnderwritings_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of deferred underwriting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PercentageOfDeferredUnderwritings_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">The percentage of deferred underwritings.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Warrants outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Warrant or Right, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WarrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Warrant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PrivatePlacementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">PRIVATE PLACEMENT UNITS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PrivatePlacementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement Units [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_PrivatePlacementTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Disclosure of private placement units.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">SEGMENT INFORMATION</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board of Directors Oversight [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase of additional units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdministrativeFeesExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Administrative Fees Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Exercised options purchasing</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Diluted allocation of net income, as adjusted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cybersecurity Risk Management, Strategy, and Governance [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfAdditionalFounderSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of additional founder shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfAdditionalFounderSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Additional Founder Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfAdditionalFounderSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of additional founder share issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Founder shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Founder Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of founder share issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Founder shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Founder Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of founder share outstanding.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfShareSubjectToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of share subject to forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfShareSubjectToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Share Subject To Forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfShareSubjectToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of share subject to forfeiture.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfSharesSubjectNotToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of share subject not to forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfSharesSubjectNotToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Shares Subject Not To Forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfSharesSubjectNotToForfeiture_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the number of share subject not to forfeiture.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderShareHolding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of founder shares holding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderShareHolding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Founder Share Holding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="tlnc_NumberOfFounderShareHolding_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Represent the holding number of founder shares.</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefFinancialOfficerMember" xlink:label="srt_ChiefFinancialOfficerMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ChiefFinancialOfficerMember" xlink:to="srt_ChiefFinancialOfficerMember_lbl" />
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ChiefFinancialOfficerMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Chief Financial Officer</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>tlnc-20251231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#Cover" roleURI="http://TCC.com/20251231/role/Cover" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#AuditInformation" roleURI="http://TCC.com/20251231/role/AuditInformation" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#BalanceSheet" roleURI="http://TCC.com/20251231/role/BalanceSheet" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#BalanceSheetParentheticals" roleURI="http://TCC.com/20251231/role/BalanceSheetParentheticals" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#StatementofOperations" roleURI="http://TCC.com/20251231/role/StatementofOperations" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#StatementofOperationsParentheticals" roleURI="http://TCC.com/20251231/role/StatementofOperationsParentheticals" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#StatementofChangesInShareholdersDeficit" roleURI="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#StatementofChangesInShareholdersDeficitParentheticals" roleURI="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#StatementofCashFlows" roleURI="http://TCC.com/20251231/role/StatementofCashFlows" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#DescriptionofOrganizationandBusinessOperations" roleURI="http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperations" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SummaryofSignificantAccountingPolicies" roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPolicies" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#InitialPublicOffering" roleURI="http://TCC.com/20251231/role/InitialPublicOffering" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#PrivatePlacementUnits" roleURI="http://TCC.com/20251231/role/PrivatePlacementUnits" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#RelatedPartyTransactions" roleURI="http://TCC.com/20251231/role/RelatedPartyTransactions" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#Commitments" roleURI="http://TCC.com/20251231/role/Commitments" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#ShareholdersDeficit" roleURI="http://TCC.com/20251231/role/ShareholdersDeficit" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SegmentInformation" roleURI="http://TCC.com/20251231/role/SegmentInformation" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SubsequentEvents" roleURI="http://TCC.com/20251231/role/SubsequentEvents" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#CybersecurityRiskManagementandStrategyDisclosure" roleURI="http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SummaryofSignificantAccountingPoliciesTables" roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesTables" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SegmentInformationTables" roleURI="http://TCC.com/20251231/role/SegmentInformationTables" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#DescriptionofOrganizationandBusinessOperationsDetails" roleURI="http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SummaryofSignificantAccountingPoliciesDetails" roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails" roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails" roleURI="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#InitialPublicOfferingDetails" roleURI="http://TCC.com/20251231/role/InitialPublicOfferingDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#PrivatePlacementUnitsDetails" roleURI="http://TCC.com/20251231/role/PrivatePlacementUnitsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#RelatedPartyTransactionsDetails" roleURI="http://TCC.com/20251231/role/RelatedPartyTransactionsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#CommitmentsDetails" roleURI="http://TCC.com/20251231/role/CommitmentsDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#ShareholdersDeficitDetails" roleURI="http://TCC.com/20251231/role/ShareholdersDeficitDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SegmentInformationDetails" roleURI="http://TCC.com/20251231/role/SegmentInformationDetails" />
  <link:roleRef xlink:type="simple" xlink:href="tlnc-20251231.xsd#SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails" roleURI="http://TCC.com/20251231/role/SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails" />
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_1008" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_1009" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember_1006" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_1005" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_1016" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember_1012" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_1018" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding_1015" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_1007" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValue_36856" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_36854" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_36350" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_36857" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_36349" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_1014" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_1017" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_1003" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_1002" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_1013" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_1004" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits" xlink:label="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits_36955" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits" xlink:label="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits_36954" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember_1011" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_36852" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_36853" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_36855" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_1007" xlink:to="us-gaap_ClassOfStockDomain_1010" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_1007" xlink:to="us-gaap_CommonClassAMember_1008" preferredLabel="http://www.xbrl.org/2009/role/netLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_1007" xlink:to="us-gaap_CommonClassBMember_1009" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_1004" xlink:to="us-gaap_CommonStockMember_1006" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_1004" xlink:to="us-gaap_EquityComponentDomain_1005" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="23.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_NetIncomeLoss_1016" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_1004" xlink:to="us-gaap_RetainedEarningsMember_1012" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="25.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_SharesOutstanding_1018" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_SharesOutstanding_1015" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_1003" xlink:to="us-gaap_StatementClassOfStockAxis_1007" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="22.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValue_36856" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_36854" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_36350" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="20.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_36857" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_36349" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockholdersEquity_1014" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" order="24.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_StockholdersEquity_1017" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract_1002" xlink:to="us-gaap_StatementTable_1003" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_1003" xlink:to="us-gaap_StatementLineItems_1013" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_1003" xlink:to="us-gaap_StatementEquityComponentsAxis_1004" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits_36955" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits_36954" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_1004" xlink:to="us-gaap_AdditionalPaidInCapitalMember_1011" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="21.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket_36852" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_36853" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_1013" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_36855" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/Cover" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany_33513" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_33507" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_33561" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_33499" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince_33538" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode_33540" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown_33537" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2_33536" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1_33535" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="dei_DocumentType_33426" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport_33438" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_33476" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable_33422" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems_33425" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_33477" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_33478" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFinStmtErrorCorrectionFlag" xlink:label="dei_DocumentFinStmtErrorCorrectionFlag_36963" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport_33437" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_33503" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract_33421" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode_33543" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_33471" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36343" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36344" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36345" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36342" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member" xlink:label="tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member_36348" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember" xlink:label="tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember_36346" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassAOrdinarySharesParValue00001PerShareMember" xlink:label="tlnc_ClassAOrdinarySharesParValue00001PerShareMember_36347" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol_33554" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName_33565" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle_33562" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber_33544" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag_37038" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer_36961" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers_36962" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber_33500" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness_33515" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany_33512" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_33498" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat_37039" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent_33443" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode_33524" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_33508" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber_33511" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod_33514" />
    <link:presentationArc xlink:type="arc" order="29.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityEmergingGrowthCompany_33513" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="25.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityCurrentReportingStatus_33507" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="41.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityCommonStockSharesOutstanding_33561" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityCentralIndexKey_33499" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="34.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressStateOrProvince_33538" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="35.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressPostalZipCode_33540" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="33.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressCityOrTown_33537" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="32.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressAddressLine2_33536" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="31.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityAddressAddressLine1_33535" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentType_33426" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="21.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentTransitionReport_33438" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentPeriodEndDate_33476" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract_33421" xlink:to="dei_DocumentInformationTable_33422" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable_33422" xlink:to="dei_DocumentInformationLineItems_33425" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentFiscalYearFocus_33477" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentFiscalPeriodFocus_33478" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="607.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentFinStmtErrorCorrectionFlag_36963" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="20.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_DocumentAnnualReport_33437" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_CurrentFiscalYearEndDate_33503" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="36.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_CityAreaCode_33543" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_AmendmentFlag_33471" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="86.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36342" xlink:to="us-gaap_ClassOfStockDomain_36343" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="us-gaap_CommonClassAMember_36344" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="us-gaap_CommonClassBMember_36345" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable_33422" xlink:to="us-gaap_StatementClassOfStockAxis_36342" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member_36348" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember_36346" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36343" xlink:to="tlnc_ClassAOrdinarySharesParValue00001PerShareMember_36347" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="39.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_TradingSymbol_33554" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="40.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_SecurityExchangeName_33565" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="38.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_Security12bTitle_33562" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="37.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_LocalPhoneNumber_33544" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="630.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_IcfrAuditorAttestationFlag_37038" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="605.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityWellKnownSeasonedIssuer_36961" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="606.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityVoluntaryFilers_36962" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="23.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityTaxIdentificationNumber_33500" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="28.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntitySmallBusiness_33515" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="26.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityShellCompany_33512" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityRegistrantName_33498" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="631.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityPublicFloat_37039" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="22.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityInteractiveDataCurrent_33443" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="24.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityIncorporationStateCountryCode_33524" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="27.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityFilerCategory_33508" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityFileNumber_33511" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="30.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems_33425" xlink:to="dei_EntityExTransitionPeriod_33514" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/StatementofOperations" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36847" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36848" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_36338" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_36339" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_36335" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract_36329" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest_36842" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_36341" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense_36843" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_36340" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:label="us-gaap_OtherNonoperatingIncomeExpenseAbstract_36840" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36845" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_36334" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_36330" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36337" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36336" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36846" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36846" xlink:to="us-gaap_CommonClassAMember_36847" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36846" xlink:to="us-gaap_CommonClassBMember_36848" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_EarningsPerShareBasic_36338" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_EarningsPerShareDiluted_36339" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_GeneralAndAdministrativeExpense_36335" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract_36840" xlink:to="us-gaap_InvestmentIncomeInterest_36842" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_NetIncomeLoss_36341" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherNonoperatingIncomeExpenseAbstract_36840" xlink:to="us-gaap_NonoperatingIncomeExpense_36843" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_OperatingIncomeLoss_36340" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_OtherNonoperatingIncomeExpenseAbstract_36840" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36330" xlink:to="us-gaap_StatementClassOfStockAxis_36845" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36330" xlink:to="us-gaap_StatementLineItems_36334" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="80.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract_36329" xlink:to="us-gaap_StatementTable_36330" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36337" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36334" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36336" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36845" xlink:to="us-gaap_ClassOfStockDomain_36846" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/BalanceSheet" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AccruedOfferingCosts" xlink:label="tlnc_AccruedOfferingCosts_36363" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredUnderwritingFeeNoncurrent" xlink:label="tlnc_DeferredUnderwritingFeeNoncurrent_36832" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_36364" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseOtherNoncurrent" xlink:label="us-gaap_PrepaidExpenseOtherNoncurrent_36830" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance_36829" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_36380" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital_36379" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_36360" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_36354" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_36357" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_36355" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_36831" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_36356" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36589" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_36375" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36367" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36368" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_36378" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_36833" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_36382" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_36361" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_36374" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_36362" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherPrepaidExpenseCurrent" xlink:label="us-gaap_OtherPrepaidExpenseCurrent_36828" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_36377" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36366" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_36371" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_36353" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_36365" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_36381" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_36376" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_36834" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_36362" xlink:to="tlnc_AccruedOfferingCosts_36363" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_36362" xlink:to="tlnc_DeferredUnderwritingFeeNoncurrent_36832" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_36362" xlink:to="us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_36364" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_36354" xlink:to="us-gaap_PrepaidExpenseOtherNoncurrent_36830" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_36355" xlink:to="us-gaap_PrepaidInsurance_36829" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="120.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_36380" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="119.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_AdditionalPaidInCapital_36379" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_36354" xlink:to="us-gaap_Assets_36360" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_AssetsAbstract_36354" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_36355" xlink:to="us-gaap_AssetsCurrent_36357" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_36354" xlink:to="us-gaap_AssetsCurrentAbstract_36355" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_36354" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_36831" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_36355" xlink:to="us-gaap_Cash_36356" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36366" xlink:to="us-gaap_ClassOfStockDomain_36589" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_CommitmentsAndContingencies_36375" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36589" xlink:to="us-gaap_CommonClassAMember_36367" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36589" xlink:to="us-gaap_CommonClassBMember_36368" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="118.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_CommonStockValue_36378" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="521.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_36361" xlink:to="us-gaap_Liabilities_36833" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_36382" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_36361" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_36362" xlink:to="us-gaap_LiabilitiesCurrent_36374" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="102.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_36361" xlink:to="us-gaap_LiabilitiesCurrentAbstract_36362" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_36355" xlink:to="us-gaap_OtherPrepaidExpenseCurrent_36828" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="117.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_PreferredStockValue_36377" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="106.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36365" xlink:to="us-gaap_StatementClassOfStockAxis_36366" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="111.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36365" xlink:to="us-gaap_StatementLineItems_36371" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_36353" xlink:to="us-gaap_StatementTable_36365" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="121.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_36376" xlink:to="us-gaap_StockholdersEquity_36381" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_StockholdersEquityAbstract_36376" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36371" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_36834" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/BalanceSheetParentheticals" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareIssued" xlink:label="tlnc_NumberOfFounderShareIssued_37042" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareOutstanding" xlink:label="tlnc_NumberOfFounderShareOutstanding_37043" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesHolding" xlink:label="tlnc_NumberOfFounderSharesHolding_37046" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfSharesSubjectToForfeiture" xlink:label="tlnc_NumberOfSharesSubjectToForfeiture_37044" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfShareSubjectNotToForfeiture" xlink:label="tlnc_NumberOfShareSubjectNotToForfeiture_37045" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_36968" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36387" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36388" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36389" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_36395" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_36396" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_36397" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_36398" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36980" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_36391" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_36392" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_36393" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember_37049" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_37047" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_37048" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfAdditionalFounderShareIssued" xlink:label="tlnc_NumberOfAdditionalFounderShareIssued_37041" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_36394" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36966" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36965" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36978" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36386" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_36390" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_36384" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_36385" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36977" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityRedemptionPricePerShare" xlink:label="us-gaap_TemporaryEquityRedemptionPricePerShare_36836" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued_36837" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital" xlink:label="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_36835" />
    <link:presentationArc xlink:type="arc" order="634.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfFounderShareIssued_37042" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="635.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfFounderShareOutstanding_37043" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="638.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfFounderSharesHolding_37046" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="636.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfSharesSubjectToForfeiture_37044" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="637.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfShareSubjectNotToForfeiture_37045" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="612.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_36966" xlink:to="tlnc_SponsorMember_36968" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="126.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36386" xlink:to="us-gaap_ClassOfStockDomain_36387" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="127.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36387" xlink:to="us-gaap_CommonClassAMember_36388" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="128.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36387" xlink:to="us-gaap_CommonClassBMember_36389" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_36395" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_CommonStockSharesAuthorized_36396" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="20.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_CommonStockSharesIssued_36397" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="21.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_CommonStockSharesOutstanding_36398" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="624.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36978" xlink:to="us-gaap_OverAllotmentOptionMember_36980" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_36391" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_PreferredStockSharesAuthorized_36392" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_PreferredStockSharesIssued_36393" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="641.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_37048" xlink:to="srt_DirectorMember_37049" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36385" xlink:to="srt_TitleOfIndividualAxis_37047" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="640.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis_37047" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_37048" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="633.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="tlnc_NumberOfAdditionalFounderShareIssued_37041" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_PreferredStockSharesOutstanding_36394" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="610.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36965" xlink:to="us-gaap_RelatedPartyDomain_36966" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36385" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36965" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="622.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36977" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36978" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36385" xlink:to="us-gaap_StatementClassOfStockAxis_36386" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36385" xlink:to="us-gaap_StatementLineItems_36390" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="124.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract_36384" xlink:to="us-gaap_StatementTable_36385" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36385" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36977" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_TemporaryEquityRedemptionPricePerShare_36836" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_TemporaryEquitySharesIssued_36837" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36390" xlink:to="us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital_36835" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/StatementofCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty" xlink:label="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty_36404" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ProceedsFromSaleOfUnderwritersReimbursement" xlink:label="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_36871" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_36868" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36866" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_36408" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_36401" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss_36402" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_36874" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireTrustPreferredInvestments" xlink:label="us-gaap_PaymentsToAcquireTrustPreferredInvestments_36867" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_36410" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_36870" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="us-gaap_ProceedsFromOtherEquity_36869" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_36411" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_36872" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_36873" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_36861" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract_36400" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" xlink:label="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_37033" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts" xlink:label="tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts_36417" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty" xlink:label="tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty_36875" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredUnderwritingFeePayable" xlink:label="tlnc_DeferredUnderwritingFeePayable_36876" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ForfeitureOfFounderShares" xlink:label="tlnc_ForfeitureOfFounderShares_36877" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_36403" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_36415" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_36414" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_36413" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_36865" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36405" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidExpensesOther" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_36863" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidInsurance" xlink:label="us-gaap_IncreaseDecreaseInPrepaidInsurance_36864" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest_36908" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_36412" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_36416" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_36403" xlink:to="tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty_36404" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" xlink:to="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_36871" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" order="534.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36866" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_36868" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_36400" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36866" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36405" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_36408" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_36400" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_36401" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_36401" xlink:to="us-gaap_NetIncomeLoss_36402" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_36874" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" order="533.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_36866" xlink:to="us-gaap_PaymentsToAcquireTrustPreferredInvestments_36867" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_36410" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_36870" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" xlink:to="us-gaap_ProceedsFromOtherEquity_36869" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_36411" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" xlink:to="us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt_36872" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_36873" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_36403" xlink:to="us-gaap_ShareBasedCompensation_36861" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_36403" xlink:to="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_37033" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="155.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_36416" xlink:to="tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts_36417" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="541.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_36416" xlink:to="tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty_36875" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="542.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_36416" xlink:to="tlnc_DeferredUnderwritingFeePayable_36876" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="543.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_36416" xlink:to="tlnc_ForfeitureOfFounderShares_36877" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_36401" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_36403" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_36400" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_36415" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_36400" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_36414" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_36400" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_36413" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36405" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_36865" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_36401" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36405" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36405" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpensesOther_36863" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_36405" xlink:to="us-gaap_IncreaseDecreaseInPrepaidInsurance_36864" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_36403" xlink:to="us-gaap_InvestmentIncomeInterest_36908" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_36412" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_36400" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_36409" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_36400" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_36416" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SummaryofSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_36464" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_36463" />
    <link:presentationArc xlink:type="arc" order="196.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36463" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_36464" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_36438" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36455" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36428" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnsecuredDebt" xlink:label="us-gaap_UnsecuredDebt_36884" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_36433" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_TransactionCosts" xlink:label="tlnc_TransactionCosts_36445" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_36437" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WorkingCapitalDeficit" xlink:label="tlnc_WorkingCapitalDeficit_36886" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WorkingCapitalLoan" xlink:label="tlnc_WorkingCapitalLoan_36887" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_YearOfInception" xlink:label="tlnc_YearOfInception_37037" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_37075" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_37074" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_36885" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36456" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_36424" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CantorMember" xlink:label="tlnc_CantorMember_36458" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashUnderwritingFee" xlink:label="tlnc_CashUnderwritingFee_36446" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes" xlink:label="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_37034" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DeferredUnderwritingFee" xlink:label="tlnc_DeferredUnderwritingFee_36447" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_DescriptionOfOrganizationAndBusinessOperationsTable" xlink:label="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialBusinessCombinationOrToRedeemPercentage" xlink:label="tlnc_InitialBusinessCombinationOrToRedeemPercentage_36451" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InterestEarnedOnTheTrustAccountPerAnnum" xlink:label="tlnc_InterestEarnedOnTheTrustAccountPerAnnum_37059" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_MaximumNetInterestToPayDissolutionExpenses" xlink:label="tlnc_MaximumNetInterestToPayDissolutionExpenses_36450" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" xlink:label="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_36449" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NoOfMaturityDays" xlink:label="tlnc_NoOfMaturityDays_36459" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_36441" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36439" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36432" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36431" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36434" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36440" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_36888" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:label="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_37076" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation_36436" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AdvanceReceivedForWorkingCapital" xlink:label="tlnc_AdvanceReceivedForWorkingCapital_36460" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_OtherOfferingCosts" xlink:label="tlnc_OtherOfferingCosts_36448" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PrivatePlacementWarrantsMember" xlink:label="tlnc_PrivatePlacementWarrantsMember_36426" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ProceedsFromSaleOfUnderwritersReimbursement" xlink:label="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_36807" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_36425" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_36443" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_36442" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_36444" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36457" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_36429" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36422" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36430" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_SharesIssuedPricePerShare_36438" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_StatementClassOfStockAxis_36455" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36428" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="546.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_UnsecuredDebt_36884" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="169.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_36432" xlink:to="tlnc_SponsorMember_36433" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="20.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_TransactionCosts_36445" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_36437" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="548.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_WorkingCapitalDeficit_36886" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="549.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_WorkingCapitalLoan_36887" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="629.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_YearOfInception_37037" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="667.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_37074" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_37075" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_BusinessAcquisitionAxis_37074" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="547.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_Cash_36885" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="192.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36455" xlink:to="us-gaap_ClassOfStockDomain_36456" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_36424" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="194.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_36432" xlink:to="tlnc_CantorMember_36458" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="21.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_CashUnderwritingFee_36446" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="628.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes_37034" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="22.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_DeferredUnderwritingFee_36447" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36422" xlink:to="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="30.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_InitialBusinessCombinationOrToRedeemPercentage_36451" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="651.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_InterestEarnedOnTheTrustAccountPerAnnum_37059" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="29.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_MaximumNetInterestToPayDissolutionExpenses_36450" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="28.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_36449" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="25.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_NoOfMaturityDays_36459" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_SaleOfStockPricePerShare_36441" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36439" preferredLabel="http://www.xbrl.org/2009/role/netLabel" />
    <link:presentationArc xlink:type="arc" order="168.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36431" xlink:to="us-gaap_RelatedPartyDomain_36432" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36431" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="170.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36428" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36434" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36440" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="550.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_SaleOfStockPricePerShare_36888" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="668.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_37075" xlink:to="us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_37076" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="dei_EntityIncorporationDateOfIncorporation_36436" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="26.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_AdvanceReceivedForWorkingCapital_36460" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="24.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_OtherOfferingCosts_36448" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="162.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_36425" xlink:to="tlnc_PrivatePlacementWarrantsMember_36426" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="23.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="tlnc_ProceedsFromSaleOfUnderwritersReimbursement_36807" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:presentationArc xlink:type="arc" order="161.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_36424" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_36425" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_36443" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_36442" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_36444" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_DescriptionOfOrganizationAndBusinessOperationsTable_36933" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_36435" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="193.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36456" xlink:to="us-gaap_CommonClassAMember_36457" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36434" xlink:to="us-gaap_IPOMember_36429" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36434" xlink:to="us-gaap_OverAllotmentOptionMember_36430" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CashHeldInTrustAccountPolicyTextBlock" xlink:label="tlnc_CashHeldInTrustAccountPolicyTextBlock_36878" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_EmergingGrowthCompanyPolicyTextBlock" xlink:label="tlnc_EmergingGrowthCompanyPolicyTextBlock_36469" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_OfferingCostsPolicyTextBlock" xlink:label="tlnc_OfferingCostsPolicyTextBlock_36880" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_36466" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_36467" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_36471" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk_36472" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_DerivativesPolicyTextBlock_36477" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_36476" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock" xlink:label="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_36881" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates_36470" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_36475" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_36474" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_36480" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="tlnc_CashHeldInTrustAccountPolicyTextBlock_36878" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="tlnc_EmergingGrowthCompanyPolicyTextBlock_36469" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="tlnc_OfferingCostsPolicyTextBlock_36880" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_36467" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_36471" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_ConcentrationRiskCreditRisk_36472" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="21.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_DerivativesPolicyTextBlock_36477" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="23.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_36476" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="22.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_36881" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_UseOfEstimates_36470" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="20.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_36475" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_36474" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="24.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36466" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_36480" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperations" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36419" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_36420" />
    <link:presentationArc xlink:type="arc" order="157.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_36419" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_36420" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/InitialPublicOffering" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract_36486" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialPublicOfferingTextBlock" xlink:label="tlnc_InitialPublicOfferingTextBlock_36487" />
    <link:presentationArc xlink:type="arc" order="216.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract_36486" xlink:to="tlnc_InitialPublicOfferingTextBlock_36487" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/InitialPublicOfferingDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_BusinessCombinationMember" xlink:label="tlnc_BusinessCombinationMember_36958" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_36583" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1" xlink:label="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_36586" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_EffectiveRedemptionPeriod" xlink:label="tlnc_EffectiveRedemptionPeriod_37069" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialPublicOfferingAbstract" xlink:label="tlnc_InitialPublicOfferingAbstract_36490" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InitialPublicOfferingTable" xlink:label="tlnc_InitialPublicOfferingTable_36491" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NoticePeriodForRedemptionOfWarrants" xlink:label="tlnc_NoticePeriodForRedemptionOfWarrants_36527" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfTradingDays" xlink:label="tlnc_NumberOfTradingDays_36532" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds" xlink:label="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds_36584" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PrivatePlacementWarrantsMember" xlink:label="tlnc_PrivatePlacementWarrantsMember_36927" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PublicWarrantMember" xlink:label="tlnc_PublicWarrantMember_36926" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_TriggerPrice" xlink:label="tlnc_TriggerPrice_36960" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnitsIssuedDuringPeriodSharesNewIssues" xlink:label="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_36536" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_36506" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36497" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_36516" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightAxis" xlink:label="us-gaap_ClassOfWarrantOrRightAxis_36509" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightDomain" xlink:label="us-gaap_ClassOfWarrantOrRightDomain_36510" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_36507" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_36519" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfWarrantOrRightOutstanding" xlink:label="us-gaap_ClassOfWarrantOrRightOutstanding_36925" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36498" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_36582" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_36494" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36495" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36493" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare_36957" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36496" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36492" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember_36512" />
    <link:presentationArc xlink:type="arc" order="603.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_36507" xlink:to="tlnc_BusinessCombinationMember_36958" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="20.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice_36583" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="23.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1_36586" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="661.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_EffectiveRedemptionPeriod_37069" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="219.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_InitialPublicOfferingAbstract_36490" xlink:to="tlnc_InitialPublicOfferingTable_36491" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_NoticePeriodForRedemptionOfWarrants_36527" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_NumberOfTradingDays_36532" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="21.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds_36584" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="580.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_36510" xlink:to="tlnc_PrivatePlacementWarrantsMember_36927" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="579.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_36510" xlink:to="tlnc_PublicWarrantMember_36926" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="604.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_TriggerPrice_36960" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="tlnc_UnitsIssuedDuringPeriodSharesNewIssues_36536" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="234.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_InitialPublicOfferingTable_36491" xlink:to="us-gaap_BusinessAcquisitionAxis_36506" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="225.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36496" xlink:to="us-gaap_ClassOfStockDomain_36497" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="244.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_InitialPublicOfferingTable_36491" xlink:to="us-gaap_ClassOfStockLineItems_36516" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="237.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_InitialPublicOfferingTable_36491" xlink:to="us-gaap_ClassOfWarrantOrRightAxis_36509" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="238.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightAxis_36509" xlink:to="us-gaap_ClassOfWarrantOrRightDomain_36510" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="235.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_36506" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_36507" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_36519" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="578.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="us-gaap_ClassOfWarrantOrRightOutstanding_36925" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="226.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36497" xlink:to="us-gaap_CommonClassAMember_36498" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_36582" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="222.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36493" xlink:to="us-gaap_IPOMember_36494" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="223.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36493" xlink:to="us-gaap_OverAllotmentOptionMember_36495" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="221.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36492" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36493" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="602.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36516" xlink:to="us-gaap_SharesIssuedPricePerShare_36957" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="224.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_InitialPublicOfferingTable_36491" xlink:to="us-gaap_StatementClassOfStockAxis_36496" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="220.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_InitialPublicOfferingTable_36491" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36492" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="240.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfWarrantOrRightDomain_36510" xlink:to="us-gaap_WarrantMember_36512" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/CommitmentsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnderwritingOptionPeriod" xlink:label="tlnc_UnderwritingOptionPeriod_37035" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis_36821" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnderwritingDiscountAmountPerUnit" xlink:label="tlnc_UnderwritingDiscountAmountPerUnit_36653" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36654" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_36652" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_36662" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsForUnderwritingExpense" xlink:label="us-gaap_PaymentsForUnderwritingExpense_36663" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LossContingenciesTable" xlink:label="us-gaap_LossContingenciesTable_36664" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36665" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36666" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36667" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_37071" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_36822" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_InterestRateMember" xlink:label="tlnc_InterestRateMember_36824" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_UnderwritingAgreementMember" xlink:label="tlnc_UnderwritingAgreementMember_37072" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherCommitmentsLineItems" xlink:label="us-gaap_OtherCommitmentsLineItems_36668" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeOther" xlink:label="us-gaap_InterestIncomeOther_36670" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:label="us-gaap_DebtInstrumentInterestRateEffectivePercentage_36671" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_36672" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PercentageOfDeferredUnderwritings" xlink:label="tlnc_PercentageOfDeferredUnderwritings_36750" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_36634" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesOther" xlink:label="us-gaap_StockIssuedDuringPeriodSharesOther_36650" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis_37070" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_36651" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36661" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="tlnc_UnderwritingOptionPeriod_37035" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_36664" xlink:to="us-gaap_DebtInstrumentAxis_36821" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="tlnc_UnderwritingDiscountAmountPerUnit_36653" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36654" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_36652" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_SaleOfStockPricePerShare_36662" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_PaymentsForUnderwritingExpense_36663" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="373.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_36634" xlink:to="us-gaap_LossContingenciesTable_36664" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_36664" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36665" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="375.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36665" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36666" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="376.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36666" xlink:to="us-gaap_OverAllotmentOptionMember_36667" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="663.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis_37070" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_37071" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="514.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis_36821" xlink:to="us-gaap_DebtInstrumentNameDomain_36822" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="516.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain_36822" xlink:to="tlnc_InterestRateMember_36824" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="664.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember_37071" xlink:to="tlnc_UnderwritingAgreementMember_37072" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_36664" xlink:to="us-gaap_OtherCommitmentsLineItems_36668" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="21.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_InterestIncomeOther_36670" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="22.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_DebtInstrumentInterestRateEffectivePercentage_36671" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="381.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36666" xlink:to="us-gaap_IPOMember_36672" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="20.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="tlnc_PercentageOfDeferredUnderwritings_36750" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_StockIssuedDuringPeriodSharesOther_36650" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LossContingenciesTable_36664" xlink:to="us-gaap_TypeOfArrangementAxis_37070" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_36651" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherCommitmentsLineItems_36668" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36661" preferredLabel="http://www.xbrl.org/2009/role/netLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_36482" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_36882" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_36546" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashEquivalentsAtCarryingValue_36548" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashFDICInsuredAmount" xlink:label="us-gaap_CashFDICInsuredAmount_36549" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits_36550" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_36551" />
    <link:presentationArc xlink:type="arc" order="219.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36482" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_36882" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="214.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36482" xlink:to="us-gaap_Cash_36546" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="215.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36482" xlink:to="us-gaap_CashEquivalentsAtCarryingValue_36548" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="216.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36482" xlink:to="us-gaap_CashFDICInsuredAmount_36549" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="217.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36482" xlink:to="us-gaap_UnrecognizedTaxBenefits_36550" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="218.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36482" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_36551" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/Commitments" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_36630" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_36629" />
    <link:presentationArc xlink:type="arc" order="340.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_36629" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_36630" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/ShareholdersDeficitDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36721" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36722" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36723" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_36727" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract_36707" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_36732" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_36733" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_36728" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_36729" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_36731" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36724" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems_36725" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued_36952" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ShareholdersDeficitTable" xlink:label="tlnc_ShareholdersDeficitTable_36720" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ConversionOfOrdinarySharesPercentage" xlink:label="tlnc_ConversionOfOrdinarySharesPercentage_36744" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_36734" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_ShareholdersDeficitTable_36720" xlink:to="us-gaap_StatementClassOfStockAxis_36721" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="421.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36721" xlink:to="us-gaap_ClassOfStockDomain_36722" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="422.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36722" xlink:to="us-gaap_CommonClassAMember_36723" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_PreferredStockSharesAuthorized_36727" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_CommonStockSharesAuthorized_36732" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_CommonStockSharesIssued_36733" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_PreferredStockSharesIssued_36728" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_PreferredStockSharesOutstanding_36729" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_36731" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="423.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36722" xlink:to="us-gaap_CommonClassBMember_36724" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_ShareholdersDeficitTable_36720" xlink:to="us-gaap_ClassOfStockLineItems_36725" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_TemporaryEquitySharesIssued_36952" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="419.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract_36707" xlink:to="tlnc_ShareholdersDeficitTable_36720" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="20.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="tlnc_ConversionOfOrdinarySharesPercentage_36744" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems_36725" xlink:to="us-gaap_CommonStockSharesOutstanding_36734" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember" xlink:label="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember_36899" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems_36900" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract" xlink:label="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_36902" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_36903" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ClassAOrdinarySharesIssuanceCosts" xlink:label="tlnc_ClassAOrdinarySharesIssuanceCosts_36904" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract" xlink:label="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_36905" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_36906" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment" xlink:label="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_36907" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_36895" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable" xlink:label="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable_36896" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36949" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36897" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36898" />
    <link:presentationArc xlink:type="arc" order="556.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36898" xlink:to="tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember_36899" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="557.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable_36896" xlink:to="us-gaap_TemporaryEquityLineItems_36900" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems_36900" xlink:to="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_36902" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="560.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_36902" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_36903" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="561.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract_36902" xlink:to="tlnc_ClassAOrdinarySharesIssuanceCosts_36904" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems_36900" xlink:to="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_36905" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_36905" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_36906" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract_36905" xlink:to="us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment_36907" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="553.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract_36895" xlink:to="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable_36896" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems_36900" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_36949" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="554.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable_36896" xlink:to="us-gaap_StatementClassOfStockAxis_36897" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="555.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36897" xlink:to="us-gaap_ClassOfStockDomain_36898" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_36918" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract_36910" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_36911" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic_36922" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36923" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted_36924" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36913" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassAMember" xlink:label="us-gaap_CommonClassAMember_36914" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36915" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EarningsPerShareBasicLineItems" xlink:label="us-gaap_EarningsPerShareBasicLineItems_36916" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_36919" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36921" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract_36917" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36912" />
    <link:presentationArc xlink:type="arc" order="571.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract_36917" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_36918" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="564.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract_36910" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_36911" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="575.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" xlink:to="us-gaap_EarningsPerShareBasic_36922" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="576.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_36923" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="577.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" xlink:to="us-gaap_EarningsPerShareDiluted_36924" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="566.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36912" xlink:to="us-gaap_ClassOfStockDomain_36913" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="567.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36913" xlink:to="us-gaap_CommonClassAMember_36914" preferredLabel="http://www.xbrl.org/2009/role/netLabel" />
    <link:presentationArc xlink:type="arc" order="568.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36913" xlink:to="us-gaap_CommonClassBMember_36915" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_36911" xlink:to="us-gaap_EarningsPerShareBasicLineItems_36916" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="572.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract_36917" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_36919" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="573.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems_36916" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="574.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_36920" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_36921" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="570.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicLineItems_36916" xlink:to="us-gaap_NetIncomeLossAbstract_36917" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_36911" xlink:to="us-gaap_StatementClassOfStockAxis_36912" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/RelatedPartyTransactionsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_36601" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36602" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_36625" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_36627" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems_36613" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_36615" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_36616" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36603" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36605" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_36595" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36597" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_36631" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AggregateAmount" xlink:label="tlnc_AggregateAmount_36635" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AggregateShares" xlink:label="tlnc_AggregateShares_36632" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AggregateSponsorAmount" xlink:label="tlnc_AggregateSponsorAmount_36647" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_AmountOfFairValue" xlink:label="tlnc_AmountOfFairValue_36637" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_FairValueOfShares" xlink:label="tlnc_FairValueOfShares_36745" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_FairValuePerSharePrice" xlink:label="tlnc_FairValuePerSharePrice_36746" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_FounderShareMember" xlink:label="tlnc_FounderShareMember_36612" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_OutstandingBalancePromissoryNote" xlink:label="tlnc_OutstandingBalancePromissoryNote_36648" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders" xlink:label="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders_36618" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_36619" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputSharePriceMember" xlink:label="us-gaap_MeasurementInputSharePriceMember_36642" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="us-gaap_MeasurementInputTypeDomain_36641" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentMeasurementInput" xlink:label="us-gaap_DebtInstrumentMeasurementInput_36639" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_36693" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36598" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputOptionVolatilityMember" xlink:label="us-gaap_MeasurementInputOptionVolatilityMember_37077" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionAxis" xlink:label="us-gaap_RelatedPartyTransactionAxis_36610" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionDomain" xlink:label="us-gaap_RelatedPartyTransactionDomain_36611" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_36643" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputCommodityMarketPriceMember" xlink:label="us-gaap_MeasurementInputCommodityMarketPriceMember_36644" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis_36640" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36606" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36607" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyMember" xlink:label="us-gaap_RelatedPartyMember_36609" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember_36600" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_36617" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_36624" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_WorkingCapitalLoan" xlink:label="tlnc_WorkingCapitalLoan_36646" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdministrativeFeesExpense" xlink:label="us-gaap_AdministrativeFeesExpense_36951" />
    <link:presentationArc xlink:type="arc" order="316.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36598" xlink:to="us-gaap_OverAllotmentOptionMember_36601" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_StatementClassOfStockAxis_36602" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="17.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_36625" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <link:presentationArc xlink:type="arc" order="18.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_36627" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_RelatedPartyTransactionLineItems_36613" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_36615" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_36616" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="318.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36602" xlink:to="us-gaap_ClassOfStockDomain_36603" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="320.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36603" xlink:to="us-gaap_CommonClassBMember_36605" preferredLabel="http://www.xbrl.org/2009/role/netLabel" />
    <link:presentationArc xlink:type="arc" order="311.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract_36595" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36597" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="19.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_CommonStockSharesIssued_36631" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="21.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_AggregateAmount_36635" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="20.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_AggregateShares_36632" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="29.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_AggregateSponsorAmount_36647" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="23.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_AmountOfFairValue_36637" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="22.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_FairValueOfShares_36745" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="25.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_FairValuePerSharePrice_36746" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="325.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionDomain_36611" xlink:to="tlnc_FounderShareMember_36612" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="30.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_OutstandingBalancePromissoryNote_36648" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders_36618" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="332.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_36607" xlink:to="tlnc_SponsorMember_36619" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="351.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_36641" xlink:to="us-gaap_MeasurementInputSharePriceMember_36642" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="350.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeAxis_36640" xlink:to="us-gaap_MeasurementInputTypeDomain_36641" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="26.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_DebtInstrumentMeasurementInput_36639" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="31.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_OtherLiabilitiesCurrent_36693" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="313.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36597" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36598" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="669.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_36641" xlink:to="us-gaap_MeasurementInputOptionVolatilityMember_37077" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_RelatedPartyTransactionAxis_36610" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="324.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionAxis_36610" xlink:to="us-gaap_RelatedPartyTransactionDomain_36611" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="352.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_36641" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_36643" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="353.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MeasurementInputTypeDomain_36641" xlink:to="us-gaap_MeasurementInputCommodityMarketPriceMember_36644" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_MeasurementInputTypeAxis_36640" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_36596" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36606" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="322.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36606" xlink:to="us-gaap_RelatedPartyDomain_36607" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_36607" xlink:to="us-gaap_RelatedPartyMember_36609" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="315.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36598" xlink:to="us-gaap_PrivatePlacementMember_36600" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_36617" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_SharePrice_36624" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="28.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="tlnc_WorkingCapitalLoan_36646" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="600.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems_36613" xlink:to="us-gaap_AdministrativeFeesExpense_36951" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_36891" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_TemporaryEquityTableTextBlock" xlink:label="us-gaap_TemporaryEquityTableTextBlock_36892" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract_36890" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36890" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_36891" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract_36890" xlink:to="us-gaap_TemporaryEquityTableTextBlock_36892" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/AuditInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLineItems" xlink:label="dei_AuditorLineItems_33573" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorName" xlink:label="dei_AuditorName_33577" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId_33578" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation_33579" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AuditorOpinionTextBlock" xlink:label="dei_AuditorOpinionTextBlock_33580" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorLineItems_33573" xlink:to="dei_AuditorName_33577" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorLineItems_33573" xlink:to="dei_AuditorFirmId_33578" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorLineItems_33573" xlink:to="dei_AuditorLocation_33579" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_AuditorLineItems_33573" xlink:to="dei_AuditorOpinionTextBlock_33580" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SegmentInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NumberOfReportableSegments" xlink:label="us-gaap_NumberOfReportableSegments_36686" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription" xlink:label="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_36687" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract_36680" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration" xlink:label="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_36688" />
    <link:presentationArc xlink:type="arc" order="387.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_36680" xlink:to="us-gaap_NumberOfReportableSegments_36686" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="388.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_36680" xlink:to="us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription_36687" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="389.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_36680" xlink:to="us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration_36688" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SubsequentEvents" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract_36696" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock_36697" />
    <link:presentationArc xlink:type="arc" order="397.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsequentEventsAbstract_36696" xlink:to="us-gaap_SubsequentEventsTextBlock_36697" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_37014" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_37015" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_37016" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_37022" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_37023" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_37008" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_37009" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_36945" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfAdditionalFounderShareIssued" xlink:label="tlnc_NumberOfAdditionalFounderShareIssued_37060" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareIssued" xlink:label="tlnc_NumberOfFounderShareIssued_37061" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareOutstanding" xlink:label="tlnc_NumberOfFounderShareOutstanding_37062" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfSharesSubjectToForfeiture" xlink:label="tlnc_NumberOfSharesSubjectToForfeiture_37063" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfShareSubjectNotToForfeiture" xlink:label="tlnc_NumberOfShareSubjectNotToForfeiture_37064" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesHolding" xlink:label="tlnc_NumberOfFounderSharesHolding_37065" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_37025" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_37066" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_37067" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember_37068" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SaleOfStockNumberOfSharesIssued" xlink:label="tlnc_SaleOfStockNumberOfSharesIssued_37073" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_37011" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_37013" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_37008" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_37014" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_37014" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_37015" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_37015" xlink:to="us-gaap_OverAllotmentOptionMember_37016" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_37008" xlink:to="us-gaap_StatementClassOfStockAxis_37022" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_37022" xlink:to="us-gaap_ClassOfStockDomain_37023" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="597.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract_36945" xlink:to="us-gaap_StatementTable_37008" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_37008" xlink:to="us-gaap_StatementLineItems_37009" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_37008" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37010" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="652.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfAdditionalFounderShareIssued_37060" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="653.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfFounderShareIssued_37061" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="654.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfFounderShareOutstanding_37062" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="655.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfSharesSubjectToForfeiture_37063" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="656.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfShareSubjectNotToForfeiture_37064" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="657.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_NumberOfFounderSharesHolding_37065" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_37023" xlink:to="us-gaap_CommonClassBMember_37025" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_37008" xlink:to="srt_TitleOfIndividualAxis_37066" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="659.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis_37066" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_37067" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="660.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_37067" xlink:to="srt_DirectorMember_37068" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="665.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_37009" xlink:to="tlnc_SaleOfStockNumberOfSharesIssued_37073" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_37010" xlink:to="us-gaap_RelatedPartyDomain_37011" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_37011" xlink:to="tlnc_SponsorMember_37013" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingInformationProfitLossAbstract" xlink:label="us-gaap_SegmentReportingInformationProfitLossAbstract_36690" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="us-gaap_Cash_36692" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsHeldInTrustNoncurrent" xlink:label="us-gaap_AssetsHeldInTrustNoncurrent_36930" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest_36932" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_37036" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract_36690" xlink:to="us-gaap_Cash_36692" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract_36690" xlink:to="us-gaap_AssetsHeldInTrustNoncurrent_36930" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract_36690" xlink:to="us-gaap_InvestmentIncomeInterest_36932" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingInformationProfitLossAbstract_36690" xlink:to="us-gaap_GeneralAndAdministrativeExpense_37036" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/ShareholdersDeficit" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract_36698" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_36699" />
    <link:presentationArc xlink:type="arc" order="399.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract_36698" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_36699" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/PrivatePlacementUnitsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36576" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_36568" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_36571" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_36569" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:label="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36959" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare_36574" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_CohenMember" xlink:label="tlnc_CohenMember_36581" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PrivatePlacementAbstract" xlink:label="tlnc_PrivatePlacementAbstract_36563" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_36577" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember_36570" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember_36578" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_36580" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis_36579" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36575" />
    <link:presentationArc xlink:type="arc" order="302.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36575" xlink:to="us-gaap_RelatedPartyDomain_36576" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="293.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="tlnc_PrivatePlacementAbstract_36563" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_36568" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_36571" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="295.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_36568" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_36569" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_36571" xlink:to="us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_36959" preferredLabel="http://www.xbrl.org/2009/role/netLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems_36571" xlink:to="us-gaap_SaleOfStockPricePerShare_36574" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="307.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain_36580" xlink:to="tlnc_CohenMember_36581" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="303.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_36576" xlink:to="tlnc_SponsorMember_36577" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="296.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36569" xlink:to="us-gaap_IPOMember_36570" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="304.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_36569" xlink:to="us-gaap_PrivatePlacementMember_36578" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="306.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis_36579" xlink:to="dei_EntityDomain_36580" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" xlink:to="dei_LegalEntityAxis_36579" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_36567" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36575" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/RelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_36592" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_36593" />
    <link:presentationArc xlink:type="arc" order="309.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract_36592" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_36593" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SegmentInformationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract_36677" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_36678" />
    <link:presentationArc xlink:type="arc" order="384.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_36677" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_36678" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/SegmentInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract_36674" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_36675" />
    <link:presentationArc xlink:type="arc" order="383.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SegmentReportingAbstract_36674" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_36675" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/PrivatePlacementUnits" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_PrivatePlacementTextBlock" xlink:label="tlnc_PrivatePlacementTextBlock_36561" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDisclosuresAbstract" xlink:label="us-gaap_ClassOfStockDisclosuresAbstract_36560" />
    <link:presentationArc xlink:type="arc" order="288.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDisclosuresAbstract_36560" xlink:to="tlnc_PrivatePlacementTextBlock_36561" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_1012" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_1013" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" xlink:label="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_1005" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_1010" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock" xlink:label="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_1011" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" xlink:label="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_1014" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_1002" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems" xlink:label="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_1004" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_1004" xlink:to="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_1012" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_1012" xlink:to="cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_1013" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_1004" xlink:to="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_1005" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_1005" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_1010" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="16.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock_1005" xlink:to="cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock_1011" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock_1012" xlink:to="cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_1014" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract_1002" xlink:to="cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems_1004" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
  <link:presentationLink xlink:role="http://TCC.com/20251231/role/StatementofOperationsParentheticals" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_36987" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember_36989" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_36990" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36998" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis_36986" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract_36984" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_36985" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RelatedPartyDomain" xlink:label="us-gaap_RelatedPartyDomain_36999" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_SponsorMember" xlink:label="tlnc_SponsorMember_37001" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_37002" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_37003" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OverAllotmentOptionMember" xlink:label="us-gaap_OverAllotmentOptionMember_37004" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfAdditionalFounderSharesIssued" xlink:label="tlnc_NumberOfAdditionalFounderSharesIssued_37050" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesIssued" xlink:label="tlnc_NumberOfFounderSharesIssued_37051" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderSharesOutstanding" xlink:label="tlnc_NumberOfFounderSharesOutstanding_37052" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfShareSubjectToForfeiture" xlink:label="tlnc_NumberOfShareSubjectToForfeiture_37053" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfSharesSubjectNotToForfeiture" xlink:label="tlnc_NumberOfSharesSubjectNotToForfeiture_37054" />
    <link:loc xlink:type="locator" xlink:href="tlnc-20251231.xsd#tlnc_NumberOfFounderShareHolding" xlink:label="tlnc_NumberOfFounderShareHolding_37055" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis_37056" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_37057" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember_37058" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis_36986" xlink:to="us-gaap_ClassOfStockDomain_36987" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain_36987" xlink:to="us-gaap_CommonClassBMember_36989" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="15.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36985" xlink:to="us-gaap_StatementLineItems_36990" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36985" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36998" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="13.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36985" xlink:to="us-gaap_StatementClassOfStockAxis_36986" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract_36984" xlink:to="us-gaap_StatementTable_36985" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_36998" xlink:to="us-gaap_RelatedPartyDomain_36999" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="11.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyDomain_36999" xlink:to="tlnc_SponsorMember_37001" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="12.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36985" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_37002" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis_37002" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_37003" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="10.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain_37003" xlink:to="us-gaap_OverAllotmentOptionMember_37004" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="642.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfAdditionalFounderSharesIssued_37050" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="643.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfFounderSharesIssued_37051" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="644.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfFounderSharesOutstanding_37052" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="645.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfShareSubjectToForfeiture_37053" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="646.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfSharesSubjectNotToForfeiture_37054" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="647.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_36990" xlink:to="tlnc_NumberOfFounderShareHolding_37055" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" order="14.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_36985" xlink:to="srt_TitleOfIndividualAxis_37056" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="649.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis_37056" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_37057" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" order="650.00" priority="1" use="optional" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain_37057" xlink:to="srt_DirectorMember_37058" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Mar. 25, 2026</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Talon Capital Corp.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0002073340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">00-0000000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">440 Louisiana Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">407-0686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,679,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember', window );">Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TLNCU<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tlnc_ClassAOrdinarySharesParValue00001PerShareMember', window );">Class A ordinary shares, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A ordinary shares, par value $0.0001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TLNC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member', window );">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TLNCW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tlnc_ClassAOrdinarySharesParValue00001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tlnc_ClassAOrdinarySharesParValue00001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLineItems', window );"><strong>Auditor [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">WithumSmith+Brown, PC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">New York, New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorOpinionTextBlock', window );">Auditor Opinion [Text Block]</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">Opinion on the Financial Statements</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">We have audited the accompanying balance sheet of Talon Capital Corp. (the &#8220;Company&#8221;) as of December 31, 2025, the related statements of operations, changes in shareholders&#8217; deficit and cash flows for the period from May 1, 2025 (inception) through December 31, 2025, and the related notes (collectively referred to as the &#8220;financial statements&#8221;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the period from May 1, 2025 (inception) through December 31, 2025 in conformity with accounting principles generally accepted in the United States of America.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorOpinionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-X<br> -Number 210<br> -Section 2<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorOpinionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet<br></strong></div></th>
<th class="th" colspan="2">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 2,872,627<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherPrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">3,443<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Prepaid insurance</a></td>
<td class="nump">77,500<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,953,570<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseOtherNoncurrent', window );">Long-term prepaid insurance</a></td>
<td class="nump">51,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash held in Trust Account</a></td>
<td class="nump">252,095,639<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">255,100,876<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">53,702<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_AccruedOfferingCosts', window );">Accrued offering costs</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">128,702<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_DeferredUnderwritingFeeNoncurrent', window );">Deferred underwriting fee</a></td>
<td class="nump">10,200,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">10,328,702<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments (Note 6)</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(7,241,716)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders&#8217; Deficit</a></td>
<td class="num">(7,240,808)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders&#8217; Deficit</a></td>
<td class="nump">255,100,876<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A ordinary shares subject to possible redemption, $0.0001 par value; 24,900,000 shares at redemption value of $10.12 per share</a></td>
<td class="nump">252,012,982<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares value</a></td>
<td class="nump">78<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; Deficit</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Ordinary shares value</a></td>
<td class="nump">$ 830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes 1,125,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares (after taking into account the assignment of 40,000 founder shares to the directors) (Note 5).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding (Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_AccruedOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of accrued offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_AccruedOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_DeferredUnderwritingFeeNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred underwriting fee, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_DeferredUnderwritingFeeNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 19: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 64<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481620/480-10-55-64<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 31: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherPrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherPrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseOtherNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseOtherNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479772/718-30-S55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet (Parentheticals)<br></strong></div></th>
<th class="th" colspan="2">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preference shares, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preference shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preference shares, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preference shares, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital', window );">Subject to possible redemption, par value | $</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Subject to possible redemption, shares</a></td>
<td class="nump">24,900,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityRedemptionPricePerShare', window );">Subject to possible redemption, per share | $ / shares</a></td>
<td class="nump">$ 10.12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">779,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">779,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">8,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">8,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfSharesSubjectToForfeiture', window );">Number of share subject to forfeiture</a></td>
<td class="nump">1,125,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes 1,125,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares (after taking into account the assignment of 40,000 founder shares to the directors) (Note 5).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding (Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of share subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of the par value of temporary equity outstanding. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Operations<br></strong></div></th>
<th class="th" colspan="2">8 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative costs</a></td>
<td class="nump">$ 546,385<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(546,385)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest earned on cash held in Trust Account</a></td>
<td class="nump">3,171,560<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">3,171,560<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 2,625,175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding | shares</a></td>
<td class="nump">11,787,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding | shares</a></td>
<td class="nump">11,787,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share | $ / shares</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share | $ / shares</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding | shares</a></td>
<td class="nump">7,867,213<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding | shares</a></td>
<td class="nump">7,867,213<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share | $ / shares</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share | $ / shares</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding. All share and per share amounts have been retroactively presented (Note 5).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statement of Operations (Parentheticals) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 10, 2025</div></th>
<th class="th"><div>Aug. 08, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfShareSubjectToForfeiture', window );">Number of share subject to forfeiture</a></td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfShareSubjectToForfeiture', window );">Number of share subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfSharesSubjectNotToForfeiture', window );">Number of share subject not to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfFounderShareHolding', window );">Number of founder shares holding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember', window );">Sponsor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfAdditionalFounderSharesIssued', window );">Number of additional founder shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfFounderSharesIssued', window );">Founder shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfFounderSharesOutstanding', window );">Founder shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfFounderShareHolding', window );">Number of founder shares holding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfAdditionalFounderSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of additional founder share issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfAdditionalFounderSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfFounderShareHolding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the holding number of founder shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfFounderShareHolding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfFounderSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of founder share issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfFounderSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfFounderSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of founder share outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfFounderSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfShareSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of share subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfShareSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfSharesSubjectNotToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of share subject not to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfSharesSubjectNotToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Statement of Changes In Shareholders&#8217; Deficit - 8 months ended Dec. 31, 2025 - USD ($)<br></strong></div></th>
<th class="th">
<div>Class A </div>
<div>Ordinary Shares</div>
</th>
<th class="th" colspan="2">
<div>Class B </div>
<div>Ordinary Shares</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Apr. 30, 2025</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Apr. 30, 2025</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Class B ordinary shares issued to sponsor</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 863<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">24,137<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Class B ordinary shares issued to sponsor (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits', window );">Sale of 779,000 Private Placement Units</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,789,922<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,790,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits', window );">Sale of 779,000 Private Placement Units (in Shares)</a></td>
<td class="nump">779,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Fair value of Public Warrants at issuance</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,817,700<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,817,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Allocated value of transaction costs to Class A non-redeemable shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(122,734)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(122,734)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of founder shares</a></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (33)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">33<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of founder shares (in Shares)</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(325,000)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket', window );">Fair value of founder Shares assigned to directors</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">74,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">74,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Accretion for Class A ordinary shares to redemption amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,583,058<span></span>
</td>
<td class="nump">9,866,891<span></span>
</td>
<td class="nump">19,449,949<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,625,175<span></span>
</td>
<td class="nump">2,625,175<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2025</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 830<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">$ (7,241,716)<span></span>
</td>
<td class="num">$ (7,240,808)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance (in Shares) at Dec. 31, 2025</a></td>
<td class="nump">779,000<span></span>
</td>
<td class="nump">8,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes 1,125,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares (after taking into account the assignment of 40,000 founder shares to the directors) (Note 5).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding. All share and per share amounts have been retroactively presented (Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The shares of sale private placement units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of sale private placement units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to additional paid in capital (APIC) resulting from changes in fair value of common and preferred stock issued to employee benefit trust but unearned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 16: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Changes In Shareholders&#8217; Deficit (Parentheticals) - shares<br></strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Sep. 10, 2025</div></th>
<th class="th"><div>Aug. 08, 2025</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_SaleOfStockNumberOfSharesIssued', window );">Sale of private placement warrants shares</a></td>
<td class="nump">779,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfSharesSubjectToForfeiture', window );">Number of share subject to forfeiture</a></td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfSharesSubjectToForfeiture', window );">Number of share subject to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfShareSubjectNotToForfeiture', window );">Number of share subject not to forfeiture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option | Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfFounderSharesHolding', window );">Number of founder shares holding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfAdditionalFounderShareIssued', window );">Number of additional founder shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,875,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfFounderShareIssued', window );">Founder shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfFounderShareOutstanding', window );">Founder shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,625,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfFounderSharesHolding', window );">Number of founder shares holding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,260,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfAdditionalFounderShareIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of additional founder share issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfAdditionalFounderShareIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfFounderShareIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of founder share issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfFounderShareIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfFounderShareOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of founder share outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfFounderShareOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfFounderSharesHolding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the holding number of founder shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfFounderSharesHolding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfShareSubjectNotToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of share subject not to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfShareSubjectNotToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfSharesSubjectToForfeiture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of share subject to forfeiture.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfSharesSubjectToForfeiture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_SaleOfStockNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares sale of stock number of shares issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_SaleOfStockNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Statement of Cash Flows<br></strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 2,625,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty', window );">Payment of general and administrative costs through advances from related party</a></td>
<td class="nump">10,420<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest earned on cash held in Trust Account</a></td>
<td class="num">(3,171,560)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes', window );">Cash withdrawn from Trust Account for working capital purposes</a></td>
<td class="nump">75,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Compensation expense</a></td>
<td class="nump">74,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther', window );">Prepaid expenses</a></td>
<td class="num">(80,943)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidInsurance', window );">Long-term prepaid insurance</a></td>
<td class="num">(51,667)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">53,702<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(464,952)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireTrustPreferredInvestments', window );">Investment of cash in Trust Account</a></td>
<td class="num">(249,000,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(249,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of Class B ordinary shares to Sponsor</a></td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromOtherEquity', window );">Proceeds from sale of Units, net of underwriting discounts paid</a></td>
<td class="nump">244,260,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from sale of Private Placement Units</a></td>
<td class="nump">7,790,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_ProceedsFromSaleOfUnderwritersReimbursement', window );">Underwriters&#8217; reimbursement</a></td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt', window );">Repayment of advances from related party</a></td>
<td class="num">(39,936)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from promissory note - related party</a></td>
<td class="nump">83,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of promissory note - related party</a></td>
<td class="num">(83,927)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of offering costs</a></td>
<td class="num">(397,485)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">252,337,579<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">Net Change in Cash</a></td>
<td class="nump">2,872,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; Beginning of period</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash &#8211; End of period</a></td>
<td class="nump">2,872,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts', window );">Offering costs included in accrued offering costs</a></td>
<td class="nump">75,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty', window );">Deferred offering costs paid through advances from related party</a></td>
<td class="nump">29,516<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_DeferredUnderwritingFeePayable', window );">Deferred underwriting fee payable</a></td>
<td class="nump">10,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_ForfeitureOfFounderShares', window );">Forfeiture of founder shares</a></td>
<td class="nump">$ 33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash withdrawn from Trust Account for working capital purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of offering costs included in or accrued offering costs that were incurred during a noncash or partial noncash transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred offering costs paid through advances from related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_DeferredUnderwritingFeePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred underwriting fee payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_DeferredUnderwritingFeePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_ForfeitureOfFounderShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of forfeiture of founder shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_ForfeitureOfFounderShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of payment of operating expenses through advances from related party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_ProceedsFromSaleOfUnderwritersReimbursement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of underwriters&#8217; reimbursement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_ProceedsFromSaleOfUnderwritersReimbursement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpensesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpensesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for insurance that provides economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireTrustPreferredInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of trust preferred securities, which possess characteristics of both equity and debt securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireTrustPreferredInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromOtherEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from the issuance of equity classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromOtherEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Description of Organization and Business Operations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><span id="a_032" style="display: inline-block;"></span>1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Talon Capital Corp. (the &#8220;Company&#8221;) was incorporated as a Cayman Islands exempted company on May&#160;1, 2025. The Company is a newly organized blank check company or special purpose acquisition company (&#8220;SPAC&#8221;), formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses (the &#8220;Business Combination&#8221;). The Company has not selected any specific Business Combination target. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus on target businesses in the energy and power industries. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> As of December 31, 2025, the Company had not commenced any operations. All activity for the period from May&#160;1, 2025 (inception) through December 31, 2025 relates to the Company&#8217;s formation, the initial public offering (the &#8220;Initial Public Offering&#8221;), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after completion of the Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on investments from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31 as its fiscal year end. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The registration statement for the Company&#8217;s Initial Public Offering was declared effective on September 8, 2025. On September 10, 2025, the Company consummated the Initial Public Offering of 24,900,000 units (the &#8220;Units&#8221; and, with respect to the Class A ordinary shares included in the Units being offered, the &#8220;Public Shares&#8221;), which includes the partial exercise by the underwriters of their over-allotment option in the amount of 2,400,000 Units, at $10.00 per Unit, generating gross proceeds of $249,000,000. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (each, a &#8220;Public Warrant&#8221;). </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 779,000 units (the &#8220;Private Placement Units&#8221;) at a price of $10.00 per Private Placement Unit, in a private placement to the Company&#8217;s sponsor, Talon Capital Sponsor LLC (the &#8220;Sponsor&#8221;) and Cohen and Company Capital Markets, a division of Cohen &amp; Company Securities, LLC (&#8220;Cohen&#8221;), as representative of the underwriters, generating gross proceeds of $7,790,000. Each Private Placement Unit consists of one Class A ordinary share and one-third of one redeemable warrant (the &#8220;Private Placement Warrants&#8221; and together with the Public Warrants, the &#8220;Warrants&#8221;). Each whole Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Of those 779,000 Private Placement Units, the Sponsor purchased 530,000 Private Placement Units, and Cohen purchased 249,000 Private Placement Units. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Transaction costs amounted to $14,742,001, consisting of $4,040,000 of cash underwriting fees (net of $700,000 underwriters&#8217; reimbursement), $10,200,000 of deferred underwriting fees, and $502,001 of other offering costs. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Following the closing of the Initial Public Offering, on September 10, 2025, an amount of $249,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units and the Private Placement Units was placed in the trust account (the &#8220;Trust Account&#8221;), located in the United States, and will be invested or held only in either (i)&#160;U.S.&#160;government treasury obligations with a maturity of 185&#160;days or less or in money market funds meeting certain conditions under&#160;Rule&#160;2a-7&#160;under&#160;the&#160;Investment Company Act&#160;of&#160;1940 which invest only in direct U.S.&#160;government treasury obligations, (ii)&#160;as uninvested cash, or (iii)&#160;an interest bearing bank demand deposit account or other accounts at a bank. Funds will remain in the Trust Account until the earlier of (i)&#160;the completion of the Business Combination or (ii)&#160;the distribution of the Trust Account as described below. The Company is permitted to withdraw amounts from the Trust Account (i) to fund its working capital requirements, which amount will be the lesser of $500,000 or 5% of the interest earned on the Trust Account per annum, and/or (ii) to pay its taxes (other than excise taxes, if any), provided that all permitted withdrawals can only be made (x) from interest and not from the principal held in the Trust Account and (y) only to the extent such interest is in amount sufficient to cover the permitted withdrawal amount (&#8220;permitted withdrawals&#8221;). On November 13, 2025 the Company withdrew $75,921 from the Trust Account for working capital purposes. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company will provide the holders of the public units, or the &#8220;public shareholders,&#8221; with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination at a&#160;per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two&#160;business days prior to consummation of the initial Business Combination, including interest (which interest shall be net of permitted withdrawals), divided by the number of then issued and outstanding public shares, subject to limitations. The amount in the Trust Account is initially invested at $10.00 per public share. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company&#8217;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, &#8220;Target Business&#8221; must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less the deferred underwriting commissions and the taxes payable on interest earned) at the time the Company signs a definitive agreement in connection with the Business Combination. There is no assurance that the Company will be able to successfully effect a Business Combination. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company, after signing a definitive agreement for a Business Combination, will either (i)&#160;seek shareholder approval of the Business Combination at a meeting called for such purpose in connection with which shareholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes payable) or (ii)&#160;provide shareholders with the opportunity to have their shares redeemed by the Company by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, net of taxes payable, if any. The decision as to whether the Company will seek shareholder approval of the Business Combination or will allow shareholders to redeem their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval unless a vote is required by the Nasdaq rules. If the Company seeks shareholder approval, it will complete its Business Combination only if a majority of the outstanding shares are voted in favor of the Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company will have 24&#160;months from the closing date of the Initial Public Offering to complete its initial Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i)&#160;cease all operations except for the purposes of winding up; (ii)&#160;as promptly as reasonably possible, but not more than ten (10)&#160;business&#160;days thereafter, redeem 100% of the outstanding public shares, at a&#160;per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of permitted withdrawals, and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders&#8217; rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Board of Directors, liquidate and dissolve, subject (in the case of (ii)&#160;and (iii)&#160;above) to obligations under the Cayman Islands laws to provide for claims of creditors and the requirements of other applicable law. The initial shareholders will each enter into agreements with the Company, pursuant to which they will agree (1)&#160;to waive their redemption rights with respect to their founder shares, private placement units and any Class&#160;A ordinary shares issuable upon conversion thereof in connection with the consummation of the initial Business Combination or a tender offer conducted prior to a Business Combination or in connection with it; and (2)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and private placement units if the Company fails to complete the initial Business Combination within 24&#160;months from the closing of this offering, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 480, &#8220;Distinguishing Liabilities from Equity.&#8221;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Liquidity</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company&#8217;s liquidity needs up to December 31, 2025 had been satisfied through the loan under an unsecured promissory note from the Sponsor of up to $250,000. On September 10, 2025, Simultaneously with the closing of the initial public offering, the Company consummated the sale of 779,000 private placement units at a price of $10.00 per private placement unit, generating gross proceeds of $7,790,000. On November 13, the Company withdrew cash from the Trust Account for working capital purposes of $75,921. As of December 31, 2025, the Company had cash of $2,872,627 and working capital surplus of $2,824,868. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#8217;s officers and directors may, but is not obligated to, loan the Company funds as may be required (the &#8220;Working Capital Loans&#8221;). If the Company completes a Business Combination, the Company would repay such loaned amounts at that time. Up to $1,500,000 of such Working Capital Loans may be converted into units upon consummation of the Business Combination at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of December 31, 2025, the Company had <span style="-sec-ix-hidden:fc_311650695">no</span> borrowings under the Working Capital Loans. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In connection with the Company&#8217;s assessment of going concern considerations in accordance with ASC 205-40, &#8220;Presentation of Financial Statements - Going Concern,&#8221; the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. The Company will have 24 months from the closing of the Initial Public Offering to complete the initial Business Combination. Management has determined that the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480922/205-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481034/205-10-S45-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Basis of Presentation</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Emerging Growth Company</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The preparation of the financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Cash and Cash Equivalents</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company considers all short-term investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company has $2,872,627 in cash and <span style="-sec-ix-hidden:fc_329852981">no</span> cash equivalents as of December 31, 2025. </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Cash Held in Trust Account</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> As of December 31, 2025, the assets held in the Trust Account, amounting to $252,095,639, were held in a demand deposit account. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Concentration of Credit Risk</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s financial condition, results of operations, and cash flows. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Offering Costs</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, &#8220;Expenses of Offering.&#8221; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, &#8220;Debt with Conversion and Other Options,&#8221; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the warrants and to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Warrants and Private Placement Units were charged to shareholders&#8217; deficit as Public Warrants and Private Placement Warrants after management&#8217;s evaluation were accounted for under equity treatment.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Income Taxes</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company follows the asset and liability method of accounting for income taxes under ASC&#160;740, &#8220;Income Taxes&#8221; (&#8220;ASC&#160;740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> ASC&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span style="-sec-ix-hidden:fc_551881478">no</span> unrecognized tax benefits and <span style="-sec-ix-hidden:fc_1991878236">no</span> amounts accrued for interest and penalties as of December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands, and the Company believes it is presently not subject to income taxes or income tax filing requirements in the United&#160;States. As such, the Company&#8217;s tax provision was zero for the period presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Fair Value of Financial Instruments</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Warrant Instruments</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company accounted for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Class A Ordinary Shares Subject to Possible Redemption</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#8217;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#8217;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#8217; deficit section of the Company&#8217;s balance sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As of December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Gross proceeds</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">249,000,000</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Proceeds allocated to Public Warrants</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(1,817,700</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class A ordinary shares issuance costs</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(14,619,267</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,449,949</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Class A ordinary shares subject to possible redemption, December 31, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">252,012,982</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<span style="font-weight: bold;"><i>Net Income per Ordinary Share</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; Net income per ordinary share is computed by dividing net income by the weighted average number of shares of ordinary shares outstanding for the period. The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary Shares and Class&#160;B ordinary shares. Accretion associated with the redeemable shares of Class&#160;A Ordinary Shares is excluded from income per ordinary share as the redemption value approximates fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period from<br/> May 1, 2025<br/> (Inception) Through<br/> December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Basic net income per ordinary share</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Basic net income per ordinary share</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Numerator:</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,574,371</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,050,804</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Basic weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,787,082</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,867,213</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic net income per ordinary share</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period from<br/> May 1, 2025<br/> (Inception) Through<br/> December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Diluted net income per ordinary share</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Diluted net income per ordinary share</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Numerator:</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,574,371</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,050,804</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Diluted weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,787,082</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,867,213</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Diluted net income per ordinary share</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>Recent Accounting Standards</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In November&#160;2023, the FASB issued ASU&#160;2023-07,&#8221;<i>Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures</i>&#8221;. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (&#8220;CODM&#8221;), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic&#160;280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU&#160;2023-07 on May&#160;1, 2025, inception (see Note 8 for more information).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Class of Stock Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_InitialPublicOfferingTextBlock', window );">INITIAL PUBLIC OFFERING</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">3. INITIAL PUBLIC OFFERING</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> In the Initial Public Offering on September 10, 2025, the Company sold 24,900,000&#160;Units, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 2,400,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Public Share, $0.0001 par value, and one-third of one redeemable Public Warrant. The Warrants will only be exercisable for whole shares at $11.50 per share. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> <span style="font-weight: bold;">Warrants&#160;&#8212;</span>&#160;As of December 31, 2025, there were 8,559,667 Warrants outstanding, including 8,300,000 Public Warrants and 259,667 Private Placement Warrants. Each whole warrant entitles the registered holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share, at any time commencing on the later of 12&#160;months from the closing of the Initial Public Offering and after the completion of the initial Business Combination. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class&#160;A ordinary shares. This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants will be issued upon separation of the Units&#160;and only whole warrants will trade. The warrants will expire at 5:00&#160;p.m., New&#160;York City time, on the fifth anniversary of the completion of an initial Business Combination, or earlier upon redemption. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good faith by the Board of Directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by them prior to such issuance), (y)&#160;the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of Class&#160;A ordinary shares during the 20 trading-day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates its initial Business Combination (such price, the &#8220;Market Value&#8221;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i)&#160;the Market Value or (ii)&#160;the price at which the Company issue the additional Class&#160;A ordinary shares or equity-linked securities. On the exercise of any warrant, the exercise price will be paid directly to the Company and not placed in the Trust Account. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company has agreed that as soon as practicable, but in no event later than 15&#160;business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration under the Securities Act&#160;of&#160;the warrant shares and thereafter use its best efforts to cause the registration statement to become effective and to maintain the effectiveness of such registration statement until the expiration of the warrants. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the issuance of the warrant shares and a current prospectus relating thereto.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">If a registration statement covering the issuance of the warrant shares is not effective within 90&#160;days following the consummation of the initial Business Combination, warrant holders may nevertheless, until such time as there is such an effective registration statement and during any period when the Company shall have failed to maintain such an effective registration statement, exercise warrants on a cashless basis in accordance with Section&#160;3(a)(9)&#160;of the Securities Act. In this circumstance, each holder would pay the exercise price by surrendering warrants exercisable for the number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A ordinary shares underlying such warrants and the difference between the exercise price of such warrants and the &#8220;fair market value&#8221; (defined below) by (y)&#160;the fair market value. The &#8220;fair market value&#8221; means the average reported last sale price of the Class&#160;A ordinary shares for the five&#160;trading days ending on the&#160;trading day prior to the date of exercise.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><i>Redemption of Warrants:</i> The Company may redeem the outstanding warrants:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tbody><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-size: 10pt">at a price of $0.01 per warrant;</span></td> </tr></tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tbody><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-size: 10pt">upon a minimum of 30&#160;days&#8217; prior written notice of redemption (the &#8220;30-day redemption period&#8221;); and</span></td> </tr></tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"> <tbody><tr style="vertical-align: top; text-align: justify"> <td style="text-align: left; width: 0.25in"></td><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td><td style="text-align: left"><span style="font-size: 10pt">if, and only if, the last reported sale price of the Class&#160;A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, dividends, reorganizations, recapitalizations and the like) for any 20&#160;trading days within a 30-trading&#160;day period ending on the third&#160;trading day prior to the date on which the Company will send the notice of redemption to the warrant holders.</span></td> </tr></tbody> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company will not redeem the warrants unless a registration statement under the Securities Act covering the issuance of the warrant shares underlying the warrants to be so redeemed is then effective and a current prospectus relating to those warrant shares is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by the Company, it may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> If the foregoing conditions are satisfied and the Company issues a notice of redemption, each warrant holder may exercise his, her or its warrants prior to the scheduled redemption date. However, the price of the Class&#160;A ordinary shares may fall below the $18.00 trigger price (as adjusted) as well as the $11.50 exercise price (as adjusted) after the redemption notice is issued. The redemption criteria for the warrants have been established at a price which is intended to provide warrant holders a reasonable premium to the initial exercise price and provide a sufficient differential between the then-prevailing share price and the exercise price so that if the share price declines as a result of the redemption call, the redemption will not cause the share price to drop below the exercise price of the warrants. If the Company calls the warrants for redemption as described above, the management will have the option to require all holders that wish to exercise warrants to do so on a &#8220;cashless basis.&#8221; In making such determination, management will consider, among other factors, the Company&#8217;s cash position, the number of warrants that are outstanding and the dilutive effect on shareholders of issuing the maximum number of warrant shares issuable upon exercise of outstanding warrants. In such event, the holder would pay the exercise price by surrendering the warrants for that number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the product of the number of warrant shares underlying the warrants to be so exercised, and the difference between the exercise price of the warrants and the fair market value by (y)&#160;the fair market value. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">No fractional Class&#160;A ordinary share will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class&#160;A ordinary shares to be issued to the holder.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_InitialPublicOfferingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for initial public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_InitialPublicOfferingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement Units<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockDisclosuresAbstract', window );"><strong>Class of Stock Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_PrivatePlacementTextBlock', window );">PRIVATE PLACEMENT UNITS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">4. PRIVATE PLACEMENT UNITS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Simultaneously with the closing of the Initial Public Offering, the Sponsor and Cohen purchased an aggregate of 779,000 Private Placement Units at $10.00 per Private Placement Unit, for an aggregate purchase price of $7,790,000, of which 530,000 Private Placement Units were purchased by the Sponsor and 249,000 Private Placement Units were purchased by Cohen, in a private placement. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Certain proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, such proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_PrivatePlacementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of private placement units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_PrivatePlacementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">5. RELATED PARTY TRANSACTIONS</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Founder Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> On May&#160;19, 2025, the Sponsor purchased 5,750,000 Class&#160;B ordinary shares from the Company for an aggregate purchase price of $25,000, or $0.004 per share. On August 8, 2025, the Company effected a 1 for 1.5 share split of the founder shares. All share and per share amounts have been retroactively restated. Up to 1,125,000 founder shares were subject to forfeiture depending on the extent to which the underwriters&#8217; over-allotment option is exercised during the Initial Public Offering. The forfeiture will be adjusted to the extent that the over-allotment option is not exercised in full by the underwriters so that the Sponsor will own 25% of the Company&#8217;s issued and outstanding Class&#160;A and Class&#160;B ordinary shares after the Initial Public Offering. On September 10, 2025, the underwriters partially exercised their over-allotment option and forfeited the unexercised balance. As a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> On August 19, 2025, the Sponsor assigned a total of 40,000 founder shares to the two directors of the Company (20,000 each) for an aggregate consideration of $0.003 per share, or an aggregate total amount of $115.94. The founder shares will automatically be forfeited and be returned to the Sponsor if the holder of such founder shares is not a member of the board of directors of the Company on or prior to the closing of the Company&#8217;s Initial Public Offering. The assignment of the founder shares to the directors of the Company are in the scope of FASB ASC Topic 718, &#8220;Compensation-Stock Compensation&#8221; (&#8220;ASC 718&#8221;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the assignment date. The total fair value of the 40,000 founder shares granted to the Company&#8217;s directors on August 19, 2025 was $74,000 or $1.85 per share. The founder shares were granted subject to a performance condition (i.e., to be a member of the board of directors of the Company on or prior to the closing of the Company&#8217;s Initial Public Offering). Thus, the fair value of $74,000 was recorded as compensation expense on September 10, 2025, the date of the Company&#8217;s Initial Public Offering. The fair value of the founder shares was derived through a third party valuation using the Monte Carlo simulation with the following market assumptions; (i) stock price of $9.92, (ii) risk-free rate of 4.36%, (iii) market adjustments of 18.7%, and (iv) volatility of 5%. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Promissory Note&#160;&#8212;&#160;Related Party</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Sponsor has agreed to loan the Company an aggregate of up to $250,000 to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing and unsecured with maturity date at the earlier of December&#160;31, 2025 or the closing of the Initial Public Offering. On September 10, 2025, the Company repaid the total outstanding balance of the Promissory Note amounting to $83,927. Borrowings under the Note are no longer available. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Advances from Related Party</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Advances from related party represents payment of expenses by an affiliate of the Sponsor that are not covered by the Promissory Note. As of December 31, 2025, <span style="-sec-ix-hidden:fc_1494614152">no</span> advances from related party have been made. </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Working Capital Loans</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company&#8217;s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at the option of the lender. The units would be identical to the Private Placement Units. As of December 31, 2025, <span style="-sec-ix-hidden:fc_319930502">no</span> such Working Capital Loans were outstanding. </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Administrative Support Agreement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company entered into an agreement with the Sponsor, commencing on September 8, 2025 through the earlier of the Company&#8217;s consummation of initial Business Combination and its liquidation, to pay the Sponsor an aggregate of $40,000 per month for office space, secretarial and administrative services. On September 16, 2025, the Company and the Sponsor entered into the amended and restated administrative services agreement, to add that the Sponsor or its affiliates may make available to the Company certain office space, utilities and secretarial support as may be required by the Company from time to time. For the period from May 1, 2025 (inception) through December 31, 2025, the Company incurred and paid $150,667 in fees for these services. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/850/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">6. COMMITMENTS<i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Risks and Uncertainties</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company&#8217;s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company&#8217;s control. The Company&#8217;s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company&#8217;s ability to complete an initial Business Combination.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Registration Rights</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company&#8217;s initial shareholders and their permitted transferees can demand that the Company register the founder shares, the Private Placement Shares, the Private Placement Warrants and underlying securities and any securities issued upon conversion of Working Capital Loans, pursuant to an agreement signed on September 8, 2025. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities. The holders of a majority of these securities or units issued in payment of working capital loans made to the Company (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain piggyback registration rights on registration statements filed after the Company&#8217;s consummation of a Business Combination. Notwithstanding anything to the contrary, the representative of the underwriters may only make a demand on one occasion and only during the five-year period beginning on the effective date of Initial Public Offering. In addition, the representative of the underwriters may participate in a piggyback registration only during the seven-year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>Underwriting Agreement</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company granted the underwriters a 45-day option to purchase up to 3,375,000 additional Units&#160;to cover any over-allotments, at the initial public offering price less the underwriting discounts. On September 10, 2025, the underwriters partially exercised their over-allotment option, purchasing 2,400,000 Units and forfeiting the remaining unexercised balance of 975,000 Units. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The underwriters were entitled to a cash underwriting discount of $0.20 per Unit sold in the Initial Public Offering, or $4,980,000 in the aggregate. The underwriter paid the Company an aggregate amount of $940,000 at the closing of the Initial Public Offering as reimbursement to the Company for certain of its expenses and fees incurred in connection with the Initial Public Offering, $240,000 of which is payable to the underwriters upon the completion of an initial Business Combination. In addition, the underwriters were entitled to $0.40 per Unit sold in the offering, or up to $9,960,000 in the aggregate, payable to the underwriters based on the percentage of funds remaining in the Trust Account after redemptions of public shares, for deferred underwriting commissions, and to be released to the underwriters only upon the completion of an initial Business Combination. Furthermore, 50% of such deferred underwriting commissions will be contingent upon permitted withdrawals of interest, at the lesser of $500,000 or 5% of the interest earned per annum, on the Trust Account per annum, for working capital from the Trust Account. </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Deficit<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Shareholders' Deficit [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">SHAREHOLDERS' DEFICIT</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">7. SHAREHOLDERS&#8217; DEFICIT</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Preference Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company is authorized to issue 1,000,000 shares of preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Board of Directors. As of December 31, 2025, there were <span style="-sec-ix-hidden:fc_1730245694"><span style="-sec-ix-hidden:fc_314223251">no</span></span> preference shares issued or outstanding. </p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Class&#160;A Ordinary Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company is authorized to issue 200,000,000 Class&#160;A ordinary shares with a par value of $0.0001 per share. As of December 31, 2025, there were 779,000 Class A ordinary shares issued and outstanding, excluding 24,900,000 shares subject to possible redemption. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Class&#160;B Ordinary Shares</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company is authorized to issue 20,000,000 Class&#160;B ordinary shares with a par value of $0.0001 per share. As of December 31, 2025, there were 8,300,000 Class B ordinary shares issued and outstanding. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The founder shares will automatically convert into Class A ordinary shares in connection with the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. The Class A ordinary shares issuable in connection with the conversion of the founder shares may result in material dilution to public shareholders due to the anti-dilution rights of founder shares that may result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion. In the case that additional Class A ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class B ordinary shares convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 25% of the sum of (i) the aggregate of issued and outstanding founder shares, private placement shares and public shares after this offering and the private placement, plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent units issued to the Sponsor or any of its affiliates or to officers or directors upon conversion of working capital loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders in connection with an initial Business Combination; provided that such conversion of founder shares will never occur on a less than one-for-one basis.&#160;<span style="font-weight: bold;">&#160;</span> </p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">8. SEGMENT INFORMATION</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">&#160;</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">ASC Topic 280, &#8220;Segment Reporting,&#8221; establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#8217;s chief operating decision maker (&#8220;CODM&#8221;), or group, in deciding how to allocate resources and assess performance.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company&#8217;s CODM has been identified as the <span style="-sec-ix-hidden:fc_444643047">Chief Financial Officer</span>, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statements of operations as net income or loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company&#8217;s performance and making key decisions regarding resource allocation the CODM reviews the key metrics below. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Cash</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,872,627</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash held in Trust Account</td><td>&#160;</td><td style="text-align: left">$</td><td style="text-align: right">252,095,639</td><td style="text-align: left">&#160;</td> </tr> </tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-weight: bold;">For the<br/> Period from</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-weight: bold;">May&#160;1,&#160;2025<br/> (Inception)<br/> through<br/> December 31,<br/> 2025</span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">General and administrative costs</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">546,385</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest earned on cash held in Trust Account</td><td>&#160;</td><td style="text-align: left">$</td><td style="text-align: right">3,171,560</td><td style="text-align: left">&#160;</td> </tr> </tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The CODM reviews interest earned on the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">General and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also reviews General and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative costs, as reported on the statements of operations, are the significant segment expenses provided to the CODM on a regular basis.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;">NOTE 9. SUBSEQUENT EVENTS</span>&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company evaluated subsequent events and transactions that occurred after the balance sheet date, the date that the financial statements was issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text">We are a special purpose acquisition company with no business operations. Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if any. We have not encountered any cybersecurity incidents since our Initial Public Offering.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]</a></td>
<td class="text">We have not encountered any cybersecurity incidents since our Initial Public Offering.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if any.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if any. We have not encountered any cybersecurity incidents since our Initial Public Offering.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure<br></strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 2,625,175<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Basis of Presentation</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;).</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_EmergingGrowthCompanyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Emerging Growth Company</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company is an &#8220;emerging growth company,&#8221; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#8220;JOBS Act&#8221;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>&#160;</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#8217;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Use of Estimates</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The preparation of the financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Cash and Cash Equivalents</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> The Company considers all short-term investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company has $2,872,627 in cash and <span style="-sec-ix-hidden:fc_329852981">no</span> cash equivalents as of December 31, 2025. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_CashHeldInTrustAccountPolicyTextBlock', window );">Cash Held in Trust Account</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Cash Held in Trust Account</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> As of December 31, 2025, the assets held in the Trust Account, amounting to $252,095,639, were held in a demand deposit account. </p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Concentration of Credit Risk</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#8217;s financial condition, results of operations, and cash flows. </p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_OfferingCostsPolicyTextBlock', window );">Offering Costs</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Offering Costs</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, &#8220;Expenses of Offering.&#8221; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, &#8220;Debt with Conversion and Other Options,&#8221; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the warrants and to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Warrants and Private Placement Units were charged to shareholders&#8217; deficit as Public Warrants and Private Placement Warrants after management&#8217;s evaluation were accounted for under equity treatment.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Income Taxes</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company follows the asset and liability method of accounting for income taxes under ASC&#160;740, &#8220;Income Taxes&#8221; (&#8220;ASC&#160;740&#8221;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"> ASC&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were <span style="-sec-ix-hidden:fc_551881478">no</span> unrecognized tax benefits and <span style="-sec-ix-hidden:fc_1991878236">no</span> amounts accrued for interest and penalties as of December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands, and the Company believes it is presently not subject to income taxes or income tax filing requirements in the United&#160;States. As such, the Company&#8217;s tax provision was zero for the period presented.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Fair Value of Financial Instruments</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The fair value of the Company&#8217;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#8220;Fair Value Measurements and Disclosures,&#8221; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Warrant Instruments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Warrant Instruments</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company accounted for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#8220;Derivatives and Hedging&#8221;. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock', window );">Class A Ordinary Shares Subject to Possible Redemption</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><span style="font-weight: bold;"><i>Class A Ordinary Shares Subject to Possible Redemption</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#8217;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#8217;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#8217; deficit section of the Company&#8217;s balance sheet.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As of December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Gross proceeds</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">249,000,000</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Proceeds allocated to Public Warrants</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(1,817,700</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class A ordinary shares issuance costs</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(14,619,267</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,449,949</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Class A ordinary shares subject to possible redemption, December 31, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">252,012,982</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income per Ordinary Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<span style="font-weight: bold;"><i>Net Income per Ordinary Share</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#8220;Earnings Per Share.&#8221; Net income per ordinary share is computed by dividing net income by the weighted average number of shares of ordinary shares outstanding for the period. The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary Shares and Class&#160;B ordinary shares. Accretion associated with the redeemable shares of Class&#160;A Ordinary Shares is excluded from income per ordinary share as the redemption value approximates fair value.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period from<br/> May 1, 2025<br/> (Inception) Through<br/> December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Basic net income per ordinary share</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Basic net income per ordinary share</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Numerator:</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,574,371</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,050,804</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Basic weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,787,082</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,867,213</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic net income per ordinary share</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period from<br/> May 1, 2025<br/> (Inception) Through<br/> December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Diluted net income per ordinary share</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Diluted net income per ordinary share</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Numerator:</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,574,371</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,050,804</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Diluted weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,787,082</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,867,213</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Diluted net income per ordinary share</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-weight: bold;"><i>Recent Accounting Standards</i></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">In November&#160;2023, the FASB issued ASU&#160;2023-07,&#8221;<i>Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures</i>&#8221;. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (&#8220;CODM&#8221;), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic&#160;280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU&#160;2023-07 on May&#160;1, 2025, inception (see Note 8 for more information).</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The Company does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#8217;s financial statements.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_CashHeldInTrustAccountPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash held in trust account.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_CashHeldInTrustAccountPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_EmergingGrowthCompanyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for emerging growth company status.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_EmergingGrowthCompanyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_OfferingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_OfferingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479693/815-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-7<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4F<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/815/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/480/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478671/942-235-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482836/275-10-55-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 275<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Schedule of Class A Ordinary Shares Subject To Possible Redemption</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As of December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Gross proceeds</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">249,000,000</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Less:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Proceeds allocated to Public Warrants</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(1,817,700</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Class A ordinary shares issuance costs</td><td>&#160;</td><td style="text-align: left">&#160;</td><td style="text-align: right">(14,619,267</td><td style="text-align: left">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Plus:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">19,449,949</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Class A ordinary shares subject to possible redemption, December 31, 2025</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">252,012,982</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Income Per Ordinary Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period from<br/> May 1, 2025<br/> (Inception) Through<br/> December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Basic net income per ordinary share</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Basic net income per ordinary share</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Numerator:</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,574,371</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,050,804</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Basic weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,787,082</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,867,213</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic net income per ordinary share</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the Period from<br/> May 1, 2025<br/> (Inception) Through<br/> December 31, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Diluted net income per ordinary share</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;A</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Class&#160;B</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Diluted net income per ordinary share</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom"> <td>Numerator:</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td> <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Allocation of net income, as adjusted</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,574,371</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,050,804</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Denominator:</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td> <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Diluted weighted average shares outstanding</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,787,082</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,867,213</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Diluted net income per ordinary share</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td><td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">0.13</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td> </tr> </tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Information Related to CODM</a></td>
<td class="text">When evaluating the Company&#8217;s performance and making key decisions regarding resource allocation the CODM reviews the key metrics below.<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December&#160;31,<br/> 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">Cash</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,872,627</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Cash held in Trust Account</td><td>&#160;</td><td style="text-align: left">$</td><td style="text-align: right">252,095,639</td><td style="text-align: left">&#160;</td> </tr> </tbody></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;</p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tbody><tr style="vertical-align: bottom"> <td style="text-align: left">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-weight: bold;">For the<br/> Period from</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-weight: bold;">May&#160;1,&#160;2025<br/> (Inception)<br/> through<br/> December 31,<br/> 2025</span></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: left">General and administrative costs</td><td style="width: 1%">&#160;</td><td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">546,385</td><td style="width: 1%; text-align: left">&#160;</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Interest earned on cash held in Trust Account</td><td>&#160;</td><td style="text-align: left">$</td><td style="text-align: right">3,171,560</td><td style="text-align: left">&#160;</td> </tr> </tbody></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Description of Organization and Business Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 13, 2025</div></th>
<th class="th"><div>Sep. 10, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May  01,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Warrants price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_TransactionCosts', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,742,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_CashUnderwritingFee', window );">Cash underwriting fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,040,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_DeferredUnderwritingFee', window );">Deferred underwriting fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_ProceedsFromSaleOfUnderwritersReimbursement', window );">Proceeds from sale of Underwriters Reimbursement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_OtherOfferingCosts', window );">Other offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">502,001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NoOfMaturityDays', window );">Maturity days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">185 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_AdvanceReceivedForWorkingCapital', window );">Advance received for working capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_MaximumNetInterestToPayDissolutionExpenses', window );">Maximum net interest to pay dissolution expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_InitialBusinessCombinationOrToRedeemPercentage', window );">Initial business combination or to redeem percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,872,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_WorkingCapitalDeficit', window );">Working capital surplus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,824,868<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_WorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Units price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes', window );">Cash withdrawn from trust Account for working capital purposes</a></td>
<td class="nump">$ 75,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,921<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_YearOfInception', window );">Year of Inception</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May&#160;1, 2025 (inception) through December 31, 2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_InterestEarnedOnTheTrustAccountPerAnnum', window );">InterestEarnedOnTheTrustAccountPerAnnum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_WorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_WorkingCapitalLoan', window );">Working capital loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes', window );">Cash withdrawn from trust Account for working capital purposes</a></td>
<td class="nump">$ 75,921<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 249,000,000<span></span>
</td>
<td class="nump">$ 4,980,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of private placement warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Warrants price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance', window );">Percentage of fair market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Units price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Warrants price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Units price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,790,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">530,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Cantor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants purchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of private placement warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Warrants price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Units price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | IPO [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of private placement warrants shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">779,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member] | Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Description of Organization and Business Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Purchase of each warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_AdvanceReceivedForWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of advance received for working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_AdvanceReceivedForWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_CashUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of cash underwriting fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_CashUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash withdrawn from Trust Account for working capital purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_DeferredUnderwritingFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of deferred underwriting fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_DeferredUnderwritingFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_InitialBusinessCombinationOrToRedeemPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial Business Combination or to redeem percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_InitialBusinessCombinationOrToRedeemPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_InterestEarnedOnTheTrustAccountPerAnnum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest earned on the trust account per annum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_InterestEarnedOnTheTrustAccountPerAnnum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_MaximumNetInterestToPayDissolutionExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum net interest to pay dissolution expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_MaximumNetInterestToPayDissolutionExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of fair market value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NoOfMaturityDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>No of maturity days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NoOfMaturityDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_OtherOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the amount of other offering costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_OtherOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_ProceedsFromSaleOfUnderwritersReimbursement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of underwriters&#8217; reimbursement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_ProceedsFromSaleOfUnderwritersReimbursement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_TransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses related to transaction costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_TransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of units issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_WorkingCapitalDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of working capital deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_WorkingCapitalDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_WorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of working capital loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_WorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_YearOfInception">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The term of year of inception.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_YearOfInception</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_CantorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_CantorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Summary of Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 2,872,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFDICInsuredAmount', window );">Federal deposit insurance corporation coverage limit</a></td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized accrued for interest and penalties</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Assets held in trust account</a></td>
<td class="nump">$ 252,095,639<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFDICInsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFDICInsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption (Details) - Class A ordinary shares subject to possible redemption<br></strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Schedule of Class A Ordinary Shares Subject to Possible Redemption [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="nump">$ 249,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds allocated to Public Warrants</a></td>
<td class="nump">1,817,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_ClassAOrdinarySharesIssuanceCosts', window );">Class A ordinary shares issuance costs</a></td>
<td class="num">(14,619,267)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract', window );"><strong>Plus:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment', window );">Accretion of carrying value to redemption value</a></td>
<td class="nump">19,449,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Class A ordinary shares subject to possible redemption, December 31, 2025</a></td>
<td class="nump">$ 252,012,982<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_ClassAOrdinarySharesIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of class A ordinary shares issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_ClassAOrdinarySharesIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section S55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479772/718-30-S55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Income Per Ordinary Share (Details)<br></strong></div></th>
<th class="th" colspan="2">8 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Basic allocation of net income, as adjusted | $</a></td>
<td class="nump">$ 1,574,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Diluted allocation of net income, as adjusted | $</a></td>
<td class="nump">$ 1,574,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding | shares</a></td>
<td class="nump">11,787,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per ordinary share | $ / shares</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding | shares</a></td>
<td class="nump">11,787,082<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per ordinary share | $ / shares</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Basic allocation of net income, as adjusted | $</a></td>
<td class="nump">$ 1,050,804<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Diluted allocation of net income, as adjusted | $</a></td>
<td class="nump">$ 1,050,804<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding | shares</a></td>
<td class="nump">7,867,213<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per ordinary share | $ / shares</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding | shares</a></td>
<td class="nump">7,867,213<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per ordinary share | $ / shares</a></td>
<td class="nump">$ 0.13<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding. All share and per share amounts have been retroactively presented (Note 5).</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Initial Public Offering (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 10, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NumberOfTradingDays', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_NoticePeriodForRedemptionOfWarrants', window );">Notice period for redemption of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice', window );">Business combination issue price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds', window );">Percentage of equity proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_EffectiveRedemptionPeriod', window );">Effective Redemption Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1', window );">Percentage of exercise price of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,559,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PublicWarrantMember', window );">Public Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember', window );">Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_TriggerPrice', window );">Trigger price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares | Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares | Private Placement Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares | Business Combination [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="nump">24,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Class A Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="nump">24,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Initial Public Offering [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues', window );">Number of units issued</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Price per share</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of adjustment of exercise price of warrants based on market value and newly issued price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Class of Warrant or Right, Adjustment of Redemption Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price 1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_EffectiveRedemptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective redemption period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_EffectiveRedemptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NoticePeriodForRedemptionOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum threshold written notice period for redemption of public warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NoticePeriodForRedemptionOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_NumberOfTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represent the number of trading days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_NumberOfTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the percentage of gross proceeds on total equity proceeds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_TriggerPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of trigger price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_TriggerPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_UnitsIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of units issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_UnitsIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PublicWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tlnc_PublicWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=tlnc_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=tlnc_BusinessCombinationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=tlnc_BusinessCombinationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Private Placement Units (Details)<br></strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Private Placement Units [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Warrants price per share | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Private Placement Units [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Purchased aggregate shares</a></td>
<td class="nump">249,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Warrants price per share | $ / shares</a></td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Private Placement Units [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Purchased aggregate shares</a></td>
<td class="nump">530,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Cohen [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Private Placement Units [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Purchased aggregate shares</a></td>
<td class="nump">779,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Warrants price per share | $ / shares</a></td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member] | Sponsor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Private Placement Units [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Purchased aggregate shares</a></td>
<td class="nump">7,790,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=tlnc_CohenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=tlnc_CohenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 10, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 08, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 19, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Aug. 08, 2025</div></th>
<th class="th">
<div>May 19, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Class B ordinary shares issued to sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_AggregateShares', window );">Aggregate shares | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_AggregateAmount', window );">Aggregate amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_FairValueOfShares', window );">Fair value of shares | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_AmountOfFairValue', window );">Amount of fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_FairValuePerSharePrice', window );">Fair value share price | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_WorkingCapitalLoan', window );">Working capital loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_AggregateSponsorAmount', window );">Aggregate sponsor amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_OutstandingBalancePromissoryNote', window );">Outstanding balance promissory note</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 83,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdministrativeFeesExpense', window );">Administrative Fees Expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,667<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember', window );">Stock Price [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember', window );">Risk Free Rate [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCommodityMarketPriceMember', window );">Market Adjustments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember', window );">Volatility [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentMeasurementInput', window );">Measurement input</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=tlnc_FounderShareMember', window );">Founder Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.003<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Class B ordinary shares issued to sponsor (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,260,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Number of shares forfeiture | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Share split</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 for 1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember', window );">Related Party [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Advances from related party</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember', window );">Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders', window );">Sponsor owns issue and outstanding percentage</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_AggregateAmount', window );">Aggregate amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_WorkingCapitalLoan', window );">Working capital loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Class B ordinary shares issued to sponsor</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share Price | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member] | Sponsor [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Class B ordinary shares issued to sponsor (in Shares) | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_WorkingCapitalLoan', window );">Working capital loans</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Number of shares forfeiture | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">975,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member] | Founder Shares [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transactions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Number of shares forfeiture | shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes 1,125,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares (after taking into account the assignment of 40,000 founder shares to the directors) (Note 5).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding (Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_AggregateAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of aggregate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_AggregateAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_AggregateShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of aggregate shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_AggregateShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_AggregateSponsorAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of aggregate sponsor amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_AggregateSponsorAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_AmountOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_AmountOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_FairValueOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_FairValueOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_FairValuePerSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of fair value share price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_FairValuePerSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_OutstandingBalancePromissoryNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding balance promissory note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_OutstandingBalancePromissoryNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_WorkingCapitalLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of working capital loan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_WorkingCapitalLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdministrativeFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 850<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdministrativeFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 850<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(c)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(g)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCommodityMarketPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputCommodityMarketPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=tlnc_FounderShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=tlnc_FounderShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=tlnc_SponsorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 10, 2025</div></th>
<th class="th"><div>May 19, 2025</div></th>
<th class="th"><div>Dec. 31, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesOther', window );">Purchase of additional units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,375,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised options purchasing</a></td>
<td class="nump">2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Units price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForUnderwritingExpense', window );">Payable to underwriters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 240,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_PercentageOfDeferredUnderwritings', window );">Percentage of deferred underwriting</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOther', window );">Interest earned per annum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=tlnc_UnderwritingAgreementMember', window );">Underwriting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,960,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,960,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=tlnc_InterestRateMember', window );">Interest Rate [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Percentage of interest earned</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnderwritingOptionPeriod', window );">Underwriting option period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Forfeiting unexercised units</a></td>
<td class="nump">975,000<span></span>
</td>
<td class="nump">1,125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_UnderwritingDiscountAmountPerUnit', window );">Underwriting discount amount per unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="nump">$ 249,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,980,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Aggregate amount</a></td>
<td class="nump">$ 249,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,980,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Units price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO [Member] | Underwriting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 940,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Aggregate amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 940,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_PercentageOfDeferredUnderwritings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of deferred underwritings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_PercentageOfDeferredUnderwritings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_UnderwritingDiscountAmountPerUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of underwriting discount amount per unit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_UnderwritingDiscountAmountPerUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_UnderwritingOptionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The term of underwriting grant option period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_UnderwritingOptionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income earned from interest bearing assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForUnderwritingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForUnderwritingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued attributable to transactions classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=tlnc_UnderwritingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=tlnc_UnderwritingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=tlnc_InterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=tlnc_InterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Deficit (Details)<br></strong></div></th>
<th class="th" colspan="2">8 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Dec. 31, 2025 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preference shares, shares authorized</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preference shares, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preference shares, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_tlnc_ConversionOfOrdinarySharesPercentage', window );">Conversion of ordinary shares percentage</a></td>
<td class="nump">25.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Ordinary share possible redemption</a></td>
<td class="nump">24,900,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">779,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">779,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Shareholders&#8217; Deficit [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Ordinary shares, shares authorized</a></td>
<td class="nump">20,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Ordinary shares, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ordinary shares, shares issued</a></td>
<td class="nump">8,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ordinary shares, shares outstanding</a></td>
<td class="nump">8,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes 1,125,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares (after taking into account the assignment of 40,000 founder shares to the directors) (Note 5).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding (Note 5).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_tlnc_ConversionOfOrdinarySharesPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Conversion of ordinary shares percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">tlnc_ConversionOfOrdinarySharesPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>tlnc_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-8A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483014/272-10-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482987/272-10-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Details)<br></strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>Segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription', window );">Description of operating segment</a></td>
<td class="text">The Company&#8217;s CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration', window );">Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]</a></td>
<td class="text">Chief Financial Officer<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Performance and Making Key Decisions Regarding Resource Allocation (Details)<br></strong></div></th>
<th class="th" colspan="1">8 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2025 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationProfitLossAbstract', window );"><strong>Schedule of Performance and Making Key Decisions Regarding Resource Allocation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 2,872,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsHeldInTrustNoncurrent', window );">Cash held in Trust Account</a></td>
<td class="nump">252,095,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative costs</a></td>
<td class="nump">546,385<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest earned on cash held in Trust Account</a></td>
<td class="nump">$ 3,171,560<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldInTrustNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldInTrustNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-14<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 605<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477548/944-605-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-21<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 210<br> -Topic 946<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477796/946-210-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>88</ContextCount>
  <ElementCount>229</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>29</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995300 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995301 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995302 - Statement - Balance Sheet</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/BalanceSheet</Role>
      <ShortName>Balance Sheet</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995303 - Statement - Balance Sheet (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/BalanceSheetParentheticals</Role>
      <ShortName>Balance Sheet (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>995304 - Statement - Statement of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/StatementofOperations</Role>
      <ShortName>Statement of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>995305 - Statement - Statement of Operations (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/StatementofOperationsParentheticals</Role>
      <ShortName>Statement of Operations (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>995306 - Statement - Statement of Changes In Shareholders??? Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit</Role>
      <ShortName>Statement of Changes In Shareholders??? Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>995307 - Statement - Statement of Changes In Shareholders??? Deficit (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals</Role>
      <ShortName>Statement of Changes In Shareholders??? Deficit (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>995308 - Statement - Statement of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/StatementofCashFlows</Role>
      <ShortName>Statement of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>995309 - Disclosure - Description of Organization and Business Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperations</Role>
      <ShortName>Description of Organization and Business Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>995310 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>995311 - Disclosure - Initial Public Offering</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/InitialPublicOffering</Role>
      <ShortName>Initial Public Offering</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>995312 - Disclosure - Private Placement Units</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/PrivatePlacementUnits</Role>
      <ShortName>Private Placement Units</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>995313 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>995314 - Disclosure - Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/Commitments</Role>
      <ShortName>Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>995315 - Disclosure - Shareholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/ShareholdersDeficit</Role>
      <ShortName>Shareholders' Deficit</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>995316 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995317 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995318 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>996319 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>996320 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>996321 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/SegmentInformation</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>996322 - Disclosure - Description of Organization and Business Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails</Role>
      <ShortName>Description of Organization and Business Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperations</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>996323 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>996324 - Disclosure - Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>996325 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Income Per Ordinary Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Income Per Ordinary Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>996326 - Disclosure - Initial Public Offering (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/InitialPublicOfferingDetails</Role>
      <ShortName>Initial Public Offering (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/InitialPublicOffering</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>996327 - Disclosure - Private Placement Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/PrivatePlacementUnitsDetails</Role>
      <ShortName>Private Placement Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/PrivatePlacementUnits</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>996328 - Disclosure - Related Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/RelatedPartyTransactions</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>996329 - Disclosure - Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/CommitmentsDetails</Role>
      <ShortName>Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/Commitments</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>996330 - Disclosure - Shareholders' Deficit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/ShareholdersDeficitDetails</Role>
      <ShortName>Shareholders' Deficit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/ShareholdersDeficit</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>996331 - Disclosure - Segment Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SegmentInformationDetails</Role>
      <ShortName>Segment Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://TCC.com/20251231/role/SegmentInformationTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ea0280278-10k_talon.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>996332 - Disclosure - Segment Information - Schedule of Performance and Making Key Decisions Regarding Resource Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://TCC.com/20251231/role/SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails</Role>
      <ShortName>Segment Information - Schedule of Performance and Making Key Decisions Regarding Resource Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="ea0280278-10k_talon.htm">ea0280278-10k_talon.htm</File>
    <File>tlnc-20251231.xsd</File>
    <File>tlnc-20251231_cal.xml</File>
    <File>tlnc-20251231_def.xml</File>
    <File>tlnc-20251231_lab.xml</File>
    <File>tlnc-20251231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="241">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/cyd/2025</BaseTaxonomy>
    <BaseTaxonomy items="48">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>56
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0280278-10k_talon.htm": {
   "nsprefix": "tlnc",
   "nsuri": "http://TCC.com/20251231",
   "dts": {
    "inline": {
     "local": [
      "ea0280278-10k_talon.htm"
     ]
    },
    "schema": {
     "local": [
      "tlnc-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "tlnc-20251231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "tlnc-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "tlnc-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tlnc-20251231_pre.xml"
     ]
    }
   },
   "keyStandard": 166,
   "keyCustom": 63,
   "axisStandard": 12,
   "axisCustom": 0,
   "memberStandard": 16,
   "memberCustom": 13,
   "hidden": {
    "total": 52,
    "http://fasb.org/us-gaap/2025": 42,
    "http://xbrl.sec.gov/dei/2025": 5,
    "http://TCC.com/20251231": 5
   },
   "contextCount": 88,
   "entityCount": 1,
   "segmentCount": 29,
   "elementCount": 442,
   "unitCount": 5,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2025": 241,
    "http://xbrl.sec.gov/dei/2025": 48,
    "http://xbrl.sec.gov/ecd/2025": 5,
    "http://xbrl.sec.gov/cyd/2025": 5
   },
   "report": {
    "R1": {
     "role": "http://TCC.com/20251231/role/Cover",
     "longName": "995300 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://TCC.com/20251231/role/AuditInformation",
     "longName": "995301 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://TCC.com/20251231/role/BalanceSheet",
     "longName": "995302 - Statement - Balance Sheet",
     "shortName": "Balance Sheet",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "cref_1598680374",
      "name": "us-gaap:Cash",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1598680374",
      "name": "us-gaap:OtherPrepaidExpenseCurrent",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://TCC.com/20251231/role/BalanceSheetParentheticals",
     "longName": "995303 - Statement - Balance Sheet (Parentheticals)",
     "shortName": "Balance Sheet (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "cref_1598680374",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "uref_533780696",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1598680374",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "uref_533780696",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://TCC.com/20251231/role/StatementofOperations",
     "longName": "995304 - Statement - Statement of Operations",
     "shortName": "Statement of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "cref_144417410",
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_144417410",
      "name": "us-gaap:OperatingIncomeLoss",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://TCC.com/20251231/role/StatementofOperationsParentheticals",
     "longName": "995305 - Statement - Statement of Operations (Parentheticals)",
     "shortName": "Statement of Operations (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "cref_194733324",
      "name": "tlnc:NumberOfShareSubjectToForfeiture",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_194733324",
      "name": "tlnc:NumberOfShareSubjectToForfeiture",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit",
     "longName": "995306 - Statement - Statement of Changes In Shareholders\u2019 Deficit",
     "shortName": "Statement of Changes In Shareholders\u2019 Deficit",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "cref_1134712074",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1134712074",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
     "longName": "995307 - Statement - Statement of Changes In Shareholders\u2019 Deficit (Parentheticals)",
     "shortName": "Statement of Changes In Shareholders\u2019 Deficit (Parentheticals)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "cref_144417410",
      "name": "tlnc:SaleOfStockNumberOfSharesIssued",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_144417410",
      "name": "tlnc:SaleOfStockNumberOfSharesIssued",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://TCC.com/20251231/role/StatementofCashFlows",
     "longName": "995308 - Statement - Statement of Cash Flows",
     "shortName": "Statement of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "cref_144417410",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_144417410",
      "name": "tlnc:PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "unique": true
     }
    },
    "R10": {
     "role": "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperations",
     "longName": "995309 - Disclosure - Description of Organization and Business Operations",
     "shortName": "Description of Organization and Business Operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://TCC.com/20251231/role/SummaryofSignificantAccountingPolicies",
     "longName": "995310 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://TCC.com/20251231/role/InitialPublicOffering",
     "longName": "995311 - Disclosure - Initial Public Offering",
     "shortName": "Initial Public Offering",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "tlnc:InitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "tlnc:InitialPublicOfferingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://TCC.com/20251231/role/PrivatePlacementUnits",
     "longName": "995312 - Disclosure - Private Placement Units",
     "shortName": "Private Placement Units",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "tlnc:PrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "tlnc:PrivatePlacementTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://TCC.com/20251231/role/RelatedPartyTransactions",
     "longName": "995313 - Disclosure - Related Party Transactions",
     "shortName": "Related Party Transactions",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://TCC.com/20251231/role/Commitments",
     "longName": "995314 - Disclosure - Commitments",
     "shortName": "Commitments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://TCC.com/20251231/role/ShareholdersDeficit",
     "longName": "995315 - Disclosure - Shareholders' Deficit",
     "shortName": "Shareholders' Deficit",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://TCC.com/20251231/role/SegmentInformation",
     "longName": "995316 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://TCC.com/20251231/role/SubsequentEvents",
     "longName": "995317 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure",
     "longName": "995318 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "cref_144417410",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R21": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "996319 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "23",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "996320 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://TCC.com/20251231/role/SegmentInformationTables",
     "longName": "996321 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1363532388",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
     "longName": "996322 - Disclosure - Description of Organization and Business Operations (Details)",
     "shortName": "Description of Organization and Business Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "26",
     "firstAnchor": {
      "contextRef": "cref_144417410",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_144417410",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "996323 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "27",
     "firstAnchor": {
      "contextRef": "cref_1598680374",
      "name": "us-gaap:Cash",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1598680374",
      "name": "us-gaap:CashFDICInsuredAmount",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:ConcentrationRiskCreditRisk",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "unique": true
     }
    },
    "R28": {
     "role": "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails",
     "longName": "996324 - Disclosure - Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Class A Ordinary Shares Subject to Possible Redemption (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "28",
     "firstAnchor": {
      "contextRef": "cref_81526736",
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_81526736",
      "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:TemporaryEquityTableTextBlock",
       "us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails",
     "longName": "996325 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Basic and Diluted Net Income Per Ordinary Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "cref_198494574",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_198494574",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
     "longName": "996326 - Disclosure - Initial Public Offering (Details)",
     "shortName": "Initial Public Offering (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "cref_1979561439",
      "name": "tlnc:UnitsIssuedDuringPeriodSharesNewIssues",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "tlnc:InitialPublicOfferingTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_144417410",
      "name": "tlnc:NumberOfTradingDays",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "tbody",
       "table",
       "tlnc:InitialPublicOfferingTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails",
     "longName": "996327 - Disclosure - Private Placement Units (Details)",
     "shortName": "Private Placement Units (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "cref_1598680374",
      "name": "us-gaap:SaleOfStockPricePerShare",
      "unitRef": "uref_533780696",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_259879653",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "tlnc:PrivatePlacementTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "unique": true
     }
    },
    "R32": {
     "role": "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
     "longName": "996328 - Disclosure - Related Party Transactions (Details)",
     "shortName": "Related Party Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "cref_144417410",
      "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_1476606103",
      "name": "tlnc:AggregateShares",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "unique": true
     }
    },
    "R33": {
     "role": "http://TCC.com/20251231/role/CommitmentsDetails",
     "longName": "996329 - Disclosure - Commitments (Details)",
     "shortName": "Commitments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "cref_144417410",
      "name": "us-gaap:StockIssuedDuringPeriodSharesOther",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_144417410",
      "name": "us-gaap:StockIssuedDuringPeriodSharesOther",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://TCC.com/20251231/role/ShareholdersDeficitDetails",
     "longName": "996330 - Disclosure - Shareholders' Deficit (Details)",
     "shortName": "Shareholders' Deficit (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "cref_1598680374",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "unitRef": "uref_504548813",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_144417410",
      "name": "tlnc:ConversionOfOrdinarySharesPercentage",
      "unitRef": "uref_714491979",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://TCC.com/20251231/role/SegmentInformationDetails",
     "longName": "996331 - Disclosure - Segment Information (Details)",
     "shortName": "Segment Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "cref_144417410",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "uref_493518290",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "cref_144417410",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "uref_493518290",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription",
       "p",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://TCC.com/20251231/role/SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails",
     "longName": "996332 - Disclosure - Segment Information - Schedule of Performance and Making Key Decisions Regarding Resource Allocation (Details)",
     "shortName": "Segment Information - Schedule of Performance and Making Key Decisions Regarding Resource Allocation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "cref_1598680374",
      "name": "us-gaap:Cash",
      "unitRef": "uref_144417410",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0280278-10k_talon.htm",
      "first": true
     },
     "uniqueAnchor": null
    }
   },
   "tag": {
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Summary of Significant Accounting Policies [Abstract]",
        "terseLabel": "Summary of Significant Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued expenses",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19"
     ]
    },
    "tlnc_AccruedOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "AccruedOfferingCosts",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued offering costs",
        "documentation": "The amount of accrued offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r596"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 109.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Total",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r540",
      "r747"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r669",
      "r670",
      "r671",
      "r672",
      "r730",
      "r750"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Noncash Item [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalMarkToMarket": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalMarkToMarket",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of founder Shares assigned to directors",
        "label": "Adjustments to Additional Paid in Capital, Fair Value",
        "documentation": "Amount of increase (decrease) to additional paid in capital (APIC) resulting from changes in fair value of common and preferred stock issued to employee benefit trust but unearned."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r44"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Allocated value of transaction costs to Class A non-redeemable shares",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r44"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of Public Warrants at issuance",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r17",
      "r44"
     ]
    },
    "us-gaap_AdministrativeFeesExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AdministrativeFeesExpense",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Administrative Fees Expense",
        "documentation": "Amount of expense for administrative fee from service provided, including, but not limited to, salary, rent, or overhead cost."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r748",
      "r749"
     ]
    },
    "tlnc_AdvanceReceivedForWorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "AdvanceReceivedForWorkingCapital",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Advance received for working capital",
        "documentation": "The amount of advance received for working capital."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_AggregateAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "AggregateAmount",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate amount",
        "documentation": "The amount of aggregate."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_AggregateShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "AggregateShares",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate shares",
        "documentation": "Number of aggregate shares"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_AggregateSponsorAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "AggregateSponsorAmount",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate sponsor amount",
        "label": "Aggregate sponsor amount",
        "documentation": "The amount of aggregate sponsor amount."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r647"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r567",
      "r578",
      "r588",
      "r621"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r570",
      "r581",
      "r591",
      "r624"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r648"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r582",
      "r592",
      "r616",
      "r625",
      "r629",
      "r637"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_AmountOfFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "AmountOfFairValue",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of fair value",
        "documentation": "The amount of fair value."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Assets",
        "label": "Assets, Total",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r55",
      "r69",
      "r86",
      "r87",
      "r88",
      "r125",
      "r138",
      "r144",
      "r147",
      "r154",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r333",
      "r335",
      "r365",
      "r389",
      "r390",
      "r392",
      "r458",
      "r516",
      "r517",
      "r530",
      "r540",
      "r541",
      "r542",
      "r553",
      "r691",
      "r692",
      "r740"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets:",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current, Total",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r73",
      "r86",
      "r87",
      "r88",
      "r154",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r333",
      "r335",
      "r365",
      "r540",
      "r691",
      "r692",
      "r740"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsHeldInTrustNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AssetsHeldInTrustNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assets held in trust account",
        "terseLabel": "Cash held in Trust Account",
        "label": "Asset, Held-in-Trust, Noncurrent",
        "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r663"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://TCC.com/20251231/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r557",
      "r558",
      "r574"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://TCC.com/20251231/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r557",
      "r558",
      "r574"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://TCC.com/20251231/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r557",
      "r558",
      "r574"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r651"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r633"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r631"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r629"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": [
      "r660"
     ]
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Domain]",
        "documentation": "Business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r410",
      "r532",
      "r533",
      "r727",
      "r728",
      "r729"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r410",
      "r532",
      "r533",
      "r727",
      "r728",
      "r729"
     ]
    },
    "tlnc_BusinessCombinationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "BusinessCombinationMember",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_CantorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "CantorMember",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cantor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Cash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Cash",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash",
        "terseLabel": "Cash",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r395",
      "r435",
      "r453",
      "r540",
      "r541",
      "r542",
      "r553",
      "r655"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Cash \u2013 End of period",
        "periodStartLabel": "Cash \u2013 Beginning of period",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation",
        "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r38",
      "r83"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Change in Cash",
        "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation, Total",
        "documentation": "Amount, excluding effect from change in exchange rate, of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r38"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r744"
     ]
    },
    "us-gaap_CashFDICInsuredAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CashFDICInsuredAmount",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal deposit insurance corporation coverage limit",
        "label": "Cash, FDIC Insured Amount",
        "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_CashHeldInTrustAccountPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "CashHeldInTrustAccountPolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Held in Trust Account",
        "label": "Cash Held in Trust Account [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash held in trust account."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_CashUnderwritingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "CashUnderwritingFee",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash underwriting fee",
        "documentation": "Represent the amount of cash underwriting fee."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_CashWithdrawnFromTrustAccountForWorkingCapitalPurposes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "CashWithdrawnFromTrustAccountForWorkingCapitalPurposes",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash withdrawn from trust Account for working capital purposes",
        "label": "Cash withdrawn from Trust Account for working capital purposes",
        "documentation": "The amount of cash withdrawn from Trust Account for working capital purposes."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r604"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r602"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_ClassAOrdinarySharesIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ClassAOrdinarySharesIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class A ordinary shares issuance costs",
        "label": "Class A ordinary shares issuance costs",
        "documentation": "Amount of class A ordinary shares issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_ClassAOrdinarySharesParValue00001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ClassAOrdinarySharesParValue00001PerShareMember",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A ordinary shares, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_ClassAOrdinarySharesSubjectToPossibleRedemptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ClassAOrdinarySharesSubjectToPossibleRedemptionMember",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class A ordinary shares subject to possible redemption",
        "label": "Class A Ordinary Shares Subject to Possible Redemption [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/Cover",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r70",
      "r71",
      "r72",
      "r86",
      "r88",
      "r112",
      "r113",
      "r120",
      "r122",
      "r127",
      "r128",
      "r154",
      "r170",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r198",
      "r199",
      "r201",
      "r202",
      "r204",
      "r208",
      "r211",
      "r212",
      "r215",
      "r218",
      "r225",
      "r365",
      "r415",
      "r416",
      "r417",
      "r418",
      "r423",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r445",
      "r466",
      "r488",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r654",
      "r664",
      "r666",
      "r673"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders\u2019 Deficit [Line Items]",
        "label": "Initial Public Offering [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r70",
      "r71",
      "r72",
      "r127",
      "r201",
      "r211",
      "r212",
      "r213",
      "r215",
      "r218",
      "r223",
      "r225",
      "r343",
      "r415",
      "r416",
      "r417",
      "r418",
      "r531",
      "r654",
      "r661",
      "r664"
     ]
    },
    "tlnc_ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business combination issue price per share",
        "label": "Class of Warrant or Right, Adjustment of Exercise Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price",
        "documentation": "Percentage of adjustment of exercise price of warrants based on market value and newly issued price."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of exercise price of warrants",
        "label": "Class of Warrant or Right, Adjustment of Redemption Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price 1",
        "documentation": "Class of Warrant or Right, Adjustment of Redemption Price of Warrants or Rights, Percent, Based On Market Value And Newly Issued Price 1"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r700"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price per share",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r226"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of each warrants",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of warrants purchased",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r226"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Warrants outstanding",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "tlnc_CohenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "CohenMember",
     "presentation": [
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cohen [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Organization and Business Operations [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments (Note 6)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r51",
      "r394",
      "r444"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/Commitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r164",
      "r165",
      "r502",
      "r684",
      "r688"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/Cover",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit",
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Class A",
        "terseLabel": "Class A Ordinary Shares",
        "label": "Class A Ordinary Shares [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/Cover",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class B",
        "terseLabel": "Class B Ordinary Shares",
        "label": "Class B Ordinary Shares [Member]",
        "netLabel": "Class B Ordinary Shares [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockMember",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Ordinary Shares",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r544",
      "r545",
      "r547",
      "r548",
      "r549",
      "r550",
      "r669",
      "r670",
      "r672",
      "r730",
      "r745",
      "r750"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, par value",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares authorized",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r445"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares issued",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares, shares outstanding",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r28",
      "r445",
      "r464",
      "r750",
      "r751"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 108.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares value",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r199",
      "r207",
      "r397",
      "r540"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r613"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r612"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r611"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk. Includes, but is not limited to, policy for entering into master netting arrangement or similar agreement to mitigate credit risk of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r364"
     ]
    },
    "tlnc_ConversionOfOrdinarySharesPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ConversionOfOrdinarySharesPercentage",
     "presentation": [
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of ordinary shares percentage",
        "label": "Conversion of Ordinary Shares Percentage",
        "documentation": "Conversion of ordinary shares percentage."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r563",
      "r645"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r563",
      "r645"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r561",
      "r643"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r560",
      "r642"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r560",
      "r642"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r562",
      "r644"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r562",
      "r644"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2025",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/CybersecurityRiskManagementandStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r563",
      "r645"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r18",
      "r19",
      "r49",
      "r50",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r539",
      "r661",
      "r662",
      "r665",
      "r668",
      "r685",
      "r686",
      "r687",
      "r736",
      "r737",
      "r742"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of interest earned",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r195",
      "r372",
      "r373",
      "r539"
     ]
    },
    "us-gaap_DebtInstrumentMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentMeasurementInput",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement input",
        "label": "Debt Instrument, Measurement Input",
        "documentation": "Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r732",
      "r733"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r539",
      "r661",
      "r662",
      "r665",
      "r668",
      "r685",
      "r686",
      "r687",
      "r736",
      "r737",
      "r742"
     ]
    },
    "tlnc_DeferredOfferingCostsIncludedInAccruedOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "DeferredOfferingCostsIncludedInAccruedOfferingCosts",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering costs included in accrued offering costs",
        "label": "Deferred offering costs included in accrued offering costs",
        "documentation": "The amount of offering costs included in or accrued offering costs that were incurred during a noncash or partial noncash transaction."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred offering costs paid through advances from related party",
        "documentation": "Amount of deferred offering costs paid through advances from related party."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_DeferredUnderwritingFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "DeferredUnderwritingFee",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred underwriting fee",
        "documentation": "Represent the amount of deferred underwriting fee."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_DeferredUnderwritingFeeNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "DeferredUnderwritingFeeNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred underwriting fee",
        "label": "Deferred Underwriting Fee, Noncurrent",
        "documentation": "Amount of deferred underwriting fee, noncurrent."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_DeferredUnderwritingFeePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "DeferredUnderwritingFeePayable",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred underwriting fee payable",
        "documentation": "Amount of deferred underwriting fee payable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant Instruments",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r92",
      "r108",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r344",
      "r345"
     ]
    },
    "tlnc_DescriptionOfOrganizationAndBusinessOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "DescriptionOfOrganizationAndBusinessOperationsTable",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Organization and Business Operations [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_DirectorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "DirectorMember",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Director",
        "label": "Director [Member]"
       }
      }
     },
     "auth_ref": [
      "r681",
      "r746"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r558",
      "r574"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r557",
      "r558",
      "r574",
      "r617"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r595"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r606"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Basic and Diluted Net Income Per Ordinary Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic net income per share",
        "verboseLabel": "Basic net income per ordinary share",
        "label": "Earnings Per Share, Basic, Total",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r80",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r109",
      "r112",
      "r120",
      "r121",
      "r122",
      "r124",
      "r197",
      "r257",
      "r275",
      "r331",
      "r358",
      "r359",
      "r388",
      "r404",
      "r507"
     ]
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareBasicLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Income Per Ordinary Share [Line Item]",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r120",
      "r122"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted net income per share",
        "verboseLabel": "Diluted net income per ordinary share",
        "label": "Earnings Per Share, Diluted, Total",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r80",
      "r98",
      "r99",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r105",
      "r112",
      "r120",
      "r121",
      "r122",
      "r124",
      "r197",
      "r257",
      "r275",
      "r331",
      "r358",
      "r359",
      "r388",
      "r404",
      "r507"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income per Ordinary Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r13",
      "r123"
     ]
    },
    "tlnc_EffectiveRedemptionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "EffectiveRedemptionPeriod",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Redemption Period",
        "documentation": "The effective redemption period."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_EmergingGrowthCompanyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "EmergingGrowthCompanyPolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Emerging Growth Company",
        "label": "Emerging Growth Company [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for emerging growth company status."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r653"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Date of incorporation",
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r555"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r646"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r60",
      "r61",
      "r62",
      "r77",
      "r78",
      "r79",
      "r93",
      "r94",
      "r95",
      "r97",
      "r104",
      "r106",
      "r108",
      "r126",
      "r155",
      "r156",
      "r163",
      "r196",
      "r227",
      "r257",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r330",
      "r331",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r374",
      "r375",
      "r376",
      "r403",
      "r405",
      "r406",
      "r407",
      "r423",
      "r488"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r610"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r567",
      "r578",
      "r588",
      "r621"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r564",
      "r575",
      "r585",
      "r618"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r734"
     ]
    },
    "tlnc_FairValueOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "FairValueOfShares",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value of shares",
        "documentation": "The number of shares fair value."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_FairValuePerSharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "FairValuePerSharePrice",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value share price",
        "label": "Fair Value Share Price",
        "documentation": "The number of fair value share price."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_ForfeitureOfFounderShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ForfeitureOfFounderShares",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forfeiture of founder shares",
        "documentation": "Amount of forfeiture of founder shares."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r582",
      "r592",
      "r625"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r582",
      "r592",
      "r625"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r582",
      "r592",
      "r625"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r582",
      "r592",
      "r625"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r582",
      "r592",
      "r625"
     ]
    },
    "tlnc_FounderShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "FounderShareMember",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Founder Shares [Member]",
        "label": "Founder Share [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r605"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails",
      "http://TCC.com/20251231/role/StatementofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative costs",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r468"
     ]
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IPOMember",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r557",
      "r558",
      "r574"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r262",
      "r263",
      "r266",
      "r267",
      "r268",
      "r269",
      "r414"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued expenses",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidExpensesOther",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses",
        "label": "Increase (Decrease) in Prepaid Expenses, Other",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "IncreaseDecreaseInPrepaidInsurance",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Long-term prepaid insurance",
        "label": "Increase (Decrease) in Prepaid Insurance",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for insurance that provides economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r582",
      "r592",
      "r616",
      "r625",
      "r629",
      "r637"
     ]
    },
    "tlnc_InitialBusinessCombinationOrToRedeemPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "InitialBusinessCombinationOrToRedeemPercentage",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial business combination or to redeem percentage",
        "label": "Initial business combination or to redeem percentage",
        "documentation": "Initial Business Combination or to redeem percentage."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_InitialPublicOfferingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "InitialPublicOfferingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Public Offering [Abstract]",
        "label": "Initial Public Offering [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_InitialPublicOfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "InitialPublicOfferingTable",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Initial Public Offering [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_InitialPublicOfferingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "InitialPublicOfferingTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOffering"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INITIAL PUBLIC OFFERING",
        "label": "Initial Public Offering [Text Block]",
        "documentation": "The entire disclosure for initial public offering."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r559",
      "r641"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r559",
      "r641"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r559",
      "r641"
     ]
    },
    "tlnc_InterestEarnedOnTheTrustAccountPerAnnum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "InterestEarnedOnTheTrustAccountPerAnnum",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestEarnedOnTheTrustAccountPerAnnum",
        "documentation": "Interest earned on the trust account per annum"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InterestIncomeOther",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest earned per annum",
        "label": "Interest Income, Other",
        "documentation": "Amount of interest income earned from interest bearing assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r505"
     ]
    },
    "tlnc_InterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "InterestRateMember",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      },
      "http://TCC.com/20251231/role/StatementofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/SegmentInformationScheduleofPerformanceandMakingKeyDecisionsRegardingResourceAllocationDetails",
      "http://TCC.com/20251231/role/StatementofCashFlows",
      "http://TCC.com/20251231/role/StatementofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest earned on cash held in Trust Account",
        "negatedLabel": "Interest earned on cash held in Trust Account",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r139",
      "r147",
      "r516",
      "r658"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 511.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r18",
      "r19",
      "r20",
      "r22",
      "r23",
      "r24",
      "r25",
      "r86",
      "r87",
      "r88",
      "r154",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r334",
      "r335",
      "r336",
      "r365",
      "r443",
      "r509",
      "r530",
      "r553",
      "r691",
      "r740",
      "r741"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders\u2019 Deficit",
        "label": "Liabilities and Equity, Total",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r52",
      "r400",
      "r540",
      "r541",
      "r542",
      "r661",
      "r667",
      "r682",
      "r735"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities, Class A Ordinary Shares Subject to Possible Redemption and Shareholders\u2019 Deficit",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current, Total",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r68",
      "r86",
      "r87",
      "r88",
      "r154",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r334",
      "r335",
      "r336",
      "r365",
      "r540",
      "r691",
      "r740",
      "r741"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r166",
      "r167",
      "r168",
      "r169",
      "r260",
      "r524",
      "r689",
      "r690"
     ]
    },
    "tlnc_MaximumNetInterestToPayDissolutionExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "MaximumNetInterestToPayDissolutionExpenses",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum net interest to pay dissolution expenses",
        "documentation": "Represents the maximum net interest to pay dissolution expenses."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_MeasurementInputCommodityMarketPriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputCommodityMarketPriceMember",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Adjustments [Member]",
        "label": "Measurement Input, Commodity Market Price [Member]",
        "documentation": "Measurement input using market price of commodity."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r732",
      "r733"
     ]
    },
    "us-gaap_MeasurementInputOptionVolatilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputOptionVolatilityMember",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility [Member]",
        "label": "Measurement Input, Option Volatility [Member]",
        "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r732",
      "r733"
     ]
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk Free Rate [Member]",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r731",
      "r732",
      "r733"
     ]
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputSharePriceMember",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price [Member]",
        "label": "Measurement Input, Share Price [Member]",
        "documentation": "Measurement input using share price of saleable stock."
       }
      }
     },
     "auth_ref": [
      "r731",
      "r732",
      "r733"
     ]
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r360",
      "r361",
      "r362",
      "r535",
      "r536",
      "r537",
      "r538"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r360",
      "r361",
      "r362",
      "r535",
      "r536",
      "r537",
      "r538"
     ]
    },
    "tlnc_MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance": {
     "xbrltype": "percentItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of fair market value",
        "documentation": "The percentage of fair market value."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r628"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation, Total",
        "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Financing Activities:",
        "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 524.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation, Total",
        "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Investing Activities:",
        "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in operating activities",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation, Total",
        "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39",
      "r40"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash Flows from Operating Activities:",
        "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://TCC.com/20251231/role/StatementofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit",
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "verboseLabel": "Net income",
        "totalLabel": "Net income",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r40",
      "r53",
      "r62",
      "r66",
      "r74",
      "r75",
      "r79",
      "r86",
      "r87",
      "r88",
      "r91",
      "r96",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r107",
      "r108",
      "r118",
      "r154",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r197",
      "r200",
      "r203",
      "r209",
      "r257",
      "r275",
      "r331",
      "r359",
      "r365",
      "r402",
      "r465",
      "r486",
      "r487",
      "r504",
      "r505",
      "r506",
      "r551",
      "r691"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Numerator:",
        "label": "Net Income (Loss) Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic allocation of net income, as adjusted",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic, Total",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r81",
      "r100",
      "r101",
      "r102",
      "r103",
      "r109",
      "r110",
      "r119",
      "r122",
      "r200",
      "r203",
      "r209",
      "r331"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted allocation of net income, as adjusted",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted, Total",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r111",
      "r114",
      "r115",
      "r116",
      "r117",
      "r119",
      "r122"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Standards",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NoOfMaturityDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NoOfMaturityDays",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity days",
        "documentation": "No of maturity days."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r571",
      "r582",
      "r592",
      "r616",
      "r625"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other income, net",
        "label": "Nonoperating Income (Expense), Total",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "tlnc_NoticePeriodForRedemptionOfWarrants": {
     "xbrltype": "durationItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NoticePeriodForRedemptionOfWarrants",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notice period for redemption of warrants",
        "label": "Notice period for redemption of warrants",
        "documentation": "Minimum threshold written notice period for redemption of public warrants."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfAdditionalFounderShareIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfAdditionalFounderShareIssued",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of additional founder shares issued",
        "label": "Number Of Additional Founder Share Issued",
        "documentation": "Represent the number of additional founder share issued."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfAdditionalFounderSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfAdditionalFounderSharesIssued",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of additional founder shares issued",
        "label": "Number Of Additional Founder Shares Issued",
        "documentation": "Represent the number of additional founder share issued."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfFounderShareHolding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfFounderShareHolding",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of founder shares holding",
        "label": "Number of Founder Share Holding",
        "documentation": "Represent the holding number of founder shares."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfFounderShareIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfFounderShareIssued",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Founder shares issued",
        "label": "Number of Founder Share Issued",
        "documentation": "Represent the number of founder share issued."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfFounderShareOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfFounderShareOutstanding",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Founder shares outstanding",
        "label": "Number Of Founder Share Outstanding",
        "documentation": "Represent the number of founder share outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfFounderSharesHolding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfFounderSharesHolding",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of founder shares holding",
        "label": "Number of Founder Shares Holding",
        "documentation": "Represent the holding number of founder shares."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfFounderSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfFounderSharesIssued",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Founder shares issued",
        "label": "Number Of Founder Shares Issued",
        "documentation": "Represent the number of founder share issued."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfFounderSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfFounderSharesOutstanding",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Founder shares outstanding",
        "label": "Number of Founder Shares Outstanding",
        "documentation": "Represent the number of founder share outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://TCC.com/20251231/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segment",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r511",
      "r521",
      "r676"
     ]
    },
    "tlnc_NumberOfShareSubjectNotToForfeiture": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfShareSubjectNotToForfeiture",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share subject not to forfeiture",
        "label": "Number of Share Subject Not to Forfeiture",
        "documentation": "Represent the number of share subject not to forfeiture."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfShareSubjectToForfeiture": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfShareSubjectToForfeiture",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share subject to forfeiture",
        "label": "Number of Share Subject To Forfeiture",
        "documentation": "Represent the number of share subject to forfeiture."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfSharesSubjectNotToForfeiture": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfSharesSubjectNotToForfeiture",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share subject not to forfeiture",
        "label": "Number of Shares Subject Not To Forfeiture",
        "documentation": "Represent the number of share subject not to forfeiture."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfSharesSubjectToForfeiture": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfSharesSubjectToForfeiture",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of share subject to forfeiture",
        "label": "Number of Shares Subject to Forfeiture",
        "documentation": "Represent the number of share subject to forfeiture."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_NumberOfTradingDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "NumberOfTradingDays",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of trading days",
        "documentation": "Represent the number of trading days."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_OfferingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "OfferingCostsPolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offering Costs",
        "label": "Offering Costs [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss), Total",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r504",
      "r506",
      "r510",
      "r675",
      "r677",
      "r678",
      "r679",
      "r680"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of Organization and Business Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r63",
      "r64",
      "r65",
      "r411",
      "r412"
     ]
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments [Line Items]",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advances from related party",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r540"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income:",
        "label": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_OtherOfferingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "OtherOfferingCosts",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other offering costs",
        "documentation": "Represent the amount of other offering costs."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r608"
     ]
    },
    "us-gaap_OtherPrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OtherPrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "Other Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r657",
      "r683"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r569",
      "r580",
      "r590",
      "r623"
     ]
    },
    "tlnc_OutstandingBalancePromissoryNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "OutstandingBalancePromissoryNote",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding balance promissory note",
        "label": "Outstanding balance promissory note",
        "documentation": "The amount of outstanding balance promissory note."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r572",
      "r583",
      "r593",
      "r626"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r572",
      "r583",
      "r593",
      "r626"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/CommitmentsDetails",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "tlnc_PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Payment of general and administrative costs through advances from related party",
        "label": "Payment of general and administrative costs through advances from related party",
        "documentation": "Amount of payment of operating expenses through advances from related party."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForUnderwritingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsForUnderwritingExpense",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payable to underwriters",
        "label": "Payments for Underwriting Expense",
        "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of offering costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PaymentsToAcquireTrustPreferredInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PaymentsToAcquireTrustPreferredInvestments",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 523.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investment of cash in Trust Account",
        "label": "Payments to Acquire Trust Preferred Investments",
        "documentation": "The cash outflow for the purchase of trust preferred securities, which possess characteristics of both equity and debt securities."
       }
      }
     },
     "auth_ref": [
      "r659"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r616"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r609"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "tlnc_PercentageOfDeferredUnderwritings": {
     "xbrltype": "percentItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "PercentageOfDeferredUnderwritings",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of deferred underwriting",
        "documentation": "The percentage of deferred underwritings."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_PercentageOfGrossProceedsOnTotalEquityProceeds": {
     "xbrltype": "percentItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "PercentageOfGrossProceedsOnTotalEquityProceeds",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of equity proceeds",
        "label": "Percentage Of Gross Proceeds On Total Equity Proceeds",
        "documentation": "Represents the percentage of gross proceeds on total equity proceeds."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders": {
     "xbrltype": "percentItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sponsor owns issue and outstanding percentage",
        "label": "Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders",
        "documentation": "Percentage Of Issued And Outstanding Shares After The Initial Public Offering Collectively Held By Initial Stockholders."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r649"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r599"
     ]
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, par value",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r211"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, shares authorized",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r445"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, shares issued",
        "label": "Preference shares, shares issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r211"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, shares outstanding",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r445",
      "r464",
      "r750",
      "r751"
     ]
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 107.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; no shares issued or outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r199",
      "r206",
      "r396",
      "r540"
     ]
    },
    "us-gaap_PrepaidExpenseOtherNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidExpenseOtherNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term prepaid insurance",
        "label": "Prepaid Expense Other, Noncurrent",
        "documentation": "Carrying amount as of the balance sheet date of amounts paid in advance which will be charged against earnings in periods after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r656"
     ]
    },
    "us-gaap_PrepaidInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrepaidInsurance",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid insurance",
        "label": "Prepaid Insurance",
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r503",
      "r523",
      "r683"
     ]
    },
    "tlnc_PrivatePlacementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "PrivatePlacementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Units [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrivatePlacementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "PrivatePlacementMember",
     "presentation": [
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement [Member]",
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_PrivatePlacementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "PrivatePlacementTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/PrivatePlacementUnits"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PRIVATE PLACEMENT UNITS",
        "label": "Private Placement Units [Text Block]",
        "documentation": "Disclosure of private placement units."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_PrivatePlacementWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "PrivatePlacementWarrantsMember",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Aggregate amount",
        "verboseLabel": "Gross proceeds",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of Class B ordinary shares to Sponsor",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of Private Placement Units",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds allocated to Public Warrants",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromIssuanceOrSaleOfEquityAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less:",
        "label": "Proceeds from Issuance or Sale of Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromOtherEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromOtherEquity",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of Units, net of underwriting discounts paid",
        "label": "Proceeds from Other Equity",
        "documentation": "Amount of cash inflow from the issuance of equity classified as other."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from promissory note - related party",
        "label": "Proceeds from Related Party Debt",
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repayment of advances from related party",
        "label": "Proceeds from (Repayments of) Related Party Debt",
        "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_ProceedsFromSaleOfUnderwritersReimbursement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ProceedsFromSaleOfUnderwritersReimbursement",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Underwriters\u2019 reimbursement",
        "negatedLabel": "Proceeds from sale of Underwriters Reimbursement",
        "label": "Proceeds from sale of Underwriters Reimbursement",
        "documentation": "The amount of underwriters\u2019 reimbursement."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_PublicWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "PublicWarrantMember",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Public Warrant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r597"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r564",
      "r575",
      "r585",
      "r618"
     ]
    },
    "us-gaap_RelatedPartyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyDomain",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Domain]",
        "documentation": "Related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r90",
      "r91",
      "r153",
      "r228",
      "r229",
      "r380",
      "r381",
      "r393",
      "r401",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r463",
      "r495",
      "r748"
     ]
    },
    "us-gaap_RelatedPartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyMember",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party [Member]",
        "documentation": "Party related to reporting entity. Includes, but is not limited to, affiliate, entity for which investment is accounted for by equity method, trust for benefit of employees, and principal owner, management, and members of immediate family."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r90",
      "r91",
      "r380",
      "r381",
      "r382",
      "r383",
      "r393",
      "r401",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r463",
      "r495"
     ]
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionAxis",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Axis]",
        "documentation": "Information by type of related party transaction."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r90",
      "r91",
      "r380",
      "r381",
      "r739"
     ]
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionDomain",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Domain]",
        "documentation": "Transaction between related party."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r90",
      "r91",
      "r739"
     ]
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Related Party Transactions [Line Items]",
        "label": "Related Party Transaction [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r90",
      "r91",
      "r153",
      "r380",
      "r381",
      "r383",
      "r469",
      "r470",
      "r473"
     ]
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related and Nonrelated Parties [Axis]",
        "documentation": "Information by related and nonrelated parties. Related party includes, but is not limited to, affiliate, other entity for which investment is accounted for under equity method, trust for benefit of employee, principal owner, management, and member of immediate family, and other party that may be prevented from pursuing separate interests because of control, significant influence, or ownership interest."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r90",
      "r91",
      "r153",
      "r228",
      "r229",
      "r380",
      "r381",
      "r393",
      "r401",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r463",
      "r495",
      "r739",
      "r748"
     ]
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactions"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RELATED PARTY TRANSACTIONS",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates."
       }
      }
     },
     "auth_ref": [
      "r377",
      "r378",
      "r379",
      "r381",
      "r384",
      "r420",
      "r421",
      "r422",
      "r471",
      "r472",
      "r473",
      "r492",
      "r494"
     ]
    },
    "us-gaap_RepaymentsOfRelatedPartyDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RepaymentsOfRelatedPartyDebt",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of promissory note - related party",
        "label": "Repayments of Related Party Debt",
        "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r565",
      "r576",
      "r586",
      "r619"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r566",
      "r577",
      "r587",
      "r620"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r573",
      "r584",
      "r594",
      "r627"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 110.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit), Total",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r44",
      "r399",
      "r408",
      "r409",
      "r419",
      "r446",
      "r540"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r61",
      "r62",
      "r93",
      "r94",
      "r95",
      "r97",
      "r104",
      "r106",
      "r108",
      "r155",
      "r156",
      "r163",
      "r196",
      "r257",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r330",
      "r331",
      "r346",
      "r348",
      "r349",
      "r351",
      "r357",
      "r374",
      "r375",
      "r405",
      "r407",
      "r423",
      "r750"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r636"
     ]
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/CommitmentsDetails",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_SaleOfStockNumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "SaleOfStockNumberOfSharesIssued",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of private placement warrants shares",
        "label": "Sale of Stock Number of Shares Issued",
        "documentation": "The number of shares sale of stock number of shares issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Sale of private placement warrants shares",
        "netLabel": "Purchased aggregate shares",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants price per share",
        "verboseLabel": "Units price per share",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ScheduleOfClassAOrdinarySharesSubjectToPossibleRedemptionTable",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Class A Ordinary Shares Subject to Possible Redemption [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Income Per Ordinary Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Income Per Ordinary Share [Table]",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]",
        "documentation": "Disclosure of information about basic earnings per share by class of stock. Includes, but is not limited to, two-class method."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r120",
      "r122"
     ]
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transaction [Table]",
        "documentation": "Disclosure of information about related party transaction."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r90",
      "r91",
      "r380",
      "r381",
      "r383",
      "r469",
      "r470",
      "r473"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Information Related to CODM",
        "label": "Schedule of Segment Reporting Information",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r15",
      "r16"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r556"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration",
     "presentation": [
      "http://TCC.com/20251231/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "label": "Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]",
        "documentation": "Indicates title and position of individual or name of group identified as chief operating decision maker (CODM) for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r515",
      "r522"
     ]
    },
    "us-gaap_SegmentReportingCodmProfitLossMeasureHowUsedDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingCodmProfitLossMeasureHowUsedDescription",
     "presentation": [
      "http://TCC.com/20251231/role/SegmentInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Description of operating segment",
        "label": "Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description",
        "documentation": "Description of how chief operating decision maker (CODM) uses reported segment profit (loss) measure to assess performance and allocate resource."
       }
      }
     },
     "auth_ref": [
      "r143",
      "r512",
      "r519"
     ]
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEGMENT INFORMATION",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r125",
      "r133",
      "r134",
      "r135",
      "r136",
      "r138",
      "r140",
      "r141",
      "r142",
      "r145",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r511",
      "r513",
      "r514",
      "r516",
      "r518",
      "r520",
      "r521"
     ]
    },
    "us-gaap_SegmentReportingInformationProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SegmentReportingInformationProfitLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Performance and Making Key Decisions Regarding Resource Allocation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination [Member]",
        "label": "Business Combination, Series of Individually Immaterial Business Combinations [Member]",
        "documentation": "Series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r727",
      "r728",
      "r729"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://TCC.com/20251231/role/StatementofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense, Total",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharePrice",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_ShareholdersDeficitTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "ShareholdersDeficitTable",
     "presentation": [
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders' Deficit [Table]",
        "label": "Shareholder\u2019s Deficit [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesIssuedPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesIssuedPricePerShare",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share",
        "label": "Shares Issued, Price Per Share",
        "documentation": "Per share or per unit amount of equity securities issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodEndLabel": "Balance (in Shares)",
        "periodStartLabel": "Balance (in Shares)",
        "label": "Shares, Outstanding, Ending Balance",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class A Ordinary Shares Subject to Possible Redemption",
        "label": "Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security."
       }
      }
     },
     "auth_ref": [
      "r693"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r85"
     ]
    },
    "tlnc_SponsorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "SponsorMember",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sponsor",
        "label": "Sponsor [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/Cover",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r70",
      "r71",
      "r72",
      "r86",
      "r88",
      "r112",
      "r113",
      "r120",
      "r122",
      "r127",
      "r128",
      "r154",
      "r170",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r198",
      "r199",
      "r201",
      "r202",
      "r204",
      "r208",
      "r211",
      "r212",
      "r215",
      "r218",
      "r225",
      "r365",
      "r415",
      "r416",
      "r417",
      "r418",
      "r423",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r433",
      "r434",
      "r436",
      "r445",
      "r466",
      "r488",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r654",
      "r664",
      "r666",
      "r673"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r28",
      "r31",
      "r32",
      "r60",
      "r61",
      "r62",
      "r77",
      "r78",
      "r79",
      "r93",
      "r94",
      "r95",
      "r97",
      "r104",
      "r106",
      "r108",
      "r126",
      "r155",
      "r156",
      "r163",
      "r196",
      "r227",
      "r257",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r276",
      "r330",
      "r331",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r357",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r374",
      "r375",
      "r376",
      "r403",
      "r405",
      "r406",
      "r407",
      "r423",
      "r488"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r126",
      "r198",
      "r199",
      "r201",
      "r204",
      "r375",
      "r387",
      "r413",
      "r424",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r445",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r467",
      "r468",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r505",
      "r506",
      "r546",
      "r748"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StatementTable",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]",
        "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r126",
      "r153",
      "r198",
      "r199",
      "r201",
      "r204",
      "r375",
      "r387",
      "r413",
      "r424",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r445",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r454",
      "r455",
      "r456",
      "r457",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r467",
      "r468",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r488",
      "r505",
      "r506",
      "r546",
      "r748"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r568",
      "r579",
      "r589",
      "r622"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class B ordinary shares issued to sponsor (in Shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r28",
      "r44",
      "r415",
      "r488",
      "r497"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesOther": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesOther",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase of additional units",
        "label": "Stock Issued During Period, Shares, Other",
        "documentation": "Number of shares of stock issued attributable to transactions classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of shares forfeiture",
        "terseLabel": "Forfeiting unexercised units",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r28",
      "r44"
     ]
    },
    "tlnc_StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of 779,000 Private Placement Units (in Shares)",
        "label": "Stock Issued During Period, Shares Sale of Private Placement Units",
        "documentation": "The shares of sale private placement units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Forfeiture of founder shares (in Shares)",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, Forfeited",
        "documentation": "Number of shares (or other type of equity) forfeited during the period."
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised options purchasing",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r28",
      "r44",
      "r238"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class B ordinary shares issued to sponsor",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r27",
      "r28",
      "r44",
      "r423",
      "r488",
      "r497",
      "r552"
     ]
    },
    "tlnc_StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of 779,000 Private Placement Units",
        "label": "Stock Issued During Period, Value Sale of Private Placement Units",
        "documentation": "The amount of sale private placement units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeiture of founder shares",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, Forfeited",
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 111.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance",
        "periodEndLabel": "Balance",
        "totalLabel": "Total Shareholders\u2019 Deficit",
        "label": "Equity, Attributable to Parent, Total",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r28",
      "r31",
      "r32",
      "r41",
      "r447",
      "r464",
      "r489",
      "r490",
      "r540",
      "r553",
      "r661",
      "r666",
      "r667",
      "r682",
      "r735",
      "r750"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders\u2019 Deficit",
        "label": "Shareholder\u2019s Deficit [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders' Deficit [Abstract]",
        "terseLabel": "Shareholders' Deficit [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/ShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SHAREHOLDERS' DEFICIT",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r210",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r224",
      "r227",
      "r343",
      "r356",
      "r491",
      "r493",
      "r501"
     ]
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockholdersEquityReverseStockSplit",
     "presentation": [
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share split",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUBSEQUENT EVENTS",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r385",
      "r386"
     ]
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Private Placement Units [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/CommitmentsDetails",
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails",
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/PrivatePlacementUnitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Private Placement Units [Line Items]",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash investing and financing activities:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r615"
     ]
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accretion for Class A ordinary shares to redemption amount",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "documentation": "Value of accretion of temporary equity to its redemption value during the period."
       }
      }
     },
     "auth_ref": [
      "r694",
      "r696",
      "r697",
      "r698"
     ]
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValueAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityAccretionToRedemptionValueAdjustment",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accretion of carrying value to redemption value",
        "label": "Temporary Equity, Accretion to Redemption Value, Adjustment",
        "documentation": "Amount of decrease to net income for accretion of temporary equity to its redemption value to derive net income apportioned to common stockholders."
       }
      }
     },
     "auth_ref": [
      "r200",
      "r203",
      "r209"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://TCC.com/20251231/role/BalanceSheet": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheet",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class A ordinary shares subject to possible redemption, December 31, 2025",
        "terseLabel": "Class A ordinary shares subject to possible redemption, $0.0001 par value; 24,900,000 shares at redemption value of $10.12 per share",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r172",
      "r173",
      "r174",
      "r177",
      "r178",
      "r198",
      "r199",
      "r201",
      "r205",
      "r258",
      "r259",
      "r398"
     ]
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Class A Ordinary Shares Subject to Possible Redemption [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityLineItems",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Class A Ordinary Shares Subject to Possible Redemption [Line Items]",
        "label": "Temporary Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r201",
      "r202",
      "r204",
      "r208"
     ]
    },
    "us-gaap_TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityNumberOfSharesRedemptionValueAndOtherDisclosuresAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofClassAOrdinarySharesSubjecttoPossibleRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plus:",
        "label": "Temporary Equity, Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityRedemptionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityRedemptionPricePerShare",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subject to possible redemption, per share",
        "label": "Temporary Equity, Redemption Price Per Share",
        "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquitySharesIssued",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/ShareholdersDeficitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Ordinary share possible redemption",
        "terseLabel": "Subject to possible redemption, shares",
        "label": "Temporary Equity, Shares Issued",
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r201"
     ]
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityTableTextBlock",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Class A Ordinary Shares Subject To Possible Redemption",
        "label": "Temporary Equity [Table Text Block]",
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698"
     ]
    },
    "us-gaap_TemporaryEquityValueExcludingAdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TemporaryEquityValueExcludingAdditionalPaidInCapital",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subject to possible redemption, par value",
        "label": "Temporary Equity, Par Value",
        "documentation": "Carrying amount of the par value of temporary equity outstanding. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r681",
      "r738"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://TCC.com/20251231/role/BalanceSheetParentheticals",
      "http://TCC.com/20251231/role/StatementofChangesInShareholdersDeficitParentheticals",
      "http://TCC.com/20251231/role/StatementofOperationsParentheticals"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r607"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r614"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r635"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_TransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "TransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction costs",
        "documentation": "The amount of expenses related to transaction costs."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r639"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r637"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r640"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r638"
     ]
    },
    "tlnc_TriggerPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "TriggerPrice",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trigger price",
        "documentation": "The price per share of trigger price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "tlnc_UnderwritingAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "UnderwritingAgreementMember",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting Agreement [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_UnderwritingDiscountAmountPerUnit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "UnderwritingDiscountAmountPerUnit",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting discount amount per unit",
        "label": "Underwriting Discount Amount Per Unit",
        "documentation": "Amount of underwriting discount amount per unit."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_UnderwritingOptionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "UnderwritingOptionPeriod",
     "presentation": [
      "http://TCC.com/20251231/role/CommitmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underwriting option period",
        "documentation": "The term of underwriting grant option period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r634"
     ]
    },
    "tlnc_UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_UnitsIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "UnitsIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of units issued",
        "documentation": "The number of units issued."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits",
        "label": "Unrecognized Tax Benefits, Beginning Balance",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r265",
      "r534"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized accrued for interest and penalties",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r264",
      "r534"
     ]
    },
    "us-gaap_UnsecuredDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UnsecuredDebt",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured promissory note",
        "label": "Unsecured Debt",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r50",
      "r743"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r129",
      "r130",
      "r131",
      "r132",
      "r389",
      "r391",
      "r508"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r603"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WarrantMember",
     "presentation": [
      "http://TCC.com/20251231/role/InitialPublicOfferingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r543",
      "r544",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "tlnc_WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member",
     "presentation": [
      "http://TCC.com/20251231/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted weighted average shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r122"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://TCC.com/20251231/role/StatementofOperations",
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic weighted average shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r122"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "presentation": [
      "http://TCC.com/20251231/role/SummaryofSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomePerOrdinaryShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Denominator:",
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_WorkingCapitalDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "WorkingCapitalDeficit",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Working capital surplus",
        "label": "Working capital deficit",
        "documentation": "The amount of working capital deficit."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_WorkingCapitalLoan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "WorkingCapitalLoan",
     "crdr": "credit",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails",
      "http://TCC.com/20251231/role/RelatedPartyTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Working capital loan",
        "terseLabel": "Working capital loans",
        "documentation": "The amount of working capital loan."
       }
      }
     },
     "auth_ref": []
    },
    "tlnc_YearOfInception": {
     "xbrltype": "stringItemType",
     "nsuri": "http://TCC.com/20251231",
     "localname": "YearOfInception",
     "presentation": [
      "http://TCC.com/20251231/role/DescriptionofOrganizationandBusinessOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year of Inception",
        "documentation": "The term of year of inception."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "850",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481284/470-20-25-2"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB Topic 4.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "210",
   "Topic": "946",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-20"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-5"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-11"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-6"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-29"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-4"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-5"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "S55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479772/718-30-S55-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-2"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-4A"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-4"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/815/tableOfContent"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4F"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-7"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8A"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-8C"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479693/815-10-S50-1"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480870/815-30-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/850/tableOfContent"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-6"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/855/tableOfContent"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478671/942-235-S50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "805",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478072/944-805-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-5"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-6"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-6"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-21"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482836/275-10-55-6"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "64",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-64"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-11"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-6"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-8"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "43",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-43"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479303/805-10-55-47"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-11"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "605",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477548/944-605-55-14"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r657": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r659": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r660": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r661": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-4"
  },
  "r663": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r670": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r671": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r672": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r673": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r674": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r675": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r677": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r678": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r679": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r680": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r681": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r682": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r684": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r685": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r686": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r689": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r690": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r691": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r692": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r693": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/480/tableOfContent"
  },
  "r694": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-2"
  },
  "r695": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-2"
  },
  "r697": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r701": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r702": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r703": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r705": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r706": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r707": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r708": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r709": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r710": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r711": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r714": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r715": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r716": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r717": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r718": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r720": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r721": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r722": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r723": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r724": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r725": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r726": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r727": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r728": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r732": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r733": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r734": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r736": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r737": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r740": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r741": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r742": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r746": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r749": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r751": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>57
<FILENAME>0001213900-26-035558-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-26-035558-xbrl.zip
M4$L#!!0    ( /2#>UQ9P,L(I88" %0A$  7    96$P,C@P,C<X+3$P:U]T
M86QO;BYH=&WLO7ESVUB6)_H_/@6>NKK;CJ!D[HN=J0FE+%>KRVEY+&7E]'OQ
MH@,D+B6408"%13+[T\]9[@80("E9DBF:$]-9%K'=Y=RSG]_YY7]]FX7NK4C2
M((Y^_??64?/?71%-8C^(KG_]]Y/+T_/S?_]?Q\XO-QG<!K=&Z=LLC":_'MQD
MV?SMFS=7IZ='DWCVIMUL]UKM3NM WA0&T5=]T]W=W=&W<1(>Q<DUW-GLO,'+
M8R\5ZO9O2_??=>CNUF@T>D-7]:WP(C_0]]KO[;_AB_K6-*AZ)]S9>O-_?O]X
M.;D1,^\PB-+,BR9Z+,&WNH&W.F^"",8B_L]O7SZ:V[/J^\VM;[+$B])IG,R\
M#)89%ZM]V&P?MOK62PY3,2F\"/X^NHYO5[ZGU3ML#@_-LN=94KOJHS=P57\P
MC;OMUF#%%LD[U -^EAQFB[E(JQ^!RV_P,LZM>]AL66/">X)5'RJM?YX>7GO>
M7#\Q]=(QW2TO$*T5J"&KI(8>4T.F9R!*5*,6&"X4WBDF?O6-<*%P8YIDRZ.$
M'XMOB_)9NVJ [>8;\2T341J,0W&(MXF$]C4];!\UU>.31<U@X(+]G?K#@T?W
MX-AQW5]NA.?C/^"?69"%XAB/\J$ZNK^\X1_YAIG(/!=?>2C^F0>WOQZ<QA$,
M-CN\@ET^<"?\UZ\'&<SA#7WB#7WCC?K(+^/87\B7^<&MFV:+4/QZX ?I//06
M;Z,X$@=\&6X(OKW%YT2B?I&_!;XO(O,;_PJ/?DB\"2Z5&WDS>*FDC+>?$S$5
M22+\RRR>?+V\\1*1GJ=I+GPYXF_9%S']]6 "]_UWJS<:]H?-SJ![X :PR-/)
M?[<&'2#?7G\$/^51P#?G>'.OV>UUA\-6!Y8[#=Y&00A33W*8PB]OBD/ZOM%>
MY!F>!F2_FPVYT^JVVQW8P><?\=^],!>;C7(X'+7;S4%W:5U;W6ZW->BVFH\X
MRA/?#_!G+_SL!?YY=.K-@\P+-R2!?K_31EDR?(ZAGGKIS1F>+R^$TY2>9*=>
MDBQ@\^^QMIWV:-B#_UNB@*<8\!]1(B;Q=13\C_"OO&^_B4A,@RS=;*2]7@L(
MLCMXEJ6M&>DY*#<S 3]\%D @62#2DPAH)!-P^+*3R239G%F,1JWA8-CN])]R
M.B"<WIY%P)D7G_-Q&$P^A+&750VPWQEVX</#MD7*YJ?: :83#]DR_,L7DV#F
MA2G^<=R\_TA1F+S],TZ^ OG*(_<Q]J)-V5BKWVOV1[VG7,O-1]B!S>TT>\VV
M-4#]R]/3[D5V(Y*/@3<.P@!)]#0'IAM5;GMWU.VWNJV>M>W63\_ P>+9+,AF
MQ+TB'Y4$6%RP(&#4&QXC&!+\OT[K28_1HVD(?1A0N]7I+"WNUFH(8"4T>]U.
MK_\L*L(F@QPU6WU8Q&Y?C]'ZY1F&B(MY$X>@;J8H?+/%1F.$=1PT^V!'#9Z#
M4#?:[&ZGW>\-P JT3I/Y:4M6LFJ4S=ZHV^T-.L^BLVPXRB8,M-GO#JVU-#]M
MR2C;S5$7_J\_M,G2_+0EHVPU^^WV<##JV3MN?GJF43);?Y\G<'@^BR2(?3Y3
MG\0=7:J23_W6"$Y)?]BQI6E["$9!>XD(GNQ +0^<K(%[CKL_:HY097D6+>"A
MXP:Y#UQ@,&H92W$TZ [[[=ZS6(H;4C.P_%ZOW;54+.NGIQ_E)Y&QU?(Q3C?;
M_%Z_TVJ/6H/1-@ROU>IT!RVT_BW3J=\%$=!['B-[[0!!9VH.N]W1R QP"-9(
MNSMX!GMD):^Z!./L8OHY"6Z]3'P.O8E 3?N/J,;D7E[I0:_5Z;4'G4=E7I_0
M51E,RH=)7./@OHAYG* 1<!K[LW-076X#/_?"*_0M@H7P.4[).7.1_#6)\_E%
MP@9$)L0G>-N9=HB>&7]HI;36NR G"C_T05AW!P?'=1[9?SF]"<3T0Q!Y8)YX
MX<5T&DQ$\KN8C46B9BVG]GU[1VSON[>NW00N R;QD^I(CSR-97[>&@*9]5'T
M/X_K[Q]YRM;H55SC!_S32Q(ORFJMO@I9BII_<SAZ'A/U,>90Q7-[HV879$+_
MF7RPWS^)"F)JMT>P,_WF$C_[47.PC@[^%^-8IW%:>38JZ&K4[X%:/&H_BQGT
MR-.I(+%AK]L#R=Y]%@/YD:=306S-YJ#7;G66-?]G-UGHO[]YJ?!!6LY!0I)<
M_! G4Q%D&S(QV*P.G/]EQ?JY[9C'F P06G?0:3=_M&US_[E4T-EHU.[U01U^
M/F?(H\UF60]K=4!G 3I;&71X5B;PNY=\O8KQOZ+*@[Y,7.A1&?2&,(L7,H4J
M:=\&71A^&6V-RK)F#A7GHM/J#-O=_K/LPI68@=GB)0MV V @4.!M5_$7X<,U
M_'==3':9@H8],+O:O>ZSJ"G?,_0*RNFVNZ-V=_@\:B+&OTLQ\"\BS< " WZ#
M%\!B+/Y@W;F9YQ$4WAZ0UB-;\D43V 1I3V%@B1>"W2N^_4U4NI,Z_4ZOT^X,
MI:,Y^'9[.,!XTC'8>[ 3G4ZWN=X:7?[^"1P_'X_@A]"K#!94?[=S<#SUPE0\
MY)/OXTE.7PPPBLR"Y /\5KDSU9_O'AQ_^*^'?)N7^\K[=N[#" (PY4E8P8U@
MS6_P?>3S[7Z_VP$#%9?^L,G_KW8L=*&<D(3#2S!&)T"U3 L#QYS%MRFE&,(H
M7,IA?.LEDR3&>/LFF9'TQ$V"4R@D:AU]2WUU&7/N?CU(@]D\%)R!98VV:F0\
MXC3.D_* *4_OK5PX6J/RPMFWZP<$;43QDKX8R,T1B4M+(2HS'$_/_U:D_O+#
MI0^_J?^R_.Z<:+%F4&GF)=E[+Q/'N**8K-ALJ7>::]7/PADS3[;:AYV6&8V_
M_)RZN#P>=46N]T8[H1G6CFY$[Z5LA FR[\A.< YN5K&:ZLK3K::Q/[=D,0U]
MLD>[?%5>]V%LW^9A, DR]B&[?C!#[W4<V>86D"*^Y#3TTO1B2N;7R;<@/3BV
M,VCBB*[_IIS1E>]?&N6;%<-\R10!%O$ 5.A.9VM$SH\CB9,]23#+'0#'[>XD
M0;P7X^P<5C A99HI@>(R*BWU"Q#,G@R0#+I-L*Q[6R-V'Y,*L*[B8GJ"(9%K
M42*$/\"<3.Z2 ,.J)]>)H.O;0Q$O5H\#XZ_=:0ZVQ[1Y5#F3C]/ #[QDP3'<
M"CES_OEB>ZCHAXJ7=K_=:W=ZHSTA;$0(>\:VU8QMU 0J:[>'>W+>$U'QRGUX
MXA",L-:HW=]-PWP]%5W<BN0D#&,*;%U0'&5[J6ITV&H^B*H*3SX#58T&HUZ_
MU>UL#6_Z:7>B-QIVFCOK>-NQ\_U2I 9L=9-"KOUMH:K'/]_-X4//MWGRZ7>B
M/^CV6T,L -F2C7CFXUW.6=Z>L_TC+=UVJ]DDA(NMD;^/219?1 A;[G^&4[FX
M0K <3N!(?UO85RP#]'(.5^-D>VCCI?)]])^,AECDN8-D];OPTCPA+G(>S?,,
M71I%9E.^@]6)O\= =%C#O]@> ONA[GM0^P>M07MK,AA^+)%0F,]'ZJ"L2!!8
MDWV<1]HF[3Z"0NSI!._X$J1?/R1"[..!RSZJSF T'';Z.QG!N3^E4 ;_GH]8
M*7.#?K_9;S6WAI,\MGXX/&R-'F:-VD\^AU^@/>SU>]U.:UMVXAGL#LO0^!#G
M&.NB [JE9[- $<]@B3:'_<ZPWQKL).]^J13Q4NW/U@!5QG:_NY,&Z#-XL_?$
MO;W$C4ADS5Z_OY,^N]V+U#Q4(^L]JT;6&XPZP\Z.YCSM"H<:/CC8-'S68%.K
MV>T A^KT=E/\[D051X&_/$>DJ35L#KJ[R5]>+$6\5&D%"M"@,^BWMB=OZ*60
MTR.(S1<=/WTA]-T;#0>C?F]K')7/K.)O;[;&2S4:.332Z@UVD:*>A5'M27S+
M2;S5[ V[@T%[)SW(3TU1FXP%D58^BFLO/*.EM,[3:7PCML@)\V.#C/UFM]]I
M=G<RK65/AL4EW4U&.NIWVH/68#=K?:11)?%F+Y(OP?5-5B1A>6U[*.E',K1.
MI]7IC(:MG0S5OT1B>+%LI3GJ=9KM=F]KBD%^G-/F?D N]QG';WD:1 *^,/EG
M'C"ZOB4AU548RCB(O.V*G?W@FO]AM]OL[5&&GI(X7R*[_:%4V1P,L-5 YV?3
MQ(A9E2T)>6.ZIPT)Q=GOM7N=T4X:FFMI@_J?[IE%P<7;;;7;>S5]&TFA4,W_
M'!4SHU%OT.FU=U+5W@7>\,P$,1PVV_TV=BO=07IXZ3F#/Y(PNKWAJ#?L_K2X
M %L-#O5BP&-:K5Y_B(VE=Y**=B>[ZX4X"D?#[JC;VQY ]9?BBME34P4U#=K]
M7F_4V]&T@'IJXH@H$=%%X@<12D'N'Y>/_R$FV57\.4ZINZKI#+0]U/9##6D"
M'-@>S*H]P>PP>VH-6KU6MSG837C6VFB4Z1.=! +HT/2&#A?GLQFL>1)X8<7C
M>^^O]/!T82M!4]K)R,#.99ZW6H>MSL/8D?WD,]0! E$U^_W>S^9&?KR T]Y!
ML84."A"OPW:OM9OE9WNR?L$.V%&_/^@.^C]I%'<'*/.GUFM>C@3H]-K-3G?0
MWAH)\+-JF*U^N]GJ#GN#G>1X>]%W'TKH#%JC3J>UDYZVK9-]]Q8^IS"<;9(]
M/]3?TN\V>X/6WH+84EK=.D7IQP+A]CJ]5F?8W3/69S$J7FI(]X>VGNAUA_U!
MN[F30?ZM(]&7ST]?;GROWQSU1\W=S+#;.D)_:?;72R7K=KO;&0RZ/RW [E-Z
M"5^L/O%BG8.#$?K@^YV?E9J? RXZ3;*W5T&&(S#)'CP,O/0^2,1D>]T-S^P:
MZ_4ZP\&HW=])@GSYRNB/)0TP[[N=T9XT7@!IV+C+3T\:@^YPU.GV6[L965%:
MT=D_<Y@&:$"P]?!G6A1E7T3F!9'PS[PD"J+K?;H@IS2W^]U.N]O?22-T0\I@
MG9FTGRU1W;>H5NA'$F>_TVR/.L/NGCBWB3BWR*[\D<0Y&'1Z@\Y@M),)L2]>
MIKY4]UFK-QHVA]WN:"?#R1N2U8GO4TF'%W[V O\\.O7F0>:%>^KZ_GKL3G?0
M@HW?R>#:BY6H6Z3NO53*[K=&W5ZWOYM53R^6L+=(57RIA-UJ#;J]7K?]TV;%
M[D,054O_0@-JP\Y@T.X/ASMIT;]\'_5+)2L0_K#;G?9NJ[4O7)<L",ZM%KG=
MYA"K[UH[J4SN'I=Z*=U/.WVL;]K1 .V+Y5*6#[E_V.P<MGO/YT-NM8#3@'Z_
MXX'9EV8K_DB2& W;W>:@N]ONWQJ,*94$?.9-;OZ\B4,A?SC[)I))D'KC4'R(
MDXM(5(!1G60GD;Q/?$Z""9ARK5:ON3U$599:K1?B@.BVAX-N>]3ZV:16+>H9
MZ$=_]\)<P(B;K<];WQO^I=!9N]F!_S\ (O@9">V/*&"^=PK*=I!F071],:WA
M=)$/%[*;(/'I%@3=$S-DCEN';/Y2:;'5[PR[K6YW>_Q4CYHIT>P?=IXQ,;73
M&HTZS=YN%CJ]?'/ZQS9%'77[K6ZK]]/31M4S>QHABZC9ZK?:K=VL6=^'=A];
MMG6?5;:UNIUVOS=H[KAY]-*H<SO]BS^ .IM H,U^=[<Q[E]X-N&/I)!V<]2%
M_^L/?V;INKUIS#^4>33[[?9P,.IMC6A[V:O9' UZO?9/7<SRLECQT]HY>10P
M>>0LJ;O=UJ!;%PB<"2^%^XZ#-.ZV6X.W?UR^5U]0ERH^CI]8^^7NJ--K#=MU
M.,/J]>R[X#5_K$\/8-:CUFA0$^Q2KY=K#/]\K _WFMU>=SBL2_ H?C@EK_^C
M?;K3&0R;_5&-O*7DPSJ7*+[I4SX3B9?%=<KT?6FE/(':]UMC>"^B>(9=XC<8
MQ89K6!Y&[2?43<L+5;L-P;>W"7I5T/5R$\Q=+YDD<5CDH?CH49Q<OVDWFYTW
M\HXW4V^2'4[C.(OB3!RX6?Q%3--?#Z;DU1Q0+F.W<^!.DW@FKTR J%NM;J_5
MZKCP![#B87<X *Z/?PW:@VX/>/. +[7:W?ZHV\(_^L-.M]T&=?W@S3,,O37J
M]IN#;G-4&KH>Q=+X2B,O3$K-]WF&WL9FI:-^;U@:>V<X[/2&P$)Q3*W>J-5O
MCD:M]O,,"MCG:#@:-5NE01GO &WR8#CL]YN]/BUBJ],;(/.C2X,>XE /B&9:
MP!]Z@U:[_TPKVNF,>IUN9] L#UZ/HSS"XM@+T[+\(=;@?WE#8T_C/)F(5/U.
MO]X(SU="_I<W<*J/?YF[:;; >4U!>+YU6\UYYEZ!SI&ZG\2=^R6>>5&#?VBX
MV"9H^LZ=><EU$+UU\=;F.Q=%[J$7!M?PTP0$ED@.CG]Y,S_^Y?\Y/'0_!"+T
MW[I?\E <?O:NA7MX>/P+?%A]]2[PLQO\;/-?#PH7<#B':? _ B[.LW?N.$Y@
MZ(=9/'_K_A9ZDZ]N&SZ?QF'@ZXOC.,OBF;K>4M</CO_M7X!"W\D9\W^MP;TI
MCNYI5D0-8?YD2Y[.O:BP>G<"<>#>PNJ$_KN#XS\^G5^=O7<OKTZNSBY_>8.W
M'__(\5R>G?[QY?SJ_.S2/?GTWCW[/Z?_<?+IKV?NZ<7OOY]?7IY??-J"0?[I
MP>F/KK,8WO[^Z/3(;3=[W=$6#$S1TU,/Q%T[D@\77WXG?AG%$2DTP<2-/#2;
M?!&\?1]/<E1CKQ9S8(920P>VISL"]#N]3AL$R@&I;<&WV\,AV ,'QZWFX=^(
M:9G7'LOINC_IPD^]61 NWJY^.4QAW5Z<1%'NA5_$/$ZR-7LRC9.9E^&^9&^G
MP3?A'V9)+@I[U<<U&0VZ_7<UVR57;-W"GGSZ],?)1_?+V>>++U?NYS^^7/YQ
M\NG*O;IP@5-< 3MP0<V[^.*V>J_\U^[%!_?J/\Y<BXEH!G)R>H676Z-.]QD(
MYLD9^P8G,$[<[$:XTR"=>*&[$%[BBL@7_OIC^9F,Z3-.\K@'+?AP^^$,[K[!
M=Q[ZWN(0/WLHH@)M#%90XVF>)#""#S3H_X*''V44I0$,#X[?BPF[4M"_4"30
MQOH%,L/[ +^D]QA<E,\._3@[],4DF'EA85A@A*/78_G _+S\;NU +KYLP2!V
M@/M3<@1Y!A\H :9>F!9$0*<I14#W.T7 U9>33Y?GQ.OW8N"^I*FD0*;WUV57
M*5F:+@_P8?_-XN]Y^N<^MJ61U![/,_*B?Q'708H[F'V"*QLKS)T6'!XOA"V7
M7G[W-$[F1RM/XP^5*J_.OGF3C*;OQE,WT=-VO=1-YR RIP'H+T'D!EGJ3&Z\
M!-[[^C$WL'!D,\SHA=&'X=SS?3#X?CUH'M#?\,&)^OO>'[2\&]I),8G#T)NG
M A9+_NO@V/DE&\?^ L:1J(_<BB0+0/-0*YO%<R2OS%<WE'P>8_9Y'/6,5V1Y
M8_2(.NU_K=HDZ6^!F6VPA6LH^3R:  G&";G0*&1U&N=1EBQ.8_\>.MYA*B9O
MA7_M)?,DOIWP*XI*7J=]<'SJ+6#]W?,T]"(_K:%[_3^9?VRMY(IUPF529%)\
M:-N7_T,0"K@&>N_F3*2#$<W68;<]; ]^BB6T;T!".PR^'=X$OB^BM^AY;??[
MW4YKV#TX_O3FI+P 9AV D68)GN'5AQ=N\.$_/XKATA%T04>(04E(W'_D29#Z
M >7( @>V..L/&V)@<PP::7+M1<'_T-\%WO^&5G(5^15H;MVMWTE&KS 7+D@Q
M2._BL7/YW+VN(!6B@=+(?B!-G!]].;H\<L]F\S!>8%+ CR>"<YE ,6$JD$OI
MEG=?'KDW4FZ^(0&^LTI!0?!7,)>E"$@%+Y6?[8[^%?6('[2[:X36B>\G(DWE
M_WP,(M':7'H!F^YVF^['. _2P(L\]S)+A,CNX?.I&T1[\T'T#HXO\P 8;:O9
M:];*T/FV[\ I_/,BN8KOHLVGWC\X_H\X3[,X>NB2DXBZ2#Z#H@>RX+Y*8HI/
MHY*(;R]IB ,PC\0WKUXQG"^I-)7';*U.4WZ*#^0FYW.%KD-G]FG51;D#GV-8
MQ?#_#>8;*.G6\@X/C@>#9K.]@=)X#V7I*46VG"_:GO,$B"V8@\TLOHE)G@6W
M:)*"!!+IIB+\*4<*F^'B;E2-Y3FDX-8Y2I WG23"NQ^)CF IV\/6ZS*)UK.F
MCS$0Y>>;.+JO'=6%!>PV!X?-_K"_C1[]5\;)]&__,FRW!N]2>%$HYCA7-Z+)
M-EPX%&&.6H_CP6+#W&T2W&$WZJ<X<T_FF!2+AVD+?)>O/H"@ XL-*;-!4@_^
M\"3_\B)?_<31/P?#<+![4W=RXT77 G@3RE(W]-+,3<CA_U-LXR6P\B3( O@.
M.Q=% FLQSY,T1R]C%L/'V/AMM5^-7SL@"-!Y?C+)WO[$7D;63XKB]X>[:0@L
M%"4U0C:X5'+VMD8PW]\?M5TS33PD"_=R,8-?=G22GZ3/GW;S[!NS*1<.XI\W
M ?SR19_6JODO:8]C&/YU$N>1CS0?)V_=Y'K\JMWL-D L-]J]WNN#E=:S4M"?
M0'6KU2PD;UJTVF.B[0K-P@)HL36+UL$Q@9<T7(&K-]'X);B@*+WI=+@G;BQ!
M3%Q*!B<Q 9</"<A$W9MH+!/WCL%,[N?TK;20UKCB'O+X4VV#/&U\V#;?@S:<
MTX^?3O_XN19+T:PZL#7A27O-EJ(X\.BR;=[MP'J"Y/WDI;[W3Y=*C=W?O>2K
MR-R/'T\?9%(N,P7@+9EXD9S 0(+9B]8].*X^ZL :YE[BWB)HEON7YA'B9F$>
M %_]N6AVW0&O7MH>G^^?:ZDV/-[6BFUXNOO/<;IW0N1K,$I[^0:8@LY C5+F
MWR%6HQ+8Z+)2:(VX(RMU@ S4 /6 0+?7A/2PO[1 ^ZOW5>\DN:_C#)5[,63&
M\.?/M50;<@:S8ALRAM%C,8;']GX6E_<?.>C7T\6+<VE<:Y>&-K'0M^%^ @ZQ
M[?X?^XVAF&9+/A47&X=,,)]AO' G-P)(!^[XBEXOG+'Q;[I!ZGKNG0C#PZ]1
M? ?+*[P45L"'"VF.;DXO=7TQ#2).-L-*,+?;[+ER[:PEA]4[<O\+_O'@S%R=
M(BM=P*LC,G_"H/^&8[Z40SZG$6_LA>XUT9>Y[.[^KM'WWWVO WOMWFX3Z40Q
M^DS_F0=XT.!\33&[@YVH:?7!ZV#>"J<F5QR_9R6@O\=A'F4@_S$G)5E7N6 1
M3NME$LYW#/!IDX-QM/6$=W<C*"&K1'VO6J]Y7#? H9#N?-<+0TU\-E6.A;P!
M7BP)D1^UJ)%_6.9J-G4BQ6*VO.O#U>B:;ITG8B+()]EJ\SNHW"9U7\&;4>%,
M<]!)TYL8\W-5OGEV [IF:3YW7KI\E.AA.:77#?)2O6I;\QZ#T@ WC?\!L\*'
MZ'YX$L<C7X85#2F-A(:+48Y1D]_@>XOT:-TID55(7 J!*F'F96O+?*S#TCXX
M_B^QE%>@TM^)\NU<^$^Q=:G[)#G83&Y/IJYL3LU64C=N)NSC+,@RV'X1PGXF
M<81Z;;AP!>BX"W@A4!!B=MX*][V7>9Q*5Z)S\PZ;^Z+4YOE*T0UTEW/MOGMY
M>.6^PHN#=^U.^TC+=N#N0/ESS"I_/'I/ZNF=1ZXI6*2OUY*FM2*X())2-R?-
MSL])FO>C3%(00W@G&,B3"5!F@HBP#FX1:H>1_:NK?@7%(#JLN)#.@*#A&XGB
M)K!7,Y JBP8R8K2^80^N\??K)+[+;M3E(YB<8#V4"G<H+P5C\^WF.QJ;L_PQ
MNMQZIVY;ND%>;Z@;:L>F7H3<5]Y;,TQYIR,592EDVN/#=J6R\QP$M/TAU:7"
MC65%1@7M>FN#:Q_+A,I[[<HS6])DZG/T[_O=D[HO/L&WY"36ES<DIS">ZSA9
MW+>:A-Y TYC(-Q1]$SW,^*\ZX4M*<8&-/L%:7-8=VG6R@Q[\+4_!L$WO4[1<
M7>./J(0U-?[+4]\PPV_5D:ASACW]?:NWXZR:+Z[;#/787^FI4W[H^S>E'GBA
M?E.>UEGV3*KG=(4HQ<2U509^22DE512.-UKZH*7EJ:"[X*,,H%!13 N2'+\5
M+O#C=P%\&DD@@OG$>%!O@Y381>1%D\ +D5ECT1K>C*"&OI?XJ8MIRH%?[;U3
MMMLKKVBU%61K74'U]Q:)2X+]9HK$&2'B^XO$>X-U1>(O5N-\@#$D+7K)V#'[
M!=4O#TP;3&-'<@."","RA?%XUV3EZEQ-+TV!J>-/2NT2TZD@.R&2.<WX9(#F
M0P04B#N7Q*$;WU*6H"),(U-R(/5$^["ZS>ZKL79?77K)V(/7'EY\"\6"W 2O
M6CWWCZ-+1$,:M/N8/?<:)VYF*?W2XQ!(RR+_:9#,V%8"*VONX4UP8L@1Z].(
MO=P/5)+BT1,@()Q/ILD)?B-.3LQ*?PB]ZT<@[^&/(^^M]WQ-W=2XG# 6N4E*
MIFM2,FN9NGW"#&6G"B W5>^P#3[*:V9W/S\FW4G3D+Q,\-,D3A*A*B-)UB0)
M.IAB)-S;(,[3<*'HMNJK3T&[!H\FNLQFV1F.Z%2/\Y%H>+2GX8<Y%5 #(%*+
M08%@:C%$I$C>$(A#7%"[AU ,3&+R@@&W#Q=IP$P\PG :</7#L8<Z!6H=(DI9
M/*"?"BZ1TU=_W29T+2ZLJI9_^Y=^M]T;O9N())5>+X>?"L4M'@X]#JGLV(=3
M.M&ZS:-6\_UA"T[H=]!YV7S<7<%?#D:F-R(,M>7P:CG^N,:M\IJ"2!L9R9?X
MJ<<R-_K-->;&;GD1W:ME?^X:O "[D5T42]+.8,NE*J3VW*/3_9]Y)-Q.L^$B
M$!AI?T@R C9"@#+D3KP(;1*PFB?HRF:SQ+N^AB'A7S/.E. T/ZGPW<:D9N&K
MT#\I_YQ0HQ97$%:\"Q1!+(,<F%.4??"V5 Z)G-.(J7;T<K?MA&;RNY? 5-H]
M6MU^@Y?6O8/_% [.AX2;A"U'A4R3'>Y#>I%G9+W!BE:=)--:VD5$;+I2 C]W
ML3I'D#M2(L*E],>&D'']UL$QS*<_&#6:39VMI28@E[4V)50G@NK44)C+DRR%
MZ;O^9"L!QVO8Z#2;:Q?BMPT6HJ$4.4J1-U-[I"/PJ 3_/+C*&C>Y!E=9XRX_
M,Z[R$R\ECO,=W/O/7(#>!:\L+RD_SRO5:L]U H)>GKZUGB4H:E-><[ T]@C)
M/KQW#H2JS+&'U:P8%:?_48$[;9 UHW$BO*^'8Y(Y;^%(X +8K^M7O YG;L_!
M6M7"9VPZV!H2>/#Z79W\]O$,T01/+SY=G7VZNBQQAZH7WW>.:X:PU4&O35*R
MG=59K?= ['GG5C[_B^?>)"AO_L7[;^#Q&V14?C[Y<L5?/=>6B+=9H=VZ&6Q>
MD_+0=7F2-;S?#.Z]R9K($-'B'*QA:>P<;3([_?"P\Z_EW0:=0$6[CKYG#\TW
MX!/M_4ZN&"!NG]LZV6CKRMO5.3C^$J1?W0^@M<7)]VT90BGO-VKM1OWVH(WJ
M8L$I-A,)T==TF8'-Z*)%0&[.[]NU7G^_:VMW[?1!N]8[.#Y=C$4BO>Z+_4X]
M^4ZU'[11?=!!DGB.-XK]>7KZ7>H\:)<&!\<?Q378:+!7$T'IH?O->OK-ZCYH
MLX8'Q[^#'NA>>E.1+=SW03H)8^R M]^R)]VRQ[7>1AM:;^[YWG)[SC/9>\B9
MQ$:KLK03LZ<JX,?8R>QR0]L&W!%2TB5YG6]@MT7B_H[),0DC7G$IG/LY3R8W
M7BK(Y<_/6K4MWWO<!WMJ6$<-_0=10^O@^/_[(E*1@$GQ_^\WZ8DWB3\R>-!.
MM?'<+N6?H4C-&>X:#^.)E;+P06?#G,81MY^F>V"[\Y#3<2[F@A&^]P?TN?;^
M03X:[-?\OS'W(\ TN5O&D((?0O6WI5FY)^,XSU3Y/GIVOG-O^WN/SEKF.WS0
MKG8/CLTAO32)<KB[E_E\'M+?&#+%FK/]-C[Y-HX>M(WHX:&4(,SSI<V#X^A=
M)T)NYY^8EW["N;<>)4)&ZD^5(V+(P)SD_7X_#TL>/8@E8X.64T[FY@-+_@C_
M$6S;_<9M<% ?Y$%O]0^.+R@9\#SB!!=0??:[]?2[]2#/>6MP<&RX(5JJ7D+5
MX!_B1, S[G]:;7-2+F;XG(A;K,4XC[!OV6-HMOO]?3Y/$[8-N4^>P-[?]/S2
MLM5\T%G&WK\!YN#'2=IPSW0:_ 4U=Y"NI%/9<DJX?\7,=U2)OEL+:NWW=;-]
MW2SOH[ROHX-CLYFG5E'$]^[;<+]OF^W;@X*=[::&L%NX%W<1G,";8(XNH5-X
MU@,SYC<1"3B::)+P=3JAQ@,E74FUON']_C_3_C\HC-IN@?4B=YHV$34EH("T
ML*U4>,RYW&E#&K;,P['81LRQ+/O[6?1@KV%MN-4/"L*VVYC7H-HJ&3>$^T$(
MZ6H2R2UV6/K>?>SL]_&Y-.5V9^.8[-_W.O*S']0'16;;7=2E;H)Q(%W %;YA
M]W)R(_P\_/[#VMWOY69[^:"X:KMW<(RMHMQ6\_!O[F4^FWG)]V;^#7H__9;!
M5>1EOQZT#^ZQ%WW0=<__^NGDZH\O9Y??N0>%O*.M[O6WOJJJ_<Z]F)-R]Q;?
M*0$?WKE_QUJ\72NZLM9!K< []VHQAXE^C.]$0I][YR*B.J_4IQCG'Q2*I]23
MM#*[7\:%>L23(*K3#;Z8R/[B;PGT)@PBH>[#"E,N'%*/^$$Z#[W%6S>(\,;#
M<0@F)V+ELW;#NLX*"(/'F,L&^/./\1FNGCX]^>/J_.+3R9?_<C]=7)VY7\[^
M>O+E_?FGO[H?+K[\"?\\_'AQ\3?XV[F\.KDZ^QTKX9YV1(_!G):/:<(Z:[/J
MW%8A32\+BSL6=]*>=2S$&8*5"5+W)(IRX#!?-,"3D<VOL)9?0FT6;I, FZ]A
M6 MJ[I4%69[I>^& WWF)?QC&\5>))R:_JI Y,;UNGB?S6";%$<"- $)'?!H#
MP1-Z=^F1>Y$3I&W-*Q503L,=YQDAF" >01C,@HP0;1OVO8D.E,1YXF ?$GBW
M@:Z")?5F%B )QDD\:>+?Q'/<L;$( S%-&P1;%4D05)36Z)N]ECT/Y#=H5GF&
M\6KW/,)>F)1IU" @E&64E:F0V#WQ/X1R+""OG'AI1A^)*3XWN?&PB!PHYW\\
M#<+*GW$IPD/W3H)DDL^P2GPB4JM+*GV;>0H!PWEIFL]8TC6P@^J*E3XBK(F[
M&('A%)HKK  :SYDHX[S2.MTN_8QU^$&45_R>A[[ZT5'PKD!7LXIW\\:4?Z4-
M\<N_ H4N_82GJOPC,-!HZ;<X30/07LKCFL>T]5ZX]$ B,.:V_#/M:/GG],:>
MM/KU#G^TL6Y3(.702Y <L94J[I2#YR[P<1#3Q8H=XS-!B!SCE(0SG[54;:,?
M"^X>,!->Q&%"SSRO6@N4/G"$+,+^83U;H?&J<XJ'7WSS9G-86?MP>IB<]?:)
M(#=6,,>GKUC>0 TKE#6#Z-X$K[=& M=I[P50U^91NQ=$!V]LF-'"I6HI-^H/
M1M\-3XI,UQL'(3K8@>$12J4 \8$\F9"E@7#&LDH6KX[!V"?UN]AA% V-1[<S
M]I2S[91CBV60][@MR-.<N4@H<<6P.12EG.MP*]P,(:DS0U? A-2_1;JGK#UE
M4<^$"9)&@+!UJ"^3HI@XH((E>8 )B82//Y$)C1H7+X#%Q>=C&;!ON%_%PA7
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MW\/ ,3?_0/L'MFK"36!+SGI0;&7\'-\(AA9Y6&7LVA>W(HSG'!*7?08"VPG
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M,!_6'CD4+C@E!4RDCV.YCOY>V?B\G>4W@) -672<WI!D=#^*Q5=4\O!]\%N
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M)AR)5:+PE?AF-_#R$>=!Z^7(Z5#44G(J=XABAHWE;%J^4Q9K@7V]=F7J$'E
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M@ Z?@U#AJ'%-/9ZF(L>VX66*BA+2=*"D8K#)B2/;BT[<C2(S-99-:$LE%U)
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M(=FX&!W=FAAD< :3Y.:9)SM^%3B)L^<D/R/=8%8OQB@PJ<BC,(=*7R>RT,%
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M[B/W=S@H,>$SE#JLE794OX74BQ1./^F?D=T("]F_Z91E \(1?*)1JVV,"%9
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MJBT-[(CNK&#S=%HZ!O%6G4N*;$TGGX'V$R[2@(@UVV!3C+/22NQBDP7?H@R
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M%G8-M]A!6?FB,VS8+-OF-M""8<4:N<PU_)22R*>?<6QA6'G\E];**:R5W8-
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M&"E3*!$GH-!O*@DJ#M-T\JKYM= #,^1%Y3N2!H(M7Z[[==5ZP[4F808%707
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MRM._R\L&.$WQ@NR2)6Y#NJ+R=,W?ZI3*)/C%+@M\P>P:D;ZO)/;#W%^XN6A
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M$\B?X28I2X3B"\A/*]T:O,YY6UP52X[6?)3I;\<'?U0V02 9_PI7J&R?!3J
MM7>L?FF\[2.=!L\A$-: JP+U&"M7O(@<IYK$#<-%L4Y$],')NJFZ\U00RR.
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MZC8XQ,$:+@P,E5#:],<P+Z!N%QA;\I%(RV1&++"X0L:RJLX W1?@O L!W(I
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MX+*A]_KL:9X]?_K\<WH>,*X,)L0W]4R HF\J;ZC^2_\/#*MLL^_AF#LOX&&
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M"W/SJKD5P8IZ-!.)&:-B[L\DHM$M.CGR&"8-_'$:=$72 9;T-)YT=GNQ4_5
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ML^-B+F3+/O)#MN>SMKE:GRM&5_-<+7+O]8#900_H;O: F/$4PGO![]1G+4O
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MQ-H.UC-.O1/:,Q&-UB@GZ,RO-151E_B2:;B>F%WZZP]W/@9&9VQ]Q,VOZCP
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MW FZ#$G[RHAQAU["FRB8I/P*OP/G PC/S#QG/QQF,@!KAI:5PM]E%1GVF-0
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M4DXF*#PI(6WR. =25!41JFRIHX+:,>QP["(^?\@BTOZ.E=2J>=/6;Z(:OB#
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MS!I$I@8Q>6?'5-8]JK*_)=)+,04HUBSAN%DN+YJV;L_![8MEI!_R3P#8;EX
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M!8J(GS_J&A4@"R^M:#U) ^,$E.Q3J;=B)B<B1?&.IV?4#!*Q^$C"(I  6A*
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M@^V 0* *:]_1V1MAO4^>)]W$*V1N4(UC4Y@\"G..4R2M.$#N#':&CIZ".ER
M)9 9#(A'1^H1K=?\]K<?,: W9H^+E3A+((17NB=>A_FL8\RUSO/NFW8NO52G
MO!Y&W]K31$IRK=1Y KT$)]R_>ISP,5Q_(B3>V_C0FEIG+\P-I?5W'#^$H<;L
M7(::\]Y<1"IDVQL\#M5P,A!;K/FP[OU 88M/UL47B .)P*\3)3GU0"+C9DX5
M+CU57 4A>XE&5BUXUVJ=X[H/@J @*TWR,!TM 2 GP<@'CZU=J7DW+'@5S'#$
M.U<E'#3*K &[(]QB4$J^F8$D)"R/'FL?*3F;?JQ'6I ">ZH07N/'ZK+M1'&R
M*U'2G8C9H,HJ@8;C&<I#[@V/OITP*<F:HJY>2*$.[27A656,<RH,.;B5I9%.
MN7*S <K,[!<+4.NV#%.YG5(;E-#1+3.LB_I\D_N(0P:"./ \R]1WJF21VIN"
M%^FR(54%I(L0VHRO%[L$WF*YA$I/C8-N1=,-O!D2$PQKV_\J.==.#P8?M.-J
M--[',88+,4:8IS0"DJL.7-.E58U7A&>E9\\IX#1QTCA4B2*G["5#QL%-Y@X6
M9V$D=!D>G4P(4JO0NZSRP_*P8HXUO/&*IBLEH(+7E&"4.AY$_=1?QG^VYZ 2
MB4\J\6-%H'5Y@V,I=%9"E4+#^1O!0YD?Z)L'BX</GCP4^J')S8D*/[ECWI'V
MDK90*7L8''RZ]B".2HS&GIO(!TY8[-1"C)[[RP?%PP<O]+'=Q%I&$?%4)-'?
M#LD@\W0YV#6,&SWFMWA3@K,!:;S-[?@8N+A3M]QC#@OV-+" 0+9_O:,U$&>>
MK9T[#M^-94<X?S06'7&=(.2Q*)I UPKY1B(G+CJ_SQ67%[0O'*>A3"6KG6#B
M!1-"W,VCFW,</>GK%L@8+5)O?F?;UH6I:M XL?'_5_7]7_$OBI -=C%!AO8K
MEEYP=/]@RYSX%(/;?IN ]<JWX,A_ESFA#@(/GMX##P1X\.SQ/?#@5%K?+K##
M1'!M!B4=V(:Q5;0'%LU16]4LB_E$1&(V'O#A!068_65+U?[P!*NV)!>)-\[B
M^[KIW \?O,W!GX[ZWK@/:7J'1 ,5R 8Z#^*NQ0QMR/8'#/F2^W?8N0SA-##
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MWK,KN)_V6Y]V!#UIH@3Q3-X%(BB*LG[2D^%M8[N$".$^'/@8[: K.64.*7[
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M@10=7-D^[]KMI12S(5EA)SGJQ76,/@$7Q00P3T,];Y^DB!&JD3RO37-S=;!
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M-YSK,#_-]Q5B-&EY\K;>-BM,HO$G O#O?C%\:HM!-TQN1UN#R#'E= H?W.V
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MU*F*O5"O@##*HU55;T,7LU)?4]6HP&YG/@^^ QLZ='KNF!:5]7AEH>/]B0E
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MI'F.NC'IEO WD*^%2;\.+6]#T(/:-$7M.)BC_$X:]9E)[N:GS(;^!P02D!E
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M/"0XW?@R%-.Q,9$(!F%8 H 26E)!'R$L6]VR#[7-!+U0+B2[!QQ<-F6!9@)
ME(>\D+$H#?]^\N2YVMJ%GP^*.> G^X1:(<8UD-DU$'@71F5M4Z(8NNH<HPCX
M"@>3>\Y[U]FCA*OPE@YX-[I?W30:ZL4]&DK14%_?HZ'^TR'J+R-H_2F<I"[F
M.F5P*.FC%,AN#A(=X*8T[SKJVR(7J5R3#(-84'D,4T$M@CAB'7/A#SJ8)%L*
MPRT0N5V8NN!=#Y3?515 TAW. -NUU\Z@D[<-N(TERJ?IC D#+W\EBM'P=,A4
M"+Q'J<S+@EI!N/=W3*CK)+$ @C/EHYW?[WC;YO(Q]\S*1F6:^N#''P1P^U>I
M-I-NNNV*U*9;#+PP+F[\D/=^D&F0 JV?%HD";'O#]!"6X,S4DI/-CPIST7!B
MX5KPTZ3*J(@>LD5OZFT-S=O%;B/MO_!0FPH$RFGT#[!F&::1NVBZO[=^6Z>>
MXJ3)ZN0A=C<TQ-E'-L1"ILZ]DS_Z%_6^_E7O3]3^]((]G? 6BLH(>4D+>!#6
M%I+C1(DKI W3!BPA6'A7RG;*?X)7(63()=)D-H0NNV+TYDYR6\F)U?J8Q,/(
MJ4,P"*(OM<&:17A[)/?W+PAP_RWYDR5&Z]H0UK2#6U> CH -Q-_,.Q10^J,
M&+]T4?0$R5B5:SQ8,Z$^8DK0SO#T.\CO"VA\6A#-<H6M-]QDQ[U"/D2A](+_
M&S8_O6[:J[I<G9>YZU_#&8&Z]>!$5%+"DMVWN?:B#%PQ9.9T#^1WE/9<;/.
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M/6^U*^  S/_YXWN8O\+\O_GX8?XWS8*#F)\68?#"GE:LH!-H0!+DU:JCOD&
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M.S* +)89:\HH2/^"P,#8 JH[FA49F0!S V_B&Y4+'_FRZ736+2$P/9T32!C
M4?.+V91DXU5-5^8(;#-(-0L;:RR7 +(U3]VN7#!:W(WDE"%7G'93@7BS^3O
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MJ0>_#N":_09^I&/LG7 <@E^>QU'N(PDD'E/&#D3P'((- @UQ='QBD2$\]J0
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M)FK>!C*BU/G?M, E8'>+4-=]FASN1R#'[)9;-'Z3BE0]V6AN.QP0)6_U8[8
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MTTD,OY"I=MF#K/EO9 W5T2MC\5\DT,9HC1:TGV8MY&]2;>2K7+*BD,D# Z-
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M;#S:0G(G%! 5X8=8&%X8+C$;VU8A'LQ+3/&8?[SR#3^I648HZ*#AQQ*\D?H
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M!F]/$2"'@*XP/V650YCE@:QW50KT@AIX@%$'YSHG\,#475<,;1AC/IS;4+G
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MX7/AH.Q$ORZIJ29^X@(G^)W.:!4,P"ZZD0[DL@7?VRBSD@/R4J1DA&A[<+E
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MY@0WC%$.1G+,?[63Z%_FW.>BZ=Q=(\-_S,-_MC,Z_ TTN/HT#>ZNN;WG, X
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M#Q).2C(P8X-MA@N]*,W7TA9!NQ6FT7/"UTWJNIQFG"NO?#HF.($K?RK<TPN
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M9>^QD'X/VE%Z5.VK4HFF,?:B6[PF3 =/CG7'> B/;O?'_LB-]'J!!<NJZ.S
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M6BN[,"JI!)Z\REK17N&M'$^ Z'(.AW1NA?^:TK=JDIJ;KT-%80"^(OUET_"
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MAP(DH0R0Q!P@B9, R40&2"(5(#&-ORP6+=?PP3""YQW_:^9/'ZF^\_@7-C;
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M+SGYHE UU9HU]JOT 'DQTY$/%+[&*K*E1)BODOQ^YGM+Q)J]8;%F=9QFK>4
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M4;'"0%@J8$8U:F51,;[KZ7*VN;U]..RY\9UQ,@H?8F,8A6/C?$*Q$5 >772
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MD7)C9+N7S"@W*2B*+@%TOWBW?A"@?D#;E([C-5LF)3AXK:;3J#<V- 5A\Z9
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M8-H#U9=,6(C:<]#CTLE@^X0!!=AX00]%2^RB6X!C(/FK(ZV^,Q/<07\R)$5
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MN2L#1%A9\^[G=X58I,V:PUQ^-5>_^GF5M!,OHBS#=,D4F8OHHQ-!4KE-CFM
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MX0\?JT;QUON!Y(A6Z$$.U^F7[:N1@9[/C">+7QIO^%BT!(8_[CEW85<)3TE
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M_M[11Q3][ZTO3C2YL]H#JD_KF\LI&+:S<M0/#^_+QE@MF]1;!BM?\RY^9YV
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M..AG/8=U_():/2PE@>?Q'&[B-QSTZ_@-BQQZ<-YTW/#?N\5L>O3_4$L#!!0
M   ( /2#>UP7^.[VBD(  "+I 0 5    96$P,C@P,C<X,#%E>#$Y+3$N:'1M
M[7U[<]LXMN?_JM)WX,V]TR7=DA4[C^[I))-;CNU,NR:Q/;;3V=ZMK2U*A"Q,
M*%+-AQW-I]_S @A2U,.)9"NV4M7IV*( $#@X[_,[;WZ[_/CA;;/QYK>C_4/X
MOX=_WEP>7WXX>OOF*?\?/GTJ'[]Y=WKXAW=Q^<>'H[\]&<11]LK;VQUGWJ4>
MJ=0[43?>>3SRHP[_HN-=J$0/GL 7X:MGM_W>:V_D)U<Z>N7AH[NOO4Q]S7;\
M4%_!KQ)]-<R>O'WS[NW1UZ'NZ<S;^[6[]^;I.UCVV7=.N)/%8YK4_J(79UD\
MDM^YR^BK*%/)D[<_1;UT_/I>IH8MN-S_<'KB'>R?'<._O(/3\[/NO>W$F_>G
M)Y=F/GH@2_PH'<0)?"L?CU72]U-%RS:;ABO%;VW\@H^C5 <J:38N$S_0T95W
M=OKA^."/E;Y!+;7_*T\S/9C(+W44*!QTM_M21ZNCO=J90S7(ZJ>]],,X\@[\
ML<[\T#N(DW'7:V5#Y?T4!G_F\>LWG]X>Q*.Q'TW>//WT]J>$?MEN-H9^ZOE!
M/,Y4X.'C@S@,XQO<S7$<ZO[$\Z/ &R=Q7P5Y JN&@_!2U<\3G6GX,9.M[TWH
MVS(%?<GY^:<DQ>E2+]")ZF=Q B^K1N,PGB@8 QYN-F)X//'@I?2U#G(_3+U6
MG"?.ZN6T/7O8M#SW9;K>*7RC_CE/IS!XIF#38&4QO)&ZANVC18YTFJ?*BP>P
M\T"#V@^;C2B.QGD/O@G?0MKS,QW#06D9W+RVCIS-Z-C73F'P1'G].$K5G[F*
M^OB6:1KWM8_[?*.SH7>MXY!&37'FZL"A?Y-VFXWC#!<^P9V(8357] 5</RQ?
MJYN.E\,+)6D&$_/L?=CP<,(S9$/X[HSMP&?]\1C^[?="Q=/1]KV+_23 %1V:
MH_* 1)H->#B)KXE(9H[*2[A1\(UKA</'N.7UE' PU&K@O=>1'\&NA-[I8*#[
M,"*0HWD\U/"9LI^T\*6:#?A4)UZ@4K@0"C=]FLC+7W1)!+?.#T8ZTFF&NPU?
M=<@</NS!NJ]]'=*NX,-1>@,/T@G 2:9T8-V[Y2MXO2O\^1ZF/]L_O_2.@4A^
M/SK__?CH\[TMY,VQW8KCM_>YBOTNK^/S,&XV/L+33+63_[F?A=VO^)G-%8AW
MA"0LX#Z%(3(7O$XE >"-U*@'G,Q\.,V&D/GVPYP&!D821\J,$*#T ;'D]S/Z
M$ :T@@:'0($4#XAS3+&A-._!FK6?,/].@7O!"G$(_-*43+H9QJ-9_&GD3X0M
M 9/'(60[0)(%:J C7*<"V0I"MZ?Z/HH<&&DBS+(/,H)VR,@@KU8$>7XOSC.7
MH]XQ,[I7*CN&]P\"S;+8(:5"K6@VU%<0R)F^1H%.!P/[#X=ACV "*^C35N[]
MC-_'K;PH%)JCK_VA'UTI;[^?X<=[OSY_083ACUAYJ"A5[O.NI(%31K)F$K)D
M$3A4/T*.49;7JK@ZA<;%9 ]?!67CS$\R[_B8USU;NE?6*)\V&\6H[E)?H\B^
MT;"=B1J@5(QQ*4">+N7#Y#2C$9?IM&I&@W9E5.^R_FU0BX"'FXTD#T6=O!FJ
MJ+@L?3\B+0BGI\-UM$W<4?5U'/JT&L5Z:<JC (T%/M# !'6[G7ZH_(2N)VP5
M/#:.4U1$<%Q0=/Z(<W[AGD)5#^A<X_X.4,Y[OFANN!QEE0*[0N0!J)0EH-EI
M>6#Q*3Z\6SIWYOGB )55/#)SYIU9I ^$%Y.:.A&B=,T3^"(JSZV"#O?APH>L
M8I_QIRZ9OUK91M#?>SI:9D-VZL_B<O_=AR/OX.C#A[/]P\/CD[__[<GN$_KY
MXFS_P/PLR[S103;$=>[^Y;6W4AL<5)G+<S,-V"P9V .A>2'X(CJ+WEP>5A8B
MK_3FZ>7AV[I/G_''KB7/JXY0C(5+.:E^^L]??_[EU]?6D"]/51473]Y.RM;B
M>W^D@6H^LE;AD(&EE_(3YE.\_"V_S0I_.H[), 0&'H]0]^\W&V/@P)%*.EY_
MJ,,@4;!P,"7&Q4]7P':"XD=X'N@@Y:?L#_10\9$&,1]=,7^# T)KC-@,W '-
MC)"L2A!!WA"7-(Q#,)E]L@P[7JLGZS6SXHJ=%[#*COT<QPYB.(YL[A0>S^#U
M0./ C1D8:RU$36>LB,3!=(]D'?VVZ%IBL9+L&_ ^&_VN=FIZO)@6YX/G4$%"
MWX_?9S,9E\"2GN4X38I;U@IHXFDG@@<6:R)#@885YV#QXPN1R@4\/DOBT%A^
M_)1]1= ,P7Y-^'FCD\%[T+<TK%!UO=;'FM^3H(7QID>ZB?,P,.*<.:#ZZH/D
M4$@F$U9LG=7;<T,RH4W!74,V PKN>(@:< ^$6+?=?LWWX^GE.?Z%K&7+Z!XJ
MHT.U-TO@"& (N5O"D]*A'C,/X7N03<:*#"HX']:?T(R NS,P_*&G(E"+,^07
M^#OD /(KN$M@.,FMM3=:YJ,I^&;I_K"X4?A]'TA29R2OP6P)R?E%')0N+OSN
M&ACI" DZ4'V=TL6&NP-Z>H07H%#V-IBF_V-GQWNO51B\ H7\2KV&>=C+!\OQ
M=G8D<//F\/AWLU:70O>>U9#HS_B[7IR .F1_]R[T^U^\O>Y+6' *NE, I'96
M1QCL.U_V'L!;O'D*:ZM99B]1_I>=G@)B@'<9T[NY@_Y<,RB^CKLP9[-K)G.V
M[BGN'6_79ASKEE6MC%7)OC.W,IHZBGZVSI588EX<&48T]$/8'N LFWOMM_2Q
M!E'F"(1!'@5H"XIP2U0&,H,^ 8L_2CLE.0<*>)R 6B4AE#E2#T39VF65!R:'
M>#8"-#8Z^(MA?(-Q(/XY&_H9NR!K[%Q1B*VEBUITFL-RZ1TF]&7X]Q4PS-2H
MZL[JX&4=)XE\#K($-- $-=,\X?"6SE)0(U,=J11VI:6Z5]T.JYRE,\ M<+:Z
MC8X1'%$6@Q%#>-P'FR4=HML$1HUOHJD0ENC7:36"".OK6^]ILT%.$R<4Y;P)
MV4%D$V5>"QV\D><7)CXOITWK2=08AE8<;8I+H4C:.UQC]:LPPRNR]7ACFXUO
MWUB.2<$*QNA:!.HRNXRD@>89D5QIT^9L%AB9,W:+/4R5'7(=XW1,9AKS"AB$
M2R(_+/F1>WZ2:#3(8+M4E,)<O%.X90O"H.X=<'<:IBHN&7K#>PJ63@;>.,:]
MP!N$KC.D]73H)R842JX\$1*P!)?R1_X7,JAJ[R)]678=W\,]JS3-V4IT5OB:
MK44T4^%U_1L_41*N+9,<;#\GL>!;\<+P3O"2@&)!CB'1+?#4S]BE01*/O'&>
M]&$(_(SBZ6%89BC&,6VW-N'OP7Z.\@AN"IN9M%/NG,([F!/*RBE$[/5UTL]'
M&"GN,U7Q4>F,?9D^/ E4,T$[ "Z2XOCGT)R&# 6/AOJ+8B8E[P 71U[!67]W
M35)\4YR?LT,4?X@'&<D2G<BXCV3IXQVC0ZM>Y[D!]?+5KA$=R#A\BFS D2L-
M+P$T+Z$14JVFG:(/SQ<])R[I.I"$@5=B@'"-BGM7S6.!D[P"BS@A'T^:]_XE
MK(;3(>#NE[]@738U:10V/<,Y^UJYUVQ0.L;C#JZ_L\%UU)O@AIP)4S9<?>:E
M>8SA=^(Z0%\S;GRS@80\+G:0A GI/9+%5-5'<#!ZJ#;3"7^R^4L+@I%=XY6W
MZ7HRI'&YPS=;>VT[4:N73\IRL5T5TN2:ZLL5O1DJ]C,;IY9Q]#I.+?LK3 8@
MX=A!,:Y#Z_AV%!0G#VR&9&^!@.2 LF9=BL+Z-C3O9W9Q,'_K61L,BK0?QB3N
MIX=&Y:8:WR]>#W@-+9C-9]2J.#@:\[I[H$2(MH!J;C%0UQZ'53%!?0:)D8<9
M*96)'FE4"H$J4HJ8QQ%LRK]\'7H9$"1&):XB/0#NA&8!:K.LR/-VJ!$JD'Z:
MLM7 >U]-^WN<>5)RRXB4(GL9=-1L&*E2I!L\,C;U&2/])L9>,@O(WWS;U)>.
MO?PPD.:<C\2+%*9)7@,%FYFJC,^RFEF\@U8SFWFT9V@2I5Q0T:\YVE,8C63W
MP,?QF'421Y&>>@A#Y1/'K5&Q1^G*N]H*<@<R?(!#H=;NHRF#*1UH::59W/^"
M7I.(?$:H<@2J!Z>3TWIN\#I'F<FQX*26'>(UF)W+JVUSO WG LZBKVF?IY8D
MCA V1F&^>(0,X\\<G@_%)(UOQ+E@\K/F[R9E=R&-4" -#* ,SEZ\-#$'_/#?
M'<[LC3&D00>-(TMZCIP8+"%7%>NJ]OA@"]28.9OX*D?(=N&LTMQ'"L&IT"WE
MV<Q81Q6LI(;!Y$A%25#1^B69QHH,DT-RGL/I[.WV7N[LB?F& [NI1IN@P\\)
M@SQ[[9TRR;S"94C&U6OO=]Q^^/BNHB2W=&'6E20LZY-U=L/LPVOO$F[M*V\_
M\7NZ_]H[\4>*]^HDQAUX5@J'F&_A)P\T2+/Y$@JSUHQX&!>2/"7Y/2_E+HC1
MY0OR =V]UI/[BE1;4+S45Y7T-7L+\4?) F2N+,* $^'&_L0X[HB!FB^.$V E
MP-Z;C9$DQ_7]=&@T3'P460?F3]348Z#@()E"_Z(Y\S',B$XU4K8'J!IF,$5F
M1 6.3,^D*LM"9=94/ 9V,P\4H7<5W6\@#M+!Q#5J,_]K:5F2-(>#I>A61O<K
MB2KW(3>Y3M[#&1*9+LF#&[2P_:M$T7#DA4)7*VU:*"F>65QL(,TSM2 L7 /A
M)^Q=IC-G7.-\?2SI?6NX(G _@KBX'AU/ B0=X[*7*AS0\JBB!;]J"-C5,6*\
M(Q2A(#I@7Y=[5]"!KCGUTR_=L Y'5D -*>X!*DDT%#[<2^(O(%O KL$"D8"N
M6(@9II7[6PP7. Y7V,XO*N/Q@3MSN <T!DP^Q2^R)RDSWCRZOY%2IB3)G]3=
M>'?"-9/9G9I/M<:2'H]A=QZ9571&^O+RSH%2="LV1HGQT5?<!'!!@FLB7/8B
MX%5;RH& ;/A+A(&]4JYW9H[(9E1RHCO6UX4AF%XAIU?7V5WC.2\ZW]*C]X1!
MM,+<X42%8N&17<"U("'>>WIY8NF]?&)<2,@$F'W0KR0MT:;GZ0@D6L[R;<&>
M% 8GVIDQ)P=R62$Y:J@&)4=?<;,18/HFG/V_%6;KL5'"04S#+B35JLV;P^*)
M=[?K[4N9 XXUVY!-,,"&=0G$4F(W7F5C-\ ,^3<<YJ2L>HQ5#A+,HI]R!-)F
M%TYSC(;&X74EB%5K,9FMO4%JNT+#T#H3@0(QU%L?$:L=S,G%+X</O\%-\."Y
M9N&BO2@Y24_Q.(S;Z?%YFRX+$]O2F*NP ..Z\O'VUWJ_Y2I6:Q!JW>&HM-"5
M[INMKD;NJK3>A_V*1U3[@.G!(8;B.S:[W,UG(2,45 &X *R!LF/I1M'EN(F3
M+^3*,@X?LB$B=15GFC4-3)KH@S:=:E/"7*0W&&;H7GA.5.E3KG)/%9=-=#3W
M/2?MKH<N/5;B HIOLF9C,R,X#5TER "$1;+M0PLH6RG,YR1I@*+SRWL%C1#L
MFZ%*Q8+H]1IH) Y=28-@#E^*@!<1;G\PH'#?4*'11;J=U<E<-W^=QZI52N_&
M $">IJ;:&]Y!110.(-$0Y.S'HG.23831RUO=@5/5?*%QFR+CLIR.]CCB7QAZ
M-;&@6'JGCE/71#(Z>!\X-XI"&4KHI"0<QZ W8T8!&UZL<'0X<\*(GD+Z^=9"
MR_PO"F?VHPR?J@MF/"*N=2R7!F\VD.55'OH)D"/+80P.#X$WA!(A,W3%&43U
M)([,*5*F5-)P&(?OX$ ./T+J2H=T_[$,#N-%UO(M?)O-AG%NLB?*Y8SB<5AP
M11YE=.@P3^RI.&X$*Y,>G8A6:;TW@;1%$&"Y(I&&(H:#TC%A1(0Q5WHCL:*5
M0NSS]LIBUSM77./0,89$VD^PB$?_&U>$-Y$"UD42B=2->D%,*5LH)0R4Q,#'
M&(2]++:Z8N -X;U3M$M LT^)Z>-P?5@6K"/#V>46S5'%.\SXS=6$MQWD4GG$
MV@LBFAAOF5/]JD=8_TK>K&DM9PA;IW _^NSA\_-L&#O5MF(ULDV%D",L#<L6
M@O-Z&T"[<\(2S[<1B'($XODV K%Y+'$Y)(W)_)0?Y$PNDZ2,UPH$D6LC>ZQW
MP,),=KQ-6!6G!:O('8I<-AL+$Q;)AB_\]C-KO*<3&(G#6NZ?.=;7C'=N-LQ+
MY_"ED&8*D>\#^^,(#'%GG8"I9YA?X$^<8G)VU))T2!1L 1LOP$0CJLLUJ0 #
M4+?@&O^9@Q+%X8$BX9DVK@0RXL9FIB=GL>&F6\\P<-@))V^/><=B(<FC&/_&
ME&HZ;7)"\VB/4KTZ+X)8EM1@R#AX;(K5>\IS@7'(P*)\+@IF11%'QDS=!6H9
M49Q'?1O@L]0XWR%K<#O<++$ -) P'G-TC[A&,327;\-3NJ_'>&D[Z,( 2Q5L
MR!$%2'QXD1%6]!"$1\G#Y=@6%400KEDHN"+6 C":QU42YV,N!+*0*W%"VY"P
MIBC)\(PD,S:9DGVL%G*23,>2Q7@<26$"XL:QE61408L@ M]1.R-,H0,N]=2Z
M5T;*CVQ*/[TMOYG F7!!>^!8!D;'JFK%7>\P+_P#8Z+L#MY]<?$Z:V=_$"VM
MK\H>@<H6MIRT9N*<>D0>9LZ 85T\590*DPTK.##M1YZE?%#-4OXXS<N/BWOT
M&%.3Y^HSAK991ZDF'/OS'&SS(@3UK,NFU(K/#U33H8UL';\UC _/J!3:*AZQ
MAXK/6*0CT9P8Q\NB!-I045\EJ."4%F4U,JI!PA4[Y43 -UC, WN5I#.<4^P_
MGZQ$]+""7BSH0S.]-"8#;5W7M.[8-T,3D$,S]]&>57$(C^P>'D_=B5R$M 5.
M,1=$VX#OJ+)]&HM(/0X.."[SGBKD6,EO7E]#RWD9F(^$:3@<31W'&?LN3:T?
MRFK4;5EJBMLY3VSR9KG4;OZ"'"4%X2M"X[#)8@3+'>FO5:;!J2Q*,CK&8."K
MZJ:5W?-=[[-"Y</_XHWB-".'[5R(-AXM4+ 4A".%#PR_F&)>S4:>EA@$,B7+
MBCJ$#&/!>_S(#R<8OG:4HJF !R/1C!/%R<EUO+<FNL6E:Q3>V@0_SQV"#J8:
MPS@>GA4,5I3'5M(E2+A(GO;4GM_BTE1C366%K>N]0\%E4]ZI8M@DO9?FY1K<
MPB+T/G/)2V:*<%%J:D&ZY=C!@(L'9U ,NCTQW2ZH\H>.%9A9":0-%,D1:_ZV
M+']J:'%H]DJH>X5[$Y9F;HFR=R1#X$P<UBQ@"^[V,($B;-H#:(K_4GV+ESW(
ML6ZA\-  3PY)!2SR4(H/KW)-F?<;#"FT)9G5DXRXZ;"HW29[<0&<\1L !;%W
M#44HZ>_(%4GQ9N&*0'<2\ XVF'KFA#Q>;$,>Y9#'B\<6\MARITWB3HQ\9*T=
MJJ< '49\IO5U:0Z4I'VV(X5M5(OMYX$FC $T3?C?XI3L^^SMK:T5+((&"68\
MD4?2?-].3C\CP$Z<9!O, K<DN@:=2S*+T3PW$-H&=0M4;Y5<4<*0DUZ(\%V*
M"A9C,&?PPW]A#Q#O6NI,)6?)>,!3PN5W0P@^Z'#9)F,_;NEL]73F<+)419K!
MW$$$VB35VH806R)Y5$12XA)49>%15!X4,V YP)E"8"G2( D^N,)06(04Y!N0
M0?F4F-#(_Q>R(C=@J2.IE^"4K"U]/2[ZZD\0G]S4"24Z_6+PV/OD&IM*Z4?#
M$(F,JVL=ZKS.0ZSS(W!) 2] \Z$_W&A0XRU-K5C'GYD9D:@K/S&A?<S]1V6^
MKA[$(Z.;H$ZC##-&B9;$&J#DTSSIJP+*D]%*K#)FG&(&+XG'V(+%/PH:K%.N
MJ+$ UBJ.)5DO4/W0-Q"ZMB(Z!?++V)%:B@*!0F]\K:4:2OC=EJ8>%4T5[HM
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M;_DMMGIZ?Y?8@UONU7?LSZJ-_>_:F3ILKNEML3B9?5S78,)]!(Y?>:V]MK'
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MNW[6YHVYW2$_?7=Z^ <Y%W^[_/CA[?\'4$L#!!0    ( /2#>UQ+ K X)@<
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M>'^(WM.C]_/<"WOT7M\_4$L#!!0    ( /2#>USZ<2FC#P<  #XG   5
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MJ]G/I_(?;R-X@2]O]/KB_P=02P,$%     @ ](-[7,ZC=,4@!   S1   !4
M  !E83 R.# R-S@P,65X,S(M,BYH=&WM6&UOXD80_AZ)_S"RU"B1#!BXI+W
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M16[E!3SBUA'CQ%/EPB0&NG.-2> $8ZK%"]>['X$Z,BO9_XWECZUNC<8B1U8
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M>ND\-G3?P?8W@G&=!..VU=%++Z\W>#"+R*:ES*?O'N\?!0%#IUUL-1BK3\8
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M&2*CL%316-'T9A6]U-QN-WJ!XUAI]AZ6#%(H=\_;8TZ$[<%"@"=?%@FUK0+
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MB4JA IHWQK!SZ GG.W9%Y&1\E90YO1,KZ0;A#V;4'_JAOI'ZA_.:&6R9>5E
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MA15JKLQ(L/5-<?#2BS\+:]?YP$LOU W9Q?DXG$SW;HXI(O .6R,@G)(T8@?
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M!GR^QH ]Y8^XZ,IUZJO%SCV9/14EU1Z:JJ2(4RZ9 >4EG(;><@0Z80].T5B
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MGS8^0<ELGX+D "*.@6=-.2?LIO3(W-(YJ>ZSD[?0-#5JRG=E/T'+[]?XY8<
MA9QS^D?.,/W'+[<Q/= .MUM$UK3#/A+\FFY@4?GQH<1N8^FAF+W>$T)[ZQ'M
M,$DI&]!_^W+G-A<?C-U\;VV:R&TK#<8Z[3?B1U,JT;S]#9DG1*7<4 Q.@H#V
M3<)6T(S,"7X)^=5"SZ>I^,#LSC$=RN@_P]TU#AJ9+14>F-5K^N>,+/!K^1BN
M+3DPD^(_5!I''YK8+)9UQ^CE$8Q>#L'H#5[NX1!:4(H:WHJ?!V2'^'$2@G*
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M&R9^V\HN@'U!X7I#]\()O>G[:_2PA^?FV4KLD&U?@(^F,B*H%>[JCL C:9P
M,XWB)>/]\@.WH?L=_/(+7,RIH#];K1"(^M<X2<N+IJ9<?WS<($J8H.!S3"7'
M5Q+"=+Y#B,[N)5=DZ9AJ4:D_#N68W.$]-,>&AM^2=*S5E;;+DWE5M:MBE[OD
M1WHW.(*UO'S_?(D+_/[Y'VB9+K"XL^])^;AK6\D2AZ*M!WP<CZ9J_7'Y1&\9
M"29:NR-=@?Y:GOL'?MW,#G)QZ"6+#<'[]682O(!1<G)'\/8116#S.O=)15O0
ME5B/B A>(A2P-I[\",U6V:9&;]*/*-P^[TG"!%PMAF.J.[*IN_:3#;/1"%!P
M=?B<H& :<_F7=OED26\== ,W:J6.(3!N@ U2W2F$1@0X6T2GCJB6P+@!GC:B
MM81< !8;H319!'$%]CV=3-BNBDL0"SQ9_G,?$K0@^R2=$R$JYA?N)DAM"#@!
MJ&SULK]G*\7 T(2KN9X3?6>XCL-5N/3CE-XQJ.0'*V*.HW!)U\,"O:57D1E3
MV\KNK)RYS#\GX1))+6&MM;.VO!/V]\])&(0^.7!YHM'JV5S>!?N?J?Q&+X$H
MN$'/IGVY5,8%F]59VW"6U%7H3QJ%X^I'%-'-CFU^HE'6XL&T)H^IV!^G6MOU
M%HRVJ]<?GP7%20O^ZLOWQQ<SLO29C951]U,MTU_[G^,P38Y]J3ZJ9G^\?L'D
M*PR)OPM3/[I!]. )M;<Q0T%;G-QCOVS.;2S5'P]@4S9;3:D4P8QY= Q4BKC8
M8J_V21B# 39(<]R>6 AVJ-8AK46]L< QG\K&TDZ\%^GA8."3?W+"%'?2^N(3
MNLNE,_((BOB:'JTIW^?Y&Z=UBK7B]W[/_9(RW73*5XKUR\67,-T$Q'^-X;JB
MRA)WF!3WM?F>['"B/R-.I63]7>.(UXQ^N4F6)&2;\6PU(VL_#O_%[-4F<2"W
M"J&6P'&B,UDZG4Q_**;TY _]2+9$A;?G,&9M@<,2V)>B+14&EO2.[J^U (ZE
MT"?O_($?3$=0,(L7&U20E!$!F_*MGNF65?OC]I/_%F[W6^;LS!M?X+E_N F3
M!$=[Z"^I*M<Q?$SM'GD.8V@U'[[9ZLX/R2>??$4ILU"=K33'X@*KG7GE1W[5
M\] "_1[?C/!L]<E/J2B<'F[\@W9$JF6<J!9R!4$KQ8BQN.,0#',JW1)F=\0M
MGQMPM*KI&!*_/4WVZ0:3\%]&P[?:&J. H'V9;RP]"M:;S6+L>I.?9,<$#CU1
MA)EB?,8D@]IP%#7EW>C4A>QURKIN6]D]L):KNZG26(#4KO&Z"F-YMA%BZ'S_
M'(5+J?$[XOG&4-]-,)K<+J)6K:(KZ)IA1<&97!W4+S6*@&,(.):R'OPM_5-A
MLG:$VE1T#:A@C,67-3PY9'RV@-9,P@E(NH;I>;Z:TL/\)0SV?A0=IMLMG4]$
MN; J]XKZL$^GDQO+'CE;4:'_A3(\C_RESO[IV,JN@3&K[5K?-6-IUZP7]F[S
MNVI]%?<@=IG1RDF ZJJ[.<F.!C0^$'HWVCI3"4UAQWZ3H&V^B_!KTQM^?14G
MUS=%AWL--KM1&$B%+A6D$U!T<6WO71C3C96>'1F()K0]T3Z[;KD)DV6$DSU!
M359,_3<S5!PL<#@B$.>!R880A6U5^*D$^)B*/;JX<//M1[1$X0L**L\^.D5I
M<QV';Y4\T&\V[DT+L+%6?UVM>5 Q/V+6%.[Q+5'[7!O\8\]M.&>KVS=$EF&"
MF&HY*YB(DHE0\[/#9A8K2GZZ-A_0*Y6F<X,][0ODH.T/V&]Y&)<>."]'SW/#
M0H]6::L5Q*UZ00J+S#I):XIF+MS[FVE15638.-I4L,R9\>FYKG2?;VDI?VAB
M8=-(/C#Y'-,_K[6HUK^7V(+XH/DW/OKIBO7HN:0\A'XD.$GD;6D6+S ]*OGE
M5?ZH8_!8"GUZ716U W*4S(=64XT>>6-37-"O84A7K$_[T'"]1L1XOA6_.S&(
M\Y.0'A,EP^@&&^!C*[LREZ,'%?P'5L"+'X&\WPY7R[INWCOC)8LOS2*[ALG7
M:X*",(6_C,^=-35<0+A!;!>@1W;+X:BK,(8P-^U0--;JTRP\MX&;-<A/YK+N
MW'XR__!/?AQ *X=<&+C>^/$:)=.X% FQW2#T2-^)7TY"#_G;) WA#<+TM%8N
MY,0S)TE0FBB^+,90%*UJN+(L";FK(IP%F!UP* :GH?;*J6.)N-F/G]-I3*\F
M/"BO^<U65]#5T:Z<RY/TFLIO!]JQ=2%5FRJY G)W,[VFG0J.=),MB%$U_&O*
MNO$.)&B)US'8LRS\MRL4HU5H] @VEAX1ZSST$_UACF(_8K[D<2#-;D7PGN/@
MM:-H6P]0YR/75*-G;=AD1NC]&1Q<BT?PG-Y8P^=(4=_4.&Z<1F@$$:#O&^)G
MFHL[BMV0AW:;O/AA!"JB!58L)T60TKJH7$=3L2, PSD+>R7?,:EP"ZZ/39*P
MH9(3D7BY0<$>+&^TD3[IMB("NC$]7J, ?"JU<<0K?L!I4UR_IDICN#$V0# 7
M'^$$O#HH^1UKXS0?3\>UM4MF"46X[5NK>,['$!B+,7"SU7QC+?NOYI-]$%(:
MIK-47V0PML#:T\P1_SH8,W<AV4[+(JOF^W"#!J3T-@V5$H,Q-=N%,3B7&<[,
MVI).Y#+Q%L53YL 6^836==&8ZBJX"HN#_KF'6.LO+8R?S,5'<S"87C3;5K)[
MRZH+0M:VT@AN3T5K\Y)BEHJLS,RWO4E/;]1'T#52B\4O*I,T)>'S/N47K;E?
MHV\]@<X(X)HS(>6F+>T MZ/DVDZM26]@*#N"D6KA9%9;PXW["#L<L^3(2D)%
MNH^OPI1I,AK.K.-HC.$4;M09F,N/1RO0_DWFB/ICF(37.-CF,^<3\H'''_$K
MA$%50HFTG(ZMJ8U@"VFET&JH,P(8^<PZ3B[1U>LQ_'BFC3E2JVXT+NQ*T=E>
M8@J#]XAHMX?+5.@\)J\^"3IENVL@.([-]!&]T+\15_/LHHJN_*B:HWVX;[+Z
M/X[&B%RPFR3&YFHC M,D;#57<ZLP;^?EWDYI?A0ME['#Z8ZF/J75)\%JJN0"
M"$A&A25?-T"FPFZC3L^$U_,GE&ZPB+J.D.+ ?W6H%I;%:N=CKTV,)C1WTZ[9
M5&E,>V;[F]!1%'IT*5RO"5K3EK4&3_HB%EKG,EEMZ[*(C=9Y=I\675 JV2,O
MC"(/P*<SG3,5ZH^#C*C4ONHXT!2RP$%FEFWRU3"5[)$7)7.7V0A*5ZK'2.MJ
MMCP697%.\!9B3A*F)M%QU%S'CK\4OV:!ACYG0,3;6J6(+#;Z$$_7.(JXRV!T
M 'OCJX,HIMYH=#B':]O%<2)T03R;ZFZ?YG.\-D9.<[4Q@%G0MFK#-M55&(,6
M\$BM\U@N0#7:<"H>\H_M3=:.I-:CLJQ.J\,EPK)K(TNPH%63G4S+.AYVO/4#
MIYF4$[>4(&!QNNBV[(?TSB+B4=1N< UUW,"0+Y209\O GT^^@H,3>.T;D1U+
M9JQ@E4G8)N]:-Y)C[01A5%+[Y'H"'2=PN4=Q,O</H"B@8I9PF;@/_><P8MG^
MKNO=R8ZAX,@*<T=[72BZ9#+R>A^YACH.83"O)$W,=W,Q-QJ3E IT*)#VQW1*
M[+=[I@/1YR,ZIN*(SK/C3C*7'J(F3L5'=XPU)9(K%7+':,,V6"SCG,U6W5HI
MVY_@*PTO;_WEY@N];B/Q@X@C!4?%'2:S&&F>L"?I)"[%F[J\_,-[LZ;&8F-]
MNDJ%G$.(G1>R',FSE8&G.* ?TDU( E:$9WH!&(UQ5FRT8M=T=NYS;=][^C^7
M\T:MW-$D[!NYBXA%3X?M,RX?"9KO]AEZ@GRA87JX?5NR( L&CPE]L>'8N_SP
MO C3R@N8OHA]MNXIC6B^P3'BALH:MJI%[+,U7:Z(<(Z8I"E*>)#-N\@O.Q U
M%1XJVN87%$5_B_%K_(3\A'85N]9IN[.A_% ,_X0C>H.AN\E=&%4UTC7EAF)P
MX;]- WI0LQS2,*#&"=I0?BB&G[9^E(5M-[)9*C48<QLZX40J73-OA4)#L?:(
MUB'(8G%JV++UQ89BCS^QW$78+\N5AC+#!?A-$4BPX0NZ\5-?+ZHW%W<2CYC%
M2+X&'0HY7./ /.H-M89BGFU^U[3U-2;F]5,J-21S#9NC6F0HMF[?F-5':(P0
M5E]T9,:=QYMRNH,@XE_4!BRJ%'-B"Y>K2TT&<&H)QRS2 :Z:)3?S;:@V1C -
M"I3VU1V#JU=;C45)7^6C??_WH<7JGH,!W@B*SP;U/5]7P7VPBKK]4EO2C4M%
MEJ DRS@QQR)]?.O<)C55Q^$G<G08'@L $I(JS--_Y8S3?_QR$Q*T3 VIX'4%
MAF*,*8_4O&*:J(LUY9RQ"=G@F=$P6 EOPMT"<^E0:UIU$H7^X[OGKUZJY:3V
ME?R(>B/P*RPE<&C(L]JV\@B L;W[]FT9[4$_?=P;YVFD>K2?A?,SM_8TA-W0
ME>J/AQMQ$!8:H-=TV@F0I5$80C0R>1(9RRA@W!8;@O?KC4@R5,F3UQI**UK]
MXU'=G.X0$@8J=5R;:O1I><Z<4/>$[M7J;J>WQS<7=FP:!<8P?K)A/CD0UF-)
M_PUJ%340Y0)#)-TYP?0\0L'5 1S?I_%LAT"!1;<(4+_Q^U/#4[7U9EU%)"Y%
M2LZ=ED5:A.(/2DF3(J,;S;/K!JX>HT-/D)^@&\3_FQU"\EGSD>XR/'F1C7X[
M@0D7'5UFD!TKC89[A@X[E=@X@&=[@9!*&O:?8PB, V!1JY P&:@U.'WE40%K
MLH%L4]%1M&?=V204$.K99 !V#(%Q VQ8<Z<0<N/BO-M%3(_D1S)'KN(KTQAU
ML65MA\'1BFD-:SV[:FN,!D)#(LMRBL>.M$8#.XN]R VK0&WN1Q$L+68T62A[
M3!<<1_<,NJ,\B/UT1I6JFP?1B,)@%@0O: (<K9%\KX6[E>&S&K'@OBE.8J]-
M.!$[YK-:-S7ENPOV%"?][.4BSQ4D\K896&]9UY&P)]*XM$HO9B[N1NYY55(S
M$AS3/[D+9G),EL?CR3A1 U46M:]?Q_7.GL=2<0&UF(<+;.UJ!2!S\?X4B#*S
M$>@3S$;RNE+N.[#L^M^J&ZN5G#WOM[:J,);NTYLD5U5/U@0AWE=FMY":XF.(
M&\$S8OZ$X<$R8L&NC@B%8:KL;*8HIG!- E-->3?G,-\Y^ %;KSK2E'2_R:A;
M7Y:R/@\HTVK/::0QHBAD-6DD:VN,"$+MH=I09PQ[%V1XOJ-[:N/9? J!,0!D
M%K(!;*PL/,7QL8KJ"(P!( 0AJEE(YN*N5U'M*.@*]AC:)H_/6$SL8;;X::S2
M(W= 5UC%B<@!YGC:QK)C"$@%@>1SLRYFYT4O3-)8<48^$KS?S80(D2+FQ7G[
MEJ*8!?^^C>F)1G09H09HST7W:5/>-0EA395Z](#&,<3NAIY<E9R833+*$?7<
M& X7HT[5;DFFPGUV\ ;59;95/_<8+;&$R_#RTU#63O1&G7538]A%0Z71*/";
M\R@V5W,!IBZ @Z&,O5E:F[:ZIO!0;G/:BT'U\QA.Z2.RXK2I.4"T [3V(]Z/
M&LE76Z(OII:'@#-%_\B9HO_XY?KP#(DM>.P'N!5=81^BDTCW@63&#D&ZD$V]
M?#(55^ R.6I&GO;/2_FO1Y1 -.I0A*XY'?;)])VL*E-@:%T!9]XYIIBB==JR
M-A7=&/5NPY@%$P =UQU"27T:B9KR3AP:*.W92GE,JKG%&\J.;AJQCUREG4@+
MDY.R(!D(.=CI/OFQS_N<I6E-$@1Y2" (69) >&$>K(2EQ8P#5IC^N:!M^^:D
M>38;<F0\EUNQ3U[\,.))017W=*FC"*.].3'6"72<",((SAL43.C10X>LJ \J
M!+JG5_$&0[H3:;D?Y48K2%U9)^LWI?N*'T6'"7L.00&]3[%H371N'>[#KR@Z
M0/#B8JD\3(TF6I7%=LZP@X[<Y'IKS$%7B8V9;LO<UA76I65!N/<FG1ZA3R!\
MH?6!GF ?,64.#+E,:?:ZD1H?3),BMR.MH9RA:]Y&6E;LG],C^7/!E5G9U[).
M__RQ1K)4J[FG9AU_YCJ6^).Y8!_P<3P:Z]D=YQ^I6'K$$&?%2UQ!M0DILN:3
MI21+_R0X0GRKHCO5Z^OK]VRW DGNP_OWO_]!E/@!W$O1+GW'*,KJ*X*W^K3P
M16UEBNM*_1(]5[WA!V6<W09X,-VB,KK >*74F!B_:L7XU:@89W.@B6^ED'.V
M>7@'B(2)8WJ2FB>YMJ!S]@MW*!W;A0+.V2WG/S#/%'U)YP",![;*>Z60>[9E
M/"AUJU9UB07V386=P5#"1VX1 9W61X)?TTTIRBV :"@Z @C"6CI[((/NWB=Z
M#/JR8P"1;^2U2Z)=C3$ HMU,P%TH0&]_0X8I52HT K;I=8IV9<*6[(PPAV+%
M<;S(O;[L>$#,,9T/T7^&.S5,L!9"H>1X %S3/V=D@5_C6N[S8N-A7?P'= 8?
M:IE7"XZ2_<NV[%\Z9?\&+YDM/KS:E3E6OXV#R2QD,S^)C R7RHV">?YD>!L'
M-WYJ[.I"H5&PK41**%CVECDOEQL;\_=EE68-@*SL*$#<A<G2C_Z.?')'?S'R
M7RHV(M;YI&[!O%)P).Q307&;WA*"R34F8-94R@E3Q6&J,0I DSC>^U']YJF6
M<<JTN'3D\]JP=YK*N64>WC_*KT49Q^I'MVR"2$*0KQ-UU6].F9S0:1FPU:59
M>86/SA4<I7"M$)T-L2,1YP%J"T&_585'Z\K.8=8FR1:>'0C>?<%FC>?&XL\;
M^:-74=-S,KE1=\4#>F5?#.JM%A7'"D^\7_4VU*WHC;LS3AGL4LUQ -0F&ZF
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MD&T70E:KVY_:UQXAT*+J)V$B7SN0NIKC!5AK(-U<RSDP>L3ICC6A)5*/-1W
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M;V4-!)S#-83Q-.41KRD^5BCF([^V@G,XY1WK,4R^WM'MN%XD.+[VZ( RX_
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M!9M1R,/$DW2'@#+'=,RC_PQW>7*9SD X38\2]8#J$#"NZ9\SLL"O)\O5)0Q
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M>3?.F.*M>VPQ(/HNH^K-;+W[]PXBJN'?YM-=[@XI=+O61 /> @)GR"&% SO
M(A43:,0=BPA%E'U*"9IA&U).Z!>8:=B&E!9TB+H+#.9ALBXR] <H&@&6JE>X
M4)G/]\]1N)1V\\>'-Y"9P"?K-6&Q#L3#VEFAT=[%/Q+(Q;43C9TCGFSB:7WW
MY9L);\.3C5@$JD9M[&1[)PBQ%\P''$O+?R#,O"GM6^&I4!3WAN3JH'[I8)G5
M!-&VB9ZB&7KPM_1/!66GL2MYB=L?*A5)(0HWW\W!MS)#UFW'D-!V)'R!G7 7
M^4N>F?15*BCYCG]N:"N[_9QRL/$A\I*?[?OG":U6@5F)&<];XC[!65LV(=,M
MF=Z(5U-Z;7T)@[T?18?I=DN[FRAOZ\J[3-+]LJDW";9_5QL*:V2&245FQ@2W
MK\_9\'(^M"8&R3!W65UHGSG?:^9RJ^DOII$,%BM:\+(F//9*<79(ZZ4A'="!
M(++4G+=T6A\?R[IY]-A8L9R^A7"X8.$60$B\/7LV\\.AKA\=P&H'D.<UY00'
M@E 08SO&GBF"*<6?\=Y9#[UN Y]VG!X5 ?9@.V!-$<TNBU78Y\AE=)D[^*#Q
M\FW#U [@MWD+%/%WPPYH+^C,(1D+8^EN$5H8P\*@#3MF3&2^@DL"! 1!5%H^
M13 O.%<I=*1-V.@!R)L%$'O'J'DR8.L$+H5K)FKP-*3@3" L[>Q'*&;:?)YR
M QPI6/3@KG&])$D6&#*/23Q($"_5MOT:XFQ&82"-ZN?<ZI";'Z_NJ-@>+ZDP
MG_';%?A)9O:C[Y0\Y$DO\6QN;I^N'Z?SQ73V $$V9X\?)P_3_YRP?T\>;KRK
MST_3A]NG)V\VOWUD/]N,M.FZ9\3,4=FX\ J,L)FCLL(2*4IFO)P;3XE-8SF&
M9X#"7V[CE K;TWB)R0[SV7Q#66&^XOE/G68*7,.X@WA.\*S0B-'EQ+T"J0M/
MPIM:AL<SGG/1]!$M4?B"@HI;W(G(!%DJ&W&Z.C^W<X%4G]"]!5";]K+"Y9MI
M)/-UWCF.OG3\YFIXA?  L2@U/D&]J_+L.X9K7?&#?^QY8//9ZO8-D668(&8%
MFQ5,1,E$6-PSB7 6*_;V]/QY0*_108DPW(LZ5_4%8R_. ]@9C[ZGRLNA' ?A
MPLL9A>^256';G-=(LBK)A2<XOO"XO#^+/<ZU,)V9P)L>,"[?$QBQWV+WEW;>
MH@^,7^AY)'M^)WL^>U1[9KU,I[7J*L*DIYCU,K>OX!7M129HZF9P>=RR*T(/
M'7W92>E8Z&9SQ_Y&N^K8/2'GUL*NX%W^1D>AM#7\VD?C=K5"D+8(*;W.XB^>
M>O.0] H=PBB.'H)&'D<9')+#V3'J%OVX-398?02&-UA>#2!Y]PHI&B6:+M$R
MC%#L1L1XP"GWO:.SF5YF\^63;[E=IALG+U8+N[XJ:VB X]X"O.A7BZRT]PGW
M;,@^C9(-C@(/7N]3%,/;5"WV'9_#L@OL>4X+4ZP%\<&UIH/S=&YME7):=KVH
MN_-=&U\HUJ*QER)<<>!GELOR]786LX<D;B$A?^SQ]L#HVC23'@!>5$$V6WG<
M_CM[!*<"(FM)V)ID'\X3<7U<CF(4AG7!$)[%8F$=41IZ>U.[9/@EM]9..L.J
M55MV2;"M.>32A6BN&PB^Q\LKD6W&%R1<KQ'IHF@3)+BN88Q\ZF*2%-6D?$M7
M8%B-7NPG(;VDEQ)4]9D(A[7 S1_SE\:S0Q25P.3D+SR1?F28-"1J(.%)',!_
M8*=^\2/87?O.MP4Z3O:'TL:Y@8H:\+@:0!S#&<@?9Q_#Y.LUE:_#%/[J9L.D
MD&5F,HRL!W3/ TVD P*$+E0LCD;M!K%S/7Q!?:XU><!.XR0E>]MYB_O#((9*
M(>AH6"!:(-V+$^F8WN/8/*"4&5)L^1&=!;.P[9O>,R2IMA54<_?Z@4=,I +*
MW01FW771*CD/J[K;L0.H26)1<*58\R<)VVKI8@KBI_WS/] R7>!/]-CT4TP.
MN0+J>@.6I<DTSG_BD2%Z%$#8B\RDM.(23[ %<1SG].(8/D?J&\2OL5?$-*_B
MSUA0.H">DIP+\")4WF88(XZVY\\)FJUNDS0$+[=.RB%*B9E)2%JC93K2\^MH
M "9)@M)$2?4*UN![0DYP<RNZ)'/"^MRMYX&G<N?9#)1CV *62!F4"Y9>^%T8
MOV-$N0, )VLYVE:8<I-W>I'#[(J,8DA"W;.U]_7LTZ?IXM/MP\*F%;==/-E5
M)VN$WU#59@8TOLXO",]I?A7I$&0"""F7FF$2/RE7^TEZ36]6!]J7[/3KO#6@
MP;0@_8%0U1\%K8>?>I(P%PXL0[J[F5[3N4#G<3!AUL]=AN.."C:$Y6/<X22$
MZ-Z4,+.C5DS>Z=_TM()7ABC<6LE"V2L^9:0N/*#F"7+>Q';(H\\Q04N\CB&(
MU\)_NT(Q6H7=K )4DE[JOWG/@NCX840:!)2<)^E=T+_680P7:4^$)A\>%-=)
MT!_F*/8C"-I##R@97I]*+:1C:+0">I_38V8 62!].*IVLO%?1P<TC[Q0!<&/
M6;NL)[*4$J+I88V2^I"HI@_3Q71R[\T_7]W3S6=V=W?[.'WX>!Y Q,B9+:SL
M:[7Z!:0S4J1B(94"@UP@Y.N10Q8&.3)'O%U#](G4RI24(E(CDRL>N@<,DHH@
M7(PC["6Y(F0G%4'$IB)H./A1$?EQ*K A@@4M:%M4RB(';B9R'\9HFJ)M)XGA
M:;E!P9Z'E3D5.3#B,4[. ;T8YHR<M/T9" ;+QP/'V3WMRLF+'T9@AKK 2LAL
M, FD0P3OWLNN5@!+SX_H3IB]3/*L/- ^O8PDPAW':IQ2RX"CRHO1M]#0=U[6
M%,Q;-7JX:(TY"81+>S$9*H\6-R(V$[]9S!&!.$[=Q$5-Y"?IY@H/9_O8R@W,
M#C+=PY(D+&YC[ 7M\SF!*DD4D\P%61NUJSQV5M^;Q,X_6Y5?/=FZH'+]31CM
M(:@.6Z]]"+OJ82,V)RK$BV8\90G/AWST':@CHFH?Z!Z&J_W"'14&>K10=TA^
M,#[@%'4-(0/0!-%_\V[HK6X9IL/$2ND73V$RNP-5GJ==A^?T93G0(-:OT*L#
M/]Z9_'J2JU!/FY1%GZ+!ND+,">/6=.$]'Z0XQ5IAZIEHS[PA%J_X';]%?$+I
M!@<#=(@VKBCA887Y@N]CL=^C)/G36:(0XVF*D$H'5P05E=>@(1:T+@]#3XF/
MS!D9ADE]U#.T2$5530-B-_\1A%*:T)6=8M+UNBW(V+YE*QQ#A/N.S ()NTS>
MA60[/55C+MD$(M[TQO($$$J$CKQ*,G:9G>W"&!+:=I35)=."W%"F -*+\1'M
M,$GA 'U":V:IT,FF-O-=)!E=+^&$SP),5,:1D_0D39N2U_XY0?_<TU9N7WJ(
M+IF3\SB]H4Y>71CV/CS2,PE#*!SA!1I[16^VX0/,=W1&-P>6MXC(^.0AV[_&
M2;>Q,KWNA!+@$EHX&VC1KQ*5476X;(73INZP]!93S-Q2LL.>Q &+Y]]#G,/"
M=A/MK=[('$$TO$Y=B)P(JEWB$,=%J1>D[1J?BY,T)>'S/N7O.7._NV7S::_.
M%]X-6K+75^_WEQ?>A_<?_G#.7=+]&?["^V_OOW___OUEGK;TS]Z'_^_BC^_?
M7]"?LZR8J1I>A ?8H]O+?[M\__WEAT%2U5OO2^-RRJPP>5L7GMH:$UQ\RU;;
M)>Q@P81@(!:XO+MDH="ZS*2,/CM!)'H^Z!1N>2*<-W#CL.>]0#%7'77R%@<*
M_GNR6L7T$O'??_<_/US^^Y_S]PB[^I9>,8E1,YJ3#0.E-#V[)(DM'F[%E.P#
MF4]90%68>@WGD/7\@3WB,FX:A3R!5I/E,24&5VO0&3^-5YAL?1ZL$Z_"E%G0
M]/?6-T>$-0!7!GCC^N2S^.=_0Y!&9ADF+*/%(UK[A#WN/ KNO4EN433,\U])
M\]*/+<+GJZ?;__WY]F'AW?YDV:&I-P!FW9%+ZX">G<R>?IP\WOXXN[^Y?7SZ
M-^_F]FYZ/5V<(R@Q6O)A;: A*FTBUSC8YKO')^0#I!_QZ^<$!4J&FTZ9/8J)
M<C!/AT-W#/O:Y8'0RG7'6_.RYN@]8G;SZ<+C34K+0]'LA4<;]J!EN*!F;0]W
M&-HQW&JR$EX,'2*@5]0&(6!8(ZP2HGPKZO'P/]78VWH X-S"Y4BK_R[F+GWT
MC'W;'SBHN!1ZLX<K$8]_(E62=%S"92H,#R:O5&J[PV2%PK3KQ25_<1.*HQ6G
MN[=KECD8VH*/*R<"I]<^EED4 F:,:_5Q<3"P<L*S%$$B##YO4D22E_>="R]O
M5V048BU?>%G;@PIEC^@%QHF;U>RB;I;SW%PO 3+G!4(=OLSX5%Y4!74Q6D^6
MT;4*T] UI942I6&0NZ::HG5!_#BA[='=O1<]73%3JT(]&4JWU3>ZJ &88UQ=
ME25U S:LW;,)X-6A\*6#!%0SAO9M>$4Z8WJPJ XX(FMNIU=B_R ?=#*'&_KY
M;+!$&0R^!X+O<<%!ZM9ZQF2XTQ8V]RZS#(B50NT,(#?OGY,P"*DH/R/\J.36
MZ=/XA4HX"'$S:W9H7AVJA66Q+KBKD<G!F6Q8\ K,7HXS(Z9A]OQ^@2F:54[T
M(C.,Y]*4XY.L9QWKX^W]9'%[X\TGCXN_>XO'R</3Y-IV=F:+V)H/[.$B>O%T
MMNLU06O*3*>P1!D5X1@Z4F[K<^U*VM:"8V3<\XMKY[ZV]FC9![>EOLYU,_[@
M_.\@L3GI'E=,Z7E.<JC9W@E!==J<$?/M5FP)DKT%S,C/5G=^2+K$V\M-9%>4
MDC5#IGYXKAV"G']KG9XQ+HU:3^STNXS57$,\6IXUG1Y7M-L#]GT6:+YK1G!E
M%(1YD<UD//WPKTX@GJ"5JV6M9L[NA_7:>;32CH6]R829:H.!Z1[X2U"3CUZV
MTT]U9S[2\&V=;<7O5@2CG!.\#1-Z6#+KD2XCH-#VGCEQR,<FJ$..2&N+HV]8
MT:\.4>VIC9MQ#I(KDC_K@5=*SA!?SY,5G6F4:6W8Q&L<13PA<W2 ..97!U%,
M?6WJ].HFQ$G\&G-O)6YWJ'9;GJ7PM]914E-8R%<I'F@A<;FZB,3FS)CT8 Z:
M;*953EEL>N_JD!56N?VM]79I'3OJ=9L^>L(*#4!.X]T^S86=[D("5XDR8D,$
MONP;BEAJ"EF/T;U0!5 7P!:TT@W>^N&I%HH52!Z0]'[F1(>T.^UJJB9,+14;
M^*'?7&O,\:\.XF/OUI4ZW%*K#7$L9S>?SA]\9,:=-:CV@#53PSJK*_ZJ5,Y3
MS)ZX.@VV>%7Z]W__(_/%-+VB?1O&XL#Y[MSA1^JA46=RECVY&3KEW#M"<WF0
ML:E67@+8=P+X+@/.+ ^MW1H,R)F"Q.T".'/$+>:\4'F-:LKWW0VUU^6A9WR6
M_"L(0N"'7C3\,)C&U_XN3/VHNUB<$_: \CNZA0O:YX(F:@(RA%2<>V$G"VR"
MYY.OD Z2?$7=<AH57B]61>6GGR3A.N:25Q 2>J7#5FW'; //1C=K!I"5!MO+
M!_O"RW7SCF$K^]5I077^R+L@9@^;@5RP6:BJ; JDBN4CBZ/#Q&[A$A+C^!VX
M-Z,MCYYFV[MYD)XY>7*HA]M%'ASKVE*4I6,Z143GZN[@7MP?2M',((**#+IT
MSH"/'_HL>;IMGWB1"C01AKR3.!"IGNY#_SF,0D@%==T]":ELQML)@V'02\L$
M7(C;V%J=T_9@1B6$<P6A:,136KGPKJTG+)T3M*,S2M@NL\A6_>22O<?Q^AU+
MYKWC3>0Y"L\%CGP&$/P+HCS\UT#Y9$7;4]EU'<,Q#ST.)_-=ZOKI "P_HM0/
MJ80IPZW3!;G?[IFZ3T3PZ;BK26I>P,F=%18Q())PGB_C6Q69(/Z=O4P^#5>M
MGJZ,.W'36KJZ,O9S62S("=9'A.7Q/GH @"LQ (Q#C],9':.RAUGEH7JSC^B<
MG)+-^)S=>"UT[# /2[RM4V75RHP58@#H*(:8N1V%3S&!!96A9K)HKH\)?>VD
MNWN9WEFW#Q"\0]Z,;_WEYLN&LB)^N.61%.#B<8?)+$::V!Z3=!*+<OQQ?[:Z
MO/S#^TZ*3,G/A8<H1]XKL.2]BLLKRIEBCI4X1IX^X"I<]/U85A &G3Q6ZN7W
M?WAO+QM=R+OR&L=)F,"SZ&QEZ+PXH!_234@"5N0QTU*)+NC4C8P1T8?+C!=F
M\E;39V#:%:-WC"E95M&>B6$8,A[WW.>VO^\A..Z\#[-30X#>BSSR;AZ+UV)
M7<A]L2 ^LZ@Z;)_QJ;*<H.%Q(I88?4+T\ K3P^W;<D.KHPZ96B0I3]*RF;-%
M-G;YX7D1IB?[ K.ZL!XN/WS[_)TGJ5IB&A*N1/,-77O<5>QDQ^TER/= Q^.$
M+/$[7:Z(R+LR25.4\*?#N\@_-772]/KNT9.97!22'M"T!.(V3NF(?D%1]+<8
MO\9/R$]HQS']_,DCP&EZ0/3=5Z#J2;)<"VMK0'B[/^%H'Z=T@[L+H].-6P6&
MC)C'J5GE?.&_30/(XKX*>=#23NM (*!$O2)5NZN"-_NT]:/H:I^$,4HZ#@$C
MY4E:=KG>T"E[C;<[/SYT9!HH>8*459X?T3H$43E..QQ.@NN<ELW#B3?&'ZCN
M(NR?>F<03(N7+D;)*L?3F%ZS?&8L?>.G?K=[IF!>H>D!48M/&BJ0)280MA%V
M@R=ZQJ!K>' AAVL<=)Q!!=+P[@H&,_0T$PUXT()5;&R;OJ:MKC'IN(89*4_2
MLLYU'YL]T!EB>[]]8Q$KF#*5FV-UX_OVS<L)"K,S-_'@.FE>E!!PWX++EO<_
M;%C$6D 150' G;A TS(2V(GP\NM)#NH%G\12_AG;.4*Z\JYT/9WZ(F>J2/)A
MW69!>4WOKN=5B(V397E!')I/NCJK\35[[>^+4T,!PRJO2<IR1OU3'5P&3@8<
MM:W&;X+32VKO7_6 =WQ!T _\, ]F/5AX&5_-HJ%WJV[W&IU]UJ"KS\)+FJLA
MZ&]%#/2P)J$P$["BK5D/EH_2VFD (\?^ (BQX#DQ2Z9R QDPKA!M).A'NN;D
M$!A/R^<C30+'2W"7*N1OW*<;3,)_H>#/7HS5++ H /6 $E=AW'T1J=U 9+CY
MX01VIE"!"]IL=4>/?7HQ\R-ZS+-[<U<_9DD:'GPRXIZD/I!/LQ7!R8W T[N(
MH\ 0*)(\>Z+-T4E(^LN-\"KJ[GLF*8V2T:C(HTTG,F"6O;#.5E.Z];V$P=Z/
M)F_AJ?=:_EH+LJ^R9BFYP7C_$J8;%@$ PMANPMT"<_5>IS@1.E3V8D0P>PR9
M03LW%U5C?W7WU%$BH>8&J=*AKW VGA/"J !NME*]<HHASZR=DM:PE9R#']&.
M<@!'95H(IV<:3C&: ^:YSV_\S#Y-&A!U.D0;$J@ZR,+=$TJYTU32J2IZ$QYH
M9R[G\' 8F61Y^[:,]B =6[#K;QQ7WUY\VB$Q&T=Y[MMS'.:1_>#RE\<(.]WC
ME=\BL0S>M;3DOMH3T[6;IA**4 /*6A21&W%O*P";QC#3$)U:PLNP$^S"8U0!
ME1>*AL#Q1+IL#C.: ^"6DK.\&>/?$/;Z6)OFCH" Y=J^H&O$3[U7!+(#]Z,,
MO( '9?'!MW_I)QNH33=G%JI/_J3$!!AV#<'6O-@0O%]O)L$+^"(F=P1OU40:
M/4\HIDE+>9-4\N)M>BO:*#V^N+\=](X-PXU!NZ$TM_+(\4''CK$^0=3T3W<(
M"7?NKM-@KR:56B$D'>'/ TWS:)KP68S*+7.DSE;J5>GD,/L9/350C>5P^WUA
M,([/J@:5W1!06:B+![[)L\Q."_R(EO3?8#B&4C"[VR)(6;; U[3(G."7D)XQ
M5P=(ZCV-9S+1^01,#?D;;!^^D\4P'$1RY,4HA7.+\@2_P[_8Z;1/Q+&7Y5WW
M,WZL>F".K ^C<O=!+V6\>)09;YKU'O#B26:\YX/W[6?>C=]Y&4N>X.G XRY
M#4 XC,X>&(3_@_L4O2A"+S]F^7CAPR0.BC\H)8_MNAVS#;R-95PDUCM,&W[Y
M9^\V9MY;.^OV@\,C?DKID:W#?(7681P+'[=?%_(HAWO!ET%.K)#SF9< '7'I
MQT(%;LVXAZX2"\=*O-9>NHJ;P-)-@" _03>(_S=3B4@?LD<JS=U2Z>^$;5PQ
M.(']YIK[I+&(",GF-]LM/4\YSJ\G&?:^E2Q_=^%E7.<>@<"WQQF_\/@-%;Y#
M0D ^=VD;V=2U;U53[F=V5VX,_G3.P:V&02PFF696P/IK'_YJ^/'/! ZA@^W%
MRHK-_:0D%_)P%P!=L;ZR*2/: VM3VC/,H;QH%@QU"$FPVH=%&ZJ$*95/#(2Y
M<&,*UC.F5EM R4Z,+G76B N4QX<H,X^:FYAW/4([:O"&",I&]P[=5558;ZE7
MU:[R(;M3[I1]:27;4.[P9XE4$?D,&V_62''C=2R=M>^17DYIZ)Z["+\*37*E
M3RP?S_;1VID' YE-[G>[B!EO^A$ @(%2LI+T,0$></R.;0)A_()X4!V0SG3;
M@,UY8 EI)&TA<NI>-N6'3^W#G'MF*Q$0:48>P_4F[61&Q]V%\"J+AXR)QZ@.
MD7%)"Z<40$O&OQ)?D\LND_6V&/YJ"-.D03 V#29H%03RN0S\E84 EX6L>O+J
M>D%:Y(GX0>#@XD<1;.(L^%JA;"?G!,K8!@0RBIH'41/0?TV FZ= ;EZ:M^]Q
M!N \ Q8JM<;30^4UTH^AK9P)WD[,$:M*\F$1=YX1P^X0.**_L @A+V@"#:^1
MC&$ ;U>&SXO<L"6Y#V/$'O!.-B5(EB3D=IVT3V9D[<?AO_S,/U;&&LJEN,3[
M&1IECVI6[.FSR^I\ULEO@=8?(N^-DMT^\Q2B]]V4L+?S9(ZC<'F\AWLYF<5/
M,IE%[HVD-')N\*+6R"X\WH+WL_@OI"_T6/Y"R]H[O$4+_XVWVDO"2*'8I$1M
M*^EZ83TJ<^UH*![0JW@&@'QG!,?T3YYS3$R^'H?H$4$^82]O#Z(VQ8%/ KOZ
M'+L((ZFZ>E61%1MR-+C50\_7GW/=PKVJ!ZFGM,G?DY1_<ZOR=./'7K'2 #?#
M&_2<YCL?!)WK=,L%<LI.>L'"V%GW%V-!W%"2PO-MM]-;$.(/P0.<X\7N+^=X
M[K*KJ.F=0R!V-BA,4ZF2L-IV_(&>\T8-:B'=,Q Q)GRG&B@%E(AKGAOC3M8$
M(3[#.@4H5\Q[,Y(N4KC/V WH)PP.N[0[#]T]NW-:YXLGJNY?C/J%Q^E[PX)D
M4UZ)RW?RW=<4J'"@BVUO. I;@0,@\HSF=X23'O^+%R1QY".?0(!L4%7[<;S?
MCAM"66#AI.S;*12/>E7PXF9S5&R=(P(7&G_=+=!-1@6NZ6%QE,X5H$FT*<B=
M%U[6DI<W934;6^X<I5Q_.D3"$!0]1M)3:-H+B-$ IM.MI@:._1M:^91]#).O
M=U1JZ7[I*2@A*%4/R YV];&'RRQ!Y"@'O^F5X;)XLP%(22P_-WLM[#Z,G)BG
M^@6=-3;S4&9M> (S?V]U@'9!*W78*RO8/" X[$;9:7"*NZ/% 6 7PB<?8AZQ
MT%[9BQ[S >P>%@A(,R<>$K[ KK"+?*ZHS%\O[3I1]HPM*L+B.=B5IT@>Z,AN
M,*">(6G\_//H/R)R4R+P)@QOY;.]4$ <L!+J3L2&6YSBIVP*G_=O><0Y1M?>
M0NL)2%3!4(V=9PU)9K6&UC!M'M$.$^91@(-M'C>-A3B;Q($,<#8C'PG>[V;B
MOIPBEG?L]BU%,0O/<TLGE7B8[C2LG"DOXXJ>:K.;3W =D)QYFNAKF'B,/:%;
MS]GR%+Y^$YT9G7<_RAS5,FS6E9^$RU[T2T_+#0KV?!MD5!GRFS#:PT&M.+Q
M/*UB '-%C7,^V,5$R))^9V'"+CC\"["R$1D>F)F.:C>\>,4BF/LGE&YP8%N1
MQ5-.XOB%#ABLCU4I\60OZI.</HN 4\K)L;.I5K"&+])!*X??MZHQL0:M)->T
M'3V;<2_F7 J>2R&XTQU!$/,R:M;O"==X@^*.#_B4@G4^R]W<T8"^VM$L(>\
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M&FL+%G[6FI<U9WNPS. S%=.,/.V?E_)?CRC98:[;N</$?K=D;("@H#+B*9Q
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MWQ'8A[5?5#D>3D]#>.QU^.DFF,=B@?7*"+JHGIVN_=/5^2#!TQ1@M*OYN!N
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MNM$Q#_ON68J]Y$'O17%_PN_0)@T;_9OLGNO*<Q[X3C=&W$"8W0:^+6ID'HF
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M@C;ZS%X8C5R0:Z=P[$6 <AL8G32;O?!(M4+1K$RAAP)MRT$V*W#HT%'X&-I
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M^NZ*ZP1SSF\*9[5F%8VQ0#Q1NX8_XI2-$\Z'_LTFC\'/2Q:S:=CHW&48+19
M%8FE(&G=1)SQ2RP7W"6>+'4USGK2N3*JJ<,3 8C6D3^X-6;M^;#$K&SF>03U
M0T@L56W@*S-@U&*I%-ZRM@"9F3V^38_"^MX6/^4U@P\;A8[1!C;#]88/'$4T
MCT?@7*[,/G><+JFJ6Z./6<7&J#JFMWL(1-CL4U+%44-HMS;/TY3.:+- R>W2
M:E?T^8"#8>XEB?BWR:XYZQJ'^;;97WRV@SIK6?*B^RGNU!#UK&6^JA?FT[Y!
MX-D16>&.Q8D$& OC]'">OW".]&^E=JR?!,LA:XC&"5H<XJ*MPI<D-_%\_22Q
M'+(NHNORB9:?1C-#+*1E&W/_"RD<([:+*$;# GIT3K1K4$^ \T%DIY1196[,
M:I@%"Z)J-;OA!J=GQU37X/J:N+2]3RY+]PE1KJ^/ON!G5$U^']GL-4F#]+VX
M!2Q.N68&U'WTF@8OD5!EA7ZT8P'>=OJ9@BHN^[_QEX2B8]8HY?Q Q,0##LK:
M!];S!+4G5#NY?@E9-+#63 %>TEA*+[-"K#:0+.#!H$T@FKE/: KNFA"0Z-%*
M)085+>H"N]6ER\T-<J5IUU.SM)>D+$;&1C5#CS"B<#HY(F>A.>U%8%97V*JZ
M&CIDU)RLY1FMJH9[$8#J 36)$KH7)2':GU&3JHL-WPEY*W 'T:.F7^]J E9+
M^5^[*?>Z.8[B6%H8#_ CJ$Y( M#L3/!K"*VV*'JL!F$K!-.><S:Y[$75FJZR
MKL2^TVL7MU76P=?Q"YO,(Y9,"WV[NE.^SI_^8N,\3^Z3+ OY:7M@$\['(+NO
M%YTJ-$0_2HA6E_QM]2 1^GI!Y NIW2<F\[MJN+A[#HA">&0I/EQ>A932@DR#
M+]?^ ;!,JOX#,BI732Q=EK::!,MIYQQU.$C+]UXE68-.NTE )Y%)O[;CO\S%
MB>7L?U'+;7F203$:QA-(45M',YF2F3P]'0#JAP-L&7%=Q X/\SP-G^:Y$+$X
M PPT^5#.SX%%$Z4BU8@5,:E,?*C'I/[1)G_-,XAYLUNVS9-@X431)35RK6,D
MC?/@$FRWA56NSX5,,M+))+);6>T@[?1$6"'1?L6L87Q!E9/F,Y3Q_((J?*M3
M*./Y12-(R+I&U(#:*EE=15T/[2)98RNF@P&F%\8C;S(:G!H2_UZX'4P@R#P/
MKCH%^AX]I3 ]N>-BB6U#J<''D\+5WP5/-^5K+ZSQ[@?=LP:W%[YOSY@9/XJ]
M+DE0/YR":V!_ !>M%E]6ZX%$H=:'Z_XK+V+>K@? ^9'7M HN/J<8#/ =^AM2
M*HR:-V9MY %)+7@3 OI8B:JJW &M/KD.+X-,C)E<A]$\9Y,O;%%=]I[?3>6-
MMVTIMJN%B/*)PS=.>R%ZE%S#BX@$0$!A[W%\BN!3AT098S=!&HO"HLM ,8-M
M6#4<ED#5ZV[%^>K4 ;J7[Z40+UWG;.?GP**)\L>D)%I^M-6FHTJF_I.%SR^<
M;0SY71L\LZ5,NV FMNDXCD^!!1.EE]:_P()&R^^U& T+Z$'>G[NI^^*0"/=N
M6?L7AZ2Y:6V30R\.B=S+4C[SR1"FHI\$RR%RQ-G?XOKC[/P<6#218T[!5!O<
M%#Z305AH]2S@<D22A!/!/A8-BR62(*K;4O\EI6-AFY(5 O'G/[XX;(A!U@KI
M&87)1/LUFLIH2VT$WRE#X44P*302@TA;-0$=4)+.>9V8?A-MK>Y"8-@CZ:?G
M&=.6BA/^_J7(C]WP_JWI<@0[^)2D(Z3I_K6TH8(FB6EQ/J7.T:XN70*34G/M
MUA[#'2GJ#!\'I&K*,H$KF<*1V5IRL;R6&UH[_HU!$2*Q,7&\9@[ 1Y-BD]KM
M+&NAQN[>QH>60M?!$2/UE@Y\I"E")]MN8BTKV8MX,X]WE%'F[*DO_H%%HG['
M?9#F[^6&PMOF2U=V<E?8Z+2=WP^(K*0^#8VG5/FHVEZ%#XRSF7"<+RKO#'\$
MZ>0V2:<L5+LTVC]0P$!5_[-9A>*!B8()K$CY?XU"^Q+2C9FP,")KN()CF%QO
MIFEB2;2>V\T5_CVE<I(JC@[0]X7]@%_4S,5B+BR.JNU?IS"!TY8)[L3^]E.J
M=&Z5H&!PYIFF\24-6J;W>HSE4E%Y^5[YQ2J>R^%9L'BBT_-U_I2%DU#$3JZ;
MK.MD#=5X6$1?>AJT; 5PVK(RNR+#?/C\G+)G_JVEO3ME0X &KUGNJQ<42]72
M4 P!&KP6&5^_X)4?@"2U@*,R4E!TTFYKJ2B"YXZFMT&8RKK#R@<!,E[I6#UZ
M:<*0T=$8!/6TO.Z2U2N6TLH]%Z:EH,A' D7M.)B*(H[]9/$*=3VEYBB01+SN
MWHI5*1*)'_=I,@LSOCVAHIR,+M,<V-'MHJ\55*ZKK8VF!3\3B5EK,A;UAZ<Y
M2Q]?Y*DK5TD4,7Y)O;'H7?1@O7Q?#"MK(K+58KT;OJU7U!9L1KW!*@/@_40Q
M<I]9(-*_A)9_%[_.\_79TPJ/IFFP$8DL!'7:'OF[M *\>@(L@\A:<\V>.#E<
MC)T+PNHT*I:BGP07#=%&@V3.3V'P%$:A:*UYI>U2KQ@M%G!!I%B5Y-(OP8S_
M9TGZUFXO\T20<8F29NI[I#!6_G?"=0F!_;L3&Y!/_G9\=G#6+W.21A/1S !&
M313/JR!+N_.T<V Q1+RMOF\>PNS[;<K8LMGN R?;:>.I'P LG(AEU*D$#7$B
MSD60?F>Y^S6K?@ LDRC%0W9_:@Z8:C@LH5^GJV95<><:D@> E8W(*E.FQ9IS
ME&R:/6#BVO/2' AD$XD\_'B^<7+NHV#,"G%,0[I\,)!/E8NJ<XRU-._7)L,=
M1)5VH;)'- > /ZP=<U4HB'\FZ7>AG@:O81Y$GY*@?A 5HX!'$C&/X606QJ&P
MJPM]^I:Q[.;G*XLS%7[*\= QH"%Y6/<B)VEC8B_$+^A.'((!,.NBT ;"M/!>
M-/$TQB5@XDD14VWK[)9!US78@2"^F"(8NR/$=O$5Z%%P)/U2_!Y^VP^S%Q&&
M[7>I0V3)7I1:]<Y2Y8$LV%@>DS!/XP4MV8_*(!K$R_R8O"U2=>FJ8RL+VL'-
MD#HFJ:]G&^TC.:1=+J%=+UOH6SPWA?)@XDDA\7BYE64A1.A=XGITR#7HZ2*>
M$/<:R>71%:UJ;!8F6MMQ,BW"Q]!/Y7;(Q_I8-\R=MAV:F3XF#Q,OBE(K7?&2
MA@VB:UM]@J[JY:_CI@QP1,=LBVY-V_!+=(M)C[:="4/LH$[T_7Q,?=U4_?4U
M^*6!IY@FE@&%3F&.\&SJ8K8AKN@;;$#!,4U!.V;\FIACRC04/N/V=@"[,%Y\
M8_)6@6B((<9'CZ1.DLD8)['?68<Z(!Y@_LUZPO5<[PU]3/1>M#?#<0&7([11
MG484D%I@8 U<55-$%08I9&4?A]H<;XXO%E)<+SZP- >UHS-)D@A#OTS2)+!C
M.N%H"T1N\L[1Q/>C7D'4-@<[2/2P5NT6N^YTM['8F-,:,#<9B96Q2]RU/J4"
M<X/U2$*T4)S=<C?VXG+N &8CBP33[+4=H=.&9!?L'<;9PU; 9IUHT]/BH':-
M.D$PVYY*H8:BK\-5GU%8UR,G]9(3LEJ LNZ7T].^B0ZM1+G=M2;(5LO4SH'%
M$-42:6Y'0T$Z]0181B.5L]?I!>;%2.Z[;CL679J@D/W;X&IU1+JBMTEN/YQ/
MPOPNGB;I#&:3</2,C7][3MX^3EA8''_^'^M3S__Q#<A,TD^*>K.R(=^.CP=G
M'DI,6!,G-"$U7>)7(,E#8K4U2;=A.KNK5T9L_ YD>2AT8_\9Q:-*FTWR%1<C
M@#0/A0*L21N]<J$MB557HV:D(/5\.VX2W7%9\SC%YMU5$Z4S*-7#LZN&"V=8
MZD<7$QA,6Y@S,"J&T5<]D#T7;HJ5;+!M[2&6_6(>&)?1<B&:+=:D*H^BGB#4
M_'.JHLT%#051$&@YF=VGR33,10^7A4?I'\F//S(VN6;9. U?)9=KQZ<! %0U
M86HD&Y0]U7!8 E75'@GJ=_$D? LG\R!Z%">)ZV#W218*L$?I[VDR?QVEP@D;
MYCECX@*^$4<I"_FNO(GG,Y;*1*B-OP] ;,B*UMZ*<XK"'*8-T53KS(P /9#@
MG"1EW!FYCNP%'U:2XAM>8/5ZGOMLHQ#1DNQ?<S[YYJU\>_=> *D3;KJX%,,A
M-I:P8T29)J-I7#4>%M$0(*S/Z07)Q6'X())S:EI^K\_9LD!(,KUZ">)GEMW%
M8"->=@METW <YO> VPO+PW&P1=J Q]XG9P>'1$5=-UKNFB^+J"F/QT9^?!%4
MK-)?([^S@R,BUUJG_EJ<;*HR\$LLM>V:*H,$N0=$Y=U7E'PR--!K#@2RB4KG
MHM9CY@>9K,3N O3%]JZ4#33)<#9S102(WY8^2X5U.)F$A3Q4SB67-LBRGB<^
MQ6F[3V&@UHU&!65>FWC)WE5*@[8EKS0%:/3:HJC:!IN+*7^Q<?Z8+&J"SAMM
M*^TF 9WMN+<-G8LW?DG<*)5/ UJ]5GZ6?<3L'_SL.GSTY7B@CDB0ZM1GDE_?
M/LG.TKQ$,O_7FES^CV]@M!A-UU8,R;VA' <8^Y3S7(G],\Q?X,X2U]=+^/J8
MW,1<!9+7[V_Q!%B@3WN[88'78<K/F:(Y5G, D.>W.5=)0:GP*O7%8)@"R9Q$
M\FBGE@Y<\O%ZJ;GV/>/O;\#6RS@&O6 OM\YH57I,7S5%-+,1  EFUH:#G0?/
M&HDFBD:#Q7YDG-N>4Y-E9.>WF@F )F9J>PPB6 ,:,[V+SJW9;95=N:MA2ZW/
M8L,"M>NYH+8(N1NU,"NTD!1S4&^:-7S.]B?TA#.2V@W.T*G-8OB D0H5;0"3
M&.KP42-E_[:H&0V'^+B1U -IA9O>C(F/'*F4UN:<UFVK>Y&0IA;I)>*_TIZ+
M#A7IK:F0U8R&9%21##/FT+AR TAV9FK4FH.8&GD'3*K RNWGZ*S_M-?"AJ5%
M'YVE]:CRA$:MU*NF5>_"KBOOZI77MYS,][$U*5G+O/YD>L]2^&L\9ER?^1R(
MJBW_9._7;!QF8ML\L.<@%2+4 \N2>3IFPAP]WLJ\KGHP? F/=:J!8Y*0]AD0
MO$L4C'059"\J'S[_"4BC*L.192S/1*W_N_@QG6=<OXG'13EG!<6:&<(^>TR$
M\5W\QK*\.%K\U*WJARI6H1H.2R#Z%K^SF*5<L(LGU;I#^F;@AEF"'1XWHBQZ
MS?=;G6N).E4Z6NC2!HG%U@]N%@=\+]JP>(+3Q&GVPVOL!TM+7M?K!)UF,L[V
M"&T-SZSHS62,IM9-@F]-%L$OH^PZS,91(E)<C7ERMO-AD8UX?_N\.9+\5JO/
M)O,U.X+2Y\-:KW/[1QSFV;:I6IWB&$\'9X19JT6<VR@M-M)GEK\DD^(^9:QD
M9[I\;PY>#M,F$WE\A8#*:[ O35HD7P05-Y81]<F46Z6=!-N7J%CG1K,\^5<B
M2A\S6'>%QK"BUF*!ID= G5WZI4*5Z66U3?.R*L-A$WI-=+E*7I@\M[;^LWCW
MN=<X]/J-J!#^M&-A_WI-4W*-CC_U4L*QE9GJ?J3-Z5G]#D02V=+DY?T5%"M[
M 2#5H]3D[-1_AN/@ 5,S49_8<Q 5KY;<PY(1@-<^I 3S9382U*PUH8/>=V.!
MU=DY\0K1&K-GP05F6(?5%2#1'S<@D^^ZHW03F.F^C$)KV-7RJ3V N:'28%N-
MCRY(3/"F+2>!SUI]VA^NH-M(>@1M]3-++"\*+&.6;Z%WK3N<4KT0O5SB 6;D
ML$H$KT7P2'16S 9L!Q3QKFJ9L :.5'E%E1M)HO2M&;G$YUK7HE$W$XELT@$M
MO0:/"AWF1M-HX6N,5/QK5SLHX,BZ&N@Q@:45(S:I1+C;+'H:+JM:R%9Z7\L+
M,$1-F*9!;U:B.$45;?:1$PY/@(6V+F5S?$ 1.V'[\>S/K0:8/L=/-(/=MZWG
MI+^V%50>IW7;0$T0'K]JBA_MVV8Z/0T Z-!RH@\QB_6/*5'UNX&S72=Y+\\P
M5<GP&DT.,8KFF;"P]CZY<Q+UQ/"1)&?3'H@^GT-I1"+64;2,"5'M2?U@4&:(
M@K4J6?JKC6&2T0VS8$&MFTD>D30+LEQ2S4!I_*9]/E%7[T_B?>.Y0/DAS+Y_
M#N+@&=81Q).O(L. /;^OP2"Y]Y81)^/W2;&?^7^LMS'_Q[?&,BZ3()V,ILN<
M]4R4+\S"YQ?E\6SYE&^'!X<>%-&V*URU1QJE7^=/X^6_'E@FK.:B4])MDG98
M>\OG"U0\-BYV0&6]?>_39,RRC&6<0I'4E65"$IWP7\+IN[@T18XQ'\S_\Y&_
M.U!W!MK<BSA.!QX*5K?"B?.9,(BB]^%TRC<WFXS2!Q9DG+4^1>^?PN\L>G],
MZJ,>V#-D'<7Y;134RXIO[#UB-WF,6T-$R7%'>7J9P,N#*-$"K\51X >A4)7X
MEM\TF_+\2H&=!S6G$^=:WKJ<<?R>< IC41)!(8UU>93@/C1WEX' 3XJ\AT[/
M$JMM?-E>.DM\+',MHW83;'8U3*@;*C;H=A.=]@IWOWO;IV2VJS64-PZ<\1MY
M$PLQ/Q%F@,:V?Z*Z.+JKH0T;O4DV(]WNU:=P$X:M[Q:KFZJG826E-KFCUT4;
M[6Q+F^)V:O=Y>G%.Y)?NU.:,DTV5%=RE[>?I!54).MP<OPNZDB[>^O?R+494
M^:*H$[4BS>"%4HR&!5"YJ]MT\N7D$C5<[%8@Y:)9V0<SE?WLX("JPH7/9NP^
MS'"]*]/!ET74N]!K,_:FT;#+!M>WB]&TBK2:*.@=;+S1L065*MHVWNHX:]'K
M.*OU4!ELKMEQFU['BHXE@\VU.EXV27'M=:R8!]1NO-FQ8Z_C4CN.P3;U#![L
M>L_@0;][!@]:Q_'VK0]C(>*O#1YF17E7G1+FE4M04NKE^U$>6*J_-&%2VP%V
M?3/9(N1N6MCY[$O7O:7B;9A 43!W@_%#@U@%V5V'R?V$Z4]IU?BQZWQ,O?(U
M2FK3S'ZT'K!E6"8;T*Z?1", $LRL+4T[#YXU$DT4C18N]#9N)WWIZEQ(HS5>
MYF1MP\>N+VV=M=AI;(#XB/6EK[,]8A*C)#YL?>FUJ(7-9"7%AZTO?9W-L!E,
MMOC0]:6QL_5!K1F2]Z.AD4'@-5JP$66UTY/>-"L>^&A6/$!N5CS8@F;% XMF
MQ8.-UIA8_"+^YRG(V'_^?U!+ 0(4 Q0    ( /2#>UQ9P,L(I88" %0A$  7
M              "  0    !E83 R.# R-S@M,3!K7W1A;&]N+FAT;5!+ 0(4
M Q0    ( /2#>UP7^.[VBD(  "+I 0 5              "  =J& @!E83 R
M.# R-S@P,65X,3DM,2YH=&U02P$"% ,4    " #T@WM<2P*P."8'  #>)P
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M,C<X,#%E>#,R+3(N:'1M4$L! A0#%     @ ](-[7 ['7)Y6)0  B*X  !0
M             ( !LN " &5A,#(X,#(W.# Q97@T+34N:'1M4$L! A0#%
M  @ ](-[7!P"5<_1#0  FY   !$              ( !.@8# '1L;F,M,C R
M-3$R,S$N>'-D4$L! A0#%     @ ](-[7%V*VP3+!@  15(  !4
M     ( !.A0# '1L;F,M,C R-3$R,S%?8V%L+GAM;%!+ 0(4 Q0    ( /2#
M>URQ 852*3   ,$A P 5              "  3@; P!T;&YC+3(P,C4Q,C,Q
M7V1E9BYX;6Q02P$"% ,4    " #T@WM<VRHJT@=9  !1*@0 %0
M    @ &42P, =&QN8RTR,#(U,3(S,5]L86(N>&UL4$L! A0#%     @ ](-[
M7#*&_ U'/0  U0 $ !4              ( !SJ0# '1L;F,M,C R-3$R,S%?
=<')E+GAM;%!+!08     #  , "$#  !(X@,    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>ea0280278-10k_talon_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:tlnc="http://TCC.com/20251231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="tlnc-20251231.xsd" xlink:type="simple"/>
    <context id="cref_1363532388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_144417410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1598680374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_504548813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1997855338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_15768048">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">tlnc:InterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_4055154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tlnc:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1318230788">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_126252359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">tlnc:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_900732289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1878519263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-10</startDate>
            <endDate>2025-09-10</endDate>
        </period>
    </context>
    <context id="cref_1979561439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
        </entity>
        <period>
            <startDate>2025-09-10</startDate>
            <endDate>2025-09-10</endDate>
        </period>
    </context>
    <context id="cref_1598308813">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_2070764536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
        </entity>
        <period>
            <startDate>2025-09-08</startDate>
            <endDate>2025-09-08</endDate>
        </period>
    </context>
    <context id="cref_674618302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2100456949">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_625298015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_443971720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputCommodityMarketPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_15267773">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1837988368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1476606103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
        </entity>
        <period>
            <startDate>2025-08-19</startDate>
            <endDate>2025-08-19</endDate>
        </period>
    </context>
    <context id="cref_2028565431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tlnc:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-19</instant>
        </period>
    </context>
    <context id="cref_2086386178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tlnc:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1752672645">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tlnc:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_612105669">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-19</startDate>
            <endDate>2025-05-19</endDate>
        </period>
    </context>
    <context id="cref_579383359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">tlnc:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-08</startDate>
            <endDate>2025-08-08</endDate>
        </period>
    </context>
    <context id="cref_1043056355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-19</instant>
        </period>
    </context>
    <context id="cref_211807459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-19</startDate>
            <endDate>2025-05-19</endDate>
        </period>
    </context>
    <context id="cref_2107376139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-19</startDate>
            <endDate>2025-05-19</endDate>
        </period>
    </context>
    <context id="cref_259879653">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_837988157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_105847728">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">tlnc:CohenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1460463040">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">tlnc:CohenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1963271763">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_331339811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1095302256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">tlnc:BusinessCombinationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1268440538">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1077089133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1366525390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_8341221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-10</instant>
        </period>
    </context>
    <context id="cref_1599573526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-10</instant>
        </period>
    </context>
    <context id="cref_880262097">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-10</instant>
        </period>
    </context>
    <context id="cref_458958402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-10</startDate>
            <endDate>2025-09-10</endDate>
        </period>
    </context>
    <context id="cref_1115681054">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_198494574">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_726559528">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:ClassAOrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_81526736">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:ClassAOrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1715140789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1543401983">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-11-13</endDate>
        </period>
    </context>
    <context id="cref_540106651">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-10</startDate>
            <endDate>2025-09-10</endDate>
        </period>
    </context>
    <context id="cref_1789825159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-10</instant>
        </period>
    </context>
    <context id="cref_966747690">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-10</startDate>
            <endDate>2025-09-10</endDate>
        </period>
    </context>
    <context id="cref_1352034729">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
        </entity>
        <period>
            <startDate>2025-11-13</startDate>
            <endDate>2025-11-13</endDate>
        </period>
    </context>
    <context id="cref_1620148570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-10</instant>
        </period>
    </context>
    <context id="cref_1637193316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:CantorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1640571159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1853513846">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_254867204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1760969002">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">tlnc:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_224377445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-10</startDate>
            <endDate>2025-09-10</endDate>
        </period>
    </context>
    <context id="cref_1797476635">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-10</instant>
        </period>
    </context>
    <context id="cref_553879265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-09-10</instant>
        </period>
    </context>
    <context id="cref_551854395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-08</instant>
        </period>
    </context>
    <context id="cref_748934610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_826432462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_630293842">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_773573791">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1598084499">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1134712074">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_619454683">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1174554270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-10</startDate>
            <endDate>2025-09-10</endDate>
        </period>
    </context>
    <context id="cref_837726882">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-10</startDate>
            <endDate>2025-09-10</endDate>
        </period>
    </context>
    <context id="cref_194733324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-31</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1408966713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-08</startDate>
            <endDate>2025-08-08</endDate>
        </period>
    </context>
    <context id="cref_360148395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-25</instant>
        </period>
    </context>
    <context id="cref_1108974510">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-25</instant>
        </period>
    </context>
    <context id="cref_98240749">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_428742915">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:ClassAOrdinarySharesParValue00001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_2032037207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">tlnc:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnethirdOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_1638414482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_319930502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">tlnc:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1494614152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_901612146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="cref_1432657015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="cref_1401430648">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="cref_2094209686">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="cref_1062287955">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="cref_1009755242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002073340</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <unit id="uref_144417410">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_493518290">
        <measure>tlnc:Segment</measure>
    </unit>
    <unit id="uref_714491979">
        <measure>pure</measure>
    </unit>
    <unit id="uref_504548813">
        <measure>shares</measure>
    </unit>
    <unit id="uref_533780696">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1598680374"
      id="fc_1730245694"
      unitRef="uref_504548813"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1598680374"
      id="fc_314223251"
      unitRef="uref_504548813"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_1598680374"
      id="fc_889220744"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_1598680374"
      id="fc_1663220068"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="cref_1598680374"
      id="fc_329852981"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_1598680374"
      id="fc_551881478"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="cref_1598680374"
      id="fc_1991878236"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <dei:EntityPublicFloat
      contextRef="cref_1638414482"
      decimals="0"
      id="fc_1638414482"
      unitRef="uref_144417410">0</dei:EntityPublicFloat>
    <tlnc:WorkingCapitalLoan
      contextRef="cref_1598680374"
      id="fc_311650695"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <tlnc:WorkingCapitalLoan
      contextRef="cref_319930502"
      id="fc_319930502"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_1494614152"
      id="fc_1494614152"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_1598680374"
      id="fc_1417777316"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1598680374"
      id="fc_1674121332"
      unitRef="uref_504548813"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1598680374"
      id="fc_2010543561"
      unitRef="uref_504548813"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_901612146"
      id="fc_901612146"
      unitRef="uref_504548813"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_901612146"
      id="fc_2017060097"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1432657015"
      id="fc_1432657015"
      unitRef="uref_504548813"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1432657015"
      id="fc_1059445731"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1401430648"
      id="fc_1401430648"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_2094209686"
      id="fc_2094209686"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1062287955"
      id="fc_1062287955"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_619454683"
      id="fc_1492816628"
      unitRef="uref_504548813"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_619454683"
      id="fc_1690999302"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_773573791"
      id="fc_897486254"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1009755242"
      id="fc_1009755242"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_619454683"
      id="fc_563129179"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1134712074"
      id="fc_1964059568"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1598084499"
      id="fc_1865024795"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <tlnc:StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits
      contextRef="cref_1134712074"
      id="fc_75135273"
      unitRef="uref_504548813"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_144417410" id="fc_444643047">http://fasb.org/srt/2025#ChiefFinancialOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits
      contextRef="cref_1134712074"
      id="fc_200090691"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits
      contextRef="cref_773573791"
      id="fc_1848862879"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_619454683"
      id="fc_1017008916"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1134712074"
      id="fc_1590491764"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_773573791"
      id="fc_1229468603"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_619454683"
      id="fc_1965622921"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1134712074"
      id="fc_854596447"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_773573791"
      id="fc_1007521328"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_619454683"
      id="fc_471349154"
      unitRef="uref_504548813"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_619454683"
      id="fc_54547320"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_773573791"
      id="fc_1992560591"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_144417410"
      id="fc_1390649182"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_619454683"
      id="fc_2094758649"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_1134712074"
      id="fc_1230420796"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_773573791"
      id="fc_131382469"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_619454683"
      id="fc_855132543"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1134712074"
      id="fc_424924864"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1062287955"
      id="fc_764535795"
      unitRef="uref_144417410"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="cref_1363532388" id="ixv-7332">0002073340</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="cref_1363532388" id="ixv-7333">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_1363532388" id="ixv-7334">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityTaxIdentificationNumber contextRef="cref_1363532388" id="fc_226643184">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:DocumentType contextRef="cref_1363532388" id="ixv-8025">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="cref_1363532388" id="ixv-8026">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="cref_1363532388" id="ixv-8027">2025-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="cref_1363532388" id="ixv-8028">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_1363532388" id="ixv-8029">2025</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_1363532388" id="ixv-8030">false</dei:DocumentTransitionReport>
    <dei:EntityRegistrantName contextRef="cref_1363532388" id="ixv-8031">Talon Capital Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_1363532388" id="ixv-8032">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="cref_1363532388" id="ixv-8033">001-42827</dei:EntityFileNumber>
    <dei:EntityAddressAddressLine1 contextRef="cref_1363532388" id="ixv-8034">440 Louisiana Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="cref_1363532388" id="ixv-8035">Suite 1050</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="cref_1363532388" id="ixv-8036">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_1363532388" id="ixv-8037">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_1363532388" id="ixv-8038">77002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_1363532388" id="ixv-8039">(281)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_1363532388" id="ixv-8040">407-0686</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_2032037207" id="ixv-8041">Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_2032037207" id="ixv-8042">TLNCU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_2032037207" id="ixv-8043">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_428742915" id="ixv-8044">Class A ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_428742915" id="ixv-8045">TLNC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_428742915" id="ixv-8046">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_98240749" id="ixv-8047">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_98240749" id="ixv-8048">TLNCW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_98240749" id="ixv-8049">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="cref_1363532388" id="ixv-8050">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="cref_1363532388" id="ixv-8051">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="cref_1363532388" id="ixv-8052">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_1363532388" id="ixv-8053">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_1363532388" id="ixv-8054">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_1363532388" id="ixv-8055">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_1363532388" id="ixv-8056">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_1363532388" id="ixv-8057">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="cref_1363532388" id="ixv-8058">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="cref_1363532388" id="ixv-8059">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="cref_1363532388" id="ixv-8060">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1108974510"
      decimals="0"
      id="ixv-8061"
      unitRef="uref_504548813">25679000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_360148395"
      decimals="0"
      id="ixv-8062"
      unitRef="uref_504548813">8300000</dei:EntityCommonStockSharesOutstanding>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="cref_1363532388" id="ixv-8063">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="cref_1363532388" id="ixv-8064">We are a special purpose acquisition company with no business operations. Since our Initial Public Offering, our sole business activity has been identifying and evaluating suitable acquisition transaction candidates. Therefore, we do not consider that we face significant cybersecurity risk and have not adopted any cybersecurity risk management program or formal processes for assessing cybersecurity risk. Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if any. We have not encountered any cybersecurity incidents since our Initial Public Offering.</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="cref_1363532388" id="ixv-8065">Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if any. We have not encountered any cybersecurity incidents since our Initial Public Offering.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="cref_1363532388" id="ixv-8066">Our board of directors is generally responsible for the oversight of risks from cybersecurity threats, if any.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock contextRef="cref_1363532388" id="ixv-8067">We have not encountered any cybersecurity incidents since our Initial Public Offering.</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="cref_1363532388" id="ixv-8068">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_1363532388" id="ixv-8069">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_1363532388" id="ixv-8070">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_1363532388" id="ixv-8071">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_1363532388" id="ixv-8072">false</ecd:NonRule10b51ArrTrmntdFlag>
    <dei:AuditorOpinionTextBlock contextRef="cref_1363532388" id="ixv-5187">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;Opinion on the Financial Statements&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;We have audited the accompanying balance sheet of Talon Capital Corp. (the &#x201c;Company&#x201d;) as of December 31, 2025, the related statements of operations, changes in shareholders&#x2019; deficit and cash flows for the period from May 1, 2025 (inception) through December 31, 2025, and the related notes (collectively referred to as the &#x201c;financial statements&#x201d;). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2025, and the results of its operations and its cash flows for the period from May 1, 2025 (inception) through December 31, 2025 in conformity with accounting principles generally accepted in the United States of America.&lt;/p&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="cref_1363532388" id="ixv-8073">WithumSmith+Brown, PC</dei:AuditorName>
    <dei:AuditorLocation contextRef="cref_1363532388" id="ixv-8074">New York, New York</dei:AuditorLocation>
    <dei:AuditorFirmId contextRef="cref_1363532388" id="ixv-8075">100</dei:AuditorFirmId>
    <us-gaap:Cash
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8076"
      unitRef="uref_144417410">2872627</us-gaap:Cash>
    <us-gaap:OtherPrepaidExpenseCurrent
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8077"
      unitRef="uref_144417410">3443</us-gaap:OtherPrepaidExpenseCurrent>
    <us-gaap:PrepaidInsurance
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8078"
      unitRef="uref_144417410">77500</us-gaap:PrepaidInsurance>
    <us-gaap:AssetsCurrent
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8079"
      unitRef="uref_144417410">2953570</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseOtherNoncurrent
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8080"
      unitRef="uref_144417410">51667</us-gaap:PrepaidExpenseOtherNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8081"
      unitRef="uref_144417410">252095639</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8082"
      unitRef="uref_144417410">255100876</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8083"
      unitRef="uref_144417410">53702</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <tlnc:AccruedOfferingCosts
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8084"
      unitRef="uref_144417410">75000</tlnc:AccruedOfferingCosts>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8085"
      unitRef="uref_144417410">128702</us-gaap:LiabilitiesCurrent>
    <tlnc:DeferredUnderwritingFeeNoncurrent
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8086"
      unitRef="uref_144417410">10200000</tlnc:DeferredUnderwritingFeeNoncurrent>
    <us-gaap:Liabilities
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8087"
      unitRef="uref_144417410">10328702</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital
      contextRef="cref_1997855338"
      decimals="4"
      id="ixv-8088"
      unitRef="uref_144417410">0.0001</us-gaap:TemporaryEquityValueExcludingAdditionalPaidInCapital>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8089"
      unitRef="uref_504548813">24900000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_1997855338"
      decimals="2"
      id="ixv-8090"
      unitRef="uref_533780696">10.12</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8091"
      unitRef="uref_144417410">252012982</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_1598680374"
      decimals="4"
      id="ixv-8092"
      unitRef="uref_533780696">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8093"
      unitRef="uref_504548813">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1997855338"
      decimals="4"
      id="ixv-8094"
      unitRef="uref_533780696">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8095"
      unitRef="uref_504548813">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8096"
      unitRef="uref_504548813">779000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8097"
      unitRef="uref_504548813">779000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8098"
      unitRef="uref_144417410">78</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_504548813"
      decimals="4"
      id="fc_683422140"
      unitRef="uref_533780696">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_504548813"
      decimals="0"
      id="fc_2078487242"
      unitRef="uref_504548813">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_504548813"
      decimals="0"
      id="fc_727457337"
      unitRef="uref_504548813">8300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_504548813"
      decimals="0"
      id="fc_711145113"
      unitRef="uref_504548813">8300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_504548813"
      decimals="0"
      id="fc_201246941"
      unitRef="uref_144417410">830</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8104"
      unitRef="uref_144417410">-7241716</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8105"
      unitRef="uref_144417410">-7240808</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8106"
      unitRef="uref_144417410">255100876</us-gaap:LiabilitiesAndStockholdersEquity>
    <tlnc:NumberOfAdditionalFounderShareIssued
      contextRef="cref_551854395"
      decimals="0"
      id="ixv-8108"
      unitRef="uref_504548813">2875000</tlnc:NumberOfAdditionalFounderShareIssued>
    <tlnc:NumberOfFounderShareIssued
      contextRef="cref_551854395"
      decimals="0"
      id="ixv-8109"
      unitRef="uref_504548813">8625000</tlnc:NumberOfFounderShareIssued>
    <tlnc:NumberOfFounderShareOutstanding
      contextRef="cref_551854395"
      decimals="0"
      id="ixv-8110"
      unitRef="uref_504548813">8625000</tlnc:NumberOfFounderShareOutstanding>
    <tlnc:NumberOfSharesSubjectToForfeiture
      contextRef="cref_504548813"
      decimals="0"
      id="ixv-8112"
      unitRef="uref_504548813">1125000</tlnc:NumberOfSharesSubjectToForfeiture>
    <tlnc:NumberOfShareSubjectNotToForfeiture
      contextRef="cref_880262097"
      decimals="0"
      id="ixv-8113"
      unitRef="uref_504548813">800000</tlnc:NumberOfShareSubjectNotToForfeiture>
    <tlnc:NumberOfSharesSubjectToForfeiture
      contextRef="cref_880262097"
      decimals="0"
      id="ixv-8114"
      unitRef="uref_504548813">325000</tlnc:NumberOfSharesSubjectToForfeiture>
    <tlnc:NumberOfFounderSharesHolding
      contextRef="cref_553879265"
      decimals="0"
      id="ixv-8115"
      unitRef="uref_504548813">8260000</tlnc:NumberOfFounderSharesHolding>
    <tlnc:NumberOfFounderSharesHolding
      contextRef="cref_1797476635"
      decimals="0"
      id="ixv-8116"
      unitRef="uref_504548813">40000</tlnc:NumberOfFounderSharesHolding>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8117"
      unitRef="uref_144417410">546385</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8118"
      unitRef="uref_144417410">-546385</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8119"
      unitRef="uref_144417410">3171560</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8120"
      unitRef="uref_144417410">3171560</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8121"
      unitRef="uref_144417410">2625175</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_198494574"
      decimals="0"
      id="ixv-8122"
      unitRef="uref_504548813">11787082</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_198494574"
      decimals="0"
      id="ixv-8123"
      unitRef="uref_504548813">11787082</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_198494574"
      decimals="2"
      id="ixv-8124"
      unitRef="uref_533780696">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_198494574"
      decimals="2"
      id="ixv-8125"
      unitRef="uref_533780696">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1115681054"
      decimals="0"
      id="fc_388358174"
      unitRef="uref_504548813">7867213</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1115681054"
      decimals="0"
      id="fc_1591609912"
      unitRef="uref_504548813">7867213</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1115681054"
      decimals="2"
      id="ixv-8128"
      unitRef="uref_533780696">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1115681054"
      decimals="2"
      id="ixv-8129"
      unitRef="uref_533780696">0.13</us-gaap:EarningsPerShareDiluted>
    <tlnc:NumberOfAdditionalFounderSharesIssued
      contextRef="cref_1408966713"
      decimals="0"
      id="ixv-8131"
      unitRef="uref_504548813">2875000</tlnc:NumberOfAdditionalFounderSharesIssued>
    <tlnc:NumberOfFounderSharesOutstanding
      contextRef="cref_1408966713"
      decimals="0"
      id="ixv-8132"
      unitRef="uref_504548813">8625000</tlnc:NumberOfFounderSharesOutstanding>
    <tlnc:NumberOfFounderSharesIssued
      contextRef="cref_1408966713"
      decimals="0"
      id="ixv-8133"
      unitRef="uref_504548813">8625000</tlnc:NumberOfFounderSharesIssued>
    <tlnc:NumberOfShareSubjectToForfeiture
      contextRef="cref_194733324"
      decimals="0"
      id="ixv-8134"
      unitRef="uref_504548813">1125000</tlnc:NumberOfShareSubjectToForfeiture>
    <tlnc:NumberOfSharesSubjectNotToForfeiture
      contextRef="cref_1878519263"
      decimals="0"
      id="ixv-8135"
      unitRef="uref_504548813">800000</tlnc:NumberOfSharesSubjectNotToForfeiture>
    <tlnc:NumberOfShareSubjectToForfeiture
      contextRef="cref_1878519263"
      decimals="0"
      id="ixv-8136"
      unitRef="uref_504548813">325000</tlnc:NumberOfShareSubjectToForfeiture>
    <tlnc:NumberOfFounderShareHolding
      contextRef="cref_837726882"
      decimals="0"
      id="ixv-8137"
      unitRef="uref_504548813">8260000</tlnc:NumberOfFounderShareHolding>
    <tlnc:NumberOfFounderShareHolding
      contextRef="cref_1174554270"
      decimals="0"
      id="ixv-8138"
      unitRef="uref_504548813">40000</tlnc:NumberOfFounderShareHolding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1134712074"
      decimals="0"
      id="fc_2135791975"
      unitRef="uref_504548813">8625000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1134712074"
      decimals="0"
      id="ixv-8140"
      unitRef="uref_144417410">863</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1598084499"
      decimals="0"
      id="ixv-8141"
      unitRef="uref_144417410">24137</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8142"
      unitRef="uref_144417410">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <tlnc:SaleOfStockNumberOfSharesIssued
      contextRef="cref_144417410"
      decimals="0"
      id="fc_1814512358"
      unitRef="uref_504548813">779000</tlnc:SaleOfStockNumberOfSharesIssued>
    <tlnc:StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits
      contextRef="cref_619454683"
      decimals="0"
      id="ixv-8144"
      unitRef="uref_504548813">779000</tlnc:StockIssuedDuringPeriodSharesSaleOfPrivatePlacementUnits>
    <tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits
      contextRef="cref_619454683"
      decimals="0"
      id="ixv-8145"
      unitRef="uref_144417410">78</tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits>
    <tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits
      contextRef="cref_1598084499"
      decimals="0"
      id="ixv-8146"
      unitRef="uref_144417410">7789922</tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits>
    <tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8147"
      unitRef="uref_144417410">7790000</tlnc:StockIssuedDuringPeriodValueSaleOfPrivatePlacementUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_1598084499"
      decimals="0"
      id="ixv-8148"
      unitRef="uref_144417410">1817700</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8149"
      unitRef="uref_144417410">1817700</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_1598084499"
      decimals="0"
      id="ixv-8150"
      unitRef="uref_144417410">122734</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8151"
      unitRef="uref_144417410">122734</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_1134712074"
      decimals="0"
      id="fc_1780571263"
      unitRef="uref_504548813">-325000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_1134712074"
      decimals="0"
      id="ixv-8153"
      unitRef="uref_144417410">-33</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="cref_1598084499"
      decimals="0"
      id="ixv-8154"
      unitRef="uref_144417410">33</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_1598084499"
      decimals="0"
      id="ixv-8155"
      unitRef="uref_144417410">74000</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8156"
      unitRef="uref_144417410">74000</us-gaap:AdjustmentsToAdditionalPaidInCapitalMarkToMarket>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1598084499"
      decimals="0"
      id="ixv-8157"
      unitRef="uref_144417410">9583058</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_773573791"
      decimals="0"
      id="ixv-8158"
      unitRef="uref_144417410">9866891</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8159"
      unitRef="uref_144417410">19449949</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_773573791"
      decimals="0"
      id="ixv-8160"
      unitRef="uref_144417410">2625175</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8161"
      unitRef="uref_144417410">2625175</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_630293842"
      decimals="0"
      id="ixv-8162"
      unitRef="uref_504548813">779000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_630293842"
      decimals="0"
      id="ixv-8163"
      unitRef="uref_144417410">78</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_826432462"
      decimals="0"
      id="fc_678866056"
      unitRef="uref_504548813">8300000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_826432462"
      decimals="0"
      id="ixv-8165"
      unitRef="uref_144417410">830</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_748934610"
      decimals="0"
      id="ixv-8166"
      unitRef="uref_144417410">-7241716</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8167"
      unitRef="uref_144417410">-7240808</us-gaap:StockholdersEquity>
    <tlnc:NumberOfAdditionalFounderShareIssued
      contextRef="cref_551854395"
      decimals="0"
      id="fc_422495093"
      unitRef="uref_504548813">2875000</tlnc:NumberOfAdditionalFounderShareIssued>
    <tlnc:NumberOfFounderShareIssued
      contextRef="cref_551854395"
      decimals="0"
      id="fc_1406517433"
      unitRef="uref_504548813">8625000</tlnc:NumberOfFounderShareIssued>
    <tlnc:NumberOfFounderShareOutstanding
      contextRef="cref_551854395"
      decimals="0"
      id="fc_551854395"
      unitRef="uref_504548813">8625000</tlnc:NumberOfFounderShareOutstanding>
    <tlnc:NumberOfSharesSubjectToForfeiture
      contextRef="cref_504548813"
      decimals="0"
      id="fc_88804847"
      unitRef="uref_504548813">1125000</tlnc:NumberOfSharesSubjectToForfeiture>
    <tlnc:NumberOfShareSubjectNotToForfeiture
      contextRef="cref_880262097"
      decimals="0"
      id="fc_22075095"
      unitRef="uref_504548813">800000</tlnc:NumberOfShareSubjectNotToForfeiture>
    <tlnc:NumberOfSharesSubjectToForfeiture
      contextRef="cref_880262097"
      decimals="0"
      id="fc_1235998977"
      unitRef="uref_504548813">325000</tlnc:NumberOfSharesSubjectToForfeiture>
    <tlnc:NumberOfFounderSharesHolding
      contextRef="cref_553879265"
      decimals="0"
      id="fc_553879265"
      unitRef="uref_504548813">8260000</tlnc:NumberOfFounderSharesHolding>
    <tlnc:NumberOfFounderSharesHolding
      contextRef="cref_1797476635"
      decimals="0"
      id="ixv-8177"
      unitRef="uref_504548813">40000</tlnc:NumberOfFounderSharesHolding>
    <us-gaap:NetIncomeLoss
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8178"
      unitRef="uref_144417410">2625175</us-gaap:NetIncomeLoss>
    <tlnc:PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8179"
      unitRef="uref_144417410">10420</tlnc:PaymentOfOperatingExpensesThroughAdvancesFromRelatedParty>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8180"
      unitRef="uref_144417410">3171560</us-gaap:InvestmentIncomeInterest>
    <tlnc:CashWithdrawnFromTrustAccountForWorkingCapitalPurposes
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8181"
      unitRef="uref_144417410">75921</tlnc:CashWithdrawnFromTrustAccountForWorkingCapitalPurposes>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8182"
      unitRef="uref_144417410">74000</us-gaap:ShareBasedCompensation>
    <us-gaap:IncreaseDecreaseInPrepaidExpensesOther
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8183"
      unitRef="uref_144417410">80943</us-gaap:IncreaseDecreaseInPrepaidExpensesOther>
    <us-gaap:IncreaseDecreaseInPrepaidInsurance
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8184"
      unitRef="uref_144417410">51667</us-gaap:IncreaseDecreaseInPrepaidInsurance>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8185"
      unitRef="uref_144417410">53702</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8186"
      unitRef="uref_144417410">-464952</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireTrustPreferredInvestments
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8187"
      unitRef="uref_144417410">249000000</us-gaap:PaymentsToAcquireTrustPreferredInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8188"
      unitRef="uref_144417410">-249000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8189"
      unitRef="uref_144417410">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromOtherEquity
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8190"
      unitRef="uref_144417410">244260000</us-gaap:ProceedsFromOtherEquity>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8191"
      unitRef="uref_144417410">7790000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <tlnc:ProceedsFromSaleOfUnderwritersReimbursement
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8192"
      unitRef="uref_144417410">-700000</tlnc:ProceedsFromSaleOfUnderwritersReimbursement>
    <us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8193"
      unitRef="uref_144417410">-39936</us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8194"
      unitRef="uref_144417410">83927</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8195"
      unitRef="uref_144417410">83927</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8196"
      unitRef="uref_144417410">397485</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8197"
      unitRef="uref_144417410">252337579</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8198"
      unitRef="uref_144417410">2872627</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8199"
      unitRef="uref_144417410">2872627</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <tlnc:DeferredOfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8200"
      unitRef="uref_144417410">75000</tlnc:DeferredOfferingCostsIncludedInAccruedOfferingCosts>
    <tlnc:DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8201"
      unitRef="uref_144417410">29516</tlnc:DeferredOfferingCostsPaidThroughAdvancesFromRelatedParty>
    <tlnc:DeferredUnderwritingFeePayable
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8202"
      unitRef="uref_144417410">10200000</tlnc:DeferredUnderwritingFeePayable>
    <tlnc:ForfeitureOfFounderShares
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8203"
      unitRef="uref_144417410">33</tlnc:ForfeitureOfFounderShares>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_1363532388" id="ixv-6511">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;span id="a_032" style="display: inline-block;"&gt;&lt;/span&gt;1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; Talon Capital Corp. (the &#x201c;Company&#x201d;) was incorporated as a Cayman Islands exempted company on May&#160;1, 2025. The Company is a newly organized blank check company or special purpose acquisition company (&#x201c;SPAC&#x201d;), formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses (the &#x201c;Business Combination&#x201d;). The Company has not selected any specific Business Combination target. Its efforts to identify a prospective target business will not be limited to a particular industry or geographic region although it intends to focus on target businesses in the energy and power industries. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; As of December 31, 2025, the Company had not commenced any operations. All activity for the period from May&#160;1, 2025 (inception) through December 31, 2025 relates to the Company&#x2019;s formation, the initial public offering (the &#x201c;Initial Public Offering&#x201d;), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after completion of the Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on investments from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31 as its fiscal year end. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The registration statement for the Company&#x2019;s Initial Public Offering was declared effective on September 8, 2025. On September 10, 2025, the Company consummated the Initial Public Offering of 24,900,000 units (the &#x201c;Units&#x201d; and, with respect to the Class A ordinary shares included in the Units being offered, the &#x201c;Public Shares&#x201d;), which includes the partial exercise by the underwriters of their over-allotment option in the amount of 2,400,000 Units, at $10.00 per Unit, generating gross proceeds of $249,000,000. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (each, a &#x201c;Public Warrant&#x201d;). &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 779,000 units (the &#x201c;Private Placement Units&#x201d;) at a price of $10.00 per Private Placement Unit, in a private placement to the Company&#x2019;s sponsor, Talon Capital Sponsor LLC (the &#x201c;Sponsor&#x201d;) and Cohen and Company Capital Markets, a division of Cohen &amp;amp; Company Securities, LLC (&#x201c;Cohen&#x201d;), as representative of the underwriters, generating gross proceeds of $7,790,000. Each Private Placement Unit consists of one Class A ordinary share and one-third of one redeemable warrant (the &#x201c;Private Placement Warrants&#x201d; and together with the Public Warrants, the &#x201c;Warrants&#x201d;). Each whole Warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Of those 779,000 Private Placement Units, the Sponsor purchased 530,000 Private Placement Units, and Cohen purchased 249,000 Private Placement Units. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; Transaction costs amounted to $14,742,001, consisting of $4,040,000 of cash underwriting fees (net of $700,000 underwriters&#x2019; reimbursement), $10,200,000 of deferred underwriting fees, and $502,001 of other offering costs. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; Following the closing of the Initial Public Offering, on September 10, 2025, an amount of $249,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units and the Private Placement Units was placed in the trust account (the &#x201c;Trust Account&#x201d;), located in the United States, and will be invested or held only in either (i)&#160;U.S.&#160;government treasury obligations with a maturity of 185&#160;days or less or in money market funds meeting certain conditions under&#160;Rule&#160;2a-7&#160;under&#160;the&#160;Investment Company Act&#160;of&#160;1940 which invest only in direct U.S.&#160;government treasury obligations, (ii)&#160;as uninvested cash, or (iii)&#160;an interest bearing bank demand deposit account or other accounts at a bank. Funds will remain in the Trust Account until the earlier of (i)&#160;the completion of the Business Combination or (ii)&#160;the distribution of the Trust Account as described below. The Company is permitted to withdraw amounts from the Trust Account (i) to fund its working capital requirements, which amount will be the lesser of $500,000 or 5% of the interest earned on the Trust Account per annum, and/or (ii) to pay its taxes (other than excise taxes, if any), provided that all permitted withdrawals can only be made (x) from interest and not from the principal held in the Trust Account and (y) only to the extent such interest is in amount sufficient to cover the permitted withdrawal amount (&#x201c;permitted withdrawals&#x201d;). On November 13, 2025 the Company withdrew $75,921 from the Trust Account for working capital purposes. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company will provide the holders of the public units, or the &#x201c;public shareholders,&#x201d; with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination at a&#160;per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account as of two&#160;business days prior to consummation of the initial Business Combination, including interest (which interest shall be net of permitted withdrawals), divided by the number of then issued and outstanding public shares, subject to limitations. The amount in the Trust Account is initially invested at $10.00 per public share. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company&#x2019;s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering, although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, &#x201c;Target Business&#x201d; must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less the deferred underwriting commissions and the taxes payable on interest earned) at the time the Company signs a definitive agreement in connection with the Business Combination. There is no assurance that the Company will be able to successfully effect a Business Combination. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company, after signing a definitive agreement for a Business Combination, will either (i)&#160;seek shareholder approval of the Business Combination at a meeting called for such purpose in connection with which shareholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account including interest (which interest shall be net of taxes payable) or (ii)&#160;provide shareholders with the opportunity to have their shares redeemed by the Company by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account, net of taxes payable, if any. The decision as to whether the Company will seek shareholder approval of the Business Combination or will allow shareholders to redeem their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval unless a vote is required by the Nasdaq rules. If the Company seeks shareholder approval, it will complete its Business Combination only if a majority of the outstanding shares are voted in favor of the Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company will have 24&#160;months from the closing date of the Initial Public Offering to complete its initial Business Combination. If the Company does not complete a Business Combination within this period of time, it shall (i)&#160;cease all operations except for the purposes of winding up; (ii)&#160;as promptly as reasonably possible, but not more than ten (10)&#160;business&#160;days thereafter, redeem 100% of the outstanding public shares, at a&#160;per-share&#160;price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of permitted withdrawals, and up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii)&#160;as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the Board of Directors, liquidate and dissolve, subject (in the case of (ii)&#160;and (iii)&#160;above) to obligations under the Cayman Islands laws to provide for claims of creditors and the requirements of other applicable law. The initial shareholders will each enter into agreements with the Company, pursuant to which they will agree (1)&#160;to waive their redemption rights with respect to their founder shares, private placement units and any Class&#160;A ordinary shares issuable upon conversion thereof in connection with the consummation of the initial Business Combination or a tender offer conducted prior to a Business Combination or in connection with it; and (2)&#160;to waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and private placement units if the Company fails to complete the initial Business Combination within 24&#160;months from the closing of this offering, although they will be entitled to liquidating distributions from the Trust Account with respect to any public shares they hold if the Company fails to complete the initial Business Combination within the prescribed time frame. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The ordinary shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 480, &#x201c;Distinguishing Liabilities from Equity.&#x201d;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Liquidity&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company&#x2019;s liquidity needs up to December 31, 2025 had been satisfied through the loan under an unsecured promissory note from the Sponsor of up to $250,000. On September 10, 2025, Simultaneously with the closing of the initial public offering, the Company consummated the sale of 779,000 private placement units at a price of $10.00 per private placement unit, generating gross proceeds of $7,790,000. On November 13, the Company withdrew cash from the Trust Account for working capital purposes of $75,921. As of December 31, 2025, the Company had cash of $2,872,627 and working capital surplus of $2,824,868. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company&#x2019;s officers and directors may, but is not obligated to, loan the Company funds as may be required (the &#x201c;Working Capital Loans&#x201d;). If the Company completes a Business Combination, the Company would repay such loaned amounts at that time. Up to $1,500,000 of such Working Capital Loans may be converted into units upon consummation of the Business Combination at a price of $10.00 per unit. The units would be identical to the Private Placement Units. As of December 31, 2025, the Company had &lt;span style="-sec-ix-hidden:fc_311650695"&gt;no&lt;/span&gt; borrowings under the Working Capital Loans. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;In connection with the Company&#x2019;s assessment of going concern considerations in accordance with ASC 205-40, &#x201c;Presentation of Financial Statements - Going Concern,&#x201d; the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. The Company will have 24 months from the closing of the Initial Public Offering to complete the initial Business Combination. Management has determined that the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the financial statements.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="cref_144417410" id="ixv-8204">2025-05-01</dei:EntityIncorporationDateOfIncorporation>
    <tlnc:YearOfInception contextRef="cref_144417410" id="ixv-8205">May&#160;1, 2025 (inception) through December 31, 2025</tlnc:YearOfInception>
    <tlnc:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_224377445"
      decimals="0"
      id="ixv-8206"
      unitRef="uref_504548813">24900000</tlnc:UnitsIssuedDuringPeriodSharesNewIssues>
    <tlnc:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1878519263"
      decimals="0"
      id="ixv-8207"
      unitRef="uref_504548813">2400000</tlnc:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_880262097"
      decimals="2"
      id="ixv-8208"
      unitRef="uref_533780696">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_458958402"
      decimals="0"
      id="ixv-8209"
      unitRef="uref_144417410">249000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_1760969002"
      decimals="0"
      id="ixv-8210"
      unitRef="uref_504548813">779000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1077089133"
      decimals="2"
      id="ixv-8211"
      unitRef="uref_533780696">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_254867204"
      decimals="0"
      id="ixv-8212"
      unitRef="uref_144417410">7790000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="cref_1853513846"
      decimals="0"
      id="ixv-8213"
      unitRef="uref_504548813">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1853513846"
      decimals="2"
      id="ixv-8214"
      unitRef="uref_533780696">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_1077089133"
      decimals="0"
      id="ixv-8215"
      unitRef="uref_504548813">779000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_1640571159"
      decimals="0"
      id="ixv-8216"
      unitRef="uref_504548813">530000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_1637193316"
      decimals="0"
      id="ixv-8217"
      unitRef="uref_504548813">249000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <tlnc:TransactionCosts
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8218"
      unitRef="uref_144417410">14742001</tlnc:TransactionCosts>
    <tlnc:CashUnderwritingFee
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8219"
      unitRef="uref_144417410">4040000</tlnc:CashUnderwritingFee>
    <tlnc:ProceedsFromSaleOfUnderwritersReimbursement
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8220"
      unitRef="uref_144417410">-700000</tlnc:ProceedsFromSaleOfUnderwritersReimbursement>
    <tlnc:DeferredUnderwritingFee
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8221"
      unitRef="uref_144417410">10200000</tlnc:DeferredUnderwritingFee>
    <tlnc:OtherOfferingCosts
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8222"
      unitRef="uref_144417410">502001</tlnc:OtherOfferingCosts>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_458958402"
      decimals="0"
      id="ixv-8223"
      unitRef="uref_144417410">249000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1620148570"
      decimals="2"
      id="ixv-8224"
      unitRef="uref_533780696">10</us-gaap:SharesIssuedPricePerShare>
    <tlnc:NoOfMaturityDays contextRef="cref_1979561439" id="ixv-8225">P185D</tlnc:NoOfMaturityDays>
    <tlnc:AdvanceReceivedForWorkingCapital
      contextRef="cref_1979561439"
      decimals="0"
      id="ixv-8226"
      unitRef="uref_144417410">500000</tlnc:AdvanceReceivedForWorkingCapital>
    <tlnc:InterestEarnedOnTheTrustAccountPerAnnum
      contextRef="cref_1979561439"
      decimals="2"
      id="ixv-8227"
      unitRef="uref_714491979">0.05</tlnc:InterestEarnedOnTheTrustAccountPerAnnum>
    <tlnc:CashWithdrawnFromTrustAccountForWorkingCapitalPurposes
      contextRef="cref_1352034729"
      decimals="0"
      id="ixv-8228"
      unitRef="uref_144417410">75921</tlnc:CashWithdrawnFromTrustAccountForWorkingCapitalPurposes>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1598680374"
      decimals="2"
      id="ixv-8229"
      unitRef="uref_533780696">10</us-gaap:SharesIssuedPricePerShare>
    <tlnc:MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance
      contextRef="cref_900732289"
      decimals="2"
      id="ixv-8230"
      unitRef="uref_714491979">0.80</tlnc:MinimumPercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance>
    <tlnc:InitialBusinessCombinationOrToRedeemPercentage
      contextRef="cref_144417410"
      decimals="2"
      id="ixv-8231"
      unitRef="uref_714491979">1</tlnc:InitialBusinessCombinationOrToRedeemPercentage>
    <tlnc:MaximumNetInterestToPayDissolutionExpenses
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8232"
      unitRef="uref_144417410">100000</tlnc:MaximumNetInterestToPayDissolutionExpenses>
    <us-gaap:UnsecuredDebt
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8233"
      unitRef="uref_144417410">250000</us-gaap:UnsecuredDebt>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_966747690"
      decimals="0"
      id="ixv-8234"
      unitRef="uref_504548813">779000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1789825159"
      decimals="2"
      id="ixv-8235"
      unitRef="uref_533780696">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_540106651"
      decimals="0"
      id="ixv-8236"
      unitRef="uref_144417410">7790000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <tlnc:CashWithdrawnFromTrustAccountForWorkingCapitalPurposes
      contextRef="cref_1543401983"
      decimals="0"
      id="ixv-8237"
      unitRef="uref_144417410">75921</tlnc:CashWithdrawnFromTrustAccountForWorkingCapitalPurposes>
    <us-gaap:Cash
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8238"
      unitRef="uref_144417410">2872627</us-gaap:Cash>
    <tlnc:WorkingCapitalDeficit
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8239"
      unitRef="uref_144417410">2824868</tlnc:WorkingCapitalDeficit>
    <tlnc:WorkingCapitalLoan
      contextRef="cref_1715140789"
      decimals="0"
      id="ixv-8240"
      unitRef="uref_144417410">1500000</tlnc:WorkingCapitalLoan>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1598680374"
      decimals="2"
      id="ixv-8241"
      unitRef="uref_533780696">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_1363532388" id="ixv-6556">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The preparation of the financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company considers all short-term investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company has $2,872,627 in cash and &lt;span style="-sec-ix-hidden:fc_329852981"&gt;no&lt;/span&gt; cash equivalents as of December 31, 2025. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; As of December 31, 2025, the assets held in the Trust Account, amounting to $252,095,639, were held in a demand deposit account. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the warrants and to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Warrants and Private Placement Units were charged to shareholders&#x2019; deficit as Public Warrants and Private Placement Warrants after management&#x2019;s evaluation were accounted for under equity treatment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company follows the asset and liability method of accounting for income taxes under ASC&#160;740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC&#160;740&#x201d;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; ASC&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were &lt;span style="-sec-ix-hidden:fc_551881478"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_1991878236"&gt;no&lt;/span&gt; amounts accrued for interest and penalties as of December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands, and the Company believes it is presently not subject to income taxes or income tax filing requirements in the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Warrant Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company accounted for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s balance sheet.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;As of December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;249,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,817,700&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left"&gt;Class A ordinary shares issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,619,267&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,449,949&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Class A ordinary shares subject to possible redemption, December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;252,012,982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Income per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; Net income per ordinary share is computed by dividing net income by the weighted average number of shares of ordinary shares outstanding for the period. The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary Shares and Class&#160;B ordinary shares. Accretion associated with the redeemable shares of Class&#160;A Ordinary Shares is excluded from income per ordinary share as the redemption value approximates fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period from&lt;br/&gt; May 1, 2025&lt;br/&gt; (Inception) Through&lt;br/&gt; December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Allocation of net income, as adjusted&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,574,371&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,050,804&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Basic weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,787,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,867,213&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period from&lt;br/&gt; May 1, 2025&lt;br/&gt; (Inception) Through&lt;br/&gt; December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Diluted net income per ordinary share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Diluted net income per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Allocation of net income, as adjusted&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,574,371&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,050,804&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,787,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,867,213&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted net income per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;In November&#160;2023, the FASB issued ASU&#160;2023-07,&#x201d;&lt;i&gt;Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures&lt;/i&gt;&#x201d;. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic&#160;280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU&#160;2023-07 on May&#160;1, 2025, inception (see Note 8 for more information).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="cref_1363532388" id="ixv-6561">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Basis of Presentation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The accompanying financial statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;).&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <tlnc:EmergingGrowthCompanyPolicyTextBlock contextRef="cref_1363532388" id="ixv-6568">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Emerging Growth Company&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange&#160;Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</tlnc:EmergingGrowthCompanyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_1363532388" id="ixv-6592">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The preparation of the financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements.&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="cref_1363532388" id="ixv-6603">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash and Cash Equivalents&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company considers all short-term investments with an original maturity of three&#160;months or less when purchased to be cash equivalents. The Company has $2,872,627 in cash and &lt;span style="-sec-ix-hidden:fc_329852981"&gt;no&lt;/span&gt; cash equivalents as of December 31, 2025. &lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8242"
      unitRef="uref_144417410">2872627</us-gaap:Cash>
    <tlnc:CashHeldInTrustAccountPolicyTextBlock contextRef="cref_1363532388" id="ixv-6613">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Cash Held in Trust Account&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; As of December 31, 2025, the assets held in the Trust Account, amounting to $252,095,639, were held in a demand deposit account. &lt;/p&gt;</tlnc:CashHeldInTrustAccountPolicyTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8243"
      unitRef="uref_144417410">252095639</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="cref_1363532388" id="ixv-6620">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Concentration of Credit Risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashFDICInsuredAmount
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8244"
      unitRef="uref_144417410">250000</us-gaap:CashFDICInsuredAmount>
    <tlnc:OfferingCostsPolicyTextBlock contextRef="cref_1363532388" id="ixv-6629">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Offering Costs&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering.&#x201d; Offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the warrants and to the Class A ordinary shares. Offering costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public Warrants and Private Placement Units were charged to shareholders&#x2019; deficit as Public Warrants and Private Placement Warrants after management&#x2019;s evaluation were accounted for under equity treatment.&lt;/p&gt;</tlnc:OfferingCostsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_1363532388" id="ixv-6638">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company follows the asset and liability method of accounting for income taxes under ASC&#160;740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC&#160;740&#x201d;). Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the&#160;years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; ASC&#160;740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were &lt;span style="-sec-ix-hidden:fc_551881478"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_1991878236"&gt;no&lt;/span&gt; amounts accrued for interest and penalties as of December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands, and the Company believes it is presently not subject to income taxes or income tax filing requirements in the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the period presented.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cref_1363532388" id="ixv-6651">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Fair Value of Financial Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC&#160;820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:DerivativesPolicyTextBlock contextRef="cref_1363532388" id="ixv-6665">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Warrant Instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company accounted for the Public Warrants and Private Placement Warrants issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic&#160;815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and classified the warrant instruments under equity treatment at their assigned values.&lt;/p&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="cref_1363532388" id="ixv-6672">&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, or if there is a shareholder vote or tender offer in connection with the Company&#x2019;s initial Business Combination. In accordance with ASC 480-10-S99, the Company classifies Public Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the Company&#x2019;s balance sheet.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;As of December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;249,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,817,700&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left"&gt;Class A ordinary shares issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,619,267&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,449,949&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Class A ordinary shares subject to possible redemption, December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;252,012,982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="cref_1363532388" id="ixv-6679">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;As of December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the balance sheet are reconciled in the following table:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;249,000,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;Less:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(1,817,700&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left"&gt;Class A ordinary shares issuance costs&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(14,619,267&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td&gt;Plus:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;19,449,949&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Class A ordinary shares subject to possible redemption, December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;252,012,982&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_81526736"
      decimals="0"
      id="ixv-8245"
      unitRef="uref_144417410">249000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="cref_81526736"
      decimals="0"
      id="ixv-8246"
      unitRef="uref_144417410">1817700</us-gaap:ProceedsFromIssuanceOfWarrants>
    <tlnc:ClassAOrdinarySharesIssuanceCosts
      contextRef="cref_81526736"
      decimals="0"
      id="ixv-8247"
      unitRef="uref_144417410">-14619267</tlnc:ClassAOrdinarySharesIssuanceCosts>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="cref_81526736"
      decimals="0"
      id="ixv-8248"
      unitRef="uref_144417410">19449949</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_726559528"
      decimals="0"
      id="ixv-8249"
      unitRef="uref_144417410">252012982</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_1363532388" id="ixv-6726">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Net Income per Ordinary Share&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; Net income per ordinary share is computed by dividing net income by the weighted average number of shares of ordinary shares outstanding for the period. The Company has two classes of ordinary shares, which are referred to as Class&#160;A ordinary Shares and Class&#160;B ordinary shares. Accretion associated with the redeemable shares of Class&#160;A Ordinary Shares is excluded from income per ordinary share as the redemption value approximates fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period from&lt;br/&gt; May 1, 2025&lt;br/&gt; (Inception) Through&lt;br/&gt; December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Allocation of net income, as adjusted&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,574,371&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,050,804&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Basic weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,787,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,867,213&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period from&lt;br/&gt; May 1, 2025&lt;br/&gt; (Inception) Through&lt;br/&gt; December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Diluted net income per ordinary share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Diluted net income per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Allocation of net income, as adjusted&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,574,371&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,050,804&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,787,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,867,213&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted net income per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cref_1363532388" id="ixv-6733">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per share amounts):&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period from&lt;br/&gt; May 1, 2025&lt;br/&gt; (Inception) Through&lt;br/&gt; December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Allocation of net income, as adjusted&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,574,371&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,050,804&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Basic weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,787,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,867,213&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Basic net income per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period from&lt;br/&gt; May 1, 2025&lt;br/&gt; (Inception) Through&lt;br/&gt; December 31, 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1.5pt solid; font-weight: bold"&gt;Diluted net income per ordinary share&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Diluted net income per ordinary share&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td&gt;Numerator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 76%; text-align: left"&gt;Allocation of net income, as adjusted&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,574,371&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;1,050,804&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td&gt;Denominator:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="padding-bottom: 1.5pt"&gt;Diluted weighted average shares outstanding&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;11,787,082&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;7,867,213&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Diluted net income per ordinary share&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 4pt double; text-align: right"&gt;0.13&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_198494574"
      decimals="0"
      id="ixv-8250"
      unitRef="uref_144417410">1574371</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1115681054"
      decimals="0"
      id="ixv-8251"
      unitRef="uref_144417410">1050804</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_198494574"
      decimals="0"
      id="ixv-8252"
      unitRef="uref_504548813">11787082</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1115681054"
      decimals="0"
      id="ixv-8253"
      unitRef="uref_504548813">7867213</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_198494574"
      decimals="2"
      id="ixv-8254"
      unitRef="uref_533780696">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1115681054"
      decimals="2"
      id="ixv-8255"
      unitRef="uref_533780696">0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_198494574"
      decimals="0"
      id="ixv-8256"
      unitRef="uref_144417410">1574371</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1115681054"
      decimals="0"
      id="ixv-8257"
      unitRef="uref_144417410">1050804</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_198494574"
      decimals="0"
      id="ixv-8258"
      unitRef="uref_504548813">11787082</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1115681054"
      decimals="0"
      id="ixv-8259"
      unitRef="uref_504548813">7867213</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_198494574"
      decimals="2"
      id="ixv-8260"
      unitRef="uref_533780696">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1115681054"
      decimals="2"
      id="ixv-8261"
      unitRef="uref_533780696">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_1363532388" id="ixv-6894">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Recent Accounting Standards&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;In November&#160;2023, the FASB issued ASU&#160;2023-07,&#x201d;&lt;i&gt;Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures&lt;/i&gt;&#x201d;. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating officer decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently required by Topic&#160;280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in this ASU and existing segment disclosures in Topic&#160;280. This ASU is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU&#160;2023-07 on May&#160;1, 2025, inception (see Note 8 for more information).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company&#x2019;s financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <tlnc:InitialPublicOfferingTextBlock contextRef="cref_1363532388" id="ixv-6904">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;3. INITIAL PUBLIC OFFERING&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; In the Initial Public Offering on September 10, 2025, the Company sold 24,900,000&#160;Units, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 2,400,000 Units, at a price of $10.00 per Unit. Each Unit consists of one Public Share, $0.0001 par value, and one-third of one redeemable Public Warrant. The Warrants will only be exercisable for whole shares at $11.50 per share. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; &lt;span style="font-weight: bold;"&gt;Warrants&#160;&#x2014;&lt;/span&gt;&#160;As of December 31, 2025, there were 8,559,667 Warrants outstanding, including 8,300,000 Public Warrants and 259,667 Private Placement Warrants. Each whole warrant entitles the registered holder to purchase one Class&#160;A ordinary share at a price of $11.50 per share, at any time commencing on the later of 12&#160;months from the closing of the Initial Public Offering and after the completion of the initial Business Combination. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class&#160;A ordinary shares. This means that only a whole warrant may be exercised at any given time by a warrant holder. No fractional warrants will be issued upon separation of the Units&#160;and only whole warrants will trade. The warrants will expire at 5:00&#160;p.m., New&#160;York City time, on the fifth anniversary of the completion of an initial Business Combination, or earlier upon redemption. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; In addition, if (x)&#160;the Company issues additional Class&#160;A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class&#160;A ordinary share (with such issue price or effective issue price to be determined in good faith by the Board of Directors, and in the case of any such issuance to the Sponsor or its affiliates, without taking into account any founder shares held by them prior to such issuance), (y)&#160;the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z)&#160;the volume weighted average trading price of Class&#160;A ordinary shares during the 20 trading-day period starting on the&#160;trading day prior to the&#160;day on which the Company consummates its initial Business Combination (such price, the &#x201c;Market Value&#x201d;) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i)&#160;the Market Value or (ii)&#160;the price at which the Company issue the additional Class&#160;A ordinary shares or equity-linked securities. On the exercise of any warrant, the exercise price will be paid directly to the Company and not placed in the Trust Account. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company has agreed that as soon as practicable, but in no event later than 15&#160;business days after the closing of the initial Business Combination, the Company will use its best efforts to file with the SEC a registration statement for the registration under the Securities Act&#160;of&#160;the warrant shares and thereafter use its best efforts to cause the registration statement to become effective and to maintain the effectiveness of such registration statement until the expiration of the warrants. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the issuance of the warrant shares and a current prospectus relating thereto.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;If a registration statement covering the issuance of the warrant shares is not effective within 90&#160;days following the consummation of the initial Business Combination, warrant holders may nevertheless, until such time as there is such an effective registration statement and during any period when the Company shall have failed to maintain such an effective registration statement, exercise warrants on a cashless basis in accordance with Section&#160;3(a)(9)&#160;of the Securities Act. In this circumstance, each holder would pay the exercise price by surrendering warrants exercisable for the number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A ordinary shares underlying such warrants and the difference between the exercise price of such warrants and the &#x201c;fair market value&#x201d; (defined below) by (y)&#160;the fair market value. The &#x201c;fair market value&#x201d; means the average reported last sale price of the Class&#160;A ordinary shares for the five&#160;trading days ending on the&#160;trading day prior to the date of exercise.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;i&gt;Redemption of Warrants:&lt;/i&gt; The Company may redeem the outstanding warrants:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;at a price of $0.01 per warrant;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;upon a minimum of 30&#160;days&#x2019; prior written notice of redemption (the &#x201c;30-day redemption period&#x201d;); and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt; &lt;td style="text-align: left; width: 0.25in"&gt;&lt;/td&gt;&lt;td style="width: 0.25in; text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-size: 10pt"&gt;if, and only if, the last reported sale price of the Class&#160;A ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, dividends, reorganizations, recapitalizations and the like) for any 20&#160;trading days within a 30-trading&#160;day period ending on the third&#160;trading day prior to the date on which the Company will send the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company will not redeem the warrants unless a registration statement under the Securities Act covering the issuance of the warrant shares underlying the warrants to be so redeemed is then effective and a current prospectus relating to those warrant shares is available throughout the 30-day redemption period, except if the warrants may be exercised on a cashless basis and such cashless exercise is exempt from registration under the Securities Act. If and when the warrants become redeemable by the Company, it may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; If the foregoing conditions are satisfied and the Company issues a notice of redemption, each warrant holder may exercise his, her or its warrants prior to the scheduled redemption date. However, the price of the Class&#160;A ordinary shares may fall below the $18.00 trigger price (as adjusted) as well as the $11.50 exercise price (as adjusted) after the redemption notice is issued. The redemption criteria for the warrants have been established at a price which is intended to provide warrant holders a reasonable premium to the initial exercise price and provide a sufficient differential between the then-prevailing share price and the exercise price so that if the share price declines as a result of the redemption call, the redemption will not cause the share price to drop below the exercise price of the warrants. If the Company calls the warrants for redemption as described above, the management will have the option to require all holders that wish to exercise warrants to do so on a &#x201c;cashless basis.&#x201d; In making such determination, management will consider, among other factors, the Company&#x2019;s cash position, the number of warrants that are outstanding and the dilutive effect on shareholders of issuing the maximum number of warrant shares issuable upon exercise of outstanding warrants. In such event, the holder would pay the exercise price by surrendering the warrants for that number of Class&#160;A ordinary shares equal to the quotient obtained by dividing (x)&#160;the product of the number of warrant shares underlying the warrants to be so exercised, and the difference between the exercise price of the warrants and the fair market value by (y)&#160;the fair market value. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;No fractional Class&#160;A ordinary share will be issued upon redemption. If, upon redemption, a holder would be entitled to receive a fractional interest in a share, the Company will round down to the nearest whole number of the number of Class&#160;A ordinary shares to be issued to the holder.&lt;/p&gt;</tlnc:InitialPublicOfferingTextBlock>
    <tlnc:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_458958402"
      decimals="0"
      id="ixv-8262"
      unitRef="uref_504548813">24900000</tlnc:UnitsIssuedDuringPeriodSharesNewIssues>
    <tlnc:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1878519263"
      decimals="0"
      id="ixv-8263"
      unitRef="uref_504548813">2400000</tlnc:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_880262097"
      decimals="2"
      id="ixv-8264"
      unitRef="uref_533780696">10</us-gaap:SharesIssuedPricePerShare>
    <tlnc:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1979561439"
      decimals="0"
      id="ixv-8265"
      unitRef="uref_504548813">1</tlnc:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1599573526"
      decimals="4"
      id="ixv-8266"
      unitRef="uref_533780696">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_8341221"
      decimals="2"
      id="ixv-8267"
      unitRef="uref_533780696">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1963271763"
      decimals="0"
      id="ixv-8268"
      unitRef="uref_504548813">8559667</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1366525390"
      decimals="0"
      id="ixv-8269"
      unitRef="uref_504548813">8300000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1077089133"
      decimals="0"
      id="ixv-8270"
      unitRef="uref_504548813">259667</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1268440538"
      decimals="2"
      id="ixv-8271"
      unitRef="uref_533780696">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1095302256"
      decimals="2"
      id="ixv-8272"
      unitRef="uref_533780696">9.2</us-gaap:SharesIssuedPricePerShare>
    <tlnc:PercentageOfGrossProceedsOnTotalEquityProceeds
      contextRef="cref_144417410"
      decimals="2"
      id="ixv-8273"
      unitRef="uref_714491979">0.60</tlnc:PercentageOfGrossProceedsOnTotalEquityProceeds>
    <tlnc:NumberOfTradingDays contextRef="cref_144417410" id="ixv-8274">P20D</tlnc:NumberOfTradingDays>
    <tlnc:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice
      contextRef="cref_144417410"
      decimals="2"
      id="ixv-8275"
      unitRef="uref_533780696">9.2</tlnc:ClassOfWarrantOrRightAdjustmentOfExercisePriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice>
    <tlnc:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1
      contextRef="cref_331339811"
      decimals="2"
      id="ixv-8276"
      unitRef="uref_714491979">1.15</tlnc:ClassOfWarrantOrRightAdjustmentOfRedemptionPriceOfWarrantsOrRightsPercentBasedOnMarketValueAndNewlyIssuedPrice1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1963271763"
      decimals="2"
      id="ixv-8277"
      unitRef="uref_533780696">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <tlnc:NoticePeriodForRedemptionOfWarrants contextRef="cref_144417410" id="ixv-8278">P30D</tlnc:NoticePeriodForRedemptionOfWarrants>
    <tlnc:NumberOfTradingDays contextRef="cref_144417410" id="ixv-8279">P20D</tlnc:NumberOfTradingDays>
    <tlnc:EffectiveRedemptionPeriod contextRef="cref_144417410" id="ixv-8280">P30D</tlnc:EffectiveRedemptionPeriod>
    <tlnc:TriggerPrice
      contextRef="cref_1997855338"
      decimals="2"
      id="ixv-8281"
      unitRef="uref_533780696">18</tlnc:TriggerPrice>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1997855338"
      decimals="2"
      id="ixv-8282"
      unitRef="uref_533780696">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <tlnc:PrivatePlacementTextBlock contextRef="cref_1363532388" id="ixv-6967">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;4. PRIVATE PLACEMENT UNITS&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; Simultaneously with the closing of the Initial Public Offering, the Sponsor and Cohen purchased an aggregate of 779,000 Private Placement Units at $10.00 per Private Placement Unit, for an aggregate purchase price of $7,790,000, of which 530,000 Private Placement Units were purchased by the Sponsor and 249,000 Private Placement Units were purchased by Cohen, in a private placement. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;Certain proceeds from the sale of the Private Placement Units were added to the net proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within 24 months from the closing of the Initial Public Offering, such proceeds from the sale of the Private Placement Units held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).&lt;/p&gt;</tlnc:PrivatePlacementTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_1460463040"
      decimals="0"
      id="ixv-8283"
      unitRef="uref_504548813">779000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_105847728"
      decimals="2"
      id="ixv-8284"
      unitRef="uref_533780696">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_837988157"
      decimals="0"
      id="ixv-8285"
      unitRef="uref_504548813">7790000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_259879653"
      decimals="0"
      id="ixv-8286"
      unitRef="uref_504548813">530000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_900732289"
      decimals="0"
      id="ixv-8287"
      unitRef="uref_504548813">249000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_1363532388" id="ixv-6975">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;5. RELATED PARTY TRANSACTIONS&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Founder Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; On May&#160;19, 2025, the Sponsor purchased 5,750,000 Class&#160;B ordinary shares from the Company for an aggregate purchase price of $25,000, or $0.004 per share. On August 8, 2025, the Company effected a 1 for 1.5 share split of the founder shares. All share and per share amounts have been retroactively restated. Up to 1,125,000 founder shares were subject to forfeiture depending on the extent to which the underwriters&#x2019; over-allotment option is exercised during the Initial Public Offering. The forfeiture will be adjusted to the extent that the over-allotment option is not exercised in full by the underwriters so that the Sponsor will own 25% of the Company&#x2019;s issued and outstanding Class&#160;A and Class&#160;B ordinary shares after the Initial Public Offering. On September 10, 2025, the underwriters partially exercised their over-allotment option and forfeited the unexercised balance. As a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; On August 19, 2025, the Sponsor assigned a total of 40,000 founder shares to the two directors of the Company (20,000 each) for an aggregate consideration of $0.003 per share, or an aggregate total amount of $115.94. The founder shares will automatically be forfeited and be returned to the Sponsor if the holder of such founder shares is not a member of the board of directors of the Company on or prior to the closing of the Company&#x2019;s Initial Public Offering. The assignment of the founder shares to the directors of the Company are in the scope of FASB ASC Topic 718, &#x201c;Compensation-Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;). Under ASC 718, stock-based compensation associated with equity-classified awards is measured at fair value upon the assignment date. The total fair value of the 40,000 founder shares granted to the Company&#x2019;s directors on August 19, 2025 was $74,000 or $1.85 per share. The founder shares were granted subject to a performance condition (i.e., to be a member of the board of directors of the Company on or prior to the closing of the Company&#x2019;s Initial Public Offering). Thus, the fair value of $74,000 was recorded as compensation expense on September 10, 2025, the date of the Company&#x2019;s Initial Public Offering. The fair value of the founder shares was derived through a third party valuation using the Monte Carlo simulation with the following market assumptions; (i) stock price of $9.92, (ii) risk-free rate of 4.36%, (iii) market adjustments of 18.7%, and (iv) volatility of 5%. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Promissory Note&#160;&#x2014;&#160;Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Sponsor has agreed to loan the Company an aggregate of up to $250,000 to be used for a portion of the expenses of the Initial Public Offering. The loan is non-interest bearing and unsecured with maturity date at the earlier of December&#160;31, 2025 or the closing of the Initial Public Offering. On September 10, 2025, the Company repaid the total outstanding balance of the Promissory Note amounting to $83,927. Borrowings under the Note are no longer available. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Advances from Related Party&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; Advances from related party represents payment of expenses by an affiliate of the Sponsor that are not covered by the Promissory Note. As of December 31, 2025, &lt;span style="-sec-ix-hidden:fc_1494614152"&gt;no&lt;/span&gt; advances from related party have been made. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Working Capital Loans&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into private placement units of the post Business Combination entity at the option of the lender. The units would be identical to the Private Placement Units. As of December 31, 2025, &lt;span style="-sec-ix-hidden:fc_319930502"&gt;no&lt;/span&gt; such Working Capital Loans were outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Administrative Support Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company entered into an agreement with the Sponsor, commencing on September 8, 2025 through the earlier of the Company&#x2019;s consummation of initial Business Combination and its liquidation, to pay the Sponsor an aggregate of $40,000 per month for office space, secretarial and administrative services. On September 16, 2025, the Company and the Sponsor entered into the amended and restated administrative services agreement, to add that the Sponsor or its affiliates may make available to the Company certain office space, utilities and secretarial support as may be required by the Company from time to time. For the period from May 1, 2025 (inception) through December 31, 2025, the Company incurred and paid $150,667 in fees for these services. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_2107376139"
      decimals="0"
      id="ixv-8288"
      unitRef="uref_504548813">5750000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_211807459"
      decimals="0"
      id="ixv-8289"
      unitRef="uref_144417410">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharePrice
      contextRef="cref_1043056355"
      decimals="3"
      id="ixv-8290"
      unitRef="uref_533780696">0.004</us-gaap:SharePrice>
    <us-gaap:StockholdersEquityReverseStockSplit contextRef="cref_579383359" id="ixv-8291">1 for 1.5</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="cref_612105669"
      decimals="0"
      id="ixv-8292"
      unitRef="uref_504548813">1125000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <tlnc:PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders
      contextRef="cref_2100456949"
      decimals="2"
      id="ixv-8293"
      unitRef="uref_714491979">0.25</tlnc:PercentageOfIssuedAndOutstandingSharesAfterTheInitialPublicOfferingCollectivelyHeldByInitialStockholders>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="cref_1752672645"
      decimals="0"
      id="ixv-8294"
      unitRef="uref_504548813">800000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="cref_2086386178"
      decimals="0"
      id="ixv-8295"
      unitRef="uref_504548813">325000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_2086386178"
      decimals="0"
      id="ixv-8296"
      unitRef="uref_504548813">8260000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_2028565431"
      decimals="0"
      id="ixv-8297"
      unitRef="uref_504548813">40000</us-gaap:CommonStockSharesIssued>
    <tlnc:AggregateShares
      contextRef="cref_1476606103"
      decimals="0"
      id="ixv-8298"
      unitRef="uref_504548813">20000</tlnc:AggregateShares>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_2028565431"
      decimals="3"
      id="ixv-8299"
      unitRef="uref_533780696">0.003</us-gaap:CommonStockParOrStatedValuePerShare>
    <tlnc:AggregateAmount
      contextRef="cref_1476606103"
      decimals="2"
      id="ixv-8300"
      unitRef="uref_144417410">115.94</tlnc:AggregateAmount>
    <tlnc:FairValueOfShares
      contextRef="cref_1476606103"
      decimals="0"
      id="ixv-8301"
      unitRef="uref_504548813">40000</tlnc:FairValueOfShares>
    <tlnc:AmountOfFairValue
      contextRef="cref_1476606103"
      decimals="0"
      id="ixv-8302"
      unitRef="uref_144417410">74000</tlnc:AmountOfFairValue>
    <tlnc:FairValuePerSharePrice
      contextRef="cref_1476606103"
      decimals="2"
      id="ixv-8303"
      unitRef="uref_533780696">1.85</tlnc:FairValuePerSharePrice>
    <tlnc:AmountOfFairValue
      contextRef="cref_1979561439"
      decimals="0"
      id="ixv-8304"
      unitRef="uref_144417410">74000</tlnc:AmountOfFairValue>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="cref_1837988368"
      decimals="2"
      id="ixv-8305"
      unitRef="uref_714491979">9.92</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="cref_15267773"
      decimals="2"
      id="ixv-8306"
      unitRef="uref_714491979">4.36</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="cref_443971720"
      decimals="1"
      id="ixv-8307"
      unitRef="uref_714491979">18.7</us-gaap:DebtInstrumentMeasurementInput>
    <us-gaap:DebtInstrumentMeasurementInput
      contextRef="cref_625298015"
      decimals="0"
      id="ixv-8308"
      unitRef="uref_714491979">5</us-gaap:DebtInstrumentMeasurementInput>
    <tlnc:AggregateAmount
      contextRef="cref_2100456949"
      decimals="0"
      id="ixv-8309"
      unitRef="uref_144417410">250000</tlnc:AggregateAmount>
    <tlnc:OutstandingBalancePromissoryNote
      contextRef="cref_1979561439"
      decimals="0"
      id="ixv-8310"
      unitRef="uref_144417410">83927</tlnc:OutstandingBalancePromissoryNote>
    <tlnc:WorkingCapitalLoan
      contextRef="cref_674618302"
      decimals="0"
      id="ixv-8311"
      unitRef="uref_144417410">1500000</tlnc:WorkingCapitalLoan>
    <tlnc:AggregateSponsorAmount
      contextRef="cref_2070764536"
      decimals="0"
      id="ixv-8312"
      unitRef="uref_144417410">40000</tlnc:AggregateSponsorAmount>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8313"
      unitRef="uref_144417410">150667</us-gaap:AdministrativeFeesExpense>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_1363532388" id="ixv-7034">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;6. COMMITMENTS&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Risks and Uncertainties&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company&#x2019;s ability to complete an initial Business Combination may be adversely affected by various factors, many of which are beyond the Company&#x2019;s control. The Company&#x2019;s ability to consummate an initial Business Combination could be impacted by, among other things, changes in laws or regulations, downturns in the financial markets or in economic conditions, inflation, fluctuations in interest rates, increases in tariffs, supply chain disruptions, declines in consumer confidence and spending, public health considerations, and geopolitical instability, such as the military conflicts in Ukraine and the Middle East. The Company cannot at this time predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may negatively impact the Company&#x2019;s ability to complete an initial Business Combination.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Registration Rights&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company&#x2019;s initial shareholders and their permitted transferees can demand that the Company register the founder shares, the Private Placement Shares, the Private Placement Warrants and underlying securities and any securities issued upon conversion of Working Capital Loans, pursuant to an agreement signed on September 8, 2025. The holders of a majority of these securities are entitled to make up to three demands that the Company register such securities. The holders of a majority of these securities or units issued in payment of working capital loans made to the Company (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain piggyback registration rights on registration statements filed after the Company&#x2019;s consummation of a Business Combination. Notwithstanding anything to the contrary, the representative of the underwriters may only make a demand on one occasion and only during the five-year period beginning on the effective date of Initial Public Offering. In addition, the representative of the underwriters may participate in a piggyback registration only during the seven-year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Underwriting Agreement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company granted the underwriters a 45-day option to purchase up to 3,375,000 additional Units&#160;to cover any over-allotments, at the initial public offering price less the underwriting discounts. On September 10, 2025, the underwriters partially exercised their over-allotment option, purchasing 2,400,000 Units and forfeiting the remaining unexercised balance of 975,000 Units. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The underwriters were entitled to a cash underwriting discount of $0.20 per Unit sold in the Initial Public Offering, or $4,980,000 in the aggregate. The underwriter paid the Company an aggregate amount of $940,000 at the closing of the Initial Public Offering as reimbursement to the Company for certain of its expenses and fees incurred in connection with the Initial Public Offering, $240,000 of which is payable to the underwriters upon the completion of an initial Business Combination. In addition, the underwriters were entitled to $0.40 per Unit sold in the offering, or up to $9,960,000 in the aggregate, payable to the underwriters based on the percentage of funds remaining in the Trust Account after redemptions of public shares, for deferred underwriting commissions, and to be released to the underwriters only upon the completion of an initial Business Combination. Furthermore, 50% of such deferred underwriting commissions will be contingent upon permitted withdrawals of interest, at the lesser of $500,000 or 5% of the interest earned per annum, on the Trust Account per annum, for working capital from the Trust Account. &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <tlnc:UnderwritingOptionPeriod contextRef="cref_1598308813" id="ixv-8314">P45D</tlnc:UnderwritingOptionPeriod>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8315"
      unitRef="uref_504548813">3375000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="cref_1979561439"
      decimals="0"
      id="ixv-8316"
      unitRef="uref_504548813">2400000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="cref_1878519263"
      decimals="0"
      id="ixv-8317"
      unitRef="uref_504548813">975000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <tlnc:UnderwritingDiscountAmountPerUnit
      contextRef="cref_900732289"
      decimals="2"
      id="ixv-8318"
      unitRef="uref_533780696">0.2</tlnc:UnderwritingDiscountAmountPerUnit>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_900732289"
      decimals="0"
      id="ixv-8319"
      unitRef="uref_144417410">4980000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_126252359"
      decimals="0"
      id="ixv-8320"
      unitRef="uref_144417410">940000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsForUnderwritingExpense
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8321"
      unitRef="uref_144417410">240000</us-gaap:PaymentsForUnderwritingExpense>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1318230788"
      decimals="2"
      id="ixv-8322"
      unitRef="uref_533780696">0.4</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_4055154"
      decimals="0"
      id="ixv-8323"
      unitRef="uref_144417410">9960000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <tlnc:PercentageOfDeferredUnderwritings
      contextRef="cref_144417410"
      decimals="2"
      id="ixv-8324"
      unitRef="uref_714491979">0.50</tlnc:PercentageOfDeferredUnderwritings>
    <us-gaap:InterestIncomeOther
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8325"
      unitRef="uref_144417410">500000</us-gaap:InterestIncomeOther>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="cref_15768048"
      decimals="2"
      id="ixv-8326"
      unitRef="uref_714491979">0.05</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_1363532388" id="ixv-7072">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;7. SHAREHOLDERS&#x2019; DEFICIT&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Preference Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company is authorized to issue 1,000,000 shares of preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Board of Directors. As of December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1730245694"&gt;&lt;span style="-sec-ix-hidden:fc_314223251"&gt;no&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;A Ordinary Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company is authorized to issue 200,000,000 Class&#160;A ordinary shares with a par value of $0.0001 per share. As of December 31, 2025, there were 779,000 Class A ordinary shares issued and outstanding, excluding 24,900,000 shares subject to possible redemption. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;Class&#160;B Ordinary Shares&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company is authorized to issue 20,000,000 Class&#160;B ordinary shares with a par value of $0.0001 per share. As of December 31, 2025, there were 8,300,000 Class B ordinary shares issued and outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The founder shares will automatically convert into Class A ordinary shares in connection with the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. The Class A ordinary shares issuable in connection with the conversion of the founder shares may result in material dilution to public shareholders due to the anti-dilution rights of founder shares that may result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion. In the case that additional Class A ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in this offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class B ordinary shares convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 25% of the sum of (i) the aggregate of issued and outstanding founder shares, private placement shares and public shares after this offering and the private placement, plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent units issued to the Sponsor or any of its affiliates or to officers or directors upon conversion of working capital loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders in connection with an initial Business Combination; provided that such conversion of founder shares will never occur on a less than one-for-one basis.&#160;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt; &lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8327"
      unitRef="uref_504548813">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8328"
      unitRef="uref_504548813">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1997855338"
      decimals="4"
      id="ixv-8329"
      unitRef="uref_533780696">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8330"
      unitRef="uref_504548813">779000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8331"
      unitRef="uref_504548813">779000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="cref_1997855338"
      decimals="0"
      id="ixv-8332"
      unitRef="uref_504548813">24900000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_504548813"
      decimals="0"
      id="ixv-8333"
      unitRef="uref_504548813">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_504548813"
      decimals="4"
      id="ixv-8334"
      unitRef="uref_533780696">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_504548813"
      decimals="0"
      id="ixv-8335"
      unitRef="uref_504548813">8300000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_504548813"
      decimals="0"
      id="ixv-8336"
      unitRef="uref_504548813">8300000</us-gaap:CommonStockSharesOutstanding>
    <tlnc:ConversionOfOrdinarySharesPercentage
      contextRef="cref_144417410"
      decimals="2"
      id="ixv-8337"
      unitRef="uref_714491979">0.25</tlnc:ConversionOfOrdinarySharesPercentage>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_1363532388" id="ixv-7110">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;8. SEGMENT INFORMATION&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;ASC Topic 280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), or group, in deciding how to allocate resources and assess performance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The Company&#x2019;s CODM has been identified as the &lt;span style="-sec-ix-hidden:fc_444643047"&gt;Chief Financial Officer&lt;/span&gt;, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt; The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss that also is reported on the statements of operations as net income or loss. The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODM reviews the key metrics below. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 88%; text-align: left"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,872,627&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left"&gt;Cash held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;252,095,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-weight: bold;"&gt;For the&lt;br/&gt; Period from&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-weight: bold;"&gt;May&#160;1,&#160;2025&lt;br/&gt; (Inception)&lt;br/&gt; through&lt;br/&gt; December 31,&lt;br/&gt; 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 88%; text-align: left"&gt;General and administrative costs&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;546,385&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left"&gt;Interest earned on cash held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,171,560&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The CODM reviews interest earned on the Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;General and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination or similar transaction within the business combination period. The CODM also reviews General and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative costs, as reported on the statements of operations, are the significant segment expenses provided to the CODM on a regular basis.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_144417410" id="ixv-7118">The Company&#x2019;s CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reportable segment.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:NumberOfReportableSegments
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8338"
      unitRef="uref_493518290">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="cref_1363532388" id="ixv-8339">When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODM reviews the key metrics below.&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December&#160;31,&lt;br/&gt; 2025&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 88%; text-align: left"&gt;Cash&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;2,872,627&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left"&gt;Cash held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;252,095,639&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-weight: bold;"&gt;For the&lt;br/&gt; Period from&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-weight: bold;"&gt;May&#160;1,&#160;2025&lt;br/&gt; (Inception)&lt;br/&gt; through&lt;br/&gt; December 31,&lt;br/&gt; 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="width: 88%; text-align: left"&gt;General and administrative costs&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;546,385&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: White"&gt; &lt;td style="text-align: left"&gt;Interest earned on cash held in Trust Account&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,171,560&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt; &lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Cash
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8340"
      unitRef="uref_144417410">2872627</us-gaap:Cash>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1598680374"
      decimals="0"
      id="ixv-8341"
      unitRef="uref_144417410">252095639</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8342"
      unitRef="uref_144417410">546385</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_144417410"
      decimals="0"
      id="ixv-8343"
      unitRef="uref_144417410">3171560</us-gaap:InvestmentIncomeInterest>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_1363532388" id="ixv-7178">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;span style="font-weight: bold;"&gt;NOTE 9. SUBSEQUENT EVENTS&lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;The Company evaluated subsequent events and transactions that occurred after the balance sheet date, the date that the financial statements was issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_2078487242"
          xlink:label="fc_2078487242"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_711145113"
          xlink:label="fc_711145113"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_201246941"
          xlink:label="fc_201246941"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_683422140"
          xlink:label="fc_683422140"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_727457337"
          xlink:label="fc_727457337"
          xlink:type="locator"/>
        <link:footnote id="fref_373772643" xlink:label="fref_373772643" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding (Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2078487242"
          xlink:to="fref_373772643"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_711145113"
          xlink:to="fref_373772643"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_201246941"
          xlink:to="fref_373772643"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_683422140"
          xlink:to="fref_373772643"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_727457337"
          xlink:to="fref_373772643"
          xlink:type="arc"/>
        <link:footnote id="fref_194607409" xlink:label="fref_194607409" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes 1,125,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares (after taking into account the assignment of 40,000 founder shares to the directors) (Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2078487242"
          xlink:to="fref_194607409"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_711145113"
          xlink:to="fref_194607409"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_201246941"
          xlink:to="fref_194607409"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_683422140"
          xlink:to="fref_194607409"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_727457337"
          xlink:to="fref_194607409"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_388358174"
          xlink:label="fc_388358174"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1591609912"
          xlink:label="fc_1591609912"
          xlink:type="locator"/>
        <link:footnote id="fref_1220979658" xlink:label="fref_1220979658" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding. All share and per share amounts have been retroactively presented (Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_388358174"
          xlink:to="fref_1220979658"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1591609912"
          xlink:to="fref_1220979658"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_1780571263"
          xlink:label="fc_1780571263"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_678866056"
          xlink:label="fc_678866056"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1432657015"
          xlink:label="fc_1432657015"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_75135273"
          xlink:label="fc_75135273"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2135791975"
          xlink:label="fc_2135791975"
          xlink:type="locator"/>
        <link:footnote id="fref_1829989901" xlink:label="fref_1829989901" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On August 8, 2025, the Company effected a 1 to 1.5 share split for which the Company issued an additional 2,875,000 founder shares to the Sponsor for no additional consideration, resulting in the Sponsor holding an aggregate 8,625,000 founder shares issued and outstanding. All share and per share amounts have been retroactively presented (Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1780571263"
          xlink:to="fref_1829989901"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_678866056"
          xlink:to="fref_1829989901"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1432657015"
          xlink:to="fref_1829989901"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_75135273"
          xlink:to="fref_1829989901"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2135791975"
          xlink:to="fref_1829989901"
          xlink:type="arc"/>
        <link:footnote id="fref_1339534370" xlink:label="fref_1339534370" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes 1,125,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. Subsequently, on September 10, 2025, as a result of the partial exercise and the forfeiture of the over-allotment option by the underwriters, 800,000 founder shares are no longer subject to forfeiture and 325,000 founder shares were forfeited, resulting in the Sponsor holding 8,260,000 founder shares (after taking into account the assignment of 40,000 founder shares to the directors) (Note 5).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1780571263"
          xlink:to="fref_1339534370"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_678866056"
          xlink:to="fref_1339534370"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1432657015"
          xlink:to="fref_1339534370"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_75135273"
          xlink:to="fref_1339534370"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2135791975"
          xlink:to="fref_1339534370"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
